1353340	59	87	leucodistrofia metacromatica	DISEASEORPHENOTYPICFEATURE	D007966
1353340	197	212	arilsolfatasi A	GENEORGENEPRODUCT	410
1353340	244	248	ARSA	GENEORGENEPRODUCT	410
1353340	302	330	leucodistrofia metacromatica	DISEASEORPHENOTYPICFEATURE	D007966
1353340	375	378	MLD	DISEASEORPHENOTYPICFEATURE	D007966
1353340	432	442	arginina84	SEQUENCEVARIANT	RS74315458
1353340	510	523	arilsolfatasi	GENEORGENEPRODUCT	410
1353340	654	657	MLD	DISEASEORPHENOTYPICFEATURE	D007966
1353340	697	723	arginina84 alla glutammina	SEQUENCEVARIANT	RS74315458
1353340	812	816	ARSA	GENEORGENEPRODUCT	410
1353340	884	888	ARSA	GENEORGENEPRODUCT	410
1353340	974	982	pazienti	ORGANISMTAXON	9606
1353340	1030	1033	MLD	DISEASEORPHENOTYPICFEATURE	D007966
1353340	1140	1144	ARSA	GENEORGENEPRODUCT	410
1353340	1243	1246	MLD	DISEASEORPHENOTYPICFEATURE	D007966
1711760	65	77	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
1711760	136	155	ischemia cerebrale 	DISEASEORPHENOTYPICFEATURE	D002545
1711760	211	226	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
1711760	284	296	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
1711760	386	425	occlusione dell'arteria cerebrale media	DISEASEORPHENOTYPICFEATURE	D020244
1711760	470	474	MCAO	DISEASEORPHENOTYPICFEATURE	D020244
1711760	522	537	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
1711760	623	633	isoflurano	CHEMICALENTITY	D007530
1711760	705	716	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
1711760	746	751	ratti	ORGANISMTAXON	10116
1711760	915	926	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
1711760	1040	1044	MCAO	DISEASEORPHENOTYPICFEATURE	 D020244
1711760	1106	1110	MCAO	DISEASEORPHENOTYPICFEATURE	D020244
1711760	1142	1147	ratti	ORGANISMTAXON	10116
1711760	1316	1324	ischemia	DISEASEORPHENOTYPICFEATURE	D007511
1711760	1380	1384	MCAO	DISEASEORPHENOTYPICFEATURE	D020244
1711760	1558	1567	ischemico	DISEASEORPHENOTYPICFEATURE	D007511
1711760	1625	1640	danno neuronale	DISEASEORPHENOTYPICFEATURE	D009410
1711760	1695	1719	2,3,5-trifeniltetrazolio	CHEMICALENTITY	C009591
1711760	1787	1796	ischemico	DISEASEORPHENOTYPICFEATURE	D007511
1711760	1953	1962	ischemico	DISEASEORPHENOTYPICFEATURE	D007511
1711760	2045	2050	edema	DISEASEORPHENOTYPICFEATURE	D004487
1711760	2115	2126	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
1711760	2362	2373	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
1711760	2471	2482	fenilefrina	CHEMICALENTITY	D010656
1711760	2537	2549	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
1711760	2619	2623	MCAO	DISEASEORPHENOTYPICFEATURE	D020244
1711760	2679	2684	edema	DISEASEORPHENOTYPICFEATURE	D004487
1711760	2733	2749	nucleo ischemico	DISEASEORPHENOTYPICFEATURE	D007511
1711760	2807	2812	edema	DISEASEORPHENOTYPICFEATURE	D004487
1711760	2876	2886	ischemico 	DISEASEORPHENOTYPICFEATURE	D007511
1711760	2976	2997	disfunzione neuronale	DISEASEORPHENOTYPICFEATURE	D009410
2422478	48	58	serotonina	CHEMICALENTITY	D012701
2422478	96	99	rat	ORGANISMTAXON	10116
2422478	169	187	effetto ipotensivo	DISEASEORPHENOTYPICFEATURE	D007022
2422478	222	231	metildopa	CHEMICALENTITY	D008750
2422478	352	361	metildopa	CHEMICALENTITY	D008750
2422478	431	441	serotonina	CHEMICALENTITY	D012701
2422478	530	540	ipotensiva	DISEASEORPHENOTYPICFEATURE	D007022
2422478	747	757	serotonina	CHEMICALENTITY	D012701
2422478	852	863	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
2422478	908	913	ictus	DISEASEORPHENOTYPICFEATURE	D020521
2422478	951	956	ratti	ORGANISMTAXON	10116
2422478	1007	1016	metildopa	CHEMICALENTITY	D008750
2422478	1082	1118	il gruppo cellulare della serotonina	CHEMICALENTITY	D012701
2422478	1206	1217	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
2422478	1343	1353	serotonina	CHEMICALENTITY	D012701
2422478	1398	1421	5,7-diidrossitriptamina	CHEMICALENTITY	D015116
2422478	1454	1461	5,7-DHT	CHEMICALENTITY	D015116
2422478	1576	1583	5,7-DHT	CHEMICALENTITY	D015116
2422478	1662	1672	serotonina	CHEMICALENTITY	D012701
2422478	1779	1790	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
2422478	1832	1839	5,7-DHT	CHEMICALENTITY	D015116
2422478	1882	1892	serotonina	CHEMICALENTITY	D012701
2422478	2033	2043	serotonina	CHEMICALENTITY	D012701
2422478	2173	2183	serotonina	CHEMICALENTITY	D012701
2422478	2215	2224	metildopa	CHEMICALENTITY	D008750
2422478	2352	2361	metildopa	CHEMICALENTITY	D008750
2422478	2416	2427	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
2422478	2525	2535	serotonina	CHEMICALENTITY	D012701
2422478	2610	2620	ipotensivo	DISEASEORPHENOTYPICFEATURE	D007022
2422478	2662	2671	metildopa	CHEMICALENTITY	D008750
7018927	53	97	ormone di rilascio dell'ormone luteinizzante	GENEORGENEPRODUCT	2796
7018927	138	149	aloperidolo	CHEMICALENTITY	D006220
7018927	201	218	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
7018927	292	303	aloperidolo	CHEMICALENTITY	D006220
7018927	345	355	prolattina	GENEORGENEPRODUCT	5617
7018927	389	409	ormone luteinizzante	GENEORGENEPRODUCT	1081
7018927	442	444	LH	GENEORGENEPRODUCT	1081
7018927	609	633	ormone di rilascio di LH	GENEORGENEPRODUCT	2796
7018927	666	672	LH-RH 	GENEORGENEPRODUCT	2796
7018927	732	740	pazienti	ORGANISMTAXON	9606
7018927	808	812	NaCl	CHEMICALENTITY	D012965
7018927	882	893	aloperidolo	CHEMICALENTITY	D006220
7018927	975	992	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
7018927	1069	1074	LH-RH	GENEORGENEPRODUCT	2796
7468724	43	72	Complicazioni cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
7468724	117	128	terbutalina	CHEMICALENTITY	D013726
7468724	188	208	travaglio pretermine	DISEASEORPHENOTYPICFEATURE	D007752
7468724	253	282	complicazioni cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
7468724	345	353	pazienti	ORGANISMTAXON	9606
7468724	399	410	terbutalina	CHEMICALENTITY	D013726
7468724	458	478	travaglio pretermine	DISEASEORPHENOTYPICFEATURE	D007752
7468724	526	541	corticosteroide	CHEMICALENTITY	D000305
7668252	41	46	umano	ORGANISMTAXON	9606
7668252	76	123	catena molto lunga acil-coenzima A deidrogenasi	GENEORGENEPRODUCT	37
7668252	205	213	pazienti	ORGANISMTAXON	9606
7668252	345	350	umano	ORGANISMTAXON	9606
7668252	394	446	molto -L'acil-coenzima A deidrogenasi a catena lunga	GENEORGENEPRODUCT	37
7668252	477	482	VLCAD	GENEORGENEPRODUCT	37
7668252	774	779	VLCAD	GENEORGENEPRODUCT	37
7668252	899	912	VLCAD carenti	DISEASEORPHENOTYPICFEATURE	C536353
7668252	940	948	pazienti	ORGANISMTAXON	9606
7668252	991	999	pazienti	ORGANISMTAXON	9606
7668252	1135	1140	VLCAD	GENEORGENEPRODUCT	37
7668252	1289	1294	VLCAD	GENEORGENEPRODUCT	37
7668252	1407	1423	deficit di VLCAD	DISEASEORPHENOTYPICFEATURE	C536353
7668252	1491	1496	umano	ORGANISMTAXON	9606
7668252	1526	1531	VLCAD	GENEORGENEPRODUCT	37
7668252	1581	1589	pazienti	ORGANISMTAXON	9606
7668252	1714	1750	deficit della normale proteina VLCAD	DISEASEORPHENOTYPICFEATURE	C536353
7668252	1814	1841	acido grasso a catena lunga	CHEMICALENTITY	D005227
7668252	1902	1910	pazienti	ORGANISMTAXON	9606
7668252	1954	1962	paziente	ORGANISMTAXON	9606
7668252	2031	2036	VLCAD	GENEORGENEPRODUCT	37
7668252	2145	2160	acido palmitico	CHEMICALENTITY	D019308
7668252	2400	2416	Deficit di VLCAD	DISEASEORPHENOTYPICFEATURE	C536353
7905839	27	32	Umano	ORGANISMTAXON	9606
7905839	64	91	recettore mu degli oppiacei	GENEORGENEPRODUCT	4988
7905839	203	208	umano	ORGANISMTAXON	9606
7905839	240	267	recettore mu degli oppiacei	GENEORGENEPRODUCT	4988
7905839	390	393	rat	ORGANISMTAXON	10116
7905839	426	454	 recettore mu degli oppiacei	GENEORGENEPRODUCT	25601
7905839	490	495	umano	ORGANISMTAXON	9606
7905839	527	554	recettore mu degli oppiacei	GENEORGENEPRODUCT	4988
7905839	587	595	h mu OR1	GENEORGENEPRODUCT	4988
7905839	676	679	rat	ORGANISMTAXON	10116
7905839	723	729	mu OR1	GENEORGENEPRODUCT	25601
7905839	782	790	oppiacei	CHEMICALENTITY	D053610
7905839	832	848	peptidi oppioidi	CHEMICALENTITY	D018847
7905839	887	892	sodio	CHEMICALENTITY	D012964
7905839	928	931	GTP	CHEMICALENTITY	D006160
7905839	961	964	rat	ORGANISMTAXON	10116
7905839	1070	1097	recettore degli oppiacei mu	GENEORGENEPRODUCT	25601
7905839	1145	1156	AMP ciclico	CHEMICALENTITY	D000242
7905839	1223	1226	rat	ORGANISMTAXON	10116
7905839	1260	1287	recettore mu degli oppiacei	GENEORGENEPRODUCT	25601
7905839	1373	1381	h mu OR1	GENEORGENEPRODUCT	4988
7905839	1561	1566	umano	ORGANISMTAXON	9606
7905839	1851	1877	disturbi neuropsichiatrici	DISEASEORPHENOTYPICFEATURE	D001523
8002973	30	63	Il gene dell'adrenoleucodistrofia	GENEORGENEPRODUCT	215
8002973	250	283	adrenoleucodistrofia legata all'X	DISEASEORPHENOTYPICFEATURE	D000326
8002973	329	332	ALD	DISEASEORPHENOTYPICFEATURE	D000326
8002973	421	424	ALD	GENEORGENEPRODUCT	215
8002973	603	611	paziente	ORGANISMTAXON	9606
8002973	660	663	ALD	DISEASEORPHENOTYPICFEATURE	D000326
8002973	726	729	ALD	GENEORGENEPRODUCT	215
8002973	1206	1209	ALD	GENEORGENEPRODUCT	215
8755918	86	108	atassia-telangiectasia	DISEASEORPHENOTYPICFEATURE	D001260
8755918	190	212	atassia-telangiectasia	DISEASEORPHENOTYPICFEATURE	D001260
8755918	257	260	A-T	DISEASEORPHENOTYPICFEATURE	D001260
8755918	318	321	ATM	GENEORGENEPRODUCT	472
8755918	442	445	A-T	DISEASEORPHENOTYPICFEATURE	D001260
8755918	576	597	inserimento di 137 bp	SEQUENCEVARIANT	C|INS||137
8755918	763	766	A-T	DISEASEORPHENOTYPICFEATURE	D001260
8755918	830	838	paziente	ORGANISMTAXON	9606
8755918	914	922	pazienti	ORGANISMTAXON	9606
8755918	1166	1174	pazienti	ORGANISMTAXON	9606
8755918	1263	1282	atassia cerebellare	DISEASEORPHENOTYPICFEATURE	D002524
8755918	1502	1505	A-T	DISEASEORPHENOTYPICFEATURE	D001260
8755918	1533	1541	pazienti	ORGANISMTAXON	9606
8755918	1676	1679	A-T	DISEASEORPHENOTYPICFEATURE	D001260
8755918	1925	1928	ATM	GENEORGENEPRODUCT	472
9294109	32	74	proteina chinasi della distrofia miotonica	GENEORGENEPRODUCT	13400
9294109	143	147	Ca2+	CHEMICALENTITY	D002118
9294109	239	258	Distrofia miotonica	DISEASEORPHENOTYPICFEATURE	D009223
9294109	303	305	DM	DISEASEORPHENOTYPICFEATURE	D009223
9294109	367	385	disturbo muscolare	DISEASEORPHENOTYPICFEATURE	D009135
9294109	525	543	protein chinasi DM	GENEORGENEPRODUCT	13400
9294109	577	581	DMPK	GENEORGENEPRODUCT	13400
9294109	737	741	DMPK	GENEORGENEPRODUCT	13400
9294109	834	848	Ca2 a riposo +	CHEMICALENTITY	D002118
9294109	922	927	Ca2 +	CHEMICALENTITY	D002118
9294109	1009	1037	Pompe ioniche guidate da ATP	CHEMICALENTITY	D000255
9294109	1134	1138	DMPK	GENEORGENEPRODUCT	13400
9294109	1183	1187	topi	ORGANISMTAXON	10090
9294109	1221	1225	DMPK	GENEORGENEPRODUCT	13400
9294109	1326	1331	Ca2 +	CHEMICALENTITY	D002118
9294109	1483	1488	Ca2 +	CHEMICALENTITY	D002118
9294109	1523	1527	Na +	CHEMICALENTITY	D012964
9294109	1623	1628	Ca2 +	CHEMICALENTITY	D002118
9294109	1679	1691	acetilcolina	CHEMICALENTITY	D000109
9294109	1738	1741	K +	CHEMICALENTITY	D011188
9294109	1823	1828	Ca2 +	CHEMICALENTITY	D002118
9294109	1900	1905	Ca2 +	CHEMICALENTITY	D002118
9294109	1980	1985	Ca2 +	CHEMICALENTITY	D002118
9294109	2094	2132	reticolo sarcoplasmatico Ca2 + -ATPase	CHEMICALENTITY	D053498
9294109	2198	2202	DMPK	GENEORGENEPRODUCT	13400
9294109	2283	2287	DMPK	GENEORGENEPRODUCT	13400
9647766	87	92	umano	ORGANISMTAXON	9606
9647766	135	210	subunità di proteina zolfo ferrosa (IP) codificata nucleare del complesso I	GENEORGENEPRODUCT	 4720,4722,4726
9647766	241	246	umano	ORGANISMTAXON	9606
9647766	289	291	IP	GENEORGENEPRODUCT	4720,4722,4726
9647766	353	398	NADH:ubichinone ossidoreduttasi (complesso I)	GENEORGENEPRODUCT	4720,4722,4726
9647766	585	605	proteina ferro-zolfo	GENEORGENEPRODUCT	4720,4722,4726
9647766	648	650	IP	GENEORGENEPRODUCT	4720,4722,4726
9647766	824	826	IP	GENEORGENEPRODUCT	4720,4722,4726
9647766	994	999	umano	ORGANISMTAXON	9606
9647766	1041	1081	NADH:subunità ubichinone ossidoreduttasi	GENEORGENEPRODUCT	4720,4722,4726
9647766	1142	1144	IP	GENEORGENEPRODUCT	4720,4722,4726
9647766	1189	1195	NDUFS2	GENEORGENEPRODUCT	4720
9647766	1237	1243	NDUFS3	GENEORGENEPRODUCT	4722
9647766	1286	1292	NDUFS6	GENEORGENEPRODUCT	4726
9647766	1620	1626	bovini	ORGANISMTAXON	9913
9647766	1804	1809	umani	ORGANISMTAXON	9606
9647766	1857	1862	umani	ORGANISMTAXON	9606
9647766	1948	1953	umano	ORGANISMTAXON	9606
9647766	2003	2009	NDUFS2	GENEORGENEPRODUCT	4720
9647766	2043	2049	NDUFS3	GENEORGENEPRODUCT	4722
9647766	2153	2159	NDUFS6	GENEORGENEPRODUCT	4726
9647766	2307	2313	NDUFS2	GENEORGENEPRODUCT	4720
9647766	2358	2375	protein chinasi C	GENEORGENEPRODUCT	5578
9647766	2459	2465	NDUFS3	GENEORGENEPRODUCT	 4722
9647766	2542	2559	casein chinasi II	GENEORGENEPRODUCT	1457
9647766	2702	2734	complesso enzimatico I-deficient	DISEASEORPHENOTYPICFEATURE	C537475
9647766	2762	2770	pazienti	ORGANISMTAXON	9606
9746003	52	65	carbamazepina	CHEMICALENTITY	D002220
9746003	99	109	vigabatrin	CHEMICALENTITY	D020888
9746003	167	189	convulsioni di assenza	DISEASEORPHENOTYPICFEATURE	D004832
9746003	222	235	Carbamazepina	CHEMICALENTITY	D002220
9746003	269	279	vigabatrin	CHEMICALENTITY	D020888
9746003	355	371	crisi di assenza	DISEASEORPHENOTYPICFEATURE	D004832
9746003	522	535	carbamazepina	CHEMICALENTITY	D002220
9746003	599	609	Vigabatrin	CHEMICALENTITY	D020888
9746003	769	782	carbamazepina	CHEMICALENTITY	D002220
9746003	859	877	scosse miocloniche	DISEASEORPHENOTYPICFEATURE	D009207
9746003	942	955	carbamazepina	CHEMICALENTITY	D002220
9746003	1046	1056	vigabatrin	CHEMICALENTITY	D020888
9746003	1189	1204	sodio valproato	CHEMICALENTITY	D014635
9746003	1240	1251	lamotrigina	CHEMICALENTITY	D000077213
9746003	1291	1303	etosuccimide	CHEMICALENTITY	D005013
10491763	31	62	Fattore nucleare epatocitario-6	GENEORGENEPRODUCT	3175
10491763	148	166	diabete di tipo II	DISEASEORPHENOTYPICFEATURE	D003924
10491763	253	261	insulina	GENEORGENEPRODUCT	3630
10491763	321	361	fattore nucleare degli epatociti (HNF)-6	GENEORGENEPRODUCT	3175
10491763	476	498	diabete della maturità	DISEASEORPHENOTYPICFEATURE	D003924
10491763	604	609	HNF-6	GENEORGENEPRODUCT	3175
10491763	685	735	Tipo II (non -insulino-dipendente) diabete mellito	DISEASEORPHENOTYPICFEATURE	D003924
10491763	795	803	insulina	GENEORGENEPRODUCT	3630
10491763	838	847	glucosio 	CHEMICALENTITY	D005947
10491763	982	987	HNF-6	GENEORGENEPRODUCT	3175
10491763	1081	1085	MODY	GENEORGENEPRODUCT	3172,3651,6927
10491763	1146	1151	MODY1	GENEORGENEPRODUCT	3172
10491763	1184	1189	MODY3	GENEORGENEPRODUCT	6927
10491763	1223	1228	MODY4	GENEORGENEPRODUCT	3651
10491763	1269	1277	pazienti	ORGANISMTAXON	9606
10491763	1341	1359	Diabete di tipo II	DISEASEORPHENOTYPICFEATURE	D003924
10491763	1709	1718	Pro75 Ala	SEQUENCEVARIANT	RS74805019
10491763	1825	1833	Pro75Ala	SEQUENCEVARIANT	RS74805019
10491763	1925	1933	pazienti	ORGANISMTAXON	9606
10491763	1981	2007	Diabete mellito di tipo II	DISEASEORPHENOTYPICFEATURE	D003924
10491763	2094	2102	glucosio	CHEMICALENTITY	D005947
10491763	2215	2223	glucosio	CHEMICALENTITY	D005947
10491763	2263	2271	glucosio	CHEMICALENTITY	D005947
10491763	2341	2359	Diabete di tipo II	DISEASEORPHENOTYPICFEATURE	D003924
10491763	2387	2395	pazienti	ORGANISMTAXON	9606
10491763	2525	2533	glucosio	CHEMICALENTITY	D005947
10491763	2579	2587	insulina	GENEORGENEPRODUCT	3630
10491763	2621	2630	C-peptide	GENEORGENEPRODUCT	3630
10491763	2720	2725	HNF-6	GENEORGENEPRODUCT	3175
10491763	2790	2808	Diabete di tipo II	DISEASEORPHENOTYPICFEATURE	D003924
10491763	2860	2868	insulina	GENEORGENEPRODUCT	3630
10491763	2911	2919	glucosio	CHEMICALENTITY	D005947
10661407	32	40	Langerin	GENEORGENEPRODUCT	50489
10661407	85	103	lectina di tipo C 	GENEORGENEPRODUCT	50489
10661407	282	305	tipo II Ca2+-dipendente	GENEORGENEPRODUCT	50489
10661407	348	356	mannosio	CHEMICALENTITY	D008358
10661407	481	489	Langerin	GENEORGENEPRODUCT	50489
10661407	692	700	Langerin	GENEORGENEPRODUCT	50489
10661407	796	804	Langerin	GENEORGENEPRODUCT	50489
10661407	921	929	Langerin	GENEORGENEPRODUCT	50489
10661407	1066	1074	Langerin	GENEORGENEPRODUCT	50489
10661407	1334	1342	Langerin	GENEORGENEPRODUCT	50489
10788334	63	68	BRCA1	GENEORGENEPRODUCT	672
10788334	138	157	cancro seno-ovarico	DISEASEORPHENOTYPICFEATURE	 D061325
10788334	259	264	BRCA1	GENEORGENEPRODUCT	672
10788334	297	302	BRCA2	GENEORGENEPRODUCT	675
10788334	458	464	cancro	DISEASEORPHENOTYPICFEATURE	D009369
10788334	568	589	seno o cancro ovarico	DISEASEORPHENOTYPICFEATURE	D001943,D010051
10788334	647	653	cancro	DISEASEORPHENOTYPICFEATURE	D009369
10788334	829	856	cancro al seno e alle ovaie	DISEASEORPHENOTYPICFEATURE	D001943,D010051
10788334	920	934	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
10788334	1005	1024	solo tumori al seno	DISEASEORPHENOTYPICFEATURE	D001943
10788334	1137	1142	donna	ORGANISMTAXON	9606
10788334	1227	1232	BRCA1	GENEORGENEPRODUCT	672
10788334	1265	1270	BRCA2	GENEORGENEPRODUCT	675
10788334	1596	1601	BRCA1	GENEORGENEPRODUCT	672
10788334	1650	1664	Anomalie BRCA1	DISEASEORPHENOTYPICFEATURE	OMIM:604370
10788334	1767	1781	cancro ovarico	DISEASEORPHENOTYPICFEATURE	D010051
10788334	1867	1891	cancro al seno e ovarico	DISEASEORPHENOTYPICFEATURE	D001943,D010051
10788334	1965	1984	solo cancro al seno	DISEASEORPHENOTYPICFEATURE	 D001943
10788334	2054	2059	BRCA2	GENEORGENEPRODUCT	675
10788334	2117	2149	sindrome da cancro al seno-ovaio	DISEASEORPHENOTYPICFEATURE	D061325
10788334	2417	2431	BRCA1 anomalie	DISEASEORPHENOTYPICFEATURE	OMIM:604370
10788334	2471	2479	5382insC	SEQUENCEVARIANT	C|INS|5382|C
10788334	2516	2520	C61G	SEQUENCEVARIANT	RS28897672
10788334	2560	2568	4153delA	SEQUENCEVARIANT	C|DEL|4153|A
11009181	31	41	Apomorfina	CHEMICALENTITY	D001058
11009181	118	137	morbo di Parkinson 	DISEASEORPHENOTYPICFEATURE	D010300
11009181	170	180	Apomorfina	CHEMICALENTITY	D001058
11009181	229	250	farmaco dopaminergico	CHEMICALENTITY	D004298
11009181	330	348	Morbo di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
11009181	611	621	apomorfina	CHEMICALENTITY	D001058
11009181	829	839	apomorfina	CHEMICALENTITY	D001058
11009181	956	965	 levodopa	CHEMICALENTITY	 D007980
11009181	1034	1044	apomorfina	CHEMICALENTITY	D001058
11009181	1141	1150	 pazienti	ORGANISMTAXON	9606
11009181	1263	1273	apomorfina	CHEMICALENTITY	D001058
11009181	1383	1391	pazienti	ORGANISMTAXON	9606
11009181	1526	1549	agonisti della dopamina	CHEMICALENTITY	D018491
11009181	1759	1769	apomorfina	CHEMICALENTITY	D001058
11009181	1907	1917	apomorfina	CHEMICALENTITY	D001058
11009181	2002	2011	 levodopa	CHEMICALENTITY	D007980
11009181	2063	2073	discinesie	DISEASEORPHENOTYPICFEATURE	D004409
11009181	2172	2182	apomorfina	CHEMICALENTITY	D001058
11009181	2297	2324	complicazioni psichiatriche	DISEASEORPHENOTYPICFEATURE	D001523
11009181	2443	2453	apomorfina	CHEMICALENTITY	D001058
11009181	2527	2548	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
11054569	32	37	Rab6c	GENEORGENEPRODUCT	84084
11054569	97	100	rab	GENEORGENEPRODUCT	5870,84084
11054569	235	239	Rab6	GENEORGENEPRODUCT	5870
11054569	286	291	Rab6c	GENEORGENEPRODUCT	84084
11054569	398	403	umano	ORGANISMTAXON	9606
11054569	469	483	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
11054569	675	680	Rab6c	GENEORGENEPRODUCT	84084
11054569	824	829	umano	ORGANISMTAXON	9606
11054569	877	892	sarcoma uterino	DISEASEORPHENOTYPICFEATURE	D014594
11054569	1074	1079	Rab6c	GENEORGENEPRODUCT	84084
11054569	1191	1203	doxorubicina	CHEMICALENTITY	D004317
11054569	1236	1239	DOX	CHEMICALENTITY	D004317
11054569	1274	1280	taxolo	CHEMICALENTITY	D017239
11054569	1313	1324	vinblastina	CHEMICALENTITY	D014747
11054569	1358	1369	vincristina	CHEMICALENTITY	D014750
11054569	1565	1568	DOX	CHEMICALENTITY	D004317
11054569	1672	1678	 Rab6c	GENEORGENEPRODUCT	84084
11054569	1742	1747	Rab6c	GENEORGENEPRODUCT	84084
12442272	35	39	D90A	SEQUENCEVARIANT	RS80265967
12442272	71	75	SOD1	GENEORGENEPRODUCT	6647
12442272	127	156	sclerosi laterale amiotrofica	DISEASEORPHENOTYPICFEATURE	D000690
12442272	374	409	superossido dismutasi di rame/zinco	GENEORGENEPRODUCT	6647
12442272	442	446	SOD1	GENEORGENEPRODUCT	6647
12442272	478	486	pazienti	ORGANISMTAXON	9606
12442272	534	563	sclerosi laterale amiotrofica	DISEASEORPHENOTYPICFEATURE	D000690
12442272	609	612	SLA	DISEASEORPHENOTYPICFEATURE	D000690
12442272	662	688	malattia neurodegenerativa	DISEASEORPHENOTYPICFEATURE	D019636
12442272	738	743	D90A 	SEQUENCEVARIANT	RS80265967
12442272	775	779	SOD1	GENEORGENEPRODUCT	6647
12442272	1037	1041	D90A	SEQUENCEVARIANT	RS80265967
12442272	1073	1077	SOD1	GENEORGENEPRODUCT	6647
12442272	1186	1189	ALS	DISEASEORPHENOTYPICFEATURE	D000690
12442272	1358	1361	ALS	DISEASEORPHENOTYPICFEATURE	D000690
12442272	1700	1704	D90A	SEQUENCEVARIANT	RS80265967
12442272	2051	2055	SOD1	GENEORGENEPRODUCT	6647
12442272	2200	2204	D90A	SEQUENCEVARIANT	RS80265967
12442272	2236	2240	SOD1	GENEORGENEPRODUCT	6647
12442272	2344	2347	ALS	DISEASEORPHENOTYPICFEATURE	D000690
14722929	62	69	sordità	DISEASEORPHENOTYPICFEATURE	D003638
14722929	111	115	GJB2	GENEORGENEPRODUCT	2706
14722929	190	194	GJB2	GENEORGENEPRODUCT	2706
14722929	265	309	non -sordità sindromica autosomica recessiva	DISEASEORPHENOTYPICFEATURE	C567134
14722929	354	359	NSARD	DISEASEORPHENOTYPICFEATURE	C567134
14722929	440	444	GJB2	GENEORGENEPRODUCT	2706
14722929	516	520	GJB2	GENEORGENEPRODUCT	2706
14722929	673	726	sordità non sindromica per lo più da grave a profonda	DISEASEORPHENOTYPICFEATURE	D003638
14722929	890	894	GJB2	GENEORGENEPRODUCT	2706
14722929	1113	1117	GJB2	GENEORGENEPRODUCT	2706
14722929	1610	1619	g.3512C>A	SEQUENCEVARIANT	RS763572195
14722929	1657	1666	p.Tyr65X 	SEQUENCEVARIANT	RS763572195
14722929	1728	1737	g.3395C>T	SEQUENCEVARIANT	G|SUB|C|3395|T
14722929	1778	1785	p.Thr26	SEQUENCEVARIANT	P|ALLELE|T|26
14722929	1827	1836	g.3503C>T	SEQUENCEVARIANT	G|SUB|C|3503|T
14722929	1876	1883	p.Asn62	SEQUENCEVARIANT	P|ALLELE|N|62
14722929	1926	1935	g.3627A>C	SEQUENCEVARIANT	 G|SUB|A|3627|C
14722929	1976	1984	p.Arg104	SEQUENCEVARIANT	P|ALLELE|R|104
14722929	2053	2062	g.3816C>A	SEQUENCEVARIANT	RS111033360
14722929	2100	2111	p.Val167Met	SEQUENCEVARIANT	RS111033360
14722929	2199	2209	g.3352delG	SEQUENCEVARIANT	G|DEL|3352|G
14722929	2269	2275	30delG	SEQUENCEVARIANT	C|DEL|30 |G
14722929	2313	2320	35 delG	SEQUENCEVARIANT	C|DEL|35|G
14722929	2359	2368	g.3426G>A	SEQUENCEVARIANT	RS72474224
14722929	2405	2415	p.Val37Ile	SEQUENCEVARIANT	RS72474224
14722929	2454	2464	g. 3697G>A	SEQUENCEVARIANT	RS111033196
14722929	2502	2513	p.Arg127His	SEQUENCEVARIANT	RS111033196
14722929	2552	2562	g.3774G>A 	SEQUENCEVARIANT	RS111033186
14722929	2600	2611	p.Val153Ile	SEQUENCEVARIANT	RS111033186
14722929	2650	2659	g.3795G>A	SEQUENCEVARIANT	RS34988750
14722929	2696	2707	p.Gly160Ser	SEQUENCEVARIANT	RS34988750
14722929	2845	2855	g.3352delG	SEQUENCEVARIANT	G| DEL|3352|G
14722929	3084	3089	NSARD	DISEASEORPHENOTYPICFEATURE	C567134
14722929	3193	3200	sordità	DISEASEORPHENOTYPICFEATURE	D003638
14722929	3261	3265	GJB2	GENEORGENEPRODUCT	2706
14722929	3411	3418	sordità	DISEASEORPHENOTYPICFEATURE	D003638
15033202	43	74	Sindrome da rottura di Nijmegen	DISEASEORPHENOTYPICFEATURE	D049932
15033202	160	181	microcefalia primaria	DISEASEORPHENOTYPICFEATURE	D008831
15033202	229	258	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	313	369	disturbo da instabilità cromosomica autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D043171
15033202	439	461	ritardo della crescita	DISEASEORPHENOTYPICFEATURE	D006130
15033202	506	528	microcefalia congenita	DISEASEORPHENOTYPICFEATURE	D008831
15033202	574	590	immunodeficienza	DISEASEORPHENOTYPICFEATURE	D007153
15033202	687	710	maligne linforeticolari	DISEASEORPHENOTYPICFEATURE	D049932
15033202	776	805	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	833	841	pazienti	ORGANISMTAXON	9606
15033202	948	973	5 delezione di nucleotidi	SEQUENCEVARIANT	C|DEL||5
15033202	1009	1013	NBS1	GENEORGENEPRODUCT	4683
15033202	1063	1075	Microcefalia	DISEASEORPHENOTYPICFEATURE	D008831
15033202	1144	1173	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	1202	1210	pazienti	ORGANISMTAXON	9606
15033202	1329	1358	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	1420	1441	microcefalia primaria	DISEASEORPHENOTYPICFEATURE	D008831
15033202	1607	1615	pazienti	ORGANISMTAXON	9606
15033202	1741	1746	NBS1 	GENEORGENEPRODUCT	4683
15033202	1851	1880	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	1978	2009	Sindrome da rottura di Nijmegen	DISEASEORPHENOTYPICFEATURE	D049932
15033202	2037	2045	pazienti	ORGANISMTAXON	9606
15033202	2306	2337	Sindrome da rottura di Nijmegen	DISEASEORPHENOTYPICFEATURE	D049932
15033202	2398	2427	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	2651	2680	Sindrome da rottura di Nimega	DISEASEORPHENOTYPICFEATURE	D049932
15033202	2854	2885	Sindrome da rottura di Nijmegen	DISEASEORPHENOTYPICFEATURE	D049932
15033202	2913	2922	pazienti 	ORGANISMTAXON	9606
15033202	3104	3135	Sindrome da rottura di Nijmegen	DISEASEORPHENOTYPICFEATURE	D049932
15033202	3163	3171	pazienti	ORGANISMTAXON	9606
15042318	43	64	Fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15042318	172	188	linfoma gastrico	DISEASEORPHENOTYPICFEATURE	C535648
15042318	222	230	paziente	ORGANISMTAXON	9606
15042318	278	297	distrofia miotonica	DISEASEORPHENOTYPICFEATURE	D009223
15042318	342	362	Malattia di Steinert	DISEASEORPHENOTYPICFEATURE	D009223
15042318	475	492	 linfoma gastrico	DISEASEORPHENOTYPICFEATURE	C535648
15042318	538	557	distrofia miotonica	DISEASEORPHENOTYPICFEATURE	D009223
15042318	625	657	distrofia muscolare dell'adulto 	DISEASEORPHENOTYPICFEATURE	D009136
15042318	714	735	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15042318	792	804	doxorubicina	CHEMICALENTITY	D004317
15042318	869	877	paziente	ORGANISMTAXON	9606
15042318	923	944	Fibrillazione atriale	DISEASEORPHENOTYPICFEATUR E	D001281
15042318	996	1013	aritmie cardiache	DISEASEORPHENOTYPICFEATURE	D001145
15042318	1072	1081	 pazienti	ORGANISMTAXON	9606
15042318	1156	1174	tossicità cardiaca	DISEASEORPHENOTYPICFEATURE	D066126
15042318	1331	1338	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
15042318	1402	1410	paziente	ORGANISMTAXON	9606
15064320	66	72	SRD5A2	GENEORGENEPRODUCT	6716
15064320	136	161	Pseudoermafrodita maschio	DISEASEORPHENOTYPICFEATURE	D058490
15064320	189	197	paziente	ORGANISMTAXON	9606
15064320	301	327	5-alfa-reduttasi di tipo 2	GENEORGENEPRODUCT	6716
15064320	360	366	SRD5A2	GENEORGENEPRODUCT	6716
15064320	426	451	pseudermafrodita maschile	DISEASEORPHENOTYPICFEATURE	D058490
15064320	496	499	MPH	DISEASEORPHENOTYPICFEATURE	D058490
15064320	528	536	paziente	ORGANISMTAXON	9606
15064320	572	584	testosterone	CHEMICALENTITY	D013739
15064320	617	619	 T	CHEMICALENTITY	D013739
15064320	672	697	recettore degli androgeni	GENEORGENEPRODUCT	367
15064320	729	731	AR	GENEORGENEPRODUCT	367
15064320	790	798	paziente	ORGANISMTAXON	9606
15064320	884	885	T	CHEMICALENTITY	D013739
15064320	956	985	gonadotropina corionica umana	CHEMICALENTITY	D006063
15064320	1018	1021	hCG	CHEMICALENTITY	D006063
15064320	1134	1136	AR	GENEORGENEPRODUCT	367
15064320	1184	1190	SRD5A2	GENEORGENEPRODUCT	6716
15064320	1280	1282	AR	GENEORGENEPRODUCT	367
15064320	1357	1363	SRD5A2	GENEORGENEPRODUCT	6716
15064320	1519	1598	Delezione del nucleotide T, che predice una mutazione frameshift dal codone 219	SEQUENCEVARIANT	C|DEL |CODON219|T
15064320	1701	1746	 la guanina (CGA) da parte dell'adenina (CAA)	SEQUENCEVARIANT	RS9332964
15064320	1793	1836	sostituzione della glutammina dell'arginina	SEQUENCEVARIANT	RS9332964
15064320	1873	1878	R227Q	SEQUENCEVARIANT	 RS9332964
15064320	1999	2007	paziente	ORGANISMTAXON	9606
15064320	2085	2091	SRD5A2	GENEORGENEPRODUCT	6716
15064320	2160	2168	paziente	ORGANISMTAXON	9606
15064320	2230	2235	R227Q	SEQUENCEVARIANT	RS9332964
15064320	2331	2334	MPH	DISEASEORPHENOTYPICFEATURE	D058490
15064320	2362	2370	pazienti	ORGANISMTAXON	9606
15064320	2455	2462	Tdel219	SEQUENCEVARIANT	C|DEL|CODON219|T
15064320	2590	2606	5-alfa-reduttasi	GENEORGENEPRODUCT	6716
15075188	92	105	subunità ENaC	GENEORGENEPRODUCT	24767,24768,25122
15075188	141	167	puromicina aminonucleoside	CHEMICALENTITY	D011692
15075188	219	237	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
15075188	270	276	ratti 	ORGANISMTAXON	10116
15075188	321	342	La sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
15075188	399	418	ritenzione di sodio	CHEMICALENTITY	D012964
15075188	478	483	edema	DISEASEORPHENOTYPICFEATURE	D004487
15075188	578	583	sodio	CHEMICALENTITY	D012964
15075188	670	710	subunità del canale Na epiteliale (ENaC)	GENEORGENEPRODUCT	24767,24768,25122
15075188	784	790	sodio 	CHEMICALENTITY	D012964
15075188	860	865	ratti	ORGANISMTAXON	10116
15075188	918	944	puromicina aminonucleoside	CHEMICALENTITY	D011692
15075188	978	981	PAN	CHEMICALENTITY	D011692
15075188	1103	1106	PAN	CHEMICALENTITY	D011692
15075188	1184	1195	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
15075188	1241	1255	ipoalbuminemia	DISEASEORPHENOTYPICFEATURE	D034141
15075188	1305	1310	sodio	CHEMICALENTITY	D012964
15075188	1379	1385	ascite	DISEASEORPHENOTYPICFEATURE	D001201
15075188	1444	1454	alpha-ENaC	GENEORGENEPRODUCT	25122
15075188	1489	1498	beta-ENaC	GENEORGENEPRODUCT	24767
15075188	1668	1678	gamma-ENaC	GENEORGENEPRODUCT	24768
15075188	1911	1921	alpha-ENaC	GENEORGENEPRODUCT	25122
15075188	1955	1964	beta-ENaC	GENEORGENEPRODUCT	24767
15075188	1999	2009	gamma-ENaC	GENEORGENEPRODUCT	24768
15075188	2282	2291	alfa-ENaC	GENEORGENEPRODUCT	25122
15075188	2417	2420	PAN	CHEMICALENTITY	D011692
15075188	2458	2463	ratti	ORGANISMTAXON	10116
15075188	2549	2560	alpha-ENaC 	GENEORGENEPRODUCT	25122
15075188	2659	2676	Na(+)/H(+) tipo 3	GENEORGENEPRODUCT	24784
15075188	2710	2714	NHE3	GENEORGENEPRODUCT	24784
15075188	2749	2782	Na(+)-K(+)-2Cl(-) cotrasportatore	GENEORGENEPRODUCT	25065
15075188	2817	2822	BSC-1	GENEORGENEPRODUCT	25065
15075188	2858	2906	cotrasportatore Na(+)-Cl(-) sensibile ai tiazidi	GENEORGENEPRODUCT	54300
15075188	2941	2944	TSC	GENEORGENEPRODUCT	54300
15075188	3026	3060	alfa(1)-subunità della Na-K-ATPasi	GENEORGENEPRODUCT	24211
15075188	3246	3259	subunità ENaC	GENEORGENEPRODUCT	24767,24768,25122
15075188	3425	3444	ritenzione di sodio	CHEMICALENTITY	D012964
15075188	3488	3491	PAN	CHEMICALENTITY	D011692
15075188	3543	3561	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
15075188	3629	3633	NHE3	GENEORGENEPRODUCT	24784
15075188	3667	3672	BSC-1	GENEORGENEPRODUCT	25065
15075188	3707	3710	TSC	GENEORGENEPRODUCT	54300
15075188	3745	3756	Na-K-ATPase	GENEORGENEPRODUCT	24211
15075188	3843	3862	escrezione di sodio	CHEMICALENTITY	D012964
15099351	52	57	PCSK9	GENEORGENEPRODUCT	255738
15099351	128	167	ipercolesterolemia autosomica dominante	DISEASEORPHENOTYPICFEATURE	D006938
15099351	202	250	Proproteina convertasi subtilisina/kexina tipo 9	GENEORGENEPRODUCT	255738
15099351	285	290	PCSK9	GENEORGENEPRODUCT	255738
15099351	360	399	ipercolesterolemia autosomica dominante	DISEASEORPHENOTYPICFEATURE	D006938
15099351	469	474	PCSK9	GENEORGENEPRODUCT	255738
15099351	539	550	colesterolo	CHEMICALENTITY	D002784
15099351	684	702	ipercolesterolemia	DISEASEORPHENOTYPICFEATURE	D006937
15099351	803	808	PCSK9	GENEORGENEPRODUCT	255738
15099351	923	951	ipercolesterolemia familiare	DISEASEORPHENOTYPICFEATURE	D006937
15099351	1007	1051	recettore delle lipoproteine a bassa densità	GENEORGENEPRODUCT	3949
15099351	1099	1105	R3500Q	SEQUENCEVARIANT	RS5742904
15099351	1145	1166	apolipoproteina B-100	GENEORGENEPRODUCT	338
15099351	1305	1310	PCSK9	GENEORGENEPRODUCT	255738
15099351	1343	1351	pazienti	ORGANISMTAXON	9606
15099351	1410	1415	D374Y	SEQUENCEVARIANT	RS137852912
15099351	1450	1458	paziente	ORGANISMTAXON	9606
15099351	1525	1530	D374Y	SEQUENCEVARIANT	RS137852912
15099351	1569	1575	N157K 	SEQUENCEVARIANT	RS143117125
15099351	1613	1618	D374Y	SEQUENCEVARIANT	RS137852912
15099351	1676	1694	ipercolesterolemia	DISEASEORPHENOTYPICFEATURE	D006937
15099351	1872	1877	PCSK9	GENEORGENEPRODUCT	255738
15099351	1929	1968	ipercolesterolemia autosomica dominante	DISEASEORPHENOTYPICFEATURE	D006938
15122708	43	77	La miopatia correlata alla desmina	DISEASEORPHENOTYPICFEATURE	C563319
15122708	179	206	gene della selenoproteina N	GENEORGENEPRODUCT	57190
15122708	251	282	Miopatie correlate alla desmina	DISEASEORPHENOTYPICFEATURE	C563319
15122708	327	331	DRMs	DISEASEORPHENOTYPICFEATURE	C563319
15122708	406	424	disturbi muscolari	DISEASEORPHENOTYPICFEATURE	D009135
15122708	520	526	desmin	GENEORGENEPRODUCT	1674
15122708	581	587	desmin	GENEORGENEPRODUCT	1674
15122708	621	638	alfa-B crystallin	GENEORGENEPRODUCT	1410
15122708	734	737	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	932	936	DRMs	DISEASEORPHENOTYPICFEATURE	C563319
15122708	1015	1023	pazienti	ORGANISMTAXON	9606
15122708	1109	1124	selenoprotein N	GENEORGENEPRODUCT	57190
15122708	1158	1163	SEPN1	GENEORGENEPRODUCT	57190
15122708	1229	1254	miopatia correlata a SEPN	DISEASEORPHENOTYPICFEATURE	D009135
15122708	1299	1306	SEPN-RM	DISEASEORPHENOTYPICFEATURE	D009135
15122708	1363	1371	miopatia	DISEASEORPHENOTYPICFEATURE	D009135
15122708	1476	1527	distrofia muscolare della colonna vertebrale rigida	DISEASEORPHENOTYPICFEATURE	C535683
15122708	1603	1625	malattia multiminicore	DISEASEORPHENOTYPICFEATURE	C564969
15122708	1741	1748	SEPN-RM	DISEASEORPHENOTYPICFEATURE	D009135
15122708	1868	1871	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	1906	1911	SEPN1	GENEORGENEPRODUCT	57190
15122708	1992	1995	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	2080	2085	SEPN1	GENEORGENEPRODUCT	57190
15122708	2178	2183	SEPN1	GENEORGENEPRODUCT	57190
15122708	2285	2293	pazienti	ORGANISMTAXON	9606
15122708	2387	2390	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	2436	2443	SEPN-RM	DISEASEORPHENOTYPICFEATURE	D009135
15122708	2563	2566	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	2641	2648	SEPN-RM	DISEASEORPHENOTYPICFEATURE	D009135
15122708	2750	2753	DRM	DISEASEORPHENOTYPICFEATURE	C563319
15122708	2834	2841	SEPN-RM	DISEASEORPHENOTYPICFEATURE	D009135
15122708	2956	2964	miopatie	DISEASEORPHENOTYPICFEATURE	D009135
15122711	31	35	POLG	GENEORGENEPRODUCT	5428
15122711	101	119	Sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
15122711	165	197	deplezione del DNA mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
15122711	242	260	Sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
15122711	310	332	malattia neurogenetica	DISEASEORPHENOTYPICFEATURE	D009422
15122711	490	509	 Deplezione del DNA	DISEASEORPHENOTYPICFEATURE	D028361
15122711	590	610	DNA polimerasi gamma	GENEORGENEPRODUCT	5428
15122711	643	647	POLG	GENEORGENEPRODUCT	5428
15122711	725	736	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15122711	781	799	neurodegenerazione	DISEASEORPHENOTYPICFEATURE	D019636
15122711	846	862	malattia epatica	DISEASEORPHENOTYPICFEATURE	D008107
15122711	941	959	Sindrome di Alpers	DIS EASEORPHENOTYPICFEATURE	D002549
15122711	1074	1078	POLG	GENEORGENEPRODUCT	5428
15122711	1152	1162	Glu873Stop	SEQUENCEVARIANT	RS121918047
15122711	1322	1328	G1681A	SEQUENCEVARIANT	RS113994095
15122711	1399	1408	Ala467Thr	SEQUENCEVARIANT	RS113994095
15122711	1456	1460	POLG	GENEORGENEPRODUCT	5428
15145918	60	68	estrogen	CHEMICALENTITY	D004967
15145918	110	158	alpha2 -adrenergico e recettore I1-imidazolinico	GENEORGENEPRODUCT	25083,64652
15145918	210	221	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
15145918	261	266	ratti	ORGANISMTAXON	10116
15145918	335	343	estrogen	CHEMICALENTITY	D004967
15145918	418	428	ipotensivo	DISEASEORPHENOTYPICFEATURE	D007022
15145918	472	481	clonidina	CHEMICALENTITY	D003000
15145918	527	546	alfa2-/I1-recettore	GENEORGENEPRODUCT	25083,64652
15145918	600	605	ratti	ORGANISMTAXON	10116
15145918	761	769	estrogen	CHEMICALENTITY	D004967
15145918	834	858	alfa2- e/o I1-recettori 	GENEORGENEPRODUCT	25083,64652
15145918	956	967	rilmenidina	CHEMICALENTITY	C032302
15145918	1017	1031	alfa-metildopa	CHEMICALENTITY	D008750
15145918	1093	1114	I1- e alfa2-recettore	GENEORGENEPRODUCT	25083,64652
15145918	1248	1253	ratti	ORGANISMTAXON	10116
15145918	1405	1414	estrogeno	CHEMICALENTITY	D004967
15145918	1865	1870	ratti	ORGANISMTAXON	10116
15145918	1903	1914	rilmenidina	CHEMICALENTITY	C032302
15145918	1950	1964	alfa-metildopa	CHEMICALENTITY	D008750
15145918	2028	2039	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
15145918	2215	2229	alfa-metildopa	CHEMICALENTITY	D008750
15145918	2323	2333	ipotensiva	DISEASEORPHENOTYPICFEATURE	D007022
15145918	2367	2381	alfa-metildopa	CHEMICALENTITY	D008750
15145918	2449	2460	rilmenidina	CHEMICALENTITY	C032302
15145918	2504	2515	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
15145918	2548	2562	alfa-metildopa	CHEMICALENTITY	D008750
15145918	2606	2617	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
15145918	2654	2659	ratti	ORGANISMTAXON	10116
15145918	2763	2795	una ridotta attività locomotoria	DISEASEORPHENOTYPICFEATURE	D001523
15145918	2855	2872	17beta-estradiolo	CHEMICALENTITY	D004958
15145918	2963	2968	ratti	ORGANISMTAXON	10116
15145918	3056	3070	alfa-metildopa	CHEMICALENTITY	D008750
15145918	3160	3168	estrogen	CHEMICALENTITY	D004967
15145918	3213	3239	alfa2- ma non I1-recettore	GENEORGENEPRODUCT	25083
15145918	3292	3303	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
15145918	3397	3411	alfa-metildopa	CHEMICALENTITY	D008750
15145918	3443	3468	interazione con estrogeni	CHEMICALENTITY	D004967
15177686	60	64	HIRA	GENEORGENEPRODUCT	7290
15177686	96	103	Tuple1 	GENEORGENEPRODUCT	7290
15177686	157	195	DiGeorge e sindromi velocardiofacciali	DISEASEORPHENOTYPICFEATURE	D004062
15177686	240	278	DiGeorge e sindromi velocardiofacciali	DISEASEORPHENOTYPICFEATURE	D004062
15177686	323	326	DGS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	371	375	VCFS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	484	539	malformazioni cardiovascolari, craniofacciali e timiche	DISEASEORPHENOTYPICFEATURE	D018376,D019465
15177686	942	945	DGS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	989	993	VCFS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	1085	1089	HIRA	GENEORGENEPRODUCT	7290
15177686	1121	1127	Tuple1	GENEORGENEPRODUCT	7290
15177686	1208	1211	DGS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	1255	1259	VCFS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	1408	1412	HIRA	GENEORGENEPRODUCT	7290
15177686	1444	1450	Tuple1	GENEORGENEPRODUCT	7290
15177686	1872	1875	DGS	DISEASEORPHENOTYPICFEATURE	D004062
15177686	1919	1923	VCFS	DISEASEORPHENOTYPICFEATURE	D004062
15184369	31	35	Ca2+	CHEMICALENTITY	D002118
15184369	84	88	Ca2+	CHEMICALENTITY	D002118
15184369	131	136	TRPV6	GENEORGENEPRODUCT	55503
15184369	255	260	TRPV6	GENEORGENEPRODUCT	55503
15184369	363	369	Ca(2+)	CHEMICALENTITY	D002118
15184369	413	419	Ca(2+)	CHEMICALENTITY	D002118
15184369	520	526	fura-2	CHEMICALENTITY	D016257
15184369	600	606	Ca(2+)	CHEMICALENTITY	D002118
15184369	750	756	Ca(2+)	CHEMICALENTITY	D002118
15184369	799	803	EGTA	CHEMICALENTITY	D004533
15184369	946	951	umano	ORGANISMTAXON	9606
15184369	985	990	TRPV6	GENEORGENEPRODUCT	55503
15184369	1160	1164	EGTA	CHEMICALENTITY	D004533
15184369	1238	1244	Ca(2+)	CHEMICALENTITY	D002118
15184369	1375	1380	TRPV6	GENEORGENEPRODUCT	55503
15184369	1452	1458	Ca(2+)	CHEMICALENTITY	D002118
15184369	1533	1538	TRPV6	GENEORGENEPRODUCT	55503
15184369	1598	1604	Ca(2+)	CHEMICALENTITY	D002118
15184369	1728	1733	TRPV6	GENEORGENEPRODUCT	55503
15184369	1924	1928	EGTA	CHEMICALENTITY	D004533
15184369	1964	1969	TRPV6	GENEORGENEPRODUCT	55503
15184369	2044	2050	Ca(2+)	CHEMICALENTITY	D002118
15184369	2237	2242	TRPV6	GENEORGENEPRODUCT	55503
15184369	2302	2308	Ca(2+)	CHEMICALENTITY	D002118
15184369	2424	2429	TRPV6	GENEORGENEPRODUCT	55503
15184369	2487	2492	umano	ORGANISMTAXON	9606
15184369	2525	2530	TRPV6	GENEORGENEPRODUCT	55503
15184369	2572	2577	umano	ORGANISMTAXON	 9606
15184369	2610	2615	TRPV6	GENEORGENEPRODUCT	55503
15184369	2750	2756	Ca(2+)	CHEMICALENTITY	D002118
15184369	2853	2858	umano	ORGANISMTAXON	9606
15184369	2891	2896	TRPV6	GENEORGENEPRODUCT	55503
15184369	2936	2941	D542A	SEQUENCEVARIANT	P|SUB|D|542|A
15184369	3118	3123	TRPV6	GENEORGENEPRODUCT	55503
15188772	61	117	disfunzione sistolica e diastolica ventricolare sinistra	DISEASEORPHENOTYPICFEATURE	D018487
15188772	181	191	epinefrina	CHEMICALENTITY	D004837
15188772	238	250	Catecolamine	CHEMICALENTITY	D002395
15188772	305	319	cardiomiopatia	DISEASEORPHENOTYPICFEATURE	D009202
15188772	528	550	disfunzione miocardica	DISEASEORPHENOTYPICFEATURE	D009202
15188772	633	638	donna	ORGANISMTAXON	9606
15188772	751	761	epinefrina	CHEMICALENTITY	D004837
15188772	816	838	stordimento miocardico	DISEASEORPHENOTYPICFEATURE	D017682
15188772	966	1022	ventricolare sinistro disfunzione sistolica e diastolica	DISEASEORPHENOTYPICFEATURE	D018487
15188772	1116	1134	necrosi miocardica	DISEASEORPHENOTYPICFEATURE	D009202
15191352	58	89	resistenza agli ormoni tiroidei	DISEASEORPHENOTYPICFEATURE	D018382
15191352	123	132	 paziente	ORGANISMTAXON	9606
15191352	207	219	recettore T3	GENEORGENEPRODUCT	7068
15191352	264	309	Resistenza alla sindrome dell'ormone tiroideo	DISEASEORPHENOTYPICFEATURE	D018382
15191352	354	357	RTH	DISEASEORPHENOTYPICFEATURE	D018382
15191352	464	474	I pazienti	ORGANISMTAXON	9606
15191352	522	525	RTH	DISEASEORPHENOTYPICFEATURE	D018382
15191352	655	669	tireotossicosi	DISEASEORPHENOTYPICFEATURE	D013971
15191352	729	742	ipotiroidismo	DISEASEORPHENOTYPICFEATURE	D007037
15191352	853	888	recettore dell'ormone tiroideo beta	GENEORGENEPRODUCT	7068
15191352	921	928	TR-beta	GENEORGENEPRODUCT	7068
15191352	973	981	paziente	ORGANISMTAXON	9606
15191352	1029	1032	RTH	DISEASEORPHENOTYPICFEATURE	D018382
15191352	1113	1120	TR-beta	GENEORGENEPRODUCT	7068
15191352	1199	1204	I280S	SEQUENCEVARIANT	P|SUB|I|280|S
15191352	1245	1255	 1123T-->G	SEQUENCEVARIANT	G|SUB|T|1123|G
15191352	1408	1413	I280S	SEQUENCEVARIANT	P|SUB|I|280|S
15191352	1490	1498	paziente	ORGANISMTAXON	9606
15191352	1590	1612	sviluppo intellettuale	DISEASEORPHENOTYPICFEATURE	D008607
15191352	1657	1669	ipercinetico	DISEASEORPHENOTYPICFEATURE	D006948
15191352	1715	1726	tachicardia	DISEASEORPHENOTYPICFEATURE	D013610
15191352	1779	1821	il deterioramento dell'udito e della vista	DISEASEORPHENOTYPICFEATURE	D006311,D014786
15191352	1937	1942	I280S	SEQUENCEVARIANT	P|SUB|I|280|S
15191352	2010	2018	TR-beta 	GENEORGENEPRODUCT	7068
15198485	47	56	Lys198Asn	SEQUENCEVARIANT	RS5370
15198485	93	101	-134delA	SEQUENCEVARIANT	RS1800997
15198485	164	176	endotelina-1	GENEORGENEPRODUCT	1906
15198485	208	220	endotelina-1	GENEORGENEPRODUCT	1906
15198485	253	257	ET-1	GENEORGENEPRODUCT	1906
15198485	402	406	ET-1	GENEORGENEPRODUCT	1906
15198485	444	448	EDN1	GENEORGENEPRODUCT	1906
15198485	573	582	Lys198Asn	SEQUENCEVARIANT	RS5370
15198485	678	688	sovrappeso	DISEASEORPHENOTYPICFEATURE	D050177
15198485	766	774	-134delA	SEQUENCEVARIANT	RS1800997
15198485	902	911	Lys198Asn	SEQUENZEVARI ANT	RS5370
15198485	959	963	ET-1	GENEORGENEPRODUCT	1906
15198485	1079	1083	ET-1	GENEORGENEPRODUCT	1906
15198485	1200	1204	ET-1	GENEORGENEPRODUCT	1906
15198485	1299	1303	ET-1	GENEORGENEPRODUCT	1906
15198485	1344	1348	ET-1	GENEORGENEPRODUCT	1906
15198485	1473	1477	ET-1	GENEORGENEPRODUCT	1906
15198485	1515	1519	ET-1	GENEORGENEPRODUCT	1906
15198485	1558	1597	transfettante di tipo Asn e di tipo Lys	SEQUENCEVARIANT	RS5370
15198485	1684	1688	ET-1	GENEORGENEPRODUCT	1906
15198485	1738	1749	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
15198485	1777	1785	pazienti	ORGANISMTAXON	9606
15198485	1862	1891	Lys ad Asn alla posizione 198	SEQUENCEVARIANT	RS5370
15198485	1966	1977	ipertensivi	DISEASEORPHENOTYPICFEATURE	D006973
15198485	2106	2110	ET-1	GENEORGENEPRODUCT	1906
15198485	2264	2273	Lys198Asn	SEQUENCEVARIANT	RS5370
15198485	2343	2347	ET-1	GENEORGENEPRODUCT	1906
15198485	2399	2403	ET-1	GENEORGENEPRODUCT	1906
15198485	2463	2467	EDN1	GENEORGENEPRODUCT	1906
15198485	2546	2555	Lys198Asn	SEQUENCEVARIANT	RS5370
15198485	2660	2664	EDN1	GENEORGENEPRODUCT	1906
15198485	2696	2705	Lys198Asn	SEQUENCEVARIANT	RS5370
15198485	2786	2793	obesità	DISEASEORPHENOTYPICFEATURE	D009765
15200408	71	76	umano	ORGANISMTAXON	9606
15200408	114	124	 uroplakin	GENEORGENEPRODUCT	11045,7380
15200408	176	202	reflusso vescico-ureterale	DISEASEORPHENOTYPICFEATURE	C564042
15200408	316	342	reflusso vescico-ureterale	DISEASEORPHENOTYPICFEATURE	C564042
15200408	387	390	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	441	460	disturbo ereditario	DISEASEORPHENOTYPICFEATURE	D030342
15200408	638	657	malattie ereditarie	DISEASEORPHENOTYPICFEATURE	D030342
15200408	730	740	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
15200408	809	851	insufficienza renale allo stadio terminale	DISEASEORPHENOTYPICFEATURE	D007676
15200408	953	957	topo	ORGANISMTAXON	10090
15200408	990	1008	uroplakin (UP) III	GENEORGENEPRODUCT	22270
15200408	1179	1182	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	1228	1239	idronefrosi	DISEASEORPHENOTYPICFEATURE	D006869
15200408	1338	1340	UP	GENEORGENEPRODUCT	11045,7380
15200408	1407	1412	umano	ORGANISMTAXON	9606
15200408	1456	1459	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	1536	1538	UP	GENEORGENEPRODUCT	11045,7380
15200408	1577	1585	pazienti	ORGANISMTAXON	9606
15200408	1634	1637	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	2077	2080	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	2167	2170	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	2309	2312	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	2340	2348	pazienti	ORGANISMTAXON	9606
15200408	2523	2526	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	2578	2583	UP Ia	GENEORGENEPRODUCT	11045
15200408	2642	2648	C to T	SEQUENCEVARIANT	RS373513519
15200408	2700	2707	Ala7Val	SEQUENCEVARIANT	RS373513519
15200408	2749	2755	UP III	GENEORGENEPRODUCT	7380
15200408	2809	2815	C in G	SEQUENCEVARIANT	C|SUB|C||G
15200408	2872	2881	Pro154Ala	SEQUENCEVARIANT	P|SUB|P|154|A
15200408	2970	2973	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	3168	3174	UP III	GENEORGENEPRODUCT	7380
15200408	3227	3230	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	3505	3514	uroplakin	GENEORGENEPRODUCT	11045,7380
15200408	3610	3613	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	3644	3649	umani	ORGANISMTAXON	9606
15200408	3899	3902	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	3930	3938	pazienti	ORGANISMTAXON	9606
15200408	4043	4049	UP III	GENEORGENEPRODUCT	22270
15200408	4087	4091	topi	ORGANISMTAXON	10090
15200408	4178	4181	VUR	DISEASEORPHENOTYPICFEATURE	C564042
15200408	4235	4246	idronefrosi	DISEASEORPHENOTYPICFEATURE	D006869
15200408	4292	4307	morte neonatale	DISEASEORPHENOTYPICFEATURE	D066087
15200408	4385	4394	uroplakin	GENEORGENEPRODUCT	11045,7380
15200408	4500	4505	umani	ORGANISMTAXON	9606
15241482	31	44	Paraoxonase 1	GENEORGENEPRODUCT	5444
15241482	129	142	paraoxonase 1	GENEORGENEPRODUCT	5444
15241482	175	179	PON1	GENEORGENEPRODUCT	5444
15241482	290	309	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003327
15241482	354	357	CHD	DISEASEORPHENOTYPICFEATURE	D003327
15241482	433	438	morte	DISEASEORPHENOTYPICFEATURE	D003643
15241482	529	534	55M/L	SEQUENCEVARIANT	P|SUB|M|55|L
15241482	576	582	192Q/R	SEQUENCEVARIANT	P|SUB|Q|192| R
15241482	773	776	CHD	DISEASEORPHENOTYPICFEATURE	D003327
15241482	1373	1378	192RR	SEQUENCEVARIANT	P|ALLELE|R|192
15241482	1746	1751	donne	ORGANISMTAXON	9606
15241482	1832	1853	cardiopatia ischemica	DISEASEORPHENOTYPICFEATURE	D017202
15241482	1912	1915	PON	GENEORGENEPRODUCT	5444
15241482	1954	1960	192Q/R	SEQUENCEVARIANT	P|SUB|Q|192|R
15241482	2040	2043	CHD	DISEASEORPHENOTYPICFEATURE	D003327
15241482	2139	2144	192RR	SEQUENCEVARIANT	P|ALLELE|R|192
15241482	2189	2195	donne 	ORGANISMTAXON	9606
15241482	2297	2301	PON1	GENEORGENEPRODUCT	5444
15241482	2341	2346	192RR	SEQUENCEVARIANT	P|ALLELE|R|192
15241482	2431	2436	donne	ORGANISMTAXON	9606
15241482	2575	2579	 CHD	DISEASEORPHENOTYPICFEATURE	D003327
15241482	2652	2655	CHD	DISEASEORPHENOTYPICFEATURE	D003327
15241482	2745	2748	CHD	DISEASEORPHENOTYPICFEATURE	D003327
15266215	64	80	ciclossigenasi-2	GENEORGENEPRODUCT	5743
15266215	112	123	 valdecoxib	CHEMICALENTITY	C406224
15266215	166	202	agenti antinfiammatori non steroidei	CHEMICALENTITY	D000894
15266215	275	285	trombotico	DISEASEORPHENOTYPICFEATURE	D013927
15266215	323	331	pazienti	ORGANISMTAXON	9606
15266215	379	386	artrite	DISEASEORPHENOTYPICFEATURE	D001168
15266215	496	506	trombotici	DISEASEORPHENOTYPICFEATURE	D013927
15266215	566	588	ciclossigenasi (COX)-2	GENEORGENEPRODUCT	5743
15266215	651	688	farmaci antinfiammatori non steroidei	CHEMICALENTITY	D000894
15266215	721	725	FANS	CHEMICALENTITY	D000894
15266215	816	826	valdecoxib	CHEMICALENTITY	C406224
15266215	868	873	COX-2	GENEORGENEPRODUCT	5743
15266215	936	944	pazienti	ORGANISMTAXON	9606
15266215	992	1004	osteoartrosi	DISEASEORPHENOTYPICFEATURE	D010003
15266215	1051	1069	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
15266215	1209	1219	trombotici	DISEASEORPHENOTYPICFEATURE	D013927
15266215	1326	1336	trombotici	DISEASEORPHENOTYPICFEATURE	D013927
15266215	1401	1411	valdecoxib	CHEMICALENTITY	C406224
15266215	1479	1483	FANS	CHEMICALENTITY	D000894
15266215	1516	1526	diclofenac	CHEMICALENTITY	D004008
15266215	1569	1578	ibuprofen	CHEMICALENTITY	D007052
15266215	1624	1634	naprossene	CHEMICALENTITY	D009288
15266215	1727	1739	osteoartrite	DISEASEORPHENOTYPICFEATURE	D010003
15266215	1785	1803	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
15266215	1937	1945	pazienti	ORGANISMTAXON	9606
15266215	2048	2056	aspirina	CHEMICALENTITY	D001241
15266215	2121	2129	aspirina	CHEMICALENTITY	D001241
15266215	2236	2253	eventi trombotici	DISEASEORPHENOTYPICFEATURE	D013927
15266215	2300	2310	valdecoxib	CHEMICALENTITY	C406224
15266215	2343	2347	FANS	CHEMICALENTITY	D000894
15266215	2428	2445	evento trombotico	DISEASEORPHENOTYPICFEATURE	D013927
15266215	2509	2519	valdecoxib	CHEMICALENTITY	C406224
15266215	2564	2585	Il rischio trombotico	DISEASEORPHENOTYPICFEATURE	D013927
15266215	2665	2673	aspirina	CHEMICALENTITY	D001241
15266215	2737	2745	aspirina	CHEMICALENTITY	D001241
15266215	2777	2785	aspirina	CHEMICALENTITY	D001241
15266215	2843	2853	valdecoxib	CHEMICALENTITY	C406224
15266215	2911	2915	FANS	CHEMICALENTITY	D000894
15266215	3014	3022	aspirina	CHEMICALENTITY	D001241
15266215	3111	3121	valdecoxib	CHEMICALENTITY	C406224
15266215	3286	3296	valdecoxib	CHEMICALENTITY	C406224
15266215	3393	3410	eventi trombotici	DISEASEORPHENOTYPICFEATURE	D013927
15266215	3453	3457	FANS	CHEMICALENTITY	D000894
15266215	3529	3536	artrosi	DISEASEORPHENOTYPICFEATURE	D010003
15266215	3582	3600	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
15266215	3628	3636	pazienti	ORGANISMTAXON	9606
15278670	46	57	sevoflurano	CHEMICALENTITY	C009250
15278670	92	101	lidocaina	CHEMICALENTITY	D008012
15278670	153	164	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15278670	212	223	sevoflurano	CHEMICALENTITY	C009250
15278670	258	267	lidocaina	CHEMICALENTITY	D008012
15278670	323	334	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15278670	382	387	gatti	ORGANISMTAXON	9685
15278670	442	452	convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
15278670	533	542	lidocaina	CHEMICALENTITY	D008012
15278670	711	722	sevoflurano	CHEMICALENTITY	C009250
15278670	824	835	sevoflurano	CHEMICALENTITY	C009250
15278670	916	927	sevoflurano	CHEMICALENTITY	C009250
15278670	1069	1079	convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
15278670	1115	1126	sevoflurano	CHEMICALENTITY	C009250
15278670	1161	1170	enflurano	CHEMICALENTITY	D004737
15278670	1301	1312	sevoflurano	CHEMICALENTITY	C009250
15278670	1346	1355	enflurano	CHEMICALENTITY	D004737
15278670	1451	1462	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15278670	1535	1546	sevoflurano	CHEMICALENTITY	C009250
15278670	1596	1605	enflurano	CHEMICALENTITY	D004737
15278670	1725	1734	lidocaina	CHEMICALENTITY	D008012
15278670	1836	1842	Apamin	CHEMICALENTITY	D001030
15278670	1901	1907	calcio	CHEMICALENTITY	D002118
15278670	1951	1959	potassio	CHEMICALENTITY	D011188
15278670	2054	2059	ratti	ORGANISMTAXON	10116
15278670	2116	2127	sevoflurano	CHEMICALENTITY	C009250
15278670	2219	2225	Apamin	CHEMICALENTITY	D001030
15278670	2320	2330	convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
15278670	2469	2480	sevoflurano	CHEMICALENTITY	C009250
15278670	2541	2551	convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
15278670	2587	2596	lidocaina	CHEMICALENTITY	D008012
15278670	2640	2649	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
15278670	2749	2760	depressione	DISEASEORPHENOTYPICFEATURE	D003866
15459183	30	34	CD72	GENEORGENEPRODUCT	971
15459183	143	148	umano	ORGANISMTAXON	9606
15459183	192	219	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
15459183	291	297	FCGR2B	GENEORGENEPRODUCT	2213
15459183	380	386	FCGR2B	GENEORGENEPRODUCT	2213
15459183	421	430	Ile232Thr	SEQUENCEVARIANT	RS1050501
15459183	479	506	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
15459183	551	554	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	644	648	CD72	GENEORGENEPRODUCT	12517
15459183	741	747	murina	ORGANISMTAXON	10090
15459183	791	794	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	844	849	umano	ORGANISMTAXON	9606
15459183	881	885	CD72	GENEORGENEPRODUCT	971
15459183	976	979	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	1052	1058	FCGR2B	GENEORGENEPRODUCT	 2213
15459183	1121	1124	SLE	DISEASEORPHENOTYPICFEATURE	D008180
15459183	1196	1199	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	1295	1298	SLE	DISEASEORPHENOTYPICFEATURE	D008180
15459183	1617	1620	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	1735	1742	nefrite	DISEASEORPHENOTYPICFEATURE	D009393
15459183	1787	1795	pazienti	ORGANISMTAXON	9606
15459183	2238	2244	FCGR2B	GENEORGENEPRODUCT	2213
15459183	2280	2286	232Thr	SEQUENCEVARIANT	RS1050501
15459183	2338	2341	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	2410	2414	CD72	GENEORGENEPRODUCT	971
15459183	2509	2515	FCGR2B	GENEORGENEPRODUCT	2213
15459183	2550	2556	232Ile	SEQUENCEVARIANT	RS1050501
15459183	2595	2599	CD72	GENEORGENEPRODUCT	971
15459183	3043	3047	CD72	GENEORGENEPRODUCT	12517
15459183	3098	3104	murine	ORGANISMTAXON	10090
15459183	3148	3151	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	3243	3247	CD72	GENEORGENEPRODUCT	971
15459183	3300	3305	umano	ORGANISMTAXON	9606
15459183	3349	3352	LES	DISEASEORPHENOTYPICFEATURE	D008180
15459183	3397	3403	FCGR2B	GENEORGENEPRODUCT	2213
15459183	3439	3445	232Thr	SEQUENCEVARIANT	RS1050501
15459183	3519	3523	CD72	GENEORGENEPRODUCT	971
15461822	116	135	virus dengue tipo 2	ORGANISMTAXON	11060
15461822	179	201	virus dengue di tipo 2	ORGANISMTAXON	11060
15461822	231	236	DEN-2	ORGANISMTAXON	11060
15461822	394	399	DEN-2	ORGANISMTAXON	11060
15461822	473	480	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	516	523	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	589	594	DEN-4	ORGANISMTAXON	11070
15461822	649	654	DEN-2	ORGANISMTAXON	11060
15461822	762	767	DEN-2	ORGANISMTAXON	11060
15461822	823	828	DEN-2	ORGANISMTAXON	11060
15461822	858	864	rDEN-2	ORGANISMTAXON	11060
15461822	896	901	rDEN2	ORGANISMTAXON	11060
15461822	935	942	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	1028	1032	topi	ORGANISMTAXON	10090
15461822	1076	1081	umano	ORGANISMTAXON	9606
15461822	1125	1132	epatomi	DISEASEORPHENOTYPICFEATURE	D006528
15461822	1209	1213	topi	ORGANISMTAXON	10090
15461822	1265	1279	scimmie rhesus	ORGANISMTAXON	9544
15461822	1402	1416	scimmie rhesus	ORGANISMTAXON	9544
15461822	1466	1471	rDEN2	ORGANISMTAXON	11060
15461822	1505	1512	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	1621	1625	topi	ORGANISMTAXON	10090
15461822	1692	1698	rDEN-2	ORGANISMTAXON	11060
15461822	1753	1766	zanzare Aedes	ORGANISMTAXON	1245352
15461822	1832	1852	Zanzare Toxorynchiti	ORGANISMTAXON	2498889
15461822	1884	1898	scimmie rhesus	ORGANISMTAXON	9544
15461822	1928	1933	rDEN2	ORGANISMTAXON	11060
15461822	1968	1975	Delta30	SEQUENCEVARIANT	C |DEL||30
15461822	2121	2128	viremia	DISEASEORPHENOTYPICFEATURE	D014766
15461822	2213	2218	rDEN2	ORGANISMTAXON	11060
15461822	2252	2259	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	2300	2305	rDEN2	ORGANISMTAXON	11060
15461822	2343	2355	Delta30-4995	SEQUENCEVARIANT	C|DEL|4995|30
15461822	2493	2496	NS3	GENEORGENEPRODUCT	5130010
15461822	2528	2533	DEN-4	ORGANISMTAXON	11070
15461822	2600	2605	rDEN2	ORGANISMTAXON	11060
15461822	2639	2646	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	2716	2720	topi	ORGANISMTAXON	10090
15461822	2766	2771	rDEN2	ORGANISMTAXON	11060
15461822	2805	2812	Delta30	SEQUENCEVARIANT	C|DEL||30
15461822	2844	2849	rDEN2	ORGANISMTAXON	11060
15461822	2887	2899	Delta30-4995	SEQUENCEVARIANT	C|DEL|4995|30
15461822	2996	3001	umani	ORGANISMTAXON	9606
15461822	3091	3097	dengue	DISEASEORPHENOTYPICFEATURE	D003715
15523499	68	94	recettore beta adrenergico	GENEORGENEPRODUCT	153,154,155
15523499	178	204	recettori beta-adrenergici	GENEORGENEPRODUCT	153,154,155
15523499	244	251	beta-AR	GENEORGENEPRODUCT	153,154,155
15523499	335	345	epinefrina	CHEMICALENTITY	D004837
15523499	379	392	norepinefrina	CHEMICALENTITY	D009638
15523499	520	527	beta-AR	GENEORGENEPRODUCT	153,154,155
15523499	559	564	ADRB1	GENEORGENEPRODUCT	153
15523499	597	602	ADRB2	GENEORGENEPRODUCT	154
15523499	635	640	ADRB3	GENEORGENEPRODUCT	155
15523499	799	836	disturbi cardiovascolari e metabolici	DISEASEORPHENOTYPICFEATURE	D002318,D008659
15523499	987	992	ADRB1	GENEORGENEPRODUCT	153
15523499	1032	1041	Arg389Gly	SEQUENCEVARIANT	P|SUB|R|389 |G
15523499	1081	1089	Gly49Ser	SEQUENCEVARIANT	P|SUB|G|49|S
15523499	1122	1127	ADRB2	GENEORGENEPRODUCT	154
15523499	1165	1173	Arg16Gly	SEQUENCEVARIANT	P|SUB|R|16|G
15523499	1214	1222	Gln27Glu	SEQUENCEVARIANT	P|SUB| Q|27|E
15523499	1255	1260	ADRB3	GENEORGENEPRODUCT	155
15523499	1299	1307	Arg64Trp	SEQUENCEVARIANT	P|SUB|R| 64|W
15523499	1492	1499	beta-AR	GENEORGENEPRODUCT	153,154,155
15523499	2289	2296	beta-AR	GENEORGENEPRODUCT	153,154,155
15523499	2421	2428	beta-AR	GENEORGENEPRODUCT	153,154,155 
15583840	43	49	Tumore	DISEASEORPHENOTYPICFEATURE	D009369
15583840	134	143	 pazienti	ORGANISMTAXON	9606
15583840	191	205	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15583840	250	267	Il cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15583840	356	362	tumori	DISEASEORPHENOTYPICFEATURE	D009369
15583840	448	454	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15583840	695	731	antigeni associati al cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15583840	847	861	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15583840	889	897	pazienti	ORGANISMTAXON	9606
15583840	1204	1218	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15583840	1246	1254	pazienti	ORGANISMTAXON	9606
15583840	1303	1319	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
15583840	1347	1355	pazienti	ORGANISMTAXON	9606
15583840	1993	2009	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
15583840	2038	2046	pazienti	ORGANISMTAXON	9606
15583840	2296	2302	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15583840	2333	2338	umano	ORGANISMTAXON	9606
15583840	2382	2396	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
15599941	52	81	antigene prostatico specifico	GENEORGENEPRODUCT	354
15599941	136	161	recettore degli androgeni	GENEORGENEPRODUCT	 367
15599941	235	255	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
15599941	351	380	antigene prostatico specifico	GENEORGENEPRODUCT	354
15599941	412	415	PSA	GENEORGENEPRODUCT	354
15599941	488	508	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
15599941	553	555	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	596	599	PSA	GENEORGENEPRODUCT	354
15599941	647	650	G/A	SEQUENCEVARIANT	C|SUB|G||A
15599941	709	718	androgeno	CHEMICALENTITY	D000728
15599941	787	812	recettore degli androgeni	GENEORGENEPRODUCT	367
15599941	844	846	AR	GENEORGENEPRODUCT	367
15599941	1036	1038	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	1096	1098	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	1139	1142	PSA	GENEORGENEPRODUCT	354
15599941	1215	1218	PSA	GENEORGENEPRODUCT	354
15599941	1249	1259	Il gene AR	GENEORGENEPRODUCT	367
15599941	1355	1357	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	1385	1393	pazienti	ORGANISMTAXON	9606
15599941	1462	1491	iperplasia prostatica benigna	DISEASEORPHENOTYPICFEATURE	D011470
15599941	1652	1655	PSA	GENEORGENEPRODUCT	354
15599941	1770	1775	Nhe 1	GENEORGENEPRODUCT	6548
15599941	1849	1852	G/A	SEQUENCEVARIANT	C|SUB|G||A
15599941	1891	1893	AR	GENEORGENEPRODUCT	367
15599941	2108	2111	PSA	GENEORGENEPRODUCT	354
15599941	2189	2191	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	2253	2282	iperplasia prostatica benigna	DISEASEORPHENOTYPICFEATURE	D011470
15599941	2327	2330	BPH	DISEASEORPHENOTYPICFEATURE	D011470
15599941	2491	2497	uomini	ORGANISMTAXON	9606
15599941	2597	2600	PSA	GENEORGENEPRODUCT	354
15599941	2681	2691	CAG repeat	SEQUENCEVARIANT	C|DUP||CAG|
15599941	2811	2814	BPH	DISEASEORPHENOTYPICFEATURE	D011470
15599941	2982	2985	PSA	GENEORGENEPRODUCT	354
15599941	3071	3073	PC	DISEASEORPHENOTYPICFEATURE	D011471
15599941	3127	3133	uomini	ORGANISMTAXON	9606
15599941	3227	3252	ripetizione di glutammina	SEQUENCEVARIANT	C|DUP||G|
15599941	3372	3388	malattia maligna	DISEASEORPHENOTYPICFEATURE	D009369
15602202	60	81	nefrite interstiziale	DISEASEORPHENOTYPICFEATURE	D009395
15602202	124	136	azitromicina	CHEMICALENTITY	D017963
15602202	214	226	azitromicina	CHEMICALENTITY	D017963
15602202	285	306	nefrite interstiziale	DISEASEORPHENOTYPICFEATURE	D009395
15602202	450	465	corticosteroidi	CHEMICALENTITY	D000305
15602202	581	592	antibiotico	CHEMICALENTITY	D000900
15602202	647	668	nefrite interstiziale	DISEASEORPHENOTYPICFEATURE	D009395
15602202	733	741	pazienti	ORGANISMTAXON	9606
15602202	803	817	lesione renale	DISEASEORPHENOTYPICFEATURE	D007674
15609295	123	131	Asn45Ser	SEQUENCEVARIANT	RS5030764
15609295	168	195	gene della glicoproteina IX	GENEORGENEPRODUCT	2815
15609295	229	237	paziente	ORGANISMTAXON	9606
15609295	286	313	Sindrome di Bernard-Soulier	DISEASEORPHENOTYPICFEATURE	D001606
15609295	358	385	Sindrome di Bernard-Soulier	DISEASEORPHENOTYPICFEATURE	D001606
15609295	430	433	BSS	DISEASEORPHENOTYPICFEATURE	D001606
15609295	488	518	disturbo emorragico ereditario	DISEASEORPHENOTYPICFEATURE	D025861
15609295	623	649	glicoproteina (GP) Ib/IX/V	GENEORGENEPRODUCT	2811, 2814,2815
15609295	716	741	fattore di von Willebrand	GENEORGENEPRODUCT	7450
15609295	939	942	GPV	GENEORGENEPRODUCT	2814
15609295	1001	1004	BSS	DISEASEORPHENOTYPICFEATURE	D001606
15609295	1114	1117	BSS	DISEASEORPHENOTYPICFEATURE	D001606
15609295	1194	1202	paziente	ORGANISMTAXON	9606
15609295	1323	1336	glicoproteine	GENEORGENEPRODUCT	2811,2814,2815
15609295	1392	1401	GPIb/IX/V	GENEORGENEPRODUCT	2811,2814,2815
15609295	1486	1494	paziente	ORGANISMTAXON	9606
15609295	1574	1578	GPIX	GENEORGENEPRODUCT	2815
15609295	1633	1692	delezione di nove nucleotidi a partire dalla posizione 1952	SEQUENCEVARIANT	C|DEL|1952|9
15609295	1962	2012	asparagina (AAC) per la serina (AGC) al residuo 45	SEQUENCEVARIANT	RS5030764
15609295	2091	2099	Asn45Ser	SEQUENCEVARIANT	RS5030764
15609295	2271	2275	GPIX	GENEORGENEPRODUCT	2815
15609295	2341	2344	BSS	DISEASEORPHENOTYPICFEATURE	D001606
15609295	2385	2393	paziente	ORGANISMTAXON	9606
15614572	59	68	trazodone	CHEMICALENTITY	D014196
15614572	112	132	5-HT 2A/2C recettore	GENEORGENEPRODUCT	25187,29595
15614572	194	202	dopamina	CHEMICALENTITY	D004298
15614572	235	240	ratti	ORGANISMTAXON	 10116
15614572	284	303	5-idrossitriptamina	CHEMICALENTITY	D012701
15614572	361	378	recettori 5-HT 2C	GENEORGENEPRODUCT	25187
15614572	517	534	recettori 5-HT 2A	GENEORGENEPRODUCT	29595
15614572	633	642	trazodone	CHEMICALENTITY	D014196
15614572	686	706	recettore 5-HT 2A/2C	GENEORGENEPRODUCT	25187,29595
15614572	801	810	trazodone	CHEMICALENTITY	D014196
15614572	972	981	trazodone	CHEMICALENTITY	D014196
15614572	1016	1029	dexamfetamina	CHEMICALENTITY	D003913
15614572	1065	1075	apomorfina	CHEMICALENTITY	D001058
15614572	1130	1146	stereotipi orali	DISEASEORPHENOTYPICFEATURE	D009062
15614572	1195	1205	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
15614572	1248	1259	aloperidolo	CHEMICALENTITY	D006220
15614572	1293	1303	apomorfina	CHEMICALENTITY	D001058
15614572	1376	1387	ergometrina	CHEMICALENTITY	D004874
15614572	1452	1494	 L'erezione del pene indotta da fluoxetina	CHEMICALENTITY	D005473
15614572	1543	1548	ratti	ORGANISMTAXON	10116
15614572	1607	1616	trazodone	CHEMICALENTITY	D014196
15614572	1667	1676	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
15614572	1709	1714	ratti	ORGANISMTAXON	10116
15614572	1758	1767	Trazodone	CHEMICALENTITY	D014196
15614572	1846	1856	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
15614572	1911	1921	apomorfina	CHEMICALENTITY	D001058
15614572	1983	1993	apomorfina	CHEMICALENTITY	D001058
15614572	2050	2059	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
15614572	2146	2155	trazodone	CHEMICALENTITY	D014196
15614572	2198	2211	dexamfetamina	CHEMICALENTITY	D003913
15614572	2272	2283	aloperidolo	CHEMICALENTITY	D006220
15614572	2327	2337	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
15614572	2370	2381	ergometrina	CHEMICALENTITY	D004874
15614572	2470	2480	fluoxetina	CHEMICALENTITY	D005473
15614572	2513	2522	Trazodone	CHEMICALENTITY	D014196
15614572	2591	2600	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
15614572	2648	2658	apomorfina	CHEMICALENTITY	D001058
15614572	2693	2706	dexamfetamina	CHEMICALENTITY	 D003913
15614572	2795	2804	trazodone	CHEMICALENTITY	D014196
15614572	2896	2912	 Recettori D2 DA	GENEORGENEPRODUCT	24318
15614572	3016	3031	Recettori D2 DA	GENEORGENEPRODUCT	24318
15614572	3093	3102	trazodone	CHEMICALENTITY	D014196
15614572	3148	3176	5-HT 2A e 5 -Recettori HT 2C	GENEORGENEPRODUCT	25187,29595
15614572	3224	3233	trazodone	CHEMICALENTITY	D014196
15614572	3299	3316	5-HT 2C recettori	GENEORGENEPRODUCT	25187
15614572	3424	3428	5-HT	CHEMICALENTITY	D012701
15614572	3480	3493	dexamfetamina	CHEMICALENTITY	D003913
15614572	3551	3562	aloperidolo	CHEMICALENTITY	D006220
15614572	3606	3615	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
15623763	31	36	TGFBI	GENEORGENEPRODUCT	7045
15623763	120	159	reticolo e distrofie corneali granulari	DISEASEORPHENOTYPICFEATURE	C537881,D003317
15623763	190	198	pazienti	ORGANISMTAXON	9606
15623763	281	286	TGFBI	GENEORGENEPRODUCT	7045
15623763	317	325	pazienti	ORGANISMTAXON	9606
15623763	381	412	distrofia corneale del reticolo	DISEASEORPHENOTYPICFEATURE	C537881
15623763	457	460	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	508	536	distrofia corneale granulare	DISEASEORPHENOTYPICFEATURE	 D003317
15623763	581	584	GCD	DISEASEORPHENOTYPICFEATURE	D003317
15623763	699	707	pazienti	ORGANISMTAXON	9606
15623763	773	776	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	829	832	MCD	DISEASEORPHENOTYPICFEATURE	D003317
15623763	892	895	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	941	944	MCD	DISEASEORPHENOTYPICFEATURE	D003317
15623763	1114	1119	TGFBI	GENEORGENEPRODUCT	7045
15623763	1517	1525	pazienti	ORGANISMTAXON	9606
15623763	1573	1576	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	1620	1628	pazienti	ORGANISMTAXON	9606
15623763	1676	1679	MCD	DISEASEORPHENOTYPICFEATURE	D003317
15623763	1727	1730	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	1816	1835	glicina-594-valina 	SEQUENCEVARIANT	P|SUB|G|594|V
15623763	1875	1884	Gly594Val	SEQUENCEVARIANT	P|SUB|G|594|V
15623763	1925	1933	pazienti	ORGANISMTAXON	9606
15623763	1973	1999	acido valina-539-aspartico	SEQUENCEVARIANT	P|SUB|V|539|D
15623763	2040	2049	Val539Asp	SEQUENCEVARIANT	P|SUB|V|539|D
15623763	2083	2091	paziente	ORGANISMTAXON	9606
15623763	2268	2276	paziente	ORGANISMTAXON	9606
15623763	2336	2359	arginina 124-a-cisteina	SEQUENCEVARIANT	RS121909210
15623763	2397	2406	Arg124Cys	SEQUENCEVARIANT	RS121909210
15623763	2462	2470	pazienti	ORGANISMTAXON	9606
15623763	2511	2535	istidina 626-a-arginina 	SEQUENCEVARIANT	P|SUB|H|626|R
15623763	2575	2584	His626Arg	SEQUENCEVARIANT	P|SUB|H|626|R
15623763	2625	2633	pazienti	ORGANISMTAXON	9606
15623763	2716	2719	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	2770	2778	pazienti	ORGANISMTAXON	9606
15623763	2822	2831	Gly594Val	SEQUENCEVARIANT	P|SUB|G|594|V
15623763	2949	2952	MCD	DISEASEORPHENOTYPICFEATURE	D003317
15623763	2984	2992	pazienti	ORGANISMTAXON	9606
15623763	3042	3055	GCD di tipo I	DISEASEORPHENOTYPICFEATURE	 C537304
15623763	3120	3145	arginina 555-a-triptofano	SEQUENCEVARIANT	RS121909208
15623763	3184	3193	Arg555Trp	SEQUENCEVARIANT	 RS121909208
15623763	3226	3234	paziente	ORGANISMTAXON	9606
15623763	3282	3294	GCD tipo III	DISEASEORPHENOTYPICFEATURE	C535476
15623763	3339	3365	Distrofia di Reis-Bucklers	DISEASEORPHENOTYPICFEATURE	C535476
15623763	3415	3424	Arg124Leu	SEQUENCEVARIANT	RS121909211
15623763	3575	3601	leucina 269 a fenilalanina	SEQUENCEVARIANT	RS199852470
15623763	3640	3649	Leu269Phe	SEQUENCEVARIANT	RS199852470
15623763	3706	3714	pazienti	ORGANISMTAXON	9606
15623763	3755	3764	Arg555Trp	SEQUENCEVARIANT	RS121909208
15623763	3825	3834	Arg124Cys	SEQUENCEVARIANT	RS121909210
15623763	3873	3882	Arg555Trp	SEQUENCEVARIANT	RS121909208
15623763	3981	3984	LCD	DISEASEORPHENOTYPICFEATURE	C537881
15623763	4030	4033	GCD	DISEASEORPHENOTYPICFEATURE	D003317
15649253	43	80	Linfoma maligno primario del cervello	DISEASEORPHENOTYPICFEATURE	D016543
15649253	153	156	p14	GENEORGENEPRODUCT	11102
15649253	200	206	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15649253	273	314	sistema nervoso centrale primario linfomi	DISEASEORPHENOTYPICFEATURE	D016543
15649253	359	364	PCNSL	DISEASEORPHENOTYPICFEATURE	D016543
15649253	409	426	linfomi cerebrali	DISEASEORPHENOTYPICFEATURE	D016543
15649253	486	489	p14	GENEORGENEPRODUCT	11102
15649253	1104	1107	p14	GENEORGENEPRODUCT	11102
15649253	1346	1352	tumori	DISEASEORPHENOTYPICFEATURE	D009369
15649253	1433	1437	L50R	SEQUENCEVARIANT	P |SUB|L|50|R
15649253	1548	1551	p14	GENEORGENEPRODUCT	11102
15649253	1702	1705	p14	GENEORGENEPRODUCT	11102
15649253	1842	1859	linfoma sistemico	DISEASEORPHENOTYPICFEATURE	D008223
15649253	1899	1902	p14	GENEORGENEPRODUCT	11102
15649253	2028	2041	carcinogenesi	DISEASEORPHENOTYPICFEATURE	D063646
15649253	2089	2094	PCNSL	DISEASEORPHENOTYPICFEATURE	D016543
15649253	2140	2157	sistemica linfoma	DISEASEORPHENOTYPICFEATURE	D008223
15686794	49	58	lombalgia	DISEASEORPHENOTYPICFEATURE	D017116
15686794	132	143	 amiodarone	CHEMICALENTITY	D000638
15686794	202	212	Amiodarone	CHEMICALENTITY	D000638
15686794	259	279	farmaco antiaritmico	CHEMICALENTITY	D000889
15686794	367	388	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15686794	433	435	AF	DISEASEORPHENOTYPICFEATURE	D001281
15686794	526	534	pazienti	ORGANISMTAXON	9606
15686794	589	610	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15686794	692	706	mal di schiena	DISEASEORPHENOTYPICFEATURE	D017116
15686794	802	812	amiodarone	CHEMICALENTITY	D000638
15748645	246	251	umana	ORGANISMTAXON	9606
15748645	386	424	cancro delle cellule basali e squamose	DISEASEORPHENOTYPICFEATURE	D002294,D018295
15748645	469	477	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
15748645	522	531	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
15748645	688	706	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	1002	1020	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	1080	1098	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	1428	1439	cancerogeno	DISEASEORPHENOTYPICFEATURE	D009369
15748645	1658	1682	La promozione del tumore	DISEASEORPHENOTYPICFEATURE	D009369
15748645	1769	1775	cancro	DISEASEORPHENOTYPICFEATURE	D009369
15748645	1986	2012	La progressione del tumore	DISEASEORPHENOTYPICFEATURE	D009369
15748645	2075	2081	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15748645	2263	2281	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	2413	2426	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
15748645	2491	2512	iperplasia epidermica	DISEASEORPHENOTYPICFEATURE	D006965
15748645	2596	2609	antiossidante	CHEMICALENTITY	D000975
15748645	2715	2729	ciclossigenasi	GENEORGENEPRODUCT	5742
15748645	2773	2787	prostaglandine	CHEMICALENTITY	D011453
15748645	2842	2865	ornitina decarbossilasi	GENEORGENEPRODUCT	4953
15748645	3012	3030	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	3125	3138	antiossidanti	CHEMICALENTITY	D000975
15748645	3240	3245	umana	ORGANISMTAXON	9606
15748645	3351	3356	umano	ORGANISMTAXON	9606
15748645	4085	4103	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
15748645	4134	4139	umani	ORGANISMTAXON	9606
15749661	56	61	L490R	SEQUENCEVARIANT	RS80338886
15749661	99	104	V561X	SEQUENCEVARIANT	RS80338887
15749661	146	176	recettore 2 della transferrina	GENEORGENEPRODUCT	7036
15749661	217	227	giapponesi	ORGANISMTAXON	9606
15749661	275	287	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	383	388	C282Y	SEQUENCEVARIANT	RS1800562
15749661	436	439	HFE	GENEORGENEPRODUCT	3077
15749661	540	552	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	594	602	pazienti	ORGANISMTAXON	9606
15749661	698	706	pazienti	ORGANISMTAXON	9606
15749661	835	863	recettore della transferrina	GENEORGENEPRODUCT	7036
15749661	896	900	TfR2	GENEORGENEPRODUCT	7036
15749661	966	970	TfR2	GENEORGENEPRODUCT	7036
15749661	1033	1045	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	1088	1096	pazienti	ORGANISMTAXON	9606
15749661	1148	1156	pazienti	ORGANISMTAXON	9606
15749661	1224	1236	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	1395	1398	HFE	GENEORGENEPRODUCT	3077
15749661	1432	1436	TfR2	GENEORGENEPRODUCT	7036
15749661	1591	1594	HFE	GENEORGENEPRODUCT	3077
15749661	1636	1640	TfR2	GENEORGENEPRODUCT	7036
15749661	1696	1704	1469T->G	SEQUENCEVARIANT	RS80338886
15749661	1742	1747	L490R	SEQUENCEVARIANT	RS80338886
15749661	1786	1794	1665delC	SEQUENCEVARIANT	RS80338887
15749661	1832	1837	V561X	SEQUENCEVARIANT	RS80338887
15749661	1891	1899	pazienti	ORGANISMTAXON	9606
15749661	1979	1983	714C	SEQUENCEVARIANT	RS34242818
15749661	2022	2027	I238M	SEQUENCEVARIANT	RS34242818
15749661	2061	2069	paziente	ORGANISMTAXON	9606
15749661	2109	2114	L490R	SEQUENCEVARIANT	RS80338886
15749661	2146	2154	paziente	ORGANISMTAXON	9606
15749661	2213	2218	L490R	SEQUENCEVARIANT	RS80338886
15749661	2257	2262	I238M	SEQUENCEVARIANT	RS34242818
15749661	2354	2366	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	2448	2457	cirrotico	DISEASEORPHENOTYPICFEATURE	D008103
15749661	2515	2520	ferro	CHEMICALENTITY	D007501
15749661	2575	2608	il test di tolleranza al glucosio	CHEMICALENTITY	D005947
15749661	2672	2687	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
15749661	2719	2727	paziente	ORGANISMTAXON	9606
15749661	2777	2782	V561X	SEQUENCEVARIANT	RS80338887
15749661	2843	2864	sovraccarico di ferro	DISEASEORPHENOTYPICFEATURE	D019190
15749661	2925	2932	cirrosi	DISEASEORPHENOTYPICFEATURE	D008103
15749661	2977	2992	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
15749661	3038	3059	pigmentazione cutanea	DISEASEORPHENOTYPICFEATURE	D010859
15749661	3195	3203	pazienti	ORGANISMTAXON	9606
15749661	3251	3263	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15749661	3356	3360	TfR2	GENEORGENEPRODUCT	7036
15749661	3403	3407	TfR2	GENEORGENEPRODUCT	7036
15749661	3487	3499	emocromatosi	DISEASEORPHENOTYPICFEATURE	D006432
15755837	38	60	diidrofolato reduttasi	GENEORGENEPRODUCT	1719
15755837	95	129	 Delezione della coppia di 19 basi	SEQUENCEVARIANT	C|DEL||19
15755837	213	229	parto pretermine	DISEASEORPHENOTYPICFEATURE	D047928
15755837	275	284	Il folato	CHEMICALENTITY	D005492
15755837	414	436	Diidrofolato reduttasi	GENEORGENEPRODUCT	1719
15755837	469	473	DHFR	GENEORGENEPRODUCT	1719
15755837	536	548	acido folico	CHEMICALENTITY	D005492
15755837	649	661	diidrofolato	CHEMICALENTITY	C010920
15755837	705	723	timidilato sintasi	GENEORGENEPRODUCT	7298
15755837	794	800	folato	CHEMICALENTITY	D005492
15755837	968	981	D Il gene HFR	GENEORGENEPRODUCT	1719
15755837	1053	1069	parto pretermine	DISEASEORPHENOTYPICFEATURE	D047928
15755837	1126	1131	donne	ORGANISMTAXON	9606
15755837	1173	1178	donne	ORGANISMTAXON	9606
15755837	1387	1395	Le donne	ORGANISMTAXON	9606
15755837	1516	1532	parto pretermine	DISEASEORPHENOTYPICFEATURE	D047928
15755837	1672	1677	Donne	ORGANISMTAXON	9606
15755837	1737	1741	DHFR	GENEORGENEPRODUCT	1719
15755837	1785	1807	l'assunzione di folati	CHEMICALENTITY	D005492
15755837	1954	1970	parto pretermine	DISEASEORPHENOTYPICFEATURE	D047928
15755837	2181	2186	donne	ORGANISMTAXON	9606
15755837	2271	2277	folato	CHEMICALENTITY	D005492
15755837	2345	2349	DHFR	GENEORGENEPRODUCT	1719
15755837	2384	2417	Eliminazione di 19 coppie di basi	SEQUENCEVARIANT	C|DEL||19
15755837	2507	2523	parto pretermine	DISEASEORPHENOTYPICFEATURE	D047928
15755837	2597	2603	folato	CHEMICALENTITY	D005492
15770495	80	88	pazienti	ORGANISMTAXON	9606
15770495	137	186	deficit della 5alfa-reduttasi steroidea di tipo 2	DISEASEORPHENOTYPICFEATURE	C535830
15770495	238	269	steroide 5alfa-reduttasi tipo 2	GENEORGENEPRODUCT	6716
15770495	302	308	SRD5A2	GENEORGENEPRODUCT	6716
15770495	516	522	SRD5A2	GENEORGENEPRODUCT	6716
15770495	703	711	pazienti	ORGANISMTAXON	9606
15770495	768	816	deficit di 5alfa-reduttasi di tipo 2 di steroidi	DISEASEORPHENOTYPICFEATURE	C535830
15770495	920	926	SRD5A2	GENEORGENEPRODUCT	6716
15770495	1026	1034	pazienti	ORGANISMTAXON	9606
15770495	1089	1094	G183S	SEQUENCEVARIANT	RS121434247
15770495	1140	1145	R246W	SEQUENCEVARIANT	RS121434244
15770495	1196	1203	del642T	SEQUENCEVARIANT	C|DEL|642|T
15770495	1249	1254	G196S	SEQUENCEVARIANT	RS121434250
15770495	1368	1372	A49T	SEQUENCEVARIANT	RS9282858
15770495	1479	1484	Q126R	SEQUENCEVARIANT	RS368386747
15770495	1582	1587	Q126R	SEQUENCEVARIANT	RS368386747
15770495	1624	1632	 del418T	SEQUENCEVARIANT	C|DEL|418|T
15770495	1688	1693	Q126R	SEQUENCEVARIANT	RS368386747
15770495	1733	1738	G158R	SEQUENCEVARIANT	P|SUB|G|158| R
15770495	1772	1780	pazienti	ORGANISMTAXON	9606
15770495	1839	1844	A207D	SEQUENCEVARIANT	RS767564684
15770495	1883	1888	G196S	SEQUENCEVARIANT	RS121434250
15770495	1929	1934	R266W	SEQUENCEVARIANT	P|SUB|R|266|W
15770495	1998	2002	V89L	SEQUENCEVARIANT	RS523349
15770495	2090	2095	A207D	SEQUENCEVARIANT	RS767564684
15770495	2201	2205	A49T	SEQUENCEVARIANT	RS9282858
15770495	2338	2346	pazienti	ORGANISMTAXON	9606
15770495	2409	2415	SRD5A2	GENEORGENEPRODUCT	6716
15770495	2511	2518	del642T	SEQUENCEVARIANT	C|DEL|642|T
15770495	2561	2566	G158R	SEQUENCEVARIANT	P|SUB|G|158|R
15770495	2954	2960	SRD5A2	GENEORGENEPRODUCT	6716
15770495	3086	3091	G183S	SEQUENCEVARIANT	RS121434247
15770495	3157	3166	 pazienti	ORGANISMTAXON	9606
15807692	62	75	VII collagene	GENEORGENEPRODUCT	1294
15807692	160	201	epidermolisi bollosa distrofica recessiva	DISEASEORPHENOTYPICFEATURE	D016108
15807692	395	408	VII collagene	GENEORGENEPRODUCT	1294
15807692	469	510	epidermolisi bollosa distrofica recessiva	DISEASEORPHENOTYPICFEATURE	D016108
15807692	555	582	 Variante Hallopeau-Siemens	DISEASEORPHENOTYPICFEATURE	D016108
15807692	627	634	HS-RDEB	DISEASEORPHENOTYPICFEATURE	D016108
15807692	694	765	delezione di una singola coppia di basi di un nucleotide della citosina	SEQUENCEVARIANT	C |DEL||C
15807692	828	836	3472delC	SEQUENCEVARIANT	C|DEL|3472|C
15807692	1056	1061	G-->A	SEQUENCEVARIANT	C|SUB|G||A
15807692	1654	1661	HS-RDEB	DISEASEORPHENOTYPICFEATURE	D016108
15814629	56	77	metastasi linfonodali	DISEASEORPHENOTYPICFEATURE	D009362
15814629	124	139	gastrico cancro	DISEASEORPHENOTYPICFEATURE	D013274
15814629	186	227	enzima di conversione dell'angiotensina I	GENEORGENEPRODUCT	1636
15814629	389	430	enzima di conversione dell'angiotensina I	GENEORGENEPRODUCT	1636
15814629	463	467	ACE 	GENEORGENEPRODUCT	1636
15814629	515	530	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15814629	636	652	 cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15814629	846	849	ACE	GENEORGENEPRODUCT	1636
15814629	920	927	agarose	CHEMICALENTITY	D012685
15814629	1086	1089	ACE	GENEORGENEPRODUCT	1636
15814629	1215	1230	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15814629	1258	1266	pazienti	ORGANISMTAXON	9606
15814629	1381	1384	ACE	GENEORGENEPRODUCT	1636
15814629	1476	1484	pazienti	ORGANISMTAXON	9606
15814629	1534	1549	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15814629	1603	1606	ACE	GENEORGENEPRODUCT	1636
15814629	1679	1700	metastasi linfonodali	DISEASEORPHENOTYPICFEATURE	D009362
15814629	1798	1804	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	1833	1843	I pazienti	ORGANISMTAXON	9606
15814629	1961	1982	metastasi linfonodali	DISEASEORPHENOTYPICFEATURE	D009362
15814629	2056	2062	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	2141	2149	pazienti	ORGANISMTAXON	9606
15814629	2257	2263	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	2313	2319	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	2382	2388	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	2442	2451	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
15814629	2490	2493	ACE	GENEORGENEPRODUCT	 1636
15814629	2552	2555	ACE	GENEORGENEPRODUCT	1636
15814629	2602	2617	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15814629	2669	2677	pazienti	ORGANISMTAXON	9606
15814629	2750	2753	ACE	GENEORGENEPRODUCT	1636
15814629	2872	2878	tumore	DISEASEORPHENOTYPICFEATURE	D009369
15814629	2981	2984	ACE	GENEORGENEPRODUCT	1636
15814629	3053	3068	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
15817013	82	103	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15817013	138	147	 warfarin	CHEMICALENTITY	D014859
15817013	204	213	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
15817013	259	264	ictus	DISEASEORPHENOTYPICFEATURE	D020521
15817013	306	314	paziente	ORGANISMTAXON	9606
15817013	415	424	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
15817013	470	475	ictus	DISEASEORPHENOTYPICFEATURE	D020521
15817013	559	580	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15817013	633	641	warfarin	CHEMICALENTITY	D014859
15817013	891	899	pazienti	ORGANISMTAXON	9606
15817013	1071	1092	fibrillazione atriale	DISEASEORPHENOTYPICFEATURE	D001281
15817013	1127	1135	warfarin	CHEMICALENTITY	D014859
15817013	1244	1257	sanguinamento	DISEASEORPHENOTYPICFEATURE	D006470
15817013	1302	1307	ictus	DISEASEORPHENOTYPICFEATURE	D020521
15817013	1342	1359	l'uso di warfarin	CHEMICALENTITY	D014859
15817013	1407	1415	pazienti	ORGANISMTAXON	9606
15817013	1517	1525	pazienti	ORGANISMTAXON	9606
15817013	1558	1564	uomini	ORGANISMTAXON	9606
15817013	1689	1697	warfarin	CHEMICALENTITY	D014859
15817013	1806	1815	emorragie	DISEASEORPHENOTYPICFEATURE	D006470
15817013	1955	1964	emorragie	DISEASEORPHENOTYPICFEATURE	D006470
15817013	2029	2034	ictus	DISEASEORPHENOTYPICFEATURE	D020521
15817013	2083	2091	warfarin	CHEMICALENTITY	D014859
15817013	2174	2183	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
15817013	2339	2344	ictus	DISEASEORPHENOTYPICFEATURE	D020521
15817013	2388	2396	warfarin	CHEMICALENTITY	D014859
15817013	2474	2482	warfarin	CHEMICALENTITY	D014859
15851735	48	72	encefalopatia da glicina	DISEASEORPHENOTYPICFEATURE	D020158
15851735	117	120	NKH	DISEASEORPHENOTYPICFEATURE	D020158
15851735	214	218	GLDC	GENEORGENEPRODUCT	2731
15851735	311	335	encefalopatia da glicina	DISEASEORPHENOTYPICFEATURE	D020158
15851735	380	382	GE	DISEASEORPHENOTYPICFEATURE	D020158
15851735	671	673	GE	DISEASEORPHENOTYPICFEATURE	D020158
15851735	844	848	GLDC	GENEORGENEPRODUCT	2731
15851735	880	883	AMT	GENEORGENEPRODUCT	275
15851735	918	922	GCSH	GENEORGENEPRODUCT	2653
15851735	974	978	GLDC	GENEORGENEPRODUCT	2731
15851735	1170	1178	ipotonia	DISEASEORPHENOTYPICFEATURE	D009123
15851735	1223	1241	movimenti anormali	DISEASEORPHENOTYPICFEATURE	D009069
15851735	1287	1298	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
15851735	1344	1359	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
15851735	1516	1528	Aggressività	DISEASEORPHENOTYPICFEATURE	D001523
15851735	1574	1586	irritabilità	DISEASEORPHENOTYPICFEATURE	D001523
15851735	1723	1731	pazienti	ORGANISMTAXON	9606
15851735	1849	1853	GLDC	GENEORGENEPRODUCT	2731
15851735	1917	1926	c.2607C>A	SEQUENCEVARIANT	RS386833565
15851735	1971	1975	GLDC	GENEORGENEPRODUCT	2731
15851735	2254	2263	c.2607C>A	SEQUENCEVARIANT	RS386833565
15851735	2325	2376	paziente non correlato ma aplotipicamente identico 	ORGANISMTAXON	9606
15851735	2496	2498	GE	DISEASEORPHENOTYPICFEATURE	D020158
15851735	2729	2733	GLDC	GENEORGENEPRODUCT	2731
15851735	2766	2788	glicina decarbossilasi	GENEORGENEPRODUCT	2731
15851735	2845	2849	GLDC	GENEORGENEPRODUCT	2731
15851735	2909	2917	pazienti	ORGANISMTAXON	9606
15851735	3021	3029	pazienti	ORGANISMTAXON	9606
15851735	3077	3101	encefalopatia da glicina	DISEASEORPHENOTYPICFEATURE	D020158
15858223	31	46	Acido valproico	CHEMICALENTITY	D014635
15858223	104	111	lipidi 	CHEMICALENTITY	D008055
15858223	187	204	tossicità epatica	DISEASEORPHENOTYPICFEATURE	D056486
15858223	238	253	acido valproico	CHEMICALENTITY	D014635
15858223	307	312	ratti	ORGANISMTAXON	10116
15858223	365	380	acido valproico	CHEMICALENTITY	D014635
15858223	413	416	VPA	CHEMICALENTITY	D014635
15858223	465	487	farmaco antiepilettico	CHEMICALENTITY	D000927
15858223	552	557	ratti	ORGANISMTAXON	10116
15858223	641	661	15-F(2t)-isoprostane	CHEMICALENTITY	C075750
15858223	694	708	15-F(2t)-IsoP 	CHEMICALENTITY	C075750
15858223	796	799	VPA	CHEMICALENTITY	D014635
15858223	873	887	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
15858223	947	952	ratti	ORGANISMTAXON	10116
15858223	1011	1014	VPA	CHEMICALENTITY	D014635
15858223	1237	1250	15-F(2t)-IsoP	CHEMICALENTITY	C075750
15858223	1283	1306	idroperossidi lipidici 	CHEMICALENTITY	D008054
15858223	1339	1342	LPO	CHEMICALENTITY	D008054
15858223	1377	1420	sostanze reattive dell'acido tiobarbiturico	CHEMICALENTITY	D017392
15858223	1453	1457	TBAR	CHEMICALENTITY	D017392
15858223	1507	1520	15-F(2t)-IsoP	CHEMICALENTITY	C075750
15858223	1620	1624	VPA 	CHEMICALENTITY	D014635
15858223	1698	1714	I livelli di LPO	CHEMICALENTITY	D008054
15858223	1857	1862	TBARs	CHEMICALENTITY	D017392
15858223	1984	2004	La tossicità epatica	DISEASEORPHENOTYPICFEATURE	D056486
15858223	2088	2117	alfa-glutatione S-transferasi	GENEORGENEPRODUCT	24421
15858223	2151	2160	alpha-GST	GENEORGENEPRODUCT	24421
15858223	2232	2240	alfa-GST	GENEORGENEPRODUCT	24421
15858223	2356	2370	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
15858223	2459	2494	infiammazione della capsula epatica	DISEASEORPHENOTYPICFEATURE	D006505
15858223	2539	2546	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
15858223	2592	2600	steatosi	DISEASEORPHENOTYPICFEATURE	D005234
15858223	2710	2713	VPA	CHEMICALENTITY	D014635
15858223	2804	2814	4- ene-VPA	CHEMICALENTITY	C045022
15858223	2852	2865	2,4-diene-VPA	CHEMICALENTITY	C556631
15858223	2998	3001	VPA	CHEMICALENTITY	D014635
15858223	3084	3098	15-F( 2t)-IsoP	CHEMICALENTITY	C075750
15858223	3171	3178	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
15858223	3223	3231	steatosi	DISEASEORPHENOTYPICFEATURE	D005234
15858223	3291	3299	alfa-GST	GENEORGENEPRODUCT	24421
15859361	44	53	celecoxib	CHEMICALENTITY	C105934
15859361	84	92	pazienti	ORGANISMTAXON	9606
15859361	140	156	reazioni cutanee	DISEASEORPHENOTYPICFEATURE	D003875
15859361	198	210	paracetamolo	CHEMICALENTITY	D000082
15859361	244	256	paracetamolo	CHEMICALENTITY	D000082
15859361	291	301	nimesulide	CHEMICALENTITY	C012655
15859361	361	398	farmaci antinfiammatori non steroidei	CHEMICALENTITY	D000894
15859361	443	456	Acetaminofene	CHEMICALENTITY	D000082
15859361	489	501	paracetamolo	CHEMICALENTITY	D000082
15859361	535	536	P	CHEMICALENTITY	D000082
15859361	571	581	Nimesulide	CHEMICALENTITY	C012655
15859361	599	600	N	CHEMICALENTITY	C012655
15859361	686	698	antipiretici	CHEMICALENTITY	D058633
15859361	730	753	farmaci antinfiammatori	CHEMICALENTITY	D000893
15859361	827	842	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D004342
15859361	925	962	farmaci antinfiammatori non steroidei	CHEMICALENTITY	D000894
15859361	995	999	FANS	CHEMICALENTITY	D000894
15859361	1077	1086	Celecoxib	CHEMICALENTITY	C105934
15859361	1119	1121	CE	CHEMICALENTITY	C105934
15859361	1213	1218	COX-2	GENEORGENEPRODUCT	4513
15859361	1306	1308	CE	CHEMICALENTITY	C105934
15859361	1352	1360	pazienti	ORGANISMTAXON	9606
15859361	1430	1446	reazioni cutanee	DISEASEORPHENOTYPICFEATURE	D003875
15859361	1480	1481	P	CHEMICALENTITY	D000082
15859361	1501	1502	N	CHEMICALENTITY	C012655
15859361	1578	1582	FANS	CHEMICALENTITY	D000894
15859361	1638	1646	pazienti	ORGANISMTAXON	9606
15859361	1694	1709	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D004342
15859361	1744	1745	P	CHEMICALENTITY	D000082
15859361	1764	1765	N	CHEMICALENTITY	C012655
15859361	1856	1860	FANS	CHEMICALENTITY	D000894
15859361	1908	1909	P	CHEMICALENTITY	D000082
15859361	1928	1929	N	CHEMICALENTITY	C012655
15859361	1997	2013	reazioni cutanee	DISEASEORPHENOTYPICFEATURE	D003875
15859361	2219	2221	CE	CHEMICALENTITY	C105934
15859361	2341	2349	pazienti	ORGANISMTAXON	9606
15859361	2595	2602	eritema	DISEASEORPHENOTYPICFEATURE	D004890
15859361	2654	2663	orticaria	DISEASEORPHENOTYPICFEATURE	D014581
15859361	2707	2717	angioedema	DISEASEORPHENOTYPICFEATURE	D000799
15859361	2814	2822	pazienti	ORGANISMTAXON	9606
15859361	2878	2880	CE	CHEMICALENTITY	C105934
15859361	2917	2925	paziente	ORGANISMTAXON	9606
15859361	2996	3006	angioedema	DISEASEORPHENOTYPICFEATURE	D000799
15859361	3095	3110	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D004342
15859361	3144	3146	CE	CHEMICALENTITY	C105934
15859361	3205	3206	P	CHEMICALENTITY	D000082
15859361	3225	3226	N	CHEMICALENTITY	C012655
15859361	3279	3284	FANS 	CHEMICALENTITY	D000894
15859361	3325	3333	pazienti	ORGANISMTAXON	9606
15859361	3392	3394	CE	CHEMICALENTITY	C105934
15859361	3510	3511	P	CHEMICALENTITY	D000082
15859361	3530	3531	N	CHEMICALENTITY	C012655
15893386	31	45	Succinilcolina	CHEMICALENTITY	D013390
15893386	97	125	rigidità muscolare massetere	DISEASEORPHENOTYPICFEATURE	D014313
15893386	236	271	La rigidità muscolare del massetere	DISEASEORPHENOTYPICFEATURE	D014313
15893386	409	427	ipertermia maligna	DISEASEORPHENOTYPICFEATURE	D008305
15893386	597	633	rigidità muscolare del massaggiatore	DISEASEORPHENOTYPICFEATURE	D014313
15893386	711	739	rigidità muscolare massetere	DISEASEORPHENOTYPICFEATURE	D014313
15893386	784	802	mascella d'acciaio	DISEASEORPHENOTYPICFEATURE	D014313
15893386	863	877	succinilcolina	CHEMICALENTITY	D013390
15893386	910	913	Sch	CHEMICALENTITY	D013390
15893386	1126	1134	propofol	CHEMICALENTITY	D015742
15893386	1246	1264	ipertermia maligna	DISEASEORPHENOTYPICFEATURE	D008305
15897593	31	42	Dexrazoxane	CHEMICALENTITY	D064730
15897593	98	115	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
15897593	195	204	etoposide	CHEMICALENTITY	D005047
15897593	238	251	daunorubicina	CHEMICALENTITY	D003630
15897593	290	302	doxorubicina	CHEMICALENTITY	D004317
15897593	345	357	antracicline	CHEMICALENTITY	D018943
15897593	389	402	daunorubicina	CHEMICALENTITY	D003630
15897593	437	449	doxorubicina	CHEMICALENTITY	 D004317
15897593	483	502	epipodofillotossina	CHEMICALENTITY	D011034
15897593	534	543	etoposide	CHEMICALENTITY	D005047
15897593	698	715	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
15897593	761	779	tossicità cardiaca	DISEASEORPHENOTYPICFEATURE	D066126
15897593	830	841	Dexrazoxane	CHEMICALENTITY	D064730
15897593	874	882	ICRF-187	CHEMICALENTITY	D064730
15897593	955	967	antraciclina	CHEMICALENTITY	D018943
15897593	1022	1037	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
15897593	1137	1158	tossicità ematologica	DISEASEORPHENOTYPICFEATURE	D006402
15897593	1239	1250	dexrazoxane	CHEMICALENTITY	D064730
15897593	1391	1396	umano	ORGANISMTAXON	9606
15897593	1427	1431	muri	ORGANISMTAXON	10090
15897593	1497	1506	etoposide	CHEMICALENTITY	D005047
15897593	1539	1552	daunorubicina	CHEMICALENTITY	D003630
15897593	1587	1599	doxorubicina	CHEMICALENTITY	D004317
15897593	1635	1646	dexrazoxane	CHEMICALENTITY	D064730
15897593	1789	1793	topi	ORGANISMTAXON	10090
15897593	1849	1858	etoposide	CHEMICALENTITY	D005047
15897593	1892	1905	daunorubicina	CHEMICALENTITY	D003630
15897593	1939	1951	doxorubicina	CHEMICALENTITY	D004317
15897593	1997	2008	dexrazoxane	CHEMICALENTITY	 D064730
15897593	2175	2186	dexrazoxane	CHEMICALENTITY	D064730
15897593	2238	2255	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
15897593	2302	2317	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
15897593	2352	2365	daunorubicina	CHEMICALENTITY	D003630
15897593	2399	2408	etoposide	CHEMICALENTITY	D005047
15897593	2440	2444	topi	ORGANISMTAXON	10090
15897593	2565	2576	dexrazoxane	CHEMICALENTITY	D064730
15897593	2631	2648	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
15897593	2694	2709	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
15897593	2757	2770	citotossicità	DISEASEORPHENOTYPICFEATURE	D064420
15897593	2805	2817	doxorubicina	CHEMICALENTITY	D004317
15897593	2920	2931	dexrazoxane	CHEMICALENTITY	D064730
15897593	3030	3042	doxorubicina	CHEMICALENTITY	D004317
15897593	3125	3138	daunorubicina	CHEMICALENTITY	D003630
15897593	3378	3387	etoposide	CHEMICALENTITY	D005047
15897593	3455	3466	dexrazoxane	CHEMICALENTITY	D064730
15897593	3512	3520	pazienti	ORGANISMTAXON	9606
15897593	3577	3586	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
15897593	3633	3644	dexrazoxane	CHEMICALENTITY	D064730
15897593	3691	3700	etoposide	CHEMICALENTITY	D005047
15897593	3814	3835	tossicità ematologica	DISEASEORPHENOTYPICFEATURE	D006402
15897593	4027	4038	citotossica	DISEASEORPHENOTYPICFEATURE	D064420
15957009	56	71	5-HT6 recettore	GENEORGENEPRODUCT	64354
15957009	103	113	Ro4368554 	CHEMICALENTITY	C507242
15957009	188	199	colinergico	CHEMICALENTITY	D018678
15957009	233	246	serotonergico	CHEMICALENTITY	D018490
15957009	301	319	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
15957009	352	355	rat	ORGANISMTAXON	10116
15957009	409	455	recettori della serotonina di tipo 6 (5-HT(6))	GENEORGENEPRODUCT	64354
15957009	649	661	acetilcolina	CHEMICALENTITY	D000109
15957009	694	698	ACh 	CHEMICALENTITY	D000109
15957009	845	852	5-HT(6)	GENEORGENEPRODUCT	64354
15957009	884	893	Ro4368554	CHEMICALENTITY	C507242
15957009	926	978	3-benzensolfonil-7-(4-metil-piperazin-1-il)1H-indolo	CHEMICALENTITY	C507242
15957009	1015	1018	rat	ORGANISMTAXON	10116
15957009	1103	1114	colinergico	CHEMICALENTITY	D018678
15957009	1148	1159	scopolamina	CHEMICALENTITY	D012601
15957009	1212	1225	serotonergico	CHEMICALENTITY	D018490
15957009	1259	1269	triptofano	CHEMICALENTITY	D014364
15957009	1302	1305	TRP	CHEMICALENTITY	D014364
15957009	1409	1428	acetilcolinesterasi	GENEORGENEPRODUCT	 83817
15957009	1470	1481	metrifonato	CHEMICALENTITY	D014236
15957009	1666	1677	metrifonate	CHEMICALENTITY	D014236
15957009	1788	1797	Ro4368554	CHEMICALENTITY	C507242
15957009	1853	1862	Ro4368554	CHEMICALENTITY	C507242
15957009	1944	1955	metrifonato	CHEMICALENTITY	D014236
15957009	2042	2060	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
15957009	2103	2114	scopolamine	CHEMICALENTITY	D012601
15957009	2148	2151	TRP	CHEMICALENTITY	D014364
15957009	2269	2278	Ro4368554	CHEMICALENTITY	C507242
15957009	2389	2400	colinergico	CHEMICALENTITY	D018678
15957009	2437	2450	serotonergico	CHEMICALENTITY	D018490
15957009	2494	2512	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
15957009	2665	2674	Ro4368554	CHEMICALENTITY	C507242
15957009	2730	2763	5-HT(6 ) antagonisti recettoriali	CHEMICALENTITY	D012702
15970799	64	71	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	105	112	OATP-C 	GENEORGENEPRODUCT	10599
15970799	156	163	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	199	206	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	244	251	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	290	296	C1007G	SEQUENCEVARIANT	RS72559747
15970799	469	476	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	513	520	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	604	616	pravastatina	CHEMICALENTITY	D017035
15970799	719	726	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	778	785	OATP1B1	GENEORGENEPRODUCT	10599
15970799	850	857	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	911	918	OATP1B1	GENEORGENEPRODUCT	10599
15970799	1072	1079	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	1128	1135	C1007G 	SEQUENCEVARIANT	RS72559747
15970799	1196	1204	paziente	ORGANISMTAXON	9606
15970799	1240	1252	pravastatina	CHEMICALENTITY	D017035
15970799	1304	1312	miopatia	DISEASEORPHENOTYPICFEATURE	D009135
15970799	1376	1383	OATP1B1	GENEORGENEPRODUCT	10599
15970799	1673	1679	trizio	CHEMICALENTITY	D014316
15970799	1723	1753	estradiol-17beta-D-glucuronide	CHEMICALENTITY	C025483
15970799	1787	1804	estrone-3-solfato	CHEMICALENTITY	C017296
15970799	1856	1868	pravastatina	CHEMICALENTITY	D017035
15970799	1904	1917	atorvastatina	CHEMICALENTITY	D000069059
15970799	1951	1964	cerivastatina	CHEMICALENTITY	 C086276
15970799	1998	2010	simvastatina	CHEMICALENTITY	D019821
15970799	2172	2179	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	2228	2234	C1007G	SEQUENCEVARIANT	RS72559747
15970799	2317	2324	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	2368	2374	C1007G	SEQUENCEVARIANT	RS72559747
15970799	2416	2422	C1007G	SEQUENCEVARIANT	RS72559747
15970799	2524	2536	simvastatina	CHEMICALENTITY	D019821
15970799	2591	2603	pravastatina	CHEMICALENTITY	D017035
15970799	2640	2653	atorvastatina	CHEMICALENTITY	D000069059
15970799	2818	2825	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	2874	2880	C1007G	SEQUENCEVARIANT	RS72559747
15970799	2958	2965	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	3014	3020	C1007G	SEQUENCEVARIANT	RS72559747
15970799	3207	3213	521T>C	SEQUENCEVARIANT	C|SUB|T|521|C
15970799	3272	3280	SLCO1B1 	GENEORGENEPRODUCT	10599
15970799	3329	3335	C1007G	SEQUENCEVARIANT	RS72559747
15970799	3462	3469	SLCO1B1	GENEORGENEPRODUCT	10599
15970799	3518	3524	C1007G	SEQUENCEVARIANT	RS72559747
15983230	48	54	SLC2A2	GENEORGENEPRODUCT	6514
15983230	87	92	GLUT2	GENEORGENEPRODUCT	6514
15983230	172	203	tolleranza al glucosio alterata	DISEASEORPHENOTYPICFEATURE	D018149
15983230	249	266	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	350	357	Diabete	DISEASEORPHENOTYPICFEATURE	D003920
15983230	402	436	La secrezione di insulina alterata	DISEASEORPHENOTYPICFEATURE	D003920
15983230	509	526	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	685	693	insulina	GENEORGENEPRODUCT	3630
15983230	726	733	 SLC2A2	GENEORGENEPRODUCT	6514
15983230	775	780	GLUT2	GENEORGENEPRODUCT	6514
15983230	814	817	GCK	GENEORGENEPRODUCT	2645
15983230	850	854	TCF1	GENEORGENEPRODUCT	6927
15983230	896	906	HNF-1alpha	GENEORGENEPRODUCT	6927
15983230	941	946	HNF4A	GENEORGENEPRODUCT	3172
15983230	979	982	GIP	GENEORGENEPRODUCT	2695
15983230	1016	1021	GLP1R	GENEORGENEPRODUCT	2740
15983230	1101	1132	tolleranza al glucosio alterata	DISEASEORPHENOTYPICFEATURE	D018149
15983230	1177	1180	IGT	DISEASEORPHENOTYPICFEATURE	D018149
15983230	1227	1244	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	1319	1326	Diabete	DISEASEORPHENOTYPICFEATURE	D003920
15983230	1400	1406	SLC2A2	GENEORGENEPRODUCT	6514
15983230	1496	1513	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	1573	1579	SLC2A2	GENEORGENEPRODUCT	6514
15983230	1656	1663	diabete	DISEASEORPHENOTYPICFEATURE	D003920
15983230	1698	1704	rs5393	SEQUENCEVARIANT	RS5393
15983230	1789	1806	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	1956	1973	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
15983230	2164	2170	SLC2A2	GENEORGENEPRODUCT	6514
15983230	2242	2249	diabete	DISEASEORPHENOTYPICFEATURE	D003920
15983230	2297	2302	obesi	DISEASEORPHENOTYPICFEATURE	D009765
15983230	2359	2362	IGT	DISEASEORPHENOTYPICFEATURE	D018149
16001362	50	90	atassia cerebellare autosomica dominante	DISEASEORPHENOTYPICFEATURE	OMIM:604121
16001362	306	349	Rho guanina-fattore di scambio nucleotidico	GENEORGENEPRODUCT	9138
16001362	398	438	Atassia cerebellare autosomica dominante	DISEASEORPHENOTYPICFEATURE	OMIM:604121
16001362	487	491	ADCA	DISEASEORPHENOTYPICFEATURE	OMIM:604121
16001362	562	588	disturbi neurodegenerativi	DISEASEORPHENOTYPICFEATURE	D019636
16001362	734	754	atassia degenerativa	DISEASEORPHENOTYPICFEATURE	D001259
16001362	835	839	ADCA	DISEASEORPHENOTYPICFEATURE	 OMIM:604121
16001362	924	943	atassia cerebellare	DISEASEORPHENOTYPICFEATURE	D002524
16001362	1058	1099	compromissione dell'udito neurosensoriale	DISEASEORPHENOTYPICFEATURE	D034381
16001362	1166	1173	atassia	DISEASEORPHENOTYPICFEATURE	D001259
16001362	1347	1355	pazienti	ORGANISMTAXON	9606
16001362	1458	1463	C-->T	SEQUENCEVARIANT	C|SUB|C||T
16001362	1630	1642	DKFZP434I216	GENEORGENEPRODUCT	25894
16001362	1698	1711	puratrofina-1	GENEORGENEPRODUCT	25894
16001362	1747	1802	Atrofia cellulare di Purkinje associata alla proteina-1	GENEORGENEPRODUCT	25894
16001362	1856	1869	puratrofina-1	GENEORGENEPRODUCT	25894
16001362	2028	2065	fattore di scambio guanina-nucleotide	GENEORGENEPRODUCT	9138
16001362	2098	2101	GEF	GENEORGENEPRODUCT	9138
16001362	2138	2149	Rho GTPases	GENEORGENEPRODUCT	 387
16001362	2239	2252	puratrofina-1	GENEORGENEPRODUCT	25894
16001362	2318	2323	actin	GENEORGENEPRODUCT	60
16001362	2388	2401	Puratrofina-1	GENEORGENEPRODUCT	25894
16001362	2624	2628	ADCA	DISEASEORPHENOTYPICFEATURE	OMIM:604121
16001362	2722	2735	puratrofina-1	GENEORGENEPRODUCT	25894
16001362	3003	3008	umana	ORGANISMTAXON	9606
16001362	3188	3191	GEF	GENEORGENEPRODUCT	9138
16001362	3249	3274	cerebellare degenerazione	DISEASEORPHENOTYPICFEATURE	D013132
16001362	3305	3310	umani	ORGANISMTAXON	9606
16005363	61	65	WFS1	GENEORGENEPRODUCT	7466
16005363	176	184	pazienti	ORGANISMTAXON	9606
16005363	232	248	Wolfram sindrome	DISEASEORPHENOTYPICFEATURE	D014929
16005363	293	312	Sindrome di Wolfram	DISEASEORPHENOTYPICFEATURE	D014929
16005363	357	360	WFS	DISEASEORPHENOTYPICFEATURE	D014929
16005363	412	441	disturbo autosomico recessivo	DISEASEORPHENOTYPICFEATURE	D030342
16005363	519	534	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
16005363	591	606	 atrofia ottica	DISEASEORPHENOTYPICFEATURE	D009896
16005363	651	674	sordità neurosensoriale	DISEASEORPHENOTYPICFEATURE	D006319
16005363	720	736	diabete insipido	DISEASEORPHENOTYPICFEATURE	D003919
16005363	823	849	anomalie del tratto renale	DISEASEORPHENOTYPICFEATURE	D007674
16005363	916	938	sindromi psichiatriche	DISEASEORPHENOTYPICFEATURE	D001523
16005363	971	975	WFS1	GENEORGENEPRODUCT	7466
16005363	1113	1116	WFS	DISEASEORPHENOTYPICFEATURE	D014929
16005363	1241	1245	WFS1	GENEORGENEPRODUCT	7466
16005363	1283	1291	pazienti	ORGANISMTAXON	9606
16005363	1370	1400	inserimento di nove nucleotidi	SEQUENCEVARIANT	C|INS||9
16005363	1510	1518	pazienti	ORGANISMTAXON	9606
16005363	1573	1588	ipopituitarismo	DISEASEORPHENOTYPICFEATURE	D007018
16005363	1669	1672	WFS	DISEASEORPHENOTYPICFEATURE	D014929
16005363	1799	1802	WFS	DISEASEORPHENOTYPICFEATURE	D014929
16005363	1915	1918	WFS	DISEASEORPHENOTYPICFEATURE	D014929
16120104	107	112	hPER2	GENEORGENEPRODUCT	8864
16120104	187	194	PERIOD2	GENEORGENEPRODUCT	8864
16120104	227	231	PER2	GENEORGENEPRODUCT	8864
16120104	381	386	umano	ORGANISMTAXON	9606
16120104	418	422	PER2	GENEORGENEPRODUCT	8864
16120104	502	540	sindrome della fase avanzata del sonno	DISEASEORPHENOTYPICFEATURE	C565789
16120104	585	589	ASPS	DISEASEORPHENOTYPICFEATURE	C565789
16120104	693	698	hPER2	GENEORGENEPRODUCT	8864
16120104	897	902	C111G	SEQUENCEVARIANT	C|SUB|C|111|G
16120104	969	975	G3853A	SEQUENCEVARIANT	C|SUB|G|3853|A
16120104	1028	1049	glicina in glutammina	SEQUENCEVARIANT	P |SUB|G||Q
16120104	1477	1481	111G	SEQUENCEVARIANT	C|ALLELE|G|111
16120104	1793	1797	111G	SEQUENCEVARIANT	C|ALLELE|G|111
16120104	1985	1990	C111G	SEQUENCEVARIANT	C|SUB|C|111|G
16120104	2160	2164	PER2	GENEORGENEPRODUCT	8864
16120104	2204	2208	111G	SEQUENCEVARIANT	C|ALLELE|G|111
16120104	2329	2333	ASPS	DISEASEORPHENOTYPICFEATURE	C565789
16157158	33	46	Cys 23-Ser 23	SEQUENCEVARIANT	RS6318
16157158	233	262	disturbo affettivo stagionale	DISEASEORPHENOTYPICFEATURE	D016574
16157158	386	415	disturbo affettivo stagionale	DISEASEORPHENOTYPICFEATURE	D016574
16157158	460	466	TRISTE	DISEASEORPHENOTYPICFEATURE	D016574
16157158	573	611	aumento di peso in caso di depressione	DISEASEORPHENOTYPICFEATURE	D015430
16157158	647	676	recettore della serotonina 2C	GENEORGENEPRODUCT	3358
16157158	709	717	5-HT(2C)	GENEORGENEPRODUCT	3358
16157158	835	843	5-HT(2C)	GENEORGENEPRODUCT	3358
16157158	875	885	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	974	984	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	1033	1041	5-HT(2C)	GENEORGENEPRODUCT	3358
16157158	1121	1129	5-HT(2C)	GENEORGENEPRODUCT	3358
16157158	1185	1195	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	1291	1294	SAD	DISEASEORPHENOTYPICFEATURE	D016574
16157158	1407	1410	SAD	DISEASEORPHENOTYPICFEATURE	D016574
16157158	1499	1503	SAD 	DISEASEORPHENOTYPICFEATURE	D016574
16157158	1579	1589	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	1691	1699	pazienti	ORGANISMTAXON	9606
16157158	1818	1826	pazienti	ORGANISMTAXON	9606
16157158	1882	1892	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	2152	2160	pazienti	ORGANISMTAXON	9606
16157158	2202	2212	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	2393	2403	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16157158	2522	2525	SAD	DISEASEORPHENOTYPICFEATURE	D016574
16157158	2647	2657	Cys 23 Ser	SEQUENCEVARIANT	RS6318
16158428	77	82	OPHN1	GENEORGENEPRODUCT	4983
16158428	247	252	OPHN1	GENEORGENEPRODUCT	4983
16158428	252	253	 	DISEASEORPHENOTYPICFEATURE	D008607
16158428	458	479	ipoplasia cerebellare	DISEASEORPHENOTYPICFEATURE	C562568
16158428	540	548	pazienti	ORGANISMTAXON	9606
16158428	654	682	ritardo mentale legato all'X	DISEASEORPHENOTYPICFEATURE	D038901
16158428	736	741	OPHN1	GENEORGENEPRODUCT	4983
16158428	985	1006	ipoplasia cerebellare	DISEASEORPHENOTYPICFEATURE	C562568
16158428	1241	1256	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
16160878	59	71	urotensin-II	GENEORGENEPRODUCT	24111
16160878	131	135	topi	ORGANISMTAXON	10090
16160878	169	182	Urotensina-II	GENEORGENEPRODUCT	24111
16160878	216	220	U-II	GENEORGENEPRODUCT	24111
16160878	361	365	U-II	GENEORGENEPRODUCT	24111
16160878	417	429	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16160878	477	488	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
16160878	531	541	prolattina	GENEORGENEPRODUCT	19109
16160878	576	588	tirotropina 	GENEORGENEPRODUCT	12640
16160878	674	678	U-II	GENEORGENEPRODUCT	24111
16160878	842	846	U-II	GENEORGENEPRODUCT	24111
16160878	935	939	topi	ORGANISMTAXON	10090
16160878	1010	1014	U-II	GENEORGENEPRODUCT	24111
16160878	1056	1060	topo	ORGANISMTAXON	10090
16160878	1583	1587	U-II	GENEORGENEPRODUCT	24111
16160878	1692	1697	 topo	ORGANISMTAXON	10090
16160878	1771	1775	topo	ORGANISMTAXON	10090
16160878	1867	1872	mouse	ORGANISMTAXON	10090
16160878	1963	1967	U-II	GENEORGENEPRODUCT	24111
16160878	2073	2084	apomorfina 	CHEMICALENTITY	D001058
16160878	2212	2226	corticosterone	CHEMICALENTITY	D003345
16160878	2331	2335	U-II	GENEORGENEPRODUCT	24111
16160878	2387	2392	mouse	ORGANISMTAXON	10090
16160878	2443	2452	ansiogeno	DISEASEORPHENOTYPICFEATURE	D001008
16160878	2499	2509	depressivo	DISEASEORPHENOTYPICFEATURE	D003866
16160878	2555	2560	mouse	ORGANISMTAXON	10090
16160878	2623	2627	U-II	GENEORGENEPRODUCT	24111
16160878	2718	2739	disturbi psichiatrici	DISEASEORPHENOTYPICFEATURE	D001523
16167916	58	68	raloxifene	CHEMICALENTITY	D020849
16167916	150	154	TAFI	GENEORGENEPRODUCT	1361
16167916	187	190	tPA	GENEORGENEPRODUCT	5327
16167916	224	229	PAI-1	GENEORGENEPRODUCT	5054
16167916	299	352	inibitore della fibrinolisi attivabile dalla trombina	GENEORGENEPRODUCT	1361
16167916	385	389	TAFI	GENEORGENEPRODUCT	1361
16167916	423	468	attivatore del plasminogeno di tipo tissutale	GENEORGENEPRODUCT	5327
16167916	501	504	tPA	GENEORGENEPRODUCT	5327
16167916	540	584	inibitore dell'attivatore del plasminogeno-1	GENEORGENEPRODUCT	5054
16167916	617	622	PAI-1	GENEORGENEPRODUCT	5054
16167916	760	770	raloxifene	CHEMICALENTITY	D020849
16167916	805	810	donne	ORGANISMTAXON	9606
16167916	857	862	donne	ORGANISMTAXON	9606
16167916	928	938	osteopenia	DISEASEORPHENOTYPICFEATURE	D00185 1
16167916	984	995	osteoporosi	DISEASEORPHENOTYPICFEATURE	D010024
16167916	1104	1109	donne	ORGANISMTAXON	9606
16167916	1156	1177	raloxifene cloridrato	CHEMICALENTITY	D020849
16167916	1228	1234	calcio	CHEMICALENTITY	D002118
16167916	1344	1350	calcio	CHEMICALENTITY	D002118
16167916	1390	1394	TAFI	GENEORGENEPRODUCT	1361
16167916	1427	1430	tPA	GENEORGENEPRODUCT	5327
16167916	1487	1492	PAI-1	GENEORGENEPRODUCT	 I livelli di antigene 5054
16167916	1820	1830	raloxifene	CHEMICALENTITY	D020849
16167916	1926	1930	TAFI	GENEORGENEPRODUCT	1361
16167916	2084	2087	tPA	GENEORGENEPRODUCT	5327
16167916	2242	2246	TAFI	GENEORGENEPRODUCT	1361
16167916	2391	2413	tromboembolismo venoso	DISEASEORPHENOTYPICFEATURE	D054556
16167916	2454	2464	raloxifene	CHEMICALENTITY	D020849
16167916	2555	2558	tPA	GENEORGENEPRODUCT	5327
16167916	2601	2605	TAFI	GENEORGENEPRODUCT	1361
16200390	121	130	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
16200390	219	230	L'emicrania	DISEASEORPHENOTYPICFEATURE	D008881
16200390	316	328	mal di testa	DISEASEORPHENOTYPICFEATURE	D020773
16200390	447	465	neurotrasmettitore	CHEMICALENTITY	D018377
16200390	497	516	5-idrossitriptamina	CHEMICALENTITY	D012701
16200390	550	554	5-HT	CHEMICALENTITY	D012701
16200390	587	597	serotonina	CHEMICALENTITY	D012701
16200390	721	730	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
16200390	875	879	5-HT	CHEMICALENTITY	D012701
16200390	947	957	emicrania 	DISEASEORPHENOTYPICFEATURE	D008881
16200390	1067	1072	umano	ORGANISMTAXON	9606
16200390	1105	1127	triptofano idrossilasi	GENEORGENEPRODUCT	7166
16200390	1160	1163	TPH	GENEORGENEPRODUCT	7166
16200390	1197	1223	amminoacido decarbossilasi	GENEORGENEPRODUCT	1644
16200390	1256	1260	AADC	GENEORGENEPRODUCT	1644
16200390	1295	1315	monoamino ossidasi A	GENEORGENEPRODUCT	4128
16200390	1349	1353	MAOA	GENEORGENEPRODUCT	4128
16200390	1406	1415	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
16200390	2182	2185	TPH	GENEORGENEPRODUCT	7166
16200390	2219	2223	AADC	GENEORGENEPRODUCT	1644
16200390	2257	2261	MAOA	GENEORGENEPRODUCT	4128
16200390	2351	2360	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
16288197	67	87	microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	176	196	Microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	250	305	disturbo dello sviluppo autosomico dominante dell'iride	DISEASEORPHENOTYPICFEATURE	D007499
16288197	361	367	miopia	DISEASEORPHENOTYPICFEATURE	D009216
16288197	413	448	glaucoma giovanile ad angolo aperto	DISEASEORPHENOTYPICFEATURE	D005902
16288197	700	720	microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	1410	1413	DCT	GENEORGENEPRODUCT	1638
16288197	1646	1666	microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	1787	1797	microcoria	DISEASEORPHENOTYPICFEATURE	C537550
16288197	1843	1851	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	1933	1941	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	1979	1988	miocilina	GENEORGENEPRODUCT	4653
16288197	2022	2026	MYOC	GENEORGENEPRODUCT	4653
16288197	2061	2072	optineurina	GENEORGENEPRODUCT	10133
16288197	2106	2110	OPTN	GENEORGENEPRODUCT	10133
16288197	2145	2151	CYP1B1	GENEORGENEPRODUCT	1545
16288197	2252	2259	144 G>A	SEQUENCEVARIANT	RS74315339
16288197	2310	2314	Q48H	SEQUENCEVARIANT	RS74315339
16288197	2381	2385	MYOC	GENEORGENEPRODUCT	4653
16288197	2468	2476	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	2504	2512	pazienti	ORGANISMTAXON	9606
16288197	2683	2703	microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	2736	2740	MCOR	GENEORGENEPRODUCT	8104
16288197	3067	3071	MCOR	GENEORGENEPRODUCT	8104
16288197	3161	3164	DCT	GENEORGENEPRODUCT	1638
16288197	3222	3232	tirosinasi	GENEORGENEPRODUCT	7299
16288197	3293	3306	pigmentazione	DISEASEORPHENOTYPICFEATURE	D010859
16288197	3435	3455	microcoria congenita	DISEASEORPHENOTYPICFEATURE	C537550
16288197	3540	3548	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	3655	3659	MYOC	GENEORGENEPRODUCT	4653
16288197	3695	3699	Q48H	SEQUENCEVARIANT	RS74315339
16288197	3801	3809	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	3961	3970	micocoria	GENEORGENEPRODUCT	8104
16288197	4051	4062	 microcoria	DISEASEORPHENOTYPICFEATURE	C537550
16288197	4108	4116	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	4188	4198	microcoria	DISEASEORPHENOTYPICFEATURE	C537550
16288197	4243	4251	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288197	4290	4294	MYOC	GENEORGENEPRODUCT	4653
16288197	4330	4334	Q48H	SEQUENCEVARIANT	RS74315339
16288199	60	82	ossido nitrico sintasi	GENEORGENEPRODUCT	4843
16288199	140	148	glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288199	251	267	L'ossido nitrico	CHEMICALENTITY	D009569
16288199	334	339	umano	ORGANISMTAXON	9606
16288199	532	570	disturbi neurologici e non neurologici	DISEASEORPHENOTYPICFEATURE	D009422
16288199	682	704	ossido nitrico sintasi	GENEORGENEPRODUCT	4843
16288199	737	741	iNOS	GENEORGENEPRODUCT	4843
16288199	790	823	disturbo neuropatologico glaucoma	DISEASEORPHENOTYPICFEATURE	D005901
16288199	898	904	cecità	DISEASEORPHENOTYPICFEATURE	D001766
16288199	1022	1026	iNOS	GENEORGENEPRODUCT	4843
16288199	1072	1106	glaucoma primario ad angolo aperto	DISEASEORPHENOTYPICFEATURE	D005902
16288199	1151	1155	POAG	DISEASEORPHENOTYPICFEATURE	D005902
16288199	1403	1407	iNOS	GENEORGENEPRODUCT	4843
16288199	1484	1488	POAG	DISEASEORPHENOTYPICFEATURE	D005902
16288199	1516	1524	pazienti	ORGANISMTAXON	9606
16288199	1847	1855	pazienti	ORGANISMTAXON	9606
16288199	1909	1918	(CCTTT)14	SEQUENCEVARIANT	C|DUP||CCTTT|14
16288199	2083	2087	POAG	DISEASEORPHENOTYPICFEATURE	D005902
16288199	2115	2123	pazienti	ORGANISMTAXON	9606
16288199	2173	2182	(CCTTT)10	SEQUENCEVARIANT	C| DUP||CCTTT|10
16288199	2225	2234	(CCTTT)13	SEQUENCEVARIANT	C|DUP||CCTTT|13
16288199	2312	2321	(CCTTT)14	SEQUENCEVARIANT	C|DUP||CCTTT|14
16288199	2569	2573	iNOS	GENEORGENEPRODUCT	4843
16288199	2622	2626	POAG	DISEASEORPHENOTYPICFEATURE	D005902
16309808	31	42	domperidone	CHEMICALENTITY	D004294
16309808	86	97	mirtazapina	CHEMICALENTITY	D000078785
16309808	151	184	sindrome delle gambe senza riposo	DISEASEORPHENOTYPICFEATURE	D012148
16309808	317	350	sindrome delle gambe senza riposo	DISEASEORPHENOTYPICFEATURE	D012148
16309808	395	398	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	469	472	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	546	554	levodopa	CHEMICALENTITY	D007980
16309808	588	611	agonisti della dopamina	CHEMICALENTITY	D004298
16309808	651	694	antagonisti del recettore D2 della dopamina	CHEMICALENTITY	D065127
16309808	766	769	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	890	901	domperidone	CHEMICALENTITY	D004294
16309808	937	964	recettore della dopamina D2	GENEORGENEPRODUCT	1813
16309808	1064	1067	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	1103	1114	Mirtazapina	CHEMICALENTITY	D000078785
16309808	1156	1213	antidepressivo noradrenergico e serotoninergico specifico	CHEMICALENTITY	D000928
16309808	1248	1253	NaSSA	CHEMICALENTITY	D000928
16309808	1319	1322	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	1428	1436	depresso	DISEASEORPHENOTYPICFEATURE	D003866
16309808	1464	1472	paziente	ORGANISMTAXON	9606
16309808	1533	1556	dispepsia postprandiale	DISEASEORPHENOTYPICFEATURE	D004415
16309808	1618	1621	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	1661	1672	mirtazapina	CHEMICALENTITY	D000078785
16309808	1744	1755	domperidone	CHEMICALENTITY	D004294
16309808	1794	1802	paziente	ORGANISMTAXON	9606
16309808	1878	1881	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	1950	1961	mirtazapina	CHEMICALENTITY	D000078785
16309808	2022	2025	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	2123	2134	mirtazapina	CHEMICALENTITY	D000078785
16309808	2208	2219	mirtazapina	CHEMICALENTITY	D000078785
16309808	2278	2281	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	2320	2328	paziente	ORGANISMTAXON	9606
16309808	2404	2414	domperione	CHEMICALENTITY	D004294
16309808	2453	2464	mirtazapina	CHEMICALENTITY	D000078785
16309808	2518	2521	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	2628	2639	mirtazapina	CHEMICALENTITY	D000078785
16309808	2708	2711	RLS	DISEASEORPHENOTYPICFEATURE	D012148
16309808	2812	2855	antagonisti del recettore della dopamina D2	CHEMICALENTITY	D065127
16321363	43	85	Disturbo congenito della glicosilazione Ic	DISEASEORPHENOTYPICFEATURE	C535741
16321363	154	160	hALG-6	GENEORGENEPRODUCT	29929
16321363	246	288	disturbo congenito della glicosilazione-Ic	DISEASEORPHENOTYPICFEATURE	C535741
16321363	333	339	CDG-Ic	DISEASEORPHENOTYPICFEATURE	C535741
16321363	424	427	CDG	DISEASEORPHENOTYPICFEATURE	D018981
16321363	508	539	oligosaccaridi legati ai lipidi	CHEMICALENTITY	C023023
16321363	584	592	glucosio	CHEMICALENTITY	D005947
16321363	654	658	ALG6	GENEORGENEPRODUCT	29929
16321363	789	795	338G>A	SEQUENCEVARIANT	RS768372697
16321363	878	886	paziente	ORGANISMTAXON	9606
16321363	1019	1023	ALG6	GENEORGENEPRODUCT	29929
16321363	1464	1467	CDG	DISEASEORPHENOTYPICFEATURE	D018981
16321363	1563	1569	CDG-Ic	DISEASEORPHENOTYPICFEATURE	C535741
16364460	52	62	ritanserin	CHEMICALENTITY	D016713
16364460	137	148	scopolamina	CHEMICALENTITY	 D012601
16364460	200	207	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16364460	253	258	ratti	ORGANISMTAXON	10116
16364460	304	314	ritanserin	CHEMICALENTITY	D016713
16364460	348	353	5-HT2	GENEORGENEPRODUCT	29595
16364460	402	413	scopolamina	CHEMICALENTITY	D012601
16364460	447	470	colinergico muscarinico	GENEORGENEPRODUCT	25229
16364460	536	543	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16364460	617	624	I ratti	ORGANISMTAXON	10116
16364460	828	832	DMSO	CHEMICALENTITY	D004121
16364460	882	886	DMSO	CHEMICALENTITY	D004121
16364460	920	931	scopolamina	CHEMICALENTITY	D012601
16364460	1047	1057	ritanserin	CHEMICALENTITY	D016713
16364460	1117	1121	DMSO	CHEMICALENTITY	D004121
16364460	1193	1204	scopolamina	CHEMICALENTITY	D012601
16364460	1274	1285	ritanserina	CHEMICALENTITY	D016713
16364460	1329	1340	ritanserina	CHEMICALENTITY	D016713
16364460	1393	1397	DMSO	CHEMICALENTITY	D004121
16364460	1953	1964	scopolamina	CHEMICALENTITY	D012601
16364460	2037	2047	Ritanserin	CHEMICALENTITY	D016713
16364460	2085	2090	ratti	ORGANISMTAXON	10116
16364460	2248	2252	DMSO	CHEMICALENTITY	D004121
16364460	2322	2333	scopolamina	CHEMICALENTITY	D012601
16364460	2367	2377	ritanserin	CHEMICALENTITY	D016713
16364460	2502	2513	scopolamina	CHEMICALENTITY	D012601
16364460	2551	2556	ratti	ORGANISMTAXON	10116
16364460	2642	2653	ritanserina	CHEMICALENTITY	D016713
16364460	2730	2741	scopolamine	CHEMICALENTITY	D012601
16364460	2793	2800	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16369751	31	46	5-fluorouracile	CHEMICALENTITY	D005472
16369751	90	105	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16369751	148	172	alfa-fluoro-beta-alanina	CHEMICALENTITY	C032348
16369751	217	235	La cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16369751	314	329	5-fluorouracile	CHEMICALENTITY	D005472
16369751	363	367	5-FU	CHEMICALENTITY	D005472
16369751	428	435	maligne	DISEASEORPHENOTYPICFEATURE	D009369
16369751	493	497	uomo	ORGANISMTAXON	9606
16369751	544	548	5-FU	CHEMICALENTITY	D005472
16369751	603	618	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16369751	688	712	alfa-fluoro-beta-alanina	CHEMICALENTITY	C032348
16369751	745	749	FBAL	CHEMICALENTITY	C032348
16369751	800	808	paziente	ORGANISMTAXON	9606
16369751	863	878	cancro al colon	DISEASEORPHENOTYPICFEATURE	D003110
16369751	923	932	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
16369751	1100	1108	paziente	ORGANISMTAXON	9606
16369751	1188	1192	5-FU	CHEMICALENTITY	D005472
16369751	1268	1286	dolore precordiale	DISEASEORPHENOTYPICFEATURE	D002637
16369751	1334	1357	blocco di branca destra	DISEASEORPHENOTYPICFEATURE	D002037
16369751	1460	1464	FBAL	CHEMICALENTITY	C032348
16369751	1530	1548	dolore precordiale	DISEASEORPHENOTYPICFEATURE	D002637
16369751	1674	1678	5-FU	CHEMICALENTITY	D005472
16369751	1733	1751	dolore precordiale	DISEASEORPHENOTYPICFEATURE	D002637
16369751	1789	1797	paziente	ORGANISMTAXON	9606
16369751	1858	1862	5-FU	CHEMICALENTITY	D005472
16369751	1914	1929	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16369751	1986	1990	5-FU	CHEMICALENTITY	D005472
16369751	2077	2080	S-1	CHEMICALENTITY	C079198
16369751	2128	2132	5-FU	CHEMICALENTITY	D005472
16369751	2228	2231	S-1	CHEMICALENTITY	C079198
16369751	2387	2391	5-FU	CHEMICALENTITY	D005472
16369751	2428	2432	FBAL	CHEMICALENTITY	 C032348
16369751	2491	2495	FBAL	CHEMICALENTITY	C032348
16369751	2610	2613	S-1	CHEMICALENTITY	C079198
16369751	2716	2732	sintomi cardiaci	DISEASEORPHENOTYPICFEATURE	D006331
16369751	2764	2772	paziente	ORGANISMTAXON	9606
16369751	2863	2866	S-1	CHEMICALENTITY	C079198
16369751	2998	3002	FBAL	CHEMICALENTITY	C032348
16369751	3048	3053	5- FU	CHEMICALENTITY	D005472
16369751	3105	3120	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16369751	3153	3156	S-1	CHEMICALENTITY	C079198
16369751	3224	3232	pazienti	ORGANISMTAXON	9606
16369751	3269	3273	5-FU	CHEMICALENTITY	D005472
16369751	3325	3340	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
16391785	84	89	DOCK8	GENEORGENEPRODUCT	81704
16391785	121	126	umano	ORGANISMTAXON	 9606
16391785	170	187	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
16391785	248	253	DOCK8	GENEORGENEPRODUCT	81704
16391785	287	317	dedicatore della citochinesi 8	GENEORGENEPRODUCT	81704
16391785	409	428	cancro del polmone 	DISEASEORPHENOTYPICFEATURE	D008175
16391785	536	541	DOCK8	GENEORGENEPRODUCT	81704
16391785	607	612	DOCK8	GENEORGENEPRODUCT	81704
16391785	705	710	DOCK8	GENEORGENEPRODUCT	81704
16391785	779	784	umani	ORGANISMTAXON	9606
16391785	983	1000	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
16391785	1042	1047	DOCK8	GENEORGENEPRODUCT	81704
16391785	1136	1152	cancri polmonari	DISEASEORPHENOTYPICFEATURE	D008175
16391785	1307	1325	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
16391785	1361	1385	5-Aza-2'-deossi-citidina	CHEMICALENTITY	D000077209
16391785	1421	1436	Trichostatina A	CHEMICALENTITY	C012589
16391785	1489	1494	DOCK8	GENEORGENEPRODUCT	81704
16391785	1553	1571	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
16391785	1627	1632	DOCK8	GENEORGENEPRODUCT	81704
16391785	1839	1844	DOCK8	GENEORGENEPRODUCT	81704
16391785	1892	1909	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
16391785	2015	2020	DOCK8	GENEORGENEPRODUCT	81704
16391785	2089	2103	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
16391785	2153	2157	DOCK	GENEORGENEPRODUCT	81704
16391785	2448	2453	DOCK8	GENEORGENEPRODUCT	81704
16391785	2559	2581	polmone e altri tumori	DISEASEORPHENOTYPICFEATURE	D008175 ,D009369
16410744	69	81	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	192	204	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	297	303	tumori	DISEASEORPHENOTYPICFEATURE	D009369
16410744	334	342	pazienti	ORGANISMTAXON	9606
16410744	559	571	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	615	623	pazienti	ORGANISMTAXON	9606
16410744	718	722	TP53	GENEORGENEPRODUCT	7157
16410744	784	796	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	830	834	PTEN	GENEORGENEPRODUCT	5728
16410744	989	993	EGFR	GENEORGENEPRODUCT	1956
16410744	1050	1053	p16	GENEORGENEPRODUCT	1029
16410744	1221	1233	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	1359	1371	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	1486	1498	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	1576	1580	EGFR	GENEORGENEPRODUCT	1956
16410744	1646	1649	p16	GENEORGENEPRODUCT	1029
16410744	1733	1737	TP53	GENEORGENEPRODUCT	7157
16410744	1798	1801	p16	GENEORGENEPRODUCT	1029
16410744	1858	1870	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	2052	2064	glioblastoma	DISEASEORPHENOTYPICFEATURE	D005909
16410744	2092	2100	pazienti	ORGANISMTAXON	9606
16410744	2226	2230	EGFR	GENEORGENEPRODUCT	1956
16410744	2316	2328	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	2402	2414	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	2508	2526	codone 787 CAG/CAA	SEQUENCEVARIANT	P|SUB|Q|787|Q
16410744	2564	2571	Gln/Gln	SEQUENCEVARIANT	P|SUB| Q||Q
16410744	2619	2631	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	2816	2828	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	3015	3027	glioblastomi	DISEASEORPHENOTYPICFEATURE	D005909
16410744	3303	3307	EGFR	GENEORGENEPRODUCT	1956
16412238	31	100	Deficit del recettore gamma attivato dal proliferatore perossisomiale	GENEORGENEPRODUCT	5468
16412238	172	211	Lipodistrofia parziale familiare tipo 3	DISEASEORPHENOTYPICFEATURE	D052496
16412238	256	261	FPLD3	DISEASEORPHENOTYPICFEATURE	D052496
16412238	320	370	Lipodistrofia parziale familiare (Dunnigan) tipo 3	DISEASEORPHENOTYPICFEATURE	D052496
16412238	415	420	FPLD3	DISEASEORPHENOTYPICFEATURE	D052496
16412238	465	503	Eredità mendeliana in Man [MIM] 604367	DISEASEORPHENOTYPICFEATURE	D052496
16412238	572	577	PPARG	GENEORGENEPRODUCT	5468
16412238	618	676	 recettore gamma attivato dal proliferatore perossisomiale	GENEORGENEPRODUCT	5468
16412238	853	858	FPLD3	DISEASEORPHENOTYPICFEATURE	D052496
16412238	1084	1103	insulino-resistenza	DISEASEORPHENOTYPICFEATURE	D007333
16412238	1148	1155	diabete	DISEASEORPHENOTYPICFEATURE	D003920
16412238	1207	1226	ipertrigliceridemia	DISEASEORPHENOTYPICFEATURE	D015228
16412238	1272	1283	pancreatite	DISEASEORPHENOTYPICFEATURE	D010195
16412238	1410	1422	trigliceridi	CHEMICALENTITY	D014280
16412238	1456	1465	C-peptide	CHEMICALENTITY	D002096
16412238	1509	1549	colesterolo lipoproteico ad alta densità	CHEMICALENTITY	 D008076
16412238	1645	1650	PPARG	GENEORGENEPRODUCT	5468
16412238	1711	1717	Y355X 	SEQUENCEVARIANT	P|SUB|Y|355|X
16412238	2018	2023	umano	ORGANISMTAXON	9606
16412238	2055	2060	PPARG	GENEORGENEPRODUCT	5468
16412238	2141	2151	PPAR-gamma	GENEORGENEPRODUCT	5468
16412238	2379	2384	FPLD3	DISEASEORPHENOTYPICFEATURE	D052496
16418600	58	64	TSPYL1	GENEORGENEPRODUCT	7259
16418600	111	152	improvvisa sindrome della morte infantile	DISEASEORPHENOTYPICFEATURE	D013398
16418600	209	253	Sindrome della morte improvvisa del lattante	DISEASEORPHENOTYPICFEATURE	D013398
16418600	298	302	SIDS	DISEASEORPHENOTYPICFEATURE	D013398
16418600	385	392	decesso	DISEASEORPHENOTYPICFEATURE	D003643
16418600	528	595	morte infantile improvvisa con sindrome di disgenesia dei testicoli	DISEASEORPHENOTYPICFEATURE	C563856
16418600	640	645	SIDDT	DISEASEORPHENOTYPICFEATURE	C563856
16418600	756	762	TSPYL1	GENEORGENEPRODUCT	7259
16418600	861	868	TSPYL1 	GENEORGENEPRODUCT	7259
16418600	915	919	SIDS	DISEASEORPHENOTYPICFEATURE	D013398
16418600	1016	1020	SIDS	DISEASEORPHENOTYPICFEATURE	D013398
16418600	1290	1298	pazienti	ORGANISMTAXON	9606
16418600	1400	1408	paziente	ORGANISMTAXON	9606
16418600	1448	1455	p.F366L	SEQUENCEVARIANT	RS140756663
16418600	1737	1742	SIDDT	DISEASEORPHENOTYPICFEATURE	C563856
16418600	1812	1818	TSPYL1	GENEORGENEPRODUCT	7259
16418600	1925	1941	morte improvvisa	DISEASEORPHENOTYPICFEATURE	D003645
16418600	2039	2044	SIDDT	DISEASEORPHENOTYPICFEATURE	C563856
16418600	2240	2246	TSPYL1	GENEORGENEPRODUCT	7259
16418600	2292	2296	SIDS	DISEASEORPHENOTYPICFEATURE	D013398
16418600	2390	2396	TSPYL1	GENEORGENEPRODUCT	7259
16418600	2509	2513	SIDS	DISEASEORPHENOTYPICFEATURE	D013398
16418600	2563	2587	disgenesia dei testicoli	DISEASEORPHENOTYPICFEATURE	D013733
16506214	60	65	COX-2	GENEORGENEPRODUCT	4513
16506214	131	151	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	192	197	COX-2	GENEORGENEPRODUCT	4513
16506214	269	287	acido arachidonico	CHEMICALENTITY	D016718
16506214	322	336	prostaglandine	CHEMICALENTITY	D011453
16506214	372	386	prostaglandine	CHEMICALENTITY	D011453
16506214	430	435	COX-2	GENEORGENEPRODUCT	4513
16506214	498	511	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
16506214	557	563	dolore	DISEASEORPHENOTYPICFEATURE	D010146
16506214	766	771	COX-2	GENEORGENEPRODUCT	4513
16506214	819	824	umano	ORGANISMTAXON	 9606
16506214	868	881	carcinogenesi	DISEASEORPHENOTYPICFEATURE	D009369
16506214	947	967	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	1062	1067	COX-2	GENEORGENEPRODUCT	4513
16506214	1128	1148	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	1277	1297	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	1472	1477	COX-2	GENEORGENEPRODUCT	4513
16506214	1694	1702	pazienti	ORGANISMTAXON	9606
16506214	2429	2449	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	2574	2587	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
16506214	2648	2676	carcinogenesi della prostata	DISEASEORPHENOTYPICFEATURE	D011471
16506214	2758	2763	COX-2	GENEORGENEPRODUCT	4513
16506214	2831	2851	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
16526029	46	50	RGS4	GENEORGENEPRODUCT	5999
16526029	118	131	 schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16526029	201	249	regolatore della segnalazione della proteina G 4	GENEORGENEPRODUCT	5999
16526029	282	286	RGS4	GENEORGENEPRODUCT	5999
16526029	389	401	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16526029	553	557	RGS4	GENEORGENEPRODUCT	5999
16526029	828	840	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16526029	1039	1051	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16526029	1257	1269	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16526029	1339	1343	RGS4	GENEORGENEPRODUCT	5999
16526029	1411	1423	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
16541406	86	90	MLH1	GENEORGENEPRODUCT	4292
16541406	125	129	MSH2	GENEORGENEPRODUCT	 4436
16541406	245	262	Sindrome di Lynch	DISEASEORPHENOTYPICFEATURE	D003123
16541406	307	312	HNPCC	DISEASEORPHENOTYPICFEATURE	D003123
16541406	432	436	MLH1	GENEORGENEPRODUCT	4292
16541406	470	474	MSH2	GENEORGENEPRODUCT	4436
16541406	540	557	Sindrome di Lynch	DISEASEORPHENOTYPICFEATURE	D003123
16541406	602	607	HNPCC	DISEASEORPHENOTYPICFEATURE	D003123
16541406	637	645	pazienti	ORGANISMTAXON	9606
16541406	856	860	MLH1	GENEORGENEPRODUCT	4292
16541406	906	910	MSH2	GENEORGENEPRODUCT	4436
16541406	1041	1045	MSH2	GENEORGENEPRODUCT	4436
16541406	1224	1228	MLH1	GENEORGENEPRODUCT	4292
16541406	1591	1595	MSH2	GENEORGENEPRODUCT	4436
16541406	1645	1649	MLH1	GENEORGENEPRODUCT	4292
16541406	2003	2007	MLH1	GENEORGENEPRODUCT	4292
16541406	2041	2045	MSH2	GENEORGENEPRODUCT	4436
16543197	37	43	G1103R	SEQUENCEVARIANT	RS62636275
16543197	89	93	CRB1	GENEORGENEPRODUCT	23418
16543197	156	168	ipermetropia	DISEASEORPHENOTYPICFEATURE	D006956
16543197	214	241	Amaurosi congenita di Leber	DISEASEORPHENOTYPICFEATURE	D057130
16543197	355	375	elevata ipermetropia	DISEASEORPHENOTYPICFEATURE	C565497
16543197	421	448	Amaurosi congenita di Leber	DISEASEORPHENOTYPICFEATURE	D057130
16543197	493	496	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	589	597	pazienti	ORGANISMTAXON	9606
16543197	862	865	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	1024	1027	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	1086	1098	ipermetropia	DISEASEORPHENOTYPICFEATURE	D006956
16543197	1324	1328	CRB1	GENEORGENEPRODUCT	23418
16543197	1378	1384	G1103R	SEQUENCEVARIANT	RS62636275
16543197	1478	1482	CRB1	GENEORGENEPRODUCT	23418
16543197	1538	1548	Drosophila	ORGANISMTAXON	7227
16543197	1582	1590	briciole	GENEORGENEPRODUCT	42896
16543197	1712	1731	retinite pigmentosa	DISEASEORPHENOTYPICFEATURE	D012174
16543197	1749	1751	RP	DISEASEORPHENOTYPICFEATURE	D012174
16543197	1826	1829	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	1979	1982	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	2010	2018	paziente	ORGANISMTAXON	9606
16543197	2084	2096	ipermetropia	DISEASEORPHENOTYPICFEATURE	D006956
16543197	2162	2165	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	2231	2239	pazienti	ORGANISMTAXON	9606
16543197	2323	2327	CRB1	GENEORGENEPRODUCT	23418
16543197	2370	2372	RP	DISEASEORPHENOTYPICFEATURE	D012174
16543197	2446	2449	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	2517	2526	hyperopia	DISEASEORPHENOTYPICFEATURE	D006956
16543197	2572	2575	LCA	DISEASEORPHENOTYPICFEATURE	D057130
16543197	2638	2642	CRB1	GENEORGENEPRODUCT	23418
16574712	31	35	MDMA	CHEMICALENTITY	D018817
16574712	183	231	processi di giudizio sociale ed emotivo alterati	DISEASEORPHENOTYPICFEATURE	D003072
16574712	315	333	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
16574712	384	388	MDMA	CHEMICALENTITY	D018817
16574712	422	452	3,4-metilendiossimetanfetamina	CHEMICALENTITY	D018817
16574712	485	492	ecstasy	CHEMICALENTITY	D018817
16574712	585	589	MDMA	CHEMICALENTITY	D018817
16574712	815	822	ecstasy	CHEMICALENTITY	D018817
16574712	879	886	ecstasy	CHEMICALENTITY	D018817
16574712	1276	1280	MDMA	CHEMICALENTITY	D018817
16574712	1298	1302	MDMA	CHEMICALENTITY	D018817
16574712	1761	1768	ecstasy	CHEMICALENTITY	D018817
16574713	53	83	trasportatore della serotonina	GENEORGENEPRODUCT	6532
16574713	151	158	ecstasy	CHEMICALENTITY	D018817
16574713	191	195	MDMA	CHEMICALENTITY	D018817
16574713	244	274	3,4-metilendiossimetanfetamina	CHEMICALENTITY	D018817
16574713	307	311	MDMA	CHEMICALENTITY	D018817
16574713	346	353	ecstasy	CHEMICALENTITY	D018817
16574713	427	437	serotonina	CHEMICALENTITY	D012701
16574713	471	475	5-HT	CHEMICALENTITY	D012701
16574713	542	547	umani	ORGANISMTAXON	9606
16574713	629	633	MDMA	CHEMICALENTITY	D018817
16574713	673	677	5-HT	CHEMICALENTITY	D012701
16574713	721	743	 lesioni neurotossiche	DISEASEORPHENOTYPICFEATURE	D020258
16574713	809	813	5-HT	CHEMICALENTITY	D012701
16574713	897	901	5-HT	CHEMICALENTITY	D012701
16574713	988	992	5-HT	CHEMICALENTITY	D012701
16574713	1132	1185	regione del gene del promotore del trasportatore 5-HT	GENEORGENEPRODUCT	6532
16574713	1219	1227	5-HTTLPR	GENEORGENEPRODUCT	6532
16574713	1294	1298	MDMA	CHEMICALENTITY	D018817
16574713	1449	1453	MDMA	CHEMICALENTITY	D018817
16574713	1572	1576	MDMA	CHEMICALENTITY	D018817
16574713	1639	1647	5-HTTLPR	GENEORGENEPRODUCT	6532
16574713	1820	1824	MDMA	CHEMICALENTITY	D018817
16574713	1891	1895	MDMA	CHEMICALENTITY	D018817
16574713	1966	1970	MDMA	CHEMICALENTITY	D018817
16574713	2199	2207	5-HTTLPR	GENEORGENEPRODUCT	6532
16574713	2534	2538	MDMA	CHEMICALENTITY	D018817
16574713	2720	2748	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
16574713	2823	2827	MDMA	CHEMICALENTITY	D018817
16574713	2914	2922	5-HTTLPR	GENEORGENEPRODUCT	6532
16574713	2979	2983	MDMA	CHEMICALENTITY	D018817
16574713	3099	3135	funzionamento della memoria alterato	DISEASEORPHENOTYPICFEATURE	D008569
16574713	3185	3189	MDMA	CHEMICALENTITY	D018817
16574713	3253	3271	deficit di memoria	DISEASEORPHENOTYPICFEATURE	D008569
16574713	3322	3330	5-HTTLPR	GENEORGENEPRODUCT	6532
16574713	3405	3409	MDMA	CHEMICALENTITY	D018817
16575011	43	49	Tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	81	99	timidilato sintasi	GENEORGENEPRODUCT	7298
16575011	137	145	1494del6	SEQUENCEVARIANT	C|DEL|1494|6
16575011	226	248	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
16575011	276	284	pazienti	ORGANISMTAXON	9606
16575011	329	374	trattamento adiuvante a base di fluorouracile	CHEMICALENTITY	D005472
16575011	506	512	tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	544	562	timidilato sintasi	GENEORGENEPRODUCT	7298
16575011	595	597	TS	GENEORGENEPRODUCT	7298
16575011	699	721	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
16575011	749	757	pazienti	ORGANISMTAXON	9606
16575011	812	825	fluorouracile	CHEMICALENTITY	D005472
16575011	859	861	FU	CHEMICALENTITY	D005472
16575011	910	919	PAT IENTS	ORGANISMTAXON	9606
16575011	988	1010	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
16575011	1038	1046	pazienti	ORGANISMTAXON	9606
16575011	1105	1107	FU	CHEMICALENTITY	D005472
16575011	1143	1153	levamisole	CHEMICALENTITY	D007978
16575011	1188	1198	leucovorin	CHEMICALENTITY	D002955
16575011	1278	1280	TS	GENEORGENEPRODUCT	7298
16575011	1342	1347	G > C	SEQUENCEVARIANT	C|SUB|G||C
16575011	1421	1423	TS	GENEORGENEPRODUCT	7298
16575011	1461	1469	1494del6	SEQUENCEVARIANT	C|DEL|1494|6
16575011	1589	1595	tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	1654	1656	TS	GENEORGENEPRODUCT	7298
16575011	1756	1762	tumori	DISEASEORPHENOTYPICFEATURE	D009369
16575011	1846	1855	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
16575011	1888	1890	TS	GENEORGENEPRODUCT	7298
16575011	2008	2014	tumori	DISEASEORPHENOTYPICFEATURE	D009369
16575011	2162	2192	La genotipizzazione del tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	2427	2432	G > C	SEQUENCEVARIANT	C|SUB|G||C
16575011	2543	2549	Tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	2581	2583	TS	GENEORGENEPRODUCT	7298
16575011	2622	2630	1494del6	SEQUENCEVARIANT	C|DEL| 1494|6
16575011	3144	3146	TS	GENEORGENEPRODUCT	7298
16575011	3211	3217	tumori	DISEASEORPHENOTYPICFEATURE	D009369
16575011	3263	3272	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
16575011	3305	3307	TS	GENEORGENEPRODUCT	7298
16575011	3471	3477	Tumore	DISEASEORPHENOTYPICFEATURE	D009369
16575011	3509	3511	TS	GENEORGENEPRODUCT	7298
16575011	3550	3558	1494del6	SEQUENCEVARIANT	C| DEL|1494|6
16575011	3673	3675	FU	CHEMICALENTITY	D005472
16575011	3723	3745	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
16575011	3773	3781	pazienti	ORGANISMTAXON	9606
16584858	43	54	mangiferina	CHEMICALENTITY	C013592
16584858	149	163	isoproterenolo	CHEMICALENTITY	 D007545
16584858	215	236	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
16584858	268	273	ratti	ORGANISMTAXON	10116
16584858	362	373	mangiferina	CHEMICALENTITY	C013592
16584858	409	419	polifenolo	CHEMICALENTITY	D059808
16584858	451	472	Mangifera indica Linn	ORGANISMTAXON	29780
16584858	525	539	isoproterenolo	CHEMICALENTITY	D007545
16584858	572	576	ISPH	CHEMICALENTITY	D007545
16584858	629	647	infarto miocardico	DISEASEORPHENOTYPICFEATURE	D009203
16584858	692	694	MI	DISEASEORPHENOTYPICFEATURE	D009203
16584858	727	733	ratti 	ORGANISMTAXON	10116
16584858	835	839	ISPH	CHEMICALENTITY	D007545
16584858	932	937	ratti	ORGANISMTAXON	10116
16584858	1017	1033	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
16584858	1065	1068	rat	ORGANISMTAXON	10116
16584858	1167	1187	lattato deidrogenasi	GENEORGENEPRODUCT	24533
16584858	1221	1224	LDH	GENEORGENEPRODUCT	24533
16584858	1261	1296	isoenzimi della creatinfosfochinasi	GENEORGENEPRODUCT	24264
16584858	1330	1335	CK-MB	GENEORGENEPRODUCT	24264
16584858	1380	1402	livello di acido urico	CHEMICALENTITY	D014527
16584858	1451	1456	ferro	CHEMICALENTITY	D007501
16584858	1529	1540	mangiferina	CHEMICALENTITY	C013592
16584858	1594	1621	trifenil tetrazolio cloruro	CHEMICALENTITY	C009591
16584858	1655	1658	TTC	CHEMICALENTITY	C009591
16584858	1772	1791	miocardio ischemico	DISEASEORPHENOTYPICFEATURE	D017202
16584858	1876	1897	superossido dismutasi	GENEORGENEPRODUCT	24786
16584858	1931	1939	catalasi	GENEORGENEPRODUCT	24248
16584858	1974	1996	glutatione perossidasi	GENEORGENEPRODUCT	24404
16584858	2030	2052	glutatione transferasi	GENEORGENEPRODUCT	24421
16584858	2088	2124	 attività della glutatione reduttasi	GENEORGENEPRODUCT	116686
16584858	2191	2206	cerruloplasmina	GENEORGENEPRODUCT	1356
16584858	2239	2250	Vitamina C 	CHEMICALENTITY	D001205
16584858	2283	2293	Vitamina E	CHEMICALENTITY	D014810
16584858	2327	2337	glutatione	CHEMICALENTITY	D005978
16584858	2412	2414	MI	DISEASEORPHENOTYPICFEATURE	D009203
16584858	2443	2447	rats	ORGANISMTAXON	10116
16584858	2504	2515	mangiferina	CHEMICALENTITY	C013592
16584858	2594	2611	dimetilsolfossido	CHEMICALENTITY	D004121
16584858	2711	2713	MI	DISEASEORPHENOTYPICFEATURE	D009203
16584858	2742	2747	ratti	ORGANISMTAXON	10116
16584858	3022	3033	mangiferina	CHEMICALENTITY	C013592
16584858	3076	3081	ISPH 	CHEMICALENTITY	D007545
16584858	3133	3135	MI	DISEASEORPHENOTYPICFEATURE	D009203
16584858	3164	3169	ratti	ORGANISMTAXON	10116
16584858	3238	3249	mangiferina	CHEMICALENTITY	C013592
16584858	3317	3321	ISPH	CHEMICALENTITY	D007545
16584858	3373	3375	MI	DISEASEORPHENOTYPICFEATURE	D009203
16584858	3507	3521	danno cardiaco	DISEASEORPHENOTYPICFEATURE	D006331
16586083	59	89	inibitori della ciclossigenasi	CHEMICALENTITY	D016861
16586083	285	306	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
16586083	351	356	ictus	DISEASEORPHENOTYPICFEATURE	D020521
16586083	401	413	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16586083	459	481	insufficienza cardiaca	DISEASEORPHENOTYPICFEATURE	D006333
16586083	541	571	inibitori della ciclossigenasi	CHEMICALENTITY	D016861
16586083	697	705	pazienti	ORGANISMTAXON	9606
16586083	774	808	Gli inibitori della ciclossigenasi	CHEMICALENTITY	D016861
16586083	883	894	prostanoidi	CHEMICALENTITY	D011453
16586083	1056	1086	eventi avversi cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
16586083	1216	1246	inibitori della ciclossigenasi	CHEMICALENTITY	D016861
16586083	1490	1504	prostaglandine	CHEMICALENTITY	D011453
16586083	1585	1630	peptide natriuretico pro-cervello N-terminale	CHEMICALENTITY	C109794
16586083	1663	1672	NT-proBNP	CHEMICALENTITY	C109794
16586083	1707	1726	proteina C-reattiva	GENEORGENEPRODUCT	1401
16586083	1803	1811	pazienti	ORGANISMTAXON	9606
16586083	1901	1926	tossicità cardiovascolare	DISEASEORPHENOTYPICFEATURE	D002318
16596970	31	42	Pilocarpina	CHEMICALENTITY	D010862
16596970	86	97	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16596970	147	207	compromissione della discriminazione della posizione uditiva	DISEASEORPHENOTYPICFEATURE	D001308
16596970	292	309	stato epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	359	370	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16596970	590	608	status epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	658	692	deficit di discriminazione uditiva	DISEASEORPHENOTYPICFEATURE	D001308
16596970	896	914	status epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	970	975	ratti	ORGANISMTAXON	10116
16596970	1100	1112	 pilocarpina	CHEMICALENTITY	D010862
16596970	1158	1169	Pilocarpina	CHEMICALENTITY	D010862
16596970	1245	1261	stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
16596970	1306	1325	lo stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
16596970	1450	1461	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16596970	1502	1507	ratti	ORGANISMTAXON	10116
16596970	1595	1606	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16596970	1638	1643	ratti	ORGANISMTAXON	10116
16596970	1809	1814	ratti	ORGANISMTAXON	10116
16596970	1918	1936	status epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	1971	1975	rats	ORGANISMTAXON	10116
16596970	2121	2138	Stato epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	2173	2177	rats	ORGANISMTAXON	10116
16596970	2337	2355	Status epilepticus	DISEASEORPHENOTYPICFEATURE	D013226
16596970	2387	2390	rat	ORGANISMTAXON	10116
16596970	2479	2523	compromissione della discriminazione uditiva	DISEASEORPHENOTYPICFEATURE	D001308
16596970	2613	2661	discriminazione della posizione uditiva alterata	DISEASEORPHENOTYPICFEATURE	D001308
16596970	2695	2700	umani	ORGANISMTAXON	9606
16634859	42	48	alcool	CHEMICALENTITY	D000431
16634859	285	291	alcool	CHEMICALENTITY	D000431
16634859	347	352	alcol	CHEMICALENTITY	D000431
16634859	664	670	alcool	CHEMICALENTITY	D000431
16634859	729	758	compromissione della crescita	DISEASEORPHENOTYPICFEATURE	D006130
16634859	974	979	alcol	CHEMICALENTITY	D000431
16634859	1029	1034	donne	ORGANISMTAXON	9606
16634859	1160	1165	donne	ORGANISMTAXON	9606
16634859	1292	1297	alcol	CHEMICALENTITY	D000431
16634859	1470	1475	alcol	CHEMICALENTITY	D000431
16634859	1897	1912	abuso di droghe	DISEASEORPHENOTYPICFEATURE	D019966
16634859	2061	2066	donne	ORGANISMTAXON	9606
16634859	2066	2067	 	CHEMICALENTITY	D000431
16634859	2189	2194	alcol	CHEMICALENTITY	D000431
16634859	2476	2504	ridotta crescita cerebellare	DISEASEORPHENOTYPICFEATURE	D006130
16634859	2555	2588	ridotta crescita cranica-corporea	DISEASEORPHENOTYPICFEATURE	D006130
16634859	2627	2632	donne	ORGANISMTAXON	9606
16634859	2711	2732	L'abuso di anfetamine	CHEMICALENTITY	D000661
16634859	3031	3036	alcol	CHEMICALENTITY	D000431
16720068	53	82	sindrome neurolettica maligna	DISEASEORPHENOTYPICFEATURE	D009459
16720068	157	167	paroxetina	CHEMICALENTITY	D017374
16720068	201	211	alprazolam	CHEMICALENTITY	D000525
16720068	243	258	uomo di 74 anni	ORGANISMTAXON	9606
16720068	306	324	sintomi depressivi	DISEASEORPHENOTYPICFEATURE	D003866
16720068	393	405	psichiatrico	DISEASEORPHENOTYPICFEATURE	D001523
16720068	469	477	insonnia	DISEASEORPHENOTYPICFEATURE	D007319
16720068	522	541	perdita di appetito	DISEASEORPHENOTYPICFEATURE	D001068
16720068	601	611	agitazione	DISEASEORPHENOTYPICFEATURE	D011595
16720068	716	726	paroxetina	CHEMICALENTITY	D017374
16720068	767	777	alprazolam	CHEMICALENTITY	D000525
16720068	826	836	paroxetina	CHEMICALENTITY	D017374
16720068	871	881	alprazolam	CHEMICALENTITY	D000525
16720068	926	934	paziente	ORGANISMTAXON	9606
16720068	1001	1021	ritardo psicomotorio	DISEASEORPHENOTYPICFEATURE	D011596
16720068	1091	1109	rigidità muscolare	DISEASEORPHENOTYPICFEATURE	D009127
16720068	1157	1164	tremori	DISEASEORPHENOTYPICFEATURE	D014202
16720068	1196	1204	paziente	ORGANISMTAXON	9606
16720068	1263	1269	febbre	DISEASEORPHENOTYPICFEATURE	D005334
16720068	1407	1422	extrapiramidali	DISEASEORPHENOTYPICFEATURE	D001480
16720068	1506	1527	creatina fosfochinasi	CHEMICALENTITY	D003402
16720068	1583	1609	aspartato aminotransferasi	CHEMICALENTITY	D001219
16720068	1653	1677	alanina aminotransferasi	CHEMICALENTITY	D000410
16720068	1738	1746	paziente	ORGANISMTAXON	9606
16720068	1790	1803	bromocriptina	CHEMICALENTITY	D001971
16720068	1838	1846	diazepam	CHEMICALENTITY	D003975
16720068	1935	1941	febbre	DISEASEORPHENOTYPICFEATURE	D005334
16720068	1996	2004	paziente	ORGANISMTAXON	9606
16720068	2037	2053	I livelli di CPK	CHEMICALENTITY	D003402
16720068	2124	2132	paziente	ORGANISMTAXON	9606
16720068	2198	2227	sindrome neurolettica maligna	DISEASEORPHENOTYPICFEATURE	D009459
16720068	2273	2276	SNM	DISEASEORPHENOTYPICFEATURE	D009459
16720068	2362	2365	SNM	DISEASEORPHENOTYPICFEATURE	D009459
16720068	2442	2452	paroxetina	CHEMICALENTITY	D017374
16720068	2486	2496	alprazolam	CHEMICALENTITY	D000525
16720068	2680	2688	paziente	ORGANISMTAXON	9606
16720068	2737	2765	Sintomi avversi simili a NMS	DISEASEORPHENOTYPICFEATURE	D009459
16720068	2935	2943	paziente	ORGANISMTAXON	9606
16720068	3019	3022	SNM	DISEASEORPHENOTYPICFEATURE	D009459
16720068	3107	3117	depressivi	DISEASEORPHENOTYPICFEATURE	D003866
16720068	3145	3153	pazienti	ORGANISMTAXON	9606
16720068	3228	3242	disidratazione	DISEASEORPHENOTYPICFEATURE	D003681
16720068	3287	3298	 agitazione	DISEASEORPHENOTYPICFEATURE	D011595
16720068	3343	3356	malnutrizione	DISEASEORPHENOTYPICFEATURE	D044342
16720068	3479	3487	pazienti	ORGANISMTAXON	9606
16720068	3547	3558	depressione	DISEASEORPHENOTYPICFEATURE	D003866
16725121	63	96	trasportatore della noradrenalina	GENEORGENEPRODUCT	20538
16725121	171	182	desipramina	CHEMICALENTITY	D003891
16725121	258	268	anestetici	CHEMICALENTITY	D000777
16725121	324	335	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16725121	415	425	anestetici	CHEMICALENTITY	D000777
16725121	493	526	trasportatore della noradrenalina	GENEORGENEPRODUCT	20538
16725121	560	563	NET	GENEORGENEPRODUCT	20538
16725121	624	627	NET	GENEORGENEPRODUCT	20538
16725121	709	720	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16725121	764	771	cocaina	CHEMICALENTITY	D003042
16725121	805	815	anestetici	CHEMICALENTITY	D000777
16725121	867	871	topi	ORGANISMTAXON	10090
16725121	936	947	desipramina	CHEMICALENTITY	D003891
16725121	998	1001	NET	GENEORGENEPRODUCT	20538
16725121	1057	1076	[(3)H]norepinefrina	CHEMICALENTITY	D009638
16725121	1232	1241	lidocaina	CHEMICALENTITY	D008012
16725121	1274	1285	bupivacaina	CHEMICALENTITY	D002045
16725121	1320	1328	tricaina	CHEMICALENTITY	C003636
16725121	1364	1375	desipramina	CHEMICALENTITY	D003891
16725121	1466	1473	cocaina	CHEMICALENTITY	D003042
16725121	1520	1539	[(3)H]norepinefrina	CHEMICALENTITY	D009638
16725121	1619	1630	desipramina	CHEMICALENTITY	D003891
16725121	1705	1714	lidocaina	CHEMICALENTITY	D008012
16725121	1767	1778	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16725121	1832	1839	cocaina	CHEMICALENTITY	D003042
16725121	1895	1906	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16725121	1965	1974	lidocaina	CHEMICALENTITY	D008012
16725121	2010	2021	desipramina	CHEMICALENTITY	D003891
16725121	2095	2114	attività convulsiva	DISEASEORPHENOTYPICFEATURE	D012640
16725121	2149	2158	lidocaina	CHEMICALENTITY	D008012
16725121	2192	2199	cocaina	CHEMICALENTITY	D003042
16725121	2274	2285	desipramina	CHEMICALENTITY	D003891
16725121	2387	2390	NET	GENEORGENEPRODUCT	20538
16725121	2464	2475	desipramina	CHEMICALENTITY	D003891
16725121	2532	2543	desipramina	CHEMICALENTITY	D003891
16725121	2603	2612	lidocaina	CHEMICALENTITY	D008012
16725121	2656	2667	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16725121	2724	2729	Na(+)	CHEMICALENTITY	D012964
16725121	2773	2783	anestetici	CHEMICALENTITY	D000777
16725121	2836	2847	desipramina	CHEMICALENTITY	D003891
16725121	2918	2921	NET	GENEORGENEPRODUCT	20538
16725121	2986	2993	cocaina	CHEMICALENTITY	D003042
16725121	3069	3072	NET	GENEORGENEPRODUCT	20538
16725121	3114	3125	Desipramina	CHEMICALENTITY	D003891
16725121	3185	3194	lidocaina	CHEMICALENTITY	D008012
16725121	3239	3253	le convulsioni	DISEASEORPHENOTYPICFEATURE	 D012640
16725121	3384	3391	cocaina	CHEMICALENTITY	D003042
16737910	89	93	ETV6	GENEORGENEPRODUCT	2120
16737910	127	130	TEL	GENEORGENEPRODUCT	 2120
16737910	173	177	ETV6	GENEORGENEPRODUCT	2120
16737910	212	238	Translocation-Ets-Leukemia	GENEORGENEPRODUCT	2120
16737910	272	275	TEL	GENEORGENEPRODUCT	2120
16737910	476	481	umano	ORGANISMTAXON	 9606
16737910	525	531	cancro	DISEASEORPHENOTYPICFEATURE	D009369
16737910	564	568	ETV6	GENEORGENEPRODUCT	2120
16737910	773	777	ETV6	GENEORGENEPRODUCT	2120
16737910	966	970	ETV6	GENEORGENEPRODUCT	2120
16737910	1003	1007	ETV6	GENEORGENEPRODUCT	2120
16737910	1259	1263	ETV6	GENEORGENEPRODUCT	2120
16737910	1344	1362	beta-galattosidasi	GENEORGENEPRODUCT	2720
16737910	1564	1568	ETV6	GENEORGENEPRODUCT	2120
16755009	72	85	Daucus carota	ORGANISMTAXON	4039
16755009	148	169	disfunzioni cognitive	DISEASEORPHENOTYPICFEATURE	D003072
16755009	259	272	Daucus carota	ORGANISMTAXON	4039
16755009	348	359	colesterolo	CHEMICALENTITY	D002784
16755009	421	434	colinesterasi	GENEORGENEPRODUCT	12038
16755009	467	471	topi	ORGANISMTAXON	10090
16755009	525	558	estratto di semi di Daucus carota	CHEMICALENTITY	D010936
16755009	591	594	DCE	CHEMICALENTITY	D010936
16755009	744	748	topi	ORGANISMTAXON	10090
16755009	935	943	Diazepam	CHEMICALENTITY	D003975
16755009	977	988	scopolamina	CHEMICALENTITY	D012601
16755009	1059	1066	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16755009	1155	1158	DCE	CHEMICALENTITY	D010936
16755009	1286	1304	giovani e anziani 	ORGANISMTAXON	10090
16755009	1389	1392	DCE	CHEMICALENTITY	D010936
16755009	1505	1509	topi	ORGANISMTAXON	10090
16755009	1718	1721	età	ORGANISMTAXON	10090
16755009	1770	1773	DCE	CHEMICALENTITY	D010936
16755009	1832	1839	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
16755009	1883	1894	scopolamina	CHEMICALENTITY	D012601
16755009	1946	1954	diazepam	CHEMICALENTITY	D003975
16755009	2003	2028	Estratto di Daucus carota	CHEMICALENTITY	D010936
16755009	2126	2145	acetilcolinesterasi	GENEORGENEPRODUCT	11423
16755009	2199	2210	colesterolo	CHEMICALENTITY	D002784
16755009	2244	2248	topi	ORGANISMTAXON	10090
16755009	2349	2362	colinesterasi	GENEORGENEPRODUCT	12038
16755009	2405	2408	DCE	CHEMICALENTITY	D010936
16755009	2498	2502	topi	ORGANISMTAXON	10090
16755009	2603	2614	colesterolo	CHEMICALENTITY	D002784
16755009	2749	2752	DCE	CHEMICALENTITY	D010936
16755009	2795	2798	DCE	CHEMICALENTITY	D010936
16755009	2892	2913	disfunzioni cognitive	DISEASEORPHENOTYPICFEATURE	D003072
16755009	3032	3043	colesterolo	CHEMICALENTITY	D002784
16781314	43	94	Sindrome da displasia ectodermica-fragilità cutanea	DISEASEORPHENOTYPICFEATURE	C536183
16781314	176	183	888delC	SEQUENCEVARIANT	C|DEL888|C
16781314	244	257	placofilina 1	GENEORGENEPRODUCT	5317
16781314	333	352	disturbo ereditario	DISEASEORPHENOTYPICFEATURE	D030342
16781314	412	425	placofilina 1	GENEORGENEPRODUCT	5317
16781314	486	537	sindrome da displasia ectodermica-fragilità cutanea	DISEASEORPHENOTYPICFEATURE	C536183
16781314	681	698	fragilità cutanea	DISEASEORPHENOTYPICFEATURE	C536183
16781314	755	777	cheratoderma plantare 	DISEASEORPHENOTYPICFEATURE	D017499
16781314	822	843	distrofia dell'unghia	DISEASEORPHENOTYPICFEATURE	D009260
16781314	889	897	alopecia	DISEASEORPHENOTYPICFEATURE	D000505
16781314	1109	1122	plakophilin 1	GENEORGENEPRODUCT	5317
16781314	1159	1163	PKP1	GENEORGENEPRODUCT	5317
16781314	1225	1257	delezione di C al nucleotide 888	SEQUENCEVARIANT	C|DEL888|C
16781314	1346	1350	PKP1	GENEORGENEPRODUCT	5317
16781314	1479	1492	genodermatosi	DISEASEORPHENOTYPICFEATURE	D012873
16781314	1622	1635	placofilina 1	GENEORGENEPRODUCT	5317
16786513	43	62	Malattia di McArdle	DISEASEORPHENOTYPICFEATURE	D006012
16786513	122	127	PYGM 	GENEORGENEPRODUCT	5837
16786513	200	263	La carenza dell'isoenzima muscolare della glicogeno fosforilasi	DISEASEORPHENOTYPICFEATURE	D006012
16786513	319	338	Malattia di McArdle	DISEASEORPHENOTYPICFEATURE	D006012
16786513	384	427	Malattia da accumulo di glicogeno di tipo V	DISEASEORPHENOTYPICFEATURE	D006012
16786513	472	478	GSD- V	DISEASEORPHENOTYPICFEATURE	D006012
16786513	538	567	disturbo autosomico recessivo	DISEASEORPHENOTYPICFEATURE	D030342
16786513	602	611	glicogeno	CHEMICALENTITY	D006003
16786513	750	756	crampi	DISEASEORPHENOTYPICFEATURE	D009120
16786513	802	827	mioglobinuria ricorrente 	DISEASEORPHENOTYPICFEATURE	D009212
16786513	891	895	PYGM	GENEORGENEPRODUCT	5837
16786513	962	967	GSD-V	DISEASEORPHENOTYPICFEATURE	D006012
16786513	995	1003	pazienti	ORGANISMTAXON	9606
16786513	1072	1080	pazienti	ORGANISMTAXON	9606
16786513	1173	1177	PYGM	GENEORGENEPRODUCT	5837
16786513	1336	1344	c.475G>A	SEQUENCEVARIANT	RS760654579
16786513	1382	1389	p.G159R	SEQUENCEVARIANT	RS760654579
16786513	1429	1437	c.689C>G	SEQUENCEVARIANT	C|SUB|C|689|G
16786513	1478	1485	p.P230R	SEQUENCEVARIANT	P|SUB|P |230|R
16786513	1526	1535	c.1094C>T	SEQUENCEVARIANT	C|SUB|C|1094|T
16786513	1576	1583	p.A365E	SEQUENCEVARIANT	P|SUB|A|365|E
16786513	1624	1634	c.1151C >A	SEQUENCEVARIANT	C|SUB|C|1151|A
16786513	1674	1681	p.A384D	SEQUENCEVARIANT	P|SUB|A|384|D
16786513	1720	1730	c.1182C>T,	SEQUENCEVARIANT	RS750700202
16786513	1767	1774	p.R428C	SEQUENCEVARIANT	RS750700202
16786513	1812	1822	c.1471C >T	SEQUENCEVARIANT	RS759977194
16786513	1860	1867	p.R491C	SEQUENCEVARIANT	RS759977194
16786513	1909	1918	c.2444A>C	SEQUENCEVARIANT	C|SUB|A|2444|C
16786513	1958	1965	p.D815A	SEQUENCEVARIANT	P|SUB|D|815|A
16786513	2007	2016	c.2477G>C	SEQUENCEVARIANT	C|SUB|G|2477|C
16786513	2056	2063	p.W826S	SEQUENCEVARIANT	P|SUB|W|826|S
16786513	2133	2142	c.1475G>A	SEQUENCEVARIANT	C|SUB|G|147 5|A
16786513	2182	2189	p.W492X	SEQUENCEVARIANT	P|SUB|W|492|X
16786513	2230	2239	c.1627A>T	SEQUENCEVARIANT	C|SUB|A|1627|T
16786513	2279	2287	 p.K543X	SEQUENCEVARIANT	P|SUB|K|543|X
16786513	2724	2734	p.V239del 	SEQUENCEVARIANT	P|DEL|239|V
16786513	2772	2781	c.304delA	SEQUENCEVARIANT	C|DEL|304|A
16786513	2823	2834	p.N102DfsX4	SEQUENCEVARIANT	P|FS|N |102|D|4
16786513	3047	3059	p.G705RfsX16	SEQUENCEVARIANT	P|FS|G|705|R|16
16786513	3260	3266	p.R50X	SEQUENCEVARIANT	RS116987552
16786513	3439	3447	pazienti	ORGANISMTAXON	9606
16801510	62	83	sindrome del QT lungo	DISEASEORPHENOTYPICFEATURE	D008133
16801510	169	177	metadone	CHEMICALENTITY	D008691
16801510	225	233	pazienti	ORGANISMTAXON	9606
16801510	441	452	Il metadone	CHEMICALENTITY	D008691
16801510	557	567	ricoverato	ORGANISMTAXON	9606
16801510	628	660	prolungamento dell'intervallo QT	DISEASEORPHENOTYPICFEATURE	D008133
16801510	697	721	trattamento con metadone	CHEMICALENTITY	D008691
16801510	1019	1027	metadone	CHEMICALENTITY	D008691
16801510	1087	1096	 metadone	CHEMICALENTITY	D008691
16801510	1136	1144	pazienti	ORGANISMTAXON	9606
16801510	1259	1267	pazienti	ORGANISMTAXON	9606
16801510	1318	1326	metadone	CHEMICALENTITY	D008691
16801510	1511	1519	metadone	CHEMICALENTITY	D008691
16801510	1571	1579	metadone	CHEMICALENTITY	D008691
16801510	1736	1752	QT prolungamento	DISEASEORPHENOTYPICFEATURE	D008133
16801510	1804	1812	metadone	CHEMICALENTITY	D008691
16801510	1853	1861	pazienti	ORGANISMTAXON	9606
16801510	1924	1952	Il prolungamento del QTc da 	DISEASEORPHENOTYPICFEATURE	D008133
16801510	2087	2095	pazienti	ORGANISMTAXON	9606
16801510	2145	2153	metadone	CHEMICALENTITY	D008691
16801510	2198	2215	torsioni di punta	DISEASEORPHENOTYPICFEATURE	D016171
16801510	2342	2350	metadone	CHEMICALENTITY	D008691
16801510	2554	2562	metadone	CHEMICALENTITY	D008691
16801510	2600	2619	citocromo P-450 3A4	GENEORGENEPRODUCT	1576
16801510	2692	2703	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
16801510	2793	2825	Prolungamento dell'intervallo QT	DISEASEORPHENOTYPICFEATURE	D008133
16801510	2860	2868	metadone	CHEMICALENTITY	D008691
16801510	2910	2918	pazienti	ORGANISMTAXON	9606
16801510	3021	3029	Metadone	CHEMICALENTITY	D008691
16801510	3079	3112	inibitori del citocromo P-450 3A4	CHEMICALENTITY	D065692
16801510	3146	3165	livello di potassio	CHEMICALENTITY	D011188
16801510	3248	3268	prolungamento del QT	DISEASEORPHENOTYPICFEATURE	D008133
16801510	3313	3334	Sindrome del QT lungo	DISEASEORPHENOTYPICFEATURE	D008133
16801510	3400	3408	metadone	CHEMICALENTITY	D008691
16810074	57	69	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16810074	112	126	ossido nitrico	CHEMICALENTITY	D009569
16810074	159	161	NO	CHEMICALENTITY	D009569
16810074	243	257	ossido nitrico	CHEMICALENTITY	D009569
16810074	290	292	NO	CHEMICALENTITY	D009569
16810074	340	354	l'ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16810074	423	444	disfunzione arteriosa	DISEASEORPHENOTYPICFEATURE	D018754
16810074	502	514	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16810074	572	574	NO	CHEMICALENTITY	D009569
16810074	739	751	endothelin-1	GENEORGENEPRODUCT	24323
16810074	785	789	ET-1	GENEORGENEPRODUCT	24323
16810074	1020	1043	Nomega-nitro-L-arginina	CHEMICALENTITY	D019335
16810074	1077	1081	LNNA	CHEMICALENTITY	D019335
16810074	1126	1138	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16810074	1197	1202	Ratti	ORGANISMTAXON	10116
16810074	1271	1281	NO sintasi	GENEORGENEPRODUCT	24598
16810074	1314	1318	LNNA	CHEMICALENTITY	D019335
16810074	1424	1429	ratti	ORGANISMTAXON	10116
16810074	1518	1522	LNNA	CHEMICALENTITY	D019335
16810074	1551	1556	ratti	ORGANISMTAXON	10116
16810074	1726	1739	noradrenalina	CHEMICALENTITY	D009638
16810074	1818	1822	LNNA	CHEMICALENTITY	D019335
16810074	1873	1877	rats	ORGANISMTAXON	10116
16810074	1942	1946	ET-1	GENEORGENEPRODUCT	24323
16810074	2078	2091	noradrenalina	CHEMICALENTITY	D009638
16810074	2195	2200	ET -1	GENEORGENEPRODUCT	24323
16810074	2358	2362	LNNA	CHEMICALENTITY	D019335
16810074	2406	2418	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16810074	2473	2477	LNNA	CHEMICALENTITY	D019335
16810074	2513	2524	superossido	CHEMICALENTITY	D013481
16810074	2566	2572	tempol	CHEMICALENTITY	C001803
16810074	2693	2698	ratti	ORGANISMTAXON	10116
16810074	2779	2784	 LNNA	CHEMICALENTITY	D019335
16810074	2813	2818	ratti	ORGANISMTAXON	10116
16810074	2935	2945	esametonio	CHEMICALENTITY	D018738
16810074	3030	3034	LNNA	CHEMICALENTITY	D019335
16810074	3078	3089	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
16810074	3118	3123	ratti	ORGANISMTAXON	10116
16810074	3192	3197	ratti	ORGANISMTAXON	10116
16810074	3306	3310	LNNA	CHEMICALENTITY	D019335
16810074	3339	3344	ratti	ORGANISMTAXON	10116
16810074	3413	3424	superossido	CHEMICALENTITY	D013481
16810074	3484	3489	ratti	ORGANISMTAXON	10116
16810074	3572	3574	NO	CHEMICALENTITY	D009569
16810074	3781	3793	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
16822828	54	62	pazienti	ORGANISMTAXON	9606
16822828	110	141	17alpha- deficit di idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16822828	306	311	CYP17	GENEORGENEPRODUCT	1586
16822828	366	395	Deficit di 17alfa-idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16822828	459	491	iperplasia surrenalica congenita	DISEASEORPHENOTYPICFEATURE	D000312
16822828	553	558	CYP17	GENEORGENEPRODUCT	1586
16822828	605	613	pazienti	ORGANISMTAXON	9606
16822828	668	697	deficit di 17alfa-idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16822828	751	759	PAZIENTI	ORGANISMTAXON	9606
16822828	797	805	pazienti	ORGANISMTAXON	9606
16822828	942	971	deficit di 17alfa-idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16822828	1183	1188	CYP17	GENEORGENEPRODUCT	1586
16822828	1226	1234	pazienti	ORGANISMTAXON	9606
16822828	1285	1291	V311fs	SEQUENCEVARIANT	P|FS|V|311||
16822828	1332	1338	Y329fs	SEQUENCEVARIANT	P|FS|Y|329||
16822828	1417	1423	V311fs	SEQUENCEVARIANT	P|FS|V|311||
16822828	1469	1506	8-bp nucleotide ( TTAAATGG) delezione	SEQUENCEVARIANT	C|DEL||TTAAATGG
16822828	1558	1564	Y329fs	SEQUENCEVARIANT	P|FS|Y|329||
16822828	1662	1686	(TAC-->AA) al codone 329	SEQUENCEVARIANT	C|SUB|TAC|CODON329|AA
16822828	1757	1763	Y329fs	SEQUENCEVARIANT	P|FS|Y|329||
16822828	1831	1837	Y329fs	SEQUENCEVARIANT	P|FS|Y|329||
16822828	1877	1883	V311fs	SEQUENCEVARIANT	P|FS|V|311||
16822828	2202	2231	deficit di 17alfa-idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16822828	2567	2572	CYP17	GENEORGENEPRODUCT	1586
16822828	2670	2676	Y329fs	SEQUENCEVARIANT	P|FS|Y|329||
16822828	2832	2837	CYP17	GENEORGENEPRODUCT	1586
16822828	2910	2918	pazienti	ORGANISMTAXON	9606
16822828	3005	3011	Y329fs	SEQUENCEVARIANT	P|FS|Y|329 ||
16822828	3146	3178	il deficit di 17alfa-idrossilasi	DISEASEORPHENOTYPICFEATURE	C538237
16843501	74	89	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
16843501	147	152	hOGG1	GENEORGENEPRODUCT	4968
16843501	186	191	RAD51	GENEORGENEPRODUCT	5888
16843501	422	427	hOGG1	GENEORGENEPRODUCT	4968
16843501	534	539	RAD51	GENEORGENEPRODUCT	5888
16843501	780	799	cancro allo stomaco	DISEASEORPHENOTYPICFEATURE	D013274
16843501	977	998	perossido di idrogeno	CHEMICALENTITY	D006861
16843501	1084	1100	 cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
16843501	1128	1136	pazienti	ORGANISMTAXON	9606
16843501	1315	1320	hOGG1	GENEORGENEPRODUCT	4968
16843501	1354	1359	RAD51	GENEORGENEPRODUCT	5888
16843501	1417	1440	G-->C in posizione 1245	SEQUENCEVARIANT	RS1052133
16843501	1476	1482	hOGG1 	GENEORGENEPRODUCT	4968
16843501	1537	1573	Ser-->Sostituzione Cys al codone 326	SEQUENCEVARIANT	RS1052133
16843501	1613	1622	Ser326Cys	SEQUENCEVARIANT	RS1052133
16843501	1694	1718	G-->C alla posizione 135	SEQUENCEVARIANT	G|SUB|G|135|C
16843501	1786	1791	RAD51	GENEORGENEPRODUCT	5888
16843501	1834	1839	G135C	SEQUENCEVARIANT	G|SUB|G|135|C
16843501	2058	2074	endonucleasi III	GENEORGENEPRODUCT	4913
16843501	2108	2111	Nth	GENEORGENEPRODUCT	4913
16843501	2147	2183	formammidopirimidina-DNA glicosilasi	GENEORGENEPRODUCT	79661
16843501	2217	2220	Fpg	GENEORGENEPRODUCT	79661
16843501	2495	2510	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
16843501	2581	2586	umano	ORGANISMTAXON	9606
16843501	2646	2649	G/C	SEQUENCEVARIANT	G|SUB|G||C
16843501	2693	2698	G135C	SEQUENCEVARIANT	G|SUB|G|135 |C
16843501	2752	2757	RAD51	GENEORGENEPRODUCT	5888
16843501	2875	2894	cancro allo stomaco	DISEASEORPHENOTYPICFEATURE	D013274
16843501	3059	3069	Ser1245Cys	SEQUENCEVARIANT	RS1052133
16843501	3110	3115	hOGG1	GENEORGENEPRODUCT	4968
16843501	3161	3176	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
16843501	3383	3388	G135C	SEQUENCEVARIANT	G|SUB|G|135|C
16843501	3424	3429	RAD51	GENEORGENEPRODUCT	5888
16843501	3506	3521	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
16904497	43	70	Sindrome della cauda equina	DISEASEORPHENOTYPICFEATURE	D011128
16904497	117	125	steroide	CHEMICALENTITY	D013256
16904497	263	276	radicolopatia	DISEASEORPHENOTYPICFEATURE	D011843
16904497	340	348	steroidi	CHEMICALENTITY	D013256
16904497	448	475	Sindrome della cauda equina	DISEASEORPHENOTYPICFEATURE	D011128
16904497	606	633	sindrome della cauda equina	DISEASEORPHENOTYPICFEATURE	D011128
16904497	715	728	triamcinolone	CHEMICALENTITY	D014221
16904497	762	773	bupivacaina	CHEMICALENTITY	D002045
16904497	828	833	donna	ORGANISMTAXON	9606
16904497	900	957	dolore alla parte bassa della schiena e alla gamba destra	DISEASEORPHENOTYPICFEATURE	D010146,D017116
16904497	1035	1043	steroide	CHEMICALENTITY	D013256
16904497	1400	1411	bupivacaina	CHEMICALENTITY	D002045
16904497	1445	1468	triamcinolone diacetato	CHEMICALENTITY	C030262
16904497	1617	1631	intorpidimento	DISEASEORPHENOTYPICFEATURE	D006987
16904497	1677	1707	debolezza degli arti inferiori	DISEASEORPHENOTYPICFEATURE	D020335
16904497	1791	1813	perdita di sensibilità	DISEASEORPHENOTYPICFEATURE	D006987
16904497	2088	2096	paziente	ORGANISMTAXON	9606
16904497	2419	2427	steroidi	CHEMICALENTITY	D013256
16904497	2526	2552	deterioramento neurologico	DISEASEORPHENOTYPICFEATURE	D009422
16904497	2613	2621	steroidi	CHEMICALENTITY	D013256
16920333	60	83	eslicarbazepina acetato	CHEMICALENTITY	C416835
16920333	116	126	BIA 2 -093	CHEMICALENTITY	C416835
16920333	174	179	crisi	DISEASEORPHENOTYPICFEATURE	D012640
16920333	244	256	picrotossina	CHEMICALENTITY	D010852
16920333	303	308	ratti	ORGANISMTAXON	10116
16920333	368	391	Eslicarbazepina acetato	CHEMICALENTITY	C416835
16920333	424	433	BIA 2-093	CHEMICALENTITY	C416835
16920333	467	536	S-(-)-10-acetossi-10,11-diidro-5H-dibenzo/b,f/azepina-5-carbossammide	CHEMICALENTITY	C416835
16920333	583	605	farmaco antiepilettico	CHEMICALENTITY	D000927
16920333	786	800	carbamazepina 	CHEMICALENTITY	D002220
16920333	833	836	CBZ	CHEMICALENTITY	D002220
16920333	871	884	oxcarbazepina	CHEMICALENTITY	C036006
16920333	918	921	OXC	CHEMICALENTITY	C036006
16920333	1010	1033	eslicarbazepina acetato	CHEMICALENTITY	C416835
16920333	1116	1127	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16920333	1267	1276	sequestro	DISEASEORPHENOTYPICFEATURE	D012640
16920333	1351	1363	picrotossina	CHEMICALENTITY	D010852
16920333	1427	1432	crisi	DISEASEORPHENOTYPICFEATURE	D012640
16920333	1511	1520	sequestro	DISEASEORPHENOTYPICFEATURE	D012640
16920333	1631	1643	picrotossina	CHEMICALENTITY	D010852
16920333	1713	1724	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16920333	1765	1770	ratti	ORGANISMTAXON	10116
16920333	1865	1876	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
16920333	2016	2021	crisi	DISEASEORPHENOTYPICFEATURE	D012640
16920333	2088	2093	crisi	DISEASEORPHENOTYPICFEATURE	D012640
16920333	2205	2228	eslicarbazepina acetato	CHEMICALENTITY	C416835
17000021	63	72	-1123 G>C	SEQUENCEVARIANT	RS2488457
17000021	109	118	+2740 A>G	SEQUENCEVARIANT	RS1217412
17000021	181	187	PTPN22	GENEORGENEPRODUCT	26191
17000021	236	253	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17000021	299	327	artrite idiopatica giovanile	DISEASEORPHENOTYPICFEATURE	D001171
17000021	408	414	PTPN22	GENEORGENEPRODUCT	 26191
17000021	508	516	+1858C>T	SEQUENCEVARIANT	RS2476601
17000021	553	558	R620W	SEQUENCEVARIANT	RS2476601
17000021	669	688	malattie autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
17000021	741	758	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17000021	803	806	T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	854	882	artrite idiopatica giovanile	DISEASEORPHENOTYPICFEATURE	D001171
17000021	927	930	AIG	DISEASEORPHENOTYPICFEATURE	D001171
17000021	1287	1293	PTPN22	GENEORGENEPRODUCT	26191
17000021	1403	1407	 T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	1457	1460	JIA	DISEASEORPHENOTYPICFEATURE	D001171
17000021	1518	1521	T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	1631	1640	rs2488457	SEQUENCEVARIANT	RS2488457
17000021	1684	1693	rs2476601	SEQUENCEVARIANT	RS2476601
17000021	1745	1750	R620W	SEQUENCEVARIANT	RS2476601
17000021	1795	1804	rs1217412	SEQUENCEVARIANT	RS1217412
17000021	1939	1942	T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	2004	2008	 JIA	DISEASEORPHENOTYPICFEATURE	D001171
17000021	2118	2121	T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	2591	2608	(W) al codone 620	SEQUENCEVARIANT	RS2476601
17000021	2669	2672	T1D	DISEASEORPHENOTYPICFEATURE	D003922
17000021	2790	2793	JIA	DISEASEORPHENOTYPICFEATURE	D001171
17000021	2905	2922	(R) al codone 620	SEQUENCEVARIANT	RS2476601
17000021	3051	3072	condizioni autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
17000021	3344	3350	PTPN22	GENEORGENEPRODUCT	26191
17003357	74	80	PTPN22	GENEORGENEPRODUCT	26191
17003357	128	145	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	 D003922
17003357	242	259	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	319	325	PTPN22	GENEORGENEPRODUCT	26191
17003357	384	412	fosfatasi linfoide specifica	GENEORGENEPRODUCT	26191
17003357	446	449	Lyp	GENEORGENEPRODUCT	26191
17003357	530	536	PTPN22	GENEORGENEPRODUCT	26191
17003357	583	600	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	727	734	1858C/T	SEQUENCEVARIANT	RS2476601
17003357	850	856	PTPN22	GENEORGENEPRODUCT	26191
17003357	964	981	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	1056	1061	1858T	SEQUENCEVARIANT	RS2476601
17003357	1164	1181	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	1367	1384	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	1475	1481	PTPN22	GENEORGENEPRODUCT	26191
17003357	1568	1575	2250G/C	SEQUENCEVARIANT	RS56048322
17003357	1716	1722	PTPN22	GENEORGENEPRODUCT	26191
17003357	1989	1996	1858C/T	SEQUENCEVARIANT	RS2476601
17003357	2080	2097	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17003357	2140	2146	PTPN22	GENEORGENEPRODUCT	26191
17003357	2248	2254	PTPN22	GENEORGENEPRODUCT	26191
17003357	2334	2351	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
17006606	53	80	Sostituzione da C a T a -31	SEQUENCEVARIANT	RS1143627
17006606	113	117	IL1B	GENEORGENEPRODUCT	3553
17006606	187	210	adenocarcinoma gastrico	DISEASEORPHENOTYPICFEATURE	D013274
17006606	423	438	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
17006606	478	482	IL1B	GENEORGENEPRODUCT	3553
17006606	516	522	-31T/C	SEQUENCEVARIANT	RS1143627
17006606	560	567	-511C/T	SEQUENCEVARIANT	RS1143634
17006606	699	703	IL1B	GENEORGENEPRODUCT	3553
17006606	795	815	interleuchina 1 beta	GENEORGENEPRODUCT	3553
17006606	848	855	IL1beta	GENEORGENEPRODUCT	3553
17006606	892	919	fattore nucleare di kappa B	GENEORGENEPRODUCT	4790
17006606	952	960	NFkappaB	GENEORGENEPRODUCT	4790
17006606	1028	1034	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17006606	1119	1179	antigene di superficie cellulare associato alle cellule FS-7	GENEORGENEPRODUCT	355
17006606	1211	1214	FAS	GENEORGENEPRODUCT	355
17006606	1355	1363	NFkappaB	GENEORGENEPRODUCT	4790
17006606	1410	1416	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17006606	1517	1532	cancro gastrico	DISEASEORPHENOTYPICFEATURE	D013274
17006606	1560	1568	pazienti	ORGANISMTAXON	9606
17006606	1626	1630	IL1B	GENEORGENEPRODUCT	3553
17006606	1672	1675	FAS	GENEORGENEPRODUCT	355
17006606	1795	1818	adenocarcinoma gastrico	DISEASEORPHENOTYPICFEATURE	D013274
17006606	1846	1854	pazienti	ORGANISMTAXON	9606
17006606	2035	2043	T a -511	SEQUENCEVARIANT	RS1143634
17006606	2089	2096	C a -31	SEQUENCEVARIANT	RS1143627
17006606	2146	2154	C a -511	SEQUENCEVARIANT	RS1143634
17006606	2200	2207	T a -31	SEQUENCEVARIANT	RS1143627
17006606	2242	2246	IL1B	GENEORGENEPRODUCT	3553
17006606	2326	2330	IL1B	GENEORGENEPRODUCT	3553
17006606	2373	2376	FAS	GENEORGENEPRODUCT	355
17006606	2489	2512	adenocarcinoma gastrico	DISEASEORPHENOTYPICFEATURE	D013274
17006606	2552	2555	FAS	GENEORGENEPRODUCT	355
17006606	2687	2691	IL1B	GENEORGENEPRODUCT	3553
17006606	2725	2730	-31TT	SEQUENCEVARIANT	RS1143627
17006606	2765	2769	IL1B	GENEORGENEPRODUCT	3553
17006606	2804	2810	-511CC	SEQUENCEVARIANT	RS1143634
17006606	2987	2991	IL1B	GENEORGENEPRODUCT	3553
17006606	3025	3030	-31TT	SEQUENCEVARIANT	RS1143627
17006606	3065	3069	IL1B	GENEORGENEPRODUCT	3553
17006606	3103	3109	-511CC	SEQUENCEVARIANT	RS1143634
17006606	3225	3229	IL1B	GENEORGENEPRODUCT	3553
17006606	3263	3268	-31TT	SEQUENCEVARIANT	RS1143627
17006606	3303	3307	IL1B	GENEORGENEPRODUCT	3553
17006606	3341	3347	-511CC	SEQUENCEVARIANT	RS1143634
17033686	81	86	PQBP1	GENEORGENEPRODUCT	10084
17033686	144	156	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
17033686	201	213	microcefalia	DISEASEORPHENOTYPICFEATURE	D008831
17033686	259	274	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
17033686	319	350	Il ritardo mentale legato all'X	DISEASEORPHENOTYPICFEATURE	D038901
17033686	446	450	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	523	527	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	665	670	PQBP1	GENEORGENEPRODUCT	10084
17033686	729	733	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	790	794	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	896	936	fenotipo di ritardo mentale legato all'X	DISEASEORPHENOTYPICFEATURE	D038901
17033686	981	983	MR	DISEASEORPHENOTYPICFEATURE	D008607
17033686	1029	1041	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
17033686	1086	1103	coloboma coroideo	DISEASEORPHENOTYPICFEATURE	D003103
17033686	1148	1160	microcefalia	DISEASEORPHENOTYPICFEATURE	D008831
17033686	1205	1221	ipoplasia renale	DISEASEORPHENOTYPICFEATURE	D007674
17033686	1267	1287	 paraplegia spastica	DISEASEORPHENOTYPICFEATURE	D010264
17033686	1511	1515	BCOR	GENEORGENEPRODUCT	54880
17033686	1580	1584	BCOR	GENEORGENEPRODUCT	54880
17033686	1666	1698	Sindrome da microftalmia di Lenz	DISEASEORPHENOTYPICFEATURE	C537464
17033686	1868	1872	BCOR	GENEORGENEPRODUCT	54880
17033686	1930	1938	pazienti	ORGANISMTAXON	9606
17033686	2013	2018	PQBP1	GENEORGENEPRODUCT	10084
17033686	2166	2180	c.461_462delAG	SEQUENCEVARIANT	 RS606231195
17033686	2311	2350	Sindrome cerebropalatocardiaca di Hamel	DISEASEORPHENOTYPICFEATURE	C537761
17033686	2415	2419	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	2672	2677	PQBP1	GENEORGENEPRODUCT	10084
17033686	2744	2748	XLMR	DISEASEORPHENOTYPICFEATURE	D038901
17033686	2813	2825	microftalmia	DISEASEORPHENOTYPICFEATURE	D008850
17033686	2933	2939	PQBP1 	GENEORGENEPRODUCT	10084
17035713	31	47	cloroacetaldeide	CHEMICALENTITY	C004656
17035713	84	105	reagente sulfidrilico	CHEMICALENTITY	D013439
17035713	166	171	thiol	CHEMICALENTITY	D013438
17035713	206	216	ifosfamide	CHEMICALENTITY	D007069
17035713	260	270	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
17035713	303	322	La cloroacetaldeide	CHEMICALENTITY	C004656
17035713	355	358	CAA	CHEMICALENTITY	C004656
17035713	412	429	agente alchilante	CHEMICALENTITY	D000477
17035713	461	471	ifosfamide	CHEMICALENTITY	D007069
17035713	504	507	IFO	CHEMICALENTITY	D007069
17035713	586	598	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
17035713	660	666	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17035713	710	713	IFO	CHEMICALENTITY	D007069
17035713	771	781	sulfidrile	CHEMICALENTITY	D013439
17035713	814	816	SH	CHEMICALENTITY	D013439
17035713	947	950	CAA	CHEMICALENTITY	C004656
17035713	981	986	umano	ORGANISMTAXON	9606
17035713	1138	1147	Tossicità	DISEASEORPHENOTYPICFEATURE	D064420
17035713	1182	1185	CAA	CHEMICALENTITY	C004656
17035713	1281	1284	LDH	CHEMICALENTITY	D007770
17035713	1326	1337	trypan blue	CHEMICALENTITY	D014343
17035713	1390	1399	caspase-3	GENEORGENEPRODUCT	 836
17035713	1441	1446	tioli	CHEMICALENTITY	D013438
17035713	1530	1533	CAA	CHEMICALENTITY	C004656
17035713	1693	1698	tioli	CHEMICALENTITY	D013438
17035713	1758	1765	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
17035713	1805	1808	CAA	CHEMICALENTITY	C004656
17035713	1847	1856	acroleina	CHEMICALENTITY	D000171
17035713	1911	1928	cisteina proteasi	GENEORGENEPRODUCT	 1508,836,841
17035713	1959	1968	caspase-3	GENEORGENEPRODUCT	836
17035713	2000	2010	caspase-8 	GENEORGENEPRODUCT	841
17035713	2044	2055	catepsina B	GENEORGENEPRODUCT	1508
17035713	2091	2116	Attivazione della caspasi	GENEORGENEPRODUCT	836,841
17035713	2160	2170	cisplatino	CHEMICALENTITY	D002945
17035713	2222	2225	CAA	CHEMICALENTITY	C004656
17035713	2328	2331	CAA	CHEMICALENTITY	C004656
17035713	2458	2461	CAA	CHEMICALENTITY	C004656
17035713	2504	2521	cisteina proteasi	GENEORGENEPRODUCT	1508,836,841
17035713	2565	2570	tioli	CHEMICALENTITY	D013438
17035713	2693	2696	CAA	CHEMICALENTITY	C004656
17035713	2743	2750	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
17035713	2791	2796	tiolo	CHEMICALENTITY	D013438
17035713	2849	2866	cisteina proteasi	GENEORGENEPRODUCT	1508,836,841
17035713	2942	2945	CAA	CHEMICALENTITY	C004656
17035713	3028	3033	tioli	CHEMICALENTITY	D013438
17035713	3094	3103	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
17035713	3309	3312	IFO	CHEMICALENTITY	D007069
17035713	3356	3366	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
17035713	3398	3406	pazienti	ORGANISMTAXON	9606
17042910	56	69	atorvastatina	CHEMICALENTITY	C065179
17042910	104	117	desametasone 	CHEMICALENTITY	D003907
17042910	169	181	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17042910	214	217	rat	ORGANISMTAXON	10116
17042910	254	266	Desametasone	CHEMICALENTITY	D003907
17042910	299	302	Dex	CHEMICALENTITY	D003907
17042910	356	370	l'ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17042910	458	472	ossido nitrico	CHEMICALENTITY	D009569
17042910	506	508	NO	CHEMICALENTITY	D009569
17042910	562	573	superossido	CHEMICALENTITY	D013481
17042910	606	609	O2-	CHEMICALENTITY	D013481
17042910	654	667	Atorvastatina	CHEMICALENTITY	C065179
17042910	700	703	Ato	CHEMICALENTITY	C065179
17042910	871	873	NO	CHEMICALENTITY	D009569
17042910	919	922	O2-	CHEMICALENTITY	D013481
17042910	995	1007	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17042910	1107	1110	Ato	CHEMICALENTITY	C065179
17042910	1163	1185	NO endoteliale sintasi	GENEORGENEPRODUCT	24598
17042910	1219	1223	eNOS	GENEORGENEPRODUCT	24598
17042910	1284	1287	O2-	CHEMICALENTITY	D013481
17042910	1338	1343	ratti	ORGANISMTAXON	10116
17042910	1425	1430	ratti	ORGANISMTAXON	10116
17042910	1495	1498	Ato	CHEMICALENTITY	C065179
17042910	1605	1617	Desametasone	CHEMICALENTITY	D003907
17042910	1733	1736	Ato	CHEMICALENTITY	C065179
17042910	1789	1794	ratti	ORGANISMTAXON	10116
17042910	2026	2038	acetilcolina	CHEMICALENTITY	D000109
17042910	2098	2109	fenilefrina	CHEMICALENTITY	D010656
17042910	2205	2209	eNOS	GENEORGENEPRODUCT	24598
17042910	2344	2349	ratti	ORGANISMTAXON	10116
17042910	2394	2397	Dex	CHEMICALENTITY	D003907
17042910	2551	2554	Ato	CHEMICALENTITY	C065179
17042910	2588	2591	Dex	CHEMICALENTITY	D003907
17042910	2799	2802	Dex	CHEMICALENTITY	D003907
17042910	2922	2926	eNOS	GENEORGENEPRODUCT	24598
17042910	2977	2980	Dex	CHEMICALENTITY	D003907
17042910	3014	3017	Ato	CHEMICALENTITY	C065179
17042910	3075	3078	Dex	CHEMICALENTITY	D003907
17042910	3189	3200	superossido	CHEMICALENTITY	D013481
17042910	3250	3253	Dex	CHEMICALENTITY	D003907
17042910	3288	3298	gruppo Ato	CHEMICALENTITY	C065179
17042910	3369	3372	Dex	CHEMICALENTITY	D003907
17042910	3445	3448	Ato	CHEMICALENTITY	C065179
17042910	3521	3532	superossido	CHEMICALENTITY	D013481
17042910	3592	3595	Dex	CHEMICALENTITY	D003907
17042910	3636	3641	ratti	ORGANISMTAXON	10116
17065198	54	72	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
17065198	157	165	pazienti	ORGANISMTAXON	 9606
17065198	247	254	CC a TT	SEQUENCEVARIANT	C|SUB|C||T
17065198	300	303	p53	GENEORGENEPRODUCT	7157
17065198	416	443	tumori cutanei non melanoma	DISEASEORPHENOTYPICFEATURE	D012878
17065198	488	493	NMSCs	DISEASEORPHENOTYPICFEATURE	D012878
17065198	555	583	carcinomi a cellule squamose	DISEASEORPHENOTYPICFEATURE	D002294
17065198	628	632	SCCs	DISEASEORPHENOTYPICFEATURE	D002294
17065198	697	712	lesioni cutanee	DISEASEORPHENOTYPICFEATURE	D012871
17065198	767	773	tumori	DISEASEORPHENOTYPICFEATURE	D009369
17065198	810	813	p53	GENEORGENEPRODUCT	7157
17065198	879	904	Virus del papilloma umano	ORGANISMTAXON	10566
17065198	935	938	HPV	ORGANISMTAXON	10566
17065198	991	994	p53	GENEORGENEPRODUCT	7157
17065198	1069	1072	XPD	GENEORGENEPRODUCT	2068
17065198	1155	1158	p53	GENEORGENEPRODUCT	7157
17065198	1217	1222	NMSCs	DISEASEORPHENOTYPICFEATURE	D012878
17065198	1355	1360	C a T	SEQUENCEVARIANT	C|SUB|C||T
17065198	1524	1531	CC a TT	SEQUENCEVARIANT	C|SUB|C||T
17065198	1680	1694	ciclosporina A	CHEMICALENTITY	D016572
17065198	1727	1730	CsA	CHEMICALENTITY	D016572
17065198	1792	1795	p53	GENEORGENEPRODUCT	7157
17065198	1853	1865	precancerose	DISEASEORPHENOTYPICFEATURE	D011230
17065198	1909	1927	cheratosi attinica	DISEASEORPHENOTYPICFEATURE	D055623
17065198	1972	1974	AK	DISEASEORPHENOTYPICFEATURE	D055623
17065198	2025	2028	p53	GENEORGENEPRODUCT	7157
17065198	2112	2133	cancerogenesi cutanea	DISEASEORPHENOTYPICFEATURE	D012878
17065198	2257	2260	p53	GENEORGENEPRODUCT	7157
17065198	2290	2293	HPV	ORGANISMTAXON	10566
17065198	2372	2387	lesioni cutanee	DISEASEORPHENOTYPICFEATURE	D012871
17065198	2436	2466	Carcinomi delle cellule basali	DISEASEORPHENOTYPICFEATURE	D002280
17065198	2514	2516	AK	DISEASEORPHENOTYPICFEATURE	D055623
17065198	2566	2569	SCC	DISEASEORPHENOTYPICFEATURE	D002294
17065198	2673	2682	infezioni	DISEASEORPHENOTYPICFEATURE	D007239
17065198	2714	2718	HPVs	ORGANISMTAXON	10566
17065198	2765	2769	HPVs	ORGANISMTAXON	10566
17065198	2813	2843	epidermodisplasia verruciforme	DISEASEORPHENOTYPICFEATURE	D004819
17065198	2939	2957	cancro della pelle	DISEASEORPHENOTYPICFEATURE	D012878
17065198	3040	3043	HPV	ORGANISMTAXON	10566
17065198	3090	3093	p53	GENEORGENEPRODUCT	7157
17065198	3135	3138	p53	GENEORGENEPRODUCT	7157
17065198	3199	3202	XPD	GENEORGENEPRODUCT	2068
17065198	3324	3327	p53	GENEORGENEPRODUCT	7157
17065198	3399	3406	CC a TT	SEQUENCEVARIANT	C|SUB|C||T
17065198	3653	3674	carcinogenesi cutanea	DISEASEORPHENOTYPICFEATURE	D012878
17074608	31	40	Valproato	CHEMICALENTITY	D014635
17074608	92	97	corea	DISEASEORPHENOTYPICFEATURE	D002819
17074608	143	156	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
17074608	203	230	iperglicinemia nonchetotica	DISEASEORPHENOTYPICFEATURE	D020158
17074608	275	305	L'iperglicinemia non chetotica	DISEASEORPHENOTYPICFEATURE	D020158
17074608	354	395	disturbo del metabolismo degli aminoacidi	DISEASEORPHENOTYPICFEATURE	D000592
17074608	469	476	glicina	CHEMICALENTITY	D005998
17074608	532	539	glicina	CHEMICALENTITY	D005998
17074608	667	672	apnea	DISEASEORPHENOTYPICFEATURE	D001049
17074608	727	738	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
17074608	785	793	ipotonia	DISEASEORPHENOTYPICFEATURE	D009123
17074608	849	869	ritardo psicomotorio	DISEASEORPHENOTYPICFEATURE	D011596
17074608	955	982	ipergliciemia non chetotica	DISEASEORPHENOTYPICFEATURE	D020158
17074608	1099	1107	paziente	ORGANISMTAXON	9606
17074608	1155	1174	ritardo linguistico	DISEASEORPHENOTYPICFEATURE	D007805
17074608	1221	1236	ritardo mentale	DISEASEORPHENOTYPICFEATURE	D008607
17074608	1303	1330	iperglicinemia nonchetotica	DISEASEORPHENOTYPICFEATURE	D020158
17074608	1413	1426	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
17074608	1472	1477	corea	DISEASEORPHENOTYPICFEATURE	D002819
17074608	1531	1541	 valproato	CHEMICALENTITY	D014635
17083016	86	110	proteina tensioattiva-A2	GENEORGENEPRODUCT	729238
17083016	182	205	malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	262	285	Malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	384	406	Neisseria meningitidis	DISEASEORPHENOTYPICFEATURE	D006069
17083016	448	476	Proteina tensioattiva (SP)-A	GENEORGENEPRODUCT	653509,729238
17083016	510	514	SP-D	GENEORGENEPRODUCT	6441
17083016	648	660	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
17083016	732	750	zuccheri microbici	CHEMICALENTITY	D000073893
17083016	925	930	SP-A1	GENEORGENEPRODUCT	653509
17083016	965	970	SP-A2	GENEORGENEPRODUCT	729238
17083016	1004	1008	SP-D	GENEORGENEPRODUCT	6441
17083016	1110	1118	pazienti	ORGANISMTAXON	9606
17083016	1186	1209	malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	1249	1257	pazienti	ORGANISMTAXON	9606
17083016	1306	1311	morto	DISEASEORPHENOTYPICFEATURE	D003643
17083016	1421	1426	SP-A2	GENEORGENEPRODUCT	729238
17083016	1497	1520	malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	1765	1769	SP-A	GENEORGENEPRODUCT	653509,729238
17083016	1869	1932	lisina (in 1A1) anziché glutammina (in 1A5) all'amminoacido 223	SEQUENCEVARIANT	C|SUB |Q|223|K
17083016	1968	1979	carboidrato	CHEMICALENTITY	D002241
17083016	2091	2114	malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	2225	2246	lisina al residuo 223	SEQUENCEVARIANT	C|ALLELE|K|223
17083016	2306	2314	pazienti	ORGANISMTAXON	9606
17083016	2362	2369	è morto	DISEASEORPHENOTYPICFEATURE	D003643
17083016	2526	2531	SP-A1	GENEORGENEPRODUCT	653509
17083016	2565	2569	SP-D	GENEORGENEPRODUCT	6441
17083016	2637	2660	malattia meningococcica	DISEASEORPHENOTYPICFEATURE	D008589
17083016	2765	2800	glutamina con lisina al residuo 223	SEQUENCEVARIANT	C|SUB|Q|223|K
17083016	2837	2848	carboidrati	CHEMICALENTITY	D002241
17083016	2911	2916	SP-A2	GENEORGENEPRODUCT	729238
17083016	2988	3011	meningococcico malattia	DISEASEORPHENOTYPICFEATURE	D008589
17083016	3077	3082	morte	DISEASEORPHENOTYPICFEATURE	D003643
17177139	59	64	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	102	137	recettore beta dell'ormone tiroideo	GENEORGENEPRODUCT	6955
17177139	191	236	resistenza alla sindrome dell'ormone tiroideo	DISEASEORPHENOTYPICFEATURE	D018382
17177139	282	312	Resistenza all'ormone tiroideo	DISEASEORPHENOTYPICFEATURE	D018382
17177139	357	360	RTH	DISEASEORPHENOTYPICFEATURE	D018382
17177139	462	477	ormoni tiroidei	CHEMICALENTITY	D013963
17177139	510	512	TH	CHEMICALENTITY	D013963
17177139	581	609	ormone stimolante la tiroide	GENEORGENEPRODUCT	 1081
17177139	642	645	TSH	GENEORGENEPRODUCT	1081
17177139	725	727	TH	CHEMICALENTITY	 D013963
17177139	807	842	recettore beta dell'ormone tiroideo	GENEORGENEPRODUCT	6955
17177139	876	882	TRbeta	GENEORGENEPRODUCT	6955
17177139	973	976	RTH	DISEASEORPHENOTYPICFEATURE	D018382
17177139	1016	1021	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	1125	1131	TRbeta	GENEORGENEPRODUCT	6955
17177139	1201	1206	donna	ORGANISMTAXON	9606
17177139	1319	1330	sovrappeso 	DISEASEORPHENOTYPICFEATURE	D050177
17177139	1415	1423	tiroxina	CHEMICALENTITY	D013974
17177139	1456	1458	T4	CHEMICALENTITY	D013974
17177139	1524	1539	triiodotironina	CHEMICALENTITY	D014284
17177139	1572	1574	T3	CHEMICALENTITY	D014284
17177139	1672	1675	TSH	GENEORGENEPRODUCT	1081
17177139	1852	1855	RTH	DISEASEORPHENOTYPICFEATURE	D018382
17177139	1923	1929	TRbeta	GENEORGENEPRODUCT	6955
17177139	2009	2016	1284A>C	SEQUENCEVARIANT	C|SUB|A|1284|C
17177139	2100	2140	acido glutammico 333 con acido aspartico	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	2188	2193	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	2294	2300	TRbeta	GENEORGENEPRODUCT	6955
17177139	2374	2379	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	2479	2481	T3	CHEMICALENTITY	D014284
17177139	2557	2582	recettore del retinoide X	GENEORGENEPRODUCT	6256
17177139	2615	2618	RXR	GENEORGENEPRODUCT	6256
17177139	2728	2733	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	2765	2771	TRbeta	GENEORGENEPRODUCT	6955
17177139	2964	2969	umano	ORGANISMTAXON	9606
17177139	3024	3032	TSHalpha	GENEORGENEPRODUCT	1081
17177139	3189	3195	TRbeta	GENEORGENEPRODUCT	6955
17177139	3277	3285	TSHalpha	GENEORGENEPRODUCT	1081
17177139	3381	3386	E333D	SEQUENCEVARIANT	P|SUB|E|333|D
17177139	3418	3424	TRbeta	GENEORGENEPRODUCT	6955
17177139	3506	3509	RTH	DISEASEORPHENOTYPICFEATURE	D018382
17185386	71	76	DISC1	GENEORGENEPRODUCT	27185
17185386	150	162	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17185386	246	250	NDE1	GENEORGENEPRODUCT	54820
17185386	371	399	Disrupted in Schizophrenia 1	GENEORGENEPRODUCT	27185
17185386	434	439	DISC1	GENEORGENEPRODUCT	27185
17185386	487	499	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17185386	592	604	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17185386	656	661	DISC1	GENEORGENEPRODUCT	27185
17185386	804	809	DISC1	GENEORGENEPRODUCT	27185
17185386	870	882	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17185386	1155	1160	DISC1	GENEORGENEPRODUCT	27185
17185386	1450	1454	NDE1	GENEORGENEPRODUCT	54820
17185386	1539	1544	DISC1	GENEORGENEPRODUCT	27185
17185386	1734	1738	NDE1	GENEORGENEPRODUCT	54820
17185386	1836	1848	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17185386	2320	2325	DISC1	GENEORGENEPRODUCT	27185
17185386	2387	2400	 schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
17192049	31	49	Cytochrome p4501A1	GENEORGENEPRODUCT	1543
17192049	145	166	 cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
17192049	199	205	CYP1A1	GENEORGENEPRODUCT	1543
17192049	401	421	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
17192049	545	551	A to G	SEQUENCEVARIANT	RS1048943
17192049	653	662	Ile462Val	SEQUENCEVARIANT	RS1048943
17192049	705	711	T3801C	SEQUENCEVARIANT	G|SUB|T|3801| C
17192049	761	767	CYP1A1	GENEORGENEPRODUCT	1543
17192049	820	841	cancro alla prostata 	DISEASEORPHENOTYPICFEATURE	D011471
17192049	1082	1088	CYP1A1	GENEORGENEPRODUCT	1543
17192049	1171	1177	CYP1A1	GENEORGENEPRODUCT	1543
17192049	1212	1219	Ile/Val	SEQUENCEVARIANT	RS1048943
17192049	1340	1360	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
17192049	1508	1514	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17192049	1669	1675	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17192049	1975	1995	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
17194457	81	113	steroidi androgeni anabolizzanti	CHEMICALENTITY	D045165
17194457	154	159	ratti	ORGANISMTAXON	 10116
17194457	201	211	serotonina	CHEMICALENTITY	D012701
17194457	316	348	steroidi androgeni anabolizzanti	CHEMICALENTITY	D045165
17194457	381	384	AAS	CHEMICALENTITY	D045165
17194457	440	450	serotonina	CHEMICALENTITY	D012701
17194457	483	502	5-idrossitriptamina	CHEMICALENTITY	D012701
17194457	535	539	5-HT	CHEMICALENTITY	D012701
17194457	622	627	ratti	ORGANISMTAXON	10116
17194457	660	673	La serotonina	CHEMICALENTITY	D012701
17194457	758	779	paraclorofenilalanina	CHEMICALENTITY	D010134
17194457	813	817	PCPA	CHEMICALENTITY	D010134
17194457	945	949	PCPA	CHEMICALENTITY	D010134
17194457	987	992	ratti	ORGANISMTAXON	10116
17194457	1031	1036	ratti	ORGANISMTAXON	10116
17194457	1132	1144	testosterone	CHEMICALENTITY	D013739
17194457	1164	1165	T	CHEMICALENTITY	D013739
17194457	1305	1317	irritabilità	DISEASEORPHENOTYPICFEATURE	D001523
17194457	1400	1412	aggressività	DISEASEORPHENOTYPICFEATURE	D001523
17194457	1493	1505	aggressività	DISEASEORPHENOTYPICFEATURE	D001523
17194457	1658	1662	5-HT	CHEMICALENTITY	D012701
17194457	1716	1743	acido 5-idrossiindolacetico	CHEMICALENTITY	D006897
17194457	1776	1782	5-HIAA	CHEMICALENTITY	D006897
17194457	1854	1858	PCPA	CHEMICALENTITY	D010134
17194457	1936	1940	5-HT	CHEMICALENTITY	D012701
17194457	1975	1981	5-HIAA	CHEMICALENTITY	D006897
17194457	2040	2041	T	CHEMICALENTITY	D013739
17194457	2138	2142	5-HT	CHEMICALENTITY	D012701
17194457	2177	2183	5-HIAA	CHEMICALENTITY	D006897
17194457	2281	2285	PCPA	CHEMICALENTITY	D010134
17194457	2342	2346	PCPA	CHEMICALENTITY	D010134
17194457	2463	2475	irritabilità	DISEASEORPHENOTYPICFEATURE	D001523
17194457	2599	2611	aggressività	DISEASEORPHENOTYPICFEATURE	D001523
17194457	2630	2631	T	CHEMICALENTITY	D013739
17194457	2737	2749	irritabilità	DISEASEORPHENOTYPICFEATURE	D001523
17194457	2860	2872	aggressività	DISEASEORPHENOTYPICFEATURE	D001523
17194457	2940	2941	T	CHEMICALENTITY	D013739
17194457	2987	2991	PCPA	CHEMICALENTITY	D010134
17194457	3251	3254	AAS	CHEMICALENTITY	D045165
17194457	3312	3316	5-HT	CHEMICALENTITY	D012701
17194457	3406	3430	comportamento aggressivo	DISEASEORPHENOTYPICFEATURE	D001523
17221831	37	41	G51S	SEQUENCEVARIANT	RS1049564
17221831	73	102	purina nucleoside fosforilasi	GENEORGENEPRODUCT	4860
17221831	176	193	declino cognitivo	DISEASEORPHENOTYPICFEATURE	D003072
17221831	240	261	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
17221831	289	297	pazienti	ORGANISMTAXON	9606
17221831	342	363	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
17221831	409	411	AD	DISEASEORPHENOTYPICFEATURE	D000544
17221831	805	817	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
17221831	977	979	AD	DISEASEORPHENOTYPICFEATURE	D000544
17221831	1076	1079	G/A	SEQUENCEVARIANT	RS1049564
17221831	1154	1183	purina nucleoside fosforilasi	GENEORGENEPRODUCT	4860
17221831	1216	1219	PNP	GENEORGENEPRODUCT	4860
17221831	1307	1340	serina con glicina a posizione 51	SEQUENCEVARIANT	RS1049564
17221831	1376	1380	G51S	SEQUENCEVARIANT	RS1049564
17221831	1471	1474	AD 	DISEASEORPHENOTYPICFEATURE	D000544
17221831	1502	1510	pazienti	ORGANISMTAXON	9606
17221831	1617	1620	PNP	GENEORGENEPRODUCT	4860
17221831	1668	1676	pazienti	ORGANISMTAXON	9606
17221831	1795	1797	AD	DISEASEORPHENOTYPICFEATURE	D000544
17221831	1825	1833	pazienti	ORGANISMTAXON	9606
17221831	1929	1946	declino cognitivo	DISEASEORPHENOTYPICFEATURE	D003072
17221831	2057	2060	PNP	GENEORGENEPRODUCT	4860
17221831	2125	2127	AD	DISEASEORPHENOTYPICFEATURE	D000544
17221831	2156	2164	pazienti	ORGANISMTAXON	9606
17221831	2219	2243	deterioramento cognitivo	DISEASEORPHENOTYPICFEATURE	D003072
17221831	2293	2301	pazienti	ORGANISMTAXON	9606
17221831	2424	2428	G51S	SEQUENCEVARIANT	RS1049564
17221831	2460	2463	PNP	GENEORGENEPRODUCT	4860
17221831	2544	2561	declino cognitivo	DISEASEORPHENOTYPICFEATURE	D003072
17221831	2608	2610	AD	DISEASEORPHENOTYPICFEATURE	D000544
17221831	2639	2647	pazienti	ORGANISMTAXON	9606
17221831	2782	2808	disturbo neurodegenerativo	DISEASEORPHENOTYPICFEATURE	D019636
17244258	104	118	ciclofosfamide	CHEMICALENTITY	D003520
17244258	171	178	cistite	DISEASEORPHENOTYPICFEATURE	D003556
17244258	211	214	rat	ORGANISMTAXON	10116
17244258	250	264	ciclofosfamide	CHEMICALENTITY	D003520
17244258	316	323	cistite	DISEASEORPHENOTYPICFEATURE	D003556
17244258	356	359	rat	ORGANISMTAXON	10116
17244258	456	477	recettori muscarinici	GENEORGENEPRODUCT	25229
17244258	624	632	 cistite	DISEASEORPHENOTYPICFEATURE	D003556
17244258	753	767	ciclofosfamide	CHEMICALENTITY	D003520
17244258	809	814	ratti	ORGANISMTAXON	 10116
17244258	962	1026	antagonisti dei recettori muscarinici, adrenergici e purinergici	C HEMICALENTITY	D018674,D018727,D058914
17244258	1072	1080	atropina	CHEMICALENTITY	D001285
17244258	1368	1410	alfa,beta-metilene adenosina-5'-trifosfato	CHEMICALENTITY	C002630
17244258	1443	1459	alfa,beta -meATP	CHEMICALENTITY	C002630
17244258	1559	1580	recettore muscarinico	GENEORGENEPRODUCT	25229
17244258	1624	1632	atropina	CHEMICALENTITY	D001285
17244258	1666	1701	4-difenilacetossi-N-metilpiperidina	CHEMICALENTITY	 C042375
17244258	1734	1740	4-DAMP	CHEMICALENTITY	C042375
17244258	1804	1816	metoctramina	CHEMICALENTITY	C054938
17244258	1870	1881	pirenzepina	CHEMICALENTITY	D010890
17244258	2097	2103	4-DAMP	CHEMICALENTITY	C042375
17244258	2203	2215	metoctramina	CHEMICALENTITY	C054938
17244258	2249	2260	pirenzepina	CHEMICALENTITY	D010890
17244258	2326	2363	antagonismo del recettore muscarinico	CHEMICALENTITY	D018674
17244258	2504	2515	pirenzepina	CHEMICALENTITY	 D010890
17244258	2549	2555	4-DAMP	CHEMICALENTITY	C042375
17244258	2706	2719	methoctramine	CHEMICALENTITY	C054938
17244258	2849	2858	carbacolo	CHEMICALENTITY	D002217
17244258	2892	2895	ATP	CHEMICALENTITY	D000255
17244258	3014	3022	potassio	CHEMICALENTITY	D011188
17244258	3064	3076	isoprenalina	CHEMICALENTITY	D007545
17244258	3195	3202	cistite	DISEASEORPHENOTYPICFEATURE	D003556
17244258	3348	3364	beta-adrenergici	GENEORGENEPRODUCT	24925
17244258	3456	3477	recettori muscarinici	GENEORGENEPRODUCT	25229
17250663	56	62	DFNA36	GENEORGENEPRODUCT	117531
17250663	106	116	ipoacusia 	DISEASEORPHENOTYPICFEATURE	D034381
17250663	257	261	TMC1	GENEORGENEPRODUCT	117531
17250663	452	477	ipoacusia neurosensoriale	DISEASEORPHENOTYPICFEATURE	D006319
17250663	525	543	perdita dell'udito	DISEASEORPHENOTYPICFEATURE	D034381
17250663	690	697	sordità	DISEASEORPHENOTYPICFEATURE	D003638
17250663	879	883	TMC1	GENEORGENEPRODUCT	117531
17250663	920	926	DFNA36	GENEORGENEPRODUCT	117531
17250663	1056	1063	p.D572H	SEQUENCEVARIANT	RS121908072
17250663	1101	1109	c.G1714C	SEQUENCEVARIANT	RS121908072
17250663	1154	1158	TMC1	GENEORGENEPRODUCT	117531
17250663	1308	1314	DFNA36	GENEORGENEPRODUCT	117531
17250663	1352	1360	p.D572N 	SEQUENCEVARIANT	RS121908072
17250663	1398	1406	c.G1714A	SEQUENCEVARIANT	RS121908072
17250663	1544	1548	TMC1	GENEORGENEPRODUCT	117531
17250663	1601	1608	DFNA36 	GENEORGENEPRODUCT	117531
17250663	1652	1670	perdita dell'udito	DISEASEORPHENOTYPICFEATURE	D034381
17250663	1744	1762	perdita dell'udito	DISEASEORPHENOTYPICFEATURE	D034381
17250663	1811	1818	p.D572H	SEQUENCEVARIANT	RS121908072
17250663	1890	1897	p.D572N	SEQUENCEVARIANT	RS121908072
17250663	1967	1973	DFNA36	GENEORGENEPRODUCT	117531
17250663	2020	2024	TMC1	GENEORGENEPRODUCT	117531
17273972	27	32	Umano	ORGANISMTAXON	9606
17273972	64	68	TBX1	GENEORGENEPRODUCT	6899
17273972	202	219	22q11.2 delezioni	DISEASEORPHENOTYPICFEATURE	D004062
17273972	264	293	Sindrome da delezione 22q11.2	DISEASEORPHENOTYPICFEATURE	D004062
17273972	446	501	 Sindromi di DiGeorge e Shprintzen (velocardiofacciale)	DISEASEORPHENOTYPICFEATURE	D004062
17273972	579	608	fattore di trascrizione T-box	GENEORGENEPRODUCT	6899
17273972	645	649	TBX1	GENEORGENEPRODUCT	6899
17273972	775	779	TBX1	GENEORGENEPRODUCT	6899
17273972	885	914	sindrome da delezione 22q11.2	DISEASEORPHENOTYPICFEATURE	D004062
17273972	1169	1174	H194Q	SEQUENCEVARIANT	RS74315522
17273972	1243	1265	Sindrome di Shprintzen	DISEASEORPHENOTYPICFEATURE	D004062
17273972	1520	1524	TBX1	GENEORGENEPRODUCT	6899
17277899	136	139	ACE	GENEORGENEPRODUCT	1636
17277899	244	247	APO	GENEORGENEPRODUCT	84909
17277899	280	286	FXIIIB	GENEORGENEPRODUCT	2165
17277899	352	355	A25	GENEORGENEPRODUCT	28936
17286451	43	57	Retinoblastoma	DISEASEORPHENOTYPICFEATURE	D012175
17286451	325	328	RB1	GENEORGENEPRODUCT	5925
17286451	420	426	tumori	DISEASEORPHENOTYPICFEATURE	D009369
17286451	457	465	pazienti	ORGANISMTAXON	9606
17286451	555	558	RB1	GENEORGENEPRODUCT	5925
17286451	763	777	retinoblastoma	DISEASEORPHENOTYPICFEATURE	D012175
17286451	822	824	RB	DISEASEORPHENOTYPICFEATURE	D012175
17286451	926	932	tumori	DISEASEORPHENOTYPICFEATURE	D009369
17286451	982	984	RB	DISEASEORPHENOTYPICFEATURE	D012175
17286451	1013	1021	pazienti	ORGANISMTAXON	9606
17286451	1180	1183	RB1	GENEORGENEPRODUCT	5925
17286451	1445	1451	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17286451	1519	1521	RB	DISEASEORPHENOTYPICFEATURE	D012175
17286451	1549	1557	pazienti	ORGANISMTAXON	9606
17286451	1592	1600	pazienti	ORGANISMTAXON	9606
17286451	1749	1751	RB	DISEASEORPHENOTYPICFEATURE	D012175
17286451	1779	1787	pazienti	ORGANISMTAXON	9606
17286451	1850	1853	RB1	GENEORGENEPRODUCT	5925
17286451	1960	1962	RB	DISEASEORPHENOTYPICFEATURE	D012175
17286451	1990	1998	pazienti	ORGANISMTAXON	9606
17286451	2217	2220	RB1	GENEORGENEPRODUCT	5925
17286451	2306	2312	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17286451	2409	2412	RB1	GENEORGENEPRODUCT	5925
17286451	2636	2638	RB	DISEASEORPHENOTYPICFEATURE	D012175
17304550	52	65	synaptotagmin	GENEORGENEPRODUCT	255928
17304550	100	105	SYT14	GENEORGENEPRODUCT	255928
17304550	162	188	anomalie del neurosviluppo	DISEASEORPHENOTYPICFEATURE	D009421
17304550	402	419	atrofia cerebrale	DISEASEORPHENOTYPICFEATURE	 D001927
17304550	464	476	macrocefalia	DISEASEORPHENOTYPICFEATURE	D058627
17304550	520	531	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
17304550	577	596	ritardo di sviluppo	DISEASEORPHENOTYPICFEATURE	D002658
17304550	756	769	synaptotagmin	GENEORGENEPRODUCT	255928
17304550	804	810	SYT14 	GENEORGENEPRODUCT	255928
17304550	882	887	SYT14	GENEORGENEPRODUCT	255928
17304550	929	934	umano	ORGANISMTAXON	9606
17304550	1062	1075	synaptotagmin	GENEORGENEPRODUCT	255928
17304550	1163	1169	calcio	CHEMICALENTITY	D002118
17304550	1299	1304	SYT14	GENEORGENEPRODUCT	255928
17304550	1470	1475	SYT14	GENEORGENEPRODUCT	255928
17304550	1631	1636	SYT14	GENEORGENEPRODUCT	255928
17318851	31	72	Fattore di regolazione dell'interferone 6	GENEORGENEPRODUCT	3664
17318851	105	109	IRF6	GENEORGENEPRODUCT	3664
17318851	144	195	recettore 1 del fattore di crescita dei fibroblasti	GENEORGENEPRODUCT	2260
17318851	228	233	FGFR1	GENEORGENEPRODUCT	2260
17318851	279	284	umano	ORGANISMTAXON	9606
17318851	328	344	agenesia dentale	DISEASEORPHENOTYPICFEATURE	D000848
17318851	572	595	sindromi craniofacciali	DISEASEORPHENOTYPICFEATURE	D019465
17318851	628	633	FGFR1	GENEORGENEPRODUCT	2260
17318851	668	672	IRF6	GENEORGENEPRODUCT	3664
17318851	749	765	agenesia dentale	DISEASEORPHENOTYPICFEATURE	D000848
17318851	1363	1367	IRF6	GENEORGENEPRODUCT	3664
17318851	1432	1450	schisi orofacciali	DISEASEORPHENOTYPICFEATURE	C566121
17318851	1501	1506	umano	ORGANISMTAXON	9606
17318851	1550	1568	agenesia del dente	DISEASEORPHENOTYPICFEATURE	D000848
17318851	1605	1613	rs861019	SEQUENCEVARIANT	RS861019
17318851	1661	1671	rs17015215	SEQUENCEVARIANT	RS17015215
17318851	1706	1711	V274I	SEQUENCEVARIANT	RS2235371
17318851	1756	1762	rs7802	SEQUENZEVARIANT	RS7802
17318851	1820	1824	IRF6	GENEORGENEPRODUCT	3664
17318851	1884	1929	Van der Woude e sindromi di pterigio popliteo	DISEASEORPHENOTYPICFEATURE	C536528,C562509
17318851	2049	2061	schisi orali	DISEASEORPHENOTYPICFEATURE	D002972
17318851	2108	2125	agenesi dei denti	DISEASEORPHENOTYPICFEATURE	D000848
17318851	2210	2238	fosse sulle labbra inferiori	DISEASEORPHENOTYPICFEATURE	C536528,C562509
17318851	2341	2346	FGFR1	GENEORGENEPRODUCT	2260
17318851	2392	2396	IRF6	GENEORGENEPRODUCT	3664
17318851	2528	2532	IRF6	GENEORGENEPRODUCT	3664
17318851	2589	2593	MSX1	GENEORGENEPRODUCT	4487
17318851	2652	2656	TGFA	GENEORGENEPRODUCT	7039
17327131	59	65	CYP2F1	GENEORGENEPRODUCT	1572
17327131	168	174	CYP2F1	GENEORGENEPRODUCT	1572
17327131	207	212	umano	ORGANISMTAXON	9606
17327131	245	259	citocromo P450	GENEORGENEPRODUCT	1572
17327131	430	441	cancerogeno	DISEASEORPHENOTYPICFEATURE	D009369
17327131	633	639	CYP2F1	GENEORGENEPRODUCT	1572
17327131	728	736	pazienti	ORGANISMTAXON	9606
17327131	784	802	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
17327131	1157	1163	CYP2F1	GENEORGENEPRODUCT	1572
17327131	1231	1237	CYP2F1	GENEORGENEPRODUCT	1572
17327131	1364	1370	CYP2F1	GENEORGENEPRODUCT	1572
17327131	1490	1499	Asp218Asn	SEQUENCEVARIANT	RS305974
17327131	1537	1546	Gln266His	SEQUENCEVARIANT	RS75405062
17327131	1588	1605	1-bp inserimento 	SEQUENCEVARIANT	RS11399890
17327131	1642	1653	c.14_15insC	SEQUENCEVARIANT	RS11399890
17327131	2016	2022	CYP2F1	GENEORGENEPRODUCT	1572
17327131	2337	2343	CYP2F1	GENEORGENEPRODUCT	1572
17327131	2426	2440	polmone cancro	DISEASEORPHENOTYPICFEATURE	D008175
17344330	43	50	Syncope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	96	112	Prolungamento QT	DISEASEORPHENOTYPICFEATURE	D008133
17344330	144	152	pazienti	ORGANISMTAXON	9606
17344330	197	205	metadone	CHEMICALENTITY	D008691
17344330	254	274	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
17344330	345	356	Il metadone	CHEMICALENTITY	D008691
17344330	415	435	dipendenti da eroina	DISEASEORPHENOTYPICFEATURE	D006556
17344330	491	506	uso di oppioidi	CHEMICALENTITY	D000701
17344330	551	583	Prolungamento dell'intervallo QT	DISEASEORPHENOTYPICFEATURE	D008133
17344330	623	631	pazienti	ORGANISMTAXON	9606
17344330	680	698	torsade de pointes	DISEASEORPHENOTYPICFEATURE	D016171
17344330	743	746	TdP	DISEASEORPHENOTYPICFEATURE	D016171
17344330	801	809	metadone	CHEMICALENTITY	D008691
17344330	868	888	dipendenti da eroina	DISEASEORPHENOTYPICFEATURE	D006556
17344330	1032	1039	sincope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	1154	1157	TdP	DISEASEORPHENOTYPICFEATURE	D016171
17344330	1324	1332	metadone	CHEMICALENTITY	D008691
17344330	1503	1513	eroinomani	DISEASEORPHENOTYPICFEATURE	D006556
17344330	1559	1567	metadone	CHEMICALENTITY	D008691
17344330	1601	1613	buprenorfina	CHEMICALENTITY	D002047
17344330	1666	1674	pazienti	ORGANISMTAXON	9606
17344330	1946	1953	sincope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	2005	2021	dose di oppioidi	CHEMICALENTITY	D000701
17344330	2060	2068	metadone	CHEMICALENTITY	D008691
17344330	2135	2142	sincope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	2294	2313	La dose di metadone	CHEMICALENTITY	D008691
17344330	2373	2396	intervallo QT più lungo	DISEASEORPHENOTYPICFEATURE	D008133
17344330	2501	2513	buprenorfina	CHEMICALENTITY	D002047
17344330	2580	2588	metadone	CHEMICALENTITY	D008691
17344330	2624	2630	uomini	ORGANISMTAXON	9606
17344330	2668	2673	donne	ORGANISMTAXON	9606
17344330	2725	2750	intervallo QTc prolungato	DISEASEORPHENOTYPICFEATURE	D008133
17344330	2817	2829	buprenorfina	CHEMICALENTITY	D002047
17344330	2933	2941	metadone	CHEMICALENTITY	D008691
17344330	3071	3078	sincope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	3124	3135	Il metadone	CHEMICALENTITY	D008691
17344330	3193	3213	Prolungamento del QT	DISEASEORPHENOTYPICFEATURE	D008133
17344330	3285	3292	sincope	DISEASEORPHENOTYPICFEATURE	D013575
17344330	3358	3378	dipendenti da eroina	DISEASEORPHENOTYPICFEATURE	D006556
17351238	57	84	cali di pressione sanguigna	DISEASEORPHENOTYPICFEATURE	D007022
17351238	137	141	 GTN	CHEMICALENTITY	D005996
17351238	243	258	dolore toracico	DISEASEORPHENOTYPICFEATURE	D002637
17351238	323	338	dolore toracico	DISEASEORPHENOTYPICFEATURE	D002637
17351238	404	412	paziente	ORGANISMTAXON	9606
17351238	468	496	le osservazioni del paziente	ORGANISMTAXON	9606
17351238	584	592	ossigeno	CHEMICALENTITY	D010100
17351238	657	680	trinitrato di glicerina	CHEMICALENTITY	D005996
17351238	713	716	GTN	CHEMICALENTITY	D005996
17351238	773	776	GTN	CHEMICALENTITY	D005996
17351238	807	815	paziente	ORGANISMTAXON	9606
17351238	883	911	cali di pressione sanguigna 	DISEASEORPHENOTYPICFEATURE	D007022
17351238	992	1008	atropina solfato	CHEMICALENTITY	D001285
17351238	1128	1136	paziente	ORGANISMTAXON	9606
17351238	1521	1529	paziente	ORGANISMTAXON	9606
17351238	1580	1598	episodio sincopale	DISEASEORPHENOTYPICFEATURE	D013575
17351238	1767	1775	paziente	ORGANISMTAXON	9606
17379047	44	53	valsartan	CHEMICALENTITY	C081489
17379047	85	101	idroclorotiazide	CHEMICALENTITY	D006852
17379047	330	341	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
17379047	402	410	pazienti	ORGANISMTAXON	9606
17379047	467	479	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17379047	648	660	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17379047	816	835	terapie ipertensive	DISEASEORPHENOTYPICFEATURE	D006973
17379047	939	948	valsartan	CHEMICALENTITY	C081489
17379047	981	984	VAL	CHEMICALENTITY	C081489
17379047	1019	1035	idroclorotiazide	CHEMICALENTITY	D006852
17379047	1068	1072	HCTZ	CHEMICALENTITY	D006852
17379047	1148	1156	pazienti	ORGANISMTAXON	9606
17379047	1214	1237	ipertensione essenziale	DISEASEORPHENOTYPICFEATURE	D000075222
17379047	1432	1440	Pazienti	ORGANISMTAXON	9606
17379047	1491	1514	ipertensione essenziale	DISEASEORPHENOTYPICFEATURE	D000075222
17379047	1675	1678	VAL	CHEMICALENTITY	C081489
17379047	1724	1728	HCTZ	CHEMICALENTITY	D006852
17379047	1774	1777	VAL	CHEMICALENTITY	C081489
17379047	1809	1813	HCTZ	CHEMICALENTITY	D006852
17379047	2049	2052	VAL	CHEMICALENTITY	C081489
17379047	2084	2088	HCTZ	CHEMICALENTITY	D006852
17379047	2609	2617	pazienti	ORGANISMTAXON	9606
17379047	2713	2719	uomini	ORGANISMTAXON	9606
17379047	2752	2757	donne	ORGANISMTAXON	9606
17379047	3140	3143	VAL	CHEMICALENTITY	C081489
17379047	3177	3181	HCTZ	CHEMICALENTITY	D006852
17379047	3415	3418	VAL	CHEMICALENTITY	C081489
17379047	3450	3454	HCTZ	CHEMICALENTITY	D006852
17379047	3620	3623	VAL	CHEMICALENTITY	C081489
17379047	3655	3659	HCTZ	CHEMICALENTITY	D006852
17379047	3712	3715	VAL	CHEMICALENTITY	C081489
17379047	3747	3751	HCTZ	CHEMICALENTITY	D006852
17379047	4023	4034	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
17379047	4084	4087	VAL	CHEMICALENTITY	C081489
17379047	4120	4124	HCTZ	CHEMICALENTITY	D006852
17379047	4192	4196	HCTZ	CHEMICALENTITY	D006852
17379047	4403	4406	VAL	CHEMICALENTITY	C081489
17379047	4438	4442	HCTZ	CHEMICALENTITY	D006852
17379047	4517	4525	pazienti	ORGANISMTAXON	9606
17379047	4636	4639	VAL	CHEMICALENTITY	C081489
17379047	4672	4676	HCTZ	CHEMICALENTITY	D006852
17379047	4877	4888	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
17379047	4931	4936	 HCTZ	CHEMICALENTITY	D006852
17391797	40	81	fosfatidiletanolammina N-metiltransferasi	GENEORGENEPRODUCT	10400
17391797	113	118	V175M	SEQUENCEVARIANT	RS7946
17391797	230	234	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	375	401	steatoepatite non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
17391797	446	450	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	533	542	Val175Met	SEQUENCEVARIANT	RS7946
17391797	596	637	fosfatidiletanolammina N-metiltransferasi	GENEORGENEPRODUCT	10400
17391797	672	676	PEMT	GENEORGENEPRODUCT	10400
17391797	741	763	fosfatidiletanolammina	CHEMICALENTITY	D010714
17391797	799	815	fosfatidilcolina	CHEMICALENTITY	D010713
17391797	920	929	Val175Met	SEQUENCEVARIANT	RS7946
17391797	982	986	PEMT	GENEORGENEPRODUCT	10400
17391797	1063	1067	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	1130	1138	pazienti	ORGANISMTAXON	9606
17391797	1186	1190	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	1396	1405	Val175Met	SEQUENCEVARIANT	RS7946
17391797	1463	1467	PEMT	GENEORGENEPRODUCT	10400
17391797	1551	1555	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	1583	1591	pazienti	ORGANISMTAXON	9606
17391797	1678	1687	Val175Met	SEQUENCEVARIANT	RS7946
17391797	1782	1786	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	1815	1823	pazienti	ORGANISMTAXON	9606
17391797	1910	1914	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	1942	1950	pazienti	ORGANISMTAXON	9606
17391797	2072	2077	obesi	DISEASEORPHENOTYPICFEATURE	D009765
17391797	2105	2113	pazienti	ORGANISMTAXON	9606
17391797	2224	2233	Val175Met	SEQUENCEVARIANT	RS7946
17391797	2308	2312	PEMT	GENEORGENEPRODUCT	10400
17391797	2359	2368	Val175Met	SEQUENCEVARIANT	RS7946
17391797	2413	2417	PEMT	GENEORGENEPRODUCT	10400
17391797	2534	2538	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	2624	2628	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17391797	2661	2669	pazienti	ORGANISMTAXON	9606
17391797	2719	2724	obesi	DISEASEORPHENOTYPICFEATURE	D009765
17391797	2769	2778	Val175Met	SEQUENCEVARIANT	RS7946
17391797	2823	2827	PEMT	GENEORGENEPRODUCT	10400
17391797	2899	2903	NASH	DISEASEORPHENOTYPICFEATURE	D065626
17439425	40	56	xantina ossidasi	CHEMICALENTITY	D014969
17439425	91	103	desametasone	CHEMICALENTITY	D003907
17439425	155	167	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17439425	199	204	ratti	ORGANISMTAXON	10116
17439425	240	255	Glucocorticoide	CHEMICALENTITY	D005938
17439425	307	319	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17439425	353	355	GC	CHEMICALENTITY	D005938
17439425	399	401	HT	DISEASEORPHENOTYPICFEATURE	D006973
17439425	435	438	rat	ORGANISMTAXON	10116
17439425	484	498	ossido nitrico	CHEMICALENTITY	D009569
17439425	584	600	xantina ossidasi	CHEMICALENTITY	D014969
17439425	633	635	XO	CHEMICALENTITY	D014969
17439425	705	734	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
17439425	770	782	desametasone	CHEMICALENTITY	D003907
17439425	834	846	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17439425	879	882	dex	CHEMICALENTITY	D003907
17439425	926	929	 HT	DISEASEORPHENOTYPICFEATURE	D006973
17439425	992	997	ratti	ORGANISMTAXON	10116
17439425	1111	1123	desametasone	CHEMICALENTITY	D003907
17439425	1156	1159	dex	CHEMICALENTITY	D003907
17439425	1193	1205	allopurinolo	CHEMICALENTITY	D000493
17439425	1260	1272	allopurinolo	CHEMICALENTITY	D000493
17439425	1308	1311	dex	CHEMICALENTITY	D003907
17439425	1507	1522	glucocorticoide	CHEMICALENTITY	D005938
17439425	1566	1571	urato	CHEMICALENTITY	D014527
17439425	1632	1634	XO	CHEMICALENTITY	D014969
17439425	1670	1673	Dex	CHEMICALENTITY	D003907
17439425	1825	1837	Allopurinolo	CHEMICALENTITY	D000493
17439425	1883	1888	urato	CHEMICALENTITY	D014527
17439425	2031	2064	dexGruppi trattati con (P 0,01). 	CHEMICALENTITY	D003907
17439425	2113	2115	HT	DISEASEORPHENOTYPICFEATURE	D006973
17439425	2200	2212	allopurinolo	CHEMICALENTITY	D000493
17439425	2271	2296	ormone adrenocorticotropo	GENEORGENEPRODUCT	5443
17439425	2348	2360	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17439425	2408	2410	XO	CHEMICALENTITY	D014969
17439425	2487	2489	GC	CHEMICALENTITY	D005938
17439425	2533	2535	HT	DISEASEORPHENOTYPICFEATURE	D006973
17439425	2568	2571	rat	ORGANISMTAXON	10116
17495183	32	43	Tenomodulin	GENEORGENEPRODUCT	64102
17495183	101	108	obesità	DISEASEORPHENOTYPICFEATURE	D009765
17495183	154	161	diabete	DISEASEORPHENOTYPICFEATURE	D003920
17495183	250	257	diabete	DISEASEORPHENOTYPICFEATURE	D003920
17495183	442	452	sovrappeso	DISEASEORPHENOTYPICFEATURE	D050177
17495183	510	541	alterato tolleranza al glucosio	DISEASEORPHENOTYPICFEATURE	D018149
17495183	586	589	IGT	DISEASEORPHENOTYPICFEATURE	D018149
17495183	668	680	tenomodulina	GENEORGENEPRODUCT	64102
17495183	714	718	TNMD	GENEORGENEPRODUCT	64102
17495183	910	919	adiposità	DISEASEORPHENOTYPICFEATURE	D009765
17495183	952	960	glucosio	CHEMICALENTITY	D005947
17495183	1029	1046	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
17495183	1091	1094	T2D	DISEASEORPHENOTYPICFEATURE	D003924
17495183	1293	1300	Diabete	DISEASEORPHENOTYPICFEATURE	D003920
17495183	1485	1494	adiposità	DISEASEORPHENOTYPICFEATURE	D009765
17495183	1525	1530	donne	ORGANISMTAXON	9606
17495183	1567	1576	rs5966709	SEQUENCEVARIANT	RS5966709
17495183	1612	1621	rs4828037	SEQUENCEVARIANT	RS4828037
17495183	1653	1659	uomini	ORGANISMTAXON	9606
17495183	1696	1706	rs11798018	SEQUENCEVARIANT	RS11798018
17495183	1752	1761	rs2073163	SEQUENCEVARIANT	RS2073163
17495183	1798	1807	rs1155794	SEQUENCEVARIANT	RS1155794
17495183	1892	1900	glucosio	CHEMICALENTITY	D005947
17495183	1939	1945	uomini	ORGANISMTAXON	9606
17495183	2043	2052	rs2073162	SEQUENCEVARIANT	RS2073162
17495183	2126	2129	IGT	DISEASEORPHENOTYPICFEATURE	D018149
17495183	2176	2179	T2D	DISEASEORPHENOTYPICFEATURE	D003924
17495183	2210	2216	uomini	ORGANISMTAXON	9606
17495183	2286	2289	T2D	DISEASEORPHENOTYPICFEATURE	D003924
17495183	2410	2419	glucosio 	CHEMICALENTITY	D005947
17495183	2508	2517	rs2073162	SEQUENCEVARIANT	RS2073162
17495183	2577	2587	 rs2073163	SEQUENCEVARIANT	RS2073163
17495183	2648	2657	rs1155974	SEQUENCEVARIANT	RS1155974
17495183	2742	2746	TNMD	GENEORGENEPRODUCT	64102
17495183	2809	2818	adiposità	DISEASEORPHENOTYPICFEATURE	D009765
17495183	2863	2871	glucosio	CHEMICALENTITY	D005947
17495183	2944	2947	IGT	DISEASEORPHENOTYPICFEATURE	D018149
17495183	2994	2997	T2D	DISEASEORPHENOTYPICFEATURE	 D003924
17495183	3028	3034	uomini	ORGANISMTAXON	9606
17572393	61	71	melatonina	CHEMICALENTITY	D008550
17572393	145	148	rat	ORGANISMTAXON	10116
17572393	191	195	BCNU	CHEMICALENTITY	D002330
17572393	247	266	displasia corticale	DISEASEORPHENOTYPICFEATURE	D054220
17572393	311	333	La displasia corticale	DISEASEORPHENOTYPICFEATURE	D054220
17572393	356	359	rat	ORGANISMTAXON	10116
17572393	608	618	carmustine	CHEMICALENTITY	D002330
17572393	651	685	1,3-bis (2-cloroetil)-1-nitrosoure	CHEMICALENTITY	D002330
17572393	719	724	 BCNU	CHEMICALENTITY	D002330
17572393	790	800	melatonina	CHEMICALENTITY	D008550
17572393	856	860	BCNU	CHEMICALENTITY	D002330
17572393	912	931	displasia corticale	DISEASEORPHENOTYPICFEATURE	D054220
17572393	1020	1025	ratti	ORGANISMTAXON	10116
17572393	1132	1142	melatonina	CHEMICALENTITY	D008550
17572393	1184	1188	BCNU	CHEMICALENTITY	D002330
17572393	1230	1234	BCNU	CHEMICALENTITY	D002330
17572393	1278	1288	melatonina	CHEMICALENTITY	D008550
17572393	1318	1323	Ratti	ORGANISMTAXON	10116
17572393	1376	1380	BCNU	CHEMICALENTITY	D002330
17572393	1439	1449	melatonina	CHEMICALENTITY	D008550
17572393	1632	1646	malondialdeide	CHEMICALENTITY	D008315
17572393	1680	1691	superossido	CHEMICALENTITY	D013481
17572393	1953	1957	BCNU	CHEMICALENTITY	D002330
17572393	2010	2036	gruppo displasia corticale	DISEASEORPHENOTYPICFEATURE	D054220
17572393	2189	2193	BCNU	CHEMICALENTITY	D002330
17572393	2271	2303	proteina acida fibrillare gliale	GENEORGENEPRODUCT	24387
17572393	2337	2350	synaptophysin	GENEORGENEPRODUCT	24804
17572393	2385	2449	trasformazione della crescita è stato osservato il fattore beta1	GENEORGENEPRODUCT	59086
17572393	2522	2532	melatonina	CHEMICALENTITY	D008550
17572393	2616	2630	Malondialdeide	CHEMICALENTITY	D008315
17572393	2673	2677	BCNU	CHEMICALENTITY	D002330
17572393	2776	2786	melatonina	CHEMICALENTITY	D008550
17572393	2828	2842	malondialdeide	CHEMICALENTITY	D008315
17572393	2887	2891	BCNU	CHEMICALENTITY	 D002330
17572393	3001	3022	superossido dismutasi	GENEORGENEPRODUCT	24786
17572393	3133	3137	BCNU	CHEMICALENTITY	D002330
17572393	3258	3268	melatonina	CHEMICALENTITY	D008550
17572393	3341	3345	BCNU	CHEMICALENTITY	D002330
17615423	49	61	rabdomiolisi	DISEASEORPHENOTYPICFEATURE	D012206
17615423	107	133	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
17615423	200	212	simvastatina	CHEMICALENTITY	D019821
17615423	245	255	amiodarone	CHEMICALENTITY	D000638
17615423	289	299	atazanavir	CHEMICALENTITY	C413408
17615423	386	398	simvastatina	CHEMICALENTITY	D019821
17615423	431	441	amiodarone	CHEMICALENTITY	D000638
17615423	475	485	atazanavir	CHEMICALENTITY	C413408
17615423	544	556	rabdomiolisi	DISEASEORPHENOTYPICFEATURE	D012206
17615423	602	628	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
17615423	690	694	uomo	ORGANISMTAXON	9606
17615423	727	760	virus dell'immunodeficienza umana	ORGANISMTAXON	12721
17615423	805	826	atriale fibrillazione	DISEASEORPHENOTYPICFEATURE	D001281
17615423	872	891	malattia coronarica	DISEASEORPHENOTYPICFEATURE	 D003324
17615423	937	950	iperlipidemia	DISEASEORPHENOTYPICFEATURE	D006949
17615423	1010	1016	dolore	DISEASEORPHENOTYPICFEATURE	D010146
17615423	1061	1071	stanchezza	DISEASEORPHENOTYPICFEATURE	D005221
17615423	1150	1158	paziente	ORGANISMTAXON	9606
17615423	1215	1227	simvastatina	CHEMICALENTITY	D019821
17615423	1307	1317	amiodarone	CHEMICALENTITY	D000638
17615423	1451	1461	atazanavir	CHEMICALENTITY	C413408
17615423	1588	1604	creatina chinasi	CHEMICALENTITY	D003402
17615423	1646	1669	azoto ureico nel sangue	CHEMICALENTITY	D001806
17615423	1712	1722	creatinina	CHEMICALENTITY	D003404
17615423	1764	1790	aspartato aminotransferasi	CHEMICALENTITY	D001219
17615423	1832	1856	alanina aminotransferasi	CHEMICALENTITY	D000410
17615423	1889	1901	Simvastatina	CHEMICALENTITY	D019821
17615423	1934	1944	amiodarone	CHEMICALENTITY	D000638
17615423	1975	1997	i farmaci del paziente	ORGANISMTAXON	 9606
17615423	2030	2063	virus dell'immunodeficienza umana	ORGANISMTAXON	12721
17615423	2138	2146	paziente	ORGANISMTAXON	9606
17615423	2267	2275	paziente	ORGANISMTAXON	9606
17615423	2307	2323	creatina chinasi	CHEMICALENTITY	D003402
17615423	2379	2389	creatinina	CHEMICALENTITY	D003404
17615423	2437	2445	paziente	ORGANISMTAXON	9606
17615423	2516	2529	ambulatoriale	ORGANISMTAXON	9606
17615423	2649	2661	rabdomiolisi	DISEASEORPHENOTYPICFEATURE	D012206
17615423	2756	2768	simvastatina	CHEMICALENTITY	D019821
17615423	2813	2828	La simvastatina	CHEMICALENTITY	D019821
17615423	2879	2885	CYP3A4	GENEORGENEPRODUCT	1576
17615423	2918	2928	Amiodarone	CHEMICALENTITY	D000638
17615423	2962	2972	atazanavir	CHEMICALENTITY	C413408
17615423	3023	3029	CYP3A4	GENEORGENEPRODUCT	1576
17615423	3122	3129	statine	CHEMICALENTITY	D019821
17615423	3261	3269	pazienti	ORGANISMTAXON	9606
17615423	3336	3343	statine	CHEMICALENTITY	D019821
17615423	3378	3384	CYP3A4	GENEORGENEPRODUCT	1576
17615423	3427	3439	pravastatina	CHEMICALENTITY	D017035
17615423	3472	3484	fluvastatina	CHEMICALENTITY	C065180
17615423	3518	3531	rosuvastatina	CHEMICALENTITY	C422923
17615423	3626	3639	atorvastatina	CHEMICALENTITY	C065179
17615423	3708	3720	simvastatina	CHEMICALENTITY	D019821
17615423	3755	3766	lovastatina	CHEMICALENTITY	D008148
17615423	3855	3863	pazienti	ORGANISMTAXON	9606
17615423	3926	3946	Inibitori del CYP3A4	CHEMICALENTITY in concomitanza	D065692
17628794	31	62	Superossido dismutasi manganese	GENEORGENEPRODUCT	6648
17628794	95	101	Mn-SOD	GENEORGENEPRODUCT	6648
17628794	169	179	urolitiasi	DISEASEORPHENOTYPICFEATURE	D052878
17628794	237	268	manganese superossido dismutasi	GENEORGENEPRODUCT	6648
17628794	301	307	Mn-SOD	GENEORGENEPRODUCT	6648
17628794	424	434	urolitiasi	DISEASEORPHENOTYPICFEATURE	D052878
17628794	539	560	formazione di calcoli	DISEASEORPHENOTYPICFEATURE	D002137
17628794	612	617	MnSOD	GENEORGENEPRODUCT	6648
17628794	749	814	 sostituzione da valina (Val) ad alanina (Ala) all'amminoacido 16	SEQUENCEVARIANT	P|SUB|V|16|A
17628794	909	914	MnSOD	GENEORGENEPRODUCT	6648
17628794	1011	1021	urolitiasi	DISEASEORPHENOTYPICFEATURE	D052878
17628794	1140	1145	MnSOD	GENEORGENEPRODUCT	6648
17628794	1207	1217	urolitiasi	DISEASEORPHENOTYPICFEATURE	D052878
17628794	1270	1275	MnSOD	GENEORGENEPRODUCT	6648
17628794	1325	1334	calcolosi	DISEASEORPHENOTYPICFEATURE	D002137
17628794	1604	1611	agarose	CHEMICALENTITY	D012685
17628794	1806	1814	pazienti	ORGANISMTAXON	9606
17628794	1953	1961	paziente	ORGANISMTAXON	9606
17628794	2065	2073	paziente	ORGANISMTAXON	9606
17628794	2180	2185	MnSOD	GENEORGENEPRODUCT	6648
17628794	2327	2337	urolitiasi	DISEASEORPHENOTYPICFEATURE	D052878
17628794	2449	2470	formazione di calcoli	DISEASEORPHENOTYPICFEATURE	D002137
17634480	149	163	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17634480	231	245	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17634480	463	492	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
17634480	525	528	ROS	CHEMICALENTITY	D017382
17634480	568	589	 Si ritiene che i ROS	CHEMICALENTITY	D017382
17634480	690	696	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17634480	726	734	PAZIENTI	ORGANISMTAXON	9606
17634480	966	969	CAT	GENEORGENEPRODUCT	847
17634480	1003	1007	SOD1	GENEORGENEPRODUCT	6647
17634480	1040	1044	SOD2	GENEORGENEPRODUCT	6648
17634480	1078	1082	GPX1	GENEORGENEPRODUCT	2876
17634480	1115	1119	GPX4	GENEORGENEPRODUCT	2879
17634480	1152	1155	GSR	GENEORGENEPRODUCT	2936
17634480	1189	1192	TXN	GENEORGENEPRODUCT	7295
17634480	1226	1230	TXN2	GENEORGENEPRODUCT	25828
17634480	1264	1270	TXNRD1	GENEORGENEPRODUCT	7296
17634480	1305	1311	TXNRD2	GENEORGENEPRODUCT	10587
17634480	1365	1370	donne	ORGANISMTAXON	9606
17634480	1418	1432	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17634480	1523	1527	GPX4	GENEORGENEPRODUCT	2879
17634480	1562	1570	rs713041	SEQUENCEVARIANT	RS713041
17634480	1606	1614	rs757229	SEQUENCEVARIANT	RS757229
17634480	1842	1846	GPX4	GENEORGENEPRODUCT	2879
17634480	1880	1888	rs713041	SEQUENCEVARIANT	RS713041
17634480	1940	1954	selenocisteina	CHEMICALENTITY	 D017279
17634480	2053	2057	GPX4	GENEORGENEPRODUCT	2879
17634480	2176	2181	morte	DISEASEORPHENOTYPICFEATURE	D003643
17634480	2371	2377	tumore	DISEASEORPHENOTYPICFEATURE	D009369
17634480	2425	2450	recettore degli estrogeni	GENEORGENEPRODUCT	2099
17634480	2619	2640	tumori della mammella	DISEASEORPHENOTYPICFEATURE	D001943
17634480	2751	2755	GPX4	GENEORGENEPRODUCT	2879
17634480	2904	2908	GPX4	GENEORGENEPRODUCT	2879
17634480	3002	3016	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17639754	47	55	warfarin	CHEMICALENTITY	D014859
17639754	89	102	levofloxacina	CHEMICALENTITY	D064704
17639754	150	158	Warfarin	CHEMICALENTITY	D014859
17639754	275	288	Levofloxacina	CHEMICALENTITY	D064704
17639754	324	339	fluorochinolone	CHEMICALENTITY	D024841
17639754	459	466	batteri	ORGANISMTAXON	2
17639754	644	652	warfarin	CHEMICALENTITY	D014859
17639754	686	699	levofloxacina	CHEMICALENTITY	D064704
17639754	772	785	levofloxacina	CHEMICALENTITY	D064704
17639754	879	887	warfarin	CHEMICALENTITY	D014859
17639754	973	982	emorragie	DISEASEORPHENOTYPICFEATURE	D006470
17639754	1068	1076	warfarin	CHEMICALENTITY	D014859
17639754	1110	1123	levofloxacina	CHEMICALENTITY	D064704
17639754	1265	1278	levofloxacina	CHEMICALENTITY	D064704
17639754	1308	1316	pazienti	ORGANISMTAXON	9606
17639754	1358	1366	warfarin	CHEMICALENTITY	D014859
17683901	94	99	FGFR3	GENEORGENEPRODUCT	2261
17683901	136	141	G380R	SEQUENCEVARIANT	RS28931614
17683901	211	224	acondroplasia	DISEASEORPHENOTYPICFEATURE	D000130
17683901	269	282	Acondroplasia	DISEASEORPHENOTYPICFEATURE	D000130
17683901	351	358	nanismo	DISEASEORPHENOTYPICFEATURE	D004392
17683901	498	552	G con A o da G a C nella posizione del nucleotide 1138	SEQUENCEVARIANT	RS28931614
17683901	590	597	p.G380R	SEQUENCEVARIANT	RS28931614
17683901	634	685	recettore 3 del fattore di crescita dei fibroblasti	GENEORGENEPRODUCT	2261
17683901	719	724	FGFR3	GENEORGENEPRODUCT	2261
17683901	854	863	c.1138G>A	SEQUENCEVARIANT	RS28931614
17683901	901	911	 c.1138G>C	SEQUENCEVARIANT	RS28931614
17683901	1023	1032	c.1138G>A	SEQUENCEVARIANT	RS28931614
17683901	1280	1288	pazienti	ORGANISMTAXON	9606
17683901	1336	1349	acondroplasia	DISEASEORPHENOTYPICFEATURE	D000130
17683901	1436	1449	acondroplasia	DISEASEORPHENOTYPICFEATURE	D000130
17683901	1550	1560	c .1138G>A	SEQUENCEVARIANT	RS28931614
17683901	1767	1772	FGFR3	GENEORGENEPRODUCT	2261
17683901	1808	1833	p. Genotipizzazione G380R	SEQUENCEVARIANT	RS28931614
17854040	53	63	lamivudina	CHEMICALENTITY	D019259
17854040	136	170	virus dell'epatite B (HBV) infetto	DISEASEORPHENOTYPICFEATURE	D006509
17854040	198	206	pazienti	ORGANISMTAXON	9606
17854040	262	282	 Co-infezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
17854040	382	407	Co-infezione da HBV e HIV	DISEASEORPHENOTYPICFEATURE	D006509,D015658
17854040	448	456	pazienti	ORGANISMTAXON	9606
17854040	540	550	lamivudina	CHEMICALENTITY	D019259
17854040	590	610	virus dell'epatite B	ORGANISMTAXON	10407
17854040	641	644	HBV	ORGANISMTAXON	10407
17854040	698	708	lamivudine	CHEMICALENTITY	D019259
17854040	744	747	HBV	ORGANISMTAXON	10407
17854040	813	867	coinfezione da virus dell'immunodeficienza umana (HIV)	DISEASEORPHENOTYPICFEATURE	D015658
17854040	910	918	pazienti	ORGANISMTAXON	9606
17854040	964	974	lamivudine	CHEMICALENTITY	D019259
17854040	1023	1034	HBV infetto	DISEASEORPHENOTYPICFEATURE	D006509
17854040	1063	1071	pazienti	ORGANISMTAXON	9606
17854040	1127	1145	coinfezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
17854040	1221	1237	HBV mono-infette	DISEASEORPHENOTYPICFEATURE	D006509
17854040	1265	1273	pazienti	ORGANISMTAXON	9606
17854040	1330	1354	HBV -Co-infezione da HIV	DISEASEORPHENOTYPICFEATURE	D006509,D015658
17854040	1382	1390	pazienti	ORGANISMTAXON	9606
17854040	1485	1488	HBV	ORGANISMTAXON	10407
17854040	1521	1526	HBsAg	CHEMICALENTITY	D006514
17854040	1576	1579	HBV	ORGANISMTAXON	10407
17854040	1612	1617	HBsAg	CHEMICALENTITY	D006514
17854040	1657	1665	pazienti	ORGANISMTAXON	9606
17854040	1698	1703	HBsAg	CHEMICALENTITY	D006514
17854040	1765	1772	HIV 1/2	ORGANISMTAXON	11676,11709
17854040	1996	1999	HBV	ORGANISMTAXON	10407
17854040	2229	2232	HBV	ORGANISMTAXON	10407
17854040	2265	2268	HBV	ORGANISMTAXON	10407
17854040	2344	2347	HBV	ORGANISMTAXON	10407
17854040	2436	2439	HBV	ORGANISMTAXON	10407
17854040	2471	2503	ceppi resistenti alla lamivudina	CHEMICALENTITY	D019259
17854040	2599	2608	epatite B	DISEASEORPHENOTYPICFEATURE	D006509
17854040	2636	2644	pazienti	ORGANISMTAXON	9606
17854040	2707	2730	Co-infezione da HBV-HIV	DISEASEORPHENOTYPICFEATURE	D006509,D015658
17854040	2758	2766	pazienti	ORGANISMTAXON	9606
17854040	2858	2861	HBV	ORGANISMTAXON	10407
17854040	2893	2903	lamivudine	CHEMICALENTITY	D019259
17854040	2988	3011	Co-infezione da HBV-HIV	DISEASEORPHENOTYPICFEATURE	D006509,D015658
17854040	3039	3047	pazienti	ORGANISMTAXON	9606
17854040	3095	3098	HBV	ORGANISMTAXON	10407
17854040	3103	3112	pazienti 	ORGANISMTAXON	9606
17854040	3407	3410	HBV	ORGANISMTAXON	10407
17854040	3449	3542	 I regimi di trattamento antiretrovirale altamente attivo (ARV) (HAART) contenenti lamivudina	CHEMICALENTITY	D019259
17854040	3714	3737	Co-infezione da HBV-HIV	DISEASEORPHENOTYPICFEATURE	D006509 ,D015658
17854040	3765	3773	pazienti	ORGANISMTAXON	9606
17877751	66	70	TMC1	GENEORGENEPRODUCT	117531
17877751	137	154	Sordità DFNB7/B11	DISEASEORPHENOTYPICFEATURE	C563417
17877751	211	236	La sordità non sindromica	DISEASEORPHENOTYPICFEATURE	D003638
17877751	350	383	gene transmembrana channel-like 1	GENEORGENEPRODUCT	117531
17877751	418	422	TMC1	GENEORGENEPRODUCT	117531
17877751	474	506	sordità recessiva non sindromica	DISEASEORPHENOTYPICFEATURE	C564609
17877751	550	559	DFNB7/B11	GENEORGENEPRODUCT	117531
17877751	746	750	TMC1	GENEORGENEPRODUCT	117531
17877751	866	883	sordità recessiva	DISEASEORPHENOTYPICFEATURE	C564609
17877751	1042	1077	sordità autosomica recessiva (DFNB)	DISEASEORPHENOTYPICFEATURE	C564609
17877751	1129	1133	TMC1	GENEORGENEPRODUCT	 117531
17877751	1223	1230	sordità	DISEASEORPHENOTYPICFEATURE	D003638
17877751	1273	1283	DFNB7/B11 	GENEORGENEPRODUCT	117531
17877751	1394	1403	DFNB7/B11	DISEASEORPHENOTYPICFEATURE	C563417
17877751	1439	1443	TMC1	GENEORGENEPRODUCT	117531
17877751	1546	1550	TMC1	GENEORGENEPRODUCT	117531
17877751	1608	1615	sordità	DISEASEORPHENOTYPICFEATURE	D003638
17877751	1719	1725	p.R34X	SEQUENCEVARIANT	RS121908073
17877751	1778	1785	sordità	DISEASEORPHENOTYPICFEATURE	D003638
17877751	1901	1907	p.R34X	SEQUENCEVARIANT	RS121908073
17877751	2013	2019	p.R34X	SEQUENCEVARIANT	RS121908073
17877751	2161	2167	p.R34X	SEQUENCEVARIANT	RS121908073
17877751	2222	2226	TMC1	GENEORGENEPRODUCT	117531
17877751	2327	2334	sordità	DISEASEORPHENOTYPICFEATURE	D003638
17910065	82	87	umano	ORGANISMTAXON	9606
17910065	120	124	PAX9	GENEORGENEPRODUCT	 5083
17910065	176	187	oligodonzia	DISEASEORPHENOTYPICFEATURE	C538049
17910065	220	224	PAX9	GENEORGENEPRODUCT	5083
17910065	258	262	MSX1	GENEORGENEPRODUCT	4487
17910065	400	405	umani	ORGANISMTAXON	9606
17910065	499	538	oligodontia non sindromica e sindromica	DISEASEORPHENOTYPICFEATURE	C538049
17910065	636	662	oligodonzia non sindromica	DISEASEORPHENOTYPICFEATURE	C538049
17910065	714	718	PAX9	GENEORGENEPRODUCT	5083
17910065	753	757	MSX1	GENEORGENEPRODUCT	4487
17910065	934	939	C139T	SEQUENCEVARIANT	RS121917720
17910065	974	978	PAX9	GENEORGENEPRODUCT	5083
17910065	1115	1119	MSX1	GENEORGENEPRODUCT	4487
17910065	1185	1190	C139T	SEQUENCEVARIANT	RS121917720
17910065	1259	1285	arginina con un triptofano	SEQUENCEVARIANT	RS121917720
17910065	1323	1327	R47W	SEQUENCEVARIANT	RS121917720
17910065	1430	1434	PAX9	GENEORGENEPRODUCT	5083
17910065	1548	1571	fenotipo di oligodontia	DISEASEORPHENOTYPICFEATURE	C538049
17910065	1686	1690	PAX9	GENEORGENEPRODUCT	5083
17910065	1815	1819	R47W	SEQUENCEVARIANT	RS121917720
17951029	43	67	Ipoplasia dermica focale	DISEASEORPHENOTYPICFEATURE	D005489
17951029	154	161	p.E300X	SEQUENCEVARIANT	 P|SUB|E|300|X
17951029	204	209	PORCN	GENEORGENEPRODUCT	64840
17951029	266	290	Ipoplasia dermica focale	DISEASEORPHENOTYPICFEATURE	D005489
17951029	335	338	FDH	DISEASEORPHENOTYPICFEATURE	D005489
17951029	385	396	OMIM 305600	DISEASEORPHENOTYPICFEATURE	D005489
17951029	446	477	disturbo dominante legato all'X	DISEASEORPHENOTYPICFEATURE	D040181
17951029	576	593	Sindrome di Goltz	DISEASEORPHENOTYPICFEATURE	D005489
17951029	638	641	FDH	DISEASEORPHENOTYPICFEATURE	D005489
17951029	739	756	derma ipoplastico	DISEASEORPHENOTYPICFEATURE	D005489
17951029	890	893	FDH	DISEASEORPHENOTYPICFEATURE	D005489
17951029	954	959	PORCN	GENEORGENEPRODUCT	64840
17951029	1193	1196	FDH	DISEASEORPHENOTYPICFEATURE	D005489
17951029	1306	1314	depresso	DISEASEORPHENOTYPICFEATURE	D003866
17951029	1479	1493	carie dentaria	DISEASEORPHENOTYPICFEATURE	D003731
17951029	1710	1715	PORCN	GENEORGENEPRODUCT	64840
17951029	1833	1856	G>T al nucleotide c.898	SEQUENCEVARIANT	C|SUB|G|898|T
17951029	1949	2027	residuo di acido glutammico (GAA) in un codone di terminazione prematura (TAA)	SEQUENCEVARIANT	P|SUB|E||X
17951029	2096	2103	p.E300X	SEQUENCEVARIANT	P|SUB|E|300|X
17951029	2332	2335	FDH	DISEASEORPHENOTYPICFEATURE	D005489
17951029	2424	2429	PORCN	GENEORGENEPRODUCT	 64840
17959715	43	47	MLH1	GENEORGENEPRODUCT	4292
17959715	104	110	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17959715	187	205	linfoma di Hodgkin	DISEASEORPHENOTYPICFEATURE	D006689
17959715	335	353	linfoma di Hodgkin	DISEASEORPHENOTYPICFEATURE	D006689
17959715	444	450	tumori	DISEASEORPHENOTYPICFEATURE	D009369
17959715	495	511	La citotossicità	DISEASEORPHENOTYPICFEATURE	D064420
17959715	666	670	MLH1	GENEORGENEPRODUCT	4292
17959715	781	792	citotossico	DISEASEORPHENOTYPICFEATURE	D064420
17959715	1004	1008	MLH1	GENEORGENEPRODUCT	4292
17959715	1059	1068	rs1800734	SEQUENCEVARIANT	RS1800734
17959715	1136	1142	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17959715	1212	1220	pazienti	ORGANISMTAXON	9606
17959715	1285	1291	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17959715	1379	1387	pazienti	ORGANISMTAXON	9606
17959715	1452	1469	leucemia mieloide	DISEASEORPHENOTYPICFEATURE	D007938
17959715	1502	1510	pazienti	ORGANISMTAXON	9606
17959715	1570	1597	linfoma di Hodgkin primario	DISEASEORPHENOTYPICFEATURE	D006689
17959715	1683	1687	MLH1	GENEORGENEPRODUCT	4292
17959715	1957	1963	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17959715	1999	2003	MLH1	GENEORGENEPRODUCT	4292
17959715	2254	2258	MLH1	GENEORGENEPRODUCT	4292
17959715	2307	2315	pazienti	ORGANISMTAXON	9606
17959715	2400	2423	leucemia mieloide acuta	DISEASEORPHENOTYPICFEATURE	D015470
17959715	2470	2473	AML	DISEASEORPHENOTYPICFEATURE	D015470
17959715	2537	2551	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17959715	2643	2658	Hodgkin linfoma	DISEASEORPHENOTYPICFEATURE	D006689
17959715	2697	2705	pazienti	ORGANISMTAXON	9606
17959715	2791	2794	AML	DISEASEORPHENOTYPICFEATURE	D015470
17959715	2854	2868	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
17959715	2896	2904	pazienti	ORGANISMTAXON	9606
17959715	2977	2981	MLH1	GENEORGENEPRODUCT	4292
17959715	3057	3060	AML	DISEASEORPHENOTYPICFEATURE	D015470
17959715	3128	3131	AML	DISEASEORPHENOTYPICFEATURE	D015470
17959715	3313	3316	AML	DISEASEORPHENOTYPICFEATURE	D015470
17959715	3424	3432	pazienti	ORGANISMTAXON	9606
17959715	3626	3630	MLH1	GENEORGENEPRODUCT	4292
17959715	3725	3731	cancro	DISEASEORPHENOTYPICFEATURE	D009369
17959715	3808	3826	linfoma di Hodgkin	DISEASEORPHENOTYPICFEATURE	D006689
17965424	69	79	etoricoxib	CHEMICALENTITY	D000077613
17965424	126	144	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
17965424	172	180	pazienti	ORGANISMTAXON	9606
17965424	230	240	etoricoxib	CHEMICALENTITY	D000077613
17965424	275	292	diclofenac sodico	CHEMICALENTITY	D004008
17965424	532	542	etoricoxib	CHEMICALENTITY	D000077613
17965424	577	587	diclofenac	CHEMICALENTITY	 D004008
17965424	618	626	pazienti	ORGANISMTAXON	9606
17965424	674	692	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
17965424	737	739	RA	DISEASEORPHENOTYPICFEATURE	D001172
17965424	769	777	PAZIENTI	ORGANISMTAXON	9606
17965424	833	841	pazienti	ORGANISMTAXON	9606
17965424	924	926	RA	DISEASEORPHENOTYPICFEATURE	D001172
17965424	999	1009	etoricoxib	CHEMICALENTITY	D000077613
17965424	1070	1080	diclofenac	CHEMICALENTITY	D004008
17965424	1203	1211	aspirina	CHEMICALENTITY	D001241
17965424	1328	1336	paziente	ORGANISMTAXON	9606
17965424	1402	1423	Esperienze avverse GI	DISEASEORPHENOTYPICFEATURE	D005767
17965424	1551	1577	trombotici cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
17965424	1650	1658	Paziente	ORGANISMTAXON	9606
17965424	1885	1895	etoricoxib	CHEMICALENTITY	D000077613
17965424	1930	1947	gruppi diclofenac	CHEMICALENTITY	D004008
17965424	2053	2059	GI AEs	DISEASEORPHENOTYPICFEATURE	D005767
17965424	2135	2145	etoricoxib	CHEMICALENTITY	D000077613
17965424	2188	2198	diclofenac	CHEMICALENTITY	D004008
17965424	2254	2262	paziente	ORGANISMTAXON	9606
17965424	2443	2455	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17965424	2503	2508	edema	DISEASEORPHENOTYPICFEATURE	D004487
17965424	2583	2593	etoricoxib	CHEMICALENTITY	D000077613
17965424	2666	2676	diclofenac	CHEMICALENTITY	D004008
17965424	2762	2774	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
17965424	2831	2836	edema	DISEASEORPHENOTYPICFEATURE	D004487
17965424	2892	2902	Etoricoxib	CHEMICALENTITY	D000077613
17965424	2936	2946	diclofenac	CHEMICALENTITY	D004008
17965424	3103	3113	Etoricoxib	CHEMICALENTITY	D000077613
17965424	3259	3265	GI AEs	DISEASEORPHENOTYPICFEATURE	D005767
17965424	3308	3318	diclofenac	CHEMICALENTITY	D004008
17965424	3461	3466	EA GI	DISEASEORPHENOTYPICFEATURE	D005767
17965424	3543	3553	etoricoxib	CHEMICALENTITY	D000077613
17975693	43	52	Ansiogeno	DISEASEORPHENOTYPICFEATURE	D001008
17975693	98	112	ciprofloxacina	CHEMICALENTITY	D002939
17975693	146	158	norfloxacina	CHEMICALENTITY	D009643
17975693	190	195	ratti	ORGANISMTAXON	10116
17975693	266	275	ansiogeni	DISEASEORPHENOTYPICFEATURE	D001008
17975693	318	333	fluorochinoloni	CHEMICALENTITY	D024841
17975693	379	393	ciprofloxacina	CHEMICALENTITY	D002939
17975693	427	439	norfloxacina	CHEMICALENTITY	D009643
17975693	522	527	ratti	ORGANISMTAXON	10116
17975693	1001	1015	ciprofloxacina	CHEMICALENTITY	D002939
17975693	1050	1062	norfloxacina	CHEMICALENTITY	D009643
17975693	1101	1106	ratti	ORGANISMTAXON	10116
17975693	1165	1186	comportamento ansioso	DISEASEORPHENOTYPICFEATURE	D001008
17975693	1238	1243	ratti	ORGANISMTAXON	 10116
17975693	1316	1330	ciprofloxacina	CHEMICALENTITY	D002939
17975693	1365	1377	norfloxacina	CHEMICALENTITY	D009643
17975693	1416	1421	ratti	ORGANISMTAXON	10116
17975693	1627	1636	ansiogeno	DISEASEORPHENOTYPICFEATURE	D001008
17975693	1694	1708	ciprofloxacina	CHEMICALENTITY	D002939
17975693	1742	1754	norfloxacina	CHEMICALENTITY	D009643
18000905	80	92	schisi orali	DISEASEORPHENOTYPICFEATURE	D002972
18000905	248	263	labbro leporino	DISEASEORPHENOTYPICFEATURE	D002971
18000905	311	323	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
18000905	376	380	CL/P	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	428	440	palatoschisi	DISEASEORPHENOTYPICFEATURE	D002972
18000905	490	493	CPO	DISEASEORPHENOTYPICFEATURE	D002972
18000905	733	737	CL/P	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	793	796	CPO	DISEASEORPHENOTYPICFEATURE	D002972
18000905	1559	1569	le fessure	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	1819	1823	CL/P	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	1881	1884	CPO	DISEASEORPHENOTYPICFEATURE	D002972
18000905	1979	1983	CL/P	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	2148	2156	microtia	DISEASEORPHENOTYPICFEATURE	D065817
18000905	2213	2217	CL/P	DISEASEORPHENOTYPICFEATURE	D002971,D002972
18000905	2552	2555	CPO	DISEASEORPHENOTYPICFEATURE	D002972
18000905	2670	2674	CPO 	DISEASEORPHENOTYPICFEATURE	D002972
18050247	105	132	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
18050247	278	305	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
18050247	350	353	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	409	417	pazienti	ORGANISMTAXON	9606
18050247	586	589	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	734	742	pazienti	ORGANISMTAXON	9606
18050247	808	811	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	1235	1238	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	1487	1490	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	1532	1537	N673S	SEQUENCEVARIANT	RS3917815
18050247	1591	1601	P-selectin	GENEORGENEPRODUCT	6403
18050247	1639	1643	SELP	GENEORGENEPRODUCT	6403
18050247	1718	1723	C203S	SEQUENCEVARIANT	RS10127175
18050247	1723	1724	 	GENEORGENEPRODUCT	3654
18050247	1854	1859	IRAK1	GENEORGENEPRODUCT	3654
18050247	2162	2165	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	2299	2306	TNFRSF6	GENEORGENEPRODUCT	355
18050247	2338	2341	Fas	GENEORGENEPRODUCT	355
18050247	2377	2381	IRF5	GENEORGENEPRODUCT	3663
18050247	2507	2510	LES	DISEASEORPHENOTYPICFEATURE	D008180
18050247	2556	2560	SELP	GENEORGENEPRODUCT	6403
18050247	2594	2599	IRAK1	GENEORGENEPRODUCT	3654
18050247	2679	2682	SLE	DISEASEORPHENOTYPICFEATURE	D008180
18050247	2845	2848	SLE	DISEASEORPHENOTYPICFEATURE	D008180
18083142	31	44	Norepinefrina	CHEMICALENTITY	D009638
18083142	101	127	recettori beta-adrenergici	GENEORGENEPRODUCT	11554
18083142	195	202	cocaina	CHEMICALENTITY	D003042
18083142	257	262	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	307	317	La cocaina	CHEMICALENTITY	D003042
18083142	504	511	cocaina	CHEMICALENTITY	D003042
18083142	715	720	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	815	840	dopamina beta-idrossilasi	GENEORGENEPRODUCT	13166
18083142	883	886	Dbh	GENEORGENEPRODUCT	13166
18083142	920	924	topi	ORGANISMTAXON	10090
18083142	973	986	noradrenalina	CHEMICALENTITY	D009638
18083142	1019	1021	NE	CHEMICALENTITY	D009638
18083142	1155	1162	cocaina	CHEMICALENTITY	D003042
18083142	1217	1222	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	1288	1295	cocaina	CHEMICALENTITY	D003042
18083142	1363	1368	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	1436	1439	Dbh	GENEORGENEPRODUCT	13166
18083142	1473	1477	topi	ORGANISMTAXON	10090
18083142	1576	1579	Dbh	GENEORGENEPRODUCT	13166
18083142	1612	1616	topi	ORGANISMTAXON	10090
18083142	1763	1770	cocaina	CHEMICALENTITY	D003042
18083142	1803	1810	Cocaina	CHEMICALENTITY	D003042
18083142	1865	1872	l'ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	1933	1936	Dbh	GENEORGENEPRODUCT	13166
18083142	1969	1973	topi	ORGANISMTAXON	10090
18083142	2038	2048	disulfiram	CHEMICALENTITY	D004221
18083142	2085	2110	dopamina beta-idrossilasi	GENEORGENEPRODUCT	13166
18083142	2144	2147	DBH	GENEORGENEPRODUCT	13166
18083142	2234	2257	antagonisti adrenergici	CHEMICALENTITY	D018674
18083142	2340	2366	recettore beta-adrenergico	GENEORGENEPRODUCT	11554
18083142	2410	2422	propranololo	CHEMICALENTITY	D011433
18083142	2463	2470	cocaina	CHEMICALENTITY	D003042
18083142	2523	2528	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	2583	2586	Dbh	GENEORGENEPRODUCT	13166
18083142	2641	2645	topi	ORGANISMTAXON	10090
18083142	2689	2697	alpha(1)	GENEORGENEPRODUCT	11549
18083142	2742	2750	prazosin	CHEMICALENTITY	 D011224
18083142	2785	2793	alpha(2)	GENEORGENEPRODUCT	11551
18083142	2837	2846	yohimbina	CHEMICALENTITY	D015016
18083142	2983	3009	recettori beta-adrenergici	GENEORGENEPRODUCT	11554
18083142	3057	3064	cocaina	CHEMICALENTITY	D003042
18083142	3119	3124	ansia	DISEASEORPHENOTYPICFEATURE	D001008
18083142	3156	3160	topi	ORGANISMTAXON	10090
18165598	60	71	bupivacaina	CHEMICALENTITY	D002045
18165598	105	114	lidocaina	CHEMICALENTITY	D008012
18165598	149	166	prostaglandina E2	GENEORGENEPRODUCT	5732
18165598	213	227	ciclossigenasi	GENEORGENEPRODUCT	4512,4513
18165598	292	298	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18165598	364	370	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18165598	564	577	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
18165598	677	688	bupivacaina	CHEMICALENTITY	D002045
18165598	726	743	prostaglandina E2	GENEORGENEPRODUCT	5732
18165598	776	780	PGE2	GENEORGENEPRODUCT	5732
18165598	831	845	ciclossigenasi	GENEORGENEPRODUCT	4512,4513
18165598	884	887	COX	GENEORGENEPRODUCT	4512,4513
18165598	963	984	dolore postoperatorio	DISEASEORPHENOTYPICFEATURE	D010149
18165598	1016	1021	umani	ORGANISMTAXON	9606
18165598	1165	1174	lidocaina	CHEMICALENTITY	D008012
18165598	1216	1228	 bupivacaina	CHEMICALENTITY	D002045
18165598	1295	1304	rofecoxib	CHEMICALENTITY	C116926
18165598	1644	1648	PGE2	GENEORGENEPRODUCT	5732
18165598	1682	1696	trombossano B2	CHEMICALENTITY	D013929
18165598	1729	1733	TXB2	CHEMICALENTITY	D013929
18165598	1800	1811	bupivacaina	CHEMICALENTITY	D002045
18165598	1843	1852	rofecoxib	CHEMICALENTITY	C116926
18165598	1934	1940	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18165598	2109	2120	bupivacaina	CHEMICALENTITY	D002045
18165598	2208	2214	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18165598	2257	2261	PGE2	GENEORGENEPRODUCT	5732
18165598	2416	2427	bupivacaina	CHEMICALENTITY	D002045
18165598	2512	2517	COX-2	GENEORGENEPRODUCT	4513
18165598	2580	2589	lidocaina	CHEMICALENTITY	D008012
18165598	2630	2654	I livelli di trombossano	CHEMICALENTITY	D013931
18165598	2833	2839	 COX-2	GENEORGENEPRODUCT	4513
18165598	2879	2884	COX-1	GENEORGENEPRODUCT	4512
18165598	2964	2975	bupivacaina	CHEMICALENTITY	D002045
18165598	3015	3020	COX-2	GENEORGENEPRODUCT	4513
18165598	3069	3084	danno tissutale	DISEASEORPHENOTYPICFEATURE	D017695
18165598	3148	3152	PGE2	GENEORGENEPRODUCT	5732
18165598	3210	3216	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18166824	73	78	donne	ORGANISMTAXON	9606
18166824	127	158	insufficienza ovarica prematura	DISEASEORPHENOTYPICFEATURE	D016649
18166824	317	321	DMC1	GENEORGENEPRODUCT	11144
18166824	358	362	MutS	GENEORGENEPRODUCT	850545
18166824	403	407	MSH4	GENEORGENEPRODUCT	4438
18166824	441	445	MSH5	GENEORGENEPRODUCT	4439
18166824	475	488	S. cerevisiae	ORGANISMTAXON	4932
18166824	531	536	SPO11	GENEORGENEPRODUCT	856364
18166824	600	631	insufficienza ovarica prematura	DISEASEORPHENOTYPICFEATURE	D016649
18166824	676	679	POF	DISEASEORPHENOTYPICFEATURE	D016649
18166824	887	895	pazienti	ORGANISMTAXON	9606
18166824	1042	1047	donne	ORGANISMTAXON	9606
18166824	1095	1098	POF	DISEASEORPHENOTYPICFEATURE	D016649
18166824	1139	1144	donne	ORGANISMTAXON	9606
18166824	1266	1298	residuo di citosina con timidina	SEQUENCEVARIANT	RS2075789
18166824	1346	1350	MSH5	GENEORGENEPRODUCT	4439
18166824	1402	1407	donne	ORGANISMTAXON	9606
18166824	1474	1477	POF	DISEASEORPHENOTYPICFEATURE	D016649
18166824	1615	1675	(prolina) con un amminoacido polare (serina) in posizione 29	SEQUENCEVARIANT	RS2075789
18166824	1712	1716	P29S	SEQUENCEVARIANT	RS2075789
18166824	1764	1769	donne	ORGANISMTAXON	9606
18166824	1809	1817	pazienti	ORGANISMTAXON	9606
18166824	1866	1869	POF	DISEASEORPHENOTYPICFEATURE	D016649
18166824	1963	1966	POF	DISEASEORPHENOTYPICFEATURE	D016649
18166824	1994	2002	paziente	ORGANISMTAXON	9606
18166824	2125	2129	DMC1	GENEORGENEPRODUCT	11144
18166824	2245	2250	M200V	SEQUENCEVARIANT	RS2227914
18166824	2322	2333	infertilità	DISEASEORPHENOTYPICFEATURE	D007247
18166824	2380	2384	DMC1	GENEORGENEPRODUCT	11144
18166824	2461	2469	pazienti	ORGANISMTAXON	9606
18166824	2552	2556	MSH5	GENEORGENEPRODUCT	4439
18166824	2713	2717	MSH5	GENEORGENEPRODUCT	4439
18166824	2752	2756	DMC1	GENEORGENEPRODUCT	11144
18166824	2849	2852	POF	DISEASEORPHENOTYPICFEATURE	D016649
18182964	31	40	Clonidina	CHEMICALENTITY	D003000
18182964	88	135	disturbo da deficit di attenzione/iperattività 	DISEASEORPHENOTYPICFEATURE	D001289
18182964	289	298	clonidina	CHEMICALENTITY	D003000
18182964	350	363	metilfenidato	CHEMICALENTITY	D008774
18182964	423	469	disturbo da deficit di attenzione/iperattività	DISEASEORPHENOTYPICFEATURE	D001289
18182964	514	518	ADHD	DISEASEORPHENOTYPICFEATURE	D001289
18182964	650	654	ADHD	DISEASEORPHENOTYPICFEATURE	D001289
18182964	725	735	 clonidina	CHEMICALENTITY	D003000
18182964	777	790	metilfenidato	CHEMICALENTITY	D008774
18182964	832	842	 clonidina	CHEMICALENTITY	D003000
18182964	876	889	metilfenidato	CHEMICALENTITY	D008774
18182964	1019	1028	clonidina	CHEMICALENTITY	D003000
18182964	1076	1089	metilfenidato	CHEMICALENTITY	D008774
18182964	1379	1390	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
18182964	1448	1457	clonidina	CHEMICALENTITY	D003000
18182964	1526	1535	clonidina	CHEMICALENTITY	D003000
18182964	1761	1770	clonidina	CHEMICALENTITY	D003000
18182964	1804	1817	metilfenidato	CHEMICALENTITY	D008774
18182964	1977	1986	clonidina	CHEMICALENTITY	D003000
18182964	2122	2135	La sonnolenza	DISEASEORPHENOTYPICFEATURE	D006970
18182964	2181	2190	clonidina	CHEMICALENTITY	D003000
18182964	2284	2293	Clonidina	CHEMICALENTITY	D003000
18182964	2346	2359	metilfenidato	CHEMICALENTITY	D008774
18182964	2464	2468	ADHD	DISEASEORPHENOTYPICFEATURE	D001289
18182964	2526	2535	clonidina	CHEMICALENTITY	D003000
18182964	2597	2608	bradicardia	DISEASEORPHENOTYPICFEATURE	D001919
18182964	2651	2659	pazienti	ORGANISMTAXON	9606
18182964	2734	2744	sonnolenza	DISEASEORPHENOTYPICFEATURE	D006970
18189233	31	37	RNASEL	GENEORGENEPRODUCT	6041
18189233	71	77	RNASEL	GENEORGENEPRODUCT	6041
18189233	160	180	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	322	342	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	413	433	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	625	639	ribonucleasi L	GENEORGENEPRODUCT	6041
18189233	672	678	RNASEL	GENEORGENEPRODUCT	6041
18189233	767	787	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	850	856	RNASEL	GENEORGENEPRODUCT	6041
18189233	940	960	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	1120	1126	RNASEL	GENEORGENEPRODUCT	6041
18189233	1181	1201	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	1267	1272	R462Q	SEQUENCEVARIANT	RS486907
18189233	1308	1313	D541E	SEQUENCEVARIANT	RS627928
18189233	1391	1411	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	1504	1510	RNASEL	GENEORGENEPRODUCT	6041
18189233	1543	1548	ABCE1	GENEORGENEPRODUCT	6059
18189233	1623	1643	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	1743	1748	R462Q	SEQUENCEVARIANT	RS486907
18189233	1784	1789	D541E	SEQUENCEVARIANT	RS627928
18189233	1848	1868	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	1970	1975	K294E	SEQUENCEVARIANT	RS143544690
18189233	2081	2101	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	2170	2263	polimorfismo di inserimento/cancellazione di 20 bp 1.109 bp a monte del codone di iniziazione	SEQUENCEVARIANT	C|INDEL|1109|20
18189233	2347	2367	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	2467	2472	ABCE1	GENEORGENEPRODUCT	6059
18189233	2757	2777	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	2920	2940	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18189233	2973	2979	RNASEL	GENEORGENEPRODUCT	6041
18189233	3096	3116	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
18235024	43	106	La distrofia del cono con risposta supernormale dei bastoncelli	DISEASEORPHENOTYPICFEATURE	C563678
18235024	181	186	KCNV2	GENEORGENEPRODUCT	169522
18235024	238	298	Distrofia del cono con risposta supernormale dei bastoncelli	DISEASEORPHENOTYPICFEATURE	C563678
18235024	343	348	CDSRR	DISEASEORPHENOTYPICFEATURE	C563678
18235024	398	403	CDSRR	DISEASEORPHENOTYPICFEATURE	C563678
18235024	448	465	disturbo retinico	DISEASEORPHENOTYPICFEATURE	D012164
18235024	550	582	difetti della visione del colore	DISEASEORPHENOTYPICFEATURE	D003117
18235024	758	763	PDE6H	GENEORGENEPRODUCT	5149
18235024	802	807	KCNV2	GENEORGENEPRODUCT	169522
18235024	875	880	CDSRR	DISEASEORPHENOTYPICFEATURE	C563678
18235024	983	991	pazienti	ORGANISMTAXON	9606
18235024	1039	1044	CDSRR	DISEASEORPHENOTYPICFEATURE	C563678
18235024	1129	1137	pazienti	ORGANISMTAXON	9606
18235024	1464	1469	PDE6C	GENEORGENEPRODUCT	5146
18235024	1505	1510	KCNV2	GENEORGENEPRODUCT	169522
18235024	1719	1724	PDE6H	GENEORGENEPRODUCT	5149
18235024	1775	1780	KCNV2	GENEORGENEPRODUCT	169522
18235024	1843	1851	pazienti	ORGANISMTAXON	9606
18235024	2199	2204	CDSRR	DISEASEORPHENOTYPICFEATURE	C563678
18235024	2311	2340	difetti di visione del colore	DISEASEORPHENOTYPICFEATURE	D003117
18235024	2459	2466	atrofia	DISEASEORPHENOTYPICFEATURE	D001284
18235024	2517	2525	pazienti	ORGANISMTAXON	9606
18235024	2625	2633	pazienti	ORGANISMTAXON	9606
18235024	2728	2788	distrofia del cono con risposta supernormale dei bastoncelli	DISEASEORPHENOTYPICFEATURE	C563678
18235024	2862	2867	KCNV2	GENEORGENEPRODUCT	169522
18262054	88	94	BMPR1A	GENEORGENEPRODUCT	657
18262054	151	169	poliposi giovanile	DISEASEORPHENOTYPICFEATURE	 C537702
18262054	246	252	BMPR1A	GENEORGENEPRODUCT	657
18262054	316	334	poliposi giovanile	DISEASEORPHENOTYPICFEATURE	C537702
18262054	380	395	cancro al colon	DISEASEORPHENOTYPICFEATURE	D003110
18262054	591	596	Y245X	SEQUENCEVARIANT	P|SUB|Y|245|X
18262054	636	641	G246X	SEQUENCEVARIANT	P|SUB|G|246|X
18262054	881	886	umana	ORGANISMTAXON	9606
18270997	31	57	Catecol-O-metiltransferasi	GENEORGENEPRODUCT	1312
18270997	90	94	COMT	GENEORGENEPRODUCT	1312
18270997	183	192	Val158Met	SEQUENCEVARIANT	RS4680
18270997	240	262	dipendenza da oppiacei	DISEASEORPHENOTYPICFEATURE	D009293
18270997	302	307	donne	ORGANISMTAXON	9606
18270997	340	366	Catecol-O-metiltransferasi	GENEORGENEPRODUCT	1312
18270997	399	403	COMT	GENEORGENEPRODUCT	1312
18270997	467	496	neurotrasmettitori catecolici	CHEMICALENTITY	D002395
18270997	537	545	dopamina	CHEMICALENTITY	D004298
18270997	694	699	G472A	SEQUENCEVARIANT	RS4680
18270997	748	757	Val158Met	SEQUENCEVARIANT	RS4680
18270997	901	905	COMT	GENEORGENEPRODUCT	1312
18270997	1102	1110	oppiacei	CHEMICALENTITY	D018847
18270997	1211	1216	G472A	SEQUENCEVARIANT	RS4680
18270997	1485	1490	G472A	SEQUENCEVARIANT	RS4680
18270997	1564	1586	dipendenza da oppiacei	DISEASEORPHENOTYPICFEATURE	D009293
18270997	1654	1659	G472A	SEQUENCEVARIANT	RS4680
18270997	1843	1865	dipendenza da oppiacei	DISEASEORPHENOTYPICFEATURE	D009293
18270997	1896	1901	donne	ORGANISMTAXON	9606
18270997	1938	1944	uomini	ORGANISMTAXON	9606
18310445	30	63	La proteina morfogenetica ossea-4	GENEORGENEPRODUCT	652
18310445	118	125	activin	GENEORGENEPRODUCT	3624,83729
18310445	160	164	GnRH	GENEORGENEPRODUCT	14714
18310445	216	229	gonadotropina	GENEORGENEPRODUCT	12640,14308
18310445	358	363	ovini	ORGANISMTAXON	9940
18310445	426	463	proteine morfogenetiche ossee (BMP)-4	GENEORGENEPRODUCT	443502
18310445	506	513	FSHbeta	GENEORGENEPRODUCT	443387
18310445	576	579	FSH	GENEORGENEPRODUCT	443387,443538
18310445	640	645	mouse	ORGANISMTAXON	10090
18310445	770	774	BMPs	GENEORGENEPRODUCT	652
18310445	819	827	attivina	GENEORGENEPRODUCT	16323
18310445	871	878	FSHbeta	GENEORGENEPRODUCT	14308
18310445	1096	1101	BMP-4	GENEORGENEPRODUCT	652
18310445	1143	1156	gonadotropina	GENEORGENEPRODUCT	12640,14308
18310445	1219	1227	attivina	GENEORGENEPRODUCT	16323
18310445	1262	1266	GnRH	GENEORGENEPRODUCT	14714
18310445	1298	1303	BMP-4	GENEORGENEPRODUCT	652
18310445	1393	1396	FSH	GENEORGENEPRODUCT	443387,443538
18310445	1471	1479	attivina	GENEORGENEPRODUCT	16323
18310445	1512	1516	GnRH	GENEORGENEPRODUCT	14714
18310445	1553	1560	FSHbeta	GENEORGENEPRODUCT	14308
18310445	1608	1611	FSH	GENEORGENEPRODUCT	443387,443538
18310445	1680	1692	follistatina	GENEORGENEPRODUCT	14313
18310445	1729	1734	BMP-4	GENEORGENEPRODUCT	652
18310445	1775	1781	LHbeta	GENEORGENEPRODUCT	16866
18310445	1853	1857	GnRH	GENEORGENEPRODUCT	14714
18310445	1894	1901	activin	GENEORGENEPRODUCT	16323
18310445	1948	1982	Espressione del recettore del GnRH	GENEORGENEPRODUCT	14715
18310445	2040	2043	FSH	GENEORGENEPRODUCT	443387,443538
18310445	2098	2100	LH	GENEORGENEPRODUCT	 12640,16866
18310445	2167	2173	pecora	ORGANISMTAXON	9940
18310445	2262	2300	BMP di tipo IA (BMPRIA) e II ( BMPRII)	GENEORGENEPRODUCT	101103793,101112282
18310445	2391	2397	BMPRIB	GENEORGENEPRODUCT	12167
18310445	2437	2444	Smad1/5	GENEORGENEPRODUCT	17125,17129
18310445	2501	2506	BMP-4	GENEORGENEPRODUCT	652
18310445	2568	2571	BMP	GENEORGENEPRODUCT	12159
18310445	2619	2624	BMP-4	GENEORGENEPRODUCT	652
18310445	2702	2709	activin	GENEORGENEPRODUCT	16323
18310445	2744	2748	GnRH	GENEORGENEPRODUCT	14714
18310445	2816	2823	activin	GENEORGENEPRODUCT	16323
18310445	2860	2864	GnRH	GENEORGENEPRODUCT	14714
18310445	2923	2928	BMP-4	GENEORGENEPRODUCT	652
18310445	2976	3014	fosforilazione stimolata dall'attivina	GENEORGENEPRODUCT	16323
18310445	3057	3064	Smad2/3	GENEORGENEPRODUCT	17126,17127
18310445	3103	3107	GnRH	GENEORGENEPRODUCT	14714
18310445	3155	3161	ERK1/2	GENEORGENEPRODUCT	26413,26417
18310445	3196	3244	la fosforilazione dell'elemento di risposta cAMP	GENEORGENEPRODUCT	12912
18310445	3332	3336	GnRH	GENEORGENEPRODUCT	14714
18310445	3372	3380	p38 MAPK	GENEORGENEPRODUCT	26416
18310445	3431	3436	BMP-4	GENEORGENEPRODUCT	652
18310445	3520	3527	FSHbeta	GENEORGENEPRODUCT	14308
18310445	3594	3597	FSH	GENEORGENEPRODUCT	443387,443538
18310445	3644	3650	LHbeta	GENEORGENEPRODUCT	16866
18310445	3729	3733	BMPs	GENEORGENEPRODUCT	652
18310445	3796	3803	activin	GENEORGENEPRODUCT	16323
18310445	3840	3844	GnRH	GENEORGENEPRODUCT	14714
18310445	3893	3906	gonadotropina	GENEORGENEPRODUCT	12640,14308
18310445	4088	4101	Recettore BMP	GENEORGENEPRODUCT	101103793,101112282,12167
18340638	31	42	Azatioprina	CHEMICALENTITY	D001379
18340638	138	149	Azatioprina	CHEMICALENTITY	D001379
18340638	259	270	azatioprina	CHEMICALENTITY	D001379
18340638	324	330	anemia	DISEASEORPHENOTYPICFEATURE	D000740
18340638	400	406	anemia	DISEASEORPHENOTYPICFEATURE	D000740
18340638	450	480	soppressione del midollo osseo	DISEASEORPHENOTYPICFEATURE	D001855
18340638	541	547	anemia	DISEASEORPHENOTYPICFEATURE	D000740
18340638	674	690	fosfatidilserina	CHEMICALENTITY	D010718
18340638	723	725	PS	CHEMICALENTITY	D010718
18340638	874	885	azatioprina	CHEMICALENTITY	D001379
18340638	961	972	annessina V	GENEORGENEPRODUCT	308
18340638	1019	1027	pazienti	ORGANISMTAXON	9606
18340638	1110	1112	PS	CHEMICALENTITY	D010718
18340638	1194	1205	azatioprina	CHEMICALENTITY	D001379
18340638	1280	1284	Ca2+	CHEMICALENTITY	D002118
18340638	1317	1322	Fluo3	CHEMICALENTITY	C059715
18340638	1409	1411	PS	CHEMICALENTITY	D010718
18340638	1455	1465	allegato V	GENEORGENEPRODUCT	308
18340638	1613	1624	azatioprina	CHEMICALENTITY	D001379
18340638	1707	1711	Ca2+	CHEMICALENTITY	D002118
18340638	1753	1763	allegato V	GENEORGENEPRODUCT	308
18340638	1858	1869	azatioprina	CHEMICALENTITY	D001379
18340638	1920	1931	annessina V	GENEORGENEPRODUCT	308
18340638	2037	2041	Ca2+	CHEMICALENTITY	D002118
18340638	2087	2098	Azatioprina	CHEMICALENTITY	D001379
18340638	2219	2230	azatioprina	CHEMICALENTITY	D001379
18340638	2283	2289	anemia	DISEASEORPHENOTYPICFEATURE	D000740
18356633	50	58	amikacin	CHEMICALENTITY	D000583
18356633	102	116	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
18356633	190	199	Amikacina	CHEMICALENTITY	D000583
18356633	236	250	aminoglicoside	CHEMICALENTITY	D000617
18356633	373	393	neutropenia febbrile	DISEASEORPHENOTYPICFEATURE	D009503
18356633	454	463	infezioni	DISEASEORPHENOTYPICFEATURE	D007239
18356633	750	758	amikacin	CHEMICALENTITY	D000583
18356633	814	828	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
18356633	1030	1038	pazienti	ORGANISMTAXON	9606
18356633	1123	1154	disturbo ematologico/oncologico	DISEASEORPHENOTYPICFEATURE	D006402,D009369
18356633	1222	1236	aminoglicoside	CHEMICALENTITY	D000617
18356633	1292	1300	amikacin	CHEMICALENTITY	D000583
18356633	1363	1377	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
18356633	1432	1442	creatinina	CHEMICALENTITY	D003404
18356633	1517	1526	amikacina	CHEMICALENTITY	D000583
18356633	1660	1674	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
18356633	1811	1819	pazienti	ORGANISMTAXON	9606
18356633	1997	2011	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
18366737	60	62	FH	GENEORGENEPRODUCT	2271
18366737	118	146	 mutazioni fumarato idratasi	GENEORGENEPRODUCT	2271
18366737	206	210	MCUL	DISEASEORPHENOTYPICFEATURE	C535516
18366737	255	260	HLRCC	DISEASEORPHENOTYPICFEATURE	C535516
18366737	305	322	sindrome tumorale	DISEASEORPHENOTYPICFEATURE	D009369
18366737	368	387	deficit di fumarasi	DISEASEORPHENOTYPICFEATURE	C538191
18366737	442	459	Fumarato idratasi	GENEORGENEPRODUCT	2271
18366737	529	531	FH	GENEORGENEPRODUCT	2271
18366737	581	589	fumarase	GENEORGENEPRODUCT	2271
18366737	639	660	acido tricarbossilico	CHEMICALENTITY	D014233
18366737	694	697	TCA	CHEMICALENTITY	D014233
18366737	864	880	il deficit di FH	DISEASEORPHENOTYPICFEATURE	C538191
18366737	958	971	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
18366737	1048	1057	Leiomyoma	DISEASEORPHENOTYPICFEATURE	D007889
18366737	1140	1142	FH	GENEORGENEPRODUCT	2271
18366737	1173	1181	pazienti	ORGANISMTAXON	9606
18366737	1229	1265	leiomiomi cutanei e uterini multipli	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1311	1315	MCUL	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1360	1371	OMIM 150800	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1436	1466	il cancro delle cellule renali	DISEASEORPHENOTYPICFEATURE	D002292
18366737	1591	1645	leiomiomatosi ereditaria e cancro delle cellule renali	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1690	1695	HLRCC	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1740	1751	OMIM 605839	DISEASEORPHENOTYPICFEATURE	C535516
18366737	1806	1808	FH	GENEORGENEPRODUCT	2271
18366737	1876	1882	tumore	DISEASEORPHENOTYPICFEATURE	D009369
18366737	2153	2165	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
18366737	2239	2241	FH	GENEORGENEPRODUCT	2271
18366737	2301	2304	TCA	CHEMICALENTITY	D014233
18366737	2662	2664	FH	GENEORGENEPRODUCT	2271
18366737	2928	2930	FH	GENEORGENEPRODUCT	2271
18366737	3050	3064	 Deficit di FH	DISEASEORPHENOTYPICFEATURE	C538191
18366737	3092	3100	pazienti	ORGANISMTAXON	9606
18366737	3130	3138	pazienti	ORGANISMTAXON	9606
18366737	3186	3190	MCUL	DISEASEORPHENOTYPICFEATURE	C535516
18366737	3234	3239	HLRRC	DISEASEORPHENOTYPICFEATURE	C535516
18366737	3581	3583	FH	GENEORGENEPRODUCT	2271
18366737	3667	3669	FH	GENEORGENEPRODUCT	2271
18366737	3782	3784	FH	GENEORGENEPRODUCT	2271
18366737	3917	3925	pazienti	ORGANISMTAXON	9606
18366737	4098	4100	FH	GENEORGENEPRODUCT	2271
18397285	35	41	L1503R	SEQUENCEVARIANT	RS61750097
18397285	177	180	VWF	GENEORGENEPRODUCT	7450
18397285	237	245	pazienti	ORGANISMTAXON	9606
18397285	294	331	malattia di von Willebrand di tipo 2A	DISEASEORPHENOTYPICFEATURE	D056728
18397285	376	416	La malattia di von Willebrand di tipo 2A	DISEASEORPHENOTYPICFEATURE	D056728
18397285	461	464	VWD	DISEASEORPHENOTYPICFEATURE	D014842
18397285	572	594	fattore von Willebrand	GENEORGENEPRODUCT	7450
18397285	627	630	VWF	GENEORGENEPRODUCT	7450
18397285	777	780	VWF	GENEORGENEPRODUCT	7450
18397285	831	842	tipo 2A VWD	DISEASEORPHENOTYPICFEATURE	D056728
18397285	885	893	pazienti	ORGANISMTAXON	9606
18397285	990	1027	T-->G trasversione al nucleotide 4508	SEQUENCEVARIANT	RS61750097
18397285	1096	1102	L1503R	SEQUENCEVARIANT	RS61750097
18397285	1146	1149	VWF	GENEORGENEPRODUCT	7450
18397285	1302	1305	VWF	GENEORGENEPRODUCT	7450
18397285	1447	1450	VWF	GENEORGENEPRODUCT	7450
18397285	1799	1802	VWF	GENEORGENEPRODUCT	7450
18397285	1875	1878	VWF	GENEORGENEPRODUCT	7450
18397285	2031	2037	L1503R	SEQUENCEVARIANT	RS61750097
18397285	2241	2247	L1503Q	SEQUENCEVARIANT	RS61750097
18397285	2356	2364	ADAMTS13	GENEORGENEPRODUCT	11093
18397285	2438	2444	L1503R	SEQUENCEVARIANT	RS61750097
18397285	2559	2562	VWF	GENEORGENEPRODUCT	7450
18397285	2637	2640	VWF	GENEORGENEPRODUCT	7450
18408250	97	101	IRF5	GENEORGENEPRODUCT	3663
18408250	180	198	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
18408250	271	304	Interferone Regulator Regulator 5	GENEORGENEPRODUCT	3663
18408250	337	341	IRF5	GENEORGENEPRODUCT	3663
18408250	390	393	IRF	GENEORGENEPRODUCT	3663
18408250	492	518	citochine proinfiammatorie	GENEORGENEPRODUCT	3553
18408250	575	579	IRF5	GENEORGENEPRODUCT	3663
18408250	666	693	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
18408250	738	741	LES	DISEASEORPHENOTYPICFEATURE	D008180
18408250	863	882	malattie autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
18408250	975	979	IRF5	GENEORGENEPRODUCT	3663
18408250	1046	1064	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
18408250	1109	1111	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	1300	1304	IRF5	GENEORGENEPRODUCT	3663
18408250	1441	1449	pazienti	ORGANISMTAXON	9606
18408250	1497	1499	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	1564	1572	pazienti	ORGANISMTAXON	9606
18408250	1620	1622	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	1723	1728	umano	ORGANISMTAXON	9606
18408250	1760	1793	antigene leucocitario (HLA)- DRB1	GENEORGENEPRODUCT	3123
18408250	1962	1970	rs729302	SEQUENCEVARIANT	RS729302
18408250	2028	2030	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	2180	2188	pazienti	ORGANISMTAXON	9606
18408250	2257	2265	rs729302	SEQUENCEVARIANT	RS729302
18408250	2368	2370	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	2401	2409	pazienti	ORGANISMTAXON	9606
18408250	2515	2523	pazienti	ORGANISMTAXON	9606
18408250	2735	2737	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	2775	2783	rs729302	SEQUENCEVARIANT	RS729302
18408250	2925	2929	IRF5	GENEORGENEPRODUCT	3663
18408250	3028	3030	RA	DISEASEORPHENOTYPICFEATURE	D001172
18408250	3125	3133	pazienti	ORGANISMTAXON	9606
18410508	31	44	Metamfetamina	CHEMICALENTITY	D008694
18410508	96	110	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18410508	214	242	recettore della frattalchina	GENEORGENEPRODUCT	13051
18410508	275	288	Metamfetamina	CHEMICALENTITY	D008694
18410508	321	325	METH	CHEMICALENTITY	D008694
18410508	365	373	dopamina	CHEMICALENTITY	D004298
18410508	406	408	DA	CHEMICALENTITY	D004298
18410508	694	722	recettore della fractalchina	GENEORGENEPRODUCT	13051
18410508	756	762	CX3CR1	GENEORGENEPRODUCT	13051
18410508	824	828	MPTP	CHEMICALENTITY	D015632
18410508	880	898	neurodegenerazione	DISEASEORPHENOTYPICFEATURE	D009422
18410508	933	935	DA	CHEMICALENTITY	D004298
18410508	998	1010	danno al SNC	DISEASEORPHENOTYPICFEATURE	D009422
18410508	1053	1057	METH	CHEMICALENTITY	D008694
18410508	1093	1097	MPTP	CHEMICALENTITY	D015632
18410508	1177	1179	DA	CHEMICALENTITY	D004298
18410508	1211	1217	 mouse	ORGANISMTAXON	10090
18410508	1272	1286	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18410508	1346	1352	CX3CR1	GENEORGENEPRODUCT	13051
18410508	1406	1410	METH	CHEMICALENTITY	D008694
18410508	1465	1479	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18410508	1533	1537	Topi	ORGANISMTAXON	10090
18410508	1585	1591	CX3CR1	GENEORGENEPRODUCT	13051
18410508	1675	1713	proteina fluorescente verde potenziata	CHEMICALENTITY	C485184
18410508	1746	1750	eGFP	CHEMICALENTITY	C485184
18410508	1808	1812	METH	CHEMICALENTITY	D008694
18410508	1873	1887	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18410508	1930	1934	METH	CHEMICALENTITY	D008694
18410508	1975	1977	DA	CHEMICALENTITY	D004298
18410508	2101	2107	CX3CR1	GENEORGENEPRODUCT	13051
18410508	2145	2149	topi	ORGANISMTAXON	10090
18410508	2275	2279	METH	CHEMICALENTITY	D008694
18410508	2315	2321	CX3CR1	GENEORGENEPRODUCT	13051
18410508	2360	2364	topi	ORGANISMTAXON	10090
18410508	2501	2505	eGFP	CHEMICALENTITY	C485184
18410508	2590	2594	METH	CHEMICALENTITY	D008694
18410508	2740	2744	eGFP	CHEMICALENTITY	C485184
18410508	2873	2877	METH	CHEMICALENTITY	 D008694
18410508	2959	2965	CX3CR1	GENEORGENEPRODUCT	13051
18410508	3008	3012	METH	CHEMICALENTITY	D008694
18410508	3057	3071	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18410508	3194	3198	METH	CHEMICALENTITY	D008694
18410548	31	98	Proteina che interagisce con il recettore degli idrocarburi arilici	GENEORGENEPRODUCT	9049
18410548	131	134	AIP	GENEORGENEPRODUCT	9049
18410548	236	253	adenomi ipofisari	DISEASEORPHENOTYPICFEATURE	D010911
18410548	319	340	Gli adenomi ipofisari	DISEASEORPHENOTYPICFEATURE	D010911
18410548	442	484	La predisposizione dell'adenoma ipofisario	DISEASEORPHENOTYPICFEATURE	D010911
18410548	581	648	proteina che interagisce con il recettore degli idrocarburi arilici	GENEORGENEPRODUCT	9049
18410548	681	684	AIP	GENEORGENEPRODUCT	9049
18410548	812	815	AIP	GENEORGENEPRODUCT	9049
18410548	887	904	adenomi ipofisari	DISEASEORPHENOTYPICFEATURE	D010911
18410548	1007	1010	AIP	GENEORGENEPRODUCT	9049
18410548	1093	1101	PAZIENTI	ORGANISMTAXON	9606
18410548	1222	1240	adenoma ipofisario	DISEASEORPHENOTYPICFEATURE	D010911
18410548	1268	1276	pazienti	ORGANISMTAXON	9606
18410548	1378	1388	I pazienti	ORGANISMTAXON	9606
18410548	1504	1511	adenoma	DISEASEORPHENOTYPICFEATURE	D000236
18410548	1621	1628	Y248del	SEQUENCEVARIANT	RS267606574
18410548	1666	1681	c.742_744delTAC	SEQUENCEVARIANT	RS267606574
18410548	1753	1774	adenoma secernente GH	DISEASEORPHENOTYPICFEATURE	D049912
18410548	1802	1810	paziente	ORGANISMTAXON	9606
18410548	1911	1917	tumore	DISEASEORPHENOTYPICFEATURE	D009369
18410548	2145	2166	adenoma secernente GH	DISEASEORPHENOTYPICFEATURE	D049912
18410548	2194	2202	pazienti	ORGANISMTAXON	9606
18410548	2268	2271	AIP	GENEORGENEPRODUCT	9049
18410548	2367	2387	tumori secernenti GH	DISEASEORPHENOTYPICFEATURE	D049912
18410548	2526	2529	AIP	GENEORGENEPRODUCT	9049
18410548	2560	2568	pazienti	ORGANISMTAXON	9606
18410548	2723	2726	AIP	GENEORGENEPRODUCT	9049
18410548	2784	2801	adenomi ipofisari	DISEASEORPHENOTYPICFEATURE	D010911
18422462	112	126	Infetto da HIV	DISEASEORPHENOTYPICFEATURE	D015658
18422462	155	163	pazienti	ORGANISMTAXON	9606
18422462	388	402	infetti da HIV	DISEASEORPHENOTYPICFEATURE	D015658
18422462	520	523	HIV	DISEASEORPHENOTYPICFEATURE	D015658
18422462	761	764	3TC	CHEMICALENTITY	D019259
18422462	798	801	d4T	CHEMICALENTITY	D018119
18422462	836	846	nevirapina	CHEMICALENTITY	D019829
18422462	879	882	NVP	CHEMICALENTITY	D019829
18422462	924	935	 zidovudine	CHEMICALENTITY	D015215
18422462	968	971	AZT	CHEMICALENTITY	D015215
18422462	1006	1009	3TC	CHEMICALENTITY	D019259
18422462	1043	1046	NVP	CHEMICALENTITY	D019829
18422462	1087	1090	3TC	CHEMICALENTITY	D019259
18422462	1125	1128	d4T	CHEMICALENTITY	D018119
18422462	1162	1171	efavirenz	CHEMICALENTITY	C098320
18422462	1204	1207	EFV	CHEMICALENTITY	C098320
18422462	1250	1253	AZT	CHEMICALENTITY	D015215
18422462	1287	1290	3TC	CHEMICALENTITY	D019259
18422462	1324	1327	EFV	CHEMICALENTITY	C098320
18422462	1409	1412	CD4	GENEORGENEPRODUCT	920
18422462	1485	1489	rash	DISEASEORPHENOTYPICFEATURE	D005076
18422462	1528	1531	CD4	GENEORGENEPRODUCT	920
18422462	1598	1619	neuropatia periferica	DISEASEORPHENOTYPICFEATURE	D010523
18422462	1692	1698	anemia	DISEASEORPHENOTYPICFEATURE	D000740
18422462	1731	1741	emoglobina	GENEORGENEPRODUCT	3039
18422462	1821	1829	pazienti	ORGANISMTAXON	9606
18422462	1861	1864	CD4	GENEORGENEPRODUCT	920
18422462	1931	1938	epatite	DISEASEORPHENOTYPICFEATURE	D056486
18422462	1992	1998	ittero	DISEASEORPHENOTYPICFEATURE	D007565
18422462	2034	2059	 alanina aminotransferasi	CHEMICALENTITY	D000410
18422462	2142	2150	pazienti	ORGANISMTAXON	9606
18422462	2183	2186	CD4	GENEORGENEPRODUCT	 920
18422462	2236	2244	Le donne	ORGANISMTAXON	9606
18422462	2356	2371	acidosi lattica	DISEASEORPHENOTYPICFEATURE	D000140
18422462	2408	2418	gli uomini	ORGANISMTAXON	9606
18422462	2530	2568	sindrome da ricostituzione immunitaria	DISEASEORPHENOTYPICFEATURE	D054019
18422462	2613	2621	pazienti	ORGANISMTAXON	9606
18422462	2689	2692	NVP	CHEMICALENTITY	D019829
18422462	2790	2794	rash	DISEASEORPHENOTYPICFEATURE	D005076
18422462	2828	2831	d4T	CHEMICALENTITY	D018119
18422462	2902	2923	neuropatia periferica	DISEASEORPHENOTYPICFEATURE	D010523
18422462	2978	2984	Anemia	DISEASEORPHENOTYPICFEATURE	D000740
18422462	3030	3037	epatite	DISEASEORPHENOTYPICFEATURE	D056486
18422462	3201	3210	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
18439317	80	84	MMP1	GENEORGENEPRODUCT	4312
18439317	131	157	malattia del disco lombare	DISEASEORPHENOTYPICFEATURE	C535531
18439317	220	245	Matrix metalloproteinases	GENEORGENEPRODUCT	4312
18439317	278	283	MMPs 	GENEORGENEPRODUCT	4312
18439317	568	572	MMP1	GENEORGENEPRODUCT	4312
18439317	771	774	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18439317	921	924	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18439317	1439	1443	MMP1	GENEORGENEPRODUCT	4312
18439317	1489	1492	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18439317	1621	1624	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18439317	1832	1835	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18439317	2474	2478	MMP1	GENEORGENEPRODUCT	4312
18439317	2573	2576	DDD	DISEASEORPHENOTYPICFEATURE	D055959
18442015	53	62	verapamil	CHEMICALENTITY	D014700
18442015	117	144	gastrico ulcere emorragiche	DISEASEORPHENOTYPICFEATURE	D006471,D013276
18442015	197	213	aterosclerotiche	DISEASEORPHENOTYPICFEATURE	D050197
18442015	242	247	ratti	ORGANISMTAXON	10116
18442015	327	345	emorragia gastrica	DISEASEORPHENOTYPICFEATURE	D006471
18442015	422	437	aterosclerotico	DISEASEORPHENOTYPICFEATURE	D050197
18442015	467	473	i topi	ORGANISMTAXON	10116
18442015	633	641	istamina	CHEMICALENTITY	D006632
18442015	674	693	 perossido lipidico	CHEMICALENTITY	D008054
18442015	726	729	LPO	CHEMICALENTITY	D008054
18442015	855	883	 emorragia e ulcera gastrica	DISEASEORPHENOTYPICFEATURE	D006471,D013276
18442015	915	920	ratti	ORGANISMTAXON	10116
18442015	968	981	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
18442015	1060	1071	vitamina D2	CHEMICALENTITY	D004872
18442015	1105	1116	colesterolo	CHEMICALENTITY	D002784
18442015	1199	1208	verapamil	CHEMICALENTITY	D014700
18442015	1270	1276	ulcera	DISEASEORPHENOTYPICFEATURE	D013276
18442015	1322	1327	ratti	ORGANISMTAXON	10116
18442015	1452	1464	olio di mais	CHEMICALENTITY	D003314
18442015	1507	1518	vitamina D2	CHEMICALENTITY	D004872
18442015	1552	1563	colesterolo	CHEMICALENTITY	D002784
18442015	1619	1632	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
18442015	1672	1677	ratti	ORGANISMTAXON	10116
18442015	1723	1735	olio di mais	CHEMICALENTITY	D003314
18442015	1809	1812	rat	ORGANISMTAXON	10116
18442015	1971	1974	LPO	CHEMICALENTITY	D008054
18442015	2019	2027	istamina	CHEMICALENTITY	D006632
18442015	2104	2112	luminale	CHEMICALENTITY	D010634
18442015	2145	2155	emoglobina	GENEORGENEPRODUCT	25632
18442015	2212	2231	le aree dell'ulcera	DISEASEORPHENOTYPICFEATURE	 D013276
18442015	2299	2324	parametri aterosclerotici	DISEASEORPHENOTYPICFEATURE	D050197
18442015	2376	2382	calcio	CHEMICALENTITY	D002118
18442015	2423	2434	colesterolo	CHEMICALENTITY	D002784
18442015	2468	2496	lipoproteine a bassa densità	CHEMICALENTITY	D008077
18442015	2564	2579	aterosclerotico	DISEASEORPHENOTYPICFEATURE	 D050197
18442015	2608	2613	ratti	ORGANISMTAXON	10116
18442015	2664	2680	ulcere gastriche	DISEASEORPHENOTYPICFEATURE	D013276
18442015	2810	2818	istamina	CHEMICALENTITY	D006632
18442015	2860	2863	LPO	CHEMICALENTITY	D008054
18442015	2909	2917	luminale	CHEMICALENTITY	D010634
18442015	2951	2961	emoglobina	GENEORGENEPRODUCT	25632
18442015	3034	3039	ratti	ORGANISMTAXON	10116
18442015	3111	3119	istamina	CHEMICALENTITY	D006632
18442015	3165	3183	emorragia gastrica	DISEASEORPHENOTYPICFEATURE	D006471
18442015	3230	3236	ulcera	DISEASEORPHENOTYPICFEATURE	D013276
18442015	3306	3321	aterosclerotico	DISEASEORPHENOTYPICFEATURE	D050197
18442015	3350	3356	 ratti	ORGANISMTAXON	10116
18442015	3416	3433	ulcera emorragica	DISEASEORPHENOTYPICFEATURE	D006471,D013276
18442015	3545	3554	verapamil	CHEMICALENTITY	D014700
18442015	3625	3640	L'aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
18442015	3710	3736	ulcera emorragica gastrica	DISEASEORPHENOTYPICFEATURE	D006471,D013276
18442015	3829	3832	LPO	CHEMICALENTITY	D008054
18442015	3877	3885	istamina	CHEMICALENTITY	D006632
18442015	3992	4001	verapamil	CHEMICALENTITY	D014700
18442015	4033	4037	rats	ORGANISMTAXON	10116
18470323	70	106	distrofia corneale reticolare tipo I	DISEASEORPHENOTYPICFEATURE	C537881
18470323	148	153	R124C	SEQUENCEVARIANT	RS121909210
18470323	199	204	TGFBI	GENEORGENEPRODUCT	7045
18470323	237	242	BIGH3	GENEORGENEPRODUCT	7045
18470323	366	405	distrofia corneale reticolare di tipo I	DISEASEORPHENOTYPICFEATURE	C537881
18470323	450	454	LCDI	DISEASEORPHENOTYPICFEATURE	C537881
18470323	829	868	distrofia corneale reticolare di tipo I	DISEASEORPHENOTYPICFEATURE	C537881
18470323	915	964	gene indotto dal fattore di crescita trasformante	GENEORGENEPRODUCT	7045
18470323	997	1002	TGFBI	GENEORGENEPRODUCT	7045
18470323	1099	1104	R124C	SEQUENCEVARIANT	RS121909210
18470323	1387	1391	PstI	GENEORGENEPRODUCT	6690
18470323	1664	1693	distrofia corneale reticolare	DISEASEORPHENOTYPICFEATURE	C537881
18470323	1772	1776	LCD1	DISEASEORPHENOTYPICFEATURE	C537881
18470323	2134	2142	pazienti	ORGANISMTAXON	9606
18470323	2345	2350	TGFBI	GENEORGENEPRODUCT	7045
18470323	2454	2459	C417T	SEQUENCEVARIANT	RS121909210
18470323	2542	2547	R124C	SEQUENCEVARIANT	RS121909210
18470323	2597	2621	proteina indotta dal TGF	GENEORGENEPRODUCT	7045
18470323	2831	2836	R124C	SEQUENCEVARIANT	RS121909210
18470323	2871	2876	TGFBI	GENEORGENEPRODUCT	7045
18470323	2937	2947	LCD tipo I	DISEASEORPHENOTYPICFEATURE	C537881
18470323	3071	3084	LCD di tipo I	DISEASEORPHENOTYPICFEATURE	C537881
18470323	3115	3123	pazienti	ORGANISMTAXON	9606
18483878	68	80	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
18483878	126	160	vasoactive intestinale polipeptide	GENEORGENEPRODUCT	22353
18483878	203	206	VIP	GENEORGENEPRODUCT	22353
18483878	239	243	topi	ORGANISMTAXON	10090
18483878	279	293	ciclofosfamide	CHEMICALENTITY	D003520
18483878	326	329	CYP	CHEMICALENTITY	D003520
18483878	382	389	cistite	DISEASEORPHENOTYPICFEATURE	D003556
18483878	423	457	Polipeptide intestinale vasoattivo	GENEORGENEPRODUCT	22353
18483878	491	494	VIP	GENEORGENEPRODUCT	22353
18483878	598	601	VIP	GENEORGENEPRODUCT	22353
18483878	636	640	topi	ORGANISMTAXON	10090
18483878	762	776	ciclofosfamide	CHEMICALENTITY	D003520
18483878	810	813	CYP	CHEMICALENTITY	D003520
18483878	867	874	cistite	DISEASEORPHENOTYPICFEATURE	 D003556
18483878	925	928	VIP	GENEORGENEPRODUCT	22353
18483878	993	1005	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
18483878	1062	1065	VIP	GENEORGENEPRODUCT	22353
18483878	1099	1103	topi	ORGANISMTAXON	10090
18483878	1171	1184	infiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
18483878	1259	1266	cistite	DISEASEORPHENOTYPICFEATURE	D003556
18483878	1299	1304	mouse	ORGANISMTAXON	10090
18483878	1348	1360	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
18483878	1530	1533	VIP	GENEORGENEPRODUCT	22353
18483878	1567	1571	topi	ORGANISMTAXON	10090
18483878	1615	1618	CYP	CHEMICALENTITY	D003520
18483878	1670	1677	cistite	DISEASEORPHENOTYPICFEATURE	D003556
18483878	1816	1819	CYP	CHEMICALENTITY	D003520
18483878	1860	1863	VIP	GENEORGENEPRODUCT	22353
18483878	1917	1920	CYP	CHEMICALENTITY	D003520
18483878	1993	1996	VIP	GENEORGENEPRODUCT	22353
18483878	2052	2055	CYP	CHEMICALENTITY	D003520
18483878	2119	2122	VIP	GENEORGENEPRODUCT	 22353
18483878	2176	2179	CYP	CHEMICALENTITY	D003520
18483878	2472	2480	IL-1beta	GENEORGENEPRODUCT	16176
18483878	2515	2520	CXCL1	GENEORGENEPRODUCT	14825
18483878	2553	2556	CYP	CHEMICALENTITY	D003520
18483878	2664	2669	CXCL1	GENEORGENEPRODUCT	14825
18483878	2704	2712	IL-1beta	GENEORGENEPRODUCT	16176
18483878	2776	2779	VIP	GENEORGENEPRODUCT	22353
18483878	2814	2818	topi	ORGANISMTAXON	10090
18483878	2870	2873	VIP	GENEORGENEPRODUCT	22353
18483878	2907	2911	topi	ORGANISMTAXON	10090
18483878	2947	2950	CYP	CHEMICALENTITY	D003520
18483878	3187	3190	VIP	GENEORGENEPRODUCT	22353
18483878	3224	3228	topi	ORGANISMTAXON	10090
18483878	3277	3300	infiammazione vescicale	DISEASEORPHENOTYPICFEATURE	D003556
18483878	3345	3357	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
18483878	3460	3463	CYP	CHEMICALENTITY	D003520
18483878	3570	3591	disfunzione vescicale	DISEASEORPHENOTYPICFEATURE	D001745
18483878	3627	3630	VIP	GENEORGENEPRODUCT	22353
18483878	3665	3669	topi	ORGANISMTAXON	10090
18483878	3717	3740	infiammazione vescicale	DISEASEORPHENOTYPICFEATURE	D003556
18487244	90	98	pazienti	ORGANISMTAXON	9606
18487244	135	140	POLG1	GENEORGENEPRODUCT	 5428
18487244	338	380	mitocondriale DNA (mtDNA) gamma polimerasi	GENEORGENEPRODUCT	5428
18487244	413	418	POLG1	GENEORGENEPRODUCT	5428
18487244	477	496	 Sindrome di Alpers	DISEASEORPHENOTYPICFEATURE	D002549
18487244	558	563	POLG1	GENEORGENEPRODUCT	5428
18487244	651	669	epatoencefalopatia	DISEASEORPHENOTYPICFEATURE	C563797
18487244	838	846	Pazienti	ORGANISMTAXON	9606
18487244	1035	1043	pazienti	ORGANISMTAXON	9606
18487244	1186	1194	pazienti	ORGANISMTAXON	9606
18487244	1292	1297	POLG1	GENEORGENEPRODUCT	5428
18487244	1424	1432	pazienti	ORGANISMTAXON	9606
18487244	1562	1571	Epilessia	DISEASEORPHENOTYPICFEATURE	D004827
18487244	1619	1641	disturbo del movimento	DISEASEORPHENOTYPICFEATURE	D009069
18487244	1984	1992	paziente	ORGANISMTAXON	9606
18487244	2098	2103	POLG1	GENEORGENEPRODUCT	5428
18487244	2221	2226	POLG1	GENEORGENEPRODUCT	5428
18541230	53	65	antitrombina	CHEMICALENTITY	D000991
18541230	100	126	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	170	177	nefrosi	DISEASEORPHENOTYPICFEATURE	D009401
18541230	209	214	ratti	ORGANISMTAXON	10116
18541230	279	291	antitrombina	CHEMICALENTITY	D000991
18541230	380	385	ratti	ORGANISMTAXON	10116
18541230	421	447	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	502	509	nefrosi	DISEASEORPHENOTYPICFEATURE	D009401
18541230	571	576	umano	ORGANISMTAXON	9606
18541230	620	638	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18541230	671	683	Antitrombina	CHEMICALENTITY	D000991
18541230	758	763	ratti	ORGANISMTAXON	10116
18541230	864	890	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	958	970	antitrombina	CHEMICALENTITY	D000991
18541230	1017	1043	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	1087	1108	anomalie ematologiche	DISEASEORPHENOTYPICFEATURE	D006402
18541230	1141	1167	Puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	1222	1240	disfunzione renale	DISEASEORPHENOTYPICFEATURE	D007674
18541230	1287	1308	Anche l'iperlipidemia	DISEASEORPHENOTYPICFEATURE	D006949
18541230	1406	1418	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
18541230	1526	1531	ratti	ORGANISMTAXON	10116
18541230	1620	1632	antitrombina	CHEMICALENTITY	D000991
18541230	1670	1675	ratti	ORGANISMTAXON	10116
18541230	1736	1748	antitrombina	CHEMICALENTITY	D000991
18541230	1806	1832	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	1974	2000	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	2102	2110	trombina	GENEORGENEPRODUCT	29251
18541230	2189	2215	puromicina aminonucleoside	CHEMICALENTITY	D011692
18541230	2267	2285	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18541230	2337	2349	antitrombina	CHEMICALENTITY	D000991
18541230	2413	2421	pazienti	ORGANISMTAXON	9606
18541230	2469	2487	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18544179	44	52	fentanil	CHEMICALENTITY	D005283
18544179	103	109	nausea	DISEASEORPHENOTYPICFEATURE	D009325
18544179	155	161	vomito	DISEASEORPHENOTYPICFEATURE	D014839
18544179	222	228	dolore	DISEASEORPHENOTYPICFEATURE	D010146
18544179	270	281	sevoflurano	CHEMICALENTITY	C009250
18544179	429	440	sevoflurano	CHEMICALENTITY	C009250
18544179	485	514	nausea e vomito postoperatori	DISEASEORPHENOTYPICFEATURE	D020250
18544179	574	582	Fentanyl	CHEMICALENTITY	D005283
18544179	822	859	nausea, vomito e dolore postoperatori	DISEASEORPHENOTYPICFEATURE	D010149,D020250
18544179	916	927	sevoflurano	CHEMICALENTITY	C009250
18544179	991	999	pazienti	ORGANISMTAXON	9606
18544179	1028	1038	I pazienti	ORGANISMTAXON	9606
18544179	1137	1145	fentanyl	CHEMICALENTITY	D005283
18544179	1213	1225	desametasone	CHEMICALENTITY	D003907
18544179	1265	1273	fentanil	CHEMICALENTITY	D005283
18544179	1332	1340	fentanyl	CHEMICALENTITY	D005283
18544179	1426	1455	nausea e vomito postoperatori	DISEASEORPHENOTYPICFEATURE	D020250
18544179	1529	1535	vomito	DISEASEORPHENOTYPICFEATURE	D014839
18544179	1603	1609	nausea	DISEASEORPHENOTYPICFEATURE	D009325
18544179	1682	1690	fentanyl	CHEMICALENTITY	D005283
18544179	1724	1732	fentanyl	CHEMICALENTITY	D005283
18544179	1764	1776	desametasone	CHEMICALENTITY	D003907
18544179	1926	1938	Desametasone	CHEMICALENTITY	D003907
18544179	2051	2080	nausea e vomito postoperatori	DISEASEORPHENOTYPICFEATURE	D020250
18544179	2144	2152	fentanil	CHEMICALENTITY	D005283
18544179	2278	2307	nausea e vomito postoperatori	DISEASEORPHENOTYPICFEATURE	D020250
18544179	2353	2359	nausea	DISEASEORPHENOTYPICFEATURE	D009325
18544179	2503	2509	nausea	DISEASEORPHENOTYPICFEATURE	D009325
18544179	2616	2625	Il dolore	DISEASEORPHENOTYPICFEATURE	D010146
18544179	2738	2746	fentanil	CHEMICALENTITY	D005283
18544179	2779	2787	Fentanyl	CHEMICALENTITY	D005283
18544179	2880	2891	sevoflurano	CHEMICALENTITY	C009250
18544179	2969	2993	depressione respiratoria	DISEASEORPHENOTYPICFEATURE	D012131
18544179	3038	3049	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
18544179	3096	3107	bradicardia	DISEASEORPHENOTYPICFEATURE	 D001919
18544179	3160	3168	fentanil	CHEMICALENTITY	D005283
18544179	3223	3252	nausea e vomito postoperatori	DISEASEORPHENOTYPICFEATURE	D020250
18544179	3323	3344	dolore postoperatorio	DISEASEORPHENOTYPICFEATURE	D010149
18544179	3499	3510	sevoflurano	CHEMICALENTITY	C009250
18593936	31	43	La curcumina	CHEMICALENTITY	D003474
18593936	96	120	proteina di specificità 	GENEORGENEPRODUCT	6667,6670,6671
18593936	190	210	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
18593936	243	255	La curcumina	CHEMICALENTITY	D003474
18593936	483	492	curcumina	CHEMICALENTITY	D003474
18593936	618	638	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
18593936	755	777	proteina proapoptotica	GENEORGENEPRODUCT	332
18593936	808	821	sopravvissuta	GENEORGENEPRODUCT	332
18593936	861	882	proteine angiogeniche	GENEORGENEPRODUCT	2321,7422
18593936	914	955	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	7422
18593936	989	993	VEGF	GENEORGENEPRODUCT	7422
18593936	1028	1044	Recettore VEGF 1	GENEORGENEPRODUCT	2321
18593936	1077	1083	VEGFR1	GENEORGENEPRODUCT	2321
18593936	1138	1151	sopravvissuto	GENEORGENEPRODUCT	332
18593936	1184	1188	VEGF	GENEORGENEPRODUCT	7422
18593936	1223	1229	VEGFR1	GENEORGENEPRODUCT	2321
18593936	1284	1342	fattori di trascrizione della proteina (Sp) di specificità	GENEORGENEPRODUCT	6667,6670,6671
18593936	1436	1445	curcumina	CHEMICALENTITY	D003474
18593936	1490	1492	Sp	GENEORGENEPRODUCT	6667,6670,6671
18593936	1644	1653	curcumina	CHEMICALENTITY	D003474
18593936	1696	1706	proteasoma	GENEORGENEPRODUCT	5698
18593936	1769	1772	Sp1	GENEORGENEPRODUCT	6667
18593936	1805	1808	Sp3	GENEORGENEPRODUCT	6670
18593936	1842	1846	 Sp4	GENEORGENEPRODUCT	6671
18593936	2033	2036	Sp1	GENEORGENEPRODUCT	6667
18593936	2069	2072	Sp3	GENEORGENEPRODUCT	6670
18593936	2107	2110	Sp4	GENEORGENEPRODUCT	6671
18593936	2165	2174	curcumina	CHEMICALENTITY	D003474
18593936	2232	2255	fattore nucleare kappaB	GENEORGENEPRODUCT	4790
18593936	2288	2297	NF-kappaB	GENEORGENEPRODUCT	4790
18593936	2352	2357	bcl-2	GENEORGENEPRODUCT	596
18593936	2389	2402	sopravvissuto	GENEORGENEPRODUCT	332
18593936	2435	2446	 ciclina D1	GENEORGENEPRODUCT	595
18593936	2545	2547	Sp	GENEORGENEPRODUCT	6667,6670,6671
18593936	2580	2598	Anche la curcumina	CHEMICALENTITY	D003474
18593936	2654	2674	tumore della vescica	DISEASEORPHENOTYPICFEATURE	D001749
18593936	2730	2734	topi	ORGANISMTAXON	10090
18593936	2887	2890	Sp1	GENEORGENEPRODUCT	20683
18593936	2924	2927	Sp3	GENEORGENEPRODUCT	20687
18593936	2962	2965	Sp4	GENEORGENEPRODUCT	20688
18593936	3029	3035	tumori	DISEASEORPHENOTYPICFEATURE	D009369
18593936	3164	3173	curcumina	CHEMICALENTITY	D003474
18593936	3222	3228	cancro	DISEASEORPHENOTYPICFEATURE	D009369
18593936	3342	3368	fattori di trascrizione Sp	GENEORGENEPRODUCT	6667,6670,6671
18593936	3416	3436	cancro della vescica	DISEASEORPHENOTYPICFEATURE	D001749
18631865	94	105	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18631865	261	289	inibitori della calcineurina	CHEMICALENTITY	D065095
18631865	429	438	sirolimus	CHEMICALENTITY	D020123
18631865	529	564	nefropatia cronica da allotrapianto	DISEASEORPHENOTYPICFEATURE	D051436
18631865	616	627	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18631865	816	827	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18631865	874	883	sirolimus	CHEMICALENTITY	D020123
18631865	942	970	inibitori della calcineurina	CHEMICALENTITY	D065095
18631865	1099	1110	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18631865	1151	1160	sirolimus	CHEMICALENTITY	D020123
18631865	1225	1233	pazienti	ORGANISMTAXON	9606
18631865	1285	1294	sirolimus	CHEMICALENTITY	 D020123
18631865	1373	1390	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
18631865	1479	1483	mToR	GENEORGENEPRODUCT	2475
18631865	1521	1529	pazienti	ORGANISMTAXON	9606
18631865	1683	1687	mToR	GENEORGENEPRODUCT	2475
18631865	1750	1761	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18657397	76	87	penicillina	CHEMICALENTITY	D010406
18657397	139	162	 attività epilettiforme	DISEASEORPHENOTYPICFEATURE	D004827
18657397	195	200	ratti	ORGANISMTAXON	10116
18657397	258	269	Penicillina	CHEMICALENTITY	D010406
18657397	379	388	epilessia	DISEASEORPHENOTYPICFEATURE	D004827
18657397	503	514	penicillina	CHEMICALENTITY	D010406
18657397	566	588	attività epilettiforme	DISEASEORPHENOTYPICFEATURE	D004827
18657397	667	672	ratti	ORGANISMTAXON	10116
18657397	732	737	ratti	ORGANISMTAXON	10116
18657397	803	810	uretano	CHEMICALENTITY	D014520
18657397	994	1004	epilettico	DISEASEORPHENOTYPICFEATURE	D004827
18657397	1078	1100	penicillina-G potassio	CHEMICALENTITY	D010400
18657397	1264	1275	penicillina	CHEMICALENTITY	D010406
18657397	1329	1351	attività epilettiforme	DISEASEORPHENOTYPICFEATURE	D004827
18657397	1802	1824	attività epilettiforme	DISEASEORPHENOTYPICFEATURE	D004827
18657397	1990	2012	attività epilettiforme	DISEASEORPHENOTYPICFEATURE	D004827
18657397	2322	2345	epilessie sperimentali 	DISEASEORPHENOTYPICFEATURE	D004827
18672102	31	36	GATA4	GENEORGENEPRODUCT	2626
18672102	88	96	pazienti	ORGANISMTAXON	9606
18672102	144	165	cardiopatia congenita	DISEASEORPHENOTYPICFEATURE	D006331
18672102	257	262	GATA4	GENEORGENEPRODUCT	2626
18672102	324	345	cardiopatia congenita	DISEASEORPHENOTYPICFEATURE	D006331
18672102	390	393	CHD	DISEASEORPHENOTYPICFEATURE	D006331
18672102	464	469	GATA4	GENEORGENEPRODUCT	2626
18672102	516	519	CHD	DISEASEORPHENOTYPICFEATURE	D006331
18672102	576	581	GATA4	GENEORGENEPRODUCT	2626
18672102	636	639	CHD	DISEASEORPHENOTYPICFEATURE	D006331
18672102	843	848	GATA4	GENEORGENEPRODUCT	2626
18672102	899	902	CHD	DISEASEORPHENOTYPICFEATURE	D006331
18672102	930	938	pazienti	ORGANISMTAXON	9606
18672102	1161	1167	46delS	SEQUENCEVARIANT	|DEL|46|S
18672102	1381	1384	A6V	SEQUENCEVARIANT	RS199922907
18672102	1422	1427	P163S	SEQUENCEVARIANT	RS387906769
18672102	1466	1471	E359K	SEQUENCEVARIANT	 RS368489876
18672102	1509	1514	P407Q	SEQUENCEVARIANT	RS115099192
18672102	1554	1560	 S429T	SEQUENCEVARIANT	P|SUB|S|429|T
18672102	1599	1604	A442V	SEQUENCEVARIANT	RS146017816
18672102	1671	1679	pazienti	ORGANISMTAXON	9606
18672102	1733	1763	difetto del setto ventricolare	DISEASEORPHENOTYPICFEATURE	D006345
18672102	1816	1836	Tetralogia di Fallot	DISEASEORPHENOTYPICFEATURE	D013771
18672102	1890	1921	difetto del cuscino endocardico	DISEASEORPHENOTYPICFEATURE	D004694
18672102	1966	1974	pazienti	ORGANISMTAXON	9606
18672102	2034	2039	E359K	SEQUENCEVARIANT	RS368489876
18672102	2134	2164	difetto del setto ventricolare	DISEASEORPHENOTYPICFEATURE	D006345
18672102	2209	2212	VSD	DISEASEORPHENOTYPICFEATURE	D006345
18672102	2411	2414	VSD	DISEASEORPHENOTYPICFEATURE	D006345
18672102	2442	2450	pazienti	ORGANISMTAXON	9606
18672102	2597	2602	GATA4	GENEORGENEPRODUCT	2626
18672102	2656	2661	GATA4	GENEORGENEPRODUCT	2626
18672102	2728	2731	CHD	DISEASEORPHENOTYPICFEATURE	D006331
18672102	2763	2771	pazienti	ORGANISMTAXON	9606
18674790	36	42	grassi	CHEMICALENTITY	D004041
18674790	92	97	obesi	DISEASEORPHENOTYPICFEATURE	D009765
18674790	126	131	ratti	ORGANISMTAXON	10116
18674790	190	202	doxorubicina	CHEMICALENTITY	D004317
18674790	254	269	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	330	342	doxorubicina	CHEMICALENTITY	D004317
18674790	375	386	Adriamicina	CHEMICALENTITY	D004317
18674790	471	486	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	517	525	pazienti	ORGANISMTAXON	9606
18674790	683	695	doxorubicina	CHEMICALENTITY	D004317
18674790	740	755	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	884	896	trigliceridi	CHEMICALENTITY	D014280
18674790	950	962	acidi grassi	CHEMICALENTITY	D005227
18674790	1007	1010	ATP	CHEMICALENTITY	D000255
18674790	1070	1073	JAK	GENEORGENEPRODUCT	84598
18674790	1107	1112	STAT3	GENEORGENEPRODUCT	25125
18674790	1271	1277	grasso	CHEMICALENTITY	D004041
18674790	1340	1347	obesità	DISEASEORPHENOTYPICFEATURE	 D009765
18674790	1403	1408	ratti	ORGANISMTAXON	10116
18674790	1469	1481	doxorubicina	CHEMICALENTITY	D004317
18674790	1533	1548	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	1603	1615	doxorubicina	CHEMICALENTITY	D004317
18674790	1747	1762	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	1807	1827	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
18674790	1860	1866	lipidi	CHEMICALENTITY	D008055
18674790	1950	1955	obese	DISEASEORPHENOTYPICFEATURE	D009765
18674790	2000	2002	OB	DISEASEORPHENOTYPICFEATURE	D009765
18674790	2032	2037	ratti	ORGANISMTAXON	10116
18674790	2103	2129	tossicità renale o epatica	DISEASEORPHENOTYPICFEATURE	D007674,D056486
18674790	2162	2174	Doxorubicina	CHEMICALENTITY	D004317
18674790	2282	2294	doxorubicina	CHEMICALENTITY	D004317
18674790	2329	2343	doxorubicinolo	CHEMICALENTITY	C010013
18674790	2445	2447	OB	DISEASEORPHENOTYPICFEATURE	D009765
18674790	2539	2541	OB	DISEASEORPHENOTYPICFEATURE	D009765
18674790	2570	2575	ratti	ORGANISMTAXON	10116
18674790	2719	2753	proteine di disaccoppiamento 2 e 3	GENEORGENEPRODUCT	25708,54315
18674790	2810	2868	perossisoma cardiaco proliferatori attivato recettore-alfa	GENEORGENEPRODUCT	25747
18674790	2945	2957	adiponectina	GENEORGENEPRODUCT	246253
18674790	3028	3058	ossidazione degli acidi grassi	CHEMICALENTITY	D005227
18674790	3180	3182	OB	DISEASEORPHENOTYPICFEATURE	D009765
18674790	3247	3273	proteina chinasi AMP-alfa2	GENEORGENEPRODUCT	65248
18674790	3344	3347	ATP	CHEMICALENTITY	D000255
18674790	3414	3417	ATP	CHEMICALENTITY	D000255
18674790	3450	3462	Rapporto ADP	CHEMICALENTITY	D000244
18674790	3500	3512	doxorubicina	CHEMICALENTITY	D004317
18674790	3579	3593	eritropoietina	GENEORGENEPRODUCT	24335
18674790	3639	3644	SOCS3	GENEORGENEPRODUCT	89829
18674790	3725	3728	JAK	GENEORGENEPRODUCT	84598
18674790	3761	3766	STAT3	GENEORGENEPRODUCT	25125
18674790	3838	3843	obesi	DISEASEORPHENOTYPICFEATURE	D009765
18674790	3872	3877	ratti	ORGANISMTAXON	10116
18674790	3952	3964	doxorubicina	CHEMICALENTITY	D004317
18674790	4016	4031	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
18674790	4135	4153	Generazione di ATP	CHEMICALENTITY	D000255
18674790	4239	4242	JAK	GENEORGENEPRODUCT	84598
18674790	4275	4281	 STAT3	GENEORGENEPRODUCT	25125
18681856	79	108	ipertiroidismo non autoimmune	DISEASEORPHENOTYPICFEATURE	C563786
18681856	189	196	p.M453T	SEQUENCEVARIANT	RS121908864
18681856	238	266	recettore della tireotropina	GENEORGENEPRODUCT	7253
18681856	405	434	ipertiroidismo non autoimmune	DISEASEORPHENOTYPICFEATURE	C563786
18681856	479	482	NAH	DISEASEORPHENOTYPICFEATURE	C563786
18681856	564	592	recettore della tireotropina	GENEORGENEPRODUCT	7253
18681856	625	629	TSHR	GENEORGENEPRODUCT	7253
18681856	664	672	PAZIENTI	ORGANISMTAXON	9606
18681856	1026	1030	TSHR	GENEORGENEPRODUCT	7253
18681856	1200	1205	T a C	SEQUENCEVARIANT	RS121908864
18681856	1267	1271	TSHR	GENEORGENEPRODUCT	7253
18681856	1314	1325	c.1358T-->C	SEQUENCEVARIANT	RS121908864
18681856	1395	1443	metionina (ATG) con treonina (ACG) al codone 453	SEQUENCEVARIANT	RS121908864
18681856	1481	1488	p.M453T	SEQUENCEVARIANT	RS121908864
18681856	1672	1686	ipertiroidismo	DISEASEORPHENOTYPICFEATURE	D006980
18681856	1731	1748	ventricolomegalia	DISEASEORPHENOTYPICFEATURE	D006849
18681856	1947	1964	Ventricolomegalia	DISEASEORPHENOTYPICFEATURE	D006849
18681856	2135	2138	NAH	DISEASEORPHENOTYPICFEATURE	 C563786
18681856	2215	2219	TSHR	GENEORGENEPRODUCT	7253
18699851	90	108	linfoma mantellare	DISEASEORPHENOTYPICFEATURE	D020522
18699851	218	236	Linfoma mantellare	DISEASEORPHENOTYPICFEATURE	D020522
18699851	281	284	MCL	DISEASEORPHENOTYPICFEATURE	D020522
18699851	766	769	MCL	DISEASEORPHENOTYPICFEATURE	D020522
18699851	913	923	tumori MCL	DISEASEORPHENOTYPICFEATURE	D020522
18699851	1422	1425	MCL	DISEASEORPHENOTYPICFEATURE	D020522
18699851	1611	1640	adenosina monofosfato ciclico	CHEMICALENTITY	D000242
18699851	1674	1680	PRKACB	GENEORGENEPRODUCT	5567
18699851	1818	1821	ATM	GENEORGENEPRODUCT	472
18699851	1854	1859	ERCC5	GENEORGENEPRODUCT	2073
18699851	1893	1898	FBXO5	GENEORGENEPRODUCT	26271
18699851	2074	2082	ARHGAP29	GENEORGENEPRODUCT	9411
18699851	2266	2276	tumore MCL	DISEASEORPHENOTYPICFEATURE	D020522
18752389	34	56	Simvastatina-ezetimibe	CHEMICALENTITY	D000069499
18752389	108	129	insufficienza epatica	DISEASEORPHENOTYPICFEATURE	D017093
18752389	207	250	Gli aumenti delle aminotransferasi sieriche	CHEMICALENTITY	D001219
18752389	326	402	 Terapia dell'inibitore della 3-idrossi-3-metilglutaril coenzima A reduttasi	GENEORGENEPRODUCT	3156
18752389	435	442	statina	CHEMICALENTITY	D019821
18752389	499	513	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	600	609	ezetimibe	CHEMICALENTITY	D000069438
18752389	666	688	simvastatina-ezetimibe	CHEMICALENTITY	D000069499
18752389	732	737	donna	ORGANISMTAXON	9606
18752389	820	852	insufficienza epatica fulminante	DISEASEORPHENOTYPICFEATURE	D017114
18752389	958	970	simvastatina	CHEMICALENTITY	D0198 21
18752389	1014	1026	simvastatina	CHEMICALENTITY	D019821
18752389	1067	1076	ezetimibe	CHEMICALENTITY	D000069438
18752389	1130	1138	paziente	ORGANISMTAXON	9606
18752389	1170	1175	lipid	CHEMICALENTITY	D008055
18752389	1230	1242	simvastatina	CHEMICALENTITY	D019821
18752389	1340	1354	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	1486	1510	aminotransferasi sierica	CHEMICALENTITY	D001219
18752389	1546	1566	Simvastatinezetimibe	CHEMICALENTITY	D000069499
18752389	1600	1612	escitalopram	CHEMICALENTITY	D015283
18752389	1682	1693	depressione	DISEASEORPHENOTYPICFEATURE	D003866
18752389	1785	1799	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	1914	1930	aminotransferasi	CHEMICALENTITY	D000637
18752389	2048	2068	tossicità da farmaci	DISEASEORPHENOTYPICFEATURE	D064420
18752389	2194	2210	aminotransferasi	CHEMICALENTITY	D000637
18752389	2367	2376	Ezetimibe	CHEMICALENTITY	D000069438
18752389	2455	2496	uridina difosfato glucoronosiltransferasi	GENEORGENEPRODUCT	7361
18752389	2530	2533	UGT	GENEORGENEPRODUCT	7361
18752389	2641	2666	simvastatina idrossiacido	CHEMICALENTITY	C532833
18752389	2723	2735	simvastatina	CHEMICALENTITY	D019821
18752389	2804	2818	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	2909	2931	simvastatina-ezetimibe	CHEMICALENTITY	D000069499
18752389	2986	3007	insufficienza epatica	DISEASEORPHENOTYPICFEATURE	D017093
18752389	3116	3136	simvastatinezetimibe	CHEMICALENTITY	D000069499
18752389	3188	3202	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	3248	3260	simvastatina	CHEMICALENTITY	D019821
18752389	3311	3320	ezetimibe	CHEMICALENTITY	D000069438
18752389	3367	3370	UGT	GENEORGENEPRODUCT	 7361
18752389	3474	3488	epatotossicità	DISEASEORPHENOTYPICFEATURE	D056486
18752389	3527	3549	simvastatina-ezetimibe	CHEMICALENTITY	D000069499
18752389	3603	3611	pazienti	ORGANISMTAXON	9606
18752389	3689	3713	aminotransferasi sierica	CHEMICALENTITY	D001219
18754075	51	62	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18754075	108	134	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
18754075	197	209	bisfosfonato	CHEMICALENTITY	D004164
18754075	242	253	alendronato	CHEMICALENTITY	D019386
18754075	288	296	paziente	ORGANISMTAXON	9606
18754075	344	379	glomerulosclerosi segmentale focale	DISEASEORPHENOTYPICFEATURE	D005923
18754075	411	415	uomo	ORGANISMTAXON	9606
18754075	485	503	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18754075	557	593	glomerulosclerosi segmentaria focale	DISEASEORPHENOTYPICFEATURE	D005923
18754075	667	675	steroidi	CHEMICALENTITY	D013256
18754075	830	842	bisfosfonato	CHEMICALENTITY	D004164
18754075	875	893	alendronato sodico	CHEMICALENTITY	D019386
18754075	1029	1055	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
18754075	1111	1122	alendronato	CHEMICALENTITY	D019386
18754075	1160	1168	paziente	ORGANISMTAXON	9606
18754075	1319	1329	creatinina	CHEMICALENTITY	D003404
18754075	1496	1508	bisfosfonati	CHEMICALENTITY	D004164
18754075	1622	1633	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18754075	1679	1705	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
18768591	32	79	Siero e chinasi inducibile da glucocorticoidi 1	GENEORGENEPRODUCT	20393
18768591	115	127	doxorubicina	CHEMICALENTITY	D004317
18768591	179	197	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18768591	230	242	Doxorubicina	CHEMICALENTITY	D004317
18768591	297	307	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
18768591	360	365	sodio	CHEMICALENTITY epiteliale	D012964
18768591	434	455	ritenzione del volume	DISEASEORPHENOTYPICFEATURE	D016055
18768591	501	515	renale fibrosi	DISEASEORPHENOTYPICFEATURE	D007674
18768591	551	562	aldosterone	CHEMICALENTITY	D000450
18768591	605	650	chinasi inducibile da siero e glucocorticoidi	GENEORGENEPRODUCT	20393
18768591	684	688	SGK1	GENEORGENEPRODUCT	20393
18768591	800	814	fibrosi renale	DISEASEORPHENOTYPICFEATURE	D007674
18768591	857	875	mineralocorticoide	CHEMICALENTITY	D008901
18768591	909	913	sale	CHEMICALENTITY	D012492
18768591	1019	1023	SGK1	GENEORGENEPRODUCT	20393
18768591	1073	1094	ritenzione del volume	DISEASEORPHENOTYPICFEATURE	D016055
18768591	1140	1147	fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
18768591	1199	1217	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18768591	1262	1274	doxorubicina	CHEMICALENTITY	D004317
18768591	1371	1398	topi con targeting genetico	ORGANISMTAXON	10090
18768591	1440	1444	SGK1	GENEORGENEPRODUCT	20393
18768591	1478	1482	sgk1	GENEORGENEPRODUCT	20393
18768591	1573	1577	sgk1	GENEORGENEPRODUCT	20393
18768591	1616	1647	Il trattamento con doxorubicina	CHEMICALENTITY	D004317
18768591	1714	1725	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18768591	1782	1786	crea	CHEMICALENTITY	D003404
18768591	1832	1836	sgk1	GENEORGENEPRODUCT	20393
18768591	1886	1890	sgk1	GENEORGENEPRODUCT	20393
18768591	1924	1928	topi	ORGANISMTAXON	10090
18768591	1993	2011	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18768591	2059	2065	ascite	DISEASEORPHENOTYPICFEATURE	D001201
18768591	2110	2120	 lipidemia	DISEASEORPHENOTYPICFEATURE	D006949
18768591	2166	2180	ipoalbuminemia	DISEASEORPHENOTYPICFEATURE	D034141
18768591	2243	2254	aldosterone	CHEMICALENTITY	D000450
18768591	2319	2328	nefrotico	DISEASEORPHENOTYPICFEATURE	D009404
18768591	2358	2362	topi	ORGANISMTAXON	 10090
18768591	2480	2484	SGK1	GENEORGENEPRODUCT	20393
18768591	2521	2525	sgk1	GENEORGENEPRODUCT	20393
18768591	2559	2563	topi	ORGANISMTAXON	10090
18768591	2621	2626	sodio	CHEMICALENTITY	D012964
18768591	2711	2715	sgk1	GENEORGENEPRODUCT	20393
18768591	2749	2753	topi	ORGANISMTAXON	10090
18768591	2804	2808	crea	CHEMICALENTITY	D003404
18768591	2853	2857	sgk1	GENEORGENEPRODUCT	20393
18768591	2891	2895	topi	ORGANISMTAXON	10090
18768591	2947	2951	crea	CHEMICALENTITY	D003404
18768591	3052	3067	aumento di peso	DISEASEORPHENOTYPICFEATURE	D015430
18768591	3103	3107	sgk1	GENEORGENEPRODUCT	20393
18768591	3156	3160	sgk1	GENEORGENEPRODUCT	20393
18768591	3195	3199	topi	ORGANISMTAXON	10090
18768591	3303	3321	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18768591	3384	3388	urea	CHEMICALENTITY	D014508
18768591	3474	3478	sgk1	GENEORGENEPRODUCT	20393
18768591	3512	3516	topi	ORGANISMTAXON	10090
18768591	3561	3565	sgk1	GENEORGENEPRODUCT	20393
18768591	3599	3603	topi	ORGANISMTAXON	10090
18768591	3661	3668	 uremia	DISEASEORPHENOTYPICFEATURE	D014511
18768591	3741	3745	sgk1	GENEORGENEPRODUCT	20393
18768591	3779	3784	topi 	ORGANISMTAXON	10090
18768591	3841	3845	sgk1	GENEORGENEPRODUCT	20393
18768591	3879	3884	topi 	ORGANISMTAXON	10090
18768591	3933	3937	topi	ORGANISMTAXON	10090
18768591	3994	3998	SGK1	GENEORGENEPRODUCT	20393
18768591	4067	4088	ritenzione del volume	DISEASEORPHENOTYPICFEATURE	D016055
18768591	4162	4176	fibrosi renale	DISEASEORPHENOTYPICFEATURE	D007674
18768591	4241	4259	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
18772193	52	67	alfa-sinucleina	GENEORGENEPRODUCT	6622
18772193	111	120	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
18772193	173	180	lievito	ORGANISMTAXON	4932
18772193	262	283	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
18772193	334	349	alfa-sinucleina	GENEORGENEPRODUCT	6622
18772193	382	390	alfa-syn	GENEORGENEPRODUCT	6622
18772193	445	463	neurodegenerazione	DISEASEORPHENOTYPICFEATURE	D019636
18772193	572	580	alfa-syn	GENEORGENEPRODUCT	6622
18772193	710	717	lievito	ORGANISMTAXON	4932
18772193	745	769	Saccharomyces cerevisiae	ORGANISMTAXON	4932
18772193	813	822	alpha-syn	GENEORGENEPRODUCT	6622
18772193	876	897	perossido di idrogeno	CHEMICALENTITY	D006861
18772193	949	1023	Sono stati identificati il catabolismo proteico dipendente dall'ubiquitina	GENEORGENEPRODUCT	85 0620
18772193	1160	1164	ENT3	GENEORGENEPRODUCT	853589
18772193	1199	1203	IDP3	GENEORGENEPRODUCT	855723
18772193	1239	1243	JEM1	GENEORGENEPRODUCT	853372
18772193	1278	1282	ARG2	GENEORGENEPRODUCT	853374
18772193	1318	1323	HSP82	GENEORGENEPRODUCT	855836
18772193	1410	1419	alpha-syn	GENEORGENEPRODUCT	6622
18772193	1459	1483	ossigeno reattivo specie	CHEMICALENTITY	D017382
18772193	1680	1689	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
18772193	1724	1733	alpha-syn	GENEORGENEPRODUCT	6622
18772193	1850	1859	alpha-syn	GENEORGENEPRODUCT	6622
18772193	1948	1956	alfa-sin	GENEORGENEPRODUCT	6622
18772193	2051	2060	alpha-syn	GENEORGENEPRODUCT	6622
18772193	2143	2153	 tossicità	DISEASEORPHENOTYPICFEATURE	D064420
18772193	2217	2221	A30P	SEQUENCEVARIANT	P|SUB|A|30|P
18772193	2262	2266	A53T	SEQUENCEVARIANT	 P|SUB|A|53|T
18772193	2330	2339	alpha-syn	GENEORGENEPRODUCT	6622
18772193	2391	2400	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
18772193	2547	2552	Ent3p	GENEORGENEPRODUCT	853589
18772193	2617	2625	clatrina	CHEMICALENTITY	D002966
18772193	2732	2740	alfa-syn	GENEORGENEPRODUCT	6622
18772193	2895	2900	Ent3p	GENEORGENEPRODUCT	853589
18772193	2954	2963	alpha-syn	GENEORGENEPRODUCT	6622
18772193	3051	3059	clatrina	CHEMICALENTITY	D002966
18772193	3113	3119	epsinR	GENEORGENEPRODUCT	9685
18772193	3159	3164	umani	ORGANISMTAXON	9606
18779591	93	119	recettore della prolattina	GENEORGENEPRODUCT	5618
18779591	151	156	donne	ORGANISMTAXON	9606
18779591	204	233	tumori benigni della mammella	DISEASEORPHENOTYPICFEATURE	D001943
18779591	303	320	malattia genetica	DISEASEORPHENOTYPICFEATURE	D030342
18779591	364	374	prolattina	GENEORGENEPRODUCT	5617
18779591	408	411	Prl	GENEORGENEPRODUCT	5617
18779591	464	468	PrlR	GENEORGENEPRODUCT	5618
18779591	501	506	umani	ORGANISMTAXON	 9606
18779591	664	667	Prl	GENEORGENEPRODUCT	5617
18779591	699	703	PrlR	GENEORGENEPRODUCT	5618
18779591	794	811	malattie mammarie	DISEASEORPHENOTYPICFEATURE	D001941
18779591	889	910	Fibroadenomi multipli	DISEASEORPHENOTYPICFEATURE	D018226
18779591	955	958	MFA	DISEASEORPHENOTYPICFEATURE	D018226
18779591	1010	1039	tumori benigni della mammella	DISEASEORPHENOTYPICFEATURE	 D001943
18779591	1114	1119	donne	ORGANISMTAXON	9606
18779591	1180	1183	Prl	GENEORGENEPRODUCT	5617
18779591	1330	1333	MFA	DISEASEORPHENOTYPICFEATURE	D018226
18779591	1361	1369	pazienti	ORGANISMTAXON	9606
18779591	1455	1463	pazienti	ORGANISMTAXON	9606
18779591	1574	1578	PrlR	GENEORGENEPRODUCT	5618
18779591	1636	1650	Ile(146)-->Leu	SEQUENCEVARIANT	RS72478580
18779591	1836	1840	PrlR	GENEORGENEPRODUCT	19116
18779591	1876	1881	I146L	SEQUENCEVARIANT	RS72478580
18779591	2082	2085	Prl	GENEORGENEPRODUCT	5617
18779591	2135	2139	PrlR	GENEORGENEPRODUCT	5618
18779591	2222	2275	trasduttore di segnale e attivatore di trascrizione 5	GENEORGENEPRODUCT	6776
18779591	2308	2313	STAT5	GENEORGENEPRODUCT	6776
18779591	2399	2402	Prl	GENEORGENEPRODUCT	5617
18779591	2549	2553	PrlR	GENEORGENEPRODUCT	5618
18779591	2589	2594	I146L	SEQUENCEVARIANT	RS72478580
18779591	2651	2659	paziente	ORGANISMTAXON	9606
18779591	2746	2751	STAT5	GENEORGENEPRODUCT	6776
18779591	2848	2852	PrlR	GENEORGENEPRODUCT	5618
18779591	2895	2900	umano	ORGANISMTAXON	9606
18779591	3131	3134	MFA	DISEASEORPHENOTYPICFEATURE	D018226
18790087	67	72	HIV-1	ORGANISMTAXON	11676
18790087	118	122	CCR5	GENEORGENEPRODUCT	1234
18790087	157	164	Delta32	SEQUENCEVARIANT	C|DEL||32
18790087	460	486	recettore delle chemochine	GENEORGENEPRODUCT	1234
18790087	523	527	CCR5	GENEORGENEPRODUCT	1234
18790087	585	590	32-bp	SEQUENCEVARIANT	C|DEL||32
18790087	623	627	CCR5	GENEORGENEPRODUCT	1234
18790087	662	669	Delta32	SEQUENCEVARIANT	C|DEL||32
18790087	752	756	CCR5	GENEORGENEPRODUCT	1234
18790087	791	798	Delta32	SEQUENCEVARIANT	C|DEL||32
18790087	1030	1048	infezione da HIV-1	DISEASEORPHENOTYPICFEATURE	D015658
18790087	1127	1131	AIDS	DISEASEORPHENOTYPICFEATURE	D000163
18790087	1171	1174	HIV	ORGANISMTAXON	11676
18790087	1284	1288	CCR5	GENEORGENEPRODUCT	1234
18790087	2075	2101	virus del Nilo occidentale	ORGANISMTAXON	11082
18790087	2134	2138	CCR5	GENEORGENEPRODUCT	1234
18790087	2792	2801	infezioni	DISEASEORPHENOTYPICFEATURE	D007239
18791947	54	81	Sindrome di Bernard-Soulier	DISEASEORPHENOTYPICFEATURE	D001606
18791947	152	172	cancellazione (TGAG)	SEQUENCEVARIANT	C|DEL||TGAG
18791947	213	222	GPIbalpha	GENEORGENEPRODUCT	2811
18791947	279	288	GPIbalpha	GENEORGENEPRODUCT	2811
18791947	346	355	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
18791947	471	479	pazienti	ORGANISMTAXON	9606
18791947	527	554	Sindrome di Bernard-Soulier	DISEASEORPHENOTYPICFEATURE	D001606
18791947	600	603	BSS	DISEASEORPHENOTYPICFEATURE	D001606
18791947	694	703	GPIbalpha	GENEORGENEPRODUCT	2811
18791947	822	835	sanguinamento	DISEASEORPHENOTYPICFEATURE	D006470
18791947	958	961	BSS	DISEAS EORPHENOTYPICFEATURE	D001606
18791947	989	997	paziente	ORGANISMTAXON	9606
18791947	1075	1095	cancellazione (TGAG)	SEQUENCEVARIANT	C|DEL ||TGAG
18791947	1163	1172	gpIbalpha	GENEORGENEPRODUCT	2811
18791947	1375	1386	ristocetina	CHEMICALENTITY	D012310
18791947	1538	1553	trombocitopenia	DISEASEORPHENOTYPICFEATURE	D013921
18791947	1734	1743	GPIbalpha	GENEORGENEPRODUCT	2811
18791947	1851	1859	paziente	ORGANISMTAXON	9606
18791947	2013	2019	(TGAG)	SEQUENCEVARIANT	C|DEL||TGAG
18791947	2322	2331	GPIbalpha	GENEORGENEPRODUCT	2811
18791947	2368	2386	Cancellazione TGAG	SEQUENCEVARIANT	C|DEL||TGAG
18791947	2577	2602	tendenza al sanguinamento	DISEASEORPHENOTYPICFEATURE	D006470
18808529	31	47	L'isoproterenolo	CHEMICALENTITY	D007545
18808529	110	120	distrofina	GENEORGENEPRODUCT	24907
18808529	152	155	rat	ORGANISMTAXON	10116
18808529	223	239	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
18808529	290	304	isoproterenolo	CHEMICALENTITY	D007545
18808529	359	375	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
18808529	444	452	ossigeno	CHEMICALENTITY	D010100
18808529	539	550	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
18808529	597	622	l'iperattività miocardica	DISEASEORPHENOTYPICFEATURE	D009202
18808529	850	864	isoproterenolo	CHEMICALENTITY	D007545
18808529	964	974	distrofina	GENEORGENEPRODUCT	24907
18808529	1007	1020	glicoproteina	GENEORGENEPRODUCT	11820
18808529	1079	1085	actina	GENEORGENEPRODUCT	60
18808529	1121	1129	laminina	GENEORGENEPRODUCT	309368
18808529	1270	1284	isoproterenolo	CHEMICALENTITY	D007545
18808529	1480	1494	isoproterenolo	CHEMICALENTITY	D007545
18808529	1611	1621	distrofina	GENEORGENEPRODUCT	24907
18808529	1705	1711	actina	GENEORGENEPRODUCT	60
18808529	1838	1844	actina	GENEORGENEPRODUCT	60
18808529	1927	1937	distrofina	GENEORGENEPRODUCT	24907
18808529	2020	2037	gamma-sarcoglycan	GENEORGENEPRODUCT	305941
18808529	2072	2090	beta-distroglicano	GENEORGENEPRODUCT	114489
18808529	2125	2140	beta1-integrina	GENEORGENEPRODUCT	24511
18808529	2176	2191	laminina alfa-2	GENEORGENEPRODUCT	309368
18808529	2369	2383	isoproterenolo	CHEMICALENTITY	D007545
18808529	2414	2419	ratti	ORGANISMTAXON	10116
18808529	2479	2484	ratti	ORGANISMTAXON	10116
18808529	2517	2527	distrofina	GENEORGENEPRODUCT	24907
18808529	2744	2759	danno ischemico	DISEASEORPHENOTYPICFEATURE	D007511
18808529	2934	2948	isoproterenolo	CHEMICALENTITY	D007545
18809400	31	51	L'acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	104	123	danno mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
18809400	169	183	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18809400	257	267	neuropatia	DISEASEORPHENOTYPICFEATURE	D009422
18809400	320	338	acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	424	438	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18809400	487	506	danno mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
18809400	580	613	cascata neurodegenerativa tossica	DISEASEORPHENOTYPICFEATURE	D009410
18809400	682	700	acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	829	850	neuropatia periferica	DISEASEORPHENOTYPICFEATURE	D010523
18809400	1039	1049	paclitaxel	CHEMICALENTITY	D017239
18809400	1083	1093	cisplatino	CHEMICALENTITY	D002945
18809400	1255	1273	acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	1339	1353	danno assonale	DISEASEORPHENOTYPICFEATURE	D020833
18809400	1497	1515	acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	1586	1596	cisplatino	CHEMICALENTITY	D002945
18809400	1630	1640	paclitaxel	CHEMICALENTITY	D017239
18809400	1706	1725	danno mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
18809400	1843	1863	L'acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	1972	1986	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18809400	2064	2087	tossicità mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
18809400	2145	2155	fratassina	GENEORGENEPRODUCT	2395
18809400	2293	2316	tossicità mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
18809400	2382	2392	paclitaxel	CHEMICALENTITY	D017239
18809400	2427	2437	cisplatino	CHEMICALENTITY	D002945
18809400	2489	2503	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
18809400	2536	2556	L'acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	2729	2740	 fratassina	GENEORGENEPRODUCT	2395
18809400	2807	2825	acido alfa-lipoico	CHEMICALENTITY	D008063
18809400	2911	2941	tossicità dei nervi periferici	DISEASEORPHENOTYPICFEATURE	D010523
18809400	2972	2980	pazienti	ORGANISMTAXON	9606
18827003	94	99	umano	ORGANISMTAXON	9606
18827003	132	161	recettore dei glucocorticoidi	GENEORGENEPRODUCT	2908
18827003	194	197	hGR	GENEORGENEPRODUCT	2908
18827003	251	254	hGR	GENEORGENEPRODUCT	2908
18827003	373	388	glucocorticoide	CHEMICALENTITY	D005938
18827003	461	470	cortisolo	CHEMICALENTITY	D006854
18827003	567	572	umano	ORGANISMTAXON	9606
18827003	604	629	recettore glucocorticoide	GENEORGENEPRODUCT	2908
18827003	662	665	hGR	GENEORGENEPRODUCT	2908
18827003	786	801	glucocorticoide	CHEMICALENTITY	D005938
18827003	845	860	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D004342
18827003	960	990	(G --> C) nella posizione 1201	SEQUENCEVARIANT	C|SUB|G|1201|C
18827003	1041	1044	hGR	GENEORGENEPRODUCT	2908
18827003	1100	1178	acido aspartico in sostituzione dell'istidina a posizione dell'amminoacido 401	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	1242	1250	hGRalpha	GENEORGENEPRODUCT	2908
18827003	1365	1373	hGRalpha	GENEORGENEPRODUCT	2908
18827003	1411	1417	D401H 	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	1497	1505	hGRalpha	GENEORGENEPRODUCT	2908
18827003	1559	1567	hGRalpha	GENEORGENEPRODUCT	2908
18827003	1605	1610	D401H	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	1717	1732	glucocorticoide	CHEMICALENTITY	D005938
18827003	1772	1806	virus del tumore mammario del topo	ORGANISMTAXON	11757
18827003	1862	1874	desametasone	CHEMICALENTITY	D003907
18827003	2114	2122	hGRalpha	GENEORGENEPRODUCT	2908
18827003	2160	2165	D401H	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	2356	2371	glucocorticoidi	CHEMICALENTITY	D005938
18827003	2462	2472	proteina 1	GENEORGENEPRODUCT	23426
18827003	2592	2600	hGRalpha	GENEORGENEPRODUCT	2908
18827003	2638	2643	D401H	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	2713	2745	geni reattivi ai glucocorticoidi	GENEORGENEPRODUCT	2908
18827003	2813	2818	D401H	SEQUENCEVARIANT	P|SUB|D|401|H
18827003	2891	2898	obesità	DISEASEORPHENOTYPICFEATURE	D009765
18827003	2943	2955	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
18827003	3028	3047	sindrome metabolica	DISEASEORPHENOTYPICFEATURE	D008659
18945288	36	41	R58fs	SEQUENCEVARIANT	P|FS|R|58||
18945288	100	103	HGD	GENEORGENEPRODUCT	3081
18945288	172	184	alcaptonuria	DISEASEORPHENOTYPICFEATURE	D000474
18945288	319	331	alcaptonuria	DISEASEORPHENOTYPICFEATURE	D000474
18945288	718	736	acido omogentisico	CHEMICALENTITY	D006713
18945288	1040	1043	HGD	GENEORGENEPRODUCT	3081
18945288	1263	1281	acido omogentisico	CHEMICALENTITY	D006713
18945288	1446	1449	HGA	CHEMICALENTITY	D006713
18945288	1626	1643	dolore articolare	DISEASEORPHENOTYPICFEATURE	D018771
18945288	1828	1837	c.342delA	SEQUENCEVARIANT	C|DEL|342|A
18945288	1966	1975	p.Arg58fs	SEQUENCEVARIANT	P|FS|R|58||
18945288	2014	2022	 p.R58fs	SEQUENCEVARIANT	P|FS|R|58||
18945288	2068	2082	L'alcaptonuria	DISEASEORPHENOTYPICFEATURE	D000474
18945288	2246	2251	R58fs	SEQUENCEVARIANT	P|FS|R|58||
18945509	54	73	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
18945509	117	139	 iniziale sulfanilurea	CHEMICALENTITY	D013453
18945509	182	190	pazienti	ORGANISMTAXON	9606
18945509	238	255	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18945509	409	428	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
18945509	473	476	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	558	575	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18945509	622	634	sulfaniluree	CHEMICALENTITY	D013453
18945509	691	710	diabetico di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18945509	738	746	pazienti	ORGANISMTAXON	9606
18945509	818	821	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	966	969	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	1030	1037	diabete	DISEASEORPHENOTYPICFEATURE	D003920
18945509	1201	1204	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	1315	1318	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	1442	1455	glibenclamide	CHEMICALENTITY	D005905
18945509	1519	1528	glipizide	CHEMICALENTITY	D005913
18945509	1630	1640	metformina	CHEMICALENTITY	D008687
18945509	1732	1743	glimepiride	CHEMICALENTITY	C057619
18945509	1810	1820	gliclazide	CHEMICALENTITY	D005907
18945509	1947	1964	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
18945509	2000	2013	glibenclamide	CHEMICALENTITY	D005905
18945509	2048	2057	glipizide	CHEMICALENTITY	D005913
18945509	2142	2145	CAD	DISEASEORPHENOTYPICFEATURE	D003324
18945509	2189	2199	gliclazide	CHEMICALENTITY	D005907
18945509	2233	2244	glimepiride	CHEMICALENTITY	C057619
18945509	2350	2358	pazienti	ORGANISMTAXON	9606
18945509	2408	2420	sulfaniluree	CHEMICALENTITY	D013453
18987260	55	66	adriamicina	CHEMICALENTITY	D004317
18987260	110	120	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
18987260	179	190	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
18987260	219	224	ratti	ORGANISMTAXON	10116
18987260	269	277	losartan	CHEMICALENTITY	D019808
18987260	391	428	recettore dell'angiotensina II tipo-1	GENEORGENEPRODUCT	24180
18987260	471	480	 losartan	CHEMICALENTITY	D019808
18987260	560	575	malattia renale	DISEASEORPHENOTYPICFEATURE	D007674
18987260	650	662	ipertensivo 	DISEASEORPHENOTYPICFEATURE	D006973
18987260	691	696	ratti	ORGANISMTAXON	10116
18987260	738	749	adriamicina	CHEMICALENTITY	D004317
18987260	782	785	ADR	CHEMICALENTITY	D004317
18987260	830	840	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
18987260	1029	1032	ADR	CHEMICALENTITY	D004317
18987260	1068	1071	ADR	CHEMICALENTITY	D004317
18987260	1104	1107	LOS	CHEMICALENTITY	D019808
18987260	1144	1147	ADR	CHEMICALENTITY	D004317
18987260	1187	1190	ADR	CHEMICALENTITY	D004317
18987260	1222	1225	LOS	CHEMICALENTITY	D019808
18987260	1270	1273	ADR	CHEMICALENTITY	D004317
18987260	1375	1378	ADR	CHEMICALENTITY	D004317
18987260	1410	1417	PERDITA	CHEMICALENTITY	D019808
18987260	1462	1470	losartan	CHEMICALENTITY	D019808
18987260	1574	1577	ADR	CHEMICALENTITY	D004317
18987260	1610	1613	LOS	CHEMICALENTITY	D019808
18987260	1695	1698	ADR	CHEMICALENTITY	D004317
18987260	2042	2050	losartan	CHEMICALENTITY	D019808
18987260	2207	2224	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
18987260	2299	2310	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18987260	2373	2381	losartan	CHEMICALENTITY	D019808
18987260	2463	2480	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
18987260	2569	2576	atrofia	DISEASEORPHENOTYPICFEATURE	D001284
18987260	2622	2643	fibrosi interstiziale	DISEASEORPHENOTYPICFEATURE	D005355
18987260	2712	2723	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
18987260	2769	2797	insufficienza renale cronica	DISEASEORPHENOTYPICFEATURE	D007676
18987260	2830	2838	Losartan	CHEMICALENTITY	D019808
18987260	2890	2896	uremia	DISEASEORPHENOTYPICFEATURE	D014511
18987260	2941	2945	urea	CHEMICALENTITY	D014508
18987260	3004	3007	ADR	CHEMICALENTITY	D004317
18987260	3051	3061	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
18987260	3136	3144	losartan	CHEMICALENTITY	D019808
18987260	3207	3214	atrofia	DISEASEORPHENOTYPICFEATURE	D001284
18987260	3289	3296	fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
18987260	3331	3334	ADR	CHEMICALENTITY	D004317
18987260	3378	3388	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
18987260	3434	3442	Losartan	CHEMICALENTITY	D019808
18987260	3509	3512	ADR	CHEMICALENTITY	D004317
18987260	3565	3601	glomerulosclerosi segmentaria focale	DISEASEORPHENOTYPICFEATURE	D005923
18987260	3647	3684	malattia renale allo stadio terminale	DISEASEORPHENOTYPICFEATURE	D007676
19037252	45	68	fosfolipasi C epsilon 1	GENEORGENEPRODUCT	51196
19037252	144	171	sclerosi mesangiale diffusa	DISEASEORPHENOTYPICFEATURE	C537346
19037252	216	246	La sclerosi mesangiale diffusa	DISEASEORPHENOTYPICFEATURE	C537346
19037252	390	413	fosfolipasi C epsilon 1	GENEORGENEPRODUCT	51196
19037252	447	452	PLCE1	GENEORGENEPRODUCT	51196
19037252	643	670	sclerosi mesangiale diffusa	DISEASEORPHENOTYPICFEATURE	C537346
19037252	731	771	congenito o infantile sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	C535761
19037252	828	833	PLCE1	GENEORGENEPRODUCT	51196
19037252	883	891	KIAA1516	GENEORGENEPRODUCT	51196
19037252	926	930	PLCE	GENEORGENEPRODUCT	51196
19037252	965	970	NPHS3	GENEORGENEPRODUCT	51196
19037252	1161	1196	delezione di quattro coppie di basi	SEQUENCEVARIANT	C|DEL||4
19037252	1555	1560	PLCE1	GENEORGENEPRODUCT	51196
19037252	1640	1667	sclerosi mesangiale diffusa	DISEASEORPHENOTYPICFEATURE	C537346
19048115	31	46	Neurofibromin 1	GENEORGENEPRODUCT	4763
19048115	79	82	NF1	GENEORGENEPRODUCT	4763
19048115	136	141	umano	ORGANISMTAXON	9606
19048115	185	210	carcinomi sierosi ovarici	DISEASEORPHENOTYPICFEATURE	D010051
19048115	291	295	TP53	GENEORGENEPRODUCT	7157
19048115	340	365	Carcinoma sieroso ovarico	DISEASEORPHENOTYPICFEATURE	D010051
19048115	410	413	OSC	DISEASEORPHENOTYPICFEATURE	D010051
19048115	502	528	maligno epiteliale ovarico	DISEASEORPHENOTYPICFEATURE	D002277
19048115	574	578	TP53	GENEORGENEPRODUCT	7157
19048115	626	631	Brca1	GENEORGENEPRODUCT	672
19048115	667	672	Brca2	GENEORGENEPRODUCT	675
19048115	716	722	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19048115	863	867	OSCs	DISEASEORPHENOTYPICFEATURE	D010051
19048115	954	960	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19048115	1149	1152	OSC	DISEASEORPHENOTYPICFEATURE	D010051
19048115	1222	1228	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19048115	1303	1306	NF1	GENEORGENEPRODUCT	4763
19048115	1399	1416	carcinoma ovarico	DISEASEORPHENOTYPICFEATURE	D010051
19048115	1465	1468	OSC	DISEASEORPHENOTYPICFEATURE	D010051
19048115	1524	1527	NF1	GENEORGENEPRODUCT	4763
19048115	1651	1654	Nf1	GENEORGENEPRODUCT	4763
19048115	1811	1814	NF1	GENEORGENEPRODUCT	4763
19048115	1921	1924	NF1	GENEORGENEPRODUCT	4763
19048115	2050	2053	NF1	GENEORGENEPRODUCT	4763
19048115	2119	2122	NF1	GENEORGENEPRODUCT	4763
19048115	2122	2123	 	DISEASEORPHENOTYPICFEATURE	D010051
19048115	2332	2338	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19048115	2392	2395	NF1	GENEORGENEPRODUCT	4763
19048115	2462	2465	NF1	GENEORGENEPRODUCT	4763
19048115	2497	2501	KRAS	GENEORGENEPRODUCT	3845
19048115	2534	2538	BRAF	GENEORGENEPRODUCT	673
19048115	2585	2611	 Attivazione della via Ras	GENEORGENEPRODUCT	3845
19048115	2689	2693	MAPK	GENEORGENEPRODUCT	5594
19048115	2747	2753	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19048115	2809	2812	GTP	CHEMICALENTITY	D006160
19048115	2850	2853	Ras	GENEORGENEPRODUCT	3845
19048115	2907	2911	TP53	GENEORGENEPRODUCT	7157
19048115	2955	2961	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19048115	3049	3052	OSC	DISEASEORPHENOTYPICFEATURE	D010051
19048115	3110	3113	NF1	GENEORGENEPRODUCT	4763
19048115	3208	3214	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19048115	3313	3330	carcinomi ovarici	DISEASEORPHENOTYPICFEATURE	D010051
19058010	42	50	tè verde	CHEMICALENTITY	D010936
19058010	84	94	vitamina E	CHEMICALENTITY	D014810
19058010	142	156	isoproterenolo	CHEMICALENTITY	D007545
19058010	208	226	infarto miocardico	DISEASEORPHENOTYPICFEATURE	D009203
19058010	258	263	ratti	ORGANISMTAXON	10116
19058010	367	375	tè verde	CHEMICALENTITY	D010936
19058010	409	419	vitamina E	CHEMICALENTITY	D014810
19058010	510	516	lipidi	CHEMICALENTITY	D008055
19058010	573	586	antiossidanti	CHEMICALENTITY	D000975
19058010	651	665	isoproterenolo	CHEMICALENTITY	D007545
19058010	698	701	ISO	CHEMICALENTITY	D007545
19058010	747	768	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
19058010	800	805	ratti	ORGANISMTAXON	10116
19058010	857	862	ratti	ORGANISMTAXON	10116
19058010	908	911	ISO	CHEMICALENTITY	D007545
19058010	1088	1093	lipid	CHEMICALENTITY	D008055
19058010	1142	1147	lipid	CHEMICALENTITY	D008055
19058010	1179	1201	Livello di Ca+2 ATPasi	CHEMICALENTITY	D000252
19058010	1323	1336	antiossidanti	CHEMICALENTITY	D000975
19058010	1369	1383	Na+/ K+ ATPasi	CHEMICALENTITY	D000254
19058010	1417	1428	Mg+2 ATPasi	CHEMICALENTITY	D017301
19058010	1489	1497	tè verde	CHEMICALENTITY	D010936
19058010	1556	1566	vitamina E	CHEMICALENTITY	D014810
19058010	1668	1671	ISO	CHEMICALENTITY	D007545
19058010	1818	1823	lipid	CHEMICALENTITY	D008055
19058010	1871	1882	Ca+2 ATPasi	CHEMICALENTITY	D000252
19058010	1960	1973	antiossidanti	CHEMICALENTITY	D000975
19058010	2015	2028	Na+/K+ ATPase	CHEMICALENTITY	D000254
19058010	2062	2073	Mg+2 ATPase	CHEMICALENTITY	D017301
19058010	2116	2119	ISO	CHEMICALENTITY	D007545
19058010	2169	2177	tè verde	CHEMICALENTITY	D010936
19058010	2211	2221	vitamina E	CHEMICALENTITY	D014810
19058010	2338	2346	tè verde	CHEMICALENTITY	D010936
19058010	2380	2390	vitamina E	CHEMICALENTITY	D014810
19058010	2430	2433	ISO	CHEMICALENTITY	D007545
19058010	2485	2503	infarto miocardico	DISEASEORPHENOTYPICFEATURE	D009203
19058010	2536	2541	ratti	ORGANISMTAXON	10116
19067809	152	158	renina	GENEORGENEPRODUCT	5972
19067809	190	202	angiotensina	GENEORGENEPRODUCT	183
19067809	236	246	serotonina	CHEMICALENTITY	D012701
19067809	335	341	renina	GENEORGENEPRODUCT	5972
19067809	372	384	angiotensina	GENEORGENEPRODUCT	183
19067809	426	456	trasportatore della serotonina	GENEORGENEPRODUCT	6532
19067809	644	652	pazienti	ORGANISMTAXON	9606
19067809	700	718	sincope vasovagale	DISEASEORPHENOTYPICFEATURE	D019462
19067809	786	794	pazienti	ORGANISMTAXON	9606
19067809	850	856	uomini	ORGANISMTAXON	9606
19067809	889	894	donne	ORGANISMTAXON	9606
19067809	1000	1039	enzima di conversione dell'angiotensina	GENEORGENEPRODUCT	1636
19067809	1116	1120	 ACE	GENEORGENEPRODUCT	1636
19067809	1153	1169	angiotensinogeno	GENEORGENEPRODUCT	183
19067809	1230	1235	M 235	SEQUENCEVARIANT	P|ALLELE|M|235
19067809	1268	1305	recettore dell'angiotensina II tipo 1	GENEORGENEPRODUCT	185
19067809	1337	1341	ATR1	GENEORGENEPRODUCT	185
19067809	1388	1396	A 11666C	SEQUENCEVARIANT	RS5186
19067809	1447	1477	trasportatore della serotonina	GENEORGENEPRODUCT	6532
19067809	1515	1522	5HTTLPR	GENEORGENEPRODUCT	6532
19067809	1830	1854	 Il polimorfismo A 1166C	SEQUENCEVARIANT	RS5186
19067809	2397	2404	sincope	DISEASEORPHENOTYPICFEATURE	D013575
19067809	2535	2542	A 1166C	SEQUENCEVARIANT	RS5186
19067809	2591	2595	ATR1	GENEORGENEPRODUCT	185
19067809	2670	2681	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19067809	2837	2855	sincope vasovagale	DISEASEORPHENOTYPICFEATURE	D019462
19082493	107	125	timidilato sintasi	GENEORGENEPRODUCT	7298
19082493	189	204	5 fluorouracile	CHEMICALENTITY	D005472
19082493	257	279	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19082493	308	316	pazienti	ORGANISMTAXON	 9606
19082493	426	428	TS	GENEORGENEPRODUCT	7298
19082493	531	553	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
19082493	598	601	CRC	DISEASEORPHENOTYPICFEATURE	D015179
19082493	631	639	pazienti	ORGANISMTAXON	9606
19082493	684	687	5FU	CHEMICALENTITY	D005472
19082493	739	786	28 bp numero variabile di ripetizioni in tandem	SEQUENCEVARIANT	C|DUP|| 28
19082493	832	835	G/C	SEQUENCEVARIANT	C|SUB|G||C
19082493	932	960	 di 6 bp alla posizione 1494	SEQUENCEVARIANT	C|DEL|194|6
19082493	1116	1124	pazienti	ORGANISMTAXON	9606
19082493	1202	1230	sezioni incluse in paraffina	CHEMICALENTITY	D010232
19082493	1265	1273	pazienti	ORGANISMTAXON	9606
19082493	1334	1337	CRC	DISEASEORPHENOTYPICFEATURE	D015179
19082493	1379	1381	TS	GENEORGENEPRODUCT	7298
19082493	1601	1613	ins/del 6 bp	SEQUENCEVARIANT	C|INDEL||6
19082493	1696	1698	TS	GENEORGENEPRODUCT	7298
19082493	1827	1839	ins/del 6 bp	SEQUENCEVARIANT	C |INDEL||6
19082493	1947	1959	ins/del 6 bp	SEQUENCEVARIANT	C|INDEL||6
19082493	2017	2023	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19082493	2121	2138	del lato sinistro	DISEASEORPHENOTYPICFEATURE	D009369
19082493	2229	2243	tumori rettali	DISEASEORPHENOTYPICFEATURE	D012004
19082493	2365	2373	pazienti	ORGANISMTAXON	9606
19082493	2421	2427	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19082493	2599	2605	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19082493	3094	3100	tumori	DISEASEORPHENOTYPICFEATURE	D009369
19082493	3242	3250	pazienti	ORGANISMTAXON	9606
19082493	3400	3402	TS	GENEORGENEPRODUCT	7298
19082493	3498	3502	CRC 	DISEASEORPHENOTYPICFEATURE	D015179
19082493	3530	3538	pazienti	ORGANISMTAXON	9606
19082493	3583	3586	5FU	CHEMICALENTITY	D005472
19101703	80	113	distrofia muscolare oculofaringea	DISEASEORPHENOTYPICFEATURE	D039141
19101703	170	206	La distrofia muscolare oculofaringea	DISEASEORPHENOTYPICFEATURE	D039141
19101703	251	255	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	322	361	disturbo muscolare autosomico dominante	DISEASEORPHENOTYPICFEATURE	D030342
19101703	406	410	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	537	548	polialanina	CHEMICALENTITY	C019529
19101703	589	632	poliadenilato-proteina di legame nucleare 1	GENEORGENEPRODUCT	8106
19101703	665	671	PABPN1	GENEORGENEPRODUCT	8106
19101703	757	763	PABPN1	GENEORGENEPRODUCT	8106
19101703	837	841	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	1005	1009	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	1076	1082	PABPN1	GENEORGENEPRODUCT	8106
19101703	1219	1223	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	1360	1366	PABPN1	GENEORGENEPRODUCT	8106
19101703	1690	1694	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	1829	1833	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	1861	1869	pazienti	ORGANISMTAXON	9606
19101703	1988	1994	PABPN1	GENEORGENEPRODUCT	8106
19101703	2094	2098	OPMD	DISEASEORPHENOTYPICFEATURE	D039141
19101703	2258	2264	PABPN1	GENEORGENEPRODUCT	8106
19108278	79	91	propranololo	CHEMICALENTITY	D011433
19108278	155	172	aritmie cardiache	DISEASEORPHENOTYPICFEATURE	D001145
19108278	230	242	propranololo	CHEMICALENTITY	D011433
19108278	416	428	isoprenalina	CHEMICALENTITY	D007545
19108278	465	476	propranolol	CHEMICALENTITY	D011433
19108278	556	568	propranololo	CHEMICALENTITY	D011433
19108278	615	627	propranololo	CHEMICALENTITY	D011433
19108278	690	702	isoprenalina	CHEMICALENTITY	D007545
19108278	855	867	isoprenalina	CHEMICALENTITY	D007545
19108278	899	903	cani	ORGANISMTAXON	9615
19108278	967	975	glucosio	CHEMICALENTITY	D005947
19108278	1008	1015	lattato	CHEMICALENTITY	D019344
19108278	1056	1068	grasso acidi	CHEMICALENTITY	D005227
19108278	1134	1146	propranololo	CHEMICALENTITY	D011433
19108278	1183	1194	Propranolol	CHEMICALENTITY	D011433
19108278	1278	1290	acido grasso	CHEMICALENTITY	D005227
19108278	1370	1377	lattato	CHEMICALENTITY	D019344
19108278	1411	1419	glucosio	CHEMICALENTITY	D005947
19108278	1478	1490	propranololo	CHEMICALENTITY	D011433
19108278	1600	1605	cavie	ORGANISMTAXON	10141
19108278	1655	1667	propranololo	CHEMICALENTITY	D011433
19108278	1832	1840	procaina	CHEMICALENTITY	D011343
19108278	1981	1993	propranololo	CHEMICALENTITY	D011433
19108278	2053	2063	adrenalina	CHEMICALENTITY	D004837
19108278	2119	2136	aritmie cardiache	DISEASEORPHENOTYPICFEATURE	D001145
19108278	2167	2172	gatti	ORGANISMTAXON	9685
19108278	2222	2230	alotano 	CHEMICALENTITY	D006221
19108278	2287	2299	propranololo	CHEMICALENTITY	D011433
19108278	2375	2387	propranololo	CHEMICALENTITY	D011433
19108278	2475	2487	propranololo	CHEMICALENTITY	D011433
19108278	2636	2643	aritmie	DISEASEORPHENOTYPICFEATURE	D001145
19108278	2741	2751	adrenalina	CHEMICALENTITY	D004837
19108278	2811	2823	propranololo	CHEMICALENTITY	D011433
19108278	2904	2928	tachicardia ventricolare	DISEASEORPHENOTYPICFEATURE	D017180
19108278	2983	3007	tachicardia ventricolare	DISEASEORPHENOTYPICFEATURE	D017180
19108278	3039	3046	ouabain	CHEMICALENTITY	D010042
19108278	3091	3096	gatti	ORGANISMTAXON	9685
19108278	3126	3131	 cani	ORGANISMTAXON	9615
19108278	3179	3191	propranololo	CHEMICALENTITY	D011433
19108278	3272	3284	propranololo	CHEMICALENTITY	D011433
19110214	45	76	displasia scheletrica recessiva	DISEASEORPHENOTYPICFEATURE	D010009
19110214	121	125	SEMD	DISEASEORPHENOTYPICFEATURE	D010009
19110214	156	164	aggrecan	GENEORGENEPRODUCT	176
19110214	287	296	 aggrecan	GENEORGENEPRODUCT	176
19110214	454	486	displasia spondiloepimetafisaria	DISEASEORPHENOTYPICFEATURE	D010009
19110214	554	567	breve statura	DISEASEORPHENOTYPICFEATURE	D006130
19110214	1054	1062	aggrecan	GENEORGENEPRODUCT	176
19110214	1097	1131	condroitin solfato proteoglicano 4	GENEORGENEPRODUCT	 1464
19110214	1249	1257	aggrecan	GENEORGENEPRODUCT	176
19110214	1388	1402	c.6799G -- > A	SEQUENCEVARIANT	RS545688154
19110214	1484	1492	p.D2267N	SEQUENCEVARIANT	RS545688154
19110214	1589	1598	aggrecano	GENEORGENEPRODUCT	176
19110214	1662	1667	D2267	SEQUENCEVARIANT	RS545688154
19110214	1730	1736	calcio	CHEMICALENTITY	D002118
19110214	2325	2333	aggrecan	GENEORGENEPRODUCT	176
19110214	2371	2381	tenascin-C	GENEORGENEPRODUCT	 3371
19110214	2460	2502	displasia scheletrica autosomica recessiva	DISEASEORPHENOTYPICFEATURE	D010009
19110214	2565	2573	aggrecan	GENEORGENEPRODUCT	176
19160446	31	36	P2RX7	GENEORGENEPRODUCT	5027
19160446	91	120	bipolare e unipolare disturbo	DISEASEORPHENOTYPICFEATURE	D001714,D003866
19160446	284	301	disturbo bipolare	DISEASEORPHENOTYPICFEATURE	D001714
19160446	356	385	disturbo unipolare dell'umore	DISEASEORPHENOTYPICFEATURE	D003866,D019964
19160446	485	502	disturbo bipolare	DISEASEORPHENOTYPICFEATURE	D001714
19160446	549	567	Malattia di Darier	DISEASEORPHENOTYPICFEATURE	D007644
19160446	647	652	P2RX7	GENEORGENEPRODUCT	5027
19160446	801	818	disturbo bipolare	DISEASEORPHENOTYPICFEATURE	D001714
19160446	864	885	depressione unipolare	DISEASEORPHENOTYPICFEATURE	D003866
19160446	941	950	rs2230912	SEQU ENCEVARIANT	RS2230912
19160446	1030	1035	Q460R	SEQUENCEVARIANT	RS2230912
19160446	1245	1264	disturbo bipolare I	DISEASEORPHENOTYPICFEATURE	D001714
19160446	1317	1358	unipolare depressione maggiore ricorrente	DISEASEORPHENOTYPICFEATURE	D003865
19160446	1429	1438	rs2230912	SEQUENCEVARIANT	RS2230912
19160446	1516	1521	P2RX7	GENEORGENEPRODUCT	5027
19160446	1604	1623	disturbo dell'umore	DISEASEORPHENOTYPICFEATURE	D019964
19160446	1708	1737	disturbo bipolare o unipolare	DISEASEORPHENOTYPICFEATURE	D001714,D003866
19160446	1913	1918	P2RX7	GENEORGENEPRODUCT	5027
19160446	2036	2045	rs2230912	SEQUENCEVARIANT	RS2230912
19160446	2127	2132	P2RX7	GENEORGENEPRODUCT	5027
19160446	2224	2243	disturbi dell'umore	DISEASEORPHENOTYPICFEATURE	D019964
19218574	31	60	Fosfatidilinositolo 3-chinasi	GENEORGENEPRODUCT	5295
19218574	92	100	p85alpha	GENEORGENEPRODUCT	5295
19218574	167	176	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	220	225	donne	ORGANISMTAXON	9606
19218574	274	305	sindrome dell'ovaio policistico	DISEASEORPHENOTYPICFEATURE	D011085
19218574	362	388	La resistenza all'insulina	DISEASEORPHENOTYPICFEATURE	D007333
19218574	469	500	sindrome dell'ovaio policistico	DISEASEORPHENOTYPICFEATURE	D011085
19218574	545	549	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	583	620	Il fosfatidilinositolo (PI) 3-chinasi	GENEORGENEPRODUCT	5295
19218574	687	695	insulina	GENEORGENEPRODUCT	3630
19218574	793	801	insulina	GENEORGENEPRODUCT	3630
19218574	843	851	glucosio	CHEMICALENTITY	D005947
19218574	917	925	p85alpha	GENEORGENEPRODUCT	5295
19218574	1014	1023	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	1154	1162	p85alpha	GENEORGENEPRODUCT	5295
19218574	1196	1208	 PI3-chinasi	GENEORGENEPRODUCT	5295
19218574	1279	1288	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	1377	1381	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	1409	1417	pazienti	ORGANISMTAXON	9606
19218574	1605	1614	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	1669	1673	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	1749	1758	Met326Met	SEQUENCEVARIANT	RS3730089
19218574	1793	1802	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	1838	1847	Ile326Ile	SEQUENCEVARIANT	RS3730089
19218574	1945	1949	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	2054	2058	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	2167	2173	326Ile	SEQUENCEVARIANT	RS3730089
19218574	2267	2273	326Ile	SEQUENCEVARIANT	RS3730089
19218574	2340	2349	Met326Met	SEQUENCEVARIANT	RS3730089
19218574	2420	2442	17-idrossiprogesterone	CHEMICALENTITY	D019326
19218574	2475	2481	17-OHP	CHEMICALENTITY	D019326
19218574	2599	2608	Met326Met	SEQUENCEVARIANT	RS3730089
19218574	2695	2704	Ile326Ile	SEQUENCEVARIANT	RS3730089
19218574	2741	2750	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	2807	2819	testosterone	CHEMICALENTITY	D013739
19218574	2894	2903	Met326Met	SEQUENCEVARIANT	RS3730089
19218574	2989	2998	Ile326Ile	SEQUENCEVARIANT	RS3730089
19218574	3036	3045	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	3156	3167	PI3-chinasi	GENEORGENEPRODUCT	5295
19218574	3202	3211	Met326Ile	SEQUENCEVARIANT	RS3730089
19218574	3316	3320	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	3396	3403	17-OHP 	CHEMICALENTITY	D019326
19218574	3444	3456	testosterone	CHEMICALENTITY	D013739
19218574	3503	3507	PCOS	DISEASEORPHENOTYPICFEATURE	D011085
19218574	3536	3544	pazienti	ORGANISMTAXON	9606
19234905	124	156	malattia di Parkinson idiopatica	DISEASEORPHENOTYPICFEATURE	D010300
19234905	364	396	malattia di Parkinson idiopatica	DISEASEORPHENOTYPICFEATURE	D010300
19234905	441	444	PD 	DISEASEORPHENOTYPICFEATURE	D010300
19234905	513	521	pazienti	ORGANISMTAXON	9606
19234905	583	589	uomini	ORGANISMTAXON	9606
19234905	620	625	donne	ORGANISMTAXON	9606
19234905	845	853	levodopa	CHEMICALENTITY	D007980
19234905	905	915	discinesie	DISEASEORPHENOTYPICFEATURE	D004409
19234905	978	986	pazienti	ORGANISMTAXON	9606
19234905	1104	1112	levodopa	CHEMICALENTITY	D007980
19234905	1145	1153	pazienti	ORGANISMTAXON	9606
19234905	1362	1381	Parkinson's Disease	DISEASEORPHENOTYPICFEATURE	D010300
19234905	1741	1754	parkinsoniani	DISEASEORPHENOTYPICFEATURE	D010300
19234905	1793	1801	pazienti	ORGANISMTAXON	9606
19234905	1853	1861	Levodopa	CHEMICALENTITY	D007980
19234905	2189	2197	pazienti	ORGANISMTAXON	9606
19234905	2256	2274	emianopsia omonima	DISEASEORPHENOTYPICFEATURE	D006423
19234905	2458	2467	Valproato	CHEMICALENTITY	D014635
19234905	2642	2650	pazienti	ORGANISMTAXON	9606
19234905	2698	2710	 avanzato PD	DISEASEORPHENOTYPICFEATURE	D010300
19306381	31	48	Neuregulin-1 beta	GENEORGENEPRODUCT	3084
19306381	82	99	neuregulin-1 alfa	GENEORGENEPRODUCT	3084
19306381	217	265	tumore maligno della guaina del nervo periferico	DISEASEORPHENOTYPICFEATURE	D018319
19306381	310	358	Tumori maligni della guaina dei nervi periferici	DISEASEORPHENOTYPICFEATURE	D018319
19306381	403	409	MPNSTs	DISEASEORPHENOTYPICFEATURE	D018319
19306381	473	482	malignità	DISEASEORPHENOTYPICFEATURE	D009369
19306381	526	552	neurofibromatosi di tipo 1	GENEORGENEPRODUCT	4763
19306381	586	589	NF1	GENEORGENEPRODUCT	4763
19306381	642	649	sarcomi	DISEASEORPHENOTYPICFEATURE	D012509
19306381	961	967	MPNSTs	DISEASEORPHENOTYPICFEATURE	D018319
19306381	1007	1032	neuregulin-1 (NRG-1) beta	GENEORGENEPRODUCT	3084
19306381	1151	1162	NRG-1 alpha	GENEORGENEPRODUCT	3084
19306381	1281	1291	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	1327	1338	NRG-1 alpha	GENEORGENEPRODUCT	3084
19306381	1393	1398	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	1462	1472	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	1526	1531	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	1650	1658	laminina	GENEORGENEPRODUCT	16777
19306381	1705	1724	collagene di tipo I	GENEORGENEPRODUCT	1277,1278
19306381	1758	1770	fibronectina	GENEORGENEPRODUCT	2335
19306381	1815	1820	NRG-1	GENEORGENEPRODUCT	3084
19306381	1858	1863	erbB3	GENEORGENEPRODUCT	13867,2065
19306381	1904	1909	erbB4	GENEORGENEPRODUCT	13869,2066
19306381	1971	1976	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	2089	2115	chinasi di adesione focale	GENEORGENEPRODUCT	5747
19306381	2152	2176	recettore della laminina	GENEORGENEPRODUCT	3688
19306381	2209	2226	beta(1)-integrina	GENEORGENEPRODUCT	3688
19306381	2284	2301	beta(1)-integrina	GENEORGENEPRODUCT	3688
19306381	2334	2344	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	2382	2387	umano	ORGANISMTAXON	9606
19306381	2419	2423	muro	ORGANISMTAXON	10090
19306381	2467	2472	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	2704	2714	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	2769	2773	erbB	GENEORGENEPRODUCT	13867,13869,2065,2066
19306381	2857	2864	MEK 1/2	GENEORGENEPRODUCT	26395,26396,5604,5605
19306381	2904	2908	SAPK	GENEORGENEPRODUCT	26419, 5599
19306381	2946	2949	JNK	GENEORGENEPRODUCT	26419,5599
19306381	2988	3001	PI-3 chinasi 	GENEORGENEPRODUCT	30955,5290
19306381	3040	3065	Kinasi della famiglia Src	GENEORGENEPRODUCT	20779,6714
19306381	3116	3126	ROCK -I/II	GENEORGENEPRODUCT	19877,19878,6093,9475
19306381	3173	3184	NRG-1 alpha	GENEORGENEPRODUCT	3084
19306381	3299	3304	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	3386	3396	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	3484	3491	Erk 1/2	GENEORGENEPRODUCT	26413,26417,5594,5595
19306381	3530	3534	SAPK	GENEORGENEPRODUCT	26419,5599
19306381	3572	3575	JNK	GENEORGENEPRODUCT	26419,5599
19306381	3613	3616	Akt	GENEORGENEPRODUCT	11651,207
19306381	3656	3681	Kinasi della famiglia Src	GENEORGENEPRODUCT	20779,6714
19306381	3715	3726	NRG-1 alpha	GENEORGENEPRODUCT	3084
19306381	3779	3782	Akt	GENEORGENEPRODUCT	11651,207
19306381	3918	3928	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	3995	4005	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	4075	4080	MPNST	DISEASEORPHENOTYPICFEATURE	D018319
19306381	4119	4129	NRG-1 beta	GENEORGENEPRODUCT	3084
19306381	4163	4174	NRG-1 alpha	GENEORGENEPRODUCT	3084
19319147	93	102	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
19319147	145	150	mouse	ORGANISMTAXON	10090
19319147	193	201	warfarin	CHEMICALENTITY	D014859
19319147	255	279	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
19319147	312	320	Warfarin	CHEMICALENTITY	D014859
19319147	374	398	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
19319147	432	433	W	CHEMICALENTITY	 D014859
19319147	477	480	ICH	DISEASEORPHENOTYPICFEATURE	D002543
19319147	544	549	ictus	DISEASEORPHENOTYPICFEATURE	D020521
19319147	628	629	W	CHEMICALENTITY	D014859
19319147	673	676	ICH	DISEASEORPHENOTYPICFEATURE	D002543
19319147	729	734	mouse	ORGANISMTAXON	10090
19319147	840	845	umano	ORGANISMTAXON	9606
19319147	877	916	concentrato del complesso protrombinico	CHEMICALENTITY	C025667
19319147	949	952	PCC	CHEMICALENTITY	C025667
19319147	1041	1045	topi	ORGANISMTAXON	10090
19319147	1101	1109	warfarin	CHEMICALENTITY	D014859
19319147	1319	1324	umano	ORGANISMTAXON	9606
19319147	1356	1359	PCC	CHEMICALENTITY	C025667
19319147	1435	1439	topi	ORGANISMTAXON	10090
19319147	1542	1553	collagenasi	CHEMICALENTITY	D017364
19319147	1609	1618	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
19319147	1750	1753	PCC	CHEMICALENTITY	C025667
19319147	1888	1897	emorragia	DISEASEORPHENOTYPICFEATURE	D006470
19319147	2102	2105	PCC	CHEMICALENTITY	C025667
19319147	2243	2247	topi	ORGANISMTAXON	10090
19319147	2312	2319	ematomi	DISEASEORPHENOTYPICFEATURE	D006406
19319147	2448	2451	PCC	CHEMICALENTITY	C025667
19319147	2532	2535	PCC	CHEMICALENTITY	C025667
19319147	2605	2606	W	CHEMICALENTITY	D014859
19319147	2651	2654	ICH	DISEASEORPHENOTYPICFEATURE	D002543
19319147	2842	2847	umano	ORGANISMTAXON	9606
19319147	2879	2880	W	CHEMICALENTITY	D014859
19319147	2924	2927	ICH	DISEASEORPHENOTYPICFEATURE	D002543
19346865	55	86	lesione del collicolo inferiore	DISEASEORPHENOTYPICFEATURE	D001927
19346865	121	134	metronidazolo	CHEMICALENTITY	D008795
19346865	186	199	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
19346865	399	430	lesioni del collicolo inferiore	DISEASEORPHENOTYPICFEATURE	D001927
19346865	465	478	metronidazolo	CHEMICALENTITY	D008795
19346865	530	543	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
19346865	747	755	pazienti	ORGANISMTAXON	9606
19346865	786	792	uomini	ORGANISMTAXON	9606
19346865	824	829	donne	ORGANISMTAXON	9606
19346865	903	916	metronidazolo	CHEMICALENTITY	D008795
19346865	960	973	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
19346865	1052	1065	metronidazolo	CHEMICALENTITY	D008795
19346865	1189	1198	infezione	DISEASEORPHENOTYPICFEATURE	D007239
19346865	1520	1528	pazienti	ORGANISMTAXON	9606
19346865	1607	1620	metronidazolo	CHEMICALENTITY	D008795
19346865	2348	2356	paziente	ORGANISMTAXON	9606
19346865	2643	2651	pazienti	ORGANISMTAXON	9606
19346865	2689	2697	paziente	ORGANISMTAXON	9606
19346865	2757	2772	lesione callosa	DISEASEORPHENOTYPICFEATURE	D001927
19346865	2853	2884	lesioni del collicolo inferiore	DISEASEORPHENOTYPICFEATURE	D001927
19346865	2972	2985	metronidazolo	CHEMICALENTITY	D008795
19346865	3038	3051	encefalopatia	DISEASEORPHENOTYPICFEATURE	D001927
19365571	43	70	Distrofia corneale maculare	DISEASEORPHENOTYPICFEATURE	D003317
19365571	157	162	CHST6	GENEORGENEPRODUCT	4166
19365571	232	275	gene della sulfotransferasi dei carboidrati	GENEORGENEPRODUCT	4166
19365571	308	313	CHST6	GENEORGENEPRODUCT	4166
19365571	386	413	distrofia corneale maculare	DISEASEORPHENOTYPICFEATURE	D003317
19365571	458	461	MCD	DISEASEORPHENOTYPICFEATURE	D003317
19365571	962	967	CHST6	GENEORGENEPRODUCT	4166
19365571	1261	1266	ferro	CHEMICALENTITY	D007501
19365571	1576	1584	c.892C>T	SEQUENCEVARIANT	C|SUB|C|892|T
19365571	1627	1636	c.1072T>C	SEQUENCEVARIANT	C|SUB|T |1072|C
19365571	1709	1714	CHST6	GENEORGENEPRODUCT	4166
19365571	1750	1758	pazienti	ORGANISMTAXON	9606
19365571	1871	1885	 al codone 298	SEQUENCEVARIANT	P|SUB|Q|298|X
19365571	1926	1933	p.Q298X	SEQUENCEVARIANT	P|SUB|Q|298|X
19365571	2000	2033	codone 358, tirosina all'istidina	SEQUENCEVARIANT	P|SUB|Y|358|H
19365571	2073	2080	p.Y358H	SEQUENCEVARIANT	P|SUB|Y|358|H
19365571	2404	2409	CHST6	GENEORGENEPRODUCT	4166
19365571	2485	2501	cheratan solfato	CHEMICALENTITY	 D007632
19365571	2534	2536	KS	CHEMICALENTITY	D007632
19365571	2725	2734	collagene	GENEORGENEPRODUCT	1277
19370764	108	166	subunità gamma UDP-N-acetilglucosamina-1-fosfotransferasi 	GENEORGENEPRODUCT	84572
19370764	200	205	GNPTG	GENEORGENEPRODUCT	84572
19370764	242	250	pazienti	ORGANISMTAXON	9606
19370764	298	320	mucolipidosi III gamma	DISEASEORPHENOTYPICFEATURE	C565367
19370764	365	389	Mucolipidosi di tipo III	DISEASEORPHENOTYPICFEATURE	D009081
19370764	434	439	MLIII	DISEASEORPHENOTYPICFEATURE	D009081
19370764	491	520	disturbo autosomico recessivo	DISEASEORPHENOTYPICFEATURE	D030342
19370764	618	626	pazienti	ORGANISMTAXON	9606
19370764	734	739	MLIII	DISEASEORPHENOTYPICFEATURE	D009081
19370764	826	831	GNPTG	GENEORGENEPRODUCT	84572
19370764	898	905	p.T286M	SEQUENCEVARIANT	RS193302860
19370764	958	965	p.W111X	SEQUENCEVARIANT	RS137852884
19370764	1047	1062	AG-dinucleotide	SEQUENCEVARIANT	RS193302855
19370764	1151	1162	c.610 -2A>G	SEQUENCEVARIANT	RS193302855
19370764	1270	1279	c.611delG	SEQUENCEVARIANT	RS193302856
19370764	1318	1332	c.640_667del28	SEQUENCEVARIANT	RS193302859
19370764	1585	1595	c.610-2A>G	SEQUENCEVARIANT	RS193302855
19370764	1889	1901	p.G204VfsX28	SEQUENCEVARIANT	P|FS|G|204|V|28
19370764	1962	1970	paziente	ORGANISMTAXON	9606
19370764	2145	2150	GNPTG	GENEORGENEPRODUCT	84572
19370764	2383	2391	paziente	ORGANISMTAXON	9606
19370764	2496	2507	anisomicina	CHEMICALENTITY	D000841
19370764	2645	2672	33-bp di delezione genomica	SEQUENCEVARIANT	G|DEL||33
19370764	2760	2765	GNPTG	GENEORGENEPRODUCT	84572
19370764	2877	2889	p.G204VfsX17	SEQUENCEVARIANT	P|FS|G|204|V |17
19370764	2989	2994	GNPTG	GENEORGENEPRODUCT	84572
19370764	3426	3431	GNPTG	GENEORGENEPRODUCT	84572
19445921	59	79	acido salvianolico A	CHEMICALENTITY	C066201
19445921	114	129	isoproterenolo 	CHEMICALENTITY	D007545
19445921	181	202	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
19445921	234	239	ratti	ORGANISMTAXON	10116
19445921	358	378	acido salvianolico A	CHEMICALENTITY	C066201
19445921	413	427	isoproterenolo	CHEMICALENTITY	D007545
19445921	479	500	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
19445921	532	537	ratti	ORGANISMTAXON	10116
19445921	912	926	Isoproterenolo	CHEMICALENTITY	D007545
19445921	963	968	ratti	ORGANISMTAXON	10116
19445921	1054	1074	lattato deidrogenasi	GENEORGENEPRODUCT	24533
19445921	1108	1130	aspartato transaminasi	GENEORGENEPRODUCT	25721
19445921	1164	1180	creatina chinasi	GENEORGENEPRODUCT	24264
19445921	1214	1228	malondialdeide	CHEMICALENTITY	D008315
19445921	1307	1328	superossido dismutasi	GENEORGENEPRODUCT	24786
19445921	1362	1370	catalasi	GENEORGENEPRODUCT	24248
19445921	1405	1427	glutatione perossidasi	GENEORGENEPRODUCT	24404
19445921	1482	1487	ratti	ORGANISMTAXON	10116
19445921	1769	1807	disfunzione respiratoria mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
19445921	1905	1908	ADP	CHEMICALENTITY	D000244
19445921	1964	1978	isoproterenolo	CHEMICALENTITY	D007545
19445921	2016	2021	ratti	ORGANISMTAXON	10116
19445921	2074	2094	acido salvianolico A	CHEMICALENTITY	C066201
19445921	2182	2196	isoproterenolo	CHEMICALENTITY	D007545
19445921	2252	2272	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
19445921	2318	2334	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
19445921	2450	2470	acido salvianolico A	CHEMICALENTITY	C066201
19445921	2509	2523	isoproterenolo	CHEMICALENTITY	D007545
19445921	2576	2592	danno miocardico	DISEASEORPHENOTYPICFEATURE	D009202
19445921	2731	2751	acido salvianolico A	CHEMICALENTITY	C066201
19445921	2865	2879	isoproterenolo	CHEMICALENTITY	D007545
19445921	2931	2952	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
19463742	43	86	L'attivazione del recettore melanocortina-4	GENEORGENEPRODUCT	17202,25635,4160
19463742	141	165	c-Jun N-terminal chinasi	GENEORGENEPRODUCT	 116554,26419,5599
19463742	229	237	insulina	GENEORGENEPRODUCT	16333,24505,3630
19463742	294	306	melanocortin	GENEORGENEPRODUCT	5443
19463742	402	441	recettore della melanocortina di tipo 4	GENEORGENEPRODUCT	4160
19463742	474	478	MC4R	GENEORGENEPRODUCT	4160
19463742	519	527	insulina	GENEORGENEPRODUCT	3630
19463742	591	616	c-Jun chinasi N-terminale	GENEORGENEPRODUCT	5599
19463742	650	653	JNK	GENEORGENEPRODUCT	5599
19463742	698	711	melanocortina	GENEORGENEPRODUCT	5443
19463742	743	750	NDP-MSH	CHEMICALENTITY	C027756
19463742	815	818	JNK	GENEORGENEPRODUCT	5599
19463742	926	932	 umano	ORGANISMTAXON	9606
19463742	964	968	MC4R	GENEORGENEPRODUCT	4160
19463742	1037	1066	recettore della melanocortina	GENEORGENEPRODUCT	4160
19463742	1111	1118	NDP-MSH	CHEMICALENTITY	C027756
19463742	1187	1192	IRS-1	GENEORGENEPRODUCT	3667
19463742	1306	1335	recettore della melanocortina	GENEORGENEPRODUCT	4160
19463742	1368	1375	NDP-MSH	CHEMICALENTITY	C027756
19463742	1417	1425	insulina	GENEORGENEPRODUCT	3630
19463742	1467	1470	AKT	GENEORGENEPRODUCT	207
19463742	1530	1542	melanocortin	GENEORGENEPRODUCT	5443
19463742	1583	1595	melanotan II	CHEMICALENTITY	C079282
19463742	1641	1649	insulina	GENEORGENEPRODUCT	 24505
19463742	1692	1695	AKT	GENEORGENEPRODUCT	24185
19463742	1743	1746	rat	ORGANISMTAXON	10116
19463742	1797	1804	NDP-MSH	CHEMICALENTITY	C027756
19463742	1847	1855	insulina	GENEORGENEPRODUCT	16333
19463742	1898	1922	assorbimento di glucosio	CHEMICALENTITY	D005947
19463742	2121	2129	insulina	GENEORGENEPRODUCT	16333,24505,3630
19463742	2203	2206	JNK	GENEORGENEPRODUCT	116554,26419, 5599
19508969	57	65	meckelin	GENEORGENEPRODUCT	91147
19508969	99	103	MKS3	GENEORGENEPRODUCT	91147
19508969	136	142	TMEM67	GENEORGENEPRODUCT	91147
19508969	197	229	nefronoftisi con fibrosi epatica	DISEASEORPHENOTYPICFEATURE	OMIM:613550
19508969	278	284	NPHP11	DISEASEORPHENOTYPICFEATURE	OMIM:613550
19508969	342	354	Nefronoftisi	DISEASEORPHENOTYPICFEATURE	C537699
19508969	399	403	NPHP	DISEASEORPHENOTYPICFEATURE	C537699
19508969	468	491	malattia renale cistica	DISEASEORPHENOTYPICFEATURE	D052177
19508969	573	601	insufficienza renale cronica	DISEASEORPHENOTYPICFEATURE	D007676
19508969	764	771	NPHP1-9	GENEORGENEPRODUCT	23322,261734,27031,27130,284086,4867,80184,84662,9657
19508969	817	821	NPHP	DISEASEORPHENOTYPICFEATURE	C537699
19508969	888	910	degenerazione retinica	DISEASEORPHENOTYPICFEATURE	D012162
19508969	957	981	Sindrome di Senior-Loken	DISEASEORPHENOTYPICFEATURE	C537580
19508969	1047	1067	anomalie cerebellari	DISEASEORPHENOTYPICFEATURE	D002526
19508969	1114	1133	sindrome di Joubert	DISEASEORPHENOTYPICFEATURE	C536293
19508969	1181	1196	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
19508969	1291	1299	pazienti	ORGANISMTAXON	9606
19508969	1347	1362	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
19508969	1495	1503	pazienti	ORGANISMTAXON	9606
19508969	1812	1816	MKS3	GENEORGENEPRODUCT	91147
19508969	1849	1855	TMEM67	GENEORGENEPRODUCT	91147
19508969	1928	1936	pazienti	ORGANISMTAXON	9606
19508969	1997	2001	NPHP	DISEASEORPHENOTYPICFEATURE	C537699
19508969	2058	2073	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
19508969	2165	2172	p.W290L	SEQUENCEVARIANT	RS267607117
19508969	2215	2222	p.C615R	SEQUENCEVARIANT	RS201893408
19508969	2260	2267	p.G821S	SEQUENCEVARIANT	RS267607116
19508969	2308	2315	p.G821R	SEQUENCEVARIANT	RS267607116
19508969	2381	2385	MKS3	GENEORGENEPRODUCT	91147
19508969	2418	2424	TMEM67	GENEORGENEPRODUCT	91147
19508969	2492	2530	Sindrome di Meckel-Gruber (MKS) tipo 3	DISEASEORPHENOTYPICFEATURE	C536132
19508969	2576	2609	Sindrome di Joubert (JBTS) tipo 6	DISEASEORPHENOTYPICFEATURE	C537689
19508969	2723	2731	pazienti	ORGANISMTAXON	9606
19508969	2779	2783	NPHP	DISEASEORPHENOTYPICFEATURE	C537699
19508969	2840	2855	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
19508969	3052	3055	MKS	DISEASEORPHENOTYPICFEATURE	C536133
19508969	3101	3106	JBTS 	DISEASEORPHENOTYPICFEATURE	C536293
19508969	3186	3190	MKS3	GENEORGENEPRODUCT	91147
19508969	3223	3229	TMEM67	GENEORGENEPRODUCT	91147
19508969	3265	3273	pazienti	ORGANISMTAXON	9606
19508969	3321	3325	JBTS	DISEASEORPHENOTYPICFEATURE	C536293
19508969	3419	3427	pazienti	ORGANISMTAXON	9606
19508969	3509	3524	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
19508969	3596	3600	MKS3	GENEORGENEPRODUCT	91147
19508969	3633	3639	TMEM67	GENEORGENEPRODUCT	91147
19508969	3695	3719	NPHP con fibrosi epatica	DISEASEORPHENOTYPICFEATURE	OMIM:613550
19508969	3768	3774	NPHP11	DISEASEORPHENOTYPICFEATURE	OMIM:613550
19508969	3837	3841	MKS3	GENEORGENEPRODUCT	91147
19508969	3882	3890	pazienti	ORGANISMTAXON	9606
19508969	3992	3996	NPHP	DISEASEORPHENOTYPICFEATURE	C537699
19508969	4041	4045	JBTS	DISEASEORPHENOTYPICFEATURE	C536293
19508969	4092	4095	MKS	DISEASEORPHENOTYPICFEATURE	 C536133
19508969	4153	4170	disturbi allelici	DISEASEORPHENOTYPICFEATURE	D030342
19521089	31	61	Trasportatore della serotonina	GENEORGENEPRODUCT	6532
19521089	123	132	5-HTTLPR 	GENEORGENEPRODUCT	6532
19521089	208	229	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
19521089	283	304	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
19521089	349	351	PD	DISEASEORPHENOTYPICFEATURE	D010300
19521089	401	427	disturbo neurodegenerativo	DISEASEORPHENOTYPICFEATURE	D019636
19521089	481	499	rigidità muscolare	DISEASEORPHENOTYPICFEATURE	D009127
19521089	544	560	tremore a riposo	DISEASEORPHENOTYPICFEATURE	D014202
19521089	607	619	bradicinesia	DISEASEORPHENOTYPICFEATURE	 D018476
19521089	736	738	PD	DISEASEORPHENOTYPICFEATURE	D010300
19521089	811	841	trasportatore della serotonina	GENEORGENEPRODUCT	6532
19521089	879	885	SLC6A4	GENEORGENEPRODUCT	6532
19521089	939	947	5-HTTLPR	GENEORGENEPRODUCT	6532 
19521089	1002	1068	inserimento/cancellazione (allele lungo-L/allele corto-S) di 43 bp	SEQUENCEVARIANT	C|INDEL||43
19521089	1128	1134	SLC6A4	GENEORGENEPRODUCT	6532
19521089	1218	1224	SLC6A4	GENEORGENEPRODUCT	6532
19521089	1257	1264	rs25531	SEQUENCEVARIANT	RS25531
19521089	1298	1303	A-->G	SEQUENCEVARIANT	RS25531
19521089	1420	1422	PD	DISEASEORPHENOTYPICFEATURE	D010300
19521089	1507	1515	5-HTTLPR	GENEORGENEPRODUCT	6532
19521089	1575	1577	PD	DISEASEORPHENOTYPICFEATURE	D010300
19521089	1667	1674	rs25531	SEQUENCEVARIANT	RS25531
19521089	1719	1727	5-HTTLPR	GENEORGENEPRODUCT	6532
19521089	1761	1768	rs25531	SEQUENCEVARIANT	RS25531
19521089	1843	1845	PD	DISEASEORPHENOTYPICFEATURE	D010300
19521089	1928	1936	5-HTTLPR	GENEORGENEPRODUCT	6532
19521089	1994	2000	SLC6A4	GENEORGENEPRODUCT	6532
19521089	2081	2083	PD	DISEASEORPHENOTYPICFEATURE	D010300
19536134	32	36	TAK1	GENEORGENEPRODUCT	26409
19536134	99	102	BMP	GENEORGENEPRODUCT	12159
19536134	167	193	TGFbeta chinasi attivata 1	GENEORGENEPRODUCT	26409
19536134	227	231	TAK1	GENEORGENEPRODUCT	26409
19536134	281	287	MAPKKK	GENEORGENEPRODUCT	26409
19536134	496	500	TAK1	GENEORGENEPRODUCT	26409
19536134	565	569	topi	ORGANISMTAXON	10090
19536134	640	644	Tak1	GENEORGENEPRODUCT	26409
19536134	699	709	collagen 2	GENEORGENEPRODUCT	12824
19536134	743	747	Tak1	GENEORGENEPRODUCT	26409
19536134	780	784	col2	GENEORGENEPRODUCT	12824
19536134	814	819	 topi	ORGANISMTAXON	10090
19536134	874	889	condrodisplasia	DISEASEORPHENOTYPICFEATURE	D010009
19536134	1006	1025	anomalie articolari	DISEASEORPHENOTYPICFEATURE	 D007592
19536134	1077	1098	lussazione del gomito	DISEASEORPHENOTYPICFEATURE	D004204
19536134	1147	1162	fusione tarsale	DISEASEORPHENOTYPICFEATURE	D000070604
19536134	1235	1291	recettore della proteina morfogenetica dell'osso (BMPR)1	GENEORGENEPRODUCT	12166
19536134	1326	1330	Gdf5	GENEORGENEPRODUCT	14563
19536134	1367	1371	topi	ORGANISMTAXON	10090
19536134	1405	1409	BMPR	GENEORGENEPRODUCT	12166
19536134	1514	1518	TAK1	GENEORGENEPRODUCT	26409
19536134	1614	1617	BMP	GENEORGENEPRODUCT	12159
19536134	1695	1704	Smad1/5/8	GENEORGENEPRODUCT	17125,17129,55994
19536134	1739	1742	p38	GENEORGENEPRODUCT	26416
19536134	1775	1778	Jnk	GENEORGENEPRODUCT	26419
19536134	1812	1815	Erk	GENEORGENEPRODUCT	26413
19536134	1860	1871	MAP chinasi	GENEORGENEPRODUCT	26413,26416,26419
19536134	1905	1909	TAK1	GENEORGENEPRODUCT	26409
19536134	1948	1953	Smad1	GENEORGENEPRODUCT	17125
19536134	2117	2121	TAK1	GENEORGENEPRODUCT	26409
19536134	2170	2173	BMP	GENEORGENEPRODUCT	12159
19536134	2277	2286	Smad1/5/8	GENEORGENEPRODUCT	17125,17129,55994
19536134	2377	2388	MAP chinasi	GENEORGENEPRODUCT	26413,26416,26419
19536134	2485	2489	TAK1	GENEORGENEPRODUCT	26409
19549709	47	57	everolimus	CHEMICALENTITY	D000068338
19549709	93	99	RAD001	CHEMICALENTITY	D000068338
19549709	131	139	pazienti	ORGANISMTAXON	9606
19549709	187	192	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19549709	307	311	EGFR	GENEORGENEPRODUCT	1956
19549709	450	470	pretrattato avanzato	DISEASEORPHENOTYPICFEATURE	D002289
19549709	515	520	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19549709	549	557	pazienti	ORGANISMTAXON	9606
19549709	593	599	RAD001	CHEMICALENTITY	D000068338
19549709	655	695	bersaglio della rapamicina nei mammiferi	GENEORGENEPRODUCT	2475
19549709	729	733	mTOR	GENEORGENEPRODUCT	2475
19549709	814	819	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19549709	889	894	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19549709	922	930	pazienti	ORGANISMTAXON	9606
19549709	1027	1034	platino	CHEMICALENTITY	D010984
19549709	1105	1166	recettore del fattore di crescita epidermico tirosina chinasi	GENEORGENEPRODUCT	1956
19549709	1232	1238	RAD001	CHEMICALENTITY	D000068338
19549709	1328	1338	 tossicità	DISEASEORPHENOTYPICFEATURE	D064420
19549709	1476	1480	mTOR	GENEORGENEPRODUCT	2475
19549709	1549	1555	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19549709	1744	1752	pazienti	ORGANISMTAXON	9606
19549709	2088	2098	stanchezza	DISEASEORPHENOTYPICFEATURE	D005221
19549709	2143	2150	dispnea	DISEASEORPHENOTYPICFEATURE	D004417
19549709	2195	2204	stomatite	DISEASEORPHENOTYPICFEATURE	D013280
19549709	2249	2255	anemia	DISEASEORPHENOTYPICFEATURE	D000740
19549709	2301	2317	trombocitopenia 	DISEASEORPHENOTYPICFEATURE	D013921
19549709	2362	2371	Polmonite	DISEASEORPHENOTYPICFEATURE	D011014
19549709	2574	2577	AKT	GENEORGENEPRODUCT	207
19549709	2609	2613	pAKT	GENEORGENEPRODUCT	207
19549709	2728	2734	RAD001	CHEMICALENTITY	D000068338
19549709	2866	2871	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19549709	2934	2940	RAD001	CHEMICALENTITY	D000068338
19549709	3009	3014	NSCLC	DISEASEORPHENOTYPICFEATURE	D002289
19592582	33	45	Matriptasi-2	GENEORGENEPRODUCT	164656
19592582	90	95	ferro	CHEMICALENTITY	D007501
19592582	150	176	anemia da carenza di ferro	DISEASEORPHENOTYPICFEATURE	D018798
19592582	204	212	pazienti	ORGANISMTAXON	9606
19592582	390	402	matriptasi-2	GENEORGENEPRODUCT	164656
19592582	433	438	umani	ORGANISMTAXON	9606
19592582	501	548	anemia da carenza di ferro refrattaria al ferro	DISEASEORPHENOTYPICFEATURE	C562385
19592582	593	598	IRIDA	DISEASEORPHENOTYPICFEATURE	C562385
19592582	651	670	livelli di epcidina	GENEORGENEPRODUCT	57817
19592582	771	783	matriptasi-2	GENEORGENEPRODUCT	164656
19592582	818	825	TMPRSS6	GENEORGENEPRODUCT	164656
19592582	925	930	IRIDA	DISEASEORPHENOTYPICFEATURE	C562385
19592582	1005	1011	P686fs	SEQUENCEVARIANT	P|FS|P|686||
19592582	1061	1100	inserimento dei quattro nucleotidi CCCC	SEQUENCEVARIANT	C|INS ||CCCC
19592582	1343	1351	c.467C>A	SEQUENCEVARIANT	C|SUB|C|467|A
19592582	1393	1401	c.468C>T	SEQUENCEVARIANT	C |SUB|C|468|T
19592582	1485	1490	A118D	SEQUENCEVARIANT	P|SUB|A|118|D
19592582	1584	1596	matriptasi-2	GENEORGENEPRODUCT	164656
19592582	1676	1688	matriptase-2	GENEORGENEPRODUCT	164656
19592582	1777	1784	epcidin	GENEORGENEPRODUCT	57817
19592582	1890	1895	A118D	SEQUENCEVARIANT	P|SUB|A|118|D
19592582	1992	2004	matriptasi-2	GENEORGENEPRODUCT	164656
19592582	2122	2129	TMPRSS6	GENEORGENEPRODUCT	164656
19592582	2185	2190	IRIDA	DISEASEORPHENOTYPICFEATURE	C562385
19592582	2395	2407	matriptasi-2	GENEORGENEPRODUCT	164656
19592582	2460	2476	carenza di ferro	DISEASEORPHENOTYPICFEATURE	D018798
19631624	51	85	Deficit di apprendimento e memoria	DISEASEORPHENOTYPICFEATURE	D007859,D008569
19631624	120	128	ecstasy 	CHEMICALENTITY	D018817
19631624	292	299	ecstasy	CHEMICALENTITY	D018817
19631624	360	409	compromissioni nell'apprendimento e nella memoria	DISEASEORPHENOTYPICFEATURE	D007859,D008569
19631624	541	548	ecstasy	CHEMICALENTITY	D018817
19631624	971	978	ecstasy	CHEMICALENTITY	D018817
19631624	1080	1088	cannabis	CHEMICALENTITY	D002188
19631624	1127	1134	ecstasy	CHEMICALENTITY	D018817
19631624	1221	1229	cannabis	CHEMICALENTITY	D002188
19631624	1362	1396	Deficit di apprendimento e memoria	DISEASEORPHENOTYPICFEATURE	D007859,D008569
19631624	1457	1469	iperattività	DISEASEORPHENOTYPICFEATURE	D006948
19631624	1547	1555	cannabis	CHEMICALENTITY	D002188
19631624	1614	1621	Ecstasy	CHEMICALENTITY	D018817
19631624	1750	1758	cannabis	CHEMICALENTITY	D002188
19631624	1879	1886	ecstasy	CHEMICALENTITY	D018817
19631624	1940	1952	iperattività	DISEASEORPHENOTYPICFEATURE	D006948
19631624	2130	2167	L'ipoattività specifica per l'ecstasy	CHEMICALENTITY	D018817
19631624	2339	2346	ecstasy	CHEMICALENTITY	D018817
19631624	2380	2388	cannabis	CHEMICALENTITY	D002188
19631624	2617	2624	ecstasy	CHEMICALENTITY	D018817
19631624	2728	2736	cannabis	CHEMICALENTITY	D002188
19631624	2801	2808	ecstasy	CHEMICALENTITY	D018817
19631624	2942	2954	neurotossico	DISEASEORPHENOTYPICFEATURE	D020258
19631624	2997	3004	ecstasy	CHEMICALENTITY	D018817
19642243	43	69	Insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
19642243	100	108	pazienti	ORGANISMTAXON	9606
19642243	156	160	AIDS	DISEASEORPHENOTYPICFEATURE	D000163
19642243	198	207	tenofovir	CHEMICALENTITY	D000068698
19642243	277	288	vancomicina	CHEMICALENTITY	D014640
19642243	342	354	osteomielite	DISEASEORPHENOTYPICFEATURE	D010019
19642243	399	419	Insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
19642243	490	501	vancomicina	CHEMICALENTITY	D014640
19642243	535	543	pazienti	ORGANISMTAXON	9606
19642243	600	629	tenofovir disoproxil fumarato	CHEMICALENTITY	D000068698
19642243	705	714	Tenofovir	CHEMICALENTITY	D000068698
19642243	794	813	Sindrome di Fanconi	DISEASEORPHENOTYPICFEATURE	D005198
19642243	860	880	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
19642243	967	978	Vancomicina	CHEMICALENTITY	D014640
19642243	1022	1036	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
19642243	1133	1152	agente nefrotossico	DISEASEORPHENOTYPICFEATURE	D007674
19642243	1237	1246	tenofovir	CHEMICALENTITY	D000068698
19642243	1318	1338	insufficienza renale	DISEASEORPHENOTYPICFEATURE	D051437
19642243	1409	1420	vancomicina	CHEMICALENTITY	D014640
19672862	31	53	Protein chinasi C alfa	GENEORGENEPRODUCT	5578
19672862	134	157	 cancro dell'endometrio	DISEASEORPHENOTYPICFEATURE	D016889
19672862	222	234	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
19672862	279	304	Il cancro dell'endometrio	DISEASEORPHENOTYPICFEATURE	D016889
19672862	373	393	maligno ginecologico	DISEASEORPHENOTYPICFEATURE	D005833
19672862	622	639	protein chinasi C	GENEORGENEPRODUCT	5578
19672862	672	675	PKC	GENEORGENEPRODUCT	5578
19672862	719	727	PKCalpha	GENEORGENEPRODUCT	5578
19672862	809	836	adenocarcinoma endometriale	DISEASEORPHENOTYPICFEATURE	D016889
19672862	925	933	PKCalpha	GENEORGENEPRODUCT	5578
19672862	1122	1128	tumore	DISEASEORPHENOTYPICFEATURE	D009369
19672862	1177	1181	topi	ORGANISMTAXON	10090
19672862	1254	1262	PKCalpha	GENEORGENEPRODUCT	5578
19672862	1332	1358	chinasi ciclina-dipendente	GENEORGENEPRODUCT	983
19672862	1390	1393	CDK	GENEORGENEPRODUCT	983
19672862	1436	1439	p21	GENEORGENEPRODUCT	1026
19672862	1472	1476	Cip1	GENEORGENEPRODUCT	1026
19672862	1508	1512	WAF1	GENEORGENEPRODUCT	1026
19672862	1546	1549	p21	GENEORGENEPRODUCT	1026
19672862	1584	1587	p27	GENEORGENEPRODUCT	1027
19672862	1619	1623	Kip1	GENEORGENEPRODUCT	1027
19672862	1658	1661	p27	GENEORGENEPRODUCT	1027
19672862	1742	1769	fosfatasi e tensina omologo	GENEORGENEPRODUCT	5728
19672862	1802	1806	PTEN	GENEORGENEPRODUCT	5728
19672862	1885	1893	PKCalpha	GENEORGENEPRODUCT	5578
19672862	1943	1946	Akt	GENEORGENEPRODUCT	 207
19672862	2050	2053	Akt	GENEORGENEPRODUCT	207
19672862	2094	2125	glicogeno sintasi chinasi-3beta	GENEORGENEPRODUCT	 2932
19672862	2158	2167	GSK-3beta	GENEORGENEPRODUCT	2932
19672862	2201	2209	PKCalpha	GENEORGENEPRODUCT	5578
19672862	2305	2308	ERK	GENEORGENEPRODUCT	5594
19672862	2353	2356	ERK	GENEORGENEPRODUCT	5594
19672862	2405	2408	EGF	GENEORGENEPRODUCT	1950
19672862	2454	2457	p21	GENEORGENEPRODUCT	1026
19672862	2491	2494	p27	GENEORGENEPRODUCT	1027
19672862	2628	2631	ERK	GENEORGENEPRODUCT	5594
19672862	2664	2667	Akt	GENEORGENEPRODUCT	207
19672862	2725	2733	PKCalpha	GENEORGENEPRODUCT	5578
19672862	2771	2774	CDK	GENEORGENEPRODUCT	983
19672862	2838	2841	Akt	GENEORGENEPRODUCT	207
19672862	2875	2878	ERK	GENEORGENEPRODUCT	5594
19672862	2962	2990	adenocarcinoma endometrioide	DISEASEORPHENOTYPICFEATURE	D016889
19672862	3059	3067	PKCalpha	GENEORGENEPRODUCT	5578
19672862	3135	3143	PKCalpha	GENEORGENEPRODUCT	5578
19672862	3279	3287	PKCalpha	GENEORGENEPRODUCT	5578
19672862	3337	3349	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
19672862	3418	3421	CDK	GENEORGENEPRODUCT	983
19672862	3463	3466	p21	GENEORGENEPRODUCT	1026
19672862	3501	3504	p27	GENEORGENEPRODUCT	 1027
19672862	3552	3555	Akt	GENEORGENEPRODUCT	207
19672862	3589	3592	ERK	GENEORGENEPRODUCT	5594
19672862	3680	3688	PKCalpha	GENEORGENEPRODUCT	5578
19672862	3774	3793	tumori endometriali	DISEASEORPHENOTYPICFEATURE	D016889
19692487	28	32	Topi	ORGANISMTAXON	10090
19692487	74	81	mPGES-1	GENEORGENEPRODUCT	64292
19692487	131	136	litio	CHEMICALENTITY	D008094
19692487	188	196	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	230	263	L'attività della ciclossigenasi-2	GENEORGENEPRODUCT	19225
19692487	326	331	litio	CHEMICALENTITY	D008094
19692487	383	391	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	489	503	prostaglandina	CHEMICALENTITY	D011453
19692487	536	538	PG	CHEMICALENTITY	D011453
19692487	647	652	litio	CHEMICALENTITY	D008094
19692487	707	715	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	748	752	topi	ORGANISMTAXON	10090
19692487	796	835	prostaglandina microsomiale E sintasi-1	GENEORGENEPRODUCT	64292
19692487	871	878	mPGES-1	GENEORGENEPRODUCT	64292
19692487	951	955	LiCl	CHEMICALENTITY	D018021
19692487	1019	1026	mPGES-1	GENEORGENEPRODUCT	64292
19692487	1059	1063	topi	ORGANISMTAXON	10090
19692487	1129	1138	 poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	1262	1269	mPGES-1	GENEORGENEPRODUCT	64292
19692487	1326	1332	PGE(2)	CHEMICALENTITY	D015232
19692487	1391	1398	mPGES-1	GENEORGENEPRODUCT	64292
19692487	1431	1435	topi	ORGANISMTAXON	10090
19692487	1497	1502	litio	CHEMICALENTITY	D008094
19692487	1554	1562	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	1692	1698	PGE(2)	CHEMICALENTITY	D015232
19692487	1732	1736	cAMP	CHEMICALENTITY	D000242
19692487	1899	1912	acquaporina-2	GENEORGENEPRODUCT	11827
19692487	1946	1972	 Espressione proteica AQP2	GENEORGENEPRODUCT	11827
19692487	2051	2056	litio	CHEMICALENTITY	D008094
19692487	2099	2103	topi	ORGANISMTAXON	10090
19692487	2197	2201	topi	ORGANISMTAXON	10090
19692487	2295	2299	AQP2	GENEORGENEPRODUCT	11827
19692487	2435	2443	Na-K-2Cl	GENEORGENEPRODUCT	20495
19692487	2477	2482	NKCC2	GENEORGENEPRODUCT	20495
19692487	2555	2559	topi	ORGANISMTAXON	10090
19692487	2629	2635	litio 	CHEMICALENTITY	D008094
19692487	2746	2751	NKCC2	GENEORGENEPRODUCT	20495
19692487	2825	2829	topi	ORGANISMTAXON	10090
19692487	2879	2886	mPGES-1	GENEORGENEPRODUCT	64292
19692487	2927	2933	PGE(2)	CHEMICALENTITY	D015232
19692487	2972	2977	litio	CHEMICALENTITY	D008094
19692487	3029	3037	poliuria	DISEASEORPHENOTYPICFEATURE	D011141
19692487	3103	3107	AQP2	GENEORGENEPRODUCT	11827
19692487	3142	3147	NKCC2	GENEORGENEPRODUCT	20495
19696792	71	76	ABCG2	GENEORGENEPRODUCT	9429
19696792	125	136	 irinotecan	CHEMICALENTITY	D000077146
19696792	194	211	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	247	257	Irinotecan	CHEMICALENTITY	D000077146
19696792	381	417	tumori del colon-retto e del polmone	DISEASEORPHENOTYPICFEATURE	D008175,D015179
19696792	480	489	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
19696792	538	555	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	601	608	diarrea	DISEASEORPHENOTYPICFEATURE	D003967
19696792	737	747	irinotecan	CHEMICALENTITY	D000077146
19696792	797	814	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	879	887	pazienti	ORGANISMTAXON	9606
19696792	952	969	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	1003	1011	pazienti	ORGANISMTAXON	9606
19696792	1087	1096	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
19696792	1258	1268	irinotecan	CHEMICALENTITY	D000077146
19696792	1410	1427	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	1592	1601	rs2622604	SEQUENCEVARIANT	RS2622604
19696792	1637	1642	ABCG2	GENEORGENEPRODUCT	9429
19696792	1783	1800	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19696792	2017	2022	ABCG2	GENEORGENEPRODUCT	9429
19696792	2166	2176	irinotecan	CHEMICALENTITY	D000077146
19696792	2243	2260	mielosoppressione	DISEASEORPHENOTYPICFEATURE	D001855
19707748	43	52	Sequestri	DISEASEORPHENOTYPICFEATURE	D012640
19707748	96	109	levofloxacina	CHEMICALENTITY	D064704
19707748	225	233	paziente	ORGANISMTAXON	9606
19707748	295	306	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19707748	376	389	levofloxacina	CHEMICALENTITY	D064704
19707748	503	528	citocromo P450 (CYP ) 1A2	GENEORGENEPRODUCT	1544
19707748	604	617	levofloxacina	CHEMICALENTITY	D064704
19707748	670	681	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19707748	872	885	levofloxacina	CHEMICALENTITY	D064704
19707748	1024	1037	levofloxacina	CHEMICALENTITY	D064704
19707748	1081	1092	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19707748	1207	1213	CYP1A2	GENEORGENEPRODUCT	1544
19707748	1257	1270	levofloxacina	CHEMICALENTITY	D064704
19707748	1443	1456	levofloxacina	CHEMICALENTITY	D064704
19707748	1487	1495	pazienti	ORGANISMTAXON	9606
19707748	1588	1594	CYP1A2	GENEORGENEPRODUCT	1544
19719056	31	39	Destrano	CHEMICALENTITY	D003911
19719056	71	79	etodolac	CHEMICALENTITY	D017308
19719056	163	171	Etodolac	CHEMICALENTITY	D017308
19719056	182	183	E	CHEMICALENTITY	D017308
19719056	273	297	farmaco antinfiammatorio	CHEMICALENTITY	D000893
19719056	357	365	destrano	CHEMICALENTITY	D003911
19719056	447	455	etodolac	CHEMICALENTITY	D017308
19719056	488	496	destrano	CHEMICALENTITY	D003911
19719056	547	549	ED	CHEMICALENTITY	D003911,D017308
19719056	755	763	etodolac	CHEMICALENTITY	D017308
19719056	879	887	destrano	CHEMICALENTITY	D003911
19719056	1040	1046	estere	CHEMICALENTITY	D004952
19719056	1093	1116	I contenuti di Etodolac	CHEMICALENTITY	D017308
19719056	1352	1354	ED	CHEMICALENTITY	D003911,D017308
19719056	1453	1465	plasma umano	ORGANISMTAXON	9606
19719056	1536	1544	etodolac	CHEMICALENTITY	D017308
19719056	1596	1598	ED	CHEMICALENTITY	D003911,D017308
19719056	1693	1698	umano	ORGANISMTAXON	9606
19719056	1913	1926	acido acetico	CHEMICALENTITY	D019342
19719056	1987	1991	topi	ORGANISMTAXON	10090
19719056	2026	2037	carragenina	CHEMICALENTITY	D002351
19719056	2077	2080	rat	ORGANISMTAXON	10116
19719056	2131	2144	modello edema	DISEASEORPHENOTYPICFEATURE	D004487
19719056	2195	2196	E	CHEMICALENTITY	D017308
19719056	2561	2569	etodolac	CHEMICALENTITY	D017308
19721134	87	98	pilocarpina	CHEMICALENTITY	D010862
19721134	214	225	pilocarpina	CHEMICALENTITY	D010862
19721134	320	329	aconitina	CHEMICALENTITY	D000157
19721134	366	369	rat	ORGANISMTAXON	10116
19721134	403	410	ouabain	CHEMICALENTITY	D010042
19721134	448	453	cavia	ORGANISMTAXON	10141
19721134	497	504	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
19721134	638	644	calcio	CHEMICALENTITY	D002118
19721134	678	684	Ca(2+)	CHEMICALENTITY	D002118
19721134	775	786	pilocarpina	CHEMICALENTITY	D010862
19721134	878	885	aritmie	DISEASEORPHENOTYPICFEATURE	D001145
19721134	973	1013	tachicardia ventricolare e fibrillazione	DISEASEORPHENOTYPICFEATURE	D017180|D014693
19721134	1079	1086	aritmia	DISEASEORPHENOTYPICFEATURE	D001145
19721134	1172	1180	aritmico	DISEASEORPHENOTYPICFEATURE	D001145
19721134	1209	1214	ratti	ORGANISMTAXON	10116
19721134	1246	1251	cavie	ORGANISMTAXON	10141
19721134	1285	1291	Ca(2+)	CHEMICALENTITY	D002118
19721134	1351	1360	aconitina	CHEMICALENTITY	D000157
19721134	1394	1401	ouabain	CHEMICALENTITY	D010042
19721134	1484	1495	pilocarpina	CHEMICALENTITY	D010862
19721134	1548	1592	Recettore M(3)-muscarinico dell'acetilcolina	GENEORGENEPRODUCT	100379235,24260
19721134	1636	1641	mAChR	GENEORGENEPRODUCT	100379235,24260
19721134	1686	1692	4-DAMP	CHEMICALENTITY	C042375
19721134	1725	1770	4-difenilacetossi-N-metilpiperidina-metiodide	CHEMICALENTITY	C042375
19721134	1854	1865	pilocarpina	CHEMICALENTITY	D010862
19721134	1927	1938	pilocarpina	CHEMICALENTITY	D010862
19721134	2018	2026	aritmico	DISEASEORPHENOTYPICFEATURE	D001145
19721134	2056	2059	rat	ORGANISMTAXON	10116
19721134	2090	2095	cavia	ORGANISMTAXON	10141
19721134	2146	2156	aconitina 	CHEMICALENTITY	D000157
19721134	2190	2197	ouabain	CHEMICALENTITY	D010042
19721134	2260	2271	M(3)-mAChR 	GENEORGENEPRODUCT	100379235,24260
19721134	2374	2380	Ca(2+)	CHEMICALENTITY	D002118
19728177	54	63	ipotermia	DISEASEORPHENOTYPICFEATURE	D007036
19728177	140	156	 edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	202	227	ipertensione intracranica	DISEASEORPHENOTYPICFEATURE	D019586
19728177	283	315	insufficienza epatica fulminante	DISEASEORPHENOTYPICFEATURE	D017114
19728177	420	428	pazienti	ORGANISMTAXON	9606
19728177	476	491	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	546	578	insufficienza epatica fulminante	DISEASEORPHENOTYPICFEATURE	D017114
19728177	623	626	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	713	716	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	761	770	ipotermia	DISEASEORPHENOTYPICFEATURE	D007036
19728177	964	967	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	1014	1017	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	1058	1070	paracetamolo	CHEMICALENTITY	D000082
19728177	1127	1142	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	1192	1200	paziente	ORGANISMTAXON	9606
19728177	1325	1334	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
19728177	1369	1381	paracetamolo	CHEMICALENTITY	D000082
19728177	1460	1468	paziente	ORGANISMTAXON	9606
19728177	1518	1526	depresso	DISEASEORPHENOTYPICFEATURE	D003866
19728177	1660	1663	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	1698	1711	acetaminofene	CHEMICALENTITY	D000082
19728177	1758	1773	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	1805	1813	paziente	ORGANISMTAXON	9606
19728177	1900	1916	iperventilazione	DISEASEORPHENOTYPICFEATURE	D006985
19728177	1981	1989	paralisi	DISEASEORPHENOTYPICFEATURE	D010243
19728177	2157	2166	ipotermia	DISEASEORPHENOTYPICFEATURE	D007036
19728177	2252	2260	paziente	ORGANISMTAXON	9606
19728177	2328	2343	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	2389	2414	ipertensione intracranica	DISEASEORPHENOTYPICFEATURE	D019586
19728177	2547	2555	pazienti	ORGANISMTAXON	9606
19728177	2603	2606	FHF	DISEASEORPHENOTYPICFEATURE	D017114
19728177	2653	2668	edema cerebrale	DISEASEORPHENOTYPICFEATURE	D001929
19728177	2703	2715	paracetamolo	CHEMICALENTITY	D000082
19728177	2796	2805	ipotermia	DISEASEORPHENOTYPICFEATURE	D007036
19728177	2998	3007	ipotermia	DISEASEORPHENOTYPICFEATURE	D007036
19728177	3038	3046	pazienti	ORGANISMTAXON	9606
19779499	36	43	CACNA1S	GENEORGENEPRODUCT	779
19779499	124	155	periodico ipokaliemico paralisi	DISEASEORPHENOTYPICFEATURE	D020514
19779499	229	260	Paralisi periodica ipokaliemica	DISEASEORPHENOTYPICFEATURE	D020514
19779499	305	311	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19779499	362	391	disturbo autosomico dominante	DISEASEORPHENOTYPICFEATURE	D030342
19779499	476	495	debolezza muscolare	DISEASEORPHENOTYPICFEATURE	D018908
19779499	566	574	potassio	CHEMICALENTITY	D011188
19779499	659	665	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19779499	722	729	CACNA1S	GENEORGENEPRODUCT	779
19779499	781	840	subunità alfa del canale del calcio del muscolo scheletrico	GENEORGENEPRODUCT	779
19779499	989	996	CACNA1S	GENEORGENEPRODUCT	779
19779499	1056	1062	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19779499	1091	1099	pazienti	ORGANISMTAXON	9606
19779499	1242	1249	CACNA1S	GENEORGENEPRODUCT	779
19779499	1438	1444	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19779499	1537	1542	V876E	SEQUENCEVARIANT	RS267606698
19779499	1598	1604	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19779499	1633	1641	pazienti	ORGANISMTAXON	9606
19779499	1801	1806	V876E	SEQUENCEVARIANT	RS267606698
19779499	1984	1989	morte	DISEASEORPHENOTYPICFEATURE	D003643
19779499	2074	2081	CACNA1S	GENEORGENEPRODUCT	779
19779499	2139	2146	CACNA1S	GENEORGENEPRODUCT	779
19779499	2212	2218	HypoPP	DISEASEORPHENOTYPICFEATURE	D020514
19811499	73	105	fattore di necrosi tumorale-alfa	GENEORGENEPRODUCT	21926,7124
19811499	145	168	fattore nucleare-kappaB	GENEORGENEPRODUCT	18033,4790
19811499	207	237	proteina morfogenetica ossea-2	GENEORGENEPRODUCT	12156,650
19811499	303	312	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
19811499	375	395	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19811499	606	645	metastasi del cancro alla prostata (PC)	DISEASEORPHENOTYPICFEATURE	D009362,D011471
19811499	760	809	fosfoinositide 3-chinasi (PI3K)/protein chinasi B	GENEORGENEPRODUCT	207
19811499	841	844	Akt	GENEORGENEPRODUCT	207
19811499	931	967	proteina morfogenetica ossea (BMP)-2	GENEORGENEPRODUCT	650
19811499	1024	1052	fattore nucleare (NF)-kappaB	GENEORGENEPRODUCT	4790
19811499	1126	1146	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19811499	1224	1233	NF-kappaB	GENEORGENEPRODUCT	4790
19811499	1278	1283	umano	ORGANISMTAXON	9606
19811499	1328	1366	fattore di necrosi tumorale (TNF)-alfa	GENEORGENEPRODUCT	7124
19811499	1429	1432	p65	GENEORGENEPRODUCT	5970
19811499	1761	1772	osteopontin	GENEORGENEPRODUCT	6696
19811499	1804	1815	osteocalcin	GENEORGENEPRODUCT	632
19811499	1850	1863	collagene IA1	GENEORGENEPRODUCT	1277
19811499	1932	1934	PC	DISEASEORPHENOTYPICFEATURE	D011471
19811499	2026	2028	PC	DISEASEORPHENOTYPICFEATURE	D011471
19811499	2084	2089	BMP-4	GENEORGENEPRODUCT	652
19811499	2134	2139	BMP-2	GENEORGENEPRODUCT	650
19811499	2348	2354	Noggin	GENEORGENEPRODUCT	9241
19811499	2395	2400	BMP-2	GENEORGENEPRODUCT	650
19811499	2462	2471	TNF-alpha	GENEORGENEPRODUCT	7124
19811499	2570	2579	NF-kappaB	GENEORGENEPRODUCT	4790
19811499	2612	2621	TNF-alpha	GENEORGENEPRODUCT	7124
19811499	2682	2691	TNF-alpha	GENEORGENEPRODUCT	7124
19811499	2790	2795	BMP-2	GENEORGENEPRODUCT	12156
19811499	2831	2834	BMP	GENEORGENEPRODUCT	12156
19811499	2878	2882	Smad	GENEORGENEPRODUCT	17127
19811499	2930	2980	recettore inibito attivatore del ligando NF-kappaB	GENEORGENEPRODUCT	21943
19811499	3262	3270	TNF-alfa	GENEORGENEPRODUCT	7124
19811499	3313	3317	BMP2	GENEORGENEPRODUCT	650
19811499	3514	3519	BMP-2	GENEORGENEPRODUCT	12156
19811499	3564	3573	NF-kappaB	GENEORGENEPRODUCT	4790
19811499	3846	3848	PC	DISEASEORPHENOTYPICFEATURE	D011471
19841052	39	52	crack cocaina	CHEMICALENTITY	D016578
19841052	125	141	Infezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
19841052	279	292	crack cocaina	CHEMICALENTITY	D016578
19841052	357	373	infezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
19841052	431	444	crack cocaina	CHEMICALENTITY	D016578
19841052	593	609	Infezione da HIV	DISEASEORPHENOTYPICFEATURE	 D015658
19841052	935	938	HIV	DISEASEORPHENOTYPICFEATURE	D015658
19841052	1088	1113	sieroconversione dell'HIV	DISEASEORPHENOTYPICFEATURE	D006679
19841052	1175	1188	crack cocaina	CHEMICALENTITY	D016578
19841052	1628	1644	infezione da HIV	DISEASEORPHENOTYPICFEATURE	D015658
19841052	1784	1797	crack cocaina	CHEMICALENTITY	D016578
19841052	1997	2022	sieroconversione dell'HIV	DISEASEORPHENOTYPICFEATURE	D006679
19841052	2107	2120	crack cocaina	CHEMICALENTITY	D016578
19841052	2362	2375	crack cocaina	CHEMICALENTITY	D016578
19841052	2477	2502	sieroconversione dell'HIV	DISEASEORPHENOTYPICFEATURE	D006679
19841052	2719	2732	crack cocaina	CHEMICALENTITY	D016578
19881468	31	36	hOGG1	GENEORGENEPRODUCT	4968
19881468	71	80	Ser326Cys	SEQUENCEVARIANT	RS1052133
19881468	150	168	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
19881468	217	222	Umano	ORGANISMTAXON	9606
19881468	254	285	8-ossoguanina DNA glicosilasi 1	GENEORGENEPRODUCT	4968
19881468	319	324	hOGG1	GENEORGENEPRODUCT	4968
19881468	401	417	8-idrossiguanina	CHEMICALENTITY	C024829
19881468	521	530	rs1052133	SEQUENCEVARIANT	RS1052133
19881468	621	637	326 da Ser a Cys	SEQUENCEVARIANT	RS1052133
19881468	751	756	hOGG1	GENEORGENEPRODUCT	4968
19881468	791	797	Cys326	SEQUENCEVARIANT	RS1052133
19881468	891	900	rs1052133	SEQUENCEVARIANT	RS1052133
19881468	946	964	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
19881468	1038	1056	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
19881468	1206	1224	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
19881468	1317	1323	cancro	DISEASEORPHENOTYPICFEATURE	 D009369
19881468	1510	1528	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
19881468	1805	1832	carcinoma a piccole cellule	DISEASEORPHENOTYPICFEATURE	D018288
19881468	1955	1969	adenocarcinoma	DISEASEORPHENOTYPICFEATURE	D000230
19881468	2169	2183	adenocarcinoma	DISEASEORPHENOTYPICFEATURE	D000230
19881468	2299	2344	tumori polmonari squamosi e a piccole cellule	DISEASEORPHENOTYPICFEATURE	D002289,D055752
19881468	2410	2419	rs1052133	SEQUENCEVARIANT	RS1052133
19881468	2493	2519	adenocarcinoma del polmone	DISEASEORPHENOTYPICFEATURE	D000077192
19889778	88	93	G145R	SEQUENCEVARIANT	P|SUB|G|145|R
19889778	135	140	P120T	SEQUENCEVARIANT	C|SUB|P|120|T
19889778	189	199	lamivudina	CHEMICALENTITY	D019259
19889778	242	273	virus e antigene dell'epatite B	CHEMICALENTITY	D006513
19889778	365	385	virus dell'epatite B	ORGANISMTAXON	10407
19889778	415	418	HBV	ORGANISMTAXON	10407
19889778	577	580	HBV	ORGANISMTAXON	10407
19889778	940	945	G145R	SEQUENCEVARIANT	P|SUB|G|145|R
19889778	988	993	P120T	SEQUENCEVARIANT	C|SUB|P|120|T
19889778	1174	1184	lamivudine	CHEMICALENTITY	D019259
19889778	1217	1220	LAM	CHEMICALENTITY	D019259
19889778	1257	1262	HBeAg	CHEMICALENTITY	D006513
19889778	1310	1313	HBV	ORGANISMTAXON	10407
19889778	1388	1393	G145R	SEQUENCEVARIANT	P|SUB|G|145|R
19889778	1435	1440	P120T	SEQUENCEVARIANT	C|SUB|P|120|T
19889778	1474	1477	LAM	CHEMICALENTITY	D019259
19889778	1530	1535	M204I	SEQUENCEVARIANT	P|SUB|M|204|I
19889778	1579	1584	L180M	SEQUENCEVARIANT	P|SUB|L|180|M
19889778	1625	1630	M204V	SEQUENCEVARIANT	P|SUB|M|204|V
19889778	1690	1695	HBeAg	CHEMICALENTITY	D006513
19889778	1753	1758	HBeAg	CHEMICALENTITY	D006513
19889778	1805	1821	 mutanti precore	GENEORGENEPRODUCT	944568
19889778	1856	1858	PC	GENEORGENEPRODUCT	944568
19889778	1950	1955	G145R	SEQUENCEVARIANT	P|SUB|G|145|R
19889778	2008	2013	HBsAg	CHEMICALENTITY	D006514
19889778	2126	2129	LAM	CHEMICALENTITY	D019259
19889778	2169	2172	HBV	ORGANISMTAXON	10407
19889778	2233	2236	HBV	ORGANISMTAXON	10407
19889778	2272	2274	PC	GENEORGENEPRODUCT	944568
19889778	2412	2417	P120T	SEQUENCEVARIANT	C|SUB|P|120|T
19889778	2473	2478	HBsAg	CHEMICALENTITY	D006514
19889778	2579	2582	LAM	CHEMICALENTITY	D019259
19889778	2656	2661	HBeAg	CHEMICALENTITY	D006513
19889778	2707	2709	PC	GENEORGENEPRODUCT	944568
19889778	2755	2760	P120T	SEQUENCEVARIANT	C|SUB|P|120|T
19889778	2794	2797	LAM	CHEMICALENTITY	D019259
19889778	2905	2908	HBV	ORGANISMTAXON	10407
19889778	3016	3019	LAM	CHEMICALENTITY	D019259
19889778	3078	3086	adefovir	CHEMICALENTITY	C053001
19889778	3123	3132	tenofovir	CHEMICALENTITY	D000068698
19889778	3392	3395	HBV	ORGANISMTAXON	10407
19891556	34	45	Clopidogrel	CHEMICALENTITY	D000077144
19891556	213	224	clopidogrel	CHEMICALENTITY	D000077144
19891556	301	320	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
19891556	349	357	pazienti	ORGANISMTAXON	9606
19891556	458	466	pazienti	ORGANISMTAXON	9606
19891556	556	567	Clopidogrel	CHEMICALENTITY	D000077144
19891556	659	666	CYP2C19	GENEORGENEPRODUCT	1557
19891556	783	790	CYP2C19	GENEORGENEPRODUCT	1557
19891556	923	935	clop idogrel	CHEMICALENTITY	D000077144
19891556	1228	1239	clopidogrel	CHEMICALENTITY	D000077144
19891556	1300	1307	CYP2C19	GENEORGENEPRODUCT	1557
19891556	1354	1365	clopidogrel	CHEMICALENTITY	D000077144
19891556	1547	1554	CYP2C19	GENEORGENEPRODUCT	1557
19891556	1652	1664	clopidogrel 	CHEMICALENTITY	D000077144
19918264	31	36	FGFR4	GENEORGENEPRODUCT	2264
19918264	70	79	Gly388Arg	SEQUENCEVARIANT	RS351855
19918264	149	169	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19918264	203	209	uomini	ORGANISMTAXON	9606
19918264	251	302	Recettore 4 del fattore di crescita dei fibroblasti	GENEORGENEPRODUCT	2264
19918264	335	340	FGFR4	GENEORGENEPRODUCT	2264
19918264	388	393	FGFR4	GENEORGENEPRODUCT	2264
19918264	425	465	recettore della crescita dei fibroblasti	GENEORGENEPRODUCT	2264
19918264	702	707	FGFR4	GENEORGENEPRODUCT	2264
19918264	771	804	glicina (Gly ) con arginina (Arg)	SEQUENCEVARIANT	RS351855
19918264	930	950	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19918264	979	987	pazienti	ORGANISMTAXON	9606
19918264	1084	1104	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19918264	1132	1140	pazienti	ORGANISMTAXON	9606
19918264	1189	1192	IPB	DISEASEORPHENOTYPICFEATURE	D011470
19918264	1220	1228	pazienti	ORGANISMTAXON	9606
19918264	1415	1420	FGFR4	GENEORGENEPRODUCT	2264
19918264	1604	1624	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19918264	1766	1772	cancro	DISEASEORPHENOTYPICFEATURE	D009369
19918264	1848	1851	BPH	DISEASEORPHENOTYPICFEATURE	D011470
19918264	1971	1977	cancro	DISEASEORPHENOTYPICFEATURE	D009369
19918264	2023	2026	IPB	DISEASEORPHENOTYPICFEATURE	D011470
19918264	2055	2063	pazienti	ORGANISMTAXON	9606
19918264	2127	2133	cancro	DISEASEORPHENOTYPICFEATURE	D009369
19918264	2234	2245	Gly(388)Arg	SEQUENCEVARIANT	RS351855
19918264	2280	2285	FGFR4	GENEORGENEPRODUCT	2264
19918264	2370	2390	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
19918264	2424	2430	uomini	ORGANISMTAXON	9606
19923525	31	41	Nimodipina	CHEMICALENTITY	D009553
19923525	94	122	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
19923525	165	179	nitroglicerina	CHEMICALENTITY	D005996
19923525	234	245	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19923525	287	291	topi	ORGANISMTAXON	10090
19923525	348	359	Ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19923525	503	524	disfunzione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
19923525	587	597	nimodipina	CHEMICALENTITY	D009553
19923525	630	634	NIMO	CHEMICALENTITY	D009553
19923525	698	712	nitroglicerina	CHEMICALENTITY	D005996
19923525	745	748	NTG	CHEMICALENTITY	D005996
19923525	802	813	ipotensione	DISEASEORPHENOTYPICFEATURE	 D007022
19923525	1285	1289	topi	ORGANISMTAXON	10090
19923525	1425	1428	NTG	CHEMICALENTITY	D005996
19923525	1492	1495	NTG	CHEMICALENTITY	D005996
19923525	1556	1559	NTG	CHEMICALENTITY	D005996
19923525	1593	1597	NIMO	CHEMICALENTITY	D009553
19923525	1647	1651	NIMO	CHEMICALENTITY	D009553
19923525	1716	1727	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19923525	1998	2002	Topi	ORGANISMTAXON	10090
19923525	2057	2067	ipotensivi	DISEASEORPHENOTYPICFEATURE	D007022
19923525	2239	2242	NTG	CHEMICALENTITY	D005996
19923525	2276	2280	NIMO	CHEMICALENTITY	D009553
19923525	2324	2327	NTG	CHEMICALENTITY	D005996
19923525	2589	2593	topi	ORGANISMTAXON	10090
19923525	2683	2686	NTG	CHEMICALENTITY	D005996
19923525	2728	2731	NTG	CHEMICALENTITY	D005996
19923525	2765	2769	NIMO	CHEMICALENTITY	D009553
19923525	3020	3024	topi	ORGANISMTAXON	10090
19923525	3069	3073	NIMO	CHEMICALENTITY	D009553
19923525	3327	3330	NTG	CHEMICALENTITY	D005996
19923525	3420	3423	NTG	CHEMICALENTITY	D005996
19923525	3457	3461	NIMO	CHEMICALENTITY	D009553
19923525	3637	3640	NTG	CHEMICALENTITY	D005996
19923525	3795	3799	topi	ORGANISMTAXON	10090
19923525	3851	3862	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19923525	3926	3930	NIMO	CHEMICALENTITY	D009553
19923525	4050	4053	NTG	CHEMICALENTITY	D005996
19923525	4143	4154	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19923525	4210	4214	NIMO	CHEMICALENTITY	D009553
19923525	4303	4309	calcio	CHEMICALENTITY	D002118
19923525	4371	4382	ipotensione	DISEASEORPHENOTYPICFEATURE	D007022
19996135	41	58	Acido tranexamico	CHEMICALENTITY	D014148
19996135	118	129	convulsioni	DISEASEORPHENOTYPICFEATURE	 D012640
19996135	176	184	pazienti	ORGANISMTAXON	9606
19996135	319	341	convulsioni convulsive	DISEASEORPHENOTYPICFEATURE	D012640
19996135	391	399	pazienti	ORGANISMTAXON	9606
19996135	547	564	acido tranexamico	CHEMICALENTITY	D014148
19996135	597	600	TXA	CHEMICALENTITY	D014148
19996135	838	841	TXA	CHEMICALENTITY	D014148
19996135	896	908	 convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19996135	1058	1066	pazienti	ORGANISMTAXON	9606
19996135	1131	1142	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19996135	1254	1262	pazienti	ORGANISMTAXON	9606
19996135	1300	1308	pazienti	ORGANISMTAXON	9606
19996135	1436	1444	pazienti	ORGANISMTAXON	9606
19996135	1523	1548	danno ischemico cerebrale	DISEASEORPHENOTYPICFEATURE	D001930
19996135	1596	1616	le crisi epilettiche	DISEASEORPHENOTYPICFEATURE	D012640
19996135	1689	1716	lesione cerebrale ischemica	DISEASEORPHENOTYPICFEATURE	D001930
19996135	1749	1757	pazienti	ORGANISMTAXON	9606
19996135	1794	1802	pazienti	ORGANISMTAXON	9606
19996135	1850	1855	crisi	DISEASEORPHENOTYPICFEATURE	D012640
19996135	1916	1937	anomalie neurologiche	DISEASEORPHENOTYPICFEATURE	D009422
19996135	1977	1985	pazienti	ORGANISMTAXON	9606
19996135	2033	2038	crisi	DISEASEORPHENOTYPICFEATURE	D012640
19996135	2102	2105	TXA	CHEMICALENTITY	D014148
19996135	2314	2322	pazienti	ORGANISMTAXON	9606
19996135	2449	2468	cerebrale ischemico	DISEASEORPHENOTYPICFEATURE	D002546
19996135	2526	2536	ipertermia	DISEASEORPHENOTYPICFEATURE	D005334
19996135	2606	2617	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
19996135	2739	2742	TXA	CHEMICALENTITY	D014148
19996135	2782	2793	più anziani	ORGANISMTAXON	9606
19996135	2928	2945	crisi epilettiche	DISEASEORPHENOTYPICFEATURE	D012640
19996135	2949	2957	pazienti	ORGANISMTAXON	9606
20005218	114	120	Klotho	GENEORGENEPRODUCT	9365
20005218	175	181	Klotho	GENEORGENEPRODUCT	9365
20005218	228	251	ipertensione essenziale	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	322	326	Topi	ORGANISMTAXON	10090
20005218	380	386	Klotho	GENEORGENEPRODUCT	16591
20005218	486	501	arteriosclerosi	DISEASEORPHENOTYPICFEATURE	D001161
20005218	576	582	G-395A	SEQUENCEVARIANT	RS1207568
20005218	643	648	umano	ORGANISMTAXON	9606
20005218	680	694	Il gene Klotho	GENEORGENEPRODUCT	9365
20005218	776	799	Ipertensione essenziale	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	847	849	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	924	930	G-395A	SEQUENCEVARIANT	RS1207568
20005218	965	971	Klotho	GENEORGENEPRODUCT	9365
20005218	1034	1036	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	1099	1107	pazienti	ORGANISMTAXON	9606
20005218	1159	1161	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	1224	1235	ipertensivi	DISEASEORPHENOTYPICFEATURE	D006973
20005218	1316	1319	G/A	SEQUENCEVARIANT	RS1207568
20005218	1357	1363	G-395A	SEQUENCEVARIANT	RS1207568
20005218	1578	1584	G-395A	SEQUENCEVARIANT	RS1207568
20005218	1638	1640	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	1699	1711	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20005218	1892	1898	G-395A	SEQUENCEVARIANT	RS1207568
20005218	1949	1952	EH 	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	2004	2010	G-395A	SEQUENCEVARIANT	RS1207568
20005218	2090	2092	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	2300	2302	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20005218	2343	2348	-395A	SEQUENCEVARIANT	RS1207568
20005218	2595	2600	-395A	SEQUENCEVARIANT	RS1207568
20005218	2682	2689	 G-395A	SEQUENCEVARIANT	RS1207568
20005218	2739	2745	Klotho	GENEORGENEPRODUCT	9365
20005218	2838	2843	-395G	SEQUENCEVARIANT	RS1207568
20005218	2916	2922	G-395A	SEQUENCEVARIANT	RS1207568
20005218	2955	2960	umano	ORGANISMTAXON	9606
20005218	2993	2999	Klotho	GENEORGENEPRODUCT	9365
20005218	3068	3070	EH	DISEASEORPHENOTYPICFEATURE	D000075222
20034406	43	47	CCL2	GENEORGENEPRODUCT	24770
20034406	99	103	CCR2	GENEORGENEPRODUCT	60463
20034406	178	189	pilocarpina	CHEMICALENTITY	D010862
20034406	244	260	stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
20034406	317	335	Neuroinfiammazione	DISEASEORPHENOTYPICFEATURE	D007249
20034406	396	407	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
20034406	476	480	CCR2	GENEORGENEPRODUCT	60463
20034406	518	544	recettore delle chemochine	GENEORGENEPRODUCT	60463
20034406	582	586	CCL2	GENEORGENEPRODUCT	 24770
20034406	700	718	neuroinfiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
20034406	846	850	CCR2	GENEORGENEPRODUCT	60463
20034406	885	889	CCL2	GENEORGENEPRODUCT	24770
20034406	942	958	stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
20034406	969	971	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	1049	1061	pilocarpina 	CHEMICALENTITY	D010862
20034406	1090	1092	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	1177	1188	pilocarpina	CHEMICALENTITY	D010862
20034406	1238	1243	ratti	ORGANISMTAXON	10116
20034406	1324	1335	pilocarpina	CHEMICALENTITY	D010862
20034406	1391	1393	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	1461	1465	CCR2	GENEORGENEPRODUCT	60463
20034406	1583	1587	CCR2	GENEORGENEPRODUCT	60463
20034406	1705	1726	L'espressione di CCL2	GENEORGENEPRODUCT	24770
20034406	1863	1867	CCR2	GENEORGENEPRODUCT	60463
20034406	1897	1899	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	1978	1992	Le convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
20034406	2092	2096	CCR2	GENEORGENEPRODUCT	60463
20034406	2197	2201	CCR2	GENEORGENEPRODUCT	60463
20034406	2224	2226	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	2364	2368	CCR2	GENEORGENEPRODUCT	60463
20034406	2381	2383	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	2446	2451	ratti	ORGANISMTAXON	10116
20034406	2490	2495	ratti	ORGANISMTAXON	10116
20034406	2528	2530	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	2612	2616	CCR2	GENEORGENEPRODUCT	60463
20034406	2750	2754	CCR2	GENEORGENEPRODUCT	60463
20034406	2834	2839	ratti	ORGANISMTAXON	10116
20034406	2898	2902	CCL2	GENEORGENEPRODUCT	24770
20034406	2968	2970	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	3072	3076	CCR2	GENEORGENEPRODUCT	60463
20034406	3111	3115	CCL2	GENEORGENEPRODUCT	24770
20034406	3181	3192	pilocarpina	CHEMICALENTITY	D010862
20034406	3213	3215	SE	DISEASEORPHENOTYPICFEATURE	D013226
20034406	3294	3308	Le convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
20034406	3398	3402	CCR2	GENEORGENEPRODUCT	60463
20034406	3553	3571	neuroinfiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
20034406	3658	3669	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
20046642	31	46	Metallotioneina	CHEMICALENTITY	D008668
20046642	98	107	caspase-3	GENEORGENEPRODUCT	25402
20046642	162	170	TNFalpha	GENEORGENEPRODUCT	24835
20046642	278	288	carmustine	CHEMICALENTITY	D002330
20046642	326	331	ratti	ORGANISMTAXON	10116
20046642	459	474	metallotioneina	CHEMICALENTITY	D008668
20046642	507	509	MT	CHEMICALENTITY	D008668
20046642	555	562	ZnSO(4)	CHEMICALENTITY	D019287
20046642	719	721	MT	CHEMICALENTITY	D008668
20046642	756	766	carmustina	CHEMICALENTITY	D002330
20046642	800	804	BCNU	CHEMICALENTITY	D002330
20046642	872	893	disfunzione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20046642	926	931	ratti	ORGANISMTAXON	10116
20046642	998	1003	ratti	ORGANISMTAXON	10116
20046642	1209	1213	BCNU	CHEMICALENTITY	D002330
20046642	1296	1303	ZnSO(4)	CHEMICALENTITY	D019287
20046642	1407	1412	 BCNU	CHEMICALENTITY	D002330
20046642	1498	1502	BCNU	CHEMICALENTITY	D002330
20046642	1675	1682	ZnSO(4)	CHEMICALENTITY	D019287
20046642	1776	1780	BCNU	CHEMICALENTITY	D002330
20046642	1908	1912	BCNU	CHEMICALENTITY	D002330
20046642	1977	2042	deterioramento dell'apprendimento e della memoria a breve termine	DISEASEORPHENOTYPICFEATURE	D007859,D008569
20046642	2191	2211	glutatione reduttasi	GENEORGENEPRODUCT	116686
20046642	2247	2249	GR	GENEORGENEPRODUCT	116686
20046642	2301	2311	glutatione	CHEMICALENTITY	D005978
20046642	2344	2347	GSH	CHEMICALENTITY	D005978
20046642	2400	2404	BCNU	CHEMICALENTITY	D002330
20046642	2476	2508	fattore di necrosi tumorale-alfa	GENEORGENEPRODUCT	24835
20046642	2543	2551	TNFalpha	GENEORGENEPRODUCT	24835
20046642	2597	2599	MT	CHEMICALENTITY	D008668
20046642	2633	2648	 malondialdeide	CHEMICALENTITY	D008315
20046642	2681	2684	MDA	CHEMICALENTITY	D008315
20046642	2720	2729	caspase-3	GENEORGENEPRODUCT	25402
20046642	2812	2819	ZnSO(4)	CHEMICALENTITY	D019287
20046642	2878	2882	BCNU	CHEMICALENTITY	D002330
20046642	2939	2941	GR	GENEORGENEPRODUCT	116686
20046642	2992	2995	GSH	CHEMICALENTITY	D005978
20046642	3090	3093	MDA	CHEMICALENTITY	D008315
20046642	3128	3136	TNFalpha	GENEORGENEPRODUCT	24835
20046642	3191	3200	caspase-3	GENEORGENEPRODUCT	 25402
20046642	3301	3306	ratti	ORGANISMTAXON	10116
20046642	3351	3358	ZnSO(4)	CHEMICALENTITY	D019287
20046642	3392	3396	BCNU	CHEMICALENTITY	D002330
20046642	3445	3449	BCNU	CHEMICALENTITY	D002330
20046642	3515	3517	MT	CHEMICALENTITY	D008668
20046642	3575	3579	BCNU	CHEMICALENTITY	D002330
20046642	3647	3656	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20046642	3725	3727	GR	GENEORGENEPRODUCT	116686
20046642	3761	3765	GSH 	CHEMICALENTITY	D005978
20046642	3849	3857	TNFalpha	GENEORGENEPRODUCT	24835
20046642	3890	3893	MDA	CHEMICALENTITY	D008315
20046642	3928	3937	caspase-3	GENEORGENEPRODUCT	25402
20080916	82	86	IRF5	GENEORGENEPRODUCT	3663
20080916	175	202	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
20080916	478	482	IRF5	GENEORGENEPRODUCT	3663
20080916	530	557	lupus sistemico eritematoso	DISEASEORPHENOTYPICFEATURE	D008180
20080916	602	605	LES	DISEASEORPHENOTYPICFEATURE	D008180
20080916	742	746	IRF5	GENEORGENEPRODUCT	3663
20080916	824	827	SLE	DISEASEORPHENOTYPICFEATURE	D008180
20080916	856	864	pazienti	ORGANISMTAXON	9606
20080916	1100	1109	rs2070197	SEQUENCEVARIANT	RS2070197
20080916	1216	1225	rs2004640	SEQUENCEVARIANT	RS2004640
20080916	1263	1273	rs10954213	SEQUENCEVARIANT	RS10954213
20080916	1360	1370	rs10954213	SEQUENCEVARIANT	RS10954213
20080916	1469	1473	IRF5	GENEORGENEPRODUCT	3663
20080916	1590	1593	SLE	DISEASEORPHENOTYPICFEATURE	D008180
20080916	1669	1679	rs10954213	SEQUENCEVARIANT	RS10954213
20080916	1803	1807	IRF5	GENEORGENEPRODUCT	3663
20080983	56	65	modafinil	CHEMICALENTITY	C048833
20080983	130	153	 consumatori di cocaina	CHEMICALENTITY	D003042
20080983	258	267	modafinil	CHEMICALENTITY	C048833
20080983	348	368	di giorno sonnolenza	DISEASEORPHENOTYPICFEATURE	D012893
20080983	427	434	cocaina	CHEMICALENTITY	D003042
20080983	481	488	cocaina	CHEMICALENTITY	D003042
20080983	592	601	modafinil	CHEMICALENTITY	C048833
20080983	701	711	ricoverato	ORGANISMTAXON	9606
20080983	1328	1335	cocaina	CHEMICALENTITY	D003042
20080983	1481	1490	modafinil	CHEMICALENTITY	C048833
20080983	1609	1617	 cocaina	CHEMICALENTITY	D003042
20080983	1687	1696	modafinil	CHEMICALENTITY	C048833
20080983	2041	2048	cocaina	CHEMICALENTITY	D003042
20080983	2121	2130	modafinil	CHEMICALENTITY	C048833
20080983	2165	2172	cocaina	CHEMICALENTITY	D003042
20080983	2229	2238	Modafinil	CHEMICALENTITY	C048833
20080983	2448	2465	sonnolenza diurna	DISEASEORPHENOTYPICFEATURE soggettivo	D012893
20080983	2511	2520	modafinil	CHEMICALENTITY	C048833
20080983	2663	2680	sonnolenza diurna	DISEASEORPHENOTYPICFEATURE	D012893
20080983	2728	2750	consumatori di cocaina	CHEMICALENTITY	D003042
20080983	2859	2866	cocaina	CHEMICALENTITY	D003042
20086182	113	118	CASP8	GENEORGENEPRODUCT	841
20086182	204	256	carcinoma a cellule squamose della testa e del collo	DISEASEORPHENOTYPICFEATURE	D000077195
20086182	288	297	Caspase 8	GENEORGENEPRODUCT	841
20086182	329	334	CASP8	GENEORGENEPRODUCT	841
20086182	503	508	CASP8	GENEORGENEPRODUCT	841
20086182	695	700	D302H	SEQUENCEVARIANT	RS1045485
20086182	803	823	 sviluppo del cancro	DISEASEORPHENOTYPICFEATURE	D009369
20086182	973	1003	cancro della testa e del collo	DISEASEORPHENOTYPICFEATURE	D006258
20086182	1108	1113	CASP8	GENEORGENEPRODUCT	841
20086182	1200	1204	302H	SEQUENCEVARIANT	RS1045485
20086182	1250	1258	pazienti	ORGANISMTAXON	9606
20086182	1309	1361	carcinoma a cellule squamose della testa e del collo	DISEASEORPHENOTYPICFEATURE	D000077195
20086182	1409	1414	SCCHN	DISEASEORPHENOTYPICFEATURE	D000077195
20086182	1653	1658	CASP8	GENEORGENEPRODUCT	841
20086182	1814	1819	SCCHN	DISEASEORPHENOTYPICFEATURE	D000077195
20086182	2066	2071	CASP8	GENEORGENEPRODUCT	841
20086182	2163	2167	302H	SEQUENCEVARIANT	RS1045485
20086182	2263	2275	camptotecina	CHEMICALENTITY	D002166
20086182	2318	2321	p53	GENEORGENEPRODUCT	7157
20086182	2440	2445	CASP8	GENEORGENEPRODUCT	841
20086182	2600	2605	SCCHN	DISEASEORPHENOTYPICFEATURE	D000077195
20105280	40	43	Ras	GENEORGENEPRODUCT	3265
20105280	209	212	Ras	GENEORGENEPRODUCT	3265
20105280	356	361	umano	ORGANISMTAXON	9606
20105280	405	411	cancro	DISEASEORPHENOTYPICFEATURE	D009369
20105280	456	478	Lo sviluppo del tumore	DISEASEORPHENOTYPICFEATURE	D009369
20105280	541	544	Ras	GENEORGENEPRODUCT	3265
20105280	693	697	muri	ORGANISMTAXON	10090
20105280	845	880	fattore di crescita dei fibroblasti	GENEORGENEPRODUCT	64654
20105280	914	917	FGF	GENEORGENEPRODUCT	64654
20105280	1228	1232	topi	ORGANISMTAXON	10090
20105280	1326	1331	umano	ORGANISMTAXON	9606
20105280	1364	1369	H-Ras	GENEORGENEPRODUCT	3265
20105280	1440	1443	Ras	GENEORGENEPRODUCT	3265
20105280	1606	1622	ciclina D1 e D2 	GENEORGENEPRODUCT	12443,12444
20105280	1804	1807	cdk	GENEORGENEPRODUCT	12575
20105280	1850	1857	p27Kip1	GENEORGENEPRODUCT	12576
20105280	1893	1900	p57Kip2	GENEORGENEPRODUCT	 12577
20105280	1983	1986	Ras	GENEORGENEPRODUCT	3265
20105280	2061	2065	Erk1	GENEORGENEPRODUCT	26417
20105280	2100	2104	Erk2	GENEORGENEPRODUCT	26413
20105280	2188	2194	Spry 1	GENEORGENEPRODUCT	24063
20105280	2229	2235	Spry 2	GENEORGENEPRODUCT	24064
20105280	2292	2295	Ras	GENEORGENEPRODUCT	3265
20105280	2329	2332	Raf	GENEORGENEPRODUCT	109880
20105280	2371	2375	 Erk	GENEORGENEPRODUCT	26413,26417
20105280	2632	2635	Ras	GENEORGENEPRODUCT	3265
20105280	2668	2671	Ras	GENEORGENEPRODUCT	3265
20105280	2813	2828	Attivazione Ras	GENEORGENEPRODUCT	3265
20105280	2904	2909	Prox1	GENEORGENEPRODUCT	19130
20105280	3156	3167	Keratina 12	GENEORGENEPRODUCT	268482
20105280	3271	3274	Ras	GENEORGENEPRODUCT	3265
20105280	3408	3411	Ras	GENEORGENEPRODUCT	3265
20105310	72	75	ASP	GENEORGENEPRODUCT	718
20105310	223	228	obesi	DISEASEORPHENOTYPICFEATURE	D009765
20105310	302	309	obesità	DISEASEORPHENOTYPICFEATURE	D009765
20105310	415	420	obesi	DISEASEORPHENOTYPICFEATURE	D009765
20105310	481	500	insulino-resistenza	DISEASEORPHENOTYPICFEATURE	D007333
20105310	534	558	produzione di adipochine	GENEORGENEPRODUCT	9370
20105310	686	691	obesi	DISEASEORPHENOTYPICFEATURE	D009765
20105310	756	788	Proteina stimolante l'acilazione	GENEORGENEPRODUCT	718
20105310	820	823	ASP	GENEORGENEPRODUCT	718
20105310	858	870	Trigliceridi	CHEMICALENTITY	D014280
20105310	904	906	TG	CHEMICALENTITY	D014280
20105310	952	955	ASP	GENEORGENEPRODUCT	718
20105310	989	991	TG	CHEMICALENTITY	D014280
20105310	1174	1180	lipidi	CHEMICALENTITY	D008055
20105310	1227	1240	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
20105310	1380	1387	obesità	DISEASEORPHENOTYPICFEATURE	D009765
20105310	1420	1428	insulina	GENEORGENEPRODUCT	3630
20105310	1464	1472	glucosio	CHEMICALENTITY	D005947
20105310	1554	1562	insulina	GENEORGENEPRODUCT	3630
20105310	1596	1600	InsR	GENEORGENEPRODUCT	3643
20105310	1633	1638	IRS-1	GENEORGENEPRODUCT	3667
20105310	1671	1674	ASP	GENEORGENEPRODUCT	718
20105310	1787	1796	fattore B	GENEORGENEPRODUCT	629
20105310	1829	1837	adipsina	GENEORGENEPRODUCT	1675
20105310	1869	1883	complemento C3	GENEORGENEPRODUCT	718
20105310	2066	2070	C5L2	GENEORGENEPRODUCT	27202
20105310	2118	2131	recettore ASP	GENEORGENEPRODUCT	27202
20105310	2207	2210	ASP	GENEORGENEPRODUCT	718
20105310	2287	2289	TG	CHEMICALENTITY	D014280
20105310	2384	2389	lipid	CHEMICALENTITY	D008055
20105310	2457	2461	CD36	GENEORGENEPRODUCT	948
20105310	2495	2500	DGAT1	GENEORGENEPRODUCT	8694
20105310	2534	2539	DGAT2	GENEORGENEPRODUCT	84649
20105310	2573	2577	SCD1	GENEORGENEPRODUCT	6319
20105310	2610	2614	FASN	GENEORGENEPRODUCT	2194
20105310	2648	2651	LPL	GENEORGENEPRODUCT	4023
20105310	2695	2698	HSL	GENEORGENEPRODUCT	3991
20105310	2731	2735	CES1	GENEORGENEPRODUCT	1066
20105310	2769	2779	perilipina	GENEORGENEPRODUCT	5346
20105310	2818	2851	proteine leganti gli acidi grassi	GENEORGENEPRODUCT	2168,2170
20105310	2885	2890	FABP1	GENEORGENEPRODUCT	2168
20105310	2923	2928	FABP3	GENEORGENEPRODUCT	2170
20105310	3010	3019	CEBPalpha	GENEORGENEPRODUCT	1050
20105310	3052	3060	CEBPbeta	GENEORGENEPRODUCT	1051
20105310	3093	3102	PPARgamma	GENEORGENEPRODUCT	5468
20105310	3200	3204	AMPK	GENEORGENEPRODUCT	5562
20105310	3237	3241	UCP1	GENEORGENEPRODUCT	7350
20105310	3275	3279	CPT1	GENEORGENEPRODUCT	1374
20105310	3312	3317	FABP7	GENEORGENEPRODUCT	2173
20105310	3412	3424	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
20105310	3456	3461	TGFB1	GENEORGENEPRODUCT	7040
20105310	3495	3500	TIMP1	GENEORGENEPRODUCT	7076
20105310	3533	3538	TIMP3	GENEORGENEPRODUCT	7078
20105310	3572	3577	TIMP4	GENEORGENEPRODUCT	7079
20105310	3628	3644	proinfiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
20105310	3676	3680	PIG7	GENEORGENEPRODUCT	9516
20105310	3877	3881	C5L2	GENEORGENEPRODUCT	27202
20105310	3913	3916	ASP	GENEORGENEPRODUCT	718
20105310	4043	4048	obesi	DISEASEORPHENOTYPICFEATURE	D009765
20105310	4154	4157	ASP	GENEORGENEPRODUCT	718
20105310	4191	4193	TG	CHEMICALENTITY	D014280
20129423	38	51	carbamazepina	CHEMICALENTITY	D002220
20129423	128	143	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D006967
20129423	188	198	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
20129423	333	356	farmaco ipersensibilità	DISEASEORPHENOTYPICFEATURE	D004342
20129423	449	462	carbamazepina	CHEMICALENTITY	D002220
20129423	664	677	carbamazepina	CHEMICALENTITY	D002220
20129423	752	767	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D006967
20129423	812	822	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
20129423	889	904	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D006967
20129423	948	958	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
20129423	1027	1040	carbamazepina	CHEMICALENTITY	D002220
20129423	1091	1106	ipersensibilità	DISEASEORPHENOTYPICFEATURE	D006967
20129423	1150	1160	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
20129423	1412	1420	la morte	DISEASEORPHENOTYPICFEATURE	D003643
20129423	1477	1493	shock cardiogeno	DISEASEORPHENOTYPICFEATURE	D012770
20129423	1578	1591	carbamazepina	CHEMICALENTITY	D002220
20129423	1646	1656	miocardite	DISEASEORPHENOTYPICFEATURE	D009205
20226780	27	36	Zebrafish	ORGANISMTAXON	7955
20226780	70	89	simile a un accordo	GENEORGENEPRODUCT	563085
20226780	124	131	chordin	GENEORGENEPRODUCT	30161
20226780	250	257	Chordin	GENEORGENEPRODUCT	30161
20226780	513	520	TGFbeta	GENEORGENEPRODUCT	359834
20226780	586	604	Chordin-like 1 e 2	GENEORGENEPRODUCT	373985,83453,91851,25884,419054,69121
20226780	671	679	CHL1 e 2	GENEORGENEPRODUCT	373985,83453,91851,25884 ,419054,69121
20226780	769	774	umano	ORGANISMTAXON	9606
20226780	805	810	mouse	ORGANISMTAXON	10090
20226780	840	847	pulcino	ORGANISMTAXON	9031
20226780	943	951	CHL1 e 2	GENEORGENEPRODUCT	373985,83453,91851,25884,419054,69121
20226780	1120	1131	pesce zebra	ORGANISMTAXON	7955
20226780	1160	1171	Danio rerio	ORGANISMTAXON	7955
20226780	1207	1210	CHL	GENEORGENEPRODUCT	563085
20226780	1245	1248	CHL	GENEORGENEPRODUCT	563085
20226780	1292	1295	chl	GENEORGENEPRODUCT	563085
20226780	1382	1388	murine	ORGANISMTAXON	10090
20226780	1449	1453	CHL2	GENEORGENEPRODUCT	69121
20226780	1526	1537	pesce zebra	ORGANISMTAXON	7955
20226780	1603	1607	CHL1	GENEORGENEPRODUCT	91851
20226780	1656	1659	Chl	GENEORGENEPRODUCT	563085
20226780	1712	1721	zebrafish	ORGANISMTAXON	7955
20226780	1771	1775	CHL1	GENEORGENEPRODUCT	91851
20226780	1810	1814	CHL2	GENEORGENEPRODUCT	25884
20226780	1865	1868	Chl	GENEORGENEPRODUCT	563085
20226780	2072	2083	pesce zebra	ORGANISMTAXON	7955
20226780	2116	2123	chordin	GENEORGENEPRODUCT	30161
20226780	2157	2160	Chd	GENEORGENEPRODUCT	30161
20226780	2293	2296	Chl	GENEORGENEPRODUCT	563085
20226780	2335	2338	Chd	GENEORGENEPRODUCT	30161
20226780	2443	2447	BMP1	GENEORGENEPRODUCT	30204
20226780	2567	2570	Chl	GENEORGENEPRODUCT	563085
20226780	2612	2615	BMP	GENEORGENEPRODUCT	30204
20226780	2724	2727	Chd	GENEORGENEPRODUCT	30161
20331935	75	86	risperidone	CHEMICALENTITY	D018967
20331935	121	176	inibitori selettivi della ricaptazione della serotonina	CHEMICALENTITY	D017367
20331935	319	330	risperidone	CHEMICALENTITY	D018967
20331935	382	399	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
20331935	685	696	risperidone	CHEMICALENTITY	D018967
20331935	746	759	ambulatoriale	ORGANISMTAXON	9606
20331935	1302	1319	Iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
20331935	1411	1422	risperidone	CHEMICALENTITY	D018967
20331935	1510	1522	testosterone	CHEMICALENTITY	D013739
20331935	1630	1647	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
20331935	1874	1884	prolattina	GENEORGENEPRODUCT	5617
20331935	2092	2147	inibitori selettivi della ricaptazione della serotonina	CHEMICALENTITY	D017367
20331935	2180	2184	SSRI	CHEMICALENTITY	D017367
20331935	2379	2387	pazienti	ORGANISMTAXON	9606
20331935	2495	2503	fratture	DISEASEORPHENOTYPICFEATURE	D050723
20331935	2574	2585	risperidone	CHEMICALENTITY	D018967
20331935	2620	2624	SSRI	CHEMICALENTITY	D017367
20331935	2700	2708	pazienti	ORGANISMTAXON	9606
20331935	2757	2774	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	 D006966
20331935	2857	2868	risperidone	CHEMICALENTITY	D018967
20331935	2920	2937	iperprolattinemia	DISEASEORPHENOTYPICFEATURE	D006966
20331935	2971	2975	SSRI	CHEMICALENTITY	D017367
20331935	3240	3248	frattura	DISEASEORPHENOTYPICFEATURE	D050723
20335448	77	82	umano	ORGANISMTAXON	9606
20335448	115	144	recettore dei glucocorticoidi	GENEORGENEPRODUCT	 2908
20335448	196	225	resistenza ai glucocorticoidi	DISEASEORPHENOTYPICFEATURE	C564221
20335448	356	400	la sindrome da resistenza ai glucocorticoidi	DISEASEORPHENOTYPICFEATURE	C564221
20335448	519	534	glucocorticoidi	CHEMICALENTITY	D005938
20335448	598	627	recettore dei glucocorticoidi	GENEORGENEPRODUCT	2908
20335448	660	662	GR	GENEORGENEPRODUCT	2908
20335448	761	779	mineralocorticoide	CHEMICALENTITY	D008901
20335448	815	824	androgeno	CHEMICALENTITY	D000728
20335448	955	963	PAZIENTE	ORGANISMTAXON	9606
20335448	1066	1095	resistenza ai glucocorticoidi	DISEASEORPHENOTYPICFEATURE	C564221
20335448	1136	1144	paziente	ORGANISMTAXON	9606
20335448	1217	1222	crisi	DISEASEORPHENOTYPICFEATURE	D012640
20335448	1279	1290	ipoglicemia	DISEASEORPHENOTYPICFEATURE	D007003
20335448	1336	1347	ipokaliemia	DISEASEORPHENOTYPICFEATURE	D007008
20335448	1404	1416	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20335448	1462	1479	pubarca prematuro	DISEASEORPHENOTYPICFEATURE	C567552
20335448	1521	1533	desametasone	CHEMICALENTITY	D003907
20335448	1639	1647	paziente	ORGANISMTAXON	9606
20335448	1679	1681	GR	GENEORGENEPRODUCT	2908
20335448	1759	1802	(G-->A) nella posizione del nucleotide 2141	SEQUENCEVARIANT	C|SUB|G|2141|A
20335448	1889	1942	arginina da glutammina in posizione amminoacidica 714	SEQUENCEVARIANT	C|SUB|R|714|Q
20335448	2018	2026	 GR alfa	GENEORGENEPRODUCT	2908
20335448	2342	2382	coattivatore del recettore nucleare p160	GENEORGENEPRODUCT	8648
20335448	2491	2534	arginina con glutammina nella posizione 714	SEQUENCEVARIANT	C|SUB|R|714|Q
20335448	2775	2806	Il trattamento con desametasone	CHEMICALENTITY	D003907
20335448	2880	2897	pubarca prematura	DISEASEORPHENOTYPICFEATURE	C567552
20335448	2942	2953	ipoglicemia	DISEASEORPHENOTYPICFEATURE	D007003
20335448	2998	3010	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20335448	3056	3068	ipokaliemia 	DISEASEORPHENOTYPICFEATURE	D007008
20335448	3138	3150	arginina 714	SEQUENCEVARIANT	C|ALLELE|R|714
20335448	3287	3295	GR alpha	GENEORGENEPRODUCT	2908
20367983	91	129	neoplasia endocrina multipla di tipo 1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	186	224	neoplasia endocrina multipla di tipo 1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	269	273	MEN1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	324	363	sindrome da cancro autosomico dominante	DISEASEORPHENOTYPICFEATURE	D009386
20367983	442	448	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20367983	504	511	UOMINI1	GENEORGENEPRODUCT	4221
20367983	631	635	MEN1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	738	742	MEN1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	841	845	MEN1	GENEORGENEPRODUCT	4221
20367983	963	986	inserimento di citosina	SEQUENCEVARIANT	C|INS||C
20367983	1133	1137	MEN1	GENEORGENEPRODUCT	4221
20367983	1465	1469	MEN1	GENEORGENEPRODUCT	4221
20367983	1545	1568	iperplasia paratiroidea	DISEASEORPHENOTYPICFEATURE	D006965
20367983	1614	1632	adenoma ipofisario	DISEASEORPHENOTYPICFEATURE	D010911
20367983	1694	1707	sindrome MEN1	DISEASEORPHENOTYPICFEATURE	D018761
20367983	1833	1838	 MEN1	GENEORGENEPRODUCT	4221
20401977	29	34	umano	ORGANISMTAXON	9606
20401977	65	68	AHR	GENEORGENEPRODUCT	196
20401977	212	248	2,3,7,8-tetraclorodibenzo-p-diossina	CHEMICALENTITY	D000072317
20401977	321	329	diossina	CHEMICALENTITY	D004147
20401977	416	450	recettore dell'idrocarburo arilico	GENEORGENEPRODUCT	196
20401977	483	486	AHR	GENEORGENEPRODUCT	 196
20401977	519	524	umano	ORGANISMTAXON	9606
20401977	555	558	AHR	GENEORGENEPRODUCT	196
20401977	809	817	diossine	CHEMICALENTITY	D004147
20401977	959	962	AHR	GENEORGENEPRODUCT	196
20401977	1061	1066	umano	ORGANISMTAXON	9606
20401977	1097	1100	AHR	GENEORGENEPRODUCT	196
20401977	1260	1263	AHR	GENEORGENEPRODUCT	196
20401977	1675	1678	AHR	GENEORGENEPRODUCT	196
20401977	1914	1919	umani	ORGANISMTAXON	9606
20401977	1950	1953	AHR	GENEORGENEPRODUCT	196
20401977	2129	2134	umano	ORGANISMTAXON	9606
20401977	2165	2168	AHR	GENEORGENEPRODUCT	196
20401977	2312	2317	umana	ORGANISMTAXON	9606
20415560	31	44	La vitamina E	CHEMICALENTITY	D014810
20415560	95	119	malattie cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
20415560	179	194	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
20415560	228	239	aptoglobina	GENEORGENEPRODUCT	3240
20415560	323	338	diabete mellito	DISEASEORPHENOTYPICFEATURE	D003920
20415560	383	385	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	424	435	Aptoglobina	GENEORGENEPRODUCT	3240
20415560	468	470	Hp	GENEORGENEPRODUCT	3240
20415560	557	581	malattie cardiovascolari	DISEASEORPHENOTYPICFEATURE	D002318
20415560	662	664	Hp	GENEORGENEPRODUCT	3240
20415560	772	786	 antiossidante	CHEMICALENTITY	D000975
20415560	818	846	l'integrazione di vitamina E	CHEMICALENTITY	D014810
20415560	918	920	Hp	GENEORGENEPRODUCT	3240
20415560	968	970	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	1065	1067	Hp	GENEORGENEPRODUCT	3240
20415560	1114	1116	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	1197	1207	vitamina E	CHEMICALENTITY	D014810
20415560	1242	1244	Hp	GENEORGENEPRODUCT	3240
20415560	1348	1353	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20415560	1398	1419	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
20415560	1465	1486	morte cardiovascolare	DISEASEORPHENOTYPICFEATURE	D002318
20415560	1931	1933	Hp	GENEORGENEPRODUCT	3240
20415560	1982	1984	DM	DISEASEORPHENOTYPICFEATURE	 D003920
20415560	2030	2040	vitamina E	CHEMICALENTITY	D014810
20415560	2200	2202	Hp	GENEORGENEPRODUCT	3240
20415560	2239	2249	vitamina E	CHEMICALENTITY	D014810
20415560	2328	2330	Hp	GENEORGENEPRODUCT	3240
20415560	2393	2395	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	2453	2455	Hp	GENEORGENEPRODUCT	3240
20415560	2495	2505	vitamina E	CHEMICALENTITY	D014810
20415560	2568	2589	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
20415560	2634	2639	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20415560	2685	2706	morte cardiovascolare	DISEASEORPHENOTYPICFEATURE	D002318
20415560	2777	2787	vitamina E	CHEMICALENTITY	D014810
20415560	2821	2823	Hp	GENEORGENEPRODUCT	3240
20415560	2872	2874	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	3067	3069	DM	DISEASEORPHENOTYPICFEATURE	D003920
20415560	3118	3120	Hp	GENEORGENEPRODUCT	3240
20415560	3183	3185	Hp	GENEORGENEPRODUCT	3240
20415560	3225	3235	vitamina E	CHEMICALENTITY	D014810
20428796	59	68	TGF-beta1	GENEORGENEPRODUCT	4052
20428796	114	129	oligonucleotidi	CHEMICALENTITY	 D009841
20428796	186	230	isoforme di TGF-beta e loro recettori I e II	GENEORGENEPRODUCT	7046,7048
20428796	300	318	cicatrici cheloidi	DISEASEORPHENOTYPICFEATURE	D007627
20428796	585	593	cheloide	DISEASEORPHENOTYPICFEATURE	D007627
20428796	638	658	La malattia cheloide	DISEASEORPHENOTYPICFEATURE	D007627
20428796	752	758	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20428796	803	808	umani	ORGANISMTAXON	9606
20428796	851	859	TGF-beta	GENEORGENEPRODUCT	7040,7042,7043
20428796	1016	1025	TGF-beta1	GENEORGENEPRODUCT	4052
20428796	1059	1068	TGF-beta2	GENEORGENEPRODUCT	7042
20428796	1138	1147	TGF-beta3	GENEORGENEPRODUCT	7043
20428796	1224	1232	TGF-beta	GENEORGENEPRODUCT	7040,7042,7043
20428796	1307	1343	tipo I e tipo II TGF- recettori beta	GENEORGENEPRODUCT	7046,7048
20428796	1510	1519	TGF-beta1	GENEORGENEPRODUCT	4052
20428796	1571	1586	oligonucleotidi	CHEMICALENTITY	D009841
20428796	1692	1700	TGF-beta	GENEORGENEPRODUCT	7040,7042,7043
20428796	1769	1777	cheloidi	DISEASEORPHENOTYPICFEATURE	 D007627
20428796	1947	1965	TGF-beta1 e -beta2	GENEORGENEPRODUCT	4052,7042
20428796	2037	2045	cheloidi	DISEASEORPHENOTYPICFEATURE	D007627
20428796	2119	2128	TGF-beta3	GENEORGENEPRODUCT	7043
20428796	2166	2177	TGF-betaRII	GENEORGENEPRODUCT	7048
20428796	2282	2291	TGF-beta1	GENEORGENEPRODUCT	4052
20428796	2374	2392	TGF-beta1 e -beta2	GENEORGENEPRODUCT	4052,7042
20428796	2451	2460	TGF-beta2	GENEORGENEPRODUCT	7042
20428796	2541	2550	TGF-beta3	GENEORGENEPRODUCT	7043
20428796	2625	2633	pazienti	ORGANISMTAXON	9606
20428796	2689	2699	TGF-betaRI	GENEORGENEPRODUCT	7046
20428796	2785	2796	TGF-betaRII	GENEORGENEPRODUCT	7048
20428796	2962	2971	TGF-beta1	GENEORGENEPRODUCT	4052
20428796	3126	3134	TGF-beta	GENEORGENEPRODUCT	7040,7042,7043
20428796	3186	3194	TGF-beta	GENEORGENEPRODUCT	7040,7042,7043
20428796	3460	3477	malattia cheloide	DISEASEORPHENOTYPICFEATURE	D007627
20428796	3618	3635	malattia cheloide	DISEASEORPHENOTYPICFEATURE	D007627
20431083	31	60	uso di farmaci antitrombotici	CHEMICALENTITY	D005343
20431083	105	133	microsanguinamenti cerebrali	DISEASEORPHENOTYPICFEATURE	D002543
20431083	179	203	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
20431083	321	349	Microsanguinamenti cerebrali	DISEASEORPHENOTYPICFEATURE	D002543
20431083	394	396	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	480	504	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
20431083	549	552	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	647	669	farmaci antitrombotici	CHEMICALENTITY	D005343
20431083	771	773	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	877	880	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	926	941	ictus ischemico	DISEASEORPHENOTYPICFEATURE	D002544
20431083	951	953	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	1034	1063	attacco ischemico transitorio	DISEASEORPHENOTYPICFEATURE	D002546
20431083	1108	1111	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	1259	1264	ictus	DISEASEORPHENOTYPICFEATURE	D020521
20431083	1310	1313	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	1388	1390	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	1497	1501	ICH 	DISEASEORPHENOTYPICFEATURE	D002543
20431083	1555	1557	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	1636	1639	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	1690	1693	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	1740	1748	ischemic	DISEASEORPHENOTYPICFEATURE	D007511
20431083	1939	1942	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	2024	2026	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	2114	2117	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	2133	2135	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	2215	2218	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	2263	2265	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	2333	2336	ICH	DISEASEORPHENOTYPICFEATURE	 D002543
20431083	2348	2350	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	2429	2432	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	2688	2696	warfarin	CHEMICALENTITY	D014859
20431083	2794	2796	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	2831	2839	warfarin	CHEMICALENTITY	D014859
20431083	2917	2920	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	3002	3010	warfarin	CHEMICALENTITY	D014859
20431083	3030	3032	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	3111	3114	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	3255	3257	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	3371	3374	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	3491	3493	IS	DISEASEORPHENOTYPICFEATURE	D002544
20431083	3572	3575	TIA	DISEASEORPHENOTYPICFEATURE	D002546
20431083	3762	3764	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	3886	3889	ICH	DISEASEORPHENOTYPICFEATURE successive	D002543
20431083	3998	4000	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	4035	4043	warfarin	CHEMICALENTITY	D014859
20431083	4099	4102	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20431083	4186	4188	MB	DISEASEORPHENOTYPICFEATURE	D002543
20431083	4243	4251	warfarin	CHEMICALENTITY	D014859
20431083	4305	4308	ICH	DISEASEORPHENOTYPICFEATURE	D002543
20447294	53	60	morfina	CHEMICALENTITY	D009020
20447294	105	136	 bloccante dei canali del sodio	CHEMICALENTITY	D026941
20447294	169	176	CNSB002	CHEMICALENTITY	C401121
20447294	209	212	rat	ORGANISMTAXON	10116
20447294	267	279	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
20447294	325	343	dolore neuropatico	DISEASEORPHENOTYPICFEATURE	D009437
20447294	446	453	CNSB002	CHEMICALENTITY	C401121
20447294	489	519	bloccante dei canali del sodio	CHEMICALENTITY	D026941
20447294	623	630	morfina	CHEMICALENTITY	D009020
20447294	672	675	rat	ORGANISMTAXON	10116
20447294	722	735	infiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
20447294	781	799	dolore neuropatico	DISEASEORPHENOTYPICFEATURE	D009437
20447294	886	893	morfina	CHEMICALENTITY	D009020
20447294	927	934	CNSB002	CHEMICALENTITY	C401121
20447294	944	947	rat	ORGANISMTAXON	10116
20447294	1194	1200	dolore	DISEASEORPHENOTYPICFEATURE	D010146
20447294	1241	1252	carragenina	CHEMICALENTITY	D002351
20447294	1312	1325	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
20447294	1359	1374	streptozotocina	CHEMICALENTITY	D013311
20447294	1407	1410	STZ	CHEMICALENTITY	D013311
20447294	1464	1484	neuropatia diabetica	DISEASEORPHENOTYPICFEATURE	 D003929
20447294	1564	1571	morfina	CHEMICALENTITY	D009020
20447294	1615	1622	CNSB002	CHEMICALENTITY	C401121
20447294	1676	1683	CNSB002	CHEMICALENTITY	C401121
20447294	1719	1726	morfina	CHEMICALENTITY	D009020
20447294	1852	1863	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
20447294	1940	1959	modello carragenina	CHEMICALENTITY	D002351
20447294	2024	2027	STZ	CHEMICALENTITY	D013311
20447294	2080	2090	neuropatia	DISEASEORPHENOTYPICFEATURE	D009422
20447294	2134	2141	CNSB002	CHEMICALENTITY	C401121
20447294	2175	2182	morfina	CHEMICALENTITY	D009020
20447294	2332	2339	morfina	CHEMICALENTITY	D009020
20447294	2412	2419	CNSB002	CHEMICALENTITY	C401121
20447294	2535	2546	carragenina	CHEMICALENTITY	D002351
20447294	2617	2638	modello di neuropatia	DISEASEORPHENOTYPICFEATURE	D009422
20447294	2714	2721	morfina	CHEMICALENTITY	D009020
20447294	2813	2820	CNSB002	CHEMICALENTITY	C401121
20447294	2913	2924	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
20447294	2974	2986	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
20447294	3032	3051	modelli neuropatici	DISEASEORPHENOTYPICFEATURE	D009422
20447294	3307	3314	morfina	CHEMICALENTITY	D009020
20447294	3435	3442	CNSB002	CHEMICALENTITY	 C401121
20477932	31	38	Cocaina	CHEMICALENTITY	D003042
20477932	98	136	difficoltà di memoria e apprendimento 	DISEASEORPHENOTYPICFEATURE	D007859,D008569
20477932	168	173	ratti	ORGANISMTAXON	10116
20477932	225	249	fattore nucleare kappa B	GENEORGENEPRODUCT	81736
20477932	327	337	topiramato	CHEMICALENTITY	D000077236
20477932	417	424	cocaina	CHEMICALENTITY	D003042
20477932	468	477	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20477932	639	646	cocaina	CHEMICALENTITY	D003042
20477932	698	725	Il fattore nucleare kappa B	GENEORGENEPRODUCT	81736
20477932	759	767	NFkappaB	GENEORGENEPRODUCT	81736
20477932	924	933	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20477932	1007	1015	NFkappaB	GENEORGENEPRODUCT	81736
20477932	1077	1109	ossido nitrico sintasi neuronale	GENEORGENEPRODUCT	24598
20477932	1144	1148	nNOS	GENEORGENEPRODUCT	24598
20477932	1248	1258	topiramato	CHEMICALENTITY	D000077236
20477932	1344	1365	dipendenza da cocaina	DISEASEORPHENOTYPICFEATURE	D019970
20477932	1448	1455	cocaina	CHEMICALENTITY	D003042
20477932	1503	1508	ratti	ORGANISMTAXON	10116
20477932	1542	1550	NFkappaB	GENEORGENEPRODUCT	81736
20477932	1637	1644	cocaina	CHEMICALENTITY	D003042
20477932	1683	1688	ratti	ORGANISMTAXON	10116
20477932	1728	1731	GSH	CHEMICALENTITY	D005978
20477932	1781	1820	l'attività della glutatione perossidasi	GENEORGENEPRODUCT	2876
20477932	1890	1894	nNOS	GENEORGENEPRODUCT	24598
20477932	2039	2046	cocaina	CHEMICALENTITY	D003042
20477932	2129	2137	NFkappaB	GENEORGENEPRODUCT	81736
20477932	2314	2318	nNOS	GENEORGENEPRODUCT	24598
20477932	2370	2392	glutatione perossidasi	GENEORGENEPRODUCT	2876
20477932	2543	2551	NFkappaB	GENEORGENEPRODUCT	81736
20477932	2612	2620	cocaina 	CHEMICALENTITY	D003042
20477932	2656	2666	Topiramato	CHEMICALENTITY	D000077236
20510337	31	62	Il trattamento con coenzima Q10	CHEMICALENTITY	C024989
20510337	111	121	cisplatino	CHEMICALENTITY	D002945
20510337	165	179	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
20510337	211	215	topi	ORGANISMTAXON	10090
20510337	278	290	coenzima Q10	CHEMICALENTITY	C024989
20510337	339	343	topi	ORGANISMTAXON	10090
20510337	392	410	danno renale acuto	DISEASEORPHENOTYPICFEATURE	D058186
20510337	482	492	cisplatino	CHEMICALENTITY	D002945
20510337	535	566	Il trattamento con coenzima Q10	CHEMICALENTITY	C024989
20510337	695	705	cisplatino	CHEMICALENTITY	 D002945
20510337	754	769	Il coenzima Q10	CHEMICALENTITY	C024989
20510337	831	854	azoto ureico nel sangue	CHEMICALENTITY	D001806
20510337	895	905	creatinina	CHEMICALENTITY	D003404
20510337	958	968	cisplatino	CHEMICALENTITY	D002945
20510337	1001	1016	Il coenzima Q10	CHEMICALENTITY	C024989
20510337	1139	1149	glutatione	CHEMICALENTITY	D005978
20510337	1192	1213	superossido dismutasi	GENEORGENEPRODUCT	20655
20510337	1272	1277	lipid	CHEMICALENTITY	D008055
20510337	1354	1386	fattore di necrosi tumorale-alfa	GENEORGENEPRODUCT	21926
20510337	1419	1433	ossido nitrico	CHEMICALENTITY	D009569
20510337	1468	1475	platino	CHEMICALENTITY	D010984
20510337	1561	1568	selenio	CHEMICALENTITY	D012643
20510337	1603	1608	zinco	CHEMICALENTITY	 D015032
20510337	1702	1712	cisplatino	CHEMICALENTITY	D002945
20510337	1766	1790	danno del tessuto renale	DISEASEORPHENOTYPICFEATURE	D007674
20510337	1833	1843	cisplatino	CHEMICALENTITY	D002945
20510337	1942	1970	trattamento con coenzima Q10	CHEMICALENTITY	C024989
20510337	2050	2065	il coenzima Q10	CHEMICALENTITY	C024989
20510337	2158	2168	cisplatino	CHEMICALENTITY	D002945
20510337	2212	2234	ossido nitrico sintasi	GENEORGENEPRODUCT	18125
20510337	2268	2291	fattore nucleare-kappaB	GENEORGENEPRODUCT	18033
20510337	2326	2335	caspase-3	GENEORGENEPRODUCT	12367
20510337	2370	2373	p53	GENEORGENEPRODUCT	22060
20510337	2446	2461	il coenzima Q10	CHEMICALENTITY	C024989
20510337	2565	2575	cisplatino	CHEMICALENTITY	D002945
20510337	2619	2633	nefrotossicità	DISEASEORPHENOTYPICFEATURE	D007674
20520283	56	65	asenapina	CHEMICALENTITY	C522667
20520283	115	149	studio controllato con aloperidolo	CHEMICALENTITY	 D006220
20520283	180	188	pazienti	ORGANISMTAXON	9606
20520283	259	271	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20520283	304	313	Asenapine	CHEMICALENTITY	C522667
20520283	446	458	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20520283	507	524	episodi maniacali	DISEASEORPHENOTYPICFEATURE	D001714
20520283	588	610	disturbo bipolare di I	DISEASEORPHENOTYPICFEATURE	D001714
20520283	666	692	caratteristiche psicotiche	DISEASEORPHENOTYPICFEATURE	D011618
20520283	771	779	pazienti	ORGANISMTAXON	9606
20520283	827	839	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20520283	942	951	asenapina	CHEMICALENTITY	C522667
20520283	1017	1026	asenapina	CHEMICALENTITY	C522667
20520283	1081	1092	aloperidolo	CHEMICALENTITY	D006220
20520283	1375	1384	asenapina	CHEMICALENTITY	C522667
20520283	1438	1449	aloperidolo	CHEMICALENTITY	D006220
20520283	1658	1667	asenapina	CHEMICALENTITY	C522667
20520283	1750	1761	aloperidolo	CHEMICALENTITY	D006220
20520283	1983	1992	asenapina	CHEMICALENTITY	C522667
20520283	2254	2263	asenapina	CHEMICALENTITY	C522667
20520283	2312	2323	aloperidolo	CHEMICALENTITY	D006220
20520283	2402	2425	Sintomi extrapiramidali	DISEASEORPHENOTYPICFEATURE	D001480
20520283	2538	2548	asenapina 	CHEMICALENTITY	C522667
20520283	2613	2624	aloperidolo	CHEMICALENTITY	D006220
20520283	2708	2716	pazienti	ORGANISMTAXON	9606
20520283	2870	2879	asenapina	CHEMICALENTITY	C522667
20520283	2913	2924	aloperidolo	CHEMICALENTITY	D006220
20520283	3046	3069	sintomi extrapiramidali	DISEASEORPHENOTYPICFEATURE	D001480
20523265	57	81	fattore di complemento H	GENEORGENEPRODUCT	3075
20523265	113	116	C2 	GENEORGENEPRODUCT	717
20523265	148	151	CFB	GENEORGENEPRODUCT	629
20523265	184	186	C3	GENEORGENEPRODUCT	718
20523265	232	269	degenerazione maculare legata all'età	DISEASEORPHENOTYPICFEATURE	D008268
20523265	379	403	fattore di complemento H	GENEORGENEPRODUCT	3075
20523265	436	439	CFH	GENEORGENEPRODUCT	3075
20523265	476	481	C2/BF	GENEORGENEPRODUCT	629,717
20523265	514	516	C3	GENEORGENEPRODUCT	718
20523265	605	642	degenerazione maculare legata all'età	DISEASEORPHENOTYPICFEATURE	D008268
20523265	687	690	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	952	960	pazienti	ORGANISMTAXON	9606
20523265	1008	1011	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	1044	1052	pazienti	ORGANISMTAXON	9606
20523265	1105	1111	drusen	DISEASEORPHENOTYPICFEATURE	D005128
20523265	1256	1259	CFH	GENEORGENEPRODUCT	3075
20523265	1303	1305	C2	GENEORGENEPRODUCT	717
20523265	1338	1341	CFB	GENEORGENEPRODUCT	629
20523265	1375	1377	C3	GENEORGENEPRODUCT	718
20523265	1547	1552	CFHR1	GENEORGENEPRODUCT	3078
20523265	1587	1592	CFHR3	GENEORGENEPRODUCT	10878
20523265	1736	1745	rs3753394	SEQUENCEVARIANT	RS3753394
20523265	1793	1801	rs800292	SEQUENCEVARIANT	RS800292
20523265	1850	1859	rs1061170	SEQUENCEVARIANT	RS1061170
20523265	1910	1919	rs1329428	SEQUENCEVARIANT	RS1329428
20523265	1968	1971	CFH	GENEORGENEPRODUCT	3075
20523265	2061	2064	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	2252	2255	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	2423	2432	rs2274700	SEQUENCEVARIANT	RS2274700
20523265	2469	2478	rs1410996	SEQUENCEVARIANT	RS1410996
20523265	2575	2578	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	2674	2677	CFH	GENEORGENEPRODUCT	3075
20523265	2767	2773	drusen	DISEASEORPHENOTYPICFEATURE	D005128
20523265	2828	2831	CFH	GENEORGENEPRODUCT	3075
20523265	2863	2865	C2	GENEORGENEPRODUCT	717
20523265	2898	2901	CFB	GENEORGENEPRODUCT	629
20523265	2934	2936	C3	GENEORGENEPRODUCT	718
20523265	3042	3045	AMD	DISEASEORPHENOTYPICFEATURE	 D008268
20523265	3091	3097	drusen	DISEASEORPHENOTYPICFEATURE	D005128
20523265	3175	3180	CFHR1	GENEORGENEPRODUCT	3078
20523265	3215	3220	CFHR3	GENEORGENEPRODUCT	10878
20523265	3330	3333	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	3385	3391	drusen	DISEASEORPHENOTYPICFEATURE	D005128
20523265	3475	3484	rs3753394	SEQUENCEVARIANT	RS3753394
20523265	3532	3540	rs800292	SEQUENCEVARIANT	RS800292
20523265	3589	3598	rs1061170	SEQUENCEVARIANT	RS1061170
20523265	3649	3658	rs1329428	SEQUENCEVARIANT	RS1329428
20523265	3714	3723	rs7535263	SEQUENCEVARIANT	RS7535263
20523265	3759	3768	rs1410996	SEQUENCEVARIANT	RS1410996
20523265	3806	3815	rs2274700	SEQUENCEVARIANT	RS2274700
20523265	3851	3854	CFH	GENEORGENEPRODUCT	3075
20523265	4055	4058	CFH	GENEORGENEPRODUCT	3075
20523265	4130	4133	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	4252	4257	CFHR1	GENEORGENEPRODUCT	3078
20523265	4292	4297	CFHR3	GENEORGENEPRODUCT	10878
20523265	4452	4455	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20523265	4516	4518	C2	GENEORGENEPRODUCT	717
20523265	4550	4553	CFB	GENEORGENEPRODUCT	629
20523265	4586	4588	C3	GENEORGENEPRODUCT	718
20523265	4688	4691	AMD	DISEASEORPHENOTYPICFEATURE	D008268
20528871	58	68	nelarabina	CHEMICALENTITY	C104457
20528871	101	119	etoposidee linfoma	CHEMICALENTITY	D005047
20528871	182	192	nelarabine	CHEMICALENTITY	C104457
20528871	225	229	AraG	CHEMICALENTITY	C104457
20528871	273	282	etoposide	CHEMICALENTITY	D005047
20528871	315	317	VP	CHEMICALENTITY	D005047
20528871	353	367	ciclofosfamide	CHEMICALENTITY	D003520
20528871	400	403	CPM	CHEMICALENTITY	D003520
20528871	708	712	AraG	CHEMICALENTITY	C104457
20528871	802	812	neuropatia	DISEASEORPHENOTYPICFEATURE	D009422
20528871	858	883	dolore muscoloscheletrico	DISEASEORPHENOTYPICFEATURE	D059352
20528871	928	949	Tossicità ematologica	DISEASEORPHENOTYPICFEATURE	D006402
20528871	1025	1029	AraG	CHEMICALENTITY	C104457
20528871	1191	1199	pazienti	ORGANISMTAXON	9606
20528871	1366	1370	AraG	CHEMICALENTITY	 C104457
20528871	1402	1404	VP	CHEMICALENTITY	D005047
20528871	1436	1439	CPM	CHEMICALENTITY	D003520
20528871	1532	1536	AraG	CHEMICALENTITY	C104457
20528871	1613	1622	etoposide	CHEMICALENTITY	D005047
20528871	1656	1670	ciclofosfamide	CHEMICALENTITY	D003520
20528871	1726	1747	tossicità neurologica	DISEASEORPHENOTYPICFEATURE	D009422
20533999	31	42	La dopamina	CHEMICALENTITY	D004298
20533999	110	124	 metanfetamina	CHEMICALENTITY	D008694
20533999	176	190	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
20533999	246	254	dopamina	CHEMICALENTITY	D004298
20533999	287	289	DA	CHEMICALENTITY	D004298
20533999	329	342	metamfetamina	CHEMICALENTITY	D008694
20533999	375	379	METH	CHEMICALENTITY	D008694
20533999	432	441	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20533999	552	554	DA	CHEMICALENTITY	D004298
20533999	632	641	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20533999	705	707	DA	CHEMICALENTITY	D004298
20533999	782	791	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
20533999	948	950	DA	CHEMICALENTITY	D004298
20533999	1077	1100	L-diidrossifenilalanina	CHEMICALENTITY	D007980
20533999	1169	1194	alfa-metil- para-tirosina	CHEMICALENTITY	D019805
20533999	1229	1233	METH	CHEMICALENTITY	D008694
20533999	1273	1275	DA	CHEMICALENTITY	D004298
20533999	1319	1336	la neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
20533999	1458	1462	topi	ORGANISMTAXON	10090
20533999	1550	1552	DA	CHEMICALENTITY	D004298
20533999	1595	1599	METH	CHEMICALENTITY	D008694
20533999	1643	1657	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
20533999	1721	1725	METH	CHEMICALENTITY	D008694
20533999	1796	1800	topi	ORGANISMTAXON	10090
20533999	1891	1893	DA	CHEMICALENTITY	D004298
20533999	1946	1950	METH	CHEMICALENTITY	D008694
20533999	2005	2026	deficit dopaminergici	DISEASEORPHENOTYPICFEATURE	D009461
20533999	2161	2163	DA	CHEMICALENTITY	D004298
20533999	2231	2235	METH	CHEMICALENTITY	D008694
20533999	2301	2315	neurotossicità	DISEASEORPHENOTYPICFEATURE	D020258
20533999	2393	2395	DA	CHEMICALENTITY	D004298
20534142	59	66	obesità	DISEASEORPHENOTYPICFEATURE	D009765
20534142	113	118	PCSK1	GENEORGENEPRODUCT	5122
20534142	154	162	insulina	GENEORGENEPRODUCT	3630
20534142	220	231	proinsulina	CHEMICALENTITY	D011384
20534142	276	302	La pro-ormone convertasi 1	GENEORGENEPRODUCT	5122
20534142	401	406	PCSK1	GENEORGENEPRODUCT	5122
20534142	491	498	obesità	DISEASEORPHENOTYPICFEATURE	D009765
20534142	544	575	omeostasi del glucosio anormale	DISEASEORPHENOTYPICFEATURE	D044882
20534142	637	648	proinsulina	CHEMICALENTITY	D011384
20534142	756	762	rs6232	SEQUENCEVARIANT	RS6232
20534142	796	802	rs6235	SEQUENCEVARIANT	RS6235
20534142	865	872	obesità	DISEASEORPHENOTYPICFEATURE	D009765
20534142	982	1001	insulino-resistenza	DISEASEORPHENOTYPICFEATURE	D007333
20534142	1117	1141	intolleranza al glucosio	DISEASEORPHENOTYPICFEATURE	D018149
20534142	1236	1242	rs6232	SEQUENCEVARIANT	RS6232
20534142	1276	1282	rs6235	SEQUENCEVARIANT	RS6235
20534142	1320	1326	rs6235	SEQUENCEVARIANT	RS6235
20534142	1358	1363	PCSK1	GENEORGENEPRODUCT	5122
20534142	1478	1486	glucosio	CHEMICALENTITY	D005947
20534142	1522	1530	glucosio	CHEMICALENTITY	D005947
20534142	1564	1572	insulina	GENEORGENEPRODUCT	3630
20534142	1605	1616	proinsulina	CHEMICALENTITY	D011384
20534142	1650	1676	 Misurazioni del peptide C	CHEMICALENTITY	D002096
20534142	1779	1807	iperinsulinemico-euglicemico	DISEASEORPHENOTYPICFEATURE	D044903
20534142	1908	1914	rs6235	SEQUENCEVARIANT	RS6235
20534142	1961	1967	rs6232	SEQUENCEVARIANT	RS6232
20534142	2087	2093	rs6235	SEQUENCEVARIANT	RS6235
20534142	2127	2133	rs6232	SEQUENCEVARIANT	RS6232
20534142	2298	2306	insulina	GENEORGENEPRODUCT	3630
20534142	2371	2382	proinsulina	CHEMICALENTITY	D011384
20534142	2419	2430	proinsulina	CHEMICALENTITY	D011384
20534142	2465	2473	insulina	GENEORGENEPRODUCT	3630
20534142	2507	2513	rs6235	SEQUENCEVARIANT	RS6235
20534142	2602	2608	rs6232	SEQUENCEVARIANT	RS6232
20534142	2702	2727	La secrezione di insulina	GENEORGENEPRODUCT	3630
20534142	2874	2880	rs6232	SEQUENCEVARIANT	RS6232
20534142	3010	3034	sensibilità all'insulina	GENEORGENEPRODUCT	3630
20534142	3160	3168	glucosio	CHEMICALENTITY	D005947
20534142	3269	3280	proinsulina	CHEMICALENTITY	D011384
20534142	3317	3323	rs6235	SEQUENCEVARIANT	RS6235
20534142	3452	3457	PCSK1	GENEORGENEPRODUCT	5122
20534142	3533	3541	glucosio	CHEMICALENTITY	D005947
20534142	3586	3597	proinsulina	CHEMICALENTITY	D011384
20534142	3647	3655	insulina	GENEORGENEPRODUCT	3630
20534142	3708	3714	rs6232	SEQUENCEVARIANT	RS6232
20534142	3785	3790	N221D	SEQUENCEVARIANT	RS6232
20534142	3834	3842	insulina	GENEORGENEPRODUCT	3630
20534142	3888	3896	glucosio	CHEMICALENTITY	D005947
20558148	80	94	recettori NMDA	GENEORGENEPRODUCT	24408
20558148	164	175	aloperidolo	CHEMICALENTITY	D006220
20558148	227	237	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
20558148	959	969	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
20558148	1014	1039	 recettore della dopamina	GENEORGENEPRODUCT	24316
20558148	1081	1092	aloperidolo	CHEMICALENTITY	D006220
20558148	1173	1178	ratti	ORGANISMTAXON	10116
20558148	1211	1222	Aloperidolo	CHEMICALENTITY	D006220
20558148	1274	1284	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
20558148	1386	1415	recettore NMDA del glutammato	GENEORGENEPRODUCT	24408
20558148	1460	1466	MK-801	CHEMICALENTITY	D016291
20558148	1526	1529	AP7	CHEMICALENTITY	C031231
20558148	1595	1609	recettore NMDA	GENEORGENEPRODUCT	24408
20558148	1650	1669	N-metil-d-aspartato	CHEMICALENTITY	D016202
20558148	1702	1706	NMDA	CHEMICALENTITY	D016202
20558148	1834	1840	MK-801	CHEMICALENTITY	D016291
20558148	1874	1877	AP7	CHEMICALENTITY	C031231
20558148	1946	1957	aloperidolo	CHEMICALENTITY	D006220
20558148	2039	2048	catalessi	DISEASEORPHENOTYPICFEATURE	D002375
20558148	2213	2217	NMDA	CHEMICALENTITY	D016202
20558148	2355	2365	glutammato	CHEMICALENTITY	D018698
20558148	2446	2457	aloperidolo	CHEMICALENTITY	D006220
20558148	2509	2519	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
20579626	80	87	Osterix	GENEORGENEPRODUCT	121340
20579626	119	127	paziente	ORGANISMTAXON	9606
20579626	175	207	osteogenesi imperfetta recessiva	DISEASEORPHENOTYPICFEATURE	D010013
20579626	252	274	Osteogenesi imperfetta	DISEASEORPHENOTYPICFEATURE	D010013
20579626	322	349	malattia delle ossa fragili	DISEASEORPHENOTYPICFEATURE	D010013
20579626	389	432	condizione correlata al collagene di tipo I	GENEORGENEPRODUCT	1278
20579626	488	499	osteoporosi	DISEASEORPHENOTYPICFEATURE	D010024
20579626	569	583	fratture ossee	DISEASEORPHENOTYPICFEATURE	D050723
20579626	744	783	delezione di una singola coppia di basi	SEQUENCEVARIANT	RS137853893
20579626	821	832	c .1052delA	SEQUENCEVARIANT	RS137853893
20579626	870	873	SP7	GENEORGENEPRODUCT	121340
20579626	907	914	Osterix	GENEORGENEPRODUCT	121340
20579626	949	952	OSX	GENEORGENEPRODUCT	121340
20579626	1024	1056	osteogenesi imperfetta recessiva	DISEASEORPHENOTYPICFEATURE	D010013
20579626	1115	1123	paziente	ORGANISMTAXON	9606
20579626	1177	1185	fratture	DISEASEORPHENOTYPICFEATURE	D050723
20579626	1237	1252	deformità ossee	DISEASEORPHENOTYPICFEATURE	D001847
20579626	1307	1325	eruzione dei denti	DISEASEORPHENOTYPICFEATURE	D014079
20579626	1391	1394	OSX	GENEORGENEPRODUCT	121340
20579626	1554	1558	topi	ORGANISMTAXON	10090
20579626	1703	1713	c.1052delA	SEQUENCEVARIANT	RS137853893
20579626	1921	1943	osteogenesi imperfetta	DISEASEORPHENOTYPICFEATURE	D010013
20579626	1990	1993	SP7	GENEORGENEPRODUCT	121340
20579626	2027	2030	OSX	GENEORGENEPRODUCT	121340
20579626	2097	2102	umano	ORGANISMTAXON	9606
20583543	66	75	46,XY DSD	DISEASEORPHENOTYPICFEATURE	D058490
20583543	142	166	8 delezione nucleotidica	SEQUENCEVARIANT	C|DEL||8
20583543	220	226	SRD5A2	GENEORGENEPRODUCT	6716
20583543	302	311	46,XY DSD	DISEASEORPHENOTYPICFEATURE	D058490
20583543	627	652	recettore degli androgeni	GENEORGENEPRODUCT	367
20583543	684	686	AR	GENEORGENEPRODUCT	367
20583543	722	728	SRD5A2	GENEORGENEPRODUCT	6716
20583543	784	792	pazienti	ORGANISMTAXON	9606
20583543	840	850	46 ,XY DSD	DISEASEORPHENOTYPICFEATURE	D058490
20583543	1034	1042	pazienti	ORGANISMTAXON	9606
20583543	1203	1209	SRD5A2	GENEORGENEPRODUCT	6716
20583543	1253	1261	pazienti	ORGANISMTAXON	9606
20583543	1296	1303	p.R246Q	SEQUENCEVARIANT	RS9332967
20583543	1514	1525	p.A27fsX132	SEQUENCEVARIANT	P|FS|A |27||132
20583543	1563	1570	p.R246Q	SEQUENCEVARIANT	RS9332967
20583543	1608	1616	paziente	ORGANISMTAXON	9606
20583543	1664	1681	micropene isolato	DISEASEORPHENOTYPICFEATURE	C536649
20583543	1743	1750	p.G196S	SEQUENCEVARIANT	RS121434250
20583543	1848	1850	AR	GENEORGENEPRODUCT	367
20583543	1947	1954	p.R246Q	SEQUENCEVARIANT	RS9332967
20583543	1997	2005	pazienti	ORGANISMTAXON	9606
20583543	2041	2047	SRD5A2	GENEORGENEPRODUCT	6716
20583543	2189	2195	SRD5A2	GENEORGENEPRODUCT	6716
20583543	2229	2237	paziente	ORGANISMTAXON	9606
20583543	2291	2300	ipospadia	DISEASEORPHENOTYPICFEATURE	D007021
20588063	145	171	puromicina aminonucleoside	CHEMICALENTITY	D011692
20588063	215	222	nefrosi	DISEASEORPHENOTYPICFEATURE	D009401
20588063	349	360	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
20588063	400	426	puromicina aminonucleoside	CHEMICALENTITY	D011692
20588063	470	477	nefrosi	DISEASEORPHENOTYPICFEATURE	D009401
20588063	523	526	PAN	DISEASEORPHENOTYPICFEATURE	D009401
20588063	556	561	ratti	ORGANISMTAXON	10116
20588063	734	741	nefrina	GENEORGENEPRODUCT	64563
20588063	775	785	a-actinina	GENEORGENEPRODUCT	81634
20588063	820	827	dendrin	GENEORGENEPRODUCT	25113
20588063	863	870	plekhh2	GENEORGENEPRODUCT	313866
20588063	1249	1252	ACE	GENEORGENEPRODUCT	24310
20588063	1412	1423	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
20588063	1472	1479	nefrina	GENEORGENEPRODUCT	64563
20588063	1744	1755	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
20588063	1858	1865	Nephrin	GENEORGENEPRODUCT	64563
20588063	1932	1939	dendrin	GENEORGENEPRODUCT	25113
20588063	1976	1983	plekhh2	GENEORGENEPRODUCT	313866
20588063	2037	2047	a-actinina	GENEORGENEPRODUCT	81634
20588063	2101	2104	ACE	GENEORGENEPRODUCT	24310
20588063	2224	2227	PAN	DISEASEORPHENOTYPICFEATURE	D009401
20588063	2350	2361	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
20588063	2470	2477	nephrin	GENEORGENEPRODUCT	64563
20588063	2598	2605	dendrin	GENEORGENEPRODUCT	25113
20588063	2641	2648	plekhh2	GENEORGENEPRODUCT	313866
20588063	2742	2745	PAN	DISEASEORPHENOTYPICFEATURE	D009401
20588063	2786	2796	a-actinina	GENEORGENEPRODUCT	81634
20606392	51	82	Sindrome da insensibilità al GH	DISEASEORPHENOTYPICFEATURE	D046150
20606392	134	185	insulina- come il deficit del fattore di crescita I	DISEASEORPHENOTYPICFEATURE	C563867
20606392	266	278	recettore GH	GENEORGENEPRODUCT	2690
20606392	423	442	Insensibilità al GH	DISEASEORPHENOTYPICFEATURE	D046150
20606392	488	502	Carenza di IGF	DISEASEORPHENOTYPICFEATURE	C563867
20606392	568	580	recettore GH	GENEORGENEPRODUCT	2690
20606392	613	616	GHR	GENEORGENEPRODUCT	2690
20606392	707	723	mancata crescita	DISEASEORPHENOTYPICFEATURE	D006130
20606392	792	815	proteina legante il GH 	GENEORGENEPRODUCT	2690
20606392	848	852	GHBP	GENEORGENEPRODUCT	2690
20606392	921	940	insensibilità al GH	DISEASEORPHENOTYPICFEATURE	D046150
20606392	1142	1144	GH	GENEORGENEPRODUCT	2688
20606392	1220	1226	IGF- I	GENEORGENEPRODUCT	3479
20606392	1260	1267	IGFBP-3	GENEORGENEPRODUCT	3486
20606392	1316	1320	GHBP	GENEORGENEPRODUCT	2690
20606392	1444	1447	GHR	GENEORGENEPRODUCT	2690
20606392	1498	1538	 riportato in precedenza Mutazione R211H	SEQUENCEVARIANT	P|SUB|R|211|H
20606392	1632	1639	899dupC	SEQUENCEVARIANT	C|DUP|899|C|
20606392	1761	1766	IGF-I	GENEORGENEPRODUCT	3479
20606392	1948	1951	GHR	GENEORGENEPRODUCT	2690
20606392	2013	2032	insensibilità al GH	DISEASEORPHENOTYPICFEATURE	D046150
20606392	2078	2092	Deficit di IGF	DISEASEORPHENOTYPICFEATURE	C563867
20606392	2174	2178	GHBP	GENEORGENEPRODUCT	2690
20606392	2275	2277	GH	GENEORGENEPRODUCT	2688
20606392	2373	2376	GHR	GENEORGENEPRODUCT	2690
20606392	2462	2466	GHBP	GENEORGENEPRODUCT	2690
20651814	59	65	ADRA2B	GENEORGENEPRODUCT	151
20651814	205	214	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20651814	374	383	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20651814	422	472	12 -inserimento/cancellazione nucleotidica (indel)	SEQUENCEVARIANT	C|INDEL||12
20651814	553	583	recettore alfa(2B)-adrenergico	GENEORGENEPRODUCT	151
20651814	617	623	ADRA2B	GENEORGENEPRODUCT	151
20651814	770	779	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20651814	1032	1041	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20651814	1242	1251	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20651814	1396	1402	ADRA2B	GENEORGENEPRODUCT	151
20651814	1615	1624	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
20667451	31	40	Curcumina	CHEMICALENTITY	D003474
20667451	93	114	disfunzione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20667451	168	181	fenobarbitone	CHEMICALENTITY	D010634
20667451	215	228	carbamazepina	CHEMICALENTITY	D002220
20667451	272	277	ratti	ORGANISMTAXON	10116
20667451	312	334	farmaci antiepilettici	CHEMICALENTITY	D000927
20667451	367	380	fenobarbitone	CHEMICALENTITY	D010634
20667451	415	428	carbamazepina	CHEMICALENTITY	 D002220
20667451	498	522	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20667451	687	711	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20667451	746	768	farmaci antiepilettici	CHEMICALENTITY	D000927
20667451	801	813	La curcumina	CHEMICALENTITY	D003474
20667451	857	870	antiossidante	CHEMICALENTITY	D000975
20667451	921	944	proprietà infiammatorie	DISEASEORPHENOTYPICFEATURE	D007249
20667451	1098	1107	curcumina	CHEMICALENTITY	D003474
20667451	1142	1155	fenobarbitone	CHEMICALENTITY	D010634
20667451	1190	1203	carbamazepina	CHEMICALENTITY	D002220
20667451	1258	1282	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20667451	1334	1339	ratti	ORGANISMTAXON	10116
20667451	1404	1413	curcumina	CHEMICALENTITY	D003474
20667451	1449	1462	fenobarbitone	CHEMICALENTITY	D010634
20667451	1497	1510	carbamazepina	CHEMICALENTITY	D002220
20667451	1647	1652	ratti	ORGANISMTAXON	10116
20667451	1854	1867	fenobarbitone	CHEMICALENTITY	D010634
20667451	1901	1914	carbamazepina	CHEMICALENTITY	D002220
20667451	1963	1977	malondialdeide	CHEMICALENTITY	D008315
20667451	2030	2040	glutatione	CHEMICALENTITY	D005978
20667451	2115	2128	fenobarbitone	CHEMICALENTITY	D010634
20667451	2162	2175	carbamazepina	CHEMICALENTITY	D002220
20667451	2262	2311	compromissione dell'apprendimento e della memoria	DISEASEORPHENOTYPICFEATURE	D003072
20667451	2422	2431	curcumina	CHEMICALENTITY	D003474
20667451	2490	2514	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20667451	2611	2633	farmaci antiepilettici	CHEMICALENTITY	D000927
20667451	2666	2701	La co-somministrazione di curcumina	CHEMICALENTITY	D003474
20667451	2823	2836	fenobarbitone	CHEMICALENTITY	D010634
20667451	2870	2883	carbamazepina	CHEMICALENTITY	D002220
20667451	2946	2955	curcumina	CHEMICALENTITY	D003474
20667451	3038	3077	deterioramento delle funzioni cognitive	DISEASEORPHENOTYPICFEATURE	D003072
20667451	3128	3133	ratti	ORGANISMTAXON	10116
20667451	3178	3191	fenobarbitone	CHEMICALENTITY	D010634
20667451	3226	3239	carbamazepina	CHEMICALENTITY	D002220
20667451	3370	3379	curcumina	CHEMICALENTITY	D003474
20667451	3481	3494	fenobarbitone	CHEMICALENTITY	D010634
20667451	3528	3541	carbamazepina	CHEMICALENTITY	D002220
20667451	3617	3641	compromissione cognitiva	DISEASEORPHENOTYPICFEATURE	D003072
20683499	43	82	costituenti attivi di Crocus sativus L.	CHEMICALENTITY	D010936
20683499	116	122	crocin	CHEMICALENTITY	 C029036
20683499	157	189	modello indotto da streptozocina	CHEMICALENTITY	D013311
20683499	236	257	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
20683499	297	302	ratti	ORGANISMTAXON	10116
20683499	367	396	carotenoidi solubili in acqua	CHEMICALENTITY	D002338
20683499	429	436	crocine	CHEMICALENTITY	C029036
20683499	508	537	Estratto di Crocus sativus L.	CHEMICALENTITY	D010936
20683499	660	667	crocins	CHEMICALENTITY	C029036
20683499	820	833	streptozocina	CHEMICALENTITY	D013311
20683499	866	870	 STZ	CHEMICALENTITY	D013311
20683499	913	918	ratti	ORGANISMTAX ON	10116
20683499	995	1000	ratti	ORGANISMTAXON	10116
20683499	1095	1102	crocine	CHEMICALENTITY	C029036
20683499	1154	1157	STZ	CHEMICALENTITY	D013311
20683499	1197	1200	STZ	CHEMICALENTITY	D013311
20683499	1234	1241	crocine	CHEMICALENTITY	C029036
20683499	1321	1342	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
20683499	1372	1377	ratti	ORGANISMTAXON	10116
20683499	1435	1438	STZ	CHEMICALENTITY	D013311
20683499	1543	1546	STZ	CHEMICALENTITY	D013311
20683499	1619	1622	STZ	CHEMICALENTITY	D013311
20683499	1656	1662	crocin	CHEMICALENTITY	C029036
20683499	1714	1720	crocin	CHEMICALENTITY	C029036
20683499	1883	1889	crocin	CHEMICALENTITY	C029036
20683499	2221	2227	crocin	CHEMICALENTITY	C029036
20683499	2283	2286	STZ	CHEMICALENTITY	D013311
20683499	2325	2330	ratti	ORGANISMTAXON	10116
20683499	2446	2474	STZ trattati con il veicolo 	CHEMICALENTITY	D013311
20683499	2513	2518	ratti	ORGANISMTAXON	10116
20683499	2560	2566	crocin	CHEMICALENTITY	C029036
20683499	2678	2722	apprendimento e compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D007859,D008569
20683499	2778	2781	STZ	CHEMICALENTITY	D013311
20683499	2914	2920	crocin	CHEMICALENTITY	C029036
20683499	2996	3014	deficit cognitivi 	DISEASEORPHENOTYPICFEATURE	D003072
20683499	3057	3060	STZ	CHEMICALENTITY	D013311
20683499	3096	3101	ratti	ORGANISMTAXON	10116
20683499	3184	3210	malattie neurodegenerative	DISEASEORPHENOTYPICFEATURE	D019636
20683499	3259	3280	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
20708777	84	91	CYP11B2	GENEORGENEPRODUCT	1585
20708777	123	131	 CYP11B1	GENEORGENEPRODUCT	1584
20708777	198	221	rischio di ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	253	261	pazienti	ORGANISMTAXON	9606
20708777	309	342	adenomi produttori di aldosterone	DISEASEORPHENOTYPICFEATURE	D000236
20708777	398	412	L'ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	578	590	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	800	830	geni di sintesi degli steroidi	GENEORGENEPRODUCT	1584,1585
20708777	863	870	CYP11B2	GENEORGENEPRODUCT	1585
20708777	903	910	CYP11B1	GENEORGENEPRODUCT	1584
20708777	990	1002	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	1040	1048	pazienti	ORGANISMTAXON	9606
20708777	1123	1156	adenomi produttori di aldosterone	DISEASEORPHENOTYPICFEATURE	D000236
20708777	1201	1204	APA	DISEASEORPHENOTYPICFEATURE	D000236
20708777	1253	1261	pazienti	ORGANISMTAXON	9606
20708777	1309	1312	APA	DISEASEORPHENOTYPICFEATURE	D000236
20708777	1413	1425	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	1462	1470	pazienti	ORGANISMTAXON	9606
20708777	1534	1543	rs1799998	SEQUENCEVARIANT	RS1799998
20708777	1580	1587	C-344 T	SEQUENCEVARIANT	RS1799998
20708777	1644	1650	rs4539	SEQUENCEVARIANT	RS4539
20708777	1684	1690	A2718G	SEQUENCEVARIANT	RS4539
20708777	1729	1736	CYP11B2	GENEORGENEPRODUCT	1585
20708777	1770	1776	rs6410	SEQUENCEVARIANT	RS6410
20708777	1809	1815	G22 5A	SEQUENCEVARIANT	RS6410
20708777	1849	1855	rs6387	SEQUENCEVARIANT	RS6387
20708777	1889	1895	A2803G	SEQUENCEVARIANT	RS6387
20708777	1934	1941	CYP11B1	GENEORGENEPRODUCT	1584
20708777	1994	2002	CYPB11B2	GENEORGENEPRODUCT	1585
20708777	2034	2041	CYP11B1	GENEORGENEPRODUCT	1584
20708777	2128	2140	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	2234	2241	CYP11B2	GENEORGENEPRODUCT	1585
20708777	2273	2280	CYP11B1	GENEORGENEPRODUCT	1584
20708777	2384	2396	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	2434	2442	pazienti	ORGANISMTAXON	9606
20708777	2517	2521	 APA	DISEASEORPHENOTYPICFEATURE	D000236
20708777	2597	2603	rs4539	SEQUENCEVARIANT	RS4539
20708777	2668	2680	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	2906	2918	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3070	3082	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3151	3163	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3240	3252	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3360	3366	rs4539	SEQUENCEVARIANT	RS4539
20708777	3490	3503	ipertensione 	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3535	3543	pazienti	ORGANISMTAXON	9606
20708777	3625	3628	APA	DISEASEORPHENOTYPICFEATURE	D000236
20708777	3699	3709	CYP11B2/B1	GENEORGENEPRODUCT	1584,1585
20708777	3788	3800	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
20708777	3846	3854	pazienti	ORGANISMTAXON	9606
20708777	3902	3905	APA	DISEASEORPHENOTYPICFEATURE	D000236
20722491	47	59	capecitabina	CHEMICALENTITY	D000069287
20722491	188	203	5-fluorouracile	CHEMICALENTITY	D005472
20722491	237	241	5-FU	CHEMICALENTITY	D005472
20722491	337	343	tumori	DISEASEORPHENOTYPICFEATURE	D009369
20722491	412	476	tumori del colon-retto, della mammella e della testa e del collo	DISEASEORPHENOTYPICFEATURE	D001943,D006258,D015179
20722491	619	631	capecitabina	CHEMICALENTITY	D000069287
20722491	802	814	capecitabina	CHEMICALENTITY	D000069287
20722491	871	880	 pazienti	ORGANISMTAXON	9606
20722491	942	966	malattie renali e renali	DISEASEORPHENOTYPICFEATURE	D007674
20722491	1070	1082	capecitabina	CHEMICALENTITY	D000069287
20722491	1142	1154	Capecitabina	CHEMICALENTITY	D000069287
20722491	1211	1215	5-FU	CHEMICALENTITY	D005472
20722491	1526	1641	tumori del colon-retto, della mammella, del pancreas, dello stomaco, delle cellule renali e della testa e del collo	DISEASEORPHENOTYPICFEATURE	D001943,D002292,D006258,D010190,D013274,D015179
20722491	1726	1738	capecitabina	CHEMICALENTITY	D000069287
20722491	1787	1794	diarrea	DISEASEORPHENOTYPICFEATURE	D003967
20722491	1839	1845	nausea	DISEASEORPHENOTYPICFEATURE	D009325
20722491	1890	1896	vomito	DISEASEORPHENOTYPICFEATURE	D014839
20722491	1941	1950	stomatite	DISEASEORPHENOTYPICFEATURE	D013280
20722491	1996	2015	sindrome mano-piede	DISEASEORPHENOTYPICFEATURE	D060831
20722491	2051	2063	Capecitabina	CHEMICALENTITY	D000069287
20722491	2176	2184	pazienti	ORGANISMTAXON	9606
20722491	2254	2283	disfunzioni epatiche e renali	DISEASEORPHENOTYPICFEATURE	D007674,D008107
20801104	102	106	DRD4	GENEORGENEPRODUCT	1815
20801104	155	167	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20801104	212	223	depressione	DISEASEORPHENOTYPICFEATURE	D003866
20801104	269	289	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
20801104	438	465	recettore della dopamina D4	GENEORGENEPRODUCT	1815
20801104	498	502	DRD4	GENEORGENEPRODUCT	1815
20801104	554	566	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20801104	611	622	depressione	DISEASEORPHENOTYPICFEATURE	D003866
20801104	669	689	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
20801104	789	797	pazienti	ORGANISMTAXON	9606
20801104	845	857	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20801104	890	898	pazienti	ORGANISMTAXON	9606
20801104	946	957	depressione	DISEASEORPHENOTYPICFEATURE	D003866
20801104	991	999	pazienti	ORGANISMTAXON	9606
20801104	1047	1067	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
20801104	1181	1185	DRD4	GENEORGENEPRODUCT	1815
20801104	1279	1286	-616C/G	SEQUENCEVARIANT	RS747302
20801104	1323	1330	-521C/T	SEQUENCEVARIANT	RS1800955
20801104	1717	1729	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20801104	1860	1882	schizofrenia paranoica	DISEASEORPHENOTYPICFEATURE	D012563
20801104	1988	1996	-521 C/T	SEQUENCEVARIANT	RS1800955
20801104	2064	2084	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
20801104	2240	2245	DRD4 	GENEORGENEPRODUCT	1815
20801104	2303	2315	schizofrenia	DISEASEORPHENOTYPICFEATURE	D012559
20801104	2359	2367	-521 C/T	SEQUENCEVARIANT	RS1800955
20801104	2441	2461	dipendenza da eroina	DISEASEORPHENOTYPICFEATURE	D006556
20806042	54	58	GJA8	GENEORGENEPRODUCT	2703
20806042	112	159	cataratta congenita -sindrome della microcornea	DISEASEORPHENOTYPICFEATURE	C538287
20806042	261	277	difetto genetico	DISEASEORPHENOTYPICFEATURE	D030342
20806042	383	451	cataratta autosomica dominante congenita -sindrome della microcornea	DISEASEORPHENOTYPICFEATURE	C538287
20806042	496	500	CCMC	DISEASEORPHENOTYPICFEATURE	C538287
20806042	994	1004	c.592C-->T	SEQUENCEVARIANT	C|SUB|C|592|T
20806042	1056	1076	gap-junction, alfa 8	GENEORGENEPRODUCT	2703
20806042	1109	1113	GJA8	GENEORGENEPRODUCT	2703
20806042	1275	1301	a triptofano al codone 198	SEQUENCEVARIANT	P|SUB|R|198|W
20806042	1342	1349	p.R198W	SEQUENCEVARIANT	P|SUB|R|198|W
20806042	1632	1639	p.R198W	SEQUENCEVARIANT	P|SUB|R|198|W
20806042	1674	1679	 GJA8	GENEORGENEPRODUCT	2703
20806042	1727	1731	CCMC	DISEASEORPHENOTYPICFEATURE	C538287
20806042	1812	1816	GJA8	GENEORGENEPRODUCT	2703
20806042	1880	1889	cataratta	DISEASEORPHENOTYPICFEATURE	D002386
20806042	1935	1946	microcornea	DISEASEORPHENOTYPICFEATURE	D005124
20828385	73	85	temsirolimus	CHEMICALENTITY	C401859
20828385	145	163	linfoma mantellare	DISEASEORPHENOTYPICFEATURE	 D020522
20828385	207	225	Linfoma mantellare	DISEASEORPHENOTYPICFEATURE	D020522
20828385	270	273	MCL	DISEASEORPHENOTYPICFEATURE	D020522
20828385	349	380	linfoma non Hodgkin a cellule B	DISEASEORPHENOTYPICFEATURE	D008228
20828385	409	418	Pazienti 	ORGANISMTAXON	9606
20828385	653	656	MCL	DISEASEORPHENOTYPICFEATURE	D020522
20828385	701	713	temsirolimus	CHEMICALENTITY	C401859
20828385	749	753	mTOR	GENEORGENEPRODUCT	2475
20828385	869	872	MCL	DISEASEORPHENOTYPICFEATURE	D020522
20828385	927	949	regressione del tumore	DISEASEORPHENOTYPICFEATURE	D00936 9
20828385	1014	1026	temsirolimus	CHEMICALENTITY	C401859
20828385	1205	1217	temsirolimus	CHEMICALENTITY	C401859
20828385	1297	1309	temsirolimus	CHEMICALENTITY	C401859
20828385	1364	1370	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20828385	1541	1547	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20828385	1628	1640	temsirolimus	CHEMICALENTITY	C401859
20828385	1739	1745	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20828385	1818	1822	VEGF	GENEORGENEPRODUCT	7422
20828385	2005	2014	necrotico	DISEASEORPHENOTYPICFEATURE	D009336
20828385	2025	2037	temsirolimus	CHEMICALENTITY	C401859
20828385	2165	2171	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20828385	2290	2302	temsirolimus	CHEMICALENTITY	C401859
20828385	2358	2364	tumore	DISEASEORPHENOTYPICFEATURE	D009369
20828385	2482	2485	MCL	DISEASEORPHENOTYPICFEATURE	D020522
20846357	60	71	connexin 26	GENEORGENEPRODUCT	2706
20846357	105	109	GJB2	GENEORGENEPRODUCT	2706
20846357	214	254	sindrome cheratite-ittiosi-sordità (KID)	DISEASEORPHENOTYPICFEATURE	C536168
20846357	311	351	Sindrome cheratite-ittiosi-sordità (KID)	DISEASEORPHENOTYPICFEATURE	C536168
20846357	406	436	disturbo ectodermico congenito	DISEASEORPHENOTYPICFEATURE	D004476
20846357	514	518	GJB2	GENEORGENEPRODUCT	2706
20846357	595	606	connexin 26	GENEORGENEPRODUCT	2706
20846357	682	692	p.Asp50Asn	SEQUENCEVARIANT	RS28931594
20846357	964	984	Sindrome del BAMBINO	DISEASEORPHENOTYPICFEATURE	C536168
20846357	1127	1131	GJB2	GENEORGENEPRODUCT	2706
20846357	1303	1325	compromissione uditiva	DISEASEORPHENOTYPICFEATURE	D034381
20846357	1370	1394	eritroderma ittiosiforme	DISEASEORPHENOTYPICFEATURE	D016113
20846357	1469	1495	cheratoderma palmoplantare	DISEASEORPHENOTYPICFEATURE	D007645
20846357	1540	1583	alopecia del cuoio capelluto e delle ciglia	DISEASEORPHENOTYPICFEATURE	D000505
20846357	1758	1778	sindrome del bambino	DISEASEORPHENOTYPICFEATURE	C536168
20846357	1828	1836	acantosi	DISEASEORPHENOTYPICFEATURE	D000052
20846357	1903	1916	papillomatosi	DISEASEORPHENOTYPICFEATURE	D010212
20846357	2001	2014	ipercheratosi	DISEASEORPHENOTYPICFEATURE	D017488
20846357	2102	2112	acitretina	CHEMICALENTITY	D017255
20846357	2203	2247	emorragia intraventricolare e intracerebrale	DISEASEORPHENOTYPICFEATURE	D000074042,D002543
20846357	2309	2319	idrocefalo	DISEASEORPHENOTYPICFEATURE	D006849
20846357	2416	2426	setticemia	DISEASEORPHENOTYPICFEATURE	D018805
20846357	2475	2484	meningite	DISEASEORPHENOTYPICFEATURE	D008581
20846357	2541	2550	infezione	DISEASEORPHENOTYPICFEATURE	D007239
20846357	2644	2665	Klebsiella pneumoniae	DISEASEORPHENOTYPICFEATURE	D007710
20846357	2726	2752	insufficienza respiratoria	DISEASEORPHENOTYPICFEATURE	D012131
20846357	2896	2900	GJB2	GENEORGENEPRODUCT	2706
20846357	3022	3030	c.263C>T	SEQUENCEVARIANT	C|SUB|C|263 |T
20846357	3115	3150	alanina per valina in posizione 88 	SEQUENCEVARIANT	P|SUB|A|88|V
20846357	3189	3199	p.Ala88Val	SEQUENCEVARIANT	P|SUB|A|88|V
20846357	3325	3329	Cx26	GENEORGENEPRODUCT	2706
20846357	3370	3378	c.263C>T	SEQUENCEVARIANT	C|SUB|C|263 |T
20846357	3417	3427	p.Ala88Val	SEQUENCEVARIANT	P|SUB|A|88|V
20846357	3484	3504	Sindrome del BAMBINO	DISEASEORPHENOTYPICFEATURE	C536168
20854438	32	38	SLURP1	GENEORGENEPRODUCT	57152
20854438	155	168	mal de Meleda	DISEASEORPHENOTYPICFEATURE	D007645
20854438	225	238	Mal de Meleda	DISEASEORPHENOTYPICFEATURE	D007645
20854438	283	286	MDM	DISEASEORPHENOTYPICFEATURE	D007645
20854438	334	366	eritrocheratoderma palmoplantare	DISEASEORPHENOTYPICFEATURE	C563781
20854438	486	493	SLURP-1	GENEORGENEPRODUCT	57152
20854438	527	550	antigene linfocitario 6	GENEORGENEPRODUCT	57152
20854438	583	668	proteina correlata al recettore dell'attivatore del plasminogeno di tipo urochinasi-1	GENEORGENEPRODUCT	57152
20854438	703	710	SLURP-1	GENEORGENEPRODUCT	57152
20854438	772	810	recettore nicotinico dell'acetilcolina	GENEORGENEPRODUCT	1137
20854438	844	849	nAchR	GENEORGENEPRODUCT	1137
20854438	927	933	murine	ORGANISMTAXON	10090
20854438	1003	1008	nAchR	GENEORGENEPRODUCT	11441
20854438	1117	1125	pazienti	ORGANISMTAXON	9606
20854438	1174	1180	SLURP1	GENEORGENEPRODUCT	57152
20854438	1303	1311	melanoma	DISEASEORPHENOTYPICFEATURE	D008545
20854438	1357	1373	infezione virale	DISEASEORPHENOTYPICFEATURE	D014777
20854438	1582	1588	SLURP1	GENEORGENEPRODUCT	57152
20854438	1696	1700	MDM 	DISEASEORPHENOTYPICFEATURE	D007645
20854438	1753	1760	SLURP-1	GENEORGENEPRODUCT	57152
20854438	1844	1895	Le cellule mononucleate del sangue periferico umano	ORGANISMTAXON	9606
20854438	1964	1967	MDM	DISEASEORPHENOTYPICFEATURE	D007645
20854438	2049	2074	G ad A nel nucleotide 256	SEQUENCEVARIANT	RS28937888
20854438	2111	2117	SLURP1	GENEORGENEPRODUCT	57152
20854438	2179	2235	glicina in sostituzione dell'arginina all'amminoacido 86	SEQUENCEVARIANT	RS28937888
20854438	2272	2276	G86R	SEQUENCEVARIANT	RS28937888
20854438	2325	2332	SLURP-1	GENEORGENEPRODUCT	57152
20854438	2437	2440	CD3	GENEORGENEPRODUCT	915
20854438	2476	2480	CD28	GENEORGENEPRODUCT	940
20854438	2673	2680	SLURP-1	GENEORGENEPRODUCT	57152
20854438	2716	2720	G86R	SEQUENCEVARIANT	RS28937888
20854438	2870	2875	umano	ORGANISMTAXON	9606
20854438	2908	2915	SLURP-1	GENEORGENEPRODUCT	57152
20854438	2966	2974	Pazienti	ORGANISMTAXON	9606
20854438	3022	3025	MDM	DISEASEORPHENOTYPICFEATURE	D007645
20854438	3076	3083	SLURP-1	GENEORGENEPRODUCT	57152
20854438	3119	3136	La mutazione G86R	SEQUENCEVARIANT	RS28937888
20854438	3235	3242	SLURP-1	GENEORGENEPRODUCT	57152
20949073	617	632	fibrosi cistica	DISEASEORPHENOTYPICFEATURE	D003550
20949073	660	668	pazienti	ORGANISMTAXON	9606
20949073	732	737	E831X	SEQUENCEVARIANT	RS397508387
20949073	775	782	2623G>T	SEQUENCEVARIANT	RS397508387
20949073	825	829	CFTR	GENEORGENEPRODUCT	1080
20973483	69	116	antagonista del recettore dell'adenosina A2A/A1	CHEMICALENTITY	D058915
20973483	183	204	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
20973483	278	329	antagonista del recettore dell'adenosina A(2A)/A(1)	CHEMICALENTITY	D058915
20973483	704	714	A(2A)/A(1)	CHEMICALENTITY	D058915
20973483	912	933	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	 D010300
20973483	970	974	topo	ORGANISMTAXON	10090
20973483	1006	1009	rat	ORGANISMTAXON	10116
20973483	1052	1063	aloperidolo	CHEMICALENTITY	D006220
20973483	1115	1125	catalessia	DISEASEORPHENOTYPICFEATURE	D002375
20973483	1155	1159	topo	ORGANISMTAXON	10090
20973483	1202	1211	reserpina	CHEMICALENTITY	D012110
20973483	1264	1272	acinesia	DISEASEORPHENOTYPICFEATURE	D004409
20973483	1302	1305	rat	ORGANISMTAXON	10116
20973483	1337	1355	6-idrossidopamina 	CHEMICALENTITY	D016627
20973483	1388	1394	6-OHDA	CHEMICALENTITY	D016627
20973483	1535	1540	umano	ORGANISMTAXON	9606
21059483	35	39	GALT	GENEORGENEPRODUCT	2592
21059483	144	148	GALT	GENEORGENEPRODUCT	2592
21059483	228	252	La galattosemia classica	DISEASEORPHENOTYPICFEATURE	D005693
21059483	301	361	disturbo autosomico recessivo del metabolismo del galattosio	DISEASEORPHENOTYPICFEATURE	D005693
21059483	521	529	lattosio	CHEMICALENTITY	D007785
21059483	564	572	pazienti	ORGANISMTAXON	9606
21059483	660	679	deficit neurologici	DISEASEORPHENOTYPICFEATURE	D009461
21059483	725	746	insufficienza ovarica	DISEASEORPHENOTYPICFEATURE	D016649
21059483	838	842	GALT	GENEORGENEPRODUCT	2592
21059483	900	912	galattosemia	DISEASEORPHENOTYPICFEATURE	D005693
21059483	1693	1697	GALT	GENEORGENEPRODUCT	2592
21059483	2026	2038	galattosemia	DISEASEORPHENOTYPICFEATURE	D005693
21059483	2088	2096	paziente	ORGANISMTAXON	9606
21070631	34	56	dopamina b-idrossilasi	GENEORGENEPRODUCT	1621
21070631	91	116	-1021C/ Il polimorfismo T	SEQUENCEVARIANT	RS1611115
21070631	186	207	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
21070631	378	399	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
21070631	444	446	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	481	506	La dopamina b-idrossilasi	GENEORGENEPRODUCT	1621
21070631	539	542	DBH	GENEORGENEPRODUCT	1621
21070631	604	612	dopamina	CHEMICALENTITY	D004298
21070631	646	659	noradrenalina	CHEMICALENTITY	D009638
21070631	751	757	-1021T	SEQUENCEVARIANT	RS1611115
21070631	800	809	rs1611115	SEQUENCEVARIANT	RS1611115
21070631	845	848	DBH	GENEORGENEPRODUCT	1621
21070631	916	933	geni infiammatori	DI SEASEORPHENOTYPICFEATURE	D007249
21070631	976	980	IL1A	GENEORGENEPRODUCT	3552
21070631	1014	1017	IL6	GENEORGENEPRODUCT	3569
21070631	1089	1091	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	1181	1183	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	1219	1222	DBH	GENEORGENEPRODUCT	1621
21070631	1258	1264	-1021T	SEQUENCEVARIANT	RS1611115
21070631	1388	1390	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	1537	1540	DBH	GENEORGENEPRODUCT	1621
21070631	1573	1577	IL1A	GENEORGENEPRODUCT	3552
21070631	1611	1614	IL6	GENEORGENEPRODUCT	3569
21070631	1800	1802	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	1897	1903	-1021T	SEQUENCEVARIANT	RS1611115
21070631	1963	1965	AD	DISEASEORPHENOTYPICFEATURE	D000544
21070631	2109	2115	uomini	ORGANISMTAXON	9606
21070631	2249	2252	DBH	GENEORGENEPRODUCT	1621
21070631	2287	2293	-1021T	SEQUENCEVARIANT	RS1611115
21070631	2333	2339	-889TT	SEQUENCEVARIANT	RS1800587
21070631	2384	2393	rs1800587	SEQUENCEVARIANT	RS1800587
21070631	2430	2434	IL1A	GENEORGENEPRODUCT	3552
21070631	2682	2695	noradrenalina	CHEMICALENTITY	D009638
21070631	2756	2769	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
21070631	2837	2843	-1021T	SEQUENCEVARIANT	RS1611115
21070631	2964	2977	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
21070631	3065	3067	AD	DISEASEORPHENOTYPICFEATURE	D000544
21080147	40	46	CRELD1	GENEORGENEPRODUCT	78987
21080147	97	105	pazienti	ORGANISMTAXON	9606
21080147	153	188	difetto del setto atrioventricolare	DISEASEORPHENOTYPICFEATURE	C562831
21080147	245	280	Difetti del setto atrioventricolare	DISEASEORPHENOTYPICFEATURE	C562831
21080147	325	330	AVSDs	DISEASEORPHENOTYPICFEATURE	C562831
21080147	444	472	difetti autosomici dominanti	DISEASEORPHENOTYPICFEATURE	D030342
21080147	538	551	malformazioni	DISEASEORPHENOTYPICFEATURE	D000013
21080147	716	720	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	754	768	Il gene CRELD1	GENEORGENEPRODUCT	78987
21080147	879	883	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	949	957	pazienti	ORGANISMTAXON	9606
21080147	1005	1009	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	1165	1171	CRELD1	GENEORGENEPRODUCT	78987
21080147	1355	1363	pazienti	ORGANISMTAXON	9606
21080147	1422	1430	paziente	ORGANISMTAXON	9606
21080147	1474	1519	C-to-G è stata identificato al nucleotide 857	SEQUENCEVARIANT	C|SUB|C|857|G
21080147	1608	1647	alanina per prolina all'amminoacido 286	SEQUENCEVARIANT	P|SUB|A|286|P
21080147	1689	1695	calcio	CHEMICALENTITY	D002118
21080147	1735	1738	EGF	GENEORGENEPRODUCT	1950
21080147	1782	1790	paziente	ORGANISMTAXON	9606
21080147	1860	1864	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	1981	1989	paziente	ORGANISMTAXON	9606
21080147	2050	2054	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	2113	2129	Sindrome di Down	DISEASEORPHENOTYPICFEATURE	D004314
21080147	2194	2202	c.973G>A	SEQUENCEVARIANT	RS755981922
21080147	2285	2323	 acido glutammico all'ammino acido 325	SEQUENCEVARIANT	RS755981922
21080147	2361	2366	E325K	SEQUENCEVARIANT	RS755981922
21080147	2411	2417	calcio	CHEMICALENTITY	D002118
21080147	2457	2468	dominio EGF	GENEORGENEPRODUCT	1950
21080147	2559	2565	CRELD1	GENEORGENEPRODUCT	78987
21080147	2608	2614	calcio	CHEMICALENTITY	D002118
21080147	2647	2650	EGF	GENEORGENEPRODUCT	1950
21080147	2689	2697	pazienti	ORGANISMTAXON	9606
21080147	2745	2750	 AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	2784	2790	CRELD1	GENEORGENEPRODUCT	78987
21080147	2857	2861	AVSD	DISEASEORPHENOTYPICFEATURE	C562831
21080147	2920	2942	Le mutazioni di CRELD1	GENEORGENEPRODUCT	78987
21080147	3032	3048	difetto cardiaco	DISEASEORPHENOTYPICFEATURE	D006331
21135151	42	46	CCR5	GENEORGENEPRODUCT	1234
21135151	80	88	 delta32	SEQUENCEVARIANT	C|DEL||32
21135151	182	187	HIV-1	ORGANISMTAXON	11676
21135151	338	373	C-C recettore per chemochine tipo 5	GENEORGENEPRODUCT	1234
21135151	406	410	CCR5	GENEORGENEPRODUCT	1234
21135151	516	521	HIV-1	ORGANISMTAXON	11676
21135151	1248	1252	CCR5	GENEORGENEPRODUCT	1234
21135151	1386	1391	gp120	GENEORGENEPRODUCT	3700
21135151	1462	1467	HIV-1	ORGANISMTAXON	11676
21135151	1556	1565	infezione	DISEASEORPHENOTYPICFEATURE	D007239
21135151	1627	1640	HIV-1-infetti	DISEASEORPHENOTYPICFEATURE	D015658
21135151	1702	1707	 CCR5	GENEORGENEPRODUCT	1234
21135151	1755	1760	HIV-1	ORGANISMTAXON	11676
21135151	1845	1849	CCR5	GENEORGENEPRODUCT	1234
21135151	1887	1891	DD32	SEQUENCEVARIANT	C|DEL||32
21135151	2003	2012	infezione	DISEASEORPHENOTYPICFEATURE	D007239
21135151	2171	2179	paziente	ORGANISMTAXON	9606
21135151	2571	2579	paziente	ORGANISMTAXON	9606
21135151	2771	2775	CCR5	GENEORGENEPRODUCT	1234
21135151	2880	2888	pazienti	ORGANISMTAXON	9606
21135151	2957	2977	 I sintomi dell'AIDS	DISEASEORPHENOTYPICFEATURE	D000163
21163864	33	38	M235T	SEQUENCEVARIANT	RS699
21163864	86	102	angiotensinogeno	GENEORGENEPRODUCT	183
21163864	138	146	pazienti	ORGANISMTAXON	9606
21163864	193	219	cardiomiopatia ipertrofica	DISEASEORPHENOTYPICFEATURE	D002312
21163864	279	308	La cardiomiopatia ipertrofica	DISEASEORPHENOTYPICFEATURE	D002312
21163864	353	356	HCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	452	469	malattia cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
21163864	616	621	T704C	SEQUENCEVARIANT	RS699
21163864	669	685	angiotensinogeno	GENEORGENEPRODUCT	183
21163864	717	720	AGT	GENEORGENEPRODUCT	183
21163864	774	777	HCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	917	920	HCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	968	1004	cardiomiopatia ipertrofica sporadica	DISEASEORPHENOTYPICFEATURE	D002312
21163864	1050	1054	SHCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	1104	1140	cardiomiopatia ipertrofica familiare	DISEASEORPHENOTYPICFEATURE	D024741
21163864	1186	1190	FHCM	DISEASEORPHENOTYPICFEATURE	 D024741
21163864	1220	1228	pazienti	ORGANISMTAXON	9606
21163864	1391	1423	ipertrofia ventricolare sinistra	DISEASEORPHENOTYPICFEATURE	D017379
21163864	1573	1576	AGT	GENEORGENEPRODUCT	183
21163864	1638	1689	metionina in treonina la sostituzione al codone 235	SEQUENCEVARIANT	RS699
21163864	1721	1726	M235T	SEQUENCEVARIANT	RS699
21163864	2113	2117	SHCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	2146	2154	pazienti	ORGANISMTAXON	9606
21163864	2267	2271	FHCM	DISEASEORPHENOTYPICFEATURE	D024741
21163864	2372	2375	AGT	GENEORGENEPRODUCT	183
21163864	2454	2458	SHCM	DISEASEORPHENOTYPICFEATURE	D002312
21163864	2652	2656	FHCM	DISEASEORPHENOTYPICFEATURE	D024741
21195121	43	57	ossido nitrico	CHEMICALENTITY	D009569
21195121	104	115	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	158	165	lindano	CHEMICALENTITY	D001556
21195121	197	202	ratti	ORGANISMTAXON	10116
21195121	235	242	Lindane	CHEMICALENTITY	D001556
21195121	279	292	organocloruro	CHEMICALENTITY	D006843
21195121	324	334	 pesticida	CHEMICALENTITY	D010575
21195121	368	377	scabicida	CHEMICALENTITY	D056810
21195121	428	439	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	512	529	recettori GABA(A)	GENEORGENEPRODUCT	29705
21195121	562	576	Ossido nitrico	CHEMICALENTITY	D009569
21195121	609	611	NO	CHEMICALENTITY	D009569
21195121	744	754	L-arginina	CHEMICALENTITY	D001120
21195121	802	817	NESSUNA sintesi	GENEORGENEPRODUCT	24598
21195121	852	855	NOS	GENEORGENEPRODUCT	24598
21195121	890	896	L-NAME	CHEMICALENTITY	D019331
21195121	931	934	NOS	GENEORGENEPRODUCT	24598
21195121	1018	1027	epilessia	DISEASEORPHENOTYPICFEATURE	D004827
21195121	1131	1133	NO	CHEMICALENTITY	D009569
21195121	1213	1220	lindano	CHEMICALENTITY	D001556
21195121	1272	1281	epilessia	DISEASEORPHENOTYPICFEATURE	D004827
21195121	1336	1341	ratti	ORGANISMTAXON	10116
21195121	1397	1407	L-arginina	CHEMICALENTITY	D001120
21195121	1539	1550	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	1652	1663	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	1719	1726	lindano	CHEMICALENTITY inferiori	D001556
21195121	1816	1822	L-NAME	CHEMICALENTITY	D019331
21195121	1907	1919	 convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	2015	2026	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21195121	2094	2105	 convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
21195121	2145	2152	lindano	CHEMICALENTITY	D001556
21195121	2295	2300	ratti	ORGANISMTAXON	10116
21195121	2345	2355	l-arginina	CHEMICALENTITY	D001120
21195121	2396	2403	lindano	CHEMICALENTITY	D001556
21195121	2466	2471	ratti	ORGANISMTAXON	10116
21195121	2519	2525	L-NAME	CHEMICALENTITY	D019331
21195121	2605	2607	NO	CHEMICALENTITY	D009569
21195121	2670	2683	convulsivante	DISEASEORPHENOTYPICFEATURE	D012640
21195121	2721	2724	rat	ORGANISMTAXON	10116
21195121	2767	2774	lindano	CHEMICALENTITY	D001556
21195121	2818	2830	 convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
21238926	32	36	Brat	GENEORGENEPRODUCT	35197
21238926	184	187	BMP	GENEORGENEPRODUCT	33432
21238926	229	239	Drosophila	ORGANISMTAXON	7227
21238926	336	339	Dpp	GENEORGENEPRODUCT	33432
21238926	390	397	Pumilio	GENEORGENEPRODUCT	41094
21238926	431	434	Pum	GENEORGENEPRODUCT	41094
21238926	471	476	Nanos	GENEORGENEPRODUCT	 42297
21238926	510	513	Nos	GENEORGENEPRODUCT	42297
21238926	608	611	Dpp	GENEORGENEPRODUCT	33432
21238926	660	663	Nos	GENEORGENEPRODUCT	42297
21238926	830	833	Pum	GENEORGENEPRODUCT	41094
21238926	866	869	Nos	GENEORGENEPRODUCT	42297
21238926	967	970	Dpp	GENEORGENEPRODUCT	33432
21238926	1037	1055	Tumore al cervello	GENEORGENEPRODUCT	35197
21238926	1089	1093	Brat	GENEORGENEPRODUCT	35197
21238926	1196	1199	Pum	GENEORGENEPRODUCT	41094
21238926	1232	1235	Nos	GENEORGENEPRODUCT	42297
21238926	1269	1273	Brat	GENEORGENEPRODUCT	35197
21238926	1329	1332	Pum	GENEORGENEPRODUCT	41094
21238926	1366	1369	Nos	GENEORGENEPRODUCT	42297
21238926	1418	1421	Pum	GENEORGENEPRODUCT	41094
21238926	1519	1522	Mad	GENEORGENEPRODUCT	33529
21238926	1557	1561	dMyc	GENEORGENEPRODUCT	31310
21238926	1706	1709	Dpp	GENEORGENEPRODUCT	33432
21238926	1922	1926	Brat	GENEORGENEPRODUCT	35197
21238926	2028	2032	Brat	GENEORGENEPRODUCT	35197
21238926	2094	2097	Dpp	GENEORGENEPRODUCT	33432
21325775	41	58	apolipoproteina E	GENEORGENEPRODUCT	348
21325775	100	104	ApoE	GENEORGENEPRODUCT	348
21325775	150	160	Arg158 Pro	SEQUENCEVARIANT	P|SUB|R|158|P
21325775	213	226	dislipidemico	DISEASEORPHENOTYPICFEATURE	D050171
21325775	254	262	paziente	ORGANISMTAXON	9606
21325775	310	337	glomerulopatia lipoproteica	DISEASEORPHENOTYPICFEATURE	C567089
21325775	383	410	Glomerulopatia lipoproteica	DISEASEORPHENOTYPICFEATURE	C567089
21325775	455	458	GPL	DISEASEORPHENOTYPICFEATURE	C567089
21325775	669	686	apolipoproteina E	GENEORGENEPRODUCT	348
21325775	718	722	apoE	GENEORGENEPRODUCT	348
21325775	814	818	apoE	GENEORGENEPRODUCT	348
21325775	879	882	LPG	DISEASEORPHENOTYPICFEATURE	C567089
21325775	962	965	GPL	DISEASEORPHENOTYPICFEATURE	C567089
21325775	993	1001	paziente	ORGANISMTAXON	9606
21325775	1048	1052	apoE	GENEORGENEPRODUCT	348
21325775	1094	1098	apoE	GENEORGENEPRODUCT	348
21325775	1136	1144	paziente	ORGANISMTAXON	9606
21325775	1179	1183	uomo	ORGANISMTAXON	9606
21325775	1272	1290	sindrome nefrosica	DISEASEORPHENOTYPICFEATURE	D009404
21325775	1466	1469	GPL	DISEASEORPHENOTYPICFEATURE	C567089
21325775	1522	1538	trombi lamellari	DISEASEORPHENOTYPICFEATURE	D013927
21325775	1630	1634	apoE	GENEORGENEPRODUCT	348
21325775	1669	1676	apoE3/2	GENEORGENEPRODUCT	348
21325775	1738	1750	dislipidemia	DISEASEORPHENOTYPICFEATURE	D050171
21325775	1915	1919	apoE	GENEORGENEPRODUCT	348
21325775	2021	2025	apoE	GENEORGENEPRODUCT	348
21325775	2155	2178	L'analisi del gene ApoE	GENEORGENEPRODUCT	348
21325775	2267	2289	G con C al codone 158 	SEQUENCEVARIANT	C|SUB|G|CODON158|C
21325775	2400	2462	residuo di arginina per il residuo di prolina in posizione 158	SEQUENCEVARIANT	P|SUB|R|158|P
21325775	2496	2500	apoE	GENEORGENEPRODUCT	348
21325775	2726	2730	apoE	GENEORGENEPRODUCT	348
21325775	2819	2823	apoE	GENEORGENEPRODUCT	348
21325775	2920	2924	apoE	GENEORGENEPRODUCT	348
21325775	3045	3048	GPL	DISEASEORPHENOTYPICFEATURE	C567089
21325775	3090	3094	apoE	GENEORGENEPRODUCT	348
21496008	87	118	omeobox correlato ad Aristaless	GENEORGENEPRODUCT	170302
21496008	154	157	ARX	GENEORGENEPRODUCT	170302
21496008	197	200	ARX	GENEORGENEPRODUCT	170302
21496008	276	290	disturbi umani	ORGANISMTAXON	9606
21496008	348	382	malformazioni cerebrali e genitali	DISEASEORPHENOTYPICFEATURE	D000013
21496008	441	464	Disabilità intellettiva	DISEASEORPHENOTYPICFEATURE	D008607
21496008	509	511	ID	DISEASEORPHENOTYPICFEATURE	D008607
21496008	547	550	ARX	GENEORGENEPRODUCT	170302
21496008	648	659	polialanina	CHEMICALENTITY	C019529
21496008	692	694	pA	CHEMICALENTITY	C019529
21496008	885	887	ID	DISEASEORPHENOTYPICFEATURE	D008607
21496008	965	968	ARX	GENEORGENEPRODUCT	170302
21496008	1136	1143	dup24bp	SEQUENCEVARIANT	C|DUP||24|
21496008	1251	1254	ARX	GENEORGENEPRODUCT	170302
21496008	1517	1520	ARX	GENEORGENEPRODUCT	170302
21496008	1658	1665	dup24bp	SEQUENCEVARIANT	C|DUP||24|
21496008	1733	1740	dup24bp	SEQUENCEVARIANT	C|DUP||24|
21496008	1796	1803	dup27bp	SEQUENCEVARIANT	C|DUP||27|
21496008	1841	1848	dup33bp	SEQUENCEVARIANT	C| DUP||33|
21496008	1971	1980	c.1074G>T	SEQUENCEVARIANT	C|SUB|G|1074|T
21496008	2058	2061	ARX	GENEORGENEPRODUCT	170302
21496008	2165	2173	pazienti	ORGANISMTAXON	9606
21496008	2348	2351	ARX	GENEORGENEPRODUCT	170302
21533187	68	74	PTPN11	GENEORGENEPRODUCT	5781
21533187	125	141	metacondromatosi	DISEASEORPHENOTYPICFEATURE	C562938
21533187	193	211	Malattia di Ollier	DISEASEORPHENOTYPICFEATURE	D004687
21533187	257	277	Sindrome di Maffucci	DISEASEORPHENOTYPICFEATURE	D004687
21533187	322	338	Metacondromatosi	DISEASEORPHENOTYPICFEATURE	C562938
21533187	383	385	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	505	513	esostosi	DISEASEORPHENOTYPICFEATURE	D005096
21533187	559	594	sindrome tumorale da encondromatosi	DISEASEORPHENOTYPICFEATURE	D004687
21533187	639	641	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	718	735	esostosi multipla	DISEASEORPHENOTYPICFEATURE	D005097
21533187	782	817	sindromi da encondromatosi multiple	DISEASEORPHENOTYPICFEATURE	D004687
21533187	870	874	EXT1	GENEORGENEPRODUCT	2131
21533187	908	913	 EXT2	GENEORGENEPRODUCT	2132
21533187	1004	1026	osteocondromi multipli	DISEASEORPHENOTYPICFEATURE	D005097
21533187	1071	1073	MO	DISEASEORPHENOTYPICFEATURE	D005097
21533187	1148	1150	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	1425	1427	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	1687	1693	PTPN11	GENEORGENEPRODUCT	5781
21533187	1808	1814	PTPN11	GENEORGENEPRODUCT	5781
21533187	1887	1889	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	2161	2167	PTPN11	GENEORGENEPRODUCT	5781
21533187	2249	2271	15 kb di cancellazione	SEQUENCEVARIANT	C |DEL||15K
21533187	2326	2332	PTPN11	GENEORGENEPRODUCT	5781
21533187	2393	2395	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	2438	2446	pazienti	ORGANISMTAXON	9606
21533187	2483	2489	PTPN11	GENEORGENEPRODUCT	5781
21533187	2634	2640	PTPN11	GENEORGENEPRODUCT	5781
21533187	2693	2701	pazienti	ORGANISMTAXON	9606
21533187	2762	2807	disturbi da encondromatosi Malattia di Ollier	DISEASEORPHENOTYPICFEATURE	D004687
21533187	2853	2873	Sindrome di Maffucci	DISEASEORPHENOTYPICFEATURE	D004687
21533187	2958	2964	PTPN11	GENEORGENEPRODUCT	5781
21533187	3075	3081	PTPN11	GENEORGENEPRODUCT	5781
21533187	3153	3155	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	3202	3210	pazienti	ORGANISMTAXON	9606
21533187	3258	3260	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	3360	3362	MC	DISEASEORPHENOTYPICFEATURE	C562938
21533187	3537	3543	PTPN11	GENEORGENEPRODUCT	5781
21533187	3604	3610	PTPN11	GENEORGENEPRODUCT	5781
21533187	3684	3702	Malattia di Ollier	DISEASEORPHENOTYPICFEATURE	D004687
21533187	3748	3768	Sindrome di Maffucci	DISEASEORPHENOTYPICFEATURE	D004687
21615796	33	50	Interleuchina-17F	GENEORGENEPRODUCT	112744
21615796	101	109	pazienti	ORGANISMTAXON	9606
21615796	157	192	trombocitopenia immunitaria cronica	DISEASEORPHENOTYPICFEATURE	D016553
21615796	241	247	IL-17F	GENEORGENEPRODUCT	112744
21615796	294	317	citochina infiammatoria	GENEORGENEPRODUCT	112744
21615796	406	425	malattie autoimmuni	DISEASEORPHENOTYPICFEATURE	D001327
21615796	506	517	ITP cronica	DISEASEORPHENOTYPICFEATURE	D016553
21615796	604	612	rs763780	SEQUENCEVARIANT	RS763780
21615796	647	654	7488T/C	SEQUENCEVARIANT	RS763780
21615796	706	750	Sostituzione His-to-Arg all'amminoacido 161 	SEQUENCEVARIANT	RS763780
21615796	779	787	PAZIENTI	ORGANISMTAXON	9606
21615796	847	855	pazienti	ORGANISMTAXON	9606
21615796	884	890	uomini	ORGANISMTAXON	9606
21615796	919	924	donne	ORGANISMTAXON	9606
21615796	1008	1019	PTI cronica	DISEASEORPHENOTYPICFEATURE	D016553
21615796	1069	1075	uomini	ORGANISMTAXON	9606
21615796	1104	1109	donne	ORGANISMTAXON	9606
21615796	1363	1371	pazienti	ORGANISMTAXON	9606
21615796	1419	1430	PTI cronica	DISEASEORPHENOTYPICFEATURE	D016553
21615796	1533	1539	IL-17F	GENEORGENEPRODUCT	112744
21615796	1573	1579	7488CC	SEQUENCEVARIANT	RS763780
21615796	1648	1654	IL-17F	GENEORGENEPRODUCT	112744
21615796	1688	1693	7488C	SEQUENCEVARIANT	RS763780
21615796	1737	1745	pazienti	ORGANISMTAXON	9606
21615796	1793	1804	PTI cronica	DISEASEORPHENOTYPICFEATURE	D016553
21615796	1964	1972	pazienti	ORGANISMTAXON	9606
21615796	2013	2019	IL-17F	GENEORGENEPRODUCT	112744
21615796	2054	2060	7488TT	SEQUENCEVARIANT	RS763780
21615796	2135	2151	trombocitopenico	DISEASEORPHENOTYPICFEATURE	D011696
21615796	2263	2269	IL-17F	GENEORGENEPRODUCT	112744
21615796	2303	2309	7488TC	SEQUENCEVARIANT	RS763780
21615796	2423	2429	IL-17F	GENEORGENEPRODUCT	112744
21615796	2463	2469	7488 T	SEQUENCEVARIANT	RS763780
21615796	2561	2572	ITP cronico	DISEASEORPHENOTYPICFEATURE	D016553
21615796	2631	2637	IL-17F	GENEORGENEPRODUCT	112744
21615796	2701	2712	PTI cronica	DISEASEORPHENOTYPICFEATURE	D016553
21666969	43	49	G1359A	SEQUENCEVARIANT	RS1049353
21666969	98	121	recettore cannabinoide 	GENEORGENEPRODUCT	1268
21666969	159	163	CNR1	GENEORGENEPRODUCT	1268
21666969	211	226	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
21666969	354	362	1359 G/A	SEQUENCEVARIANT	RS1049353
21666969	399	402	CB1	GENEORGENEPRODUCT	1268
21666969	476	519	G con A nella posizione del nucleotide 1359	SEQUENCEVARIANT	RS1049353
21666969	558	574	codone 435 (Thr)	SEQUENCEVARIANT	RS1049353
21666969	822	828	G1359A	SEQUENCEVARIANT	RS1049353
21666969	864	877	recettore CB1	GENEORGENEPRODUCT	1268
21666969	964	979	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
21666969	1131	1136	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21666969	1164	1172	pazienti	ORGANISMTAXON	9606
21666969	1251	1259	pazienti	ORGANISMTAXON	9606
21666969	1307	1314	obesità	DISEASEORPHENOTYPICFEATURE	D009765
21666969	1565	1571	G1359A	SEQUENCEVARIANT	RS1049353
21666969	1608	1614	A1359A	SEQUENCEVARIANT	RS1049353
21666969	1673	1679	G1359G	SEQUENCEVARIANT	RS1049353
21666969	1779	1787	pazienti	ORGANISMTAXON	9606
21666969	1848	1854	G1359G	SEQUENCEVARIANT	RS1049353
21666969	1906	1914	pazienti	ORGANISMTAXON	9606
21666969	1949	1955	G1359A	SEQUENCEVARIANT	RS1049353
21666969	1987	1995	pazienti	ORGANISMTAXON	9606
21666969	2040	2046	A1359A	SEQUENCEVARIANT	RS1049353
21666969	2078	2086	pazienti	ORGANISMTAXON	9606
21666969	2371	2379	resistin	GENEORGENEPRODUCT	56729
21666969	2459	2466	leptina	GENEORGENEPRODUCT	3952
21666969	2543	2547	IL-6	GENEORGENEPRODUCT	3569
21666969	2769	2774	A1359	SEQUENCEVARIANT	RS1049353
21666969	2831	2841	 resistina	GENEORGENEPRODUCT	56729
21666969	2874	2881	leptina	GENEORGENEPRODUCT	3952
21666969	2915	2930	interleuchina-6	GENEORGENEPRODUCT	3569
21666969	2987	3002	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
21682595	31	36	XRCC1	GENEORGENEPRODUCT	7515
21682595	69	78	Arg399Gln	SEQUENCEVARIANT	RS25487
21682595	155	182	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
21682595	296	304	pazienti	ORGANISMTAXON	9606
21682595	352	379	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	D008180
21682595	424	427	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	469	509	Ricoparazione radiografica complementare	GENEORGENEPRODUCT	7515
21682595	542	547	XRCC1	GENEORGENEPRODUCT	7515
21682595	581	590	Arg399Gln	SEQUENCEVARIANT	RS25487
21682595	625	632	rs25487	SEQUENCEVARIANT	RS25487
21682595	772	777	XRCC1	GENEORGENEPRODUCT	7515
21682595	810	819	Arg399Gln	SEQUENCEVARIANT	RS25487
21682595	851	859	pazienti	ORGANISMTAXON	9606
21682595	907	910	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	1046	1049	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	1077	1085	pazienti	ORGANISMTAXON	9606
21682595	1358	1365	399 Gln	SEQUENCEVARIANT	RS25487
21682595	1396	1404	pazienti	ORGANISMTAXON	9606
21682595	1452	1455	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	1622	1627	XRCC1	GENEORGENEPRODUCT	7515
21682595	1660	1670	 Arg399Gln	SEQUENCEVARIANT	RS25487
21682595	1865	1888	eruzione cutanea malare	DISEASEORPHENOTYPICFEATURE	D005076
21682595	1974	1977	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	2235	2238	SLE	DISEASEORPHENOTYPICFEATURE	D008180
21682595	2495	2500	XRCC1	GENEORGENEPRODUCT	7515
21682595	2533	2542	Arg399Gln	SEQUENCEVARIANT	RS25487
21682595	2627	2630	LES	DISEASEORPHENOTYPICFEATURE	D008180
21682595	2719	2722	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	35	38	MHC	GENEORGENEPRODUCT	3123,720
21695597	103	130	sistemico lupus eritematoso	DISEASEORPHENOTYPICFEATURE	D008180
21695597	175	180	donne	ORGANISMTAXON	9606
21695597	220	259	complesso maggiore di istocompatibilità	GENEORGENEPRODUCT	3123,720
21695597	296	299	MHC	GENEORGENEPRODUCT	3123,720
21695597	420	447	lupus eritematoso sistemico	DISEASEORPHENOTYPICFEATURE	 D008180
21695597	492	495	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	549	552	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	728	731	MHC	GENEORGENEPRODUCT	3123,720
21695597	790	793	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	894	897	MHC	GENEORGENEPRODUCT	3123,720
21695597	1003	1006	C4A	GENEORGENEPRODUCT	720
21695597	1056	1059	SLE	DISEASEORPHENOTYPICFEATURE	D008180
21695597	1215	1220	Women	ORGANISMTAXON	9606
21695597	1519	1522	SLE	DISEASEORPHENOTYPICFEATURE	D008180
21695597	1565	1574	rs9271366	SEQUENCEVARIANT	RS9271366
21695597	1661	1669	HLA-DRB1	GENEORGENEPRODUCT	3123
21695597	1768	1776	rs204890	SEQUENCEVARIANT	RS204890
21695597	1841	1850	rs2071349	SEQUENCEVARIANT	 RS2071349
21695597	1915	1924	rs2844580	SEQUENCEVARIANT	RS2844580
21695597	2013	2016	SLE	DISEASEORPHENOTYPICFEATURE	D008180
21695597	2067	2076	rs9271366	SEQUENCEVARIANT	RS9271366
21695597	2164	2167	C4A	GENEORGENEPRODUCT	720
21695597	2547	2556	rs9271366	SEQUENCEVARIANT	RS9271366
21695597	2653	2656	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	2857	2862	donne	ORGANISMTAXON	9606
21695597	2991	2994	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	3132	3135	MHC	GENEORGENEPRODUCT	3123,720
21695597	3203	3206	LES	DISEASEORPHENOTYPICFEATURE	D008180
21695597	3251	3256	donne	ORGANISMTAXON	9606
21699520	31	36	PTCH1	GENEORGENEPRODUCT	5727
21699520	178	183	umano	ORGANISMTAXON	9606
21699520	227	250	carcinomi basocellulari	DISEASEORPHENOTYPICFEATURE	D002280
21699520	307	333	Carcinomi a cellule basali	DISEASEORPHENOTYPICFEATURE	D002280
21699520	378	381	BCC	DISEASEORPHENOTYPICFEATURE	D002280
21699520	432	437	umano	ORGANISMTAXON	9606
21699520	481	487	cancro	DISEASEORPHENOTYPICFEATURE	D009369
21699520	610	628	Sindrome di Gorlin	DISEASEORPHENOTYPICFEATURE	D001478
21699520	683	723	malattia ereditaria autosomica dominante	DISEASEORPHENOTYPICFEATURE	D030342
21699520	796	799	BCC	DISEASEORPHENOTYPICFEATURE	D002280
21699520	851	868	difetti congeniti	DISEASEORPHENOTYPICFEATURE	D000013
21699520	918	922	BCC 	DISEASEORPHENOTYPICFEATURE	D002280
21699520	1025	1031	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21699520	1080	1085	PTCH1	GENEORGENEPRODUCT	5727
21699520	1169	1174	PTCH2	GENEORGENEPRODUCT	8643
21699520	1277	1281	BCC 	DISEASEORPHENOTYPICFEATURE	D002280
21699520	1398	1404	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21699520	1528	1533	PTCH1	GENEORGENEPRODUCT	5727
21699520	1567	1572	PTCH2	GENEORGENEPRODUCT	8643
21699520	1802	1805	BCC	DISEASEORPHENOTYPICFEATURE	D002280
21699520	1896	1899	BCC	DISEASEORPHENOTYPICFEATURE	D002280
21699520	1966	1975	g.2885G>C	SEQUENCEVARIANT	G|SUB|G|2885|C
21699520	2024	2029	PTCH1	GENEORGENEPRODUCT	5727
21699520	2098	2105	p.R962T	SEQUENCEVARIANT	P|SUB|R|962|T
21699520	2221	2227	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21699520	2261	2269	paziente	ORGANISMTAXON	9606
21699520	2318	2336	Sindrome di Gorlin	DISEASEORPHENOTYPICFEATURE	D001478
21699520	2401	2410	g.2839T>G	SEQUENCEVARIANT	G|SUB|T|2839|G
21699520	2492	2502	p.E947stop	SEQUENCEVARIANT	P|SUB|E|947|X
21699520	2603	2609	tumore	DISEASEORPHENOTYPICFEATURE	D009369
21699520	2726	2731	PTCH1	GENEORGENEPRODUCT	5727
21699520	2807	2812	PTCH1	GENEORGENEPRODUCT	5727
21699520	2812	2813	 	DISEASEORPHENOTYPICFEATURE	D002280
21771880	54	58	IRS2	GENEORGENEPRODUCT	8660
21771880	127	135	obesità 	DISEASEORPHENOTYPICFEATURE	D009765
21771880	184	192	glucosio	CHEMICALENTITY	D005947
21771880	297	337	 substrato del recettore dell'insulina 2	GENEORGENEPRODUCT	8660
21771880	370	374	IRS2	GENEORGENEPRODUCT	8660
21771880	460	467	obesità	DISEASEORPHENOTYPICFEATURE	D009765
21771880	514	541	tratti correlati al diabete	DISEASEORPHENOTYPICFEATURE	D003920
21771880	663	667	IRS2	GENEORGENEPRODUCT	8660
21771880	1045	1052	obesità	DISEASEORPHENOTYPICFEATURE	D009765
21771880	1098	1105	diabete	DISEASEORPHENOTYPICFEATURE	D003920
21771880	1783	1790	obesità	DISEASEORPHENOTYPICFEATURE	D009765
21771880	2329	2336	diabete	DISEASEORPHENOTYPICFEATURE	D003920
21771880	2487	2495	glucosio	CHEMICALENTITY	D005947
21771880	2556	2560	IRS2	GENEORGENEPRODUCT	8660
21771880	2694	2716	omeostasi del glucosio	CHEMICALENTITY	D005947
21810259	28	33	HIV-1	ORGANISMTAXON	11676
21810259	67	70	Tat	GENEORGENEPRODUCT	155871
21810259	110	138	indoleamine 2,3 diossigenasi	GENEORGENEPRODUCT	15930
21810259	170	176	murine	ORGANISMTAXON	10090
21810259	263	304	p38 protein chinasi attivata dal mitogeno	GENEORGENEPRODUCT	26416
21810259	425	435	triptofano	CHEMICALENTITY	D014364
21810259	468	496	indoleamine 2,3 diossigenasi	GENEORGENEPRODUCT	15930
21810259	530	533	IDO	GENEORGENEPRODUCT	15930
21810259	650	660	depressivo	DISEASEORPHENOTYPICFEATURE	D000275
21810259	718	761	virus dell'immunodeficienza umana di tipo 1	ORGANISMTAXON	11676
21810259	791	796	HIV-1	ORGANISMTAXON	11676
21810259	832	835	Tat	GENEORGENEPRODUCT	155871
21810259	896	926	comportamento simil-depressivo	DISEASEORPHENOTYPICFEATURE	D000275
21810259	959	963	topi	ORGANISMTAXON	10090
21810259	1042	1045	IDO	GENEORGENEPRODUCT	15930
21810259	1186	1190	topi	ORGANISMTAXON	10090
21810259	1243	1273	Comportamento simil-depressivo	DISEASEORPHENOTYPICFEATURE	D000275
21810259	1342	1346	topi	ORGANISMTAXON	10090
21810259	1461	1464	IDO	GENEORGENEPRODUCT	15930
21810259	1665	1673	p38 MAPK	GENEORGENEPRODUCT	26416
21810259	1832	1835	Tat	GENEORGENEPRODUCT	155871
21810259	1898	1908	depressiva	DISEASEORPHENOTYPICFEATURE	D000275
21810259	1999	2002	Tat	GENEORGENEPRODUCT	155871
21810259	2074	2077	IDO	GENEORGENEPRODUCT	15930
21810259	2228	2232	IFNg	GENEORGENEPRODUCT	15978
21810259	2267	2270	Tat	GENEORGENEPRODUCT	155871
21810259	2348	2352	TNFa	GENEORGENEPRODUCT	21926
21810259	2388	2392	IL-6	GENEORGENEPRODUCT	16193
21810259	2499	2546	isoforma inducibile dell'ossido nitrico sintasi	GENEORGENEPRODUCT	18126
21810259	2580	2584	iNOS	GENEORGENEPRODUCT	18126
21810259	2623	2653	trasportatore della serotonina	GENEORGENEPRODUCT	15567
21810259	2688	2692	SERT	GENEORGENEPRODUCT	15567
21810259	2728	2731	Tat	GENEORGENEPRODUCT	155871
21810259	2817	2821	IFNg	GENEORGENEPRODUCT	15978
21810259	2900	2903	Tat	GENEORGENEPRODUCT	155871
21810259	2947	2950	IDO	GENEORGENEPRODUCT	15930
21810259	3038	3080	p38 proteina chinasi attivata dal mitogeno	GENEORGENEPRODUCT	26416
21810259	3114	3118	MAPK	GENEORGENEPRODUCT	26416
21810259	3152	3161	SB 202190	CHEMICALENTITY	C090942
21810259	3228	3231	Tat	GENEORGENEPRODUCT	155871
21810259	3264	3273	SB 202190	CHEMICALENTITY	C090942
21810259	3335	3338	IDO	GENEORGENEPRODUCT	15930
21810259	3396	3399	Tat	GENEORGENEPRODUCT	155871
21810259	3492	3495	Tat	GENEORGENEPRODUCT	155871
21810259	3552	3556	TNFa	GENEORGENEPRODUCT	21926
21810259	3590	3594	IL-6	GENEORGENEPRODUCT	16193
21810259	3628	3632	iNOS	GENEORGENEPRODUCT	18126
21810259	3667	3671	SERT	GENEORGENEPRODUCT	15567
21810259	3748	3751	Tat	GENEORGENEPRODUCT	155871
21810259	3791	3794	IDO	GENEORGENEPRODUCT	15930
21810259	3851	3855	IFNg	GENEORGENEPRODUCT	15978
21810259	3944	3952	p38 MAPK	GENEORGENEPRODUCT	26416
21810259	4001	4004	IDO	GENEORGENEPRODUCT	3620
21810259	4069	4077	p38 MAPK	GENEORGENEPRODUCT	26416
21810259	4172	4191	disturbi depressivi	DISEASEORPHENOTYPICFEATURE	D000275
21810259	4238	4251	HIV-1-infetto	DISEASEORPHENOTYPICFEATURE	D015658
21810259	4280	4288	pazienti	ORGANISMTAXON	9606
21904390	60	64	PAX6	GENEORGENEPRODUCT	5080
21904390	149	157	pazienti	ORGANISMTAXON	9606
21904390	209	217	Aniridia	DISEASEORPHENOTYPICFEATURE	D015783
21904390	262	264	AN	DISEASEORPHENOTYPICFEATURE	D015783
21904390	320	349	disturbo panoculare congenito	DISEASEORPHENOTYPICFEATURE	D000013
21904390	409	435	gene omeotico paired box 6	GENEORGENEPRODUCT	5080
21904390	468	472	PAX6	GENEORGENEPRODUCT	5080
21904390	519	523	PAX6	GENEORGENEPRODUCT	5080
21904390	594	630	malformazioni del segmento anteriore	DISEASEORPHENOTYPICFEATURE	C537775
21904390	683	701	Anomalia di Peters	DISEASEORPHENOTYPICFEATURE	C537884
21904390	773	777	PAX6	GENEORGENEPRODUCT	5080
21904390	894	896	AN	DISEASEORPHENOTYPICFEATURE	D015783
21904390	941	976	coloboma dell'iride e della coroide	DISEASEORPHENOTYPICFEATURE	D003103
21904390	1023	1059	malformazioni del segmento anteriore	DISEASEORPHENOTYPICFEATURE	C537775
21904390	1088	1096	PAZIENTI	ORGANISMTAXON	9606
21904390	1168	1186	pazienti sporadici	ORGANISMTAXON	9606
21904390	1429	1433	PAX6	GENEORGENEPRODUCT	5080
21904390	1704	1712	pazienti	ORGANISMTAXON	9606
21904390	1812	1814	AN	DISEASEORPHENOTYPICFEATURE	D015783
21904390	1859	1894	coloboma dell'iride e delle coroidi	DISEASEORPHENOTYPICFEATURE	D003103
21904390	1940	1976	malformazioni del segmento anteriore	DISEASEORPHENOTYPICFEATURE	C537775
21904390	2028	2046	anomalia di Peters	DISEASEORPHENOTYPICFEATURE	C537884
21904390	2103	2107	PAX6	GENEORGENEPRODUCT	5080
21904390	2287	2298	p.Ser119fsX	SEQUENCEVARIANT	P|FS|S|119||
21904390	2362	2370	pazienti	ORGANISMTAXON	9606
21904390	2425	2427	AN	DISEASEORPHENOTYPICFEATURE	D015783
21904390	2496	2504	c.643T>C	SEQUENCEVARIANT	C|SUB|T|643|C
21904390	2545	2552	p.S216P	SEQUENCEVARIANT	P|SUB|S| 216|P
21904390	2625	2661	malformazione del segmento anteriore	DISEASEORPHENOTYPICFEATURE	C537775
21904390	2714	2721	p.S216P	SEQUENCEVARIANT	P|SUB|S|216|P
21904390	2796	2800	PAX6	GENEORGENEPRODUCT	5080
21904390	2870	2888	Anomalia di Peters	DISEASEORPHENOTYPICFEATURE	C537884
21904390	3041	3045	PAX6	GENEORGENEPRODUCT	5080
21904390	3157	3165	paziente	ORGANISMTAXON	9606
21904390	3220	3222	AN	DISEASEORPHENOTYPICFEATURE	D015783
21904390	3282	3317	coloboma dell'iride e della coroide	DISEASEORPHENOTYPICFEATURE	D003103
21904390	3683	3687	PAX6	GENEORGENEPRODUCT	5080
21911891	31	83	Inibitore dell'attivatore del plasminogeno di tipo 1	GENEORGENEPRODUCT	5054
21911891	189	194	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	230	238	pazienti	ORGANISMTAXON	9606
21911891	286	316	non alcoliche steatosi epatica	DISEASEORPHENOTYPICFEATURE	D065626
21911891	364	416	inibitore dell'attivatore del plasminogeno di tipo-1	GENEORGENEPRODUCT	5054
21911891	449	454	PAI-1	GENEORGENEPRODUCT	5054
21911891	724	729	PAI-1	GENEORGENEPRODUCT	5054
21911891	772	777	PAI-1	GENEORGENEPRODUCT	5054
21911891	844	863	fibrogenesi epatica	DISEASEORPHENOTYPICFEATURE	D008107
21911891	947	952	PAI-1	GENEORGENEPRODUCT	5054
21911891	1036	1050	fegato fibrosi	DISEASEORPHENOTYPICFEATURE	D008103
21911891	1106	1142	malattia epatica grassa non alcolica	DISEASEORPHENOTYPICFEATURE	D065626
21911891	1187	1192	NAFLD	DISEASEORPHENOTYPICFEATURE	D065626
21911891	1240	1245	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	1273	1281	pazienti	ORGANISMTAXON	9606
21911891	1374	1379	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	1407	1415	pazienti	ORGANISMTAXON	9606
21911891	1510	1515	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	1644	1649	PAI-1	GENEORGENEPRODUCT	5054
21911891	1809	1821	trigliceridi	CHEMICALENTITY	D014280
21911891	1875	1887	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
21911891	1933	1940	diabete	DISEASEORPHENOTYPICFEATURE	D003920
21911891	2021	2026	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	2055	2063	pazienti	ORGANISMTAXON	 9606
21911891	2130	2135	PAI-1	GENEORGENEPRODUCT	5054
21911891	2208	2213	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	2242	2250	pazienti	ORGANISMTAXON	9606
21911891	2460	2465	PAI-1	GENEORGENEPRODUCT	5054
21911891	2571	2576	PAI-1	GENEORGENEPRODUCT	5054
21911891	2624	2629	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	2658	2666	pazienti	ORGANISMTAXON	9606
21911891	2714	2729	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
21911891	2783	2791	pazienti	ORGANISMTAXON	9606
21911891	2841	2856	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
21911891	2912	2917	PAI-1	GENEORGENEPRODUCT	5054
21911891	3007	3015	pazienti	ORGANISMTAXON	9606
21911891	3071	3086	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
21911891	3142	3146	NASH	DISEASEORPHENOTYPICFEATURE	D065626
21911891	3223	3228	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	3256	3264	pazienti	ORGANISMTAXON	9606
21911891	3304	3309	PAI-1	GENEORGENEPRODUCT	5054
21911891	3395	3400	PAI-1	GENEORGENEPRODUCT	5054
21911891	3488	3502	soggetti obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	3697	3702	PAI-1	GENEORGENEPRODUCT	5054
21911891	3783	3798	fibrosi epatica	DISEASEORPHENOTYPICFEATURE	D008103
21911891	3845	3850	obesi	DISEASEORPHENOTYPICFEATURE	D009765
21911891	3878	3886	pazienti	ORGANISMTAXON	9606
22048266	82	86	ETS2	GENEORGENEPRODUCT	2114
22048266	120	125	 SIM2	GENEORGENEPRODUCT	6493
22048266	177	193	Sindrome di Down	DISEASEORPHENOTYPICFEATURE	D004314
22048266	326	342	Sindrome di Down	DISEASEORPHENOTYPICFEATURE	D004314
22048266	387	389	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	593	595	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	696	707	Obiettivo 2	GENEORGENEPRODUCT	6493
22048266	740	744	SIM2	GENEORGENEPRODUCT	6493
22048266	779	830	V- ets erythroblastosis virus E26 oncogene homolog2	GENEORGENEPRODUCT	2114
22048266	863	867	ETS2	GENEORGENEPRODUCT	2114
22048266	1006	1008	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	1125	1127	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	1323	1327	ETS2	GENEORGENEPRODUCT	2114
22048266	1361	1369	rs461155	SEQUENCEVARIANT	RS461155
22048266	1452	1454	DS	DISEASEORPHENOTYPICFEATURE	 D004314
22048266	1529	1533	SIM2	GENEORGENEPRODUCT	6493
22048266	1582	1591	rs2073601	SEQUENCEVARIANT	RS2073601
22048266	1627	1636	rs2073416	SEQUENCEVARIANT	RS2073416
22048266	1713	1715	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	1955	1957	DS	DISEASEORPHENOTYPICFEATURE	D004314
22048266	2079	2088	rs2073601	SEQUENCEVARIANT	RS2073601
22048266	2176	2197	leucina con metionina	SEQUENCEVARIANT	RS2073601
22048266	2269	2271	DS	DISEASEORPHENOTYPICFEATURE	D004314
22051099	51	56	CXCR1	GENEORGENEPRODUCT	3577
22051099	89	94	IL8RA	GENEORGENEPRODUCT	3577
22051099	174	193	parodontite cronica	DISEASEORPHENOTYPICFEATURE	D055113
22051099	241	276	recettore delle chemochine 1 CXCR-1	GENEORGENEPRODUCT	3577
22051099	311	321	IL8R-alpha	GENEORGENEPRODUCT	3577
22051099	384	399	interleuchina 8	GENEORGENEPRODUCT	3576
22051099	432	436	IL-8	GENEORGENEPRODUCT	3576
22051099	566	578	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
22051099	630	639	rs2234671	SEQUENCEVARIANT	RS2234671
22051099	690	700	Ex2+860G>C	SEQUENCEVARIANT	RS2234671
22051099	736	741	CXCR1	GENEORGENEPRODUCT	3577
22051099	834	839	S276T	SEQUENCEVARIANT	RS2234671
22051099	1007	1024	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
22051099	1135	1138	IL8	GENEORGENEPRODUCT	3576
22051099	1176	1181	CXCR2	GENEORGENEPRODUCT	3579
22051099	1262	1281	parodontite cronica	DISEASEORPHENOTYPICFEATURE	D055113
22051099	1367	1376	rs2234671	SEQUENCEVARIANT	RS2234671
22051099	1459	1478	parodontite cronica	DISEASEORPHENOTYPICFEATURE	D055113
22051099	1660	1669	rs2234671	SEQUENCEVARIANT	RS2234671
22051099	1710	1715	CXCR1	GENEORGENEPRODUCT	3577
22051099	1802	1821	parodontite cronica	DISEASEORPHENOTYPICFEATURE	D055113
22104738	72	77	MLYCD	GENEORGENEPRODUCT	23417
22104738	116	124	paziente	ORGANISMTAXON	9606
22104738	172	189	aciduria malonica	DISEASEORPHENOTYPICFEATURE	C535702
22104738	312	329	aciduria malonica	DISEASEORPHENOTYPICFEATURE	C535702
22104738	382	404	ritardo dello sviluppo	DISEASEORPHENOTYPICFEATURE	D002658
22104738	449	462	bassa statura	DISEASEORPHENOTYPICFEATURE	D006130
22104738	507	525	anomalie cerebrali	DISEASEORPHENOTYPICFEATURE	D001927
22104738	582	596	acido malonico	CHEMICALENTITY	C030290
22104738	630	649	acido metilmalonico	CHEMICALENTITY	D008764
22104738	833	838	MLYCD	GENEORGENEPRODUCT	23417
22104738	917	925	c.920T>G	SEQUENCEVARIANT	C| SUB|T|920|G
22104738	965	976	p.Leu307Arg	SEQUENCEVARIANT	P|SUB|L|307|R
22104738	1009	1017	paziente	ORGANISMTAXON	9606
22104738	1112	1120	paziente	ORGANISMTAXON	9606
22104738	1195	1203	c.920T>G	SEQUENCEVARIANT	C|SUB|T|920|G
22104738	1429	1434	MLYCD	GENEORGENEPRODUCT	23417
22180037	62	89	glutatione-S-transferasi P1	GENEORGENEPRODUCT	2950
22180037	123	128	GSTP1	GENEORGENEPRODUCT	2950
22180037	192	212	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22180037	275	302	Glutatione-S-transferasi P1	GENEORGENEPRODUCT	2950
22180037	335	340	GSTP1	GENEORGENEPRODUCT	2950
22180037	483	488	GSTP1	GENEORGENEPRODUCT	2950
22180037	522	545	A > G al nucleotide 313	SEQUENCEVARIANT	RS1695
22180037	629	638	Ile105Val	SEQUENCEVARIANT	RS1695
22180037	707	712	GSTP1	GENEORGENEPRODUCT	2950
22180037	778	783	GSTP1	GENEORGENEPRODUCT	2950
22180037	855	860	GSTP1	GENEORGENEPRODUCT	2950
22180037	892	901	Ile105Val	SEQUENCEVARIANT	RS1695
22180037	949	969	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22180037	1105	1125	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22180037	1179	1208	iperplasia prostatica benigna	DISEASEORPHENOTYPICFEATURE	D011470
22180037	1269	1274	GSTP1	GENEORGENEPRODUCT	2950
22180037	1307	1316	Ile105Val	SEQUENCEVARIANT	RS1695
22180037	1514	1519	GSTP1	GENEORGENEPRODUCT	2950
22180037	1551	1560	Ile105Val	SEQUENCEVARIANT	RS1695
22180037	1712	1732	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22180037	1804	1833	iperplasia prostatica benigna	DISEASEORPHENOTYPICFEATURE	D011470
22180037	1989	1994	GSTP1	GENEORGENEPRODUCT	2950
22180037	2026	2033	Ile/Val	SEQUENCEVARIANT	RS1695
22180037	2121	2126	GSTP1	GENEORGENEPRODUCT	2950
22180037	2158	2165	Ile/Val	SEQUENCEVARIANT	RS1695
22180037	2252	2272	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22303482	32	37	TBX21	GENEORGENEPRODUCT	30009
22303482	71	75	HLX1	GENEORGENEPRODUCT	3142
22303482	187	192	TBX21	GENEORGENEPRODUCT	30009
22303482	226	282	Fattore di trascrizione T-box specifico delle cellule T 	GENEORGENEPRODUCT	30009
22303482	317	321	HLX1	GENEORGENEPRODUCT	3142
22303482	354	374	H.20-like homeobox 1	GENEORGENEPRODUCT	3142
22303482	640	645	TBX21	GENEORGENEPRODUCT	30009
22303482	679	683	HLX1	GENEORGENEPRODUCT	3142
22303482	860	865	TBX21	GENEORGENEPRODUCT	30009
22303482	903	907	HLX1	GENEORGENEPRODUCT	3142
22303482	977	984	Lipid A	CHEMICALENTITY	D008050
22303482	1017	1020	LpA	CHEMICALENTITY	D008050
22303482	1053	1056	LpA	CHEMICALENTITY	D008050
22303482	1090	1104	Peptidoglicano	CHEMICALENTITY	D010457
22303482	1137	1140	Ppg	CHEMICALENTITY	D010457
22303482	1228	1260	Dermatophagoides pteronyssinus 1	GENEORGENEPRODUCT	113791973
22303482	1298	1303	Derp1	GENEORGENEPRODUCT	113791973
22303482	1348	1367	fitoemoagglutinina 	CHEMICALENTITY	D010835
22303482	1400	1403	PHA	CHEMICALENTITY	D010835
22303482	1675	1680	TBX21	GENEORGENEPRODUCT	30009
22303482	1730	1740	rs17250932	SEQUENCEVARIANT	RS17250932
22303482	1775	1779	HLX1	GENEORGENEPRODUCT	3142
22303482	1828	1837	rs2738751	SEQUENCEVARIANT	RS2738751
22303482	1931	1935	IL-5	GENEORGENEPRODUCT	3567
22303482	1968	1973	IL-13	GENEORGENEPRODUCT	3596
22303482	2007	2013	TNF-a 	GENEORGENEPRODUCT	7124
22303482	2061	2064	LpA	CHEMICALENTITY	D008050
22303482	2123	2127	HLX1	GENEORGENEPRODUCT	3142
22303482	2166	2175	rs2738751	SEQUENCEVARIANT	RS2738751
22303482	2216	2221	IL-13	GENEORGENEPRODUCT	3596
22303482	2266	2269	Ppg	CHEMICALENTITY	D010457
22303482	2341	2345	HLX1	GENEORGENEPRODUCT	3142
22303482	2393	2403	rs12141189	SEQUENCEVARIANT	RS12141189
22303482	2462	2466	IL-5	GENEORGENEPRODUCT	3567
22303482	2499	2502	LpA	CHEMICALENTITY	D008050
22303482	2547	2550	Ppg	CHEMICALENTITY	D010457
22303482	2626	2631	IL-13	GENEORGENEPRODUCT	3596
22303482	2664	2668	 LpA	CHEMICALENTITY	D008050
22303482	2711	2717	GM-CSF	GENEORGENEPRODUCT	1437
22303482	2750	2753	LpA	CHEMICALENTITY	D008050
22303482	2785	2788	Ppg	CHEMICALENTITY	D010457
22303482	2851	2856	IFN-g	GENEORGENEPRODUCT	3458
22303482	2905	2910	Derp1	GENEORGENEPRODUCT	113791973
22303482	2942	2945	LpA	CHEMICALENTITY	D008050
22303482	3025	3029	HLX1	GENEORGENEPRODUCT	3142
22303482	3078	3087	rs3806325	SEQUENCEVARIANT	RS3806325
22303482	3146	3151	IL-13	GENEORGENEPRODUCT	3596
22303482	3185	3189	IL-6	GENEORGENEPRODUCT	3569
22303482	3264	3269	TBX21	GENEORGENEPRODUCT	30009
22303482	3319	3329	rs11079788	SEQUENCEVARIANT	RS11079788
22303482	3550	3555	TBX21	GENEORGENEPRODUCT	30009
22303482	3595	3605	rs11079788	SEQUENCEVARIANT	RS11079788
22303482	3695	3712	dermatite atopica	DISEASEORPHENOTYPICFEATURE	D003876
22303482	3804	3809	TBX21	GENEORGENEPRODUCT	30009
22303482	3843	3847	HLX1	GENEORGENEPRODUCT	3142
22303482	3913	3917	IL-5	GENEORGENEPRODUCT	3567
22303482	3951	3956	IL-13	GENEORGENEPRODUCT	3596
22303482	4004	4008	 LpA	CHEMICALENTITY	D008050
22303482	4377	4400	malattie immuno-mediate	DISEASEORPHENOTYPICFEATURE	D007154
22303482	4461	4465	asma	DISEASEORPHENOTYPICFEATURE	D001249
22808010	50	54	EPOR	GENEORGENEPRODUCT	13857
22808010	144	154	Tnfr-sf13c	GENEORGENEPRODUCT	72049
22808010	211	214	EPO	GENEORGENEPRODUCT	13856
22808010	314	317	EPO	GENEORGENEPRODUCT	13856
22808010	350	354	EPOR	GENEORGENEPRODUCT	13857
22808010	427	432	Bcl-x	GENEORGENEPRODUCT	12048
22808010	561	565	EPOR	GENEORGENEPRODUCT	13857
22808010	626	634	p85/PI3K	GENEORGENEPRODUCT	18708
22808010	719	730	policitemia	DISEASEORPHENOTYPICFEATURE	D011086
22808010	766	770	Erk1	GENEORGENEPRODUCT	26417
22808010	897	900	EPO	GENEORGENEPRODUCT	13856
22808010	933	937	EPOR	GENEORGENEPRODUCT	13857
22808010	1059	1062	EPO	GENEORGENEPRODUCT	13856
22808010	1095	1099	EPOR	GENEORGENEPRODUCT	13857
22808010	1225	1228	EPO	GENEORGENEPRODUCT	13856
22808010	1261	1265	EPOR	GENEORGENEPRODUCT	13857
22808010	1433	1436	EPO	GENEORGENEPRODUCT	13856
22808010	1477	1481	Lyl1	GENEORGENEPRODUCT	17095
22808010	1516	1520	Gas5	GENEORGENEPRODUCT	14455
22808010	1555	1559	Pim3	GENEORGENEPRODUCT	223775
22808010	1593	1597	Pim1	GENEORGENEPRODUCT	18712
22808010	1631	1634	Bim	GENEORGENEPRODUCT	12125
22808010	1669	1674	Trib3	GENEORGENEPRODUCT	228775
22808010	1710	1720	Serpina 3g	GENEORGENEPRODUCT	20715
22808010	1754	1757	EPO	GENEORGENEPRODUCT	13856
22808010	1790	1794	EPOR	GENEORGENEPRODUCT	13857
22808010	1876	1882	Cdc25a	GENEORGENEPRODUCT	12530
22808010	1916	1920	Btg3	GENEORGENEPRODUCT	12228
22808010	1954	1963	Cyclin-d2	GENEORGENEPRODUCT	12444
22808010	1997	2005	p27-kip1	GENEORGENEPRODUCT	12576
22808010	2039	2048	Cyclin-g2	GENEORGENEPRODUCT	12452
22808010	2084	2097	CyclinB1-IP-1	GENEORGENEPRODUCT	239083
22808010	2131	2134	EPO	GENEORGENEPRODUCT	13856
22808010	2278	2283	Socs3	GENEORGENEPRODUCT	12702
22808010	2321	2326	Socs2	GENEORGENEPRODUCT	216233
22808010	2370	2376	Spred2	GENEORGENEPRODUCT	114716
22808010	2411	2417	Spred1	GENEORGENEPRODUCT	114715
22808010	2452	2456	Eaf1	GENEORGENEPRODUCT	74427
22808010	2500	2503	EPO	GENEORGENEPRODUCT	13856
22808010	2583	2588	Socs2	GENEORGENEPRODUCT	216233
22808010	2704	2708	EPOR	GENEORGENEPRODUCT	13857
22808010	2742	2746	Jak2	GENEORGENEPRODUCT	16452
22808010	2779	2784	Stat5	GENEORGENEPRODUCT	20850
22808010	2893	2899	anemia	DISEASEORPHENOTYPICFEATURE	D000740
22808010	2965	2982	recettore del TNF	GENEORGENEPRODUCT	72049
22808010	3015	3025	Tnfr-sf13c	GENEORGENEPRODUCT	72049
22808010	3079	3082	EPO	GENEORGENEPRODUCT	13856
22808010	3144	3154	Tnfr-sf13c	GENEORGENEPRODUCT	72049
22808010	3325	3329	EPOR	GENEORGENEPRODUCT	13857
22808010	3446	3456	Tnfr-sf13c	GENEORGENEPRODUCT	72049
22836123	59	87	crisi renale da sclerodermia	DISEASEORPHENOTYPICFEATURE	D007674
22836123	130	141	 tacrolimus	CHEMICALENTITY	D016559
22836123	175	187	prednisolone	CHEMICALENTITY	D011239
22836123	248	276	Crisi renale da sclerodermia	DISEASEORPHENOTYPICFEATURE	D007674
22836123	321	324	SRC	DISEASEORPHENOTYPICFEATURE	D007674
22836123	397	415	sclerosi sistemica	DISEASEORPHENOTYPICFEATURE	D012595
22836123	460	463	SSc	DISEASEORPHENOTYPICFEATURE	D012595
22836123	641	656	corticosteroidi	CHEMICALENTITY	D000305
22836123	762	765	SRC	DISEASEORPHENOTYPICFEATURE	D007674
22836123	849	875	microangiopatia trombotica	DISEASEORPHENOTYPICFEATURE	D057049
22836123	922	934	ciclosporina	CHEMICALENTITY	D016572
22836123	969	981	ciclosporina	CHEMICALENTITY	D016572
22836123	1009	1017	pazienti	ORGANISMTAXON	9606
22836123	1065	1068	SSc	DISEASEORPHENOTYPICFEATURE	D012595
22836123	1130	1138	paziente	ORGANISMTAXON	9606
22836123	1186	1189	SRC	DISEASEORPHENOTYPICFEATURE	D007674
22836123	1233	1243	tacrolimus	CHEMICALENTITY	D016559
22836123	1277	1292	corticosteroidi	CHEMICALENTITY	D000305
22836123	1392	1402	tacrolimus	CHEMICALENTITY	D016559
22836123	1437	1445	pazienti	ORGANISMTAXON	9606
22836123	1493	1496	SSc	DISEASEORPHENOTYPICFEATURE	D012595
22859398	45	49	IL10	GENEORGENEPRODUCT	3586
22859398	165	185	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22859398	339	343	IL10	GENEORGENEPRODUCT	3586
22859398	410	440	 specie reattive dell'ossigeno	CHEMICALENTITY	D017382
22859398	583	603	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22859398	697	703	uomini	ORGANISMTAXON	9606
22859398	957	966	paraffina	CHEMICALENTITY	D010232
22859398	1127	1131	IL10	GENEORGENEPRODUCT	3586
22859398	1164	1167	CRP	GENEORGENEPRODUCT	1401
22859398	1201	1205	GPX1	GENEORGENEPRODUCT	2876
22859398	1238	1241	GSR	GENEORGENEPRODUCT	2936
22859398	1275	1280	GSTP1	GENEORGENEPRODUCT	2950
22859398	1313	1318	hOGG1	GENEORGENEPRODUCT	4968
22859398	1351	1355	IL1B	GENEORGENEPRODUCT	3553
22859398	1389	1394	IL1RN	GENEORGENEPRODUCT	3557
22859398	1427	1430	IL6	GENEORGENEPRODUCT	3569
22859398	1464	1467	IL8	GENEORGENEPRODUCT	3576
22859398	1500	1503	MPO	GENEORGENEPRODUCT	4353
22859398	1536	1540	NOS2	GENEORGENEPRODUCT	4843
22859398	1574	1578	NOS3	GENEORGENEPRODUCT	4846
22859398	1611	1615	SOD1	GENEORGENEPRODUCT	6647
22859398	1649	1653	SOD2	GENEORGENEPRODUCT	6648
22859398	1686	1690	SOD3	GENEORGENEPRODUCT	6649
22859398	1723	1727	TLR4	GENEORGENEPRODUCT	7099
22859398	1761	1764	TNF	GENEORGENEPRODUCT	7124
22859398	1809	1813	IL10	GENEORGENEPRODUCT	3586
22859398	1847	1850	CRP	GENEORGENEPRODUCT	1401
22859398	1883	1886	GSR	GENEORGENEPRODUCT	2936
22859398	1919	1924	IL1RN	GENEORGENEPRODUCT	3557
22859398	1957	1960	IL6	GENEORGENEPRODUCT	3569
22859398	1993	1997	NOS2	GENEORGENEPRODUCT	4843
22859398	2031	2035	NOS3	GENEORGENEPRODUCT	4846
22859398	2214	2218	IL10	GENEORGENEPRODUCT	3586
22859398	2253	2262	rs1800872	SEQUENCEVARIANT	RS1800872
22859398	2318	2334	interleuchina-10	GENEORGENEPRODUCT	3586
22859398	2367	2372	IL-10	GENEORGENEPRODUCT	3586
22859398	2520	2529	rs1800896	SEQUENCEVARIANT	RS1800896
22859398	2586	2591	IL-10	GENEORGENEPRODUCT	3586
22859398	2759	2762	CRP	GENEORGENEPRODUCT	1401
22859398	2795	2800	GSTP1	GENEORGENEPRODUCT	2950
22859398	2835	2839	IL1B	GENEORGENEPRODUCT	3553
22859398	2891	2895	IL10	GENEORGENEPRODUCT	3586
22859398	2947	2951	NOS2	GENEORGENEPRODUCT	4843
22859398	3048	3052	IL10	GENEORGENEPRODUCT	3586
22859398	3085	3088	CRP	GENEORGENEPRODUCT	1401
22859398	3122	3127	GSTP1	GENEORGENEPRODUCT	2950
22859398	3160	3164	IL1B	GENEORGENEPRODUCT	3553
22859398	3198	3202	NOS2	GENEORGENEPRODUCT	4843
22859398	3262	3282	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
22859398	3500	3520	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
23791840	32	55	Superossido dismutasi 1	GENEORGENEPRODUCT	20655
23791840	104	108	topi	ORGANISMTAXON	10090
23791840	161	176	diabete materno	DISEASEORPHENOTYPICFEATURE	D016640
23791840	266	275	diabetici	DISEASEORPHENOTYPICFEATURE	D003920
23791840	319	330	embriopatia	DISEASEORPHENOTYPICFEATURE	D005315
23791840	488	497	diabetico	DISEASEORPHENOTYPICFEATURE	D003920
23791840	541	552	embriopatia	DISEASEORPHENOTYPICFEATURE	D005315
23791840	682	705	superossido dismutasi 1	GENEORGENEPRODUCT	20655
23791840	739	743	SOD1	GENEORGENEPRODUCT	20655
23791840	857	861	SOD1	GENEORGENEPRODUCT	20655
23791840	927	936	diabetico	DISEASEORPHENOTYPICFEATURE	D003920
23791840	987	991	SOD1	GENEORGENEPRODUCT	20655
23791840	1093	1116	Proteina omologa C/EBP 	GENEORGENEPRODUCT	13198
23791840	1150	1154	CHOP	GENEORGENEPRODUCT	13198
23791840	1189	1197	calnexin	GENEORGENEPRODUCT	12330
23791840	1232	1269	fattore di iniziazione eucariotica 2a	GENEORGENEPRODUCT	229317
23791840	1304	1309	eIF2a	GENEORGENEPRODUCT	229317
23791840	1345	1401	protein chinasi ribonucleico acido (RNA)-come ER chinasi	GENEORGENEPRODUCT	13666
23791840	1435	1439	PERK	GENEORGENEPRODUCT	13666
23791840	1475	1509	proteina immunoglobulinica legante	GENEORGENEPRODUCT	14828
23791840	1543	1593	isoma proteico disolfuro famiglia rase Un membro 3	GENEORGENEPRODUCT	14827
23791840	1627	1669	chinasi proteina-1a che richiede inositolo	GENEORGENEPRODUCT	78943
23791840	1703	1709	 IRE1a	GENEORGENEPRODUCT	78943
23791840	1748	1770	proteina legante X-box	GENEORGENEPRODUCT	22433
23791840	1804	1808	XBP1	GENEORGENEPRODUCT	22433
23791840	1901	1916	Diabete materno	DISEASEORPHENOTYPICFEATURE	D016640
23791840	1994	1998	CHOP	GENEORGENEPRODUCT	13198
23791840	2033	2041	calnexin	GENEORGENEPRODUCT	12330
23791840	2092	2097	eIF2a	GENEORGENEPRODUCT	229317
23791840	2134	2138	PERK	GENEORGENEPRODUCT	13666
23791840	2175	2180	IRE1a	GENEORGENEPRODUCT	78943
23791840	2223	2227	XBP1	GENEORGENEPRODUCT	22433
23791840	2346	2350	SOD1	GENEORGENEPRODUCT	20655
23791840	2433	2440	diabete	DISEASEORPHENOTYPICFEATURE	D003920
23791840	2574	2578	SOD1	GENEORGENEPRODUCT	20655
23791840	2650	2665	diabete materno	DISEASEORPHENOTYPICFEATURE	D016640
23864035	34	44	Bortezomib	CHEMICALENTITY	D000069286
23864035	78	90	desametasone	CHEMICALENTITY	D003907
23864035	149	157	pazienti	ORGANISMTAXON	9606
23864035	206	222	mieloma multiplo	DISEASEORPHENOTYPICFEATURE	D009101
23864035	328	338	Bortezomib	CHEMICALENTITY	D000069286
23864035	374	378	bort	CHEMICALENTITY	D000069286
23864035	412	424	desametasone	CHEMICALENTITY	D003907
23864035	457	460	dex	CHEMICALENTITY	D003907
23864035	561	577	mieloma multiplo	DISEASEORPHENOTYPICFEATURE	D009101
23864035	622	624	MM	DISEASEORPHENOTYPICFEATURE	D009101
23864035	721	725	bort	CHEMICALENTITY	D000069286
23864035	815	818	dex	CHEMICALENTITY	D003907
23864035	887	891	bort	CHEMICALENTITY	D000069286
23864035	958	966	pazienti	ORGANISMTAXON	9606
23864035	1018	1020	MM	DISEASEORPHENOTYPICFEATURE	D009101
23864035	1196	1204	pazienti	ORGANISMTAXON	9606
23864035	1324	1328	bort	CHEMICALENTITY	D000069286
23864035	1360	1363	dex	CHEMICALENTITY	D003907
23864035	1420	1424	bort	CHEMICALENTITY	D000069286
23864035	1456	1459	dex	CHEMICALENTITY	D003907
23864035	1573	1581	pazienti	ORGANISMTAXON	9606
23864035	1949	1970	neuropatia periferica	DISEASEORPHENOTYPICFEATURE	D010523
23864035	2032	2040	pazienti	ORGANISMTAXON	9606
23864035	2397	2405	pazienti	ORGANISMTAXON	9606
23864035	2479	2483	bort	CHEMICALENTITY	D000069286
23864035	2516	2519	dex	CHEMICALENTITY	D003907
23864035	2595	2599	Bort	CHEMICALENTITY	D000069286
23864035	2631	2634	dex	CHEMICALENTITY	D003907
23864035	2730	2732	MM	DISEASEORPHENOTYPICFEATURE	D009101
23864035	2760	2768	pazienti	ORGANISMTAXON	9606
23949582	56	66	ifosfamide	CHEMICALENTITY	D007069
23949582	99	104	mesna	CHEMICALENTITY	D015080
23949582	181	189	coniglio	ORGANISMTAXON	9986
23949582	265	275	Ifosfamide	CHEMICALENTITY	D007069
23949582	308	311	IFO	CHEMICALENTITY	D007069
23949582	350	375	senape azotata alchilante	CHEMICALENTITY	D008357
23949582	527	537	emorragica	DISEASEORPHENOTYPICFEATURE	D006470
23949582	582	589	cistite	DISEASEORPHENOTYPICFEATURE	D003556
23949582	651	654	IFO	CHEMICALENTITY	D007069
23949582	739	771	2-solfaniletansolfonato di sodio	CHEMICALENTITY	D015080
23949582	804	809	Mesna	CHEMICALENTITY	D015080
23949582	900	903	IFO	CHEMICALENTITY	D007069
23949582	937	942	Mesna	CHEMICALENTITY	D015080
23949582	1027	1035	coniglio	ORGANISMTAXON	9986
23949582	1282	1299	L'azione di Mesna	CHEMICALENTITY	D015080
23949582	1342	1345	IFO	CHEMICALENTITY	D007069
23949582	1457	1460	IFO	CHEMICALENTITY	D007069
23949582	1609	1614	Mesna	CHEMICALENTITY	D015080
23949582	1706	1709	IFO	CHEMICALENTITY	D007069
23949582	1794	1799	Mesna	CHEMICALENTITY	D015080
23949582	1857	1860	IFO	CHEMICALENTITY	D007069
23949582	1905	1918	genotossicità	DISEASEORPHENOTYPICFEATURE	 D030342
23952588	66	74	levodopa	CHEMICALENTITY	D007980
23952588	126	137	 discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	210	228	Morbo di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
23952588	276	284	levodopa	CHEMICALENTITY	D007980
23952588	340	361	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
23952588	406	408	PD	DISEASEORPHENOTYPICFEATURE	D010300
23952588	499	509	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	590	598	levodopa	CHEMICALENTITY	D007980
23952588	653	663	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	716	724	pazienti	ORGANISMTAXON	9606
23952588	773	775	PD	DISEASEORPHENOTYPICFEATURE	D010300
23952588	860	868	pazienti	ORGANISMTAXON	9606
23952588	918	920	PD	DISEASEORPHENOTYPICFEATURE	D010300
23952588	980	988	levodopa	CHEMICALENTITY	D007980
23952588	1123	1133	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	1412	1422	Discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	1496	1504	levodopa	CHEMICALENTITY	D007980
23952588	1650	1658	pazienti	ORGANISMTAXON	9606
23952588	1706	1716	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	1778	1786	Pazienti	ORGANISMTAXON	9606
23952588	1834	1844	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	1960	1968	levodopa	CHEMICALENTITY	D007980
23952588	2088	2097	 levodopa	CHEMICALENTITY	D007980
23952588	2203	2211	pazienti	ORGANISMTAXON	9606
23952588	2261	2271	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	2358	2368	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	2435	2443	levodopa	CHEMICALENTITY	D007980
23952588	2530	2538	levodopa	CHEMICALENTITY	D007980
23952588	2601	2609	levodopa	CHEMICALENTITY	D007980
23952588	2664	2674	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
23952588	2714	2722	pazienti	ORGANISMTAXON	9606
23952588	2833	2841	levodopa	CHEMICALENTITY	D007980
23952588	2901	2909	levodopa	CHEMICALENTITY	D007980
24055495	68	78	galattosio	CHEMICALENTITY	D005690
24055495	131	148	cognitivo deficit	DISEASEORPHENOTYPICFEATURE	D003072
24055495	195	200	ratti	ORGANISMTAXON	10116
24055495	278	293	streptozotocina	CHEMICALENTITY	D013311
24055495	384	391	demenza	DISEASEORPHENOTYPICFEATURE	D003704
24055495	438	459	malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
24055495	514	517	sAD	DISEASEORPHENOTYPICFEATURE	D000544
24055495	581	601	recettore insulinico	GENEORGENEPRODUCT	24954
24055495	635	637	IR	GENEORGENEPRODUCT	24954
24055495	689	697	glucosio	CHEMICALENTITY	D005947
24055495	748	756	glucosio	CHEMICALENTITY	D005947
24055495	803	808	GLUT4	GENEORGENEPRODUCT	25139
24055495	852	860	glucosio	CHEMICALENTITY	D005947
24055495	967	979	d-galattosio	CHEMICALENTITY	D005690
24055495	1029	1039	d-glucosio	CHEMICALENTITY	D005947
24055495	1111	1119	insulina	GENEORGENEPRODUCT	24505
24055495	1165	1170	GLUT3	GENEORGENEPRODUCT	25551
24055495	1254	1262	glucosio	CHEMICALENTITY	D005947
24055495	1375	1385	galattosio	CHEMICALENTITY	D005690
24055495	1438	1466	deterioramento della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24055495	1620	1630	galattosio	CHEMICALENTITY	D005690
24055495	1786	1796	galattosio	CHEMICALENTITY	D005690
24055495	1862	1880	deficit cognitivi 	DISEASEORPHENOTYPICFEATURE	D003072
24055495	1915	1930	streptozotocina	CHEMICALENTITY	D013311
24055495	1971	1974	STZ	CHEMICALENTITY	D013311
24055495	2009	2012	rat	ORGANISMTAXON	10116
24055495	2067	2070	sAD	DISEASEORPHENOTYPICFEATURE	D000544
24055495	2208	2218	galattosio	CHEMICALENTITY	D005690
24055495	2302	2305	STZ	CHEMICALENTITY	D013311
24055495	2383	2386	STZ	CHEMICALENTITY	D013311
24055495	2442	2459	deficit cognitivi	DISEASEORPHENOTYPICFEATURE	D003072
24055495	2515	2525	galattosio	CHEMICALENTITY	D005690
24055495	2584	2587	rat	ORGANISMTAXON	10116
24055495	2630	2640	galattosio	CHEMICALENTITY	D005690
24055495	2752	2762	galattosio	CHEMICALENTITY	D005690
24055495	2822	2832	galattosio	CHEMICALENTITY	D005690
24055495	2911	2921	galattosio	CHEMICALENTITY	D005690
24055495	3059	3070	 galattosio	CHEMICALENTITY	D005690
24055495	3130	3140	galattosio	CHEMICALENTITY	D005690
24055495	3315	3333	deficit cognitivi 	DISEASEORPHENOTYPICFEATURE	D003072
24055495	3389	3416	ipometabolismo del glucosio	DISEASEORPHENOTYPICFEATURE	D018149
24055495	3463	3465	AD	DISEASEORPHENOTYPICFEATURE	D000544
24100257	43	64	Sindrome di Takotsubo	DISEASEORPHENOTYPICFEATURE	D054549
24100257	111	142	sindrome da mongolfiera apicale	DISEASEORPHENOTYPICFEATURE	D054549
24100257	188	200	Zolmitriptan	CHEMICALENTITY	C089750
24100257	245	266	Sindrome di Takotsubo	DISEASEORPHENOTYPICFEATURE	D054549
24100257	311	313	TS	DISEASEORPHENOTYPICFEATURE	D054549
24100257	376	403	sindrome del cuore spezzato	DISEASEORPHENOTYPICFEATURE	D054549
24100257	605	630	sindrome coronarica acuta	DISEASEORPHENOTYPICFEATURE	D054058
24100257	761	766	donna	ORGANISMTAXON	9606
24100257	837	867	prolasso della valvola mitrale	DISEASEORPHENOTYPICFEATURE	D008945
24100257	913	922	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
24100257	1006	1021	dolore toracico	DISEASEORPHENOTYPICFEATURE	D002637
24100257	1361	1383	anomalie del movimento	DISEASEORPHENOTYPICFEATURE	D009041
24100257	1440	1442	TS	DISEASEORPHENOTYPICFEATURE	D054549
24100257	1541	1549	paziente	ORGANISMTAXON	9606
24100257	1592	1604	zolmitriptan	CHEMICALENTITY	C089750
24100257	1666	1675	emicrania	DISEASEORPHENOTYPICFEATURE	D008881
24100257	1751	1763	zolmitriptan	CHEMICALENTITY	C089750
24100257	1873	1895	emicrania mal di testa	DISEASEORPHENOTYPICFEATURE	D008881
24100257	1986	1993	cavalli	ORGANISMTAXON	9796
24100257	2154	2170	stato emicranico	DISEASEORPHENOTYPICFEATURE	D008881
24100257	2270	2303	vasospasmo dell'arteria coronaria	DISEASEORPHENOTYPICFEATURE	D003329
24100257	2348	2360	zolmitriptan	CHEMICALENTITY	C089750
24100257	2441	2443	TS	DISEASEORPHENOTYPICFEATURE	D054549
24126708	82	88	HOMER1	GENEORGENEPRODUCT	9456
24126708	125	133	levodopa	CHEMICALENTITY	D007980
24126708	196	214	Morbo di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
24126708	242	250	pazienti	ORGANISMTAXON	9606
24126708	283	291	Levodopa	CHEMICALENTITY	D007980
24126708	377	398	Malattia di Parkinson	DISEASEORPHENOTYPICFEATURE	D010300
24126708	535	545	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
24126708	591	611	allucinazioni visive	DISEASEORPHENOTYPICFEATURE	D006212
24126708	644	650	HOMER1	GENEORGENEPRODUCT	9456
24126708	721	731	glutammato	CHEMICALENTITY	D018698
24126708	881	887	HOMER1	GENEORGENEPRODUCT	94 56
24126708	1025	1033	levodopa	CHEMICALENTITY	D007980
24126708	1099	1107	pazienti	ORGANISMTAXON	9606
24126708	1155	1187	malattia di Parkinson idiopatica	DISEASEORPHENOTYPICFEATURE	D010300
24126708	1216	1226	I pazienti	ORGANISMTAXON	9606
24126708	1290	1299	rs4704559	SEQUENCEVARIANT	RS4704559
24126708	1337	1347	rs10942891	SEQUENCEVARIANT	 RS10942891
24126708	1384	1393	rs4704560	SEQUENCEVARIANT	RS4704560
24126708	1488	1497	rs4704559	SEQUENCEVARIANT	RS4704559
24126708	1582	1592	discinesia	DISEASEORPHENOTYPICFEATURE	D004409
24126708	1727	1747	allucinazioni visive	DISEASEORPHENOTYPICFEATURE	D006212
24126708	1851	1857	HOMER1	GENEORGENEPRODUCT	9456
24126708	1892	1901	rs4704559	SEQUENCEVARIANT	RS4704559
24126708	1990	1998	levodopa	CHEMICALENTITY	D007980
24132704	31	37	Crocin	CHEMICALENTITY	C029036
24132704	78	83	lipid	CHEMICALENTITY	D008055
24132704	156	164	diazinon	CHEMICALENTITY	D003976
24132704	215	221	ERK1/2	GENEORGENEPRODUCT	116590,50689
24132704	270	273	rat	ORGANISMTAXON	10116
24132704	320	328	Diazinon	CHEMICALENTITY	D003976
24132704	385	398	organofosforo	CHEMICALENTITY	D010755
24132704	502	510	diazinon	CHEMICALENTITY	D003976
24132704	581	587	lipidi	CHEMICALENTITY	D008055
24132704	674	680	crocin	CHEMICALENTITY	C029036
24132704	776	819	chinasi extracellulare regolata dal segnale	GENEORGENEPRODUCT	116590,50689
24132704	860	863	ERK	GENEORGENEPRODUCT	116590,50689
24132704	910	954	recettore delle lipoproteine a bassa densità	GENEORGENEPRODUCT	300438
24132704	989	993	LDLr	GENEORGENEPRODUCT	300438
24132704	1130	1136	lipidi	CHEMICALENTITY	D008055
24132704	1177	1180	ERK	GENEORGENEPRODUCT	116590,50689
24132704	1216	1220	LDLr	GENEORGENEPRODUCT	300438
24132704	1275	1280	ratti	ORGANISMTAXON	10116
24132704	1329	1337	diazinon	CHEMICALENTITY	D003976
24132704	1404	1410	crocin	CHEMICALENTITY	C029036
24132704	1445	1453	diazinon	CHEMICALENTITY	D003976
24132704	1505	1516	colesterolo	CHEMICALENTITY	D002784
24132704	1586	1591	Ratti	ORGANISMTAXON	10116
24132704	1710	1722	Olio di mais	CHEMICALENTITY	D003314
24132704	1767	1775	diazinon	CHEMICALENTITY	D003976
24132704	1844	1850	crocin	CHEMICALENTITY	C029036
24132704	1956	1964	diazinon	CHEMICALENTITY	D003976
24132704	2021	2032	colesterolo	CHEMICALENTITY	D002784
24132704	2065	2077	trigliceridi	CHEMICALENTITY	D014280
24132704	2112	2115	LDL	CHEMICALENTITY	D008077
24132704	2158	2163	ratti	ORGANISMTAXON	10116
24132704	2249	2253	LDLr	GENEORGENEPRODUCT	300438
24132704	2295	2301	ERK1/2	GENEORGENEPRODUCT	116590,50689
24132704	2398	2404	ERK1/2	GENEORGENEPRODUCT	116590,50689
24132704	2436	2439	rat	ORGANISMTAXON	10116
24132704	2673	2681	diazinon	CHEMICALENTITY	D003976
24132704	2766	2777	colesterolo	CHEMICALENTITY	D002784
24132704	2810	2822	trigliceridi	CHEMICALENTITY	D014280
24132704	2856	2859	LDL	CHEMICALENTITY	D008077
24132704	2900	2908	diazinon	CHEMICALENTITY	D003976
24132704	2960	2966	ERK1/2	GENEORGENEPRODUCT	116590,50689
24132704	3027	3031	LDLr	GENEORGENEPRODUCT	300438
24132704	3077	3083	Crocin	CHEMICALENTITY	C029036
24132704	3145	3148	ERK	GENEORGENEPRODUCT	116590,50689
24132704	3195	3203	diazinon	CHEMICALENTITY	D003976
24132704	3255	3266	iperlipemia	DISEASEORPHENOTYPICFEATURE	D006949
24132704	3323	3328	LDLr 	GENEORGENEPRODUCT	300438
24132704	3387	3393	Crocin	CHEMICALENTITY	C029036
24132704	3478	3486	diazinon	CHEMICALENTITY	D003976
24132704	3539	3550	iperlipemia	DISEASEORPHENOTYPICFEATURE	D006949
24132704	3619	3622	ERK	GENEORGENEPRODUCT	116590,50689
24132704	3678	3682	LDLr	GENEORGENEPRODUCT	300438
24309294	31	59	Colecistochinina-ottapeptide	CHEMICALENTITY	D012844
24309294	179	186	morfina	CHEMICALENTITY	D009020
24309294	218	223	ratti	ORGANISMTAXON	10116
24309294	256	283	Cholecystokinin-octapeptide	CHEMICALENTITY	D012844
24309294	316	321	CCK-8	CHEMICALENTITY	D012844
24309294	515	520	CCK-8	CHEMICALENTITY	D012844
24309294	584	591	morfina	CHEMICALENTITY	D009020
24309294	644	651	amnesia	DISEASEORPHENOTYPICFEATURE	D000647
24309294	778	785	morfina	CHEMICALENTITY	D009020
24309294	873	878	CCK-8	CHEMICALENTITY	D012844
24309294	1024	1027	rat	ORGANISMTAXON	10116
24309294	1110	1117	morfina	CHEMICALENTITY	D009020
24309294	1155	1160	ratti	ORGANISMTAXON	10116
24309294	1335	1342	morfina	CHEMICALENTITY	D009020
24309294	1442	1447	CCK-8	CHEMICALENTITY	D012844
24309294	1554	1561	morfina	CHEMICALENTITY	D009020
24309294	1624	1629	CCK-8	CHEMICALENTITY	D012844
24309294	1792	1797	ratti	ORGANISMTAXON	10116
24309294	1864	1878	recettore CCK2	GENEORGENEPRODUCT	25706
24309294	1910	1919	L-365,260	CHEMICALENTITY	C058121
24309294	1993	1998	CCK-8	CHEMICALENTITY	D012844
24309294	2038	2052	recettore CCK1	GENEORGENEPRODUCT	24889
24309294	2096	2105	L-364,718	CHEMICALENTITY	D020109
24309294	2190	2195	CCK-8	CHEMICALENTITY	D012844
24309294	2248	2255	morfina	CHEMICALENTITY	D009020
24309294	2318	2332	recettori CCK2	GENEORGENEPRODUCT	25706
24309294	2408	2413	CCK-8	CHEMICALENTITY	D012844
24309294	2448	2455	morfina	CHEMICALENTITY	D009020
24309294	2510	2538	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24341598	70	86	cloruro di sodio	CHEMICALENTITY	D012965
24341598	122	132	 diltiazem	CHEMICALENTITY	D004110
24341598	186	195	contrasto	CHEMICALENTITY	D003287
24341598	247	257	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
24341598	315	324	Contrasto	CHEMICALENTITY	D003287
24341598	376	386	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
24341598	432	435	CIN	DISEASEORPHENOTYPICFEATURE	D007674
24341598	522	530	pazienti	ORGANISMTAXON	9606
24341598	626	642	cloruro di sodio	CHEMICALENTITY	D012965
24341598	678	698	bicarbonato di sodio	CHEMICALENTITY	D017693
24341598	752	768	cloruro di sodio	CHEMICALENTITY	D012965
24341598	814	823	diltiazem	CHEMICALENTITY	D004110
24341598	860	868	calcio m	CHEMICALENTITY	D002118
24341598	943	946	CIN	DISEASEORPHENOTYPICFEATURE	D007674
24341598	1023	1031	pazienti	ORGANISMTAXON	9606
24341598	1106	1122	contrasto iodato	CHEMICALENTITY	D003287
24341598	1227	1237	creatinina	CHEMICALENTITY	D003404
24341598	1295	1305	I pazienti	ORGANISMTAXON	9606
24341598	1388	1396	pazienti	ORGANISMTAXON	9606
24341598	1444	1452	pazienti	ORGANISMTAXON	9606
24341598	1516	1532	cloruro di sodio	CHEMICALENTITY	D012965
24341598	1633	1642	destrosio	CHEMICALENTITY	D005947
24341598	1676	1696	bicarbonato di sodio	CHEMICALENTITY	D017693
24341598	1784	1800	cloruro di sodio	CHEMICALENTITY	D012965
24341598	1848	1857	contrasto	CHEMICALENTITY	D003287
24341598	1955	1964	diltiazem	CHEMICALENTITY	D004110
24341598	2039	2048	contrasto	CHEMICALENTITY	D003287
24341598	2095	2103	pazienti	ORGANISMTAXON	9606
24341598	2143	2166	azoto ureico nel sangue	CHEMICALENTITY	D001806
24341598	2251	2261	creatinina	CHEMICALENTITY	D003404
24341598	2372	2381	contrasto	CHEMICALENTITY	D003287
24341598	2455	2465	creatinina	CHEMICALENTITY	D003404
24341598	2562	2570	pazienti	ORGANISMTAXON	9606
24341598	2623	2631	pazienti	ORGANISMTAXON	9606
24341598	2692	2718	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
24341598	2763	2766	ARF	DISEASEORPHENOTYPICFEATURE	D058186
24341598	2823	2832	contrasto	CHEMICALENTITY	D003287
24341598	2910	2918	pazienti	ORGANISMTAXON	9606
24341598	2983	2986	ARF	DISEASEORPHENOTYPICFEATURE	D058186
24341598	3241	3257	cloruro di sodio	CHEMICALENTITY	D012965
24341598	3290	3310	bicarbonato di sodio	CHEMICALENTITY	D017693
24341598	3354	3370	cloruro di sodio	CHEMICALENTITY	D012965
24341598	3406	3415	diltiazem	CHEMICALENTITY	D004110
24341598	3493	3496	CIN	DISEASEORPHENOTYPICFEATURE	D007674
24477591	37	44	-930A>G	SEQUENCEVARIANT	RS9932581
24477591	93	106	 Il gene CYBA	GENEORGENEPRODUCT	1535
24477591	164	183	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
24477591	291	320	Specie reattive dell'ossigeno	CHEMICALENTITY	D017382
24477591	353	356	ROS	CHEMICALENTITY	D017382
24477591	436	449	aterosclerosi	DISEASEORPHENOTYPICFEATURE	D050197
24477591	495	529	malattia delle arterie coronariche	DISEASEORPHENOTYPICFEATURE	D003324
24477591	574	578	 CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	612	629	Le NADPH ossidasi	GENEORGENEPRODUCT	1666
24477591	689	692	ROS	CHEMICALENTITY	D017382
24477591	747	754	p22phox	GENEORGENEPRODUCT	1535
24477591	816	830	NADPH ossidasi	GENEORGENEPRODUCT	1666
24477591	882	886	CYBA	GENEORGENEPRODUCT	1535
24477591	919	947	gene del citocromo b245 alfa	GENEORGENEPRODUCT	1535
24477591	1000	1007	-930A>G	SEQUENCEVARIANT	RS9932581
24477591	1039	1043	CYBA	GENEORGENEPRODUCT	1535
24477591	1080	1089	rs9932581	SEQUENCEVARIANT	RS9932581
24477591	1124	1127	A>G	SEQUENCEVARIANT	RS9932581
24477591	1183	1187	CYBA	GENEORGENEPRODUCT	1535
24477591	1241	1245	CYBA	GENEORGENEPRODUCT	1535
24477591	1399	1406	-930A>G	SEQUENCEVARIANT	RS9932581
24477591	1452	1455	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	1599	1607	pazienti	ORGANISMTAXON	9606
24477591	1655	1658	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	1770	1777	-930A>G	SEQUENCEVARIANT	RS9932581
24477591	1937	1942	-930G	SEQUENCEVARIANT	RS9932581
24477591	2016	2019	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	2129	2134	-930G	SEQUENCEVARIANT	RS9932581
24477591	2182	2192	sovrappeso	DISEASEORPHENOTYPICFEATURE	D050177
24477591	2237	2244	obesità	DISEASEORPHENOTYPICFEATURE	D009765
24477591	2342	2345	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	2405	2410	-930G	SEQUENCEVARIANT	RS9932581
24477591	2626	2631	-930G	SEQUENCEVARIANT	RS9932581
24477591	2676	2686	Sovrappeso	DISEASEORPHENOTYPICFEATURE	D050177
24477591	2730	2737	obesità	DISEASEORPHENOTYPICFEATURE	D009765
24477591	2813	2816	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	2879	2884	-930G	SEQUENCEVARIANT	RS9932581
24477591	2999	3006	-930A>G	SEQUENCEVARIANT	RS9932581
24477591	3038	3042	CYBA	GENEORGENEPRODUCT	1535
24477591	3101	3104	CAD	DISEASEORPHENOTYPICFEATURE	D003324
24477591	3188	3193	-930G	SEQUENCEVARIANT	RS9932581
24477591	3286	3293	obesità	DISEASEORPHENOTYPICFEATURE	D009765
24477591	3323	3330	tabacco	ORGANISMTAXON	4097
24535067	46	55	etomidate	CHEMICALENTITY	D005045
24535067	110	118	mioclono	DISEASEORPHENOTYPICFEATURE	D009207
24535067	168	176	Fentanyl	CHEMICALENTITY	D005283
24535067	209	218	midazolam	CHEMICALENTITY	D008874
24535067	410	418	fentanyl	CHEMICALENTITY	D005283
24535067	451	460	midazolam	CHEMICALENTITY	D008874
24535067	514	522	fentanyl	CHEMICALENTITY	D005283
24535067	556	565	midazolam	CHEMICALENTITY	D008874
24535067	611	620	etomidate	CHEMICALENTITY	D005045
24535067	672	680	mioclono	DISEASEORPHENOTYPICFEATURE	D009207
24535067	897	906	etomidate	CHEMICALENTITY	D005045
24535067	937	945	pazienti	ORGANISMTAXON	9606
24535067	1045	1053	fentanil	CHEMICALENTITY	D005283
24535067	1108	1117	midazolam	CHEMICALENTITY	D008874
24535067	1175	1184	midazolam	CHEMICALENTITY	D008874
24535067	1233	1241	fentanil	CHEMICALENTITY	D005283
24535067	1294	1302	Pazienti	ORGANISMTAXON	9606
24535067	1520	1529	etomidate	CHEMICALENTITY	D005045
24535067	1634	1668	Si valutano i movimenti mioclonici	DISEASEORPHENOTYPICFEATURE	D009069
24535067	1795	1804	etomidate	CHEMICALENTITY	D005045
24535067	1873	1879	dolore	DISEASEORPHENOTYPICFEATURE	D010146
24535067	1920	1929	etomidate	CHEMICALENTITY	D005045
24535067	2127	2135	mioclono	DISEASEORPHENOTYPICFEATURE	D009207
24535067	2394	2402	fentanyl	CHEMICALENTITY	D005283
24535067	2456	2464	fentanyl	CHEMICALENTITY	D005283
24535067	2499	2508	midazolam	CHEMICALENTITY	D008874
24535067	2571	2580	etomidate	CHEMICALENTITY	D005045
24535067	2636	2644	mioclono	DISEASEORPHENOTYPICFEATURE	D009207
24587916	31	44	Antiossidante	CHEMICALENTITY	D000975
24587916	83	89	bovino	ORGANISMTAXON	9913
24587916	123	135	lattoferrina	GENEORGENEPRODUCT	301034
24587916	170	182	desametasone	CHEMICALENTITY	D003907
24587916	235	247	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
24587916	279	282	rat	ORGANISMTAXON	10116
24587916	315	327	Desametasone	CHEMICALENTITY	D003907
24587916	361	364	Dex	CHEMICALENTITY	D003907
24587916	419	433	l'ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
24587916	517	529	Lattoferrina	GENEORGENEPRODUCT	301034
24587916	564	566	LF	GENEORGENEPRODUCT	301034
24587916	605	610	ferro	CHEMICALENTITY	 D007501
24587916	651	664	glicoproteina	GENEORGENEPRODUCT	11820
24587916	808	810	LF	GENEORGENEPRODUCT	301034
24587916	880	892	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
24587916	927	930	Dex	CHEMICALENTITY	D003907
24587916	992	997	ratti	ORGANISMTAXON	10116
24587916	1052	1055	Dex	CHEMICALENTITY	D003907
24587916	1167	1173	bovino	ORGANISMTAXON	9913
24587916	1207	1209	LF	GENEORGENEPRODUCT	301034
24587916	1362	1367	ratti	ORGANISMTAXON	10116
24587916	1444	1446	LF	GENEORGENEPRODUCT	301034
24587916	1489	1492	Dex	CHEMICALENTITY	D003907
24587916	1731	1746	glucocorticoide	CHEMICALENTITY	D005938
24587916	1788	1809	perossido di idrogeno	CHEMICALENTITY	D006861
24587916	1842	1846	H2O2	CHEMICALENTITY	D006861
24587916	1883	1889	ferric	CHEMICALENTITY	D007501
24587916	1994	2006	Desametasone	CHEMICALENTITY	D003907
24587916	2083	2087	H2O2	CHEMICALENTITY	D006861
24587916	2174	2176	LF	GENEORGENEPRODUCT	301034
24587916	2269	2272	Dex	CHEMICALENTITY	D003907
24587916	2324	2336	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
24587916	2371	2373	LF	GENEORGENEPRODUCT	301034
24587916	2439	2454	perdita di peso	DISEASEORPHENOTYPICFEATURE	D015431
24587916	2537	2541	H2O2	CHEMICALENTITY	D006861
24587916	2631	2633	LF	GENEORGENEPRODUCT	301034
24587916	2729	2732	ROS	CHEMICALENTITY	D017382
24587916	2814	2817	Dex	CHEMICALENTITY	D003907
24587916	2872	2884	ipertensione	DISEASEORPHENOTYPICFEATURE	D006973
24587916	3030	3032	LF	GENEORGENEPRODUCT	301034
24588023	50	67	acido tranexamico	CHEMICALENTITY	D014148
24588023	113	136	convulsioni convulsive 	DISEASEORPHENOTYPICFEATURE	D012640
24588023	220	228	pazienti	ORGANISMTAXON	9606
24588023	329	340	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	500	508	pazienti	ORGANISMTAXON	9606
24588023	641	661	sequestro convulsivo	DISEASEORPHENOTYPICFEATURE	D012640
24588023	801	838	movimenti motori involontari anormali	DISEASEORPHENOTYPICFEATURE	D004409
24588023	983	994	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	1062	1070	pazienti	ORGANISMTAXON	9606
24588023	1145	1161	crisi convulsive	DISEASEORPHENOTYPICFEATURE	D012640
24588023	1206	1240	Convulsioni generalizzate e focali	DISEASEORPHENOTYPICFEATURE	D012640
24588023	1319	1327	pazienti	ORGANISMTAXON	9606
24588023	1463	1474	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	1646	1654	pazienti	ORGANISMTAXON	9606
24588023	1734	1745	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	1857	1893	calcificazione dell'aorta ascendente	DISEASEORPHENOTYPICFEATURE	D001018
24588023	1938	1972	insufficienza cardiaca congestizia	DISEASEORPHENOTYPICFEATURE	D006333
24588023	2026	2036	ipotermico	DISEASEORPHENOTYPICFEATURE	D007035
24588023	2124	2141	acido tranexamico	CHEMICALENTITY	D014148
24588023	2232	2249	acido tranexamico	CHEMICALENTITY	D014148
24588023	2333	2344	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	2411	2419	Pazienti	ORGANISMTAXON	9606
24588023	2467	2483	crisi convulsive	DISEASEORPHENOTYPICFEATURE	D012640
24588023	2638	2646	pazienti	ORGANISMTAXON	9606
24588023	2696	2712	crisi convulsive	DISEASEORPHENOTYPICFEATURE	D012640
24588023	2855	2863	pazienti	ORGANISMTAXON	9606
24588023	2912	2928	crisi convulsive	DISEASEORPHENOTYPICFEATURE	D012640
24588023	2993	3001	pazienti	ORGANISMTAXON	9606
24588023	3051	3062	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24588023	3119	3138	Le crisi convulsive	DISEASEORPHENOTYPICFEATURE	D012640
24588023	3197	3225	complicazione postoperatoria	DISEASEORPHENOTYPICFEATURE	D011183
24588023	3289	3306	acido tranexamico	CHEMICALENTITY	D014148
24588023	3514	3525	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24632946	93	103	b-catenina	GENEORGENEPRODUCT	12387
24632946	173	197	malformazioni anorettali	DISEASEORPHENOTYPICFEATURE	D000071056
24632946	396	419	malformazioni congenite	DISEASEORPHENOTYPICFEATURE	D000013
24632946	472	496	malformazioni anorettali	DISEASEORPHENOTYPICFEATURE	D000071056
24632946	545	549	ARMs	DISEASEORPHENOTYPICFEATURE	D000071056
24632946	696	705	b-Catenin	GENEORGENEPRODUCT	12387
24632946	790	793	Wnt	GENEORGENEPRODUCT	22408
24632946	953	963	b-catenina	GENEORGENEPRODUCT	12387
24632946	1085	1095	b-catenina	GENEORGENEPRODUCT	12387
24632946	1182	1191	tamoxifen	CHEMICALENTITY	D013629
24632946	1257	1260	Shh	GENEORGENEPRODUCT	20423
24632946	1323	1332	b-catenin	GENEORGENEPRODUCT	12387
24632946	1478	1489	ipoplastico	DISEASEORPHENOTYPICFEATURE	D029502
24632946	1652	1661	b-catenin	GENEORGENEPRODUCT	12387
24632946	1917	1926	keratin 1	GENEORGENEPRODUCT	16678
24632946	1961	1970	filaggrin	GENEORGENEPRODUCT	14246
24632946	2058	2086	proteina morfogenetica ossea	GENEORGENEPRODUCT	12159,12162
24632946	2126	2129	Bmp	GENEORGENEPRODUCT	12159,12162
24632946	2170	2174	Bmp4	GENEORGENEPRODUCT	12159
24632946	2209	2213	Bmp7	GENEORGENEPRODUCT	12162
24632946	2318	2328	b-catenina	GENEORGENEPRODUCT	12387
24632946	2389	2393	Msx2	GENEORGENEPRODUCT	17702
24632946	2460	2469	Smad1/5/8	GENEORGENEPRODUCT	17125,17129,55994
24632946	2555	2558	Bmp	GENEORGENEPRODUCT	12159,12162
24632946	2688	2701	Bmp recettore	GENEORGENEPRODUCT	12166
24632946	2735	2741	BmprIA	GENEORGENEPRODUCT	12166
24632946	2779	2782	Shh	GENEORGENEPRODUCT	20423
24632946	2827	2837	b-catenina	GENEORGENEPRODUCT	12387
24632946	2884	2900	I mutanti BmprIA	GENEORGENEPRODUCT	12166
24632946	3017	3027	b-catenina	GENEORGENEPRODUCT	12387
24632946	3133	3136	ARM	DISEASEORPHENOTYPICFEATURE	D000071056
24632946	3173	3182	b-catenin	GENEORGENEPRODUCT	12387
24632946	3281	3284	Bmp	GENEORGENEPRODUCT	12159,12162
24632946	3404	3414	b-catenina	GENEORGENEPRODUCT	12387
24632946	3468	3471	ARM	DISEASEORPHENOTYPICFEATURE	D000071056
24632946	3582	3587	umano	ORGANISMTAXON	9606
24632946	3634	3638	ARMs	DISEASEORPHENOTYPICFEATURE	D000071056
24709919	42	53	ginsenosidi	CHEMICALENTITY	D036145
24709919	88	96	oppioide	CHEMICALENTITY	D000701
24709919	148	159	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
24709919	191	195	topi	ORGANISMTAXON	10090
24709919	228	236	Oppiacei	CHEMICALENTITY	D000701
24709919	291	302	iperalgesia	DISEASEORPHENOTYPICFEATURE	D006930
24709919	348	351	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	479	487	oppioidi	CHEMICALENTITY	D000701
24709919	532	535	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	597	605	oppioidi	CHEMICALENTITY	D000701
24709919	676	684	oppioidi	CHEMICALENTITY	D000701
24709919	728	750	dipendenza da oppiacei	DISEASEORPHENOTYPICFEATURE	D009293
24709919	849	874	ginsenosidi Re, Rg1 e Rb1	CHEMICALENTITY	C035054,C049864,C442759
24709919	930	937	ginseng	ORGANISMTAXON	4054
24709919	985	988	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	1033	1036	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	1086	1090	topi	ORGANISMTAXON	10090
24709919	1161	1168	morfina	CHEMICALENTITY	D009020
24709919	1284	1288	topi	ORGANISMTAXON	10090
24709919	1345	1347	Re	CHEMICALENTITY	C049864
24709919	1381	1384	Rg1	CHEMICALENTITY	C035054
24709919	1418	1421	Rb1	CHEMICALENTITY	C442759
24709919	1525	1529	topi	ORGANISMTAXON	10090
24709919	1620	1633	acido acetico	CHEMICALENTITY	D019342
24709919	1694	1696	Re	CHEMICALENTITY	C049864
24709919	1760	1763	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	1867	1880	acido acetico	CHEMICALENTITY	D019342
24709919	1933	1954	Ginsenosidi Rg1 e Rb1	CHEMICALENTITY	C035054,C442759
24709919	2028	2031	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	2100	2103	Rg1	CHEMICALENTITY	C035054
24709919	2185	2188	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24709919	2225	2269	test di contorsioni indotto da acido acetico	CHEMICALENTITY	D019342
24709919	2339	2353	ginsenoside Re	CHEMICALENTITY	C049864
24709919	2393	2396	Rg1	CHEMICALENTITY	C035054
24709919	2431	2434	Rb1	CHEMICALENTITY	C442759
24709919	2513	2516	OIH	DISEASEORPHENOTYPICFEATURE	D006930
24742750	44	49	umano	ORGANISMTAXON	9606
24742750	209	229	Prolungamento del QT	DISEASEORPHENOTYPICFEATURE	D008133
24742750	301	373	cardiomiociti derivati da cellule staminali pluripotenti (hiPS-CM) umani	ORGANISMTAXON	9606
24742750	595	624	K(+) e Ca(2+) channel blocker	CHEMICALENTITY	D002121,D026902
24742750	834	854	prolungamento del QT	DISEASEORPHENOTYPICFEATURE	D008133
24742750	1002	1018	prolungamento QT	DISEASEORPHENOTYPICFEATURE	D008133
24742750	1377	1404	Ca(2+) bloccanti dei canali	CHEMICALENTITY	D002121
24742750	1519	1529	Amiodarone	CHEMICALENTITY	D000638
24742750	1562	1572	Paroxetina	CHEMICALENTITY	D017374
24742750	1606	1617	Terfenadina	CHEMICALENTITY	D016593
24742750	1651	1661	Citalopram	CHEMICALENTITY	D015283
24742750	1783	1794	Terfenadina	CHEMICALENTITY	D016593
24742750	1828	1838	Citalopram	CHEMICALENTITY	D015283
24742750	1912	1930	Torsade de Pointes	DISEASEORPHENOTYPICFEATURE	D016171
24742750	1975	1978	TdP	DISEASEORPHENOTYPICFEATURE	D016171
24742750	2315	2318	TdP	DISEASEORPHENOTYPICFEATURE	D016171
24743235	32	36	IL-3	GENEORGENEPRODUCT	16187
24743235	71	76	CSF-1	GENEORGENEPRODUCT	12977
24743235	154	159	CD11c	GENEORGENEPRODUCT	16411
24743235	193	198	IL-10	GENEORGENEPRODUCT	16153
24743235	352	356	IL-3	GENEORGENEPRODUCT	16187
24743235	451	456	CSF-1	GENEORGENEPRODUCT	12977
24743235	607	612	CSF-1	GENEORGENEPRODUCT	12977
24743235	648	652	IL-3	GENEORGENEPRODUCT	16187
24743235	706	711	CSF-1	GENEORGENEPRODUCT	12977
24743235	775	779	IL-3	GENEORGENEPRODUCT	16187
24743235	820	825	CD11c	GENEORGENEPRODUCT	16411
24743235	1022	1027	CSF-1	GENEORGENEPRODUCT	12977
24743235	1060	1066	CSF-1R	GENEORGENEPRODUCT	12978
24743235	1135	1139	IL-3	GENEORGENEPRODUCT	16187
24743235	1180	1185	CD11c	GENEORGENEPRODUCT	16411
24743235	1273	1278	c-Fos	GENEORGENEPRODUCT	14281
24743235	1333	1338	CD11c	GENEORGENEPRODUCT	16411
24743235	1391	1395	IL-3	GENEORGENEPRODUCT	16187
24743235	1431	1435	IL-3	GENEORGENEPRODUCT	16187
24743235	1468	1473	CSF-1	GENEORGENEPRODUCT	12977
24743235	1574	1578	IL-3	GENEORGENEPRODUCT	16187
24743235	1613	1617	IL-3	GENEORGENEPRODUCT	16187
24743235	1651	1667	Le cellule CSF-1	GENEORGENEPRODUCT	12977
24743235	1864	1869	IL-10	GENEORGENEPRODUCT	16153
24743235	1912	1916	IL-1	GENEORGENEPRODUCT	111343
24743235	1950	1954	IL-6	GENEORGENEPRODUCT	16193
24743235	1989	1993	TNFa	GENEORGENEPRODUCT	21926
24743235	2041	2044	LPS	CHEMICALENTITY	D008070
24743235	2191	2196	CSF-1	GENEORGENEPRODUCT	12977
24743235	2250	2254	IL-3	GENEORGENEPRODUCT	16187
24743235	2358	2363	CD11c	GENEORGENEPRODUCT	16411
24768818	91	114	recettore del collagene	GENEORGENEPRODUCT	4921,780
24768818	146	150	DDR1	GENEORGENEPRODUCT	 780
24768818	252	290	recettori del dominio della discoidina	GENEORGENEPRODUCT	4921,780
24768818	327	330	DDR	GENEORGENEPRODUCT	4921,780
24768818	364	368	DDR1	GENEORGENEPRODUCT	780
24768818	402	406	DDR2	GENEORGENEPRODUCT	4921
24768818	479	504	recettori tirosin-chinasi	GENEORGENEPRODUCT	4921,780
24768818	560	569	collagene	GENEORGENEPRODUCT	1277
24768818	644	648	DDR1	GENEORGENEPRODUCT	780
24768818	682	686	DDR2	GENEORGENEPRODUCT	4921
24768818	758	772	malattie umane	ORGANISMTAXON	9606
24768818	825	832	fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
24768818	878	891	aterosclerosi	DISEASEORPHENOTYPICFEATURE	 D050197
24768818	937	943	cancro	DISEASEORPHENOTYPICFEATURE	D009369
24768818	1023	1049	 recettore tirosin-chinasi	GENEORGENEPRODUCT	4921,780
24768818	1106	1112	cancro	DISEASEORPHENOTYPICFEATURE	D009369
24768818	1168	1176	imatinib	CHEMICALENTITY	D000068877
24768818	1210	1219	ponatinib	CHEMICALENTITY	C545373
24768818	1329	1338	Ponatinib	CHEMICALENTITY	C545373
24768818	1427	1431	DDR1	GENEORGENEPRODUCT	780
24768818	1466	1470	DDR2	GENEORGENEPRODUCT	4921
24768818	1549	1554	umano	ORGANISMTAXON	9606
24768818	1585	1589	DDR1	GENEORGENEPRODUCT	780
24768818	1634	1637	DFG	CHEMICALENTITY	C553185
24768818	1688	1691	DFG	CHEMICALENTITY	C553185
24768818	1724	1736	Asp- Phe-Gly	CHEMICALENTITY	C553185
24768818	1904	1919	Abelson chinasi	GENEORGENEPRODUCT	25
24768818	1950	1953	ABL	GENEORGENEPRODUCT	25
24768818	2002	2006	DDR1	GENEORGENEPRODUCT	780
24768818	2100	2103	ABL	GENEORGENEPRODUCT	25
24768818	2160	2164	DDR1	GENEORGENEPRODUCT	780
24768818	2236	2239	ABL	GENEORGENEPRODUCT	25
24768818	2318	2321	ATP	CHEMICALENTITY	D000255
24768818	2364	2372	imatinib	CHEMICALENTITY	D000068877
24768818	2406	2415	ponatinib	CHEMICALENTITY	C545373
24768818	2486	2489	DDR	GENEORGENEPRODUCT	4921,780
24768818	2521	2524	ABL	GENEORGENEPRODUCT	25
24768818	2597	2600	ABL	GENEORGENEPRODUCT	25
24768818	2660	2664	DDR1	GENEORGENEPRODUCT	780
24768818	2744	2748	DDR1	GENEORGENEPRODUCT	780
24768818	2902	2906	DDR2	GENEORGENEPRODUCT	4921
24768818	2971	2988	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
24842192	55	65	metformina	CHEMICALENTITY	D008687
24842192	107	128	toll-like recettore 4	GENEORGENEPRODUCT	29260
24842192	195	228	disfunzione ventricolare sinistra	DISEASEORPHENOTYPICFEATURE	D018487
24842192	285	306	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
24842192	364	374	metformina	CHEMICALENTITY	D008687
24842192	446	467	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
24842192	539	561	risposte infiammatorie	DISEASEORPHENOTYPICFEATURE	D007249
24842192	620	651	protein chinasi attivata da AMP	GENEORGENEPRODUCT	65248
24842192	686	690	AMPK	GENEORGENEPRODUCT	65248
24842192	786	796	metformina	CHEMICALENTITY	D008687
24842192	843	863	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
24842192	898	919	recettore toll-like 4	GENEORGENEPRODUCT	29260
24842192	953	957	TLR4	GENEORGENEPRODUCT	29260
24842192	1022	1043	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
24842192	1100	1104	AMPK	GENEORGENEPRODUCT	65248
24842192	1170	1175	ratti	ORGANISMTAXON	10116
24842192	1324	1338	isoproterenolo	CHEMICALENTITY	D007545
24842192	1427	1437	metformina	CHEMICALENTITY	D008687
24842192	1504	1520	L'isoproterenolo	CHEMICALENTITY	D007545
24842192	1650	1674	infarto miocardico acuto	DISEASEORPHENOTYPICFEATURE	D009203
24842192	1707	1723	L'isoproterenolo	CHEMICALENTITY	D007545
24842192	1906	1939	disfunzione ventricolare sinistra	DISEASEORPHENOTYPICFEATURE	D018487
24842192	2045	2055	metformina	CHEMICALENTITY	D008687
24842192	2088	2097	Metfromin	CHEMICALENTITY	D008687
24842192	2152	2166	isoproterenolo	CHEMICALENTITY	D007545
24842192	2236	2240	TLR4	GENEORGENEPRODUCT	29260
24842192	2280	2320	proteina di differenziazione mieloide 88	GENEORGENEPRODUCT	301059
24842192	2356	2361	MyD88	GENEORGENEPRODUCT	301059
24842192	2396	2428	fattore di necrosi tumorale-alfa	GENEORGENEPRODUCT	24835
24842192	2462	2467	TNF-a	GENEORGENEPRODUCT	24835
24842192	2503	2518	interleuchina 6	GENEORGENEPRODUCT	24498
24842192	2552	2556	IL-6	GENEORGENEPRODUCT	24498
24842192	2682	2687	TNF-a	GENEORGENEPRODUCT	24835
24842192	2722	2726	IL-6	GENEORGENEPRODUCT	24498
24842192	2838	2843	AMPKa	GENEORGENEPRODUCT	65248
24842192	2879	2883	AMPK	GENEORGENEPRODUCT	65248
24842192	2980	2990	metformina	CHEMICALENTITY	D008687
24842192	3100	3110	metformina	CHEMICALENTITY	D008687
24842192	3169	3187	infarto miocardico	DISEASEORPHENOTYPICFEATURE	D009203
24842192	3232	3252	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
24842192	3307	3320	infiammatorie	DISEASEORPHENOTYPICFEATURE	D007249
24842192	3397	3401	TLR4	GENEORGENEPRODUCT	29260
24842192	3524	3544	miocardio infartuato	DISEASEORPHENOTYPICFEATURE	D009203
24853300	50	64	calbindin-D28k	GENEORGENEPRODUCT	12307
24853300	129	150	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	 D000544
24853300	179	183	topo	ORGANISMTAXON	10090
24853300	224	238	Calbindin-D28k	GENEORGENEPRODUCT	12307
24853300	272	274	CB	GENEORGENEPRODUCT	12307
24853300	325	331	calcio	CHEMICALENTITY	D002118
24853300	457	472	morte neuronale	DISEASEORPHENOTYPICFEATURE	D009410
24853300	526	532	calcio	CHEMICALENTITY	D002118
24853300	647	649	CB	GENEORGENEPRODUCT	12307,793
24853300	694	699	 topi	ORGANISMTAXON	10090
24853300	729	734	umani	ORGANISMTAXON	9606
24853300	782	803	Malattia di Alzheimer	DISEASEORPHENOTYPICFEATURE	D000544
24853300	848	850	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	971	973	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	1057	1059	CB	GENEORGENEPRODUCT	12307
24853300	1115	1117	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	1203	1205	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	1253	1255	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	1290	1294	topi	ORGANISMTAXON	10090
24853300	1331	1333	CB	GENEORGENEPRODUCT	12307
24853300	1377	1380	CB 	GENEORGENEPRODUCT	12307
24853300	1412	1416	topi	ORGANISMTAXON	10090
24853300	1479	1481	CB	GENEORGENEPRODUCT	12307
24853300	1530	1532	AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	1566	1568	CB	GENEORGENEPRODUCT	12307
24853300	1603	1607	topi	ORGANISMTAXON	10090
24853300	1791	1793	CB	GENEORGENEPRODUCT	12307
24853300	1828	1832	topi	ORGANISMTAXON	10090
24853300	1960	1962	CB	GENEORGENEPRODUCT	12307
24853300	1995	1999	topi	ORGANISMTAXON	10090
24853300	2050	2067	perdita neuronale	DISEASEORPHENOTYPICFEATURE	D009410
24853300	2161	2179	peptide b amiloide	GENEORGENEPRODUCT	11820
24853300	2214	2216	Ab	GENEORGENEPRODUCT	11820
24853300	2340	2365	disfunzione mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
24853300	2408	2412	topi	ORGANISMTAXON	10090
24853300	2455	2457	CB	GENEORGENEPRODUCT	12307
24853300	2490	2494	topi	ORGANISMTAXON	10090
24853300	2570	2608	proteina chinasi attivata dal mitogeno	GENEORGENEPRODUCT	26413,26417
24853300	2648	2696	chinasi extracellulare regolata dal segnale) 1/2	GENEORGENEPRODUCT	26413,26417
24853300	2731	2777	proteina legante gli elementi di risposta cAMP	GENEORGENEPRODUCT	12912
24853300	2847	2884	N-metil-D- Recettore dell'aspartato 1	GENEORGENEPRODUCT	14810
24853300	2918	2934	Recettore NMDA 1	GENEORGENEPRODUCT	14810
24853300	2969	2986	Recettore NMDA 2A	GENEORGENEPRODUCT	14811
24853300	3020	3026	PSD-95	GENEORGENEPRODUCT	13385
24853300	3061	3074	synaptophysin	GENEORGENEPRODUCT	20977
24853300	3131	3135	topi	ORGANISMTAXON	10090
24853300	3256	3258	CB	GENEORGENEPRODUCT	12307
24853300	3294	3327	proteina precursore dell'amiloide	GENEORGENEPRODUCT	11820
24853300	3360	3371	presenilina	GENEORGENEPRODUCT	19164
24853300	3412	3416	topi	ORGANISMTAXON	10090
24853300	3469	3482	Patogenesi AD	DISEASEORPHENOTYPICFEATURE	D000544
24853300	3531	3533	CB	GENEORGENEPRODUCT	12307
24853300	3600	3614	 patogenesi AD	DISEASEORPHENOTYPICFEATURE	D000544
24902786	31	43	Testosterone	CHEMICALENTITY	D013739
24902786	84	99	streptozotocina	CHEMICALENTITY	D013311
24902786	151	179	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24902786	219	224	ratti	ORGANISMTAXON	10116
24902786	288	300	testosterone	CHEMICALENTITY	D013739
24902786	335	350	streptozotocina	CHEMICALENTITY	D013311
24902786	384	387	STZ	CHEMICALENTITY	D013311
24902786	443	471	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24902786	513	518	ratti	ORGANISMTAXON	10116
24902786	579	584	ratti	ORGANISMTAXON	10116
24902786	677	680	STZ	CHEMICALENTITY	D013311
24902786	838	841	STZ	CHEMICALENTITY	D013311
24902786	938	943	ratti	ORGANISMTAXON	10116
24902786	1058	1070	Testosterone	CHEMICALENTITY	D013739
24902786	1129	1148	androgeno recettore	GENEORGENEPRODUCT	367
24902786	1192	1201	flutamide	CHEMICALENTITY	D005485
24902786	1263	1288	recettore degli estrogeni	GENEORGENEPRODUCT	2099
24902786	1332	1341	tamoxifen	CHEMICALENTITY	D013629
24902786	1413	1422	aromatasi	GENEORGENEPRODUCT	25147
24902786	1454	1463	letrozolo	CHEMICALENTITY	C067431
24902786	1584	1587	STZ	CHEMICALENTITY	D013311
24902786	1631	1634	STZ	CHEMICALENTITY	D013311
24902786	1725	1729	STL1	GENEORGENEPRODUCT	369068
24902786	1785	1789	STL2	GENEORGENEPRODUCT	369140
24902786	1872	1904	La sostituzione del testosterone	CHEMICALENTITY	D013739
24902786	1963	1967	STL1	GENEORGENEPRODUCT	369068
24902786	2004	2008	STL2	GENEORGENEPRODUCT	369140
24902786	2040	2045	ratti	ORGANISMTAXON	10116
24902786	2126	2130	STL1	GENEORGENEPRODUCT	369068
24902786	2166	2170	STL2	GENEORGENEPRODUCT	369140
24902786	2205	2208	STZ	CHEMICALENTITY	D013311
24902786	2247	2252	ratti	ORGANISMTAXON	10116
24902786	2305	2314	flutamide	CHEMICALENTITY	D005485
24902786	2347	2356	letrozolo	CHEMICALENTITY	C067431
24902786	2391	2400	tamoxifen	CHEMICALENTITY	 D013629
24902786	2475	2480	ratti	ORGANISMTAXON	10116
24902786	2550	2579	sostituzione del testosterone	CHEMICALENTITY	D013739
24902786	2632	2635	STZ	CHEMICALENTITY	D013311
24902786	2682	2710	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24902786	2756	2768	Testosterone	CHEMICALENTITY	D013739
24902786	2829	2832	STZ	CHEMICALENTITY	D013311
24902786	2906	2934	compromissione della memoria	DISEASEORPHENOTYPICFEATURE	D008569
24902786	2982	2987	ratti	ORGANISMTAXON	10116
24911645	68	72	topi	ORGANISMTAXON	10090
24911645	120	140	 garcinielliptone FC	CHEMICALENTITY	C573355
24911645	175	186	pilocarpina	CHEMICALENTITY	D010862
24911645	241	252	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24911645	285	304	Garcinielliptone FC	CHEMICALENTITY	C573355
24911645	337	340	GFC	CHEMICALENTITY	C573355
24911645	433	455	Platonia insignis Mart	ORGANISMTAXON	198787
24911645	565	585	malattie della pelle	DISEASEORPHENOTYPICFEATURE	D012871
24911645	625	630	umani	ORGANISMTAXON	9606
24911645	743	750	diarree	DISEASEORPHENOTYPICFEATURE	D003967
24911645	796	818	malattie infiammatorie	DISEASEORPHENOTYPICFEATURE	D007249
24911645	899	902	GFC	CHEMICALENTITY	C573355
24911645	1029	1032	GFC	CHEMICALENTITY	C573355
24911645	1107	1119	convulsioni 	DISEASEORPHENOTYPICFEATURE	D012640
24911645	1242	1264	acido r-aminobutirrico	CHEMICALENTITY	D005680
24911645	1299	1303	GABA	CHEMICALENTITY	D005680
24911645	1337	1347	glutammina	CHEMICALENTITY	D018698
24911645	1380	1389	aspartato	CHEMICALENTITY	D001224
24911645	1423	1433	glutatione	CHEMICALENTITY	D005978
24911645	1489	1508	acetilcolinesterasi	GENEORGENEPRODUCT	11423
24911645	1543	1547	AChE	GENEORGENEPRODUCT	11423
24911645	1589	1593	topi	ORGANISMTAXON	10090
24911645	1653	1664	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24911645	1697	1700	GFC	CHEMICALENTITY	C573355
24911645	1786	1791	crisi	DISEASEORPHENOTYPICFEATURE	D012640
24911645	1929	1933	topi	ORGANISMTAXON	10090
24911645	1976	1980	GABA	CHEMICALENTITY	D005680
24911645	2022	2026	topi	ORGANISMTAXON	10090
24911645	2082	2087	GFC75	CHEMICALENTITY	C573355
24911645	2124	2128	P400	CHEMICALENTITY	D010862
24911645	2215	2219	topi	ORGANISMTAXON	10090
24911645	2255	2264	aspartato	CHEMICALENTITY	D001224
24911645	2297	2307	glutammina	CHEMICALENTITY	D018698
24911645	2472	2476	topi	ORGANISMTAXON	10090
24911645	2532	2537	GFC75	CHEMICALENTITY	C573355
24911645	2573	2577	P400	CHEMICALENTITY	D010862
24911645	2618	2622	topi	ORGANISMTAXON	10090
24911645	2662	2666	topi	ORGANISMTAXON	10090
24911645	2711	2716	GFC75	CHEMICALENTITY	C573355
24911645	2753	2757	P400	CHEMICALENTITY	 D010862
24911645	2827	2831	AChE	GENEORGENEPRODUCT	11423
24911645	2882	2886	topi	ORGANISMTAXON	10090
24911645	2944	2947	GFC	CHEMICALENTITY	C573355
24911645	3064	3075	pilocarpina	CHEMICALENTITY	D010862
24911645	3127	3143	stato epilettico	DISEASEORPHENOTYPICFEATURE	D013226
24911645	3240	3251	convulsioni	DISEASEORPHENOTYPICFEATURE	D012640
24911645	3382	3385	GFC	CHEMICALENTITY	C573355
24911645	3491	3502	pilocarpina	CHEMICALENTITY	D010862
24911645	3568	3572	GABA	CHEMICALENTITY	D005680
24911645	3606	3616	glutammato	CHEMICALENTITY	D018698
24911645	3654	3658	AChE	GENEORGENEPRODUCT	11423
24914936	32	81	La mutazione del recettore dell'ormone tiroideo a	GENEORGENEPRODUCT	21833
24914936	144	152	tiroxina	CHEMICALENTITY	D013974
24914936	207	228	displasia scheletrica	DISEASEORPHENOTYPICFEATURE	D001848
24914936	268	272	topi	ORGANISMTAXON	10090
24914936	385	389	THRA	GENEORGENEPRODUCT	7067
24914936	438	471	recettore dell'ormone tiroideo a1	GENEORGENEPRODUCT	7067
24914936	504	508	TRA1	GENEORGENEPRODUCT	7067
24914936	594	596	T3	CHEMICALENTITY	D014284
24914936	628	630	T4	CHEMICALENTITY	D013974
24914936	695	715	deficit intellettivo	DISEASEORPHENOTYPICFEATURE	D008607
24914936	761	772	stitichezza	DISEASEORPHENOTYPICFEATURE	D003248
24914936	842	863	displasia scheletrica	DISEASEORPHENOTYPICFEATURE	D001848
24914936	936	958	ritardo dello sviluppo	DISEASEORPHENOTYPICFEATURE	D002658
24914936	1027	1040	ipotiroidismo	DISEASEORPHENOTYPICFEATURE	D007037
24914936	1070	1078	pazienti	ORGANISMTAXON	9606
24914936	1167	1169	T4	CHEMICALENTITY	D013974
24914936	1248	1253	Thra1	GENEORGENEPRODUCT	21833
24914936	1288	1292	topi	ORGANISMTAXON	10090
24914936	1380	1384	TRa1	GENEORGENEPRODUCT	21833
24914936	1525	1530	Thra1	GENEORGENEPRODUCT	21833
24914936	1565	1569	topi	ORGANISMTAXON	10090
24914936	1668	1673	umano	ORGANISMTAXON	9606
24914936	1705	1709	THRA	GENEORGENEPRODUCT	7067
24914936	1817	1819	T4	CHEMICALENTITY	D013974
24914936	1875	1896	anomalie scheletriche	DISEASEORPHENOTYPICFEATURE	D001847
24914936	1945	1950	Thra1	GENEORGENEPRODUCT	21833
24914936	1985	1989	topi	ORGANISMTAXON	10090
24914936	2040	2053	bassa statura	DISEASEORPHENOTYPICFEATURE	D006130
24914936	2193	2195	T4	CHEMICALENTITY	D013974
24914936	2283	2286	TSH	GENEORGENEPRODUCT	12640,22094
24914936	2462	2492	resistenza all'ormone tiroideo	DISEASEORPHENOTYPICFEATURE	D018382
24914936	2571	2573	T4	CHEMICALENTITY	D013974
24914936	2761	2765	TRa1	GENEORGENEPRODUCT	7067
24914936	2876	2884	pazienti	ORGANISMTAXON	9606
24914936	2938	2942	THRA	GENEORGENEPRODUCT	7067
24914936	3007	3009	T4	CHEMICALENTITY	D013974
24927617	43	55	Rabdomiolisi	DISEASEORPHENOTYPICFEATURE	D012206
24927617	106	134	virus dell'epatite C infetto	DISEASEORPHENOTYPICFEATURE	D006526
24927617	162	170	paziente	ORGANISMTAXON	9606
24927617	215	225	telaprevir	CHEMICALENTITY	C486464
24927617	259	271	simvastatina	CHEMICALENTITY	D019821
24927617	302	306	uomo	ORGANISMTAXON	9606
24927617	373	406	infezione da virus dell'epatite C	DISEASEORPHENOTYPICFEATURE	D006526
24927617	473	483	ribavirina	CHEMICALENTITY	D012254
24927617	517	537	interferone pegilato	CHEMICALENTITY	C417083
24927617	571	581	telaprevir	CHEMICALENTITY	C486464
24927617	613	621	paziente	ORGANISMTAXON	9606
24927617	671	683	simvastatina	CHEMICALENTITY	D019821
24927617	762	770	paziente	ORGANISMTAXON	9606
24927617	866	878	rabdomiolisi	DISEASEORPHENOTYPICFEATURE	D012206
24927617	923	935	simvastatina	CHEMICALENTITY	D019821
24927617	977	995	farmaci antivirali	CHEMICALENTITY	D000998
24927617	1066	1093	si sospettava una tossicità	DISEASEORPHENOTYPICFEATURE	D064420
24927617	1167	1183	creatina chinasi	CHEMICALENTITY	D003402
24927617	1253	1261	paziente	ORGANISMTAXON	9606
24927617	1367	1375	paziente	ORGANISMTAXON	9606
24927617	1480	1496	creatina chinasi	CHEMICALENTITY	D003402
24927617	1552	1560	paziente	ORGANISMTAXON	9606
24927617	1609	1619	Telaprevir	CHEMICALENTITY	C486464
24927617	1724	1736	simvastatina	CHEMICALENTITY	D019821
24927617	1890	1896	CYP3A4	GENEORGENEPRODUCT	1576
24927617	1939	1951	simvastatina	CHEMICALENTITY	D019821
24927617	1984	2028	La concentrazione plasmatica di Simvastatina	CHEMICALENTITY	D019821
24927617	2090	2098	paziente	ORGANISMTAXON	9606
24927617	2133	2140	statina	CHEMICALENTITY	D019821
24927617	2192	2211	tossicità muscolare	DISEASEORPHENOTYPICFEATURE	D009135
24927617	2279	2286	statina	CHEMICALENTITY	D019821
24927617	2378	2388	telaprevir	CHEMICALENTITY	C486464
24927617	2427	2434	statine	CHEMICALENTITY	D019821
24971338	46	55	sirolimus	CHEMICALENTITY	D020123
24971338	96	108	ciclosporina	CHEMICALENTITY	D016572
24971338	160	170	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
24971338	203	206	rat	ORGANISMTAXON	10116
24971338	349	363	ciclosporina A	CHEMICALENTITY	D016572
24971338	396	399	CsA	CHEMICALENTITY	D016572
24971338	434	443	sirolimus	CHEMICALENTITY	D020123
24971338	476	479	SRL	CHEMICALENTITY	D020123
24971338	594	597	CsA	CHEMICALENTITY	D016572
24971338	649	659	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
24971338	853	856	CsA	CHEMICALENTITY	D016572
24971338	892	895	SRL	CHEMICALENTITY	D020123
24971338	951	954	rat	ORGANISMTAXON	10116
24971338	1068	1071	CsA	CHEMICALENTITY	D016572
24971338	1104	1107	SRL	CHEMICALENTITY	D020123
24971338	1154	1157	CsA	CHEMICALENTITY	D016572
24971338	1216	1219	SRL	CHEMICALENTITY	D020123
24971338	1397	1414	Le lesioni renali	DISEASEORPHENOTYPICFEATURE	D007674
24971338	1550	1553	SRL	CHEMICALENTITY	D020123
24971338	1591	1596	ratti	ORGANISMTAXON	10116
24971338	1652	1663	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
24971338	1699	1703	NGAL	GENEORGENEPRODUCT	170496
24971338	1795	1816	 insufficienza renale	DISEASEORPHENOTYPICFEATURE	D007674
24971338	1855	1858	CsA	CHEMICALENTITY	D016572
24971338	1953	1967	lesioni renali	DISEASEORPHENOTYPICFEATURE	D007674
24971338	2003	2008	TGF-b	GENEORGENEPRODUCT	59086
24971338	2042	2048	NF- kb	GENEORGENEPRODUCT	81736
24971338	2083	2087	mTOR	GENEORGENEPRODUCT	56718
24971338	2121	2125	PCNA	GENEORGENEPRODUCT	25737
24971338	2159	2163	TP53	GENEORGENEPRODUCT	24842
24971338	2199	2204	KIM-1	GENEORGENEPRODUCT	286934
24971338	2239	2243	CTGF	GENEORGENEPRODUCT	64032
24971338	2321	2324	CsA	CHEMICALENTITY	D016572
24971338	2390	2402	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
24971338	2517	2523	TGF- b	GENEORGENEPRODUCT	59086
24971338	2558	2562	IL-7	GENEORGENEPRODUCT	25647
24971338	2595	2600	TBARs	CHEMICALENTITY	D017392
24971338	2650	2655	TGF-b	GENEORGENEPRODUCT	59086
24971338	2691	2695	mTOR	GENEORGENEPRODUCT	56718
24971338	2743	2746	SRL	CHEMICALENTITY	D020123
24971338	2788	2791	CsA	CHEMICALENTITY	D016572
24971338	2844	2856	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
24971338	2942	2946	NGAL	GENEORGENEPRODUCT	170496
24971338	3042	3045	CsA	CHEMICALENTITY	D016572
24971338	3092	3095	SRL	CHEMICALENTITY	D020123
25054547	62	66	BCHE	GENEORGENEPRODUCT	590
25054547	149	160	p.Val204Asp	SEQUENCEVARIANT	P|SUB|V|204|D
25054547	246	251	apnea	DISEASEORPHENOTYPICFEATURE	D001049
25054547	287	298	suxametonio	CHEMICALENTITY	D013390
25054547	343	378	Il deficit di butirrilcolinesterasi	DISEASEORPHENOTYPICFEATURE	C537417
25054547	442	447	apnea	DISEASEORPHENOTYPICFEATURE	D001049
25054547	541	552	suxametonio	CHEMICALENTITY	D013390
25054547	589	600	mivacurium 	CHEMICALENTITY	D000077590
25054547	632	640	pazienti	ORGANISMTAXON	9606
25054547	700	704	BCHE	GENEORGENEPRODUCT	590
25054547	780	801	blocco neuromuscolare	DISEASEORPHENOTYPICFEATURE	D055191
25054547	869	882	suxamethonium	CHEMICALENTITY	D013390
25054547	950	954	BCHE	GENEORGENEPRODUCT	590
25054547	1003	1012	c.695T> A	SEQUENCEVARIANT	C|SUB|T|695|A
25054547	1052	1063	p.Val204Asp	SEQUENCEVARIANT	P|SUB|V|204|D
25054547	1296	1304	paziente	ORGANISMTAXON	9606
25054547	1342	1363	butirrilcolinesterasi	GENEORGENEPRODUCT	590
25054547	1400	1417	butirriltiocolina	CHEMICALENTITY	D002092
25054547	1450	1453	BTC	CHEMICALENTITY	D002092
25054547	1488	1501	benzoilcolina	CHEMICALENTITY	D001588
25054547	1547	1556	dibucaine	CHEMICALENTITY	D003992
25054547	1590	1598	fluoruro	CHEMICALENTITY	D005459
25054547	1730	1734	BChE	GENEORGENEPRODUCT	590
25054547	1806	1814	paziente	ORGANISMTAXON	9606
25054547	1927	1931	BChE	GENEORGENEPRODUCT	590
25054547	2081	2092	p.Val204Asp	SEQUENCEVARIANT	P|SUB|V|204|D
25054547	2127	2137	p.Asp70Gly	SEQUENCEVARIANT	RS1799807
25054547	2172	2183	p.Ala539Thr	SEQUENCEVARIANT	RS1803274
25054547	2214	2218	BChE	GENEORGENEPRODUCT	590
25054547	2290	2293	BTC	CHEMICALENTITY	D002092
25054547	2389	2392	BTC	CHEMICALENTITY	D002092
25054547	2538	2549	suxametonio	CHEMICALENTITY	D013390
25054547	2689	2700	p.Val204Asp	SEQUENCEVARIANT	P|SUB|V|204|D
25054547	3116	3127	p.Ala204Asp	SEQUENCEVARIANT	P|SUB|A|204|D
25054547	3162	3173	p.Asp70Gly 	SEQUENCEVARIANT	RS1799807
25054547	3208	3219	p.Ala539Thr	SEQUENCEVARIANT	RS1803274
25218136	43	48	Sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	122	150	trasportatori di amminoacidi	GENEORGENEPRODUCT	246235,25648,29642 ,84551
25218136	184	191	leucina	CHEMICALENTITY	D007930
25218136	245	249	mTOR	GENEORGENEPRODUCT	56718
25218136	365	370	sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	410	417	leucina	CHEMICALENTITY	D007930
25218136	451	454	Leu	CHEMICALENTITY	D007930
25218136	579	607	trasportatori di amminoacidi	GENEORGENEPRODUCT	246235,25648,29642,84551
25218136	679	682	Leu	CHEMICALENTITY	D007930
25218136	753	756	Leu	CHEMICALENTITY	D007930
25218136	799	803	mTOR	GENEORGENEPRODUCT	56718
25218136	844	863	Complesso Ragulator	GENEORGENEPRODUCT	295234,308869
25218136	908	913	Sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	961	966	ratti	ORGANISMTAXON	10116
25218136	1103	1107	mTOR	GENEORGENEPRODUCT	56718
25218136	1176	1182	4E-BP1	GENEORGENEPRODUCT	116636
25218136	1218	1222	S6K1	GENEORGENEPRODUCT	83840
25218136	1285	1288	Leu	CHEMICALENTITY	D007930
25218136	1362	1366	mTOR	GENEORGENEPRODUCT	56718
25218136	1459	1464	sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	1509	1514	Sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	1557	1561	CAT1	GENEORGENEPRODUCT	25648
25218136	1595	1600	 LAT2	GENEORGENEPRODUCT	84551
25218136	1635	1640	SNAT2	GENEORGENEPRODUCT	29642
25218136	1750	1754	CAT1	GENEORGENEPRODUCT	 25648
25218136	1865	1870	sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	1918	1974	trasportatore di aminoacidi assistito da protoni (PAT)-2	GENEORGENEPRODUCT	246235
25218136	2077	2081	PAT2	GENEORGENEPRODUCT	246235
25218136	2151	2156	sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	2190	2193	Leu	CHEMICALENTITY	D007930
25218136	2276	2282	RagA-D	GENEORGENEPRODUCT	117043,117044,297960,298514
25218136	2324	2337	LAMTOR-1 e -2	GENEORGENEPRODUCT	295234,308869
25218136	2372	2378	rapace	GENEORGENEPRODUCT	287871
25218136	2412	2416	Rheb	GENEORGENEPRODUCT	26954
25218136	2452	2456	mTOR	GENEORGENEPRODUCT	56718
25218136	2520	2524	mTOR	GENEORGENEPRODUCT	56718
25218136	2559	2565	PRAS40	GENEORGENEPRODUCT	292887
25218136	2602	2606	RagC	GENEORGENEPRODUCT	298514
25218136	2642	2648	raptor	GENEORGENEPRODUCT	287871
25218136	2795	2798	Leu	CHEMICALENTITY	D007930
25218136	2835	2841	PRAS40	GENEORGENEPRODUCT	292887
25218136	2876	2882	rapace	GENEORGENEPRODUCT	287871
25218136	2929	2933	RagC	GENEORGENEPRODUCT	298514
25218136	2967	2973	raptor	GENEORGENEPRODUCT	287871
25218136	3063	3068	sepsi	DISEASEORPHENOTYPICFEATURE	D018805
25218136	3137	3140	Leu	CHEMICALENTITY	D007930
25218136	3261	3264	Leu	CHEMICALENTITY	D007930
25218136	3359	3362	Leu	CHEMICALENTITY	D007930
25218136	3432	3437	ratti	ORGANISMTAXON	10116
25218136	3535	3563	trasportatori di amminoacidi	GENEORGENEPRODUCT	246235,25648,29642,84551
25218136	3643	3649	sepsi 	DISEASEORPHENOTYPICFEATURE	D018805
25218136	3689	3692	Leu	CHEMICALENTITY	D007930
25218136	3739	3742	Leu	CHEMICALENTITY	D007930
25218136	3798	3804	raptor	GENEORGENEPRODUCT	287871
25218136	3842	3846	RagC	GENEORGENEPRODUCT	298514
25218136	3898	3902	mTOR	GENEORGENEPRODUCT	56718
25218136	3936	3942	raptor	GENEORGENEPRODUCT	287871
25218136	4055	4058	Leu	CHEMICALENTITY	D007930
25218136	4118	4122	mTOR	GENEORGENEPRODUCT	56718
25263533	31	35	CD25	GENEORGENEPRODUCT	3559
25263533	69	73	Bcl6	GENEORGENEPRODUCT	604
25263533	214	219	umana	ORGANISMTAXON	9606
25263533	280	285	CXCR5	GENEORGENEPRODUCT	643
25263533	320	323	PD1	GENEORGENEPRODUCT	5133
25263533	358	361	CD4	GENEORGENEPRODUCT	920
25263533	443	447	CD25	GENEORGENEPRODUCT	3559
25263533	481	485	Bcl6	GENEORGENEPRODUCT	604
25263533	571	575	CD25	GENEORGENEPRODUCT	3559
25263533	609	613	Bcl6	GENEORGENEPRODUCT	604
25263533	670	675	FoxP3	GENEORGENEPRODUCT	50943
25263533	852	856	CD25	GENEORGENEPRODUCT	3559
25263533	890	895	Bcl6 	GENEORGENEPRODUCT	604
25263533	981	985	IL-2	GENEORGENEPRODUCT	3558
25263533	1025	1029	CD25	GENEORGENEPRODUCT	3559
25263533	1130	1134	ICOS	GENEORGENEPRODUCT	29851
25263533	1168	1172	OX40	GENEORGENEPRODUCT	7293
25263533	1244	1248	cMaf	GENEORGENEPRODUCT	4094
25263533	1304	1309	IL-21	GENEORGENEPRODUCT	59067
25263533	1343	1348	IL-17	GENEORGENEPRODUCT	 3605
25263533	1382	1387	IL-10	GENEORGENEPRODUCT	3586
25263533	1474	1478	Bcl2	GENEORGENEPRODUCT	596
25263533	1533	1537	CD25	GENEORGENEPRODUCT	3559
25263533	1571	1575	BCl6	GENEORGENEPRODUCT	604
25263533	1680	1723	citidina deaminasi indotta dall'attivazione	GENEORGENEPRODUCT	57379
25263533	1757	1760	AID	GENEORGENEPRODUCT	57379
25263533	1813	1819	CD45RO	GENEORGENEPRODUCT	5788
25263533	1863	1866	IgG	GENEORGENEPRODUCT	3500
25263533	1901	1904	IgA	GENEORGENEPRODUCT	3493
25263533	1938	1951	classe MHC II	GENEORGENEPRODUCT	3108
25263533	2026	2030	CD25	GENEORGENEPRODUCT	3559
25263533	2064	2068	Bcl6	GENEORGENEPRODUCT	604
25263533	2124	2128	IL-2	GENEORGENEPRODUCT	3558
25263533	2324	2349	Recettore dei linfociti T	GENEORGENEPRODUCT	6955
25263533	2426	2440	Recettore IL-2	GENEORGENEPRODUCT	3559,3560
25263533	2488	2492	IL-2	GENEORGENEPRODUCT	3558
25263533	2552	2556	Bcl6	GENEORGENEPRODUCT	604
25263533	2589	2593	CD25	GENEORGENEPRODUCT	3559
25263533	2675	2679	IL-2	GENEORGENEPRODUCT	3558
25305591	32	37	VPAC2	GENEORGENEPRODUCT	22355
25305591	71	123	recettore del peptide intestinale vasoattivo tipo 2 	GENEORGENEPRODUCT	22355
25305591	175	179	topi	ORGANISMTAXON	10090
25305591	248	287	encefalomielite autoimmune sperimentale	DISEASEORPHENOTYPICFEATURE	D004681
25305591	372	402	Peptide intestinale vasoattivo	GENEORGENEPRODUCT	22353
25305591	436	439	VIP	GENEORGENEPRODUCT	22353
25305591	476	526	polipeptide attivante l'adeniil ciclasi ipofisaria	GENEORGENEPRODUCT	11516
25305591	560	565	PACAP	GENEORGENEPRODUCT	11516
25305591	833	845	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
25305591	932	955	malattia infiammatoria 	DISEASEORPHENOTYPICFEATURE	D007249
25305591	985	989	topi	ORGANISMTAXON	10090
25305591	1033	1036	VIP	GENEORGENEPRODUCT	22353
25305591	1071	1076	PACAP	GENEORGENEPRODUCT	11516
25305591	1233	1272	encefalomielite autoimmune sperimentale	DISEASEORPHENOTYPICFEATURE	D004681
25305591	1317	1320	EAE	DISEASEORPHENOTYPICFEATURE	D004681
25305591	1472	1477	VPAC1	GENEORGENEPRODUCT	22354
25305591	1511	1516	VPAC2	GENEORGENEPRODUCT	22355
25305591	1551	1555	PAC1	GENEORGENEPRODUCT	11517
25305591	1640	1644	topi	ORGANISMTAXON	10090
25305591	1707	1712	VIPR2	GENEORGENEPRODUCT	22355
25305591	1767	1782	recettore VPAC2	GENEORGENEPRODUCT	22355
25305591	1836	1844	MOG35-55	GENEORGENEPRODUCT	4340
25305591	1898	1901	EAE	DISEASEORPHENOTYPICFEATURE	D004681
25305591	1957	1961	topi	ORGANISMTAXON	10090
25305591	2098	2124	citochine proinfiammatorie	GENEORGENEPRODUCT	15978,16171,16193,21926
25305591	2158	2166	TNF-alfa	GENEORGENEPRODUCT	21926
25305591	2200	2204	IL-6	GENEORGENEPRODUCT	16193
25305591	2238	2247	IFN-gamma	GENEORGENEPRODUCT	15978
25305591	2288	2293	IL-17	GENEORGENEPRODUCT	16171
25305591	2356	2382	citochine antinfiammatorie	GENEORGENEPRODUCT	16153,16189,21803
25305591	2416	2421	IL-10	GENEORGENEPRODUCT	16153
25305591	2455	2462	TGFbeta	GENEORGENEPRODUCT	21803
25305591	2499	2503	IL-4	GENEORGENEPROD UCT	16189
25305591	2640	2643	CD4	GENEORGENEPRODUCT	12504
25305591	2678	2682	CD25	GENEORGENEPRODUCT	16184
25305591	2717	2722	FoxP3	GENEORGENEPRODUCT	20371
25305591	2801	2806	VPAC2	GENEORGENEPRODUCT	22355
25305591	2843	2847	topi	ORGANISMTAXON	10090
25305591	2895	2898	EAE	DISEASEORPHENOTYPICFEATURE	D004681
25305591	3012	3017	VPAC2	GENEORGENEPRODUCT	22355
25305591	3054	3058	topi	ORGANISMTAXON	10090
25305591	3182	3187	PACAP	GENEORGENEPRODUCT	11516
25305591	3225	3240	recettore VPAC2	GENEORGENEPRODUCT	22355
25622904	50	53	Sag	GENEORGENEPRODUCT	19823
25622904	86	90	Rbx2	GENEORGENEPRODUCT	19823
25622904	123	127	Roc2	GENEORGENEPRODUCT	19823
25622904	160	180	e3 ubiquitina ligasi	GENEORGENEPRODUCT	19823
25622904	246	250	kras	GENEORGENEPRODUCT	16653
25622904	351	354	SAG	GENEORGENEPRODUCT	19823
25622904	387	391	RBX2	GENEORGENEPRODUCT	19823
25622904	425	445	E3 ubiquitina ligasi	GENEORGENEPRODUCT	19823
25622904	546	550	NOXA	GENEORGENEPRODUCT	58801
25622904	586	589	NF1	GENEORGENEPRODUCT	18015
25622904	638	642	Kras	GENEORGENEPRODUCT	16653
25622904	701	721	polmone tumorigenesi	DISEASEORPHENOTYPICFEATURE	D008175
25622904	764	772	NFkappaB	GENEORGENEPRODUCT	18033
25622904	807	811	mTOR	GENEORGENEPRODUCT	56717
25622904	901	907	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25622904	970	977	IkappaB	GENEORGENEPRODUCT	18033
25622904	1012	1018	DEPTOR	GENEORGENEPRODUCT	97998
25622904	1052	1055	p21	GENEORGENEPRODUCT	12575
25622904	1090	1093	p27	GENEORGENEPRODUCT	12576
25622904	1160	1163	Sag	GENEORGENEPRODUCT	19823
25622904	1196	1200	Rbx2	GENEORGENEPRODUCT	19823
25622904	1234	1243	E3 ligasi	GENEORGENEPRODUCT	19823
25622904	1319	1323	topo	ORGANISMTAXON	10090
25622904	1400	1403	Sag	GENEORGENEPRODUCT	19823
25622904	1492	1496	Kras	GENEORGENEPRODUCT	16653
25622904	1534	1538	G12D	SEQUENCEVARIANT	RS121913529
25622904	1599	1602	Sag	GENEORGENEPRODUCT	19823
25622904	1781	1784	p16	GENEORGENEPRODUCT	12578
25622904	1825	1828	p53	GENEORGENEPRODUCT	22059
25622904	1896	1899	Sag	GENEORGENEPRODUCT	19823
25622904	1957	1962	Jun-B	GENEORGENEPRODUCT	16477
25622904	2012	2019	Abbasso	GENEORGENEPRODUCT	19823
25622904	2052	2057	Fbxw7	GENEORGENEPRODUCT	50754
25622904	2090	2099	E3 ligase	GENEORGENEPRODUCT	19823
25622904	2190	2193	p16	GENEORGENEPRODUCT	12578
25622904	2302	2305	Sag	GENEORGENEPRODUCT	19823
25622904	2403	2409	Cdkn2a	GENEORGENEPRODUCT	12578
25622904	2463	2466	p16	GENEORGENEPRODUCT	12578
25622904	2570	2574	Kras	GENEORGENEPRODUCT	16653
25622904	2611	2615	G12D	SEQUENCEVARIANT	RS121913529
25622904	2678	2681	Sag	GENEORGENEPRODUCT	19823
25622904	2827	2833	Cdkn2a	GENEORGENEPRODUCT	12578
25622904	2914	2917	Sag	GENEORGENEPRODUCT	19823
25622904	2960	2964	Kras	GENEORGENEPRODUCT	16653
25622904	3002	3006	G12D	SEQUENCEVARIANT	RS121913529
25622904	3083	3087	MAPK	GENEORGENEPRODUCT	26413
25622904	3166	3169	p16	GENEORGENEPRODUCT	12578
25622904	3285	3288	Sag	GENEORGENEPRODUCT	19823
25622904	3326	3330	Kras	GENEORGENEPRODUCT	16653
25622904	3369	3373	G12D	SEQUENCEVARIANT	RS121913529
25622904	3441	3445	Kras	GENEORGENEPRODUCT	16653
25622904	3483	3533	Immortalizzazione e trasformazione indotte da G12D	SEQUENCEVARIANT	RS121913529
25622904	3579	3582	SAG	GENEORGENEPRODUCT	19823
25622904	3616	3619	SCF	GENEORGENEPRODUCT	50754
25622904	3652	3661	E3 ligasi	GENEORGENEPRODUCT	19823
25622904	3762	3784	trattamento del cancro	DISEASEORPHENOTYPICFEATURE	D009369
25946186	32	37	TIPE2	GENEORGENEPRODUCT	79626
25946186	90	107	Cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
25946186	284	289	TIPE2	GENEORGENEPRODUCT	79626
25946186	365	371	cancro	DISEASEORPHENOTYPICFEATURE	D009369
25946186	429	434	TIPE2	GENEORGENEPRODUCT	79626
25946186	481	498	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
25946186	577	582	TIPE2	GENEORGENEPRODUCT	79626
25946186	629	652	carcinogenesi polmonare	DISEASEORPHENOTYPICFEATURE	D008175
25946186	721	726	TIPE2	GENEORGENEPRODUCT	79626
25946186	773	800	cancro squamoso del polmone	DISEASEORPHENOTYPICFEATURE	D002289
25946186	846	849	LSC	DISEASEORPHENOTYPICFEATURE	D002289
25946186	895	932	carcinoma polmonare a piccole cellule	DISEASEORPHENOTYPICFEATURE	D055752
25946186	982	1006	adenocarcinoma polmonare	DISEASEORPHENOTYPICFEATURE	D000077192
25946186	1054	1057	AdC	DISEASEORPHENOTYPICFEATURE	D000077192
25946186	1117	1122	TIPE2	GENEORGENEPRODUCT	79626
25946186	1196	1232	cancro del polmone a piccole cellule	DISEASEORPHENOTYPICFEATURE	D055752
25946186	1246	1252	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25946186	1381	1386	TIPE2	GENEORGENEPRODUCT	79626
25946186	1475	1492	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
25946186	1606	1612	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25946186	1713	1718	TIPE2	GENEORGENEPRODUCT	79626
25946186	1831	1836	TIPE2	GENEORGENEPRODUCT	79626
25946186	1894	1903	caspase-3	GENEORGENEPRODUCT	836
25946186	1936	1945	caspase-9	GENEORGENEPRODUCT	842
25946186	1978	1981	Bax	GENEORGENEPRODUCT	581
25946186	2054	2059	Bcl-2	GENEORGENEPRODUCT	596
25946186	2199	2205	tumori	DISEASEORPHENOTYPICFEATURE	D009369
25946186	2237	2241	topi	ORGANISMTAXON	10090
25946186	2280	2285	TIPE2	GENEORGENEPRODUCT	79626
25946186	2348	2351	Akt	GENEORGENEPRODUCT	207
25946186	2430	2433	P38	GENEORGENEPRODUCT	1432
25946186	2493	2497	IkBa	GENEORGENEPRODUCT	4792
25946186	2532	2535	ERK	GENEORGENEPRODUCT	5594
25946186	2596	2601	TIPE2	GENEORGENEPRODUCT	79626
25946186	2657	2674	cancro ai polmoni	DISEASEORPHENOTYPICFEATURE	D008175
25946186	2767	2776	caspase-3	GENEORGENEPRODUCT	836
25946186	2808	2817	caspase-9	GENEORGENEPRODUCT	842
25946186	2850	2855	Bcl-2	GENEORGENEPRODUCT	596
25946186	2888	2891	Bax	GENEORGENEPRODUCT	581
25946186	2948	2952	 P38	GENEORGENEPRODUCT	1432
25946186	2985	2988	Akt	GENEORGENEPRODUCT	207
25946186	3036	3041	TIPE2	GENEORGENEPRODUCT	79626
25946186	3150	3168	cancro del polmone	DISEASEORPHENOTYPICFEATURE	D008175
25983002	45	49	LDHA	GENEORGENEPRODUCT	3939
25983002	102	108	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25983002	168	188	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
25983002	267	273	cancro	DISEASEORPHENOTYPICFEATURE	D009369
25983002	364	386	Lattato deidrogenasi A	GENEORGENEPRODUCT	3939
25983002	419	423	LDHA	GENEORGENEPRODUCT	3939
25983002	579	585	tumore	DISEASEORPHENOTYPICFEATURE	D009369
25983002	643	647	LDHA	GENEORGENEPRODUCT	3939
25983002	694	714	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
25983002	831	835	LDHA	GENEORGENEPRODUCT	3939
25983002	893	913	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
25983002	982	1011	iperplasia prostatica benigna	DISEASEORPHENOTYPICFEATURE	D011470
25983002	1136	1140	LDHA	GENEORGENEPRODUCT	3939
25983002	1206	1210	LDHA	GENEORGENEPRODUCT	3939
25983002	1264	1268	FX11	CHEMICALENTITY	C547455
25983002	1565	1573	glucosio	CHEMICALENTITY	D005947
25983002	1627	1634	lattato	CHEMICALENTITY	D019344
25983002	1692	1697	MMP-9	GENEORGENEPRODUCT	4318
25983002	1730	1734	PLAU	GENEORGENEPRODUCT	5328
25983002	1769	1780	catepsina B	GENEORGENEPRODUCT	1508
25983002	1836	1840	LDHA	GENEORGENEPRODUCT	3939
25983002	1888	1892	FX11	CHEMICALENTITY	C547455
25983002	2080	2084	LDHA	GENEORGENEPRODUCT	3939
25983002	2131	2151	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
25983002	2202	2206	LDHA	GENEORGENEPRODUCT	3939
25986755	74	78	AT2R	GENEORGENEPRODUCT	24182
25986755	157	174	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
25986755	258	266	caffeina	CHEMICALENTITY	D002110
25986755	370	397	l'esposizione alla caffeina	CHEMICALENTITY	D002110
25986755	464	499	ritardo della crescita intrauterina	DISEASEORPHENOTYPICFEATURE	D005317
25986755	545	549	IUGR	DISEASEORPHENOTYPICFEATURE	D005317
25986755	644	648	IUGR	DISEASEORPHENOTYPICFEATURE	D005317
25986755	721	738	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
25986755	817	834	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
25986755	982	999	glomerulosclerosi	DISEASEOR PHENOTYPICFEATURE	D005921
25986755	1119	1122	rat	ORGANISMTAXON	10116
25986755	1169	1173	IUGR	DISEASEORPHENOTYPICFEATURE	D005317
25986755	1413	1430	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
25986755	1484	1505	fibrosi interstiziale	DISEASEORPHENOTYPICFEATURE	D005355
25986755	1581	1591	creatinina	CHEMICALENTITY	D003404
25986755	1671	1708	recettore dell'angiotensina II tipo 2	GENEORGENEPRODUCT	24182
25986755	1742	1746	AT2R	GENEORGENEPRODUCT	24182
25986755	1833	1871	recettore dell'angiotensina II tipo 1a	GENEORGENEPRODUCT	24180
25986755	1912	1917	AT1aR	GENEORGENEPRODUCT	24180
25986755	1951	1955	AT2R	GENEORGENEPRODUCT	24182
25986755	2410	2417	nephrin	GENEORGENEPRODUCT	64563
25986755	2453	2460	podocin	GENEORGENEPRODUCT	170672
25986755	2532	2536	AT2R	GENEORGENEPRODUCT	24182
25986755	2705	2763	fattore neurotrofico derivato dalla linea cellulare gliale	GENEORGENEPRODUCT	 25453
25986755	2797	2801	GDNF	GENEORGENEPRODUCT	25453
25986755	2836	2867	recettore della tirosin-chinasi	GENEORGENEPRODUCT	24716
25986755	2901	2906	c-Ret	GENEORGENEPRODUCT	24716
25986755	3034	3059	displasia dei reni fetali	DISEASEORPHENOTYPICFEATURE	D007674
25986755	3110	3127	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
25986755	3223	3227	AT2R	GENEORGENEPRODUCT	24182
25986755	3325	3342	glomerulosclerosi	DISEASEORPHENOTYPICFEATURE	D005921
26027517	35	44	autotaxin	GENEORGENEPRODUCT	84050
26027517	84	88	LPA2	GENEORGENEPRODUCT	498609,53978
26027517	122	126	GPCR	GENEORGENEPRODUCT	295589
26027517	310	329	danno da radiazioni	DISEASEORPHENOTYPICFEATURE	D011832
26027517	398	409	autotassina	GENEORGENEPRODUCT	84050
26027517	444	447	ATX	GENEORGENEPRODUCT	84050
26027517	482	486	LPA2	GENEORGENEPRODUCT	498609
26027517	520	524	GPCR	GENEORGENEPRODUCT	295589
26027517	735	739	lpa2	GENEORGENEPRODUCT	498609
26027517	852	861	NF-kappaB	GENEORGENEPRODUCT	81736
26027517	911	915	lpa2	GENEORGENEPRODUCT	498609
26027517	978	993	chinasi ATM/ATR	GENEORGENEPRODUCT	300711,685055
26027517	1029	1036	CGK-733	CHEMICALENTITY	C512273
26027517	1086	1090	lpa2	GENEORGENEPRODUCT	498609
26027517	1180	1183	ATM	GENEORGENEPRODUCT	300711
26027517	1225	1234	NF-kappaB	GENEORGENEPRODUCT	81736
26027517	1323	1333	gamma-H2AX	GENEORGENEPRODUCT	500987
26027517	1369	1372	LPA	GENEORGENEPRODUCT	53978
26027517	1556	1560	LPA2	GENEORGENEPRODUCT	498609
26027517	1625	1635	gamma-H2AX	GENEORGENEPRODUCT	500987
26027517	1672	1676	LPA2	GENEORGENEPRODUCT	53978
26027517	1777	1784	LPA1 '3	GENEORGENEPRODUCT	14745,65086
26027517	1830	1840	gamma-H2AX	GENEORGENEPRODUCT	15270
26027517	2007	2014	ERK1 '2	GENEORGENEPRODUCT	26413,26417
26027517	2049	2053	PI3K	GENEORGENEPRODUCT	18708
26027517	2087	2090	AKT	GENEORGENEPRODUCT	11651
26027517	2179	2184	C311A	SEQUENCEVARIANT	P|SUB|C|311|A
26027517	2224	2229	C314A	SEQUENCEVARIANT	P|SUB|C|314|A
26027517	2268	2273	L351A	SEQUENCEVARIANT	P|SUB|L|351|A
26027517	2335	2339	LPA2	GENEORGENEPRODUCT	53978
26027517	2397	2400	LPA	GENEORGENEPRODUCT	53978
26027517	2460	2464	LPA2	GENEORGENEPRODUCT	53978
26027517	2513	2516	Lin	GENEORGENEPRODUCT	83557
26027517	2553	2558	Sca-1	GENEORGENEPRODUCT	110454
26027517	2593	2598	c-Kit	GENEORGENEPRODUCT	16590
26027517	2864	2874	gamma-H2AX	GENEORGENEPRODUCT	15270
26027517	2942	2946	LPA2	GENEORGENEPRODUCT	53978
26027517	2988	2992	topi	ORGANISMTAXON	10090
26027517	3035	3039	topi	ORGANISMTAXON	10090
26027517	3146	3149	ATX	GENEORGENEPRODUCT	84050
26027517	3184	3187	LPA	GENEORGENEPRODUCT	53978
26027517	3314	3322	TNFalpha	GENEORGENEPRODUCT	21926
26027517	3392	3395	ATX	GENEORGENEPRODUCT	18606,84050
26027517	3437	3441	LPA2	GENEORGENEPRODUCT	498609,53978
26102294	59	64	OCT4A	GENEORGENEPRODUCT	5460
26102294	150	170	carcinoma embrionale	DISEASEORPHENOTYPICFEATURE	D018236
26102294	223	232	etoposide	CHEMICALENTITY	D005047
26102294	527	533	tumori	DISEASEORPHENOTYPICFEATURE	D009369
26102294	684	693	etoposide	CHEMICALENTITY	D005047
26102294	726	729	ETO	CHEMICALENTITY	D005047
26102294	775	795	carcinoma embrionale	DISEASEORPHENOTYPICFEATURE	D018236
26102294	884	887	p53	GENEORGENEPRODUCT	7157
26102294	950	955	OCT4A	GENEORGENEPRODUCT	5460
26102294	989	996	p21Cip1	GENEORGENEPRODUCT	1026
26102294	1313	1316	ETO	CHEMICALENTITY	D005047
26102294	1393	1398	OCT4A	GENEORGENEPRODUCT	5460
26102294	1432	1439	p21Cip1	GENEORGENEPRODUCT	1026
26102294	1539	1544	OCT4A	GENEORGENEPRODUCT	5460
26102294	1585	1592	p21Cip1	GENEORGENEPRODUCT	1026
26102294	1722	1729	p21Cip1	GENEORGENEPRODUCT	1026
26102294	1797	1802	OCT4A	GENEORGENEPRODUCT	5460
26102294	1868	1872	SOX2	GENEORGENEPRODUCT	6657
26102294	1907	1912	NANOG	GENEORGENEPRODUCT	79923
26102294	1979	1982	ETO	CHEMICALENTITY	D005047
26102294	2062	2067	OCT4A	GENEORGENEPRODUCT	5460
26102294	2143	2146	ETO	CHEMICALENTITY	D005047
26102294	2189	2194	OCT4A	GENEORGENEPRODUCT	5460
26102294	2265	2269	AMPK	GENEORGENEPRODUCT	5562
26102294	2383	2391	p16ink4a	GENEORGENEPRODUCT	1029
26102294	2524	2527	ETO	CHEMICALENTITY	D005047
26102294	2704	2712	p16ink4a	GENEORGENEPRODUCT	1029
26102294	2844	2849	OCT4A	GENEORGENEPRODUCT	5460
26102294	3065	3072	p21Cip1	GENEORGENEPRODUCT	1026
26102294	3120	3124	AMPK	GENEORGENEPRODUCT	 5562
26115410	114	122	Arsenico	CHEMICALENTITY	D001151
26115410	375	394	arsenico inorganico	CHEMICALENTITY	D001152
26115410	428	431	iAs	CHEMICALENTITY	D001152
26115410	491	503	Inorganic As	CHEMICALENTITY	D001152
26115410	811	814	iAs	CHEMICALENTITY	D001152
26115410	931	937	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26115410	1112	1118	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26115410	1205	1208	iAs	CHEMICALENTITY	D001152
26115410	1388	1394	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26115410	1532	1535	iAs	CHEMICALENTITY	D001152
26115410	1617	1628	cancerogeno	DISEASEORPHENOTYPICFEATURE	D009369
26115410	1734	1737	iAs	CHEMICALENTITY	D001152
26115410	1795	1801	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26115410	1979	1984	umane	ORGANISMTAXON	9606
26270232	75	85	chemochine	GENEORGENEPRODUCT	3576,6347,6348,6351,6352,6374
26270232	118	122	CCL4	GENEORGENEPRODUCT	6351
26270232	156	160	CCL5	GENEORGENEPRODUCT	6352
26270232	207	216	cirrotico	DISEASEORPHENOTYPICFEATURE	D008103
26270232	244	252	pazienti	ORGANISMTAXON	9606
26270232	320	344	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
26270232	422	446	carcinomi epatocellulari	DISEASEORPHENOTYPICFEATURE	D006528
26270232	491	494	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	618	624	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26270232	662	679	alfa-fetoproteina	GENEORGENEPRODUCT	174
26270232	712	715	AFP	GENEORGENEPRODUCT	174
26270232	750	780	des-gamma-carbossi protrombina	GENEORGENEPRODUCT	2147
26270232	814	817	DCP	GENEORGENEPRODUCT	2147
26270232	980	992	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
26270232	1049	1057	cirrosi 	DISEASEORPHENOTYPICFEATURE	D008103
26270232	1085	1093	pazienti	ORGANISMTAXON	9606
26270232	1149	1152	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	1248	1257	cirrotico	DISEASEORPHENOTYPICFEATURE	D008103
26270232	1316	1324	pazienti	ORGANISMTAXON	9606
26270232	1394	1397	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	1501	1504	CRP	GENEORGENEPRODUCT	1401
26270232	1537	1546	neopterin	CHEMICALENTITY	D019798
26270232	1581	1585	IL-6	GENEORGENEPRODUCT	3569
26270232	1644	1657	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
26270232	1691	1705	trombopoietina	GENEORGENEPRODUCT	7066
26270232	1738	1741	TPO	GENEORGENEPRODUCT	7066
26270232	1775	1779	GCSF	GENEORGENEPRODUCT	1440
26270232	1813	1821	FGF base	GENEORGENEPRODUCT	2247
26270232	1855	1859	VEGF	GENEORGENEPRODUCT	7422
26270232	1892	1898	HMGB1 	GENEORGENEPRODUCT	3146
26270232	1931	1936	CK-18	GENEORGENEPRODUCT	3875
26270232	1976	1980	CK18	GENEORGENEPRODUCT	3875
26270232	2070	2097	chemochine proinfiammatorie	GENEORGENEPRODUCT	3576,6347,6348,6351,6352,6374
26270232	2131	2135	CCL2	GENEORGENEPRODUCT	 6347
26270232	2168	2172	CCL3	GENEORGENEPRODUCT	6348
26270232	2205	2209	CCL4	GENEORGENEPRODUCT	6351
26270232	2242	2246	CCL5	GENEORGENEPRODUCT	6352
26270232	2279	2284	CXCL5	GENEORGENEPRODUCT	6374
26270232	2319	2323	IL-8	GENEORG ENEPRODUCT	3576
26270232	2552	2560	Pazienti	ORGANISMTAXON	9606
26270232	2608	2611	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	2673	2676	TPO	GENEORGENEPRODUCT	7066
26270232	2735	2745	chemochine	GENEORGENEPRODUCT	3576,6347,6348,6351,6352,6374
26270232	2793	2796	TPO	GENEORGENEPRODUCT	7066
26270232	2829	2833	CCL4	GENEORGENEPRODUCT	6351
26270232	2866	2870	CCL5	GENEORGENEPRODUCT	6352
26270232	2904	2909	CXCL5	GENEORGENEPRODUCT	6374
26270232	2954	2958	CCL2	GENEORGENEPRODUCT	6347
26270232	3024	3033	cirrotico	DISEASEORPHENOTYPICFEATURE	D008103
26270232	3061	3069	pazienti	ORGANISMTAXON	9606
26270232	3119	3122	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	3274	3278	CCL4	GENEORGENEPRODUCT	6351
26270232	3312	3316	CCL5	GENEORGENEPRODUCT	6352
26270232	3401	3404	HCC	DISEASEORPHENOTYPICFEATURE	D006528
26270232	3456	3459	TPO	GENEORGENEPRODUCT	7066
26270232	3518	3528	chemochine	GENEORGENEPRODUCT	3576,6347,6348,6351,6352,6374
26270232	3635	3644	cirrotico	DISEASEORPHENOTYPICFEATURE	D008103
26270232	3672	3680	pazienti	ORGANISMTAXON	9606
26270232	3785	3797	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
26270232	3854	3864	chemochine	GENEORGENEPRODUCT	3576,6347,6348,6351,6352,6374
26270232	3901	3905	CCL4	GENEORGENEPRODUCT	6351
26270232	3939	3943	CCL5	GENEORGENEPRODUCT	6352
26270232	4000	4010	cirrotiche	DISEASEORPHENOTYPICFEATURE	D008103
26270232	4038	4046	pazienti	ORGANISMTAXON	9606
26270232	4115	4117	CC	DISEASEORPHENOTYPICFEATURE	D006528
26411452	52	72	Cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
26411452	124	143	Androgeno Recettore	GENEORGENEPRODUCT	367
26411452	195	207	Melanophilin	GENEORGENEPRODUCT	79083
26411452	295	321	 Recettore degli androgeni	GENEORGENEPRODUCT	367
26411452	515	535	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
26411452	581	584	PCa	DISEASEORPHENOTYPICFEATURE	D011471
26411452	842	849	TMPRSS2	GENEORGENEPRODUCT	7113
26411452	881	884	ERG	GENEORGENEPRODUCT	2078
26411452	1043	1046	PCa	DISEASEORPHENOTYPICFEATURE	D011471
26411452	1181	1206	recettore degli androgeni	GENEORGENEPRODUCT	367
26411452	1238	1240	AR	GENEORGENEPRODUCT	367
26411452	1364	1366	AR	GENEORGENEPRODUCT	367
26411452	1416	1426	rs11891426	SEQUENCEVARIANT	RS11891426
26411452	1462	1465	T>G	SEQUENCEVARIANT	RS11891426
26411452	1517	1537	il gene melanofilina	GENEORGENEPRODUCT	79083
26411452	1571	1575	MLPH	GENEORGENEPRODUCT	79083
26411452	1656	1658	AR	GENEORGENEPRODUCT	367
26411452	1766	1775	androgeno	CHEMICALENTITY	D000728
26411452	1821	1824	T>G	SEQUENCEVARIANT	RS11891426
26411452	1909	1911	AR	GENEORGENEPRODUCT	367
26411452	1950	1952	AR	GENEORGENEPRODUCT	367
26411452	2026	2030	MLPH	GENEORGENEPRODUCT	79083
26411452	2078	2095	tumori prostatici	DISEASEORPHENOTYPICFEATURE	D011471
26411452	2253	2255	AR	GENEORGENEPRODUCT	367
26411452	2300	2312	melanofilina	GENEORGENEPRODUCT	79083
26411452	2366	2374	pazienti	ORGANISMTAXON	9606
26411452	2519	2525	tumore	DISEASEORPHENOTYPICFEATURE	D009369
26411452	2625	2627	AR	GENEORGENEPRODUCT	367
26411452	2704	2707	PCa	DISEASEORPHENOTYPICFEATURE	D011471
26411452	2781	2790	androgeno	CHEMICALENTITY	D000728
26411452	2855	2859	MLPH	GENEORGENEPRODUCT	79083
26516699	100	119	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
26516699	212	216	Kras	GENEORGENEPRODUCT	3845
26516699	253	257	G12D	SEQUENCEVARIANT	P|SUB|G|12|D
26516699	290	294	Pdx1	GENEORGENEPRODUCT	18609
26516699	327	332	mouse	ORGANISMTAXON	10090
26516699	458	464	cancro	DISEASEORPHENOTYPICFEATURE	D009369
26516699	517	536	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
26516699	581	583	PC	DISEASEORPHENOTYPICFEATURE	D010190
26516699	698	700	PC	DISEASEORPHENOTYPICFEATURE	D010190
26516699	794	797	 PC	DISEASEORPHENOTYPICFEATURE	D010190
26516699	1041	1043	PC	DISEASEORPHENOTYPICFEATURE	D010190
26516699	1090	1094	Kras	GENEORGENEPRODUCT	3845
26516699	1131	1135	G12D	SEQUENCEVARIANT	P|SUB|G|12|D
26516699	1168	1172	Pdx1	GENEORGENEPRODUCT	18609
26516699	1210	1215	mouse	ORGANISMTAXON	10090
26516699	1353	1360	miR-150	GENEORGENEPRODUCT	387168
26516699	1395	1402	miR-494	GENEORGENEPRODUCT	723878
26516699	1444	1451	miR-138	GENEORGENEPRODUCT	387156,723956
26516699	1486	1494	miR-148a	GENEORGENEPRODUCT	387166
26516699	1529	1537	miR-216a	GENEORGENEPRODUCT	387212
26516699	1573	1580	miR-217	GENEORGENEPRODUCT	387213
26516699	1637	1645	miR-146b	GENEORGENEPRODUCT	751550
26516699	1680	1687	miR-205	GENEORGENEPRODUCT	387201
26516699	1723	1729	miR-31	GENEORGENEPRODUCT	723895
26516699	1764	1771	miR-192	GENEORGENEPRODUCT	387187
26516699	1807	1814	miR- 21	GENEORGENEPRODUCT	387140
26516699	1849	1853	topi	ORGANISMTAXON	10090
26516699	1975	1980	Dicer	GENEORGENEPRODUCT	192119
26516699	2014	2024	Exportin-5	GENEORGENEPRODUCT	72322
26516699	2058	2063	TRKRA	GENEORGENEPRODUCT	18211
26516699	2098	2104	TARBP2	GENEORGENEPRODUCT	21357
26516699	2171	2176	DGCR8	GENEORGENEPRODUCT	94223
26516699	2212	2216	Ago2	GENEORGENEPRODUCT	239528
26516699	2276	2280	topi	ORGANISMTAXON	10090
26516699	2412	2416	topi	ORGANISMTAXON	10090
26516699	2485	2492	miR-216	GENEORGENEPRODUCT	 387212
26516699	2527	2534	miR-217	GENEORGENEPRODUCT	387213
26516699	2569	2576	miR-100	GENEORGENEPRODUCT	723892
26516699	2611	2618	miR-345	GENEORGENEPRODUCT	723946
26516699	2653	2660	miR-141	GENEORGENEPRODUCT	387159
26516699	2695	2705	miR-483-3p	GENEORGENEPRODUCT	723874
26516699	2740	2747	miR-26b	GENEORGENEPRODUCT	387219
26516699	2783	2790	miR-150	GENEORGENEPRODUCT	387168
26516699	2825	2832	miR-195	GENEORGENEPRODUCT	387190
26516699	2868	2874	Let-7b	GENEORGENEPRODUCT	 387245
26516699	2967	2974	miR -21	GENEORGENEPRODUCT	387140
26516699	3009	3016	miR-205	GENEORGENEPRODUCT	387201
26516699	3051	3059	miR-146b	GENEORGENEPRODUCT	751550
26516699	3094	3101	miR-34c	GENEORGENEPRODUCT	723932
26516699	3139	3147	miR-1273	GENEORGENEPRODUCT	100422821
26516699	3184	3191	miR-223	GENEORGENEP RODUCT	723814
26516699	3227	3234	miR-195	GENEORGENEPRODUCT	387190
26516699	3285	3290	 topi	ORGANISMTAXON	10090
26516699	3386	3390	topi	ORGANISMTAXON	10090
26516699	3464	3469	umano	ORGANISMTAXON	9606
26516699	3513	3515	PC	DISEASEORPHENOTYPICFEATURE	D010190
26516699	3612	3618	Let-7b	GENEORGENEPRODUCT	406884
26516699	3773	3777	KRAS	GENEORGENEPRODUCT	3845
26516699	3982	3984	PC	DISEASEORPHENOTYPICFEATURE	D010190
26731607	66	73	GADD45A	GENEORGENEPRODUCT	13197
26731607	449	506	Arresto della crescita e danno al DNA inducibile 45 alpha	GENEORGENEPRODUCT	13197
26731607	540	547	GADD45A	GENEORGENEPRODUCT	13197
26731607	624	631	GADD45A	GENEORGENEPRODUCT	13197
26731607	815	822	GADD45A	GENEORGENEPRODUCT	13197
26731607	1045	1052	GADD45A	GENEORGENEPRODUCT	13197
26731607	1152	1158	murine	ORGANISMTAXON	10090
26731607	1249	1256	GADD45A	GENEORGENEPRODUCT	13197
26731607	1375	1382	GADD45A	GENEORGENEPRODUCT	13197
26731607	1563	1570	GADD45A	GENEORGENEPRODUCT	13197
26731607	1825	1832	GADD45A	GENEORGENEPRODUCT	13197
26731607	1951	1958	GADD45A	GENEORGENEPRODUCT	13197
26731607	2225	2232	GADD45A	GENEORGENEPRODUCT	13197
26731607	2310	2317	GADD45A	GENEORGENEPRODUCT	13197
26731607	2378	2418	p38 protein chinasi attivata da mitogeni	GENEORGENEPRODUCT	26416
26731607	2452	2456	MAPK	GENEORGENEPRODUCT	26416
26731607	2618	2625	GADD45A	GENEORGENEPRODUCT	13197
27014915	31	36	NF-kB	GENEORGENEPRODUCT	4790
27014915	126	132	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	222	228	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	307	313	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	409	415	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	504	510	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	575	581	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	666	672	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	761	767	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	856	862	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	990	993	p65	GENEORGENEPRODUCT	5970
27014915	1025	1028	p50	GENEORGENEPRODUCT	4790
27014915	1062	1065	p50	GENEORGENEPRODUCT	4790
27014915	1097	1100	p50	GENEORGENEPRODUCT	4790
27014915	1132	1138	NF -kB	GENEORGENEPRODUCT	4790
27014915	1179	1184	umano	ORGANISMTAXON	9606
27014915	1228	1253	sarcoma dei tessuti molli	DISEASEORPHENOTYPICFEATURE	D012509
27014915	1298	1301	STS	DISEASEORPHENOTYPICFEATURE	D012509
27014915	1369	1372	p65	GENEORGENEPRODUCT	5970
27014915	1404	1407	p50	GENEORGENEPRODUCT	4790
27014915	1442	1445	p50	GENEORGENEPRODUCT	4790
27014915	1477	1480	p50	GENEORGENEPRODUCT	4790
27014915	1524	1528	TNFa	GENEORGENEPRODUCT	7124
27014915	1626	1629	STS	DISEASEORPHENOTYPICFEATURE	D012509
27014915	1662	1666	TNFa	GENEORGENEPRODUCT	7124
27014915	1739	1745	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	1838	1842	Smac	GENEORGENEPRODUCT	56616
27014915	1883	1886	BV6	CHEMICALENTITY	C582180
27014915	1925	1930	cIAP1	GENEORGENEPRODUCT	329
27014915	1963	1968	cIAP2	GENEORGENEPRODUCT	330
27014915	2039	2045	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	2221	2224	STS	DISEASEORPHENOTYPICFEATURE	D012509
27014915	2295	2302	caspasi	GENEORGENEPRODUCT	836
27014915	2335	2339	RIP1	GENEORGENEPRODUCT	8737
27014915	2375	2379	RIP3	GENEORGENEPRODUCT	11035
27014915	2432	2436	TNFa	GENEORGENEPRODUCT	7124
27014915	2517	2521	RIP1	GENEORGENEPRODUCT	 8737
27014915	2560	2564	TNFa	GENEORGENEPRODUCT	7124
27014915	2603	2610	caspase	GENEORGENEPRODUCT	836
27014915	2669	2677	caspases	GENEORGENEPRODUCT	836
27014915	2711	2715	RIP1	GENEORGENEPRODUCT	8737
27014915	2894	2901	sarcoma	DISEASEORPHENOTYPICFEATURE	D012509
27014915	2930	2935	mouse	ORGANISMTAXON	10090
27014915	3002	3006	IRF3	GENEORGENEPRODUCT	54131
27014915	3040	3044	IFNb	GENEORGENEPRODUCT	15977
27014915	3099	3109	chemochine	GENEORGENEPRODUCT	20296,20304
27014915	3142	3146	CCL2	GENEORGENEPRODUCT	20296
27014915	3181	3185	CCL5	GENEORGENEPRODUCT	20304
27014915	3247	3253	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	3389	3395	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	3489	3495	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	3575	3583	perforin	GENEORGENEPRODUCT	18646
27014915	3618	3622	FasL	GENEORGENEPRODUCT	14103
27014915	3702	3708	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	3776	3779	BV6	CHEMICALENTITY	C582180
27014915	3863	3869	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	3929	3934	NF-kB	GENEORGENEPRODUCT	4790
27014915	4042	4048	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	4140	4146	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27014915	4198	4204	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27084744	31	37	NOTCH1	GENEORGENEPRODUCT	4851
27084744	71	76	SOX10	GENEORGENEPRODUCT	6663
27084744	193	199	Cancro	DISEASEORPHENOTYPICFEATURE	D009369
27084744	273	299	Carcinoma adenoide cistico	DISEASEORPHENOTYPICFEATURE	D003528
27084744	374	380	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27084744	451	477	carcinoma adenoide cistico	DISEASEORPHENOTYPICFEATURE	D003528
27084744	522	525	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	753	756	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	927	930	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	1000	1004	ROCK	GENEORGENEPRODUCT	6093
27084744	1237	1240	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	1272	1277	CD133	GENEORGENEPRODUCT	8842
27084744	1337	1343	NOTCH1	GENEORGENEPRODUCT	4851
27084744	1377	1382	SOX10	GENEORGENEPRODUCT	6663
27084744	1460	1466	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27084744	1500	1504	topi	ORGANISMTAXON	10090
27084744	1537	1542	CD133	GENEORGENEPRODUCT	8842
27084744	1588	1591	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	1650	1656	NOTCH1	GENEORGENEPRODUCT	4851
27084744	1689	1694	N1ICD	GENEORGENEPRODUCT	4851
27084744	1738	1743	CD133	GENEORGENEPRODUCT	8842
27084744	1800	1804	JAG1	GENEORGENEPRODUCT	182
27084744	1879	1884	NR2F1	GENEORGENEPRODUCT	7025
27084744	1917	1922	NR2F2	GENEORGENEPRODUCT	7026
27084744	1956	1963	p27Kip1	GENEORGENEPRODUCT	1027
27084744	2012	2018	NOTCH1	GENEORGENEPRODUCT	4851
27084744	2051	2056	SOX10	GENEORGENEPRODUCT	6663
27084744	2116	2121	FABP7	GENEORGENEPRODUCT	2173
27084744	2355	2360	FABP7	GENEORGENEPRODUCT	2173
27084744	2541	2547	NOTCH1	GENEORGENEPRODUCT	4851
27084744	2579	2584	FABP7	GENEORGENEPRODUCT	2173
27084744	2666	2670	SKP2	GENEORGENEPRODUCT	6502
27084744	2721	2728	p27Kip1	GENEORGENEPRODUCT	1027
27084744	2764	2775	g-secretasi	GENEORGENEPRODUCT	55851
27084744	2818	2822	DAPT	CHEMICALENTITY	C419410
27084744	2882	2887	CD133	GENEORGENEPRODUCT	8842
27084744	2938	2943	N1ICD	GENEORGENEPRODUCT	4851
27084744	2978	2982	SKP2	GENEORGENEPRODUCT	6502
27084744	3023	3030	p27Kip1	GENEORGENEPRODUCT	1027
27084744	3083	3086	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	3137	3142	CD133	GENEORGENEPRODUCT	8842
27084744	3279	3282	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27084744	3383	3388	CD133	GENEORGENEPRODUCT	8842
27084744	3483	3488	SOX10	GENEORGENEPRODUCT	6663
27084744	3521	3527	NOTCH1	GENEORGENEPRODUCT	4851
27084744	3561	3566	FABP7	GENEORGENEPRODUCT	2173
27084744	3650	3655	Notch	GENEORGENEPRODUCT	4851
27084744	3711	3715	SKP2	GENEORGENEPRODUCT	6502
27084744	3789	3792	ACC	DISEASEORPHENOTYPICFEATURE	D003528
27134166	148	152	mTOR	GENEORGENEPRODUCT	56717
27134166	225	231	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27134166	285	289	VEGF	GENEORGENEPRODUCT	22339,7422
27134166	376	381	umani	ORGANISMTAXON	9606
27134166	425	431	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27134166	463	467	topo	ORGANISMTAXON	10090
27134166	522	528	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27134166	653	658	mouse	ORGANISMTAXON	10090
27134166	787	793	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27134166	914	919	GLUT1	GENEORGENEPRODUCT	20525
27134166	954	958	MCT4	GENEORGENEPRODUCT	80879
27134166	1027	1044	cellule ipossiche	DISEASEORPHENOTYPICFEATURE	D000860
27134166	1083	1088	HIF1a	GENEORGENEPRODUCT	15251
27134166	1174	1193	Le cellule tumorali	DISEASEORPHENOTYPICFEATURE	D009369
27134166	1301	1305	MCT1	GENEORGENEPRODUCT	20501
27134166	1341	1345	p-S6	GENEORGENEPRODUCT	72508
27134166	1404	1408	mTOR	GENEORGENEPRODUCT	56717
27134166	1466	1483	Cancro normossico	DISEASEORPHENOTYPICFEATURE	D009369
27134166	1552	1559	lattato	CHEMICALENTITY	D019344
27134166	1630	1634	mTOR	GENEORGENEPRODUCT	56717
27134166	1687	1697	glutammina	CHEMICALENTITY	D005973
27134166	1756	1763	lattato	CHEMICALENTITY	D019344
27134166	1937	1943	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27134166	1985	1993	glucosio	CHEMICALENTITY	D005947
27134166	2038	2045	lattato	CHEMICALENTITY	D019344
27134166	2134	2141	lattato	CHEMICALENTITY	D019344
27134166	2175	2179	mTOR	GENEORGENEPRODUCT	56717
27134166	2346	2351	GLUT2	GENEORGENEPRODUCT	20526
27172902	31	41	Cisplatino	CHEMICALENTITY	D002945
27172902	129	133	 TLR	GENEORGENEPRODUCT	13982
27172902	213	218	IL-10	GENEORGENEPRODUCT	16153
27172902	349	359	cisplatino	CHEMICALENTITY	D002945
27172902	392	418	cis-diamminedicloroplatino	CHEMICALENTITY	D002945
27172902	456	460	CDDP	CHEMICALENTITY	D002945
27172902	529	535	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27172902	610	620	cisplatino	CHEMICALENTITY	D002945
27172902	783	793	cisplatino	CHEMICALENTITY	D002945
27172902	907	947	toll - stimolazione del recettore simile	GENEORGENEPRODUCT	13982
27172902	981	984	TLR	GENEORGENEPRODUCT	13982
27172902	1018	1047	Le DC trattate con cisplatino	CHEMICALENTITY	D002945
27172902	1157	1161	CD80	GENEORGENEPRODUCT	12519
27172902	1195	1199	CD86	GENEORGENEPRODUCT	12524
27172902	1239	1256	MHC classe I e II	GENEORGENEPRODUCT	14961,14972
27172902	1396	1399	TLR	GENEORGENEPRODUCT	13982
27172902	1461	1471	cisplatino	CHEMICALENTITY	D002945
27172902	1538	1543	IL-10	GENEORGENEPRODUCT	16153
27172902	1611	1619	p38 MAPK	GENEORGENEPRODUCT	26416
27172902	1655	1664	NF-kappaB	GENEORGENEPRODUCT	18033
27172902	1745	1754	TNF-alpha	GENEORGENEPRODUCT	21926
27172902	1790	1798	IL-12p70	GENEORGENEPRODUCT	16185
27172902	1865	1875	cisplatino	CHEMICALENTITY	D002945
27172902	1974	1979	IL-10	GENEORGENEPRODUCT	16153
27172902	2061	2067	IL-10 	GENEORGENEPRODUCT	16153
27172902	2099	2103	topi	ORGANISMTAXON	10090
27172902	2139	2144	IL-10	GENEORGENEPRODUCT	16153
27172902	2303	2313	cisplatino	CHEMICALENTITY	D002945
27172902	2347	2364	lipopolisaccaride	CHEMICALENTITY	D008070
27172902	2398	2401	LPS	CHEMICALENTITY	D008070
27172902	2733	2738	IL-10	GENEORGENEPRODUCT	16153
27172902	2771	2774	CD3	GENEORGENEPRODUCT	12501
27172902	2807	2810	CD4	GENEORGENEPRODUCT	12504
27172902	2843	2848	LAG-3	GENEORGENEPRODUCT	16768
27172902	2882	2887	CD49b	GENEORGENEPRODUCT	16398
27172902	2920	2924	CD25	GENEORGENEPRODUCT	16184
27172902	2957	2963	 Foxp3	GENEORGENEPRODUCT	20371
27172902	3107	3112	Foxp3	GENEORGENEPRODUCT	20371
27172902	3197	3207	cisplatino	CHEMICALENTITY	D002945
27172902	3346	3358	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
27172902	3424	3429	IL-10	GENEORGENEPRODUCT	16153
27172902	3591	3608	cellule cancerose	DISEASEORPHENOTYPICFEATURE	D009369
27184800	31	48	Metallotioneina-1	GENEORGENEPRODUCT	4495
27184800	145	169	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
27184800	222	231	sorafenib	CHEMICALENTITY	D000077157
27184800	279	288	Sorafenib	CHEMICALENTITY	D000077157
27184800	379	385	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27184800	488	495	necrosi	DISEASEORPHENOTYPICFEATURE	D009336
27184800	550	556	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27184800	666	675	sorafenib	CHEMICALENTITY	D000077157
27184800	744	750	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27184800	1043	1049	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27184800	1093	1102	sorafenib	CHEMICALENTITY	D000077157
27184800	1147	1153	Tumore	DISEASEORPHENOTYPICFEATURE	D009369
27184800	1219	1243	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
27184800	1290	1293	HCC	DISEASEORPHENOTYPICFEATURE	D006528
27184800	1379	1382	HCC	DISEASEORPHENOTYPICFEATURE	D006528
27184800	1410	1447	pazienti Sono stati utilizzati anche 	ORGANISMTAXON	9606
27184800	1495	1504	sorafenib	CHEMICALENTITY	D000077157
27184800	1581	1598	metallothionein-1	GENEORGENEPRODUCT	4495
27184800	1631	1634	MT1	GENEORGENEPRODUCT	4495
27184800	1723	1726	HCC	DISEASEORPHENOTYPICFEATURE	D006528
27184800	1804	1813	sorafenib	CHEMICALENTITY	D000077157
27184800	1849	1858	Sorafenib	CHEMICALENTITY	D000077157
27184800	1920	1924	MT1G	GENEORGENEPRODUCT	4495
27184800	1976	1981	umano	ORGANISMTAXON	9606
27184800	2025	2042	cellule cancerose	DISEASEORPHENOTYPICFEATURE	D009369
27184800	2222	2226	MT1G	GENEORGENEPRODUCT	4495
27184800	2292	2301	sorafenib	CHEMICALENTITY	D000077157
27184800	2484	2488	NRF2	GENEORGENEPRODUCT	4780
27184800	2522	2570	Fattore nucleare eritroide 2-fattore correlato 2	GENEORGENEPRODUCT	4780
27184800	2694	2698	MT1G	GENEORGENEPRODUCT	4495
27184800	2752	2758	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27184800	2844	2847	HCC	DISEASEORPHENOTYPICFEATURE	D006528
27184800	2933	2936	MT1	GENEORGENEPRODUCT	4495
27184800	3010	3013	HCC	DISEASEORPHENOTYPICFEATURE	D006528
27184800	3041	3049	pazienti	ORGANISMTAXON	9606
27184800	3103	3112	sorafenib	CHEMICALENTITY	D000077157
27184800	3262	3265	MT1	GENEORGENEPRODUCT	4495
27184800	3364	3373	sorafenib	CHEMICALENTITY	D000077157
27184800	3453	3459	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27248656	33	42	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	105	110	 sale	CHEMICALENTITY	D012492
27248656	174	184	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
27248656	296	300	sale	CHEMICALENTITY	D012492
27248656	392	406	ipossia renale	DISEASEORPHENOTYPICFEATURE	D007674
27248656	564	575	ipertensivo	DISEASEORPHENOTYPICFEATURE	D006973
27248656	614	619	ratti	ORGANISMTAXON	10116
27248656	678	682	sale	CHEMICALENTITY	D012492
27248656	750	761	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
27248656	836	856	infiammazione renale	DISEASEORPHENOTYPICFEATURE	D007674
27248656	901	908	fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
27248656	1057	1066	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	1100	1109	TGF-beta,	GENEORGENEPRODUCT	59086
27248656	1143	1152	HIF-1alfa	GENEORGENEPRODUCT	 29560
27248656	1186	1195	TNF-alpha	GENEORGENEPRODUCT	24835
27248656	1229	1233	IL-6	GENEORGENEPRODUCT	24498
27248656	1268	1273	MCP-1	GENEORGENEPRODUCT	24770
27248656	1365	1369	sale	CHEMICALENTITY	D012492
27248656	1454	1463	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	1575	1579	sale	CHEMICALENTITY	D012492
27248656	1690	1699	NF-kappaB	GENEORGENEPRODUCT	81736
27248656	1733	1737	p38 	GENEORGENEPRODUCT	81649
27248656	1784	1789	Bcl-2	GENEORGENEPRODUCT	24224
27248656	1877	1886	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	2052	2104	17-dimetilamminoetilammino-17-demetossigeldanamicina	CHEMICALENTITY	C448659
27248656	2137	2144	17-DMAG	CHEMICALENTITY	C448659
27248656	2181	2190	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	2271	2275	sale	CHEMICALENTITY	D012492
27248656	2326	2337	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
27248656	2383	2395	danno renale	DISEASEORPHENOTYPICFEATURE	D007674
27248656	2523	2532	NF-kappaB	GENEORGENEPRODUCT	81736
27248656	2566	2570	mTOR	GENEORGENEPRODUCT	56718
27248656	2606	2609	p38	GENEORGENEPRODUCT	81649
27248656	2725	2734	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	2803	2807	TAK1	GENEORGENEPRODUCT	313121
27248656	2841	2850	AMPKalpha	GENEORGENEPRODUCT	65248
27248656	2891	2904	IKKalpha/beta	GENEORGENEPRODUCT	309361,84351
27248656	2939	2949	HIF-1alpha	GENEORGENEPRODUCT	29560
27248656	2985	2991	Raptor	GENEORGENEPRODUCT	287871
27248656	3033	3043	Hsp90beta 	GENEORGENEPRODUCT	301252
27248656	3180	3189	Hsp90beta	GENEORGENEPRODUCT	301252
27248656	3320	3324	sale	CHEMICALENTITY	D012492
27248656	3428	3439	proteinuria	DISEASEORPHENOTYPICFEATURE	D011507
27248656	3485	3503	disfunzione renale	DISEASEORPHENOTYPICFEATURE	D051437
27248656	3543	3548	ratti	ORGANISMTAXON	10116
27248656	3583	3608	L'inibizione di Hsp90beta	GENEORGENEPRODUCT	301252
27248656	3785	3795	nefropatia	DISEASEORPHENOTYPICFEATURE	D007674
27248656	3850	3864	ipossia renale	DISEASEORPHENOTYPICFEATURE	D007674
27292643	64	87	Instabilità cromosomica	DISEASEORPHENOTYPICFEATURE	D043171
27292643	131	136	Mad2 	GENEORGENEPRODUCT	56150
27292643	208	222	Tumore al seno	DISEASEORPHENOTYPICFEATURE	D001943
27292643	313	338	L'instabilità cromosomica	DISEASEORPHENOTYPICFEATURE	D043171
27292643	383	386	CIN	DISEASEORPHENOTYPICFEATURE	D043171
27292643	502	509	maligne	DISEASEORPHENOTYPICFEATURE	D009369
27292643	586	589	CIN	DISEASEORPHENOTYPICFEATURE	D043171
27292643	754	758	Mad2	GENEORGENEPRODUCT	56150
27292643	795	799	Kras	GENEORGENEPRODUCT	16653
27292643	832	836	G12D	GENEORGENEPRODUCT	16653
27292643	872	876	Lei2	GENEORGENEPRODUCT	13866
27292643	943	947	topi	ORGANISMTAXON	10090
27292643	1074	1080	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27292643	1221	1227	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27292643	1353	1357	Mad2	GENEORGENEPRODUCT	56150
27292643	1441	1445	Kras	GENEORGENEPRODUCT	16653
27292643	1489	1495	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27292643	1592	1596	Mad2	GENEORGENEPRODUCT	56150
27292643	1649	1655	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27630165	43	46	CD4	GENEORGENEPRODUCT	12504
27630165	79	85	IFN-g 	GENEORGENEPRODUCT	15978
27630165	153	156	CD4	GENEORGENEPRODUCT	12504
27630165	189	194	IFN-g	GENEORGENEPRODUCT	15978
27630165	227	232	IL-10	GENEORGENEPRODUCT	16153
27630165	297	302	IL-10	GENEORGENEPRODUCT	16153
27630165	421	441	Infezione da malaria	DISEASEORPHENOTYPICFEATURE	D008288
27630165	475	478	CD4	GENEORGENEPRODUCT	12504
27630165	538	543	IFN-g	GENEORGENEPRODUCT	15978
27630165	616	621	IL-10	GENEORGENEPRODUCT	16153
27630165	673	682	infezione	DISEASEORPHENOTYPICFEATURE	D007239
27630165	804	807	CD4	GENEORGENEPRODUCT	12504
27630165	842	847	IFN-g	GENEORGENEPRODUCT	15978
27630165	883	888	IL-10	GENEORGENEPRODUCT	16153
27630165	933	942	infezione	DISEASEORPHENOTYPICFEATURE	D007239
27630165	1170	1175	IFN-g	GENEORGENEPRODUCT	15978
27630165	1245	1250	IL-10	GENEORGENEPRODUCT	16153
27630165	1297	1301	topi	ORGANISMTAXON	10090
27630165	1369	1389	infezione da malaria	DISEASEORPHENOTYPICFEATURE	D008288
27630165	1430	1433	CD4	GENEORGENEPRODUCT	12504
27630165	1563	1568	IL-10	GENEORGENEPRODUCT	16153
27630165	1639	1642	CD4	GENEORGENEPRODUCT	12504
27630165	1761	1764	CD4	GENEORGENEPRODUCT	12504
27630165	1996	2000	PD-1	GENEORGENEPRODUCT	18566
27630165	2034	2039	Lag-3	GENEORGENEPRODUCT	16768
27630165	2079	2084	TIGIT	GENEORGENEPRODUCT	100043314
27630165	2204	2207	CD4	GENEORGENEPRODUCT	12504
27630165	2342	2351	infezione	DISEASEORPHENOTYPICFEATURE	D007239
27630165	2399	2402	CD4	GENEORGENEPRODUCT	12504
27630165	2525	2530	IL-10	GENEORGENEPRODUCT	 16153
27630165	2594	2603	infezione	DISEASEORPHENOTYPICFEATURE	D007239
27630165	2653	2656	CD4	GENEORGENEPRODUCT	12504
27630165	2760	2765	IL-10	GENEORGENEPRODUCT	16153
27630165	2871	2891	infezione da malaria	DISEASEORPHENOTYPICFEATURE	D008288
27630165	2941	2946	IL-10	GENEORGENEPRODUCT	16153
27630165	3044	3047	CD4	GENEORGENEPRODUCT	12504
27630165	3272	3277	IL-10	GENEORGENEPRODUCT	16153
27630165	3321	3324	CD4	GENEORGENEPRODUCT	12504
27630165	3424	3429	IL-10	GENEORGENEPRODUCT	16153
27630165	3595	3614	infezioni malariche	DISEASEORPHENOTYPICFEATURE	D008288
27640183	31	45	Eritropoietina	GENEORGENEPRODUCT	2056
27640183	88	117	recettore dell'eritropoietina	GENEORGENEPRODUCT	2057
27640183	219	224	umano	ORGANISMTAXON	9606
27640183	278	292	Eritropoietina	GENEORGENEPRODUCT	13856
27640183	326	329	Epo	GENEORGENEPRODUCT	13856
27640183	421	425	topi	ORGANISMTAXON	10090
27640183	496	501	umani	ORGANISMTAXON	9606
27640183	533	536	Epo	GENEORGENEPRODUCT	2056
27640183	642	648	lipidi	CHEMICALENTITY	D008055
27640183	703	706	Epo	GENEORGENEPRODUCT	2056
27640183	737	742	umano	ORGANISMTAXON	9606
27640183	880	883	Epo	GENEORGENEPRODUCT	2056
27640183	914	919	umano	ORGANISMTAXON	9606
27640183	1042	1045	Epo	GENEORGENEPRODUCT	2056
27640183	1169	1201	agente stimolante l'eritropoiesi	CHEMICALENTITY	D006397
27640183	1234	1237	ESA	CHEMICALENTITY	D006397
27640183	1366	1379	Epo recettore	GENEORGENEPRODUCT	2057
27640183	1412	1417	Epo-R	GENEORGENEPRODUCT	2057
27640183	1556	1561	Epo-R	GENEORGENEPRODUCT	2057
27640183	1632	1637	Epo-R	GENEORGENEPRODUCT	2057
27640183	1694	1697	Akt	GENEORGENEPRODUCT	207
27640183	1730	1736	 STAT5	GENEORGENEPRODUCT	6776
27640183	1769	1775	p70s6k	GENEORGENEPRODUCT	6198
27640183	1808	1811	LYN	GENEORGENEPRODUCT	4067
27640183	1846	1853	p38MAPK	GENEORGENEPRODUCT	1432
27640183	1920	1924	ATGL	GENEORGENEPRODUCT	57104
27640183	1958	1961	HSL	GENEORGENEPRODUCT	3991
27640183	1995	2001	CGI-58	GENEORGENEPRODUCT	51099
27640183	2035	2040	G0S2 	GENEORGENEPRODUCT	50486
27640183	2073	2082	Perilipin	GENEORGENEPRODUCT	5346
27640183	2115	2120	Cidea	GENEORGENEPRODUCT	1149
27640183	2155	2160	Cidec	GENEORGENEPRODUCT	63924
27640183	2193	2197	AMPK	GENEORGENEPRODUCT	5562
27640183	2229	2233	 ACC	GENEORGENEPRODUCT	31
27640183	2293	2297	VDAC	GENEORGENEPRODUCT	7416
27640183	2331	2336	HSP90	GENEORGENEPRODUCT	3320
27640183	2370	2373	PDH	GENEORGENEPRODUCT	54704
27640183	2407	2411	SDHA	GENEORGENEPRODUCT	6389
27640183	2532	2537	Epo-R	GENEORGENEPRODUCT	2057
27640183	2611	2617	 Epo-R	GENEORGENEPRODUCT	2057
27640183	2725	2728	Epo	GENEORGENEPRODUCT	2056
27640183	2813	2818	umani	ORGANISMTAXON	9606
27643404	31	47	Consumo di alcol	CHEMICALENTITY	D000438
27643404	93	113	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	225	248	Il cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	308	314	cancro	DISEASEORPHENOTYPICFEATURE	D009369
27643404	346	352	uomini	ORGANISMTAXON	9606
27643404	490	495	alcol	CHEMICALENTITY	D000438
27643404	579	599	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	805	811	alcool	CHEMICALENTITY	D000438
27643404	879	899	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	990	996	uomini	ORGANISMTAXON	9606
27643404	1044	1064	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	1268	1274	alcool	CHEMICALENTITY	D000438
27643404	1329	1350	Alcohol deidrogenases	GENEORGENEPRODUCT	125
27643404	1382	1386	ADHs	GENEORGENEPRODUCT	125
27643404	1421	1441	Aldeide deidrogenasi	GENEORGENEPRODUCT	8854
27643404	1475	1480	ALDHs	GENEORGENEPRODUCT	8854
27643404	1530	1550	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	1606	1626	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	1926	1932	alcool	CHEMICALENTITY	D000438
27643404	2016	2036	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	2185	2205	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	2306	2313	ALDH1A2	GENEORGENEPRODUCT	8854
27643404	2369	2389	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	2444	2453	rs1441817	SEQUENCEVARIANT	RS1441817
27643404	2614	2624	rs12910509	SEQUENCEVARIANT	RS12910509
27643404	2716	2725	rs8041922	SEQUENCEVARIANT	RS8041922
27643404	2873	2880	ALDH1B1	GENEORGENEPRODUCT	219
27643404	2917	2927	rs10973794	SEQUENCEVARIANT	RS10973794
27643404	3045	3065	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	3106	3112	uomini	ORGANISMTAXON	9606
27643404	3160	3180	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27643404	3294	3300	alcool	CHEMICALENTITY	D000438
27643404	3372	3392	cancro alla prostata	DISEASEORPHENOTYPICFEATURE	D011471
27779699	60	69	filamin B	GENEORGENEPRODUCT	2317
27779699	138	163	 tumore a cellule giganti	DISEASEORPHENOTYPICFEATURE	D005870
27779699	216	250	Tumore a cellule giganti dell'osso	DISEASEORPHENOTYPICFEATURE	D018212
27779699	295	298	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	368	380	tumore osseo	DISEASEORPHENOTYPICFEATURE	D001859
27779699	452	458	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27779699	642	648	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27779699	728	735	Filamin	GENEORGENEPRODUCT	2316,2317,2318
27779699	782	810	proteine che legano l'actina	GENEORGENEPRODUCT	2316,2317,2318
27779699	894	910	filamin A, B e C	GENEORGENEPRODUCT	2316,2317,2318
27779699	980	984	FLNA	GENEORGENEPRODUCT	2316
27779699	1017	1021	FLNB	GENEORGENEPRODUCT	2317
27779699	1056	1060	FLNC	GENEORGENEPRODUCT	2318
27779699	1225	1231	FLNBv2	GENEORGENEPRODUCT	2317
27779699	1265	1271	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1321	1324	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	1388	1394	FLNBv2	GENEORGENEPRODUCT	2317
27779699	1428	1434	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1473	1479	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1593	1599	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1680	1683	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	1751	1757	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1898	1904	FLNBv4	GENEORGENEPRODUCT	2317
27779699	1972	1977	RANKL	GENEORGENEPRODUCT	8600
27779699	2009	2012	OCN	GENEORGENEPRODUCT	632
27779699	2045	2048	OPG	GENEORGENEPRODUCT	4982
27779699	2081	2087	 RUNX2	GENEORGENEPRODUCT	860
27779699	2166	2169	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	2254	2260	FLNBv4	GENEORGENEPRODUCT	2317
27779699	2373	2376	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	2429	2435	FLNBv2	GENEORGENEPRODUCT	2317
27779699	2511	2515	FLNB	GENEORGENEPRODUCT	2317
27779699	2598	2601	GCT	DISEASEORPHENOTYPICFEATURE	D005870
27779699	2731	2737	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27825100	36	44	glucosio	CHEMICALENTITY	D005947
27825100	80	85	umano	ORGANISMTAXON	9606
27825100	195	215	nefropatia diabetica	DISEASEORPHENOTYPICFEATURE	D003928
27825100	319	339	nefropatia diabetica	DISEASEORPHENOTYPICFEATURE	D003928
27825100	430	435	umano	ORGANISMTAXON	9606
27825100	514	519	umani	ORGANISMTAXON	9606
27825100	711	719	glucosio	CHEMICALENTITY	D005947
27825100	771	779	glucosio	CHEMICALENTITY	D005947
27825100	938	1006	perossisoma attivatore del recettore-g attivato dal proliferatore 1a	GENEORGENEPRODUCT	10891
27825100	1040	1046	PGC-1a	GENEORGENEPRODUCT	10891
27825100	1276	1284	glucosio	CHEMICALENTITY	D005947
27825100	1461	1476	acidosi lattica	DISEASEORPHENOTYPICFEATURE	D000140
27825100	1526	1615	maestri regolatori del fattore di trascrizione del metabolismo ossidativo A mitocondriale	GENEORGENEPRODUCT	10891
27825100	1649	1655	PGC-1a	GENEORGENEPRODUCT	10891
27825100	1688	1692	AMPK	GENEORGENEPRODUCT	5562
27825100	1726	1763	la serina-treonina chinasi epatica B1	GENEORGENEPRODUCT	6794
27825100	1821	1829	glucosio	CHEMICALENTITY	D005947
27825100	1951	1992	fattore potenziatore miocita-specifico 2C	GENEORGENEPRODUCT	4208
27825100	2025	2030	MEF2C	GENEORGENEPRODUCT	4208
27825100	2065	2084	fattore miogenico 5	GENEORGENEPRODUCT	4617
27825100	2117	2121	MYF5	GENEORGENEPRODUCT	4617
27825100	2188	2209	i livelli di glucosio	CHEMICALENTITY	D005947
27825100	2417	2425	glucosio	CHEMICALENTITY	 D005947
27825100	2511	2516	MEF2C	GENEORGENEPRODUCT	4208
27825100	2549	2553	MYF5	GENEORGENEPRODUCT	4617
27825100	2589	2595	PGC-1a	GENEORGENEPRODUCT	10891
27825100	2680	2688	pazienti	ORGANISMTAXON	9606
27825100	2736	2756	nefropatia diabetica	DISEASEORPHENOTYPICFEATURE	D003928
27825100	2823	2828	umani	ORGANISMTAXON	9606
27825100	2875	2880	MEF2C	GENEORGENEPRODUCT	4208
27825100	2913	2917	MYF5	GENEORGENEPRODUCT	4617
27825100	3065	3073	glucosio	CHEMICALENTITY	D005947
27825100	3277	3285	glucosio	CHEMICALENTITY	D005947
27825100	3321	3326	umano	ORGANISMTAXON	9606
27825100	3436	3456	nefropatia diabetica	DISEASEORPHENOTYPICFEATURE	D003928
27860244	41	77	proteina arginina metiltransferasi 5	GENEORGENEPRODUCT	10419
27860244	124	138	infiammazione 	DISEASEORPHENOTYPICFEATURE	D007249
27860244	231	249	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
27860244	310	346	proteina arginina metiltransferasi 5	GENEORGENEPRODUCT	10419
27860244	380	385	PRMT5	GENEORGENEPRODUCT	10419
27860244	448	461	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
27860244	586	594	pazienti	ORGANISMTAXON	9606
27860244	642	660	artrite reumatoide	DISEASEORPHENOTYPICFEATURE	D001172
27860244	705	707	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	794	802	pazienti	ORGANISMTAXON	9606
27860244	850	852	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	898	905	artrosi	DISEASEORPHENOTYPICFEATURE	D010003
27860244	950	952	OA	DISEASEORPHENOTYPICFEATURE	D010003
27860244	1003	1008	PRMT5	GENEORGENEPRODUCT	10419
27860244	1044	1053	EPZ015666	CHEMICALENTITY	C000599896
27860244	1130	1135	PRMT5	GENEORGENEPRODUCT	10419
27860244	1216	1221	PRMT5	GENEORGENEPRODUCT	10419
27860244	1413	1425	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
27860244	1806	1811	PRMT5	GENEORGENEPRODUCT	10419
27860244	1854	1862	pazienti	ORGANISMTAXON	9606
27860244	1910	1912	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	1960	1962	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	2015	2020	PRMT5	GENEORGENEPRODUCT	10419
27860244	2097	2102	IL-1b	GENEORGENEPRODUCT	3553
27860244	2136	2141	TNF-a	GENEORGENEPRODUCT	7124
27860244	2189	2194	PRMT5	GENEORGENEPRODUCT	10419
27860244	2241	2250	EPZ015666	CHEMICALENTITY	C000599896
27860244	2320	2324	IL-6	GENEORGENEPRODUCT	3569
27860244	2358	2362	IL-8	GENEORGENEPRODUCT	3576
27860244	2437	2439	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	2503	2508	PRMT5	GENEORGENEPRODUCT	10419
27860244	2603	2605	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	2654	2663	EPZ015666	CHEMICALENTITY	C000599896
27860244	2728	2739	IkB kinaseb	GENEORGENEPRODUCT	3551
27860244	2774	2778	IkBa	GENEORGENEPRODUCT	4792
27860244	2853	2856	p65	GENEORGENEPRODUCT	5970
27860244	2898	2901	AKT	GENEORGENEPRODUCT	207
27860244	2942	2947	PRMT5	GENEORGENEPRODUCT	10419
27860244	3028	3040	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
27860244	3137	3139	RA	DISEASEORPHENOTYPICFEATURE	D001172
27860244	3199	3204	NF-kB	GENEORGENEPRODUCT	5970
27860244	3238	3241	AKT	GENEORGENEPRODUCT	207
27860244	3334	3339	PRMT5	GENEORGENEPRODUCT	10419
27860244	3397	3420	infiammazione sinoviale	DISEASEORPHENOTYPICFEATURE	D013585
27860244	3527	3529	RA	DISEASEORPHENOTYPICFEATURE	D001172
27930654	104	110	RAB-28	GENEORGENEPRODUCT	189429
27930654	169	175	GTPase	GENEORGENEPRODUCT	189429
27930654	221	227	BBSome	GENEORGENEPRODUCT	260219
27930654	511	535	disturbi umani ereditari	DISEASEORPHENOTYPICFEATURE	D030342
27930654	583	593	ciliopatie	DISEASEORPHENOTYPICFEATURE	D000072661
27930654	646	656	ciliopatie	DISEASEORPHENOTYPICFEATURE	D000072661
27930654	706	725	retinite pigmentosa	DISEASEORPHENOTYPICFEATURE	D012174
27930654	771	795	Sindrome di Bardet-Biedl	DISEASEORPHENOTYPICFEATURE	D020788
27930654	840	843	BBS	DISEASEORPHENOTYPICFEATURE	D020788
27930654	1121	1130	kinesin-2	GENEORGENEPRODUCT	177685
27930654	1171	1177	dynein	GENEORGENEPRODUCT	172041
27930654	1233	1302	complesso proteico cargo-adaptor della sindrome di Bardet-Biedl (BBS)	GENEORGENEPRODUCT	260219
27930654	1339	1347	BBAlcuni	GENEORGENEPRODUCT	260219
27930654	1454	1464	C. elegans	ORGANISMTAXON	6239
27930654	1838	1845	FAM-161	GENEORGENEPRODUCT	189695
27930654	1880	1887	FAM161A	GENEORGENEPRODUCT	84140
27930654	1932	1940	CCDC-104	GENEORGENEPRODUCT	112942
27930654	1976	1983	CCDC104	GENEORGENEPRODUCT	112942
27930654	2020	2025	RPI-1	GENEORGENEPRODUCT	189281
27930654	2058	2061	RP1	GENEORGENEPRODUCT	6101
27930654	2094	2099	RP1L1	GENEORGENEPRODUCT	94137
27930654	2247	2252	umano	ORGANISMTAXON	9606
27930654	2285	2289	MAP9	GENEORGENEPRODUCT	79884
27930654	2323	2326	YAP	GENEORGENEPRODUCT	10413
27930654	2360	2367	CCDC149	GENEORGENEPRODUCT	91050
27930654	2402	2407	RAB28	GENEORGENEPRODUCT	9364
27930654	2503	2513	C. elegans	ORGANISMTAXON	6239
27930654	2547	2553	RAB-28	GENEORGENEPRODUCT	189429
27930654	2647	2665	cone-rod dystrophy	DISEASEORPHENOTYPICFEATURE	D000071700
27930654	2728	2734	GTPase	GENEORGENEPRODUCT	189429
27930654	2882	2885	PIL	CHEMICALENTITY	D006153
27930654	2925	2931	RAB-28	GENEORGENEPRODUCT	189429
27930654	3020	3023	GTP	CHEMICALENTITY	D006160
27930654	3074	3080	RAB-28	GENEORGENEPRODUCT	189429
27930654	3159	3165	BBSome	GENEORGENEPRODUCT	260219
27930654	3385	3391	rab-28	GENEORGENEPRODUCT	189429
27930654	3454	3457	PIL	CHEMICALENTITY	D006153
27930654	3491	3494	GTP	CHEMICALENTITY	D006160
27930654	3549	3555	RAB-28	GENEORGENEPRODUCT	189429
27930654	3770	3775	RAB28	GENEORGENEPRODUCT	9364
27930654	3811	3817	GTPase	GENEORGENEPRODUCT	9364
27930654	3902	3905	BBS	DISEASEORPHENOTYPICFEATURE	D020788
27930654	3938	3943	RABL4	GENEORGENEPRODUCT	11020
27930654	3977	3982	IFT27	GENEORGENEPRODUCT	11020
27930654	4049	4055	BBSome	GENEORGENEPRODUCT	260219
27941998	37	80	Canale anionico dipendente dalla tensione 1	GENEORGENEPRODUCT	7416,83529
27941998	119	124	VDAC1	GENEORGENEPRODUCT	7416 ,83529
27941998	198	223	Disfunzione mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
27941998	270	283	Desminopatia 	DISEASEORPHENOTYPICFEATURE	C563319
27941998	328	340	Desminopatie	DISEASEORPHENOTYPICFEATURE	C563319
27941998	422	428	desmin	GENEORGENEPRODUCT	1674
27941998	513	521	miopatie	DISEASEORPHENOTYPICFEATURE	D009135
27941998	566	594	La disfunzione mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
27941998	680	692	desminopatie	DISEASEORPHENOTYPICFEATURE	C563319
27941998	786	811	disfunzione mitocondriale	DISEASEORPHENOTYPICFEATURE	D028361
27941998	858	870	desminopatie	DISEASEORPHENOTYPICFEATURE	C563319
27941998	923	928	VDAC1	GENEORGENEPRODUCT	7416
27941998	1122	1134	desminopatie	DISEASEORPHENOTYPICFEATURE	C563319
27941998	1168	1211	Canale anionico dipendente dalla tensione 1	GENEORGENEPRODUCT	7416
27941998	1245	1250	VDAC1	GENEORGENEPRODUCT	7416
27941998	1364	1376	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	1405	1408	rat	ORGANISMTAXON	10116
27941998	1683	1688	VDAC1	GENEORGENEPRODUCT	7416,83529
27941998	1749	1755	desmin	GENEORGENEPRODUCT	1674,64362
27941998	1848	1860	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	1888	1896	pazienti	ORGANISMTAXON	9606
27941998	1943	1955	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	1984	1987	rat	ORGANISMTAXON	10116
27941998	2100	2103	bax	GENEORGENEPRODUCT	24887,581
27941998	2143	2147	ATF2	GENEORGENEPRODUCT	1386,81647
27941998	2215	2227	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	2255	2263	pazienti	ORGANISMTAXON	9606
27941998	2309	2322	desminopatia 	DISEASEORPHENOTYPICFEATURE	C563319
27941998	2351	2354	rat	ORGANISMTAXON	10116
27941998	2407	2412	bcl-2	GENEORGENEPRODUCT	24224,596
27941998	2450	2456	bcl-xl	GENEORGENEPRODUCT	24888,598
27941998	2496	2499	HK2	GENEORGENEPRODUCT	25059,3099
27941998	2538	2543	VDAC1	GENEORGENEPRODUCT	7416,83529
27941998	2583	2589	desmin	GENEORGENEPRODUCT	1674,64362
27941998	2682	2690	pazienti	ORGANISMTAXON	9606
27941998	2721	2726	ratti	ORGANISMTAXON	10116
27941998	2775	2787	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	2908	2920	desminopatie	DISEASEORPHENOTYPICFEATURE	C563319
27941998	2963	2966	bax	GENEORGENEPRODUCT	24887,581
27941998	3005	3009	ATF2	GENEORGENEPRODUCT	1386,81647
27941998	3054	3059	bcl-2	GENEORGENEPRODUCT	24224,596
27941998	3097	3103	bcl-xl	GENEORGENEPRODUCT	24888,598
27941998	3143	3146	HK2	GENEORGENEPRODUCT	25059,3099
27941998	3240	3245	VDAC1	GENEORGENEPRODUCT	7416,83529
27941998	3285	3291	desmin	GENEORGENEPRODUCT	1674,64362
27941998	3393	3405	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	3464	3467	rat	ORGANISMTAXON	10116
27941998	3514	3526	desminopatia	DISEASEORPHENOTYPICFEATURE	C563319
27941998	3582	3588	desmin	GENEORGENEPRODUCT	64362
27941998	3642	3650	miopatia	DISEASEORPHENOTYPICFEATURE	D009135
27959382	32	37	Bach1	GENEORGENEPRODUCT	12013
27959382	83	93	bleomicina	CHEMICALENTITY	D001761
27959382	148	165	fibrosi polmonare	DISEASEORPHENOTYPICFEATURE	D011658
27959382	228	232	topi	ORGANISMTAXON	10090
27959382	330	343	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
27959382	389	396	fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
27959382	430	435	Bach1	GENEORGENEPRODUCT	12013
27959382	620	637	polmonare fibrosi	DISEASEORPHENOTYPICFEATURE	D011658
27959382	682	684	PF	DISEASEORPHENOTYPICFEATURE	D011658
27959382	755	760	Bach1	GENEORGENEPRODUCT	12013
27959382	892	897	Bach1	GENEORGENEPRODUCT	 12013
27959382	972	976	topi	ORGANISMTAXON	10090
27959382	1012	1022	bleomicina	CHEMICALENTITY	D001761
27959382	1055	1058	BLM	CHEMICALENTITY	D001761
27959382	1111	1113	PF	DISEASEORPHENOTYPICFEATURE	D011658
27959382	1143	1178	Fibroblasti polmonari (FML) di topo	ORGANISMTAXON	10090
27959382	1235	1276	fattore di crescita trasformante (TGF)-b1	GENEORGENEPRODUCT	21803
27959382	1383	1388	Bach1	GENEORGENEPRODUCT	12013
27959382	1430	1435	Bach1	GENEORGENEPRODUCT	12013
27959382	1579	1584	Bach1	GENEORGENEPRODUCT	12013
27959382	1718	1723	mouse	ORGANISMTAXON	10090
27959382	1758	1761	BLM	CHEMICALENTITY	D001761
27959382	1814	1816	PF	DISEASEORPHENOTYPICFEATURE	D011658
27959382	1869	1874	Bach1	GENEORGENEPRODUCT	12013
27959382	1946	1950	topi	ORGANISMTAXON	10090
27959382	2058	2063	Bach1	GENEORGENEPRODUCT	12013
27959382	2154	2159	Bach1	GENEORGENEPRODUCT	12013
27959382	2229	2234	Bach1	GENEORGENEPRODUCT	12013
27959382	2348	2364	eme ossigenasi-1	GENEORGENEPRODUCT	15368
27959382	2399	2423	glutatione perossidasi 1	GENEORGENEPRODUCT	14775
27959382	2479	2485	TGF-b1	GENEORGENEPRODUCT	21803
27959382	2520	2535	interleuchina-6	GENEORGENEPRODUCT	16193
27959382	2625	2631	TGF-b1	GENEORGENEPRODUCT	21803
27959382	2673	2678	Bach1	GENEORGENEPRODUCT	12013
27959382	2782	2803	fattori antiossidanti	GENEORGENEPRODUCT	14775,15368
27959382	2874	2906	citochine correlate alla fibrosi	DISEASEORPHENOTYPICFEATURE	D005355
27959382	2938	2942	topi	ORGANISMTAXON	10090
27959382	2983	2987	topi	ORGANISMTAXON	10090
27959382	3019	3022	BLM	CHEMICALENTITY	D001761
27959382	3098	3111	infiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
27959382	3291	3296	Bach1	GENEORGENEPRODUCT	12013
27959382	3368	3371	BLM	CHEMICALENTITY	D001761
27959382	3454	3459	Bach1	GENEORGENEPRODUCT	12013
27959382	3532	3535	BLM	CHEMICALENTITY	D001761
27959382	3587	3589	PF	DISEASEORPHENOTYPICFEATURE	D011658
27959382	3621	3625	topi	ORGANISMTAXON	10090
27959382	3767	3769	PF	DISEASEORPHENOTYPICFEATURE	D011658
27974047	31	36	FGFR1	GENEORGENEPRODUCT	2260
27974047	70	75	NTRK3	GENEORGENEPRODUCT	4916
27974047	156	189	tumori stromali gastrointestinali	DISEASEORPHENOTYPICFEATURE	D046152
27974047	320	353	tumori stromali gastrointestinali	DISEASEORPHENOTYPICFEATURE	D046152
27974047	398	402	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	459	462	KIT	GENEORGENEPRODUCT	3815
27974047	495	501	PDGFRA	GENEORGENEPRODUCT	5156
27974047	535	539	SDHx	GENEORGENEPRODUCT	6390
27974047	574	577	RAS	GENEORGENEPRODUCT	3845
27974047	635	639	KRAS	GENEORGENEPRODUCT	 3845
27974047	671	675	BRAF	GENEORGENEPRODUCT	673
27974047	708	711	NF1	GENEORGENEPRODUCT	4763
27974047	831	837	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27974047	1095	1101	cancer	DISEASEORPHENOTYPICFEATURE	D009369
27974047	1168	1173	GISTs	DISEASEORPHENOTYPICFEATURE	D046152
27974047	1296	1300	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	1366	1369	KIT	GENEORGENEPRODUCT	3815
27974047	1402	1408	PDGFRA	GENEORGENEPRODUCT	5156
27974047	1440	1443	RAS	GENEORGENEPRODUCT	3845
27974047	1502	1506	SDHx	GENEORGENEPRODUCT	6390
27974047	1555	1563	pazienti	ORGANISMTAXON	9606
27974047	1640	1646	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27974047	1718	1734	metastasi nodali	DISEASEORPHENOTYPICFEATURE	D009362
27974047	1789	1793	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	1871	1877	ARID1B	GENEORGENEPRODUCT	57492
27974047	1910	1913	ATR	GENEORGENEPRODUCT	545
27974047	1946	1951	FGFR1	GENEORGENEPRODUCT	2260
27974047	1984	1988	LTK 	GENEORGENEPRODUCT	4058
27974047	2022	2026	SUFU	GENEORGENEPRODUCT	51684
27974047	2059	2064	PARK2	GENEORGENEPRODUCT	5071
27974047	2099	2105	ZNF217	GENEORGENEPRODUCT	7764
27974047	2154	2160	tumori	DISEASEORPHENOTYPICFEATURE	D009369
27974047	2203	2208	FGFR1	GENEORGENEPRODUCT	2260
27974047	2258	2263	FGFR1	GENEORGENEPRODUCT	2260
27974047	2296	2301	HOOK3	GENEORGENEPRODUCT	84376
27974047	2334	2339	FGFR1	GENEORGENEPRODUCT	2260
27974047	2371	2376	TACC1	GENEORGENEPRODUCT	6867
27974047	2427	2431	ETV6	GENEORGENEPRODUCT	2120
27974047	2464	2469	NTRK3	GENEORGENEPRODUCT	4916
27974047	2543	2546	TRK	GENEORGENEPRODUCT	4914
27974047	2648	2652	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	2714	2717	KIT	GENEORGENEPRODUCT	3815
27974047	2749	2755	PDGFRA	GENEORGENEPRODUCT	5156
27974047	2787	2791	SDHx	GENEORGENEPRODUCT	6390
27974047	2824	2827	RAS	GENEORGENEPRODUCT	3845
27974047	2901	2906	FGFR1	GENEORGENEPRODUCT	2260
27974047	2938	2944	TACC1 	GENEORGENEPRODUCT	6867
27974047	2978	2982	ETV6	GENEORGENEPRODUCT	2120
27974047	3014	3019	NTRK3	GENEORGENEPRODUCT	4916
27974047	3103	3111	paziente	ORGANISMTAXON	9606
27974047	3156	3162	tumore	DISEASEORPHENOTYPICFEATURE	D009369
27974047	3227	3231	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	3316	3336	pazienti più giovani	ORGANISMTAXON	9606
27974047	3397	3419	metastasi ai linfonodi	DISEASEORPHENOTYPICFEATURE	D009362
27974047	3553	3558	FGFR1	GENEORGENEPRODUCT	2260
27974047	3592	3597	NTRK3	GENEORGENEPRODUCT	4916
27974047	3770	3774	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27974047	3898	3906	pazienti	ORGANISMTAXON	9606
27974047	3954	3958	GIST	DISEASEORPHENOTYPICFEATURE	D046152
27999109	64	100	Recettore dell'interferone di tipo I	GENEORGENEPRODUCT	288264,686326
27999109	162	180	Diabete autoimmune	DISEASEORPHENOTYPICFEATURE	D003922
27999109	212	217	Ratti	ORGANISMTAXON	10116
27999109	263	268	umano	ORGANISMTAXON	9606
27999109	312	329	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
27999109	404	412	insulina	GENEORGENEPRODUCT	3630
27999109	517	533	infezione virale	DISEASEORPHENOTYPICFEATURE	D014777
27999109	642	663	interferone di tipo I	GENEORGENEPRODUCT	3456
27999109	696	699	IFN	GENEORGENEPRODUCT	3439
27999109	734	784	vie di segnalazione mediate dal recettore dell'IFN	GENEORGENEPRODUCT	3454
27999109	864	869	umano	ORGANISMTAXON	9606
27999109	913	930	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
27999109	996	1001	umano	ORGANISMTAXON	9606
27999109	1045	1062	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
27999109	1123	1126	rat	ORGANISMTAXON	10116
27999109	1179	1186	Diabete	DISEASEORPHENOTYPICFEATURE	D003920
27999109	1258	1263	ratti	ORGANISMTAXON	10116
27999109	1337	1371	poliinosinico:acido policitidilico	CHEMICALENTITY	D011070
27999109	1404	1412	poli I:C	CHEMICALENTITY	D011070
27999109	1506	1534	recettore dell'IFN di tipo I	GENEORGENEPRODUCT	288264,686326
27999109	1576	1609	recettore dell'IFN a/b di tipo I 	GENEORGENEPRODUCT	288264,686326
27999109	1651	1656	IFNAR	GENEORGENEPRODUCT	288264,686326
27999109	1708	1711	IFN	GENEORGENEPRODUCT	25712
27999109	1814	1821	diabete	DISEASEORPHENOTYPICFEATURE	D003920
27999109	1891	1897	IFNAR1	GENEORGENEPRODUCT	288264
27999109	1959	1964	ratti	ORGANISMTAXON	10116
27999109	2178	2184	Ifnar1	GENEORGENEPRODUCT	288264
27999109	2219	2239	Il deficit di IFNAR1	GENEORGENEPRODUCT	288264
27999109	2346	2353	diabete	DISEASEORPHENOTYPICFEATURE	D003920
27999109	2439	2448	insulitis	DISEASEORPHENOTYPICFEATURE	D007410
27999109	2485	2493	poli I:C	CHEMICALENTITY	D011070
27999109	2556	2572	Kilham rat virus	ORGANISMTAXON	12441
27999109	2616	2623	diabete	DISEASEORPHENOTYPICFEATURE	D003920
27999109	2677	2683	IFNAR1	GENEORGENEPRODUCT	288264
27999109	2852	2870	diabete autoimmune	DISEASEORPHENOTYPICFEATURE	D003922
27999109	2994	3011	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
28075473	29	38	Spirulina	ORGANISMTAXON	551299
28075473	70	87	lipopolisaccaridi	CHEMICALENTITY	D008070
28075473	139	145	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	193	214	recettore toll-like 4	GENEORGENEPRODUCT	21898
28075473	303	319	interleuchina-17	GENEORGENEPRODUCT	16171
28075473	352	368	interleuchina-23	GENEORGENEPRODUCT	83430
28075473	403	416	interferone-g	GENEORGENEPRODUCT	15978
28075473	501	522	interleuchina (IL)-17	GENEORGENEPRODUCT	16171,3605
28075473	599	606	 tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	653	658	umani	ORGANISMTAXON	9606
28075473	693	697	topi	ORGANISMTAXON	10090
28075473	731	735	IL-6	GENEORGENEPRODUCT	16193
28075473	770	775	IL-23	GENEORGENEPRODUCT	83430
28075473	928	945	lipopolisaccaridi	CHEMICALENTITY	D008070
28075473	978	981	LPS	CHEMICALENTITY	D008070
28075473	1128	1144	Escherichia coli	ORGANISMTAXON	562
28075473	1172	1179	E. coli	ORGANISMTAXON	562
28075473	1213	1216	LPS	CHEMICALENTITY	D008070
28075473	1249	1252	LPS	CHEMICALENTITY	D008070
28075473	1285	1294	Spirulina	ORGANISMTAXON	551299
28075473	1351	1360	tossicità	DISEASEORPHENOTYPICFEATURE	D064420
28075473	1438	1442	IL-6	GENEORGENEPRODUCT	16193
28075473	1477	1482	IL-23	GENEORGENEPRODUCT	83430
28075473	1514	1518	topi	ORGANISMTAXON	10090
28075473	1595	1604	Spirulina	ORGANISMTAXON	551299
28075473	1636	1639	LPS	CHEMICALENTITY	D008070
28075473	1678	1685	E. coli	ORGANISMTAXON	562
28075473	1717	1720	LPS	CHEMICALENTITY	D008070
28075473	1804	1811	epatoma	DISEASEORPHENOTYPICFEATURE	D006528
28075473	1870	1879	Spirulina	ORGANISMTAXON	551299
28075473	1911	1914	LPS	CHEMICALENTITY	D008070
28075473	1969	1975	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	2024	2028	topi	ORGANISMTAXON	10090
28075473	2072	2097	Toll- come il recettore 4	GENEORGENEPRODUCT	21898
28075473	2131	2135	TLR4	GENEORGENEPRODUCT	21898
28075473	2181	2185	topi	ORGANISMTAXON	10090
28075473	2250	2255	IL-17	GENEORGENEPRODUCT	16171
28075473	2290	2295	IL-23	GENEORGENEPRODUCT	83430
28075473	2365	2384	interferone (IFN)-g	GENEORGENEPRODUCT	15978
28075473	2461	2466	IFN-g	GENEORGENEPRODUCT	15978
28075473	2581	2590	Spirulina	ORGANISMTAXON	551299
28075473	2622	2625	LPS	CHEMICALENTITY	D008070
28075473	2761	2766	IL-17	GENEORGENEPRODUCT	16171
28075473	2805	2832	recettore toll-like (TLR)4 	GENEORGENEPRODUCT	21898
28075473	2925	2930	IL-17	GENEORGENEPRODUCT	16171
28075473	2977	2983	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	3029	3033	topi	ORGANISMTAXON	10090
28075473	3077	3086	Spirulina	ORGANISMTAXON	551299
28075473	3119	3122	LPS	CHEMICALENTITY	D008070
28075473	3189	3195	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	3249	3255	IFN -g	GENEORGENEPRODUCT	15978
28075473	3349	3354	IFN-g	GENEORGENEPRODUCT	15978
28075473	3389	3394	IL-17	GENEORGENEPRODUCT	16171
28075473	3427	3432	IL-23	GENEORGENEPRODUCT	83430
28075473	3524	3530	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	3583	3592	Spirulina	ORGANISMTAXON	551299
28075473	3624	3627	LPS	CHEMICALENTITY	D008070
28075473	3685	3690	IFN-g	GENEORGENEPRODUCT	15978
28075473	3723	3728	IL-17	GENEORGENEPRODUCT	16171
28075473	3762	3767	IL-23	GENEORGENEPRODUCT	83430
28075473	3811	3816	IFN-g	GENEORGENEPRODUCT	15978
28075473	3884	3891	 tumore	DISEASEORPHENOTYPICFEATURE	D009369
28075473	3942	3951	Spirulina	ORGANISMTAXON	551299
28075473	3983	3986	LPS	CHEMICALENTITY	D008070
28075473	4081	4095	tumori mammari	DISEASEORPHENOTYPICFEATURE	D001943
28075473	4224	4227	TLR	GENEORGENEPRODUCT	21898
28075473	4275	4281	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28098423	32	77	Il fattore neurotrofico derivato dal cervello	GENEORGENEPRODUCT	24225
28098423	117	129	doxorubicina	CHEMICALENTITY	D004317
28098423	181	201	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
28098423	262	265	Akt	GENEORGENEPRODUCT	24185
28098423	310	315	ratti	ORGANISMTAXON	10116
28098423	374	386	doxorubicina	CHEMICALENTITY	D004317
28098423	419	422	Dox	CHEMICALENTITY	D004317
28098423	505	520	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
28098423	618	660	fattore neurotrofico derivato dal cervello	GENEORGENEPRODUCT	24225
28098423	694	698	BDNF	GENEORGENEPRODUCT	24225
28098423	749	753	BDNF	GENEORGENEPRODUCT	24225
28098423	805	808	Dox	CHEMICALENTITY	D004317
28098423	863	878	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
28098423	925	930	ratti	ORGANISMTAXON	10116
28098423	980	983	Dox	CHEMICALENTITY	D004317
28098423	1092	1096	BDNF	GENEORGENEPRODUCT	24225
28098423	1227	1230	Dox	CHEMICALENTITY	D004317
28098423	1275	1279	BDNF	GENEORGENEPRODUCT	24225
28098423	1356	1360	BDNF	GENEORGENEPRODUCT	24225
28098423	1399	1402	Dox	CHEMICALENTITY	D004317
28098423	1455	1469	danno cardiaco	DISEASEORPHENOTYPICFEATURE	D006331
28098423	1572	1576	BDNF	GENEORGENEPRODUCT	24225
28098423	1627	1630	Dox	CHEMICALENTITY	D004317
28098423	1632	1635	rat	ORGANISMTAXON	10116
28098423	1724	1728	BDNF	GENEORGENEPRODUCT	24225
28098423	1780	1821	 la chinasi correlata alla tropomiosina B	GENEORGENEPRODUCT	25054
28098423	1855	1859	TrkB	GENEORGENEPRODUCT	25054
28098423	1933	1938	 BDNF	GENEORGENEPRODUCT	24225
28098423	1988	2030	Fattore neurotrofico derivato dal cervello	GENEORGENEPRODUCT	24225
28098423	2092	2132	Apoptosi cardiomiocitaria indotta da Dox	CHEMICALENTITY	D004317
28098423	2197	2217	disfunzione cardiaca	DISEASEORPHENOTYPICFEATURE	D006331
28098423	2249	2254	ratti	ORGANISMTAXON	10116
28098423	2303	2307	BDNF	GENEORGENEPRODUCT	24225
28098423	2415	2418	Dox	CHEMICALENTITY	D004317
28098423	2560	2564	BDNF	GENEORGENEPRODUCT	24225
28098423	2609	2612	Akt	GENEORGENEPRODUCT	24185
28098423	2682	2722	bersaglio dei mammiferi della rapamicina	GENEORGENEPRODUCT	56718
28098423	2757	2764	Cattivo	GENEORGENEPRODUCT	64639
28098423	2816	2858	proteina chinasi attivata dal mitogeno p38	GENEORGENEPRODUCT	81649
28098423	2894	2934	proteina chinasi regolata extracellulare	GENEORGENEPRODUCT	116590
28098423	3003	3007	BDNF	GENEORGENEPRODUCT	24225
28098423	3059	3063	BDNF	GENEORGENEPRODUCT	24225
28098423	3107	3111	TrkB	GENEORGENEPRODUCT	25054
28098423	3149	3152	Akt	GENEORGENEPRODUCT	24185
28098423	3271	3275	BDNF	GENEORGENEPRODUCT	24225
28098423	3314	3317	Dox	CHEMICALENTITY	D004317
28098423	3373	3388	cardiotossicità	DISEASEORPHENOTYPICFEATURE	D066126
28098423	3447	3450	Akt	GENEORGENEPRODUCT	24185
28098423	3519	3522	Dox	CHEMICALENTITY	D004317
28098423	3585	3591	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28101574	31	35	NEK2	GENEORGENEPRODUCT	4751
28101574	117	141	epatocellulare carcinoma	DISEASEORPHENOTYPICFEATURE	D006528
28101574	174	227	Mai nella mitosi chinasi 2 correlata al gene A (NIMA)	GENEORGENEPRODUCT	4751
28101574	260	264	NEK2	GENEORGENEPRODUCT	4751
28101574	304	337	proteina associata ai microtubuli	GENEORGENEPRODUCT	4130
28101574	414	419	umane	ORGANISMTAXON	9606
28101574	491	498	maligne	DISEASEORPHENOTYPICFEATURE	D009369
28101574	553	557	NEK2	GENEORGENEPRODUCT	4751
28101574	604	628	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
28101574	674	677	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	791	794	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	979	1000	L'espressione di NEK2	GENEORGENEPRODUCT	4751
28101574	1189	1192	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	1315	1319	NEK2	GENEORGENEPRODUCT	4751
28101574	1373	1381	pazienti	ORGANISMTAXON	9606
28101574	1430	1433	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	1530	1536	Cancro	DISEASEORPHENOTYPICFEATURE	D009369
28101574	1645	1649	NEK2	GENEORGENEPRODUCT	4751
28101574	1689	1692	AKT	GENEORGENEPRODUCT	207
28101574	1727	1732	MMP-2	GENEORGENEPRODUCT	4130
28101574	1834	1837	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	2039	2043	NEK2	GENEORGENEPRODUCT	4751
28101574	2084	2087	AKT	GENEORGENEPRODUCT	207
28101574	2156	2161	MMP-2	GENEORGENEPRODUCT	4130
28101574	2376	2379	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	2412	2416	NEK2	GENEORGENEPRODUCT	4751
28101574	2558	2561	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	2640	2644	NEK2	GENEORGENEPRODUCT	4751
28101574	2709	2712	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	2796	2799	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	2827	2835	pazienti	ORGANISMTAXON	9606
28101574	2898	2902	NEK2	GENEORGENEPRODUCT	4751
28101574	3037	3041	NEK2	GENEORGENEPRODUCT	4751
28101574	3088	3091	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	3200	3206	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28101574	3284	3288	NEK2	GENEORGENEPRODUCT	4751
28101574	3386	3389	AKT	GENEORGENEPRODUCT	207
28101574	3442	3447	MMP-2	GENEORGENEPRODUCT	4130
28101574	3521	3525	NEK2	GENEORGENEPRODUCT	4751
28101574	3627	3635	paziente	ORGANISMTAXON	9606
28101574	3683	3687	NEK2	GENEORGENEPRODUCT	4751
28101574	3769	3772	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28101574	3843	3847	NEK2	GENEORGENEPRODUCT	4751
28101574	3931	3947	metastasi di HCC	DISEASEORPHENOTYPICFEATURE	D006528,D009362
28101574	4024	4027	AKT	GENEORGENEPRODUCT	207
28101574	4088	4093	MMP-2	GENEORGENEPRODUCT	4130
28148288	31	59	Metalloproteasi-disintegrina	GENEORGENEPRODUCT	8038
28148288	91	97	ADAM12	GENEORGENEPRODUCT	8038
28148288	196	203	claudin	GENEORGENEPRODUCT	9076
28148288	253	267	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	312	318	ADAM12	GENEORGENEPRODUCT	8038
28148288	365	370	umano	ORGANISMTAXON	9606
28148288	415	429	tumori al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	503	528	recettore degli estrogeni	GENEORGENEPRODUCT	2099
28148288	582	588	tumori	DISEASEORPHENOTYPICFEATURE	 D009369
28148288	621	627	ADAM12	GENEORGENEPRODUCT	8038
28148288	748	755	claudin	GENEORGENEPRODUCT	9076
28148288	805	819	tumori al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	887	893	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28148288	985	991	ADAM12	GENEORGENEPRODUCT	8038
28148288	1095	1109	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	1156	1162	ADAM12	GENEORGENEPRODUCT	8038
28148288	1247	1254	claudin	GENEORGENEPRODUCT	9076
28148288	1303	1317	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	1674	1678	ALDH	GENEORGENEPRODUCT	217
28148288	1728	1732	CD44	GENEORGENEPRODUCT	960
28148288	1771	1775	CD24	GENEORGENEPRODUCT	100133941
28148288	1938	1942	topi	ORGANISMTAXON	10090
28148288	2143	2149	ADAM12	GENEORGENEPRODUCT	8038
28148288	2323	2329	ADAM12	GENEORGENEPRODUCT	8038
28148288	2461	2467	ADAM12	GENEORGENEPRODUCT	8038
28148288	2646	2652	ADAM12	GENEORGENEPRODUCT	8038
28148288	2728	2732	CD44	GENEORGENEPRODUCT	960
28148288	2776	2780	CD24	GENEORGENEPRODUCT	100133941
28148288	2880	2892	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
28148288	2924	2928	topi	ORGANISMTAXON	10090
28148288	3050	3056	ADAM12	GENEORGENEPRODUCT	8038
28148288	3091	3135	Recettore del fattore di crescita epidermico	GENEORGENEPRODUCT	1956
28148288	3168	3172	EGFR	GENEORGENEPRODUCT	1956
28148288	3236	3242	ADAM12	GENEORGENEPRODUCT	8038
28148288	3320	3324	EGFR	GENEORGENEPRODUCT	1956
28148288	3395	3405	batimastat	CHEMICALENTITY	C080985
28148288	3457	3474	metalloproteinasi	GENEORGENEPRODUCT	8038
28148288	3545	3548	EGF	GENEORGENEPRODUCT	1950
28148288	3632	3636	CD44	GENEORGENEPRODUCT	960
28148288	3680	3684	CD24	GENEORGENEPRODUCT	100133941
28148288	3747	3753	ADAM12	GENEORGENEPRODUCT	8038
28148288	3838	3844	ADAM12	GENEORGENEPRODUCT	8038
28148288	3916	3923	claudin	GENEORGENEPRODUCT	9076
28148288	3974	3988	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28148288	4061	4065	EGFR	GENEORGENEPRODUCT	1956
28151486	32	40	Star-PAP	GENEORGENEPRODUCT	64852
28151486	77	96	poly(A ) polimerasi	GENEORGENEPRODUCT	64852
28151486	170	176	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28151486	210	215	umano	ORGANISMTAXON	9606
28151486	259	284	modello di cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	318	326	Star-PAP	GENEORGENEPRODUCT	64852
28151486	365	383	poli(A) polimerasi	GENEORGENEPRODUCT	64852
28151486	514	522	Star-PAP	GENEORGENEPRODUCT	64852
28151486	569	575	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28151486	706	714	Star-PAP	GENEORGENEPRODUCT	64852
28151486	761	775	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	858	866	Star-PAP	GENEORGENEPRODUCT	64852
28151486	975	989	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	1043	1057	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	1085	1093	pazienti	ORGANISMTAXON	9606
28151486	1144	1152	Star-PAP	GENEORGENEPRODUCT	64852
28151486	1256	1259	BIK	GENEORGENEPRODUCT	638
28151486	1291	1314	BCL2-killer-interagente	GENEORGENEPRODUCT	638
28151486	1350	1358	Star-PAP	GENEORGENEPRODUCT	64852
28151486	1422	1436	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	1537	1551	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	1616	1620	SCID	DISEASEORPHENOTYPICFEATURE	D016511
28151486	1650	1654	topi	ORGANISMTAXON	10090
28151486	1714	1725	doxiciclina	CHEMICALENTITY	D004318
28151486	1759	1769	Stella-PAP	GENEORGENEPRODUCT	64852
28151486	1829	1837	Star-PAP	GENEORGENEPRODUCT	64852
28151486	1899	1913	cancro al seno	DISEASEORPHENOTYPICFEATURE	D001943
28151486	2055	2063	Star-PAP	GENEORGENEPRODUCT	64852
28151486	2247	2255	Star-PAP	GENEORGENEPRODUCT	64852
28151486	2308	2314	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28151486	2466	2472	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28204828	32	51	il deficit di TIEG1	GENEORGENEPRODUCT	21847
28204828	145	162	 cuore infartuato	DISEASEORPHENOTYPICFEATURE	D009203
28204828	207	211	Pten	GENEORGENEPRODUCT	19211
28204828	244	247	Akt	GENEORGENEPRODUCT	11651
28204828	303	366	fattore di crescita trasformante (TGF)-b-inducible early gene-1	GENEORGENEPRODUCT	21847
28204828	400	406	TIEG1 	GENEORGENEPRODUCT	21847
28204828	571	590	cancro del pancreas	DISEASEORPHENOTYPICFEATURE	D010190
28204828	635	643	leucemia	DISEASEORPHENOTYPICFEATURE	D007938
28204828	689	700	osteoporosi	DISEASEORPHENOTYPICFEATURE	D010024
28204828	768	773	TIEG1	GENEORGENEPRODUCT	21847
28204828	905	910	TIEG1	GENEORGENEPRODUCT	21847
28204828	957	978	cardiopatia ischemica	DISEASEORPHENOTYPICFEATURE	D017202
28204828	1084	1089	TIEG1	GENEORGENEPRODUCT	21847
28204828	1154	1159	 topi	ORGANISMTAXON	10090
28204828	1553	1574	infarto del miocardio	DISEASEORPHENOTYPICFEATURE	D009203
28204828	1619	1621	MI	DISEASEORPHENOTYPICFEATURE	D009203
28204828	1689	1694	TIEG1	GENEORGENEPRODUCT	21847
28204828	1731	1735	topi	ORGANISMTAXON	10090
28204828	1836	1838	MI	DISEASEORPHENOTYPICFEATURE	D009203
28204828	1944	1947	 MI	DISEASEORPHENOTYPICFEATURE	D009203
28204828	2058	2065	infarto	DISEASEORPHENOTYPICFEATURE	D007238
28204828	2129	2167	deossinucleotidiltransferasi terminale	GENEORGENEPRODUCT	1791
28204828	2207	2211	dUTP	CHEMICALENTITY	C027078
28204828	2307	2331	un muscolo liscio actina	GENEORGENEPRODUCT	11475
28204828	2365	2370	a-SMA	GENEORGENEPRODUCT	11475
28204828	2404	2408	CD31	GENEORGENEPRODUCT	18613
28204828	2591	2596	TIEG1	GENEORGENEPRODUCT	21847
28204828	2833	2838	TIEG1	GENEORGENEPRODUCT	21847
28204828	3041	3046	TIEG1	GENEORGENEPRODUCT	21847
28204828	3079	3083	topi	ORGANISMTAXON	10090
28204828	3255	3282	fosfatasi e omologo tensina	GENEORGENEPRODUCT	19211
28204828	3316	3320	Pten	GENEORGENEPRODUCT	19211
28204828	3356	3359	Akt	GENEORGENEPRODUCT	11651
28204828	3394	3399	Bcl-2	GENEORGENEPRODUCT	12043
28204828	3433	3436	Bax	GENEORGENEPRODUCT	12028
28204828	3477	3518	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	22339
28204828	3552	3557	 VEGF	GENEORGENEPRODUCT	22339
28204828	3652	3657	TIEG1	GENEORGENEPRODUCT	21847
28204828	3737	3758	cardiopatia ischemica	DISEASEORPHENOTYPICFEATURE	D017202
28204828	3832	3836	Pten	GENEORGENEPRODUCT	19211
28204828	3869	3872	Akt	GENEORGENEPRODUCT	11651
28260056	32	79	Fattore di crescita insulino-simile 1 recettore	GENEORGENEPRODUCT	16001
28260056	158	165	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
28260056	266	270	PI3K	GENEORGENEPRODUCT	18706
28260056	304	307	Akt	GENEORGENEPRODUCT	11651
28260056	340	344	mTOR	GENEORGENEPRODUCT	56717
28260056	409	418	L'ipossia	DISEASEORPHENOTYPICFEATURE	D000860
28260056	612	653	Fattore di crescita simile all'insulina-1	GENEORGENEPRODUCT	16000
28260056	687	692	IGF-1	GENEORGENEPRODUCT	16000
28260056	836	845	L'ipossia	DISEASEORPHENOTYPICFEATURE	D000860
28260056	915	918	IGF	GENEORGENEPRODUCT	16000
28260056	976	991	recettore IGF-1	GENEORGENEPRODUCT	16001
28260056	1025	1031	IGF-1R	GENEORGENEPRODUCT	16001
28260056	1080	1109	l'apoptosi indotta da ipossia	DISEASEORPHENOTYPICFEATURE	D000860
28260056	1253	1259	IGF-1R	GENEORGENEPRODUCT	16001
28260056	1309	1317	ipossico	DISEASEORPHENOTYPICFEATURE	D000860
28260056	1358	1362	Topo	ORGANISMTAXON	10090
28260056	1466	1472	IGF-1R	GENEORGENEPRODUCT	16001
28260056	1616	1645	specie reattive dell'ossigeno	CHEMICALENTITY	D017382
28260056	1679	1682	ROS	CHEMICALENTITY	D017382
28260056	1743	1757	3-metiladenina	CHEMICALENTITY	C025946
28260056	1849	1852	ROS	CHEMICALENTITY	D017382
28260056	1932	1941	ipossiche	DISEASEORPHENOTYPICFEATURE	D000860
28260056	2032	2061	fosfatidilinositolo 3-chinasi	GENEORGENEPRODUCT	18706
28260056	2095	2099	PI3K	GENEORGENEPRODUCT	18706
28260056	2134	2161	proteina treonina chinasi B	GENEORGENEPRODUCT	11651
28260056	2195	2198	Akt	GENEORGENEPRODUCT	11651
28260056	2233	2270	bersaglio di rapamicina nei mammiferi	GENEORGENEPRODUCT	56717
28260056	2304	2308	mTOR	GENEORGENEPRODUCT	56717
28260056	2438	2445	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
28260056	2530	2533	ROS	CHEMICALENTITY	D017382
28260056	2767	2770	ROS	CHEMICALENTITY	D017382
28260056	2954	2957	ROS	CHEMICALENTITY	D017382
28260056	3073	3079	IGF-1R	GENEORGENEPRODUCT	16001
28260056	3126	3130	PI3K	GENEORGENEPRODUCT	18706
28260056	3164	3167	Akt	GENEORGENEPRODUCT	11651
28260056	3200	3204	mTOR	GENEORGENEPRODUCT	56717
28260056	3377	3381	PI3K	GENEORGENEPRODUCT	18706
28260056	3413	3421	LY294002	CHEMICALENTITY	C085911
28260056	3491	3497	IGF-1R	GENEORGENEPRODUCT	16001
28260056	3591	3599	ipossico	DISEASEORPHENOTYPICFEATURE	D000860
28260056	3671	3674	ROS	CHEMICALENTITY	D017382
28260056	3740	3744	PI3K	GENEORGENEPRODUCT	18706
28260056	3778	3781	Akt	GENEORGENEPRODUCT	11651
28260056	3814	3818	mTOR	GENEORGENEPRODUCT	56717
28260077	34	47	Atorvastatina	CHEMICALENTITY	D000069059
28260077	103	126	nefropatia da contrasto	DISEASEORPHENOTYPICFEATURE	D007674
28260077	210	215	Hsp27	GENEORGENEPRODUCT	24471
28260077	279	302	Nefropatia da contrasto	DISEASEORPHENOTYPICFEATURE	D007674
28260077	347	350	CIN	DISEASEORPHENOTYPICFEATURE	D007674
28260077	411	437	insufficienza renale acuta	DISEASEORPHENOTYPICFEATURE	D058186
28260077	627	630	CIN	DISEASEORPHENOTYPICFEATURE	D007674
28260077	743	756	atorvastatina	CHEMICALENTITY	D000069059
28260077	817	820	CIN	DISEASEORPHENOTYPICFEATURE	D007674
28260077	912	917	Hsp27	GENEORGENEPRODUCT	24471
28260077	991	1004	atorvastatina	CHEMICALENTITY	D000069059
28260077	1061	1064	CIN	DISEASEORPHENOTYPICFEATURE	D007674
28260077	1113	1135	risposta infiammatoria	DISEASEORPHENOTYPICFEATURE	D007249
28260077	1206	1209	rat	ORGANISMTAXON	10116
28260077	1253	1262	iopamidol	CHEMICALENTITY	D007479
28260077	1314	1317	CIN	DISEASEORPHENOTYPICFEATURE	D007674
28260077	1366	1371	umano	ORGANISMTAXON	9606
28260077	1505	1510	ratti	ORGANISMTAXON	10116
28260077	1619	1624	ratti	ORGANISMTAXON	10116
28260077	1654	1659	ratti	ORGANISMTAXON	10116
28260077	1694	1707	atorvastatina	CHEMICALENTITY	D000069059
28260077	1737	1742	ratti	ORGANISMTAXON	10116
28260077	1776	1786	iopamidolo	CHEMICALENTITY	D007479
28260077	1816	1821	ratti	ORGANISMTAXON	10116
28260077	1853	1863	iopamidolo	CHEMICALENTITY	D007479
28260077	1898	1912	 atorvastatina	CHEMICALENTITY	D000069059
28260077	2021	2031	iopamidolo	CHEMICALENTITY	D007479
28260077	2091	2104	atorvastatina	CHEMICALENTITY	D000069059
28260077	2137	2170	proteina da shock termico (Hsp)27	GENEORGENEPRODUCT	3315
28260077	2243	2248	Hsp27	GENEORGENEPRODUCT	3315
28260077	2412	2425	atorvastatina	CHEMICALENTITY	D000069059
28260077	2485	2532	apoptosi e deterioramento della funzione renale	DISEASEORPHENOTYPICFEATURE	D007674
28260077	2587	2600	atorvastatina	CHEMICALENTITY	D000069059
28260077	2665	2675	iopamidolo	CHEMICALENTITY	D007479
28260077	2712	2765	Proteina X associata al linfoma a cellule B-2 (Bcl-2)	GENEORGENEPRODUCT	24887
28260077	2799	2802	Bax	GENEORGENEPRODUCT	24887
28260077	2837	2846	caspase-3	GENEORGENEPRODUCT	25402
28260077	2908	2913	Bcl-2	GENEORGENEPRODUCT	24224
28260077	3011	3016	Hsp27	GENEORGENEPRODUCT	3315
28260077	3065	3070	Hsp27	GENEORGENEPRODUCT	3315
28260077	3124	3133	iopamidol	CHEMICALENTITY	D007479
28260077	3214	3217	Bax	GENEORGENEPRODUCT	581
28260077	3249	3258	caspase-3	GENEORGENEPRODUCT	836
28260077	3309	3314	Bcl-2	GENEORGENEPRODUCT	596
28260077	3461	3474	atorvastatina	CHEMICALENTITY	D000069059
28260077	3536	3595	apoptosi delle cellule tubulari renali indotta da contrasto	DISEASEORPHENOTYPICFEATURE	D007674
28260077	3662	3667	Hsp27	GENEORGENEPRODUCT	24471
28260110	53	59	emodin	CHEMICALENTITY	D004642
28260110	94	115	acido grasso sintasi 	GENEORGENEPRODUCT	2194
28260110	160	176	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
28260110	235	257	L'acido grasso sintasi	GENEORGENEPRODUCT	2194
28260110	290	294	FASN	GENEORGENEPRODUCT	2194
28260110	368	394	sintesi degli acidi grassi	CHEMICALENTITY	D005227
28260110	468	487	carcinoma del colon	DISEASEORPHENOTYPICFEATURE	D015179
28260110	545	549	FASN	GENEORGENEPRODUCT	2194
28260110	647	663	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
28260110	704	710	Emodin	CHEMICALENTITY	D004642
28260110	746	758	antrachinone	CHEMICALENTITY	D000880
28260110	855	860	umano	ORGANISMTAXON	9606
28260110	904	910	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28260110	964	979	cancro al colon	DISEASEORPHENOTYPICFEATURE	D015179
28260110	1255	1266	Annessina V	GENEORGENEPRODUCT	308
28260110	1298	1316	ioduro di propidio	CHEMICALENTITY	D011419
28260110	1361	1379	L'attività di FASN	GENEORGENEPRODUCT	2194
28260110	1457	1498	nicotinamide adenina dinucleotide fosfato	CHEMICALENTITY	D009249
28260110	1590	1609	acido grasso libero	CHEMICALENTITY	D005230
28260110	1656	1675	acido grasso libero	CHEMICALENTITY	D005230
28260110	1977	1981	FASN	GENEORGENEPRODUCT	2194
28260110	2059	2065	emodin	CHEMICALENTITY	D004642
28260110	2117	2122	umana	ORGANISMTAXON	9606
28260110	2166	2182	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
28260110	2216	2222	Emodin	CHEMICALENTITY	D004642
28260110	2381	2385	FASN	GENEORGENEPRODUCT	2194
28260110	2574	2580	Emodin	CHEMICALENTITY	D004642
28260110	2668	2672	FASN	GENEORGENEPRODUCT	2194
28260110	2844	2850	Emodin	CHEMICALENTITY	D004642
28260110	2936	2940	FASN	GENEORGENEPRODUCT	2194
28260110	3002	3021	acidi grassi liberi	CHEMICALENTITY	D005230
28260110	3054	3060	Emodin	CHEMICALENTITY	D004642
28260110	3201	3207	emodin	CHEMICALENTITY	D004642
28260110	3241	3250	cerulenin	CHEMICALENTITY	D002569
28260110	3299	3303	FASN	GENEORGENEPRODUCT	2194
28260110	3395	3404	Palmitate	CHEMICALENTITY	D010168
28260110	3471	3475	FASN	GENEORGENEPRODUCT	2194
28260110	3517	3523	emodin	CHEMICALENTITY	D004642
28260110	3593	3599	emodin	CHEMICALENTITY	D004642
28260110	3643	3647	FASN	GENEORGENEPRODUCT	2194
28260110	3724	3753	fosfatidilinositolo 3-chinasi	GENEORGENEPRODUCT	5291
28260110	3784	3787	Akt	GENEORGENEPRODUCT	207
28260110	3827	3913	proteine chinasi attivate dal mitogeno/chinasi regolate dal segnale extracellulare 1/2	GENEORGENEPRODUCT	5594 ,5595
28260110	3983	3989	emodin	CHEMICALENTITY	D004642
28260110	4098	4102	FASN	GENEORGENEPRODUCT	2194
28260110	4191	4207	cancro del colon	DISEASEORPHENOTYPICFEATURE	D015179
28279980	32	37	GLUT4	GENEORGENEPRODUCT	20528
28279980	111	120	 Glucosio	CHEMICALENTITY	D005947
28279980	210	214	Topo	ORGANISMTAXON	10090
28279980	248	253	GLUT4	GENEORGENEPRODUCT	20528
28279980	304	312	insulina	GENEORGENEPRODUCT	3630
28279980	406	430	assorbimento di glucosio	CHEMICALENTITY	D005947
28279980	531	539	glucosio	CHEMICALENTITY	D005947
28279980	641	646	GLUT4	GENEORGENEPRODUCT	20528
28279980	698	706	glucosio	CHEMICALENTITY	D005947
28279980	826	831	mouse	ORGANISMTAXON	10090
28279980	981	1008	[(3)H]-2-desossi-d-glucosio	CHEMICALENTITY	D003847
28279980	1073	1099	l'assorbimento di glucosio	CHEMICALENTITY	D005947
28279980	1204	1209	GLUT4	GENEORGENEPRODUCT	20528
28279980	1247	1251	topi	ORGANISMTAXON	10090
28279980	1301	1306	GLUT4	GENEORGENEPRODUCT	20528
28279980	1435	1443	glucosio	CHEMICALENTITY	D005947
28279980	1609	1613	GLUT	GENEORGENEPRODUCT	170441,20525,20526,20527,20528,227659,353169,56017,56485
28279980	1656	1671	citocalasina B 	CHEMICALENTITY	D003571
28279980	1714	1719	sodio	CHEMICALENTITY	D012964
28279980	1762	1770	glucosio	CHEMICALENTITY	D005947
28279980	1828	1838	floridzina	CHEMICALENTITY	D010695
28279980	1991	1996	GLUTs	GENEORGENEPRODUCT	170441,20525,20526,20527,20528,227659 ,353169,56017,56485
28279980	2123	2127	GLUT	GENEORGENEPRODUCT	170441,20525,20526,20527,20528,227659,353169,56017,56485
28279980	2160	2167	hexose 	CHEMICALENTITY	D006601
28279980	2272	2298	[(3)H]-2-deossi-d-glucosio	CHEMICALENTITY	D003847
28279980	2368	2380	 d-fruttosio	CHEMICALENTITY	D005632
28279980	2460	2465	GLUT2	GENEORGENEPRODUCT	20526
28279980	2499	2504	GLUT5	GENEORGENEPRODUCT	56485
28279980	2538	2543	GLUT8	GENEORGENEPRODUCT	56017
28279980	2579	2585	GLUT12	GENEORGENEPRODUCT	353169
28279980	2720	2724	GLUT	GENEORGENEPRODUCT	170441,20525,20526,20527,20528,227659,353169,56017,56485
28279980	2813	2818	GLUT1	GENEORGENEPRODUCT	20525
28279980	2852	2857	GLUT3	GENEORGENEPRODUCT	20527
28279980	2893	2898	GLUT6	GENEORGENEPRODUCT	 227659
28279980	2934	2940	GLUT10	GENEORGENEPRODUCT	170441
28279980	3065	3070	GLUT4	GENEORGENEPRODUCT	20528
28279980	3158	3166	glucosio	CHEMICALENTITY	D005947
28279980	3254	3259	GLUT1	GENEORGENEPRODUCT	20525
28279980	3293	3298	GLUT3	GENEORGENEPRODUCT	20527
28279980	3334	3339	GLUT6	GENEORGENEPRODUCT	227659
28279980	3377	3383	GLUT10	GENEORGENEPRODUCT	170441
28279980	3448	3472	assorbimento di glucosio	CHEMICALENTITY	D005947
28346429	83	104	la chinasi epatica B1	GENEORGENEPRODUCT	20869
28346429	173	179	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28346429	229	270	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	22339
28346429	304	325	La chinasi epatica B1	GENEORGENEPRODUCT	20869
28346429	359	363	LKB1	GENEORGENEPRODUCT	20869
28346429	404	435	serina/treonina protein chinasi	GENEORGENEPRODUCT	20869
28346429	576	601	sindrome di Peutz-Jeghers	DISEASEORPHENOTYPICFEATURE	D010580
28346429	667	673	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28346429	746	750	LKB1	GENEORGENEPRODUCT	20869
28346429	833	839	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28346429	908	912	LKB1	GENEORGENEPRODUCT	20869
28346429	983	987	LKB1	GENEORGENEPRODUCT	20869
28346429	1026	1030	topi	ORGANISMTAXON	10090
28346429	1076	1106	caderina vascolare endoteliale	GENEORGENEPRODUCT	12562
28346429	1139	1143	topi	ORGANISMTAXON	10090
28346429	1180	1184	LKB1	GENEORGENEPRODUCT	20869
28346429	1225	1229	topi	ORGANISMTAXON	10090
28346429	1263	1319	Il livello del fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	22339
28346429	1353	1357	VEGF	GENEORGENEPRODUCT	22339
28346429	1465	1469	LKB1	GENEORGENEPRODUCT	20869
28346429	1507	1511	topi	ORGANISMTAXON	10090
28346429	1560	1564	LKB1	GENEORGENEPRODUCT	20869
28346429	1602	1606	topo	ORGANISMTAXON	10090
28346429	1753	1759	Tumori	DISEASEORPHENOTYPICFEATURE	D009369
28346429	1806	1810	LKB1	GENEORGENEPRODUCT	20869
28346429	1849	1853	topi	ORGANISMTAXON	10090
28346429	1919	1923	LKB1	GENEORGENEPRODUCT	20869
28346429	1962	1966	topi	ORGANISMTAXON	10090
28346429	2138	2143	topi 	ORGANISMTAXON	10090
28346429	2202	2206	VEGF	GENEORGENEPRODUCT	22339
28346429	2387	2393	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28346429	2471	2475	LKB1	GENEORGENEPRODUCT	20869
28346429	2557	2561	topo	ORGANISMTAXON	10090
28346429	2612	2616	VEGF	GENEORGENEPRODUCT	22339
28346429	2777	2781	LKB1	GENEORGENEPRODUCT	20869
28346429	2832	2852	recettore 2 del VEGF	GENEORGENEPRODUCT	16542
28346429	2956	2960	LKB1	GENEORGENEPRODUCT	20869
28346429	3019	3023	LKB1	GENEORGENEPRODUCT	20869
28346429	3100	3104	VEGF	GENEORGENEPRODUCT	22339
28346429	3139	3167	specificità della proteina 1	GENEORGENEPRODUCT	20683
28346429	3201	3204	Sp1	GENEORGENEPRODUCT	20683
28346429	3272	3275	Sp1	GENEORGENEPRODUCT	20683
28346429	3321	3325	VEGF	GENEORGENEPRODUCT	22339
28346429	3370	3375	VEGF 	GENEORGENEPRODUCT	22339
28346429	3421	3425	LKB1	GENEORGENEPRODUCT	20869
28346429	3537	3543	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28346429	3587	3590	Sp1	GENEORGENEPRODUCT	20683
28346429	3631	3635	VEGF	GENEORGENEPRODUCT	22339
28348168	32	37	FGFR2	GENEORGENEPRODUCT	14183
28348168	439	445	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28348168	491	512	malattia degenerativa	DISEASEORPHENOTYPICFEATURE	D019636
28348168	636	651	Recettore FGF 2	GENEORGENEPRODUCT	14183
28348168	685	690	FGFR2	GENEORGENEPRODUCT	14183
28348168	733	737	topo	ORGANISMTAXON	10090
28348168	896	901	FGFR2	GENEORGENEPRODUCT	14183
28348168	1085	1089	SOX2	GENEORGENEPRODUCT	 20674
28348168	1207	1232	recettore tirosin-chinasi	GENEORGENEPRODUCT	14183
28348168	1384	1390	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28368423	32	35	Myc	GENEORGENEPRODUCT	17869
28368423	77	102	Recettore delle cellule B	GENEORGENEPRODUCT	16019
28368423	162	174	precanceroso	DISEASEORPHENOTYPICFEATURE	D011230
28368423	243	246	Btk	GENEORGENEPRODUCT	12229
28368423	347	350	MYC	GENEORGENEPRODUCT	17869
28368423	454	486	B -linfoma non-Hodgkin a cellule	DISEASEORPHENOTYPICFEATURE	D016393
28368423	531	536	B-NHL	DISEASEORPHENOTYPICFEATURE	D016393
28368423	571	574	MYC	GENEORGENEPRODUCT	17869
28368423	638	643	B-NHL	DISEASEORPHENOTYPICFEATURE	D016393
28368423	793	796	MYC	GENEORGENEPRODUCT	17869
28368423	848	873	Recettore delle cellule B	GENEORGENEPRODUCT	16019
28368423	908	911	BCR	GENEORGENEPRODUCT	16019
28368423	981	986	B-NHL	DISEASEORPHENOTYPICFEATURE	D016393
28368423	1055	1058	Myc	GENEORGENEPRODUCT	17869
28368423	1253	1256	Myc	GENEORGENEPRODUCT	17869
28368423	1291	1294	BCR	GENEORGENEPRODUCT	16019
28368423	1394	1397	myc	GENEORGENEPRODUCT	17869
28368423	1426	1431	mouse	ORGANISMTAXON	10090
28368423	1471	1474	Myc	GENEORGENEPRODUCT	17869
28368423	1580	1583	BCR	GENEORGENEPRODUCT	16019
28368423	1665	1677	precancerosi	DISEASEORPHENOTYPICFEATURE	D011230
28368423	1728	1731	myc	GENEORGENEPRODUCT	17869
28368423	1761	1765	topi	ORGANISMTAXON	10090
28368423	1885	1888	Myc	GENEORGENEPRODUCT	17869
28368423	1972	1977	CD79a	GENEORGENEPRODUCT	12518
28368423	2012	2015	Btk	GENEORGENEPRODUCT	12229
28368423	2050	2055	Plcg2	GENEORGENEPRODUCT	234779
28368423	2096	2103	 Erk1/2	GENEORGENEPRODUCT	26413,26417
28368423	2153	2156	Myc	GENEORGENEPRODUCT	17869
28368423	2226	2229	BCR	GENEORGENEPRODUCT	16019
28368423	2304	2313	ibrutinib	CHEMICALENTITY	C551803
28368423	2348	2390	inibitore della tirosina chinasi di Bruton	GENEORGENEPRODUCT	695
28368423	2462	2466	PI3K	GENEORGENEPRODUCT	18708
28368423	2499	2502	Akt	GENEORGENEPRODUCT	11651
28368423	2566	2569	myc	GENEORGENEPRODUCT	17869
28368423	2664	2673	ibrutinib	CHEMICALENTITY	C551803
28368423	2736	2739	Btk	GENEORGENEPRODUCT	12229
28368423	2829	2838	ibrutinib	CHEMICALENTITY	C551803
28368423	2874	2877	BCR	GENEORGENEPRODUCT	16019
28368423	3002	3005	Myc	GENEORGENEPRODUCT	17869
28368423	3065	3068	BCR	GENEORGENEPRODUCT	16019
28368423	3103	3107	PI3K	GENEORGENEPRODUCT	18708
28368423	3140	3143	Akt	GENEORGENEPRODUCT	11651
28368423	3255	3258	BCR	GENEORGENEPRODUCT	16019
28368423	3354	3366	precancerosi	DISEASEORPHENOTYPICFEATURE	D011230
28368423	3647	3650	BCR	GENEORGENEPRODUCT	16019
28368423	3734	3751	Trattamento B-NHL	DISEASEORPHENOTYPICFEATURE	D016393
28368537	56	69	recettore LIF	GENEORGENEPRODUCT	16880
28368537	103	109	Murino	ORGANISMTAXON	 10090
28368537	210	243	fattore inibitorio della leucemia	GENEORGENEPRODUCT	16878
28368537	278	281	LIF	GENEORGENEPRODUCT	 16878
28368537	389	393	topi	ORGANISMTAXON	10090
28368537	428	459	L'espressione del recettore LIF	GENEORGENEPRODUCT	16880
28368537	493	497	LIFR	GENEORGENEPRODUCT	16880
28368537	593	596	LIF	GENEORGENEPRODUCT	16878
28368537	685	689	LIFR	GENEORGENEPRODUCT	16880
28368537	739	751	Janus kinase	GENEORGENEPRODUCT	16452
28368537	784	848	trasduttore di segnale e attivazione della trascrizione (STAT) 3	GENEORGENEPRODUCT	20848
28368537	882	885	Jak	GENEORGENEPRODUCT	16452
28368537	919	924	Stat3	GENEORGENEPRODUCT	20848
28368537	986	989	JAK	GENEORGENEPRODUCT	16452
28368537	1022	1026	STAT	GENEORGENEPRODUCT	20848
28368537	1210	1214	LIFR	GENEORGENEPRODUCT	16880
28368537	1281	1285	topi	ORGANISMTAXON	10090
28368537	1379	1390	lactoferrin	GENEORGENEPRODUCT	17002
28368537	1424	1427	Ltf	GENEORGENEPRODUCT	16878
28368537	1467	1496	L'espressione di lattoferrina	GENEORGENEPRODUCT	17002
28368537	1658	1662	LIFR	GENEORGENEPRODUCT	16880
28368537	1736	1741	mouse	ORGANISMTAXON	10090
28368537	1820	1824	Lifr	GENEORGENEPRODUCT	16880
28368537	1875	1878	Ltf	GENEORGENEPRODUCT	16878
28368537	1911	1915	topi	ORGANISMTAXON	10090
28368537	1953	1957	Lifr	GENEORGENEPRODUCT	 16880
28368537	1994	1998	topi	ORGANISMTAXON	10090
28368537	2040	2044	Lifr	GENEORGENEPRODUCT	16880
28368537	2083	2086	Ltf	GENEORGENEPRODUCT	16878
28368537	2319	2323	Lifr	GENEORGENEPRODUCT	16880
28368537	2362	2365	Ltf	GENEORGENEPRODUCT	16878
28368537	2587	2591	Lifr	GENEORGENEPRODUCT	16880
28368537	2661	2666	STAT3	GENEORGENEPRODUCT	20848
28368537	2765	2768	LIF	GENEORGENEPRODUCT	16878
28368537	2801	2805	Msx1	GENEORGENEPRODUCT	17701
28368537	2929	2933	LIFR	GENEORGENEPRODUCT	16880
28368537	3051	3055	LIF 	GENEORGENEPRODUCT	16878
28398555	75	86	ippocalcina	GENEORGENEPRODUCT	3208
28398555	139	144	umano	ORGANISMTAXON	9606
28398555	188	196	distonia	DISEASEORPHENOTYPICFEATURE	D004421
28398555	241	249	Distonia	DISEASEORPHENOTYPICFEATURE	D004421
28398555	298	332	disturbo del movimento neurologico	DISEASEORPHENOTYPICFEATURE	D009069
28398555	559	563	T71N	SEQUENCEVARIANT	RS775863165
28398555	602	607	A190T	SEQUENCEVARIANT	RS550921485
28398555	643	670	sensore di calcio neuronale	GENEORGENEPRODUCT	3208
28398555	703	706	NCS	GENEORGENEPRODUCT	3208
28398555	740	751	ippocalcina	GENEORGENEPRODUCT	3208
28398555	845	870	distonia primaria isolata	DISEASEORPHENOTYPICFEATURE	D004421
28398555	904	908	DYT2	GENEORGENEPRODUCT	3208
28398555	952	960	distonia	DISEASEORPHENOTYPICFEATURE	D004421
28398555	1059	1070	ippocalcina	GENEORGENEPRODUCT	3208
28398555	1198	1209	ippocalcina	GENEORGENEPRODUCT	3208
28398555	1260	1266	calcio	CHEMICALENTITY	D002118
28398555	1326	1364	canali del calcio voltaggio-dipendenti	GENEORGENEPRODUCT	783
28398555	1412	1416	T71N	SEQUENCEVARIANT	RS775863165
28398555	1455	1460	A190T	SEQUENCEVARIANT	RS550921485
28398555	1496	1507	ippocalcina	GENEORGENEPRODUCT	3208
28398555	1572	1578	calcio	CHEMICALENTITY	D002118
28398555	1674	1678	Ca2+	CHEMICALENTITY	D000069285
28398555	1787	1798	ippocalcina	GENEORGENEPRODUCT	3208
28398555	1866	1869	NCS	GENEORGENEPRODUCT	3208
28398555	2316	2322	calcio	CHEMICALENTITY	D002118
28398555	2357	2360	KCl	CHEMICALENTITY	D011189
28398555	2425	2436	ippocalcina	GENEORGENEPRODUCT	3208
28398555	2494	2542	canali del calcio voltaggio-dipendenti di tipo N	GENEORGENEPRODUCT	774
28398555	2644	2652	distonia	DISEASEORPHENOTYPICFEATURE	D004421
28398555	2732	2743	ippocalcina	GENEORGENEPRODUCT	3208
28398555	2844	2850	calcio	CHEMICALENTITY	D002118
28398555	2885	2889	DYT2	GENEORGENEPRODUCT	3208
28398555	2933	2941	distonia	DISEASEORPHENOTYPICFEATURE	D004421
28411266	54	76	Recettore sulfonilurea	GENEORGENEPRODUCT	6833
28411266	121	135	Tipo 2 Diabete	DISEASEORPHENOTYPICFEATURE	D003924
28411266	181	203	Coronary Heart Disease	DISEASEORPHENOTYPICFEATURE	D003324
28411266	301	318	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28411266	364	376	sulfonilurea	CHEMICALENTITY	D013453
28411266	685	713	recettore della sulfonilurea	GENEORGENEPRODUCT	6833
28411266	746	751	ABCC8	GENEORGENEPRODUCT	6833
28411266	785	793	p.A1369S	SEQUENCEVARIANT	RS757110
28411266	868	880	sulfonilurea	CHEMICALENTITY	D013453
28411266	969	977	insulina	GENEORGENEPRODUCT	3630
28411266	1042	1054	sulfonilurea	CHEMICALENTITY	D013453
28411266	1384	1398	tipo 2 diabete	DISEASEORPHENOTYPICFEATURE	D003924
28411266	1444	1463	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
28411266	1510	1518	p.A1369S	SEQUENCEVARIANT	RS757110
28411266	1621	1638	diabete di tipo 2	DISEASEORPHENOTYPICFEATURE	D003924
28411266	1948	1956	p.A1369S	SEQUENCEVARIANT	RS757110
28411266	2038	2057	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
28411266	2258	2270	sulfonilurea	CHEMICALENTITY	D013453
28411266	2341	2360	malattia coronarica	DISEASEORPHENOTYPICFEATURE	D003324
28416580	34	38	TSPO	GENEORGENEPRODUCT	12257
28416580	101	118	lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D001927
28416580	167	191	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
28416580	236	260	Emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
28416580	305	308	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	415	418	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	582	604	proteina traslocatrice	GENEORGENEPRODUCT	12257
28416580	638	642	TSPO	GENEORGENEPRODUCT	12257
28416580	677	681	TSPO	GENEORGENEPRODUCT	12257
28416580	764	776	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
28416580	858	873	Lesione del SNC	DISEASEORPHENOTYPICFEATURE	D002493
28416580	970	974	TSPO	GENEORGENEPRODUCT	12257
28416580	1007	1016	etifoxina	CHEMICALENTITY	C002125
28416580	1065	1082	lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D001927
28416580	1128	1141	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
28416580	1177	1182	mouse	ORGANISMTAXON	10090
28416580	1237	1240	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	1272	1276	TSPO	GENEORGENEPRODUCT	706
28416580	1332	1336	Iba1	GENEORGENEPRODUCT	199
28416580	1390	1398	pazienti	ORGANISMTAXON	9606
28416580	1446	1449	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	1488	1493	CD11b	GENEORGENEPRODUCT	16409
28416580	1528	1532	CD45	GENEORGENEPRODUCT	19264
28416580	1577	1581	topi	ORGANISMTAXON	10090
28416580	1624	1635	collagenasi	CHEMICALENTITY	D017364
28416580	1687	1690	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	1723	1732	Etifoxina	CHEMICALENTITY	C002125
28416580	1806	1818	neurodeficit	DISEASEORPHENOTYPICFEATURE	D001927
28416580	1879	1894	edema cerebrale	DISEASEORPHENOTYPICFEATURE	 D001929
28416580	1943	1946	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	2028	2040	 collagenasi	CHEMICALENTITY	D017364
28416580	2076	2087	collagenasi	CHEMICALENTITY	D017364
28416580	2139	2142	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	2172	2176	topi	ORGANISMTAXON	10090
28416580	2226	2235	etifoxina	CHEMICALENTITY	C002125
28416580	2374	2378	IL-6	GENEORGENEPRODUCT	16193
28416580	2413	2418	TNF-a	GENEORGENEPRODUCT	21926
28416580	2451	2462	L'etifoxina	CHEMICALENTITY	C002125
28416580	2624	2633	etifoxina	CHEMICALENTITY	C002125
28416580	2682	2686	topi	ORGANISMTAXON	10090
28416580	2758	2817	inibitore del recettore del fattore 1 stimolante le colonie	GENEORGENEPRODUCT	12978
28416580	2884	2888	TSPO	GENEORGENEPRODUCT	12257
28416580	2928	2937	etifoxina	CHEMICALENTITY	C002125
28416580	2990	3007	lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D001927
28416580	3053	3066	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
28416580	3115	3118	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	3152	3156	TSPO	GENEORGENEPRODUCT	12257
28416580	3283	3286	ICH	DISEASEORPHENOTYPICFEATURE	D002543
28416580	3374	3378	TSPO	GENEORGENEPRODUCT	12257
28416580	3439	3456	lesione cerebrale	DISEASEORPHENOTYPICFEATURE	D001927
28416580	3505	3529	emorragia intracerebrale	DISEASEORPHENOTYPICFEATURE	D002543
28428256	98	110	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
28428256	155	172	prostaglandina A2	CHEMICALENTITY	C100008
28428256	216	229	recettore EP4	GENEORGENEPRODUCT	19219
28428256	277	294	prostaglandina A2	CHEMICALENTITY	C100008
28428256	327	331	PGA2	CHEMICALENTITY	C100008
28428256	466	470	PGA2	CHEMICALENTITY	C100008
28428256	576	588	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
28428256	686	690	PGA2	CHEMICALENTITY	C100008
28428256	834	842	trombina	GENEORGENEPRODUCT	14061
28428256	888	904	proinfiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
28428256	953	970	lipopolisaccaride	CHEMICALENTITY	D008070
28428256	1004	1007	LPS	CHEMICALENTITY	D008070
28428256	1139	1142	EP4	GENEORGENEPRODUCT	5734
28428256	1188	1202	recettore PGA2	GENEORGENEPRODUCT	5734
28428256	1235	1238	EP4	GENEORGENEPRODUCT	5734
28428256	1309	1313	PGA2	CHEMICALENTITY	C100008
28428256	1361	1377	Rap1/Rac1 GTPase	GENEORGENEPRODUCT	5879,5906
28428256	1411	1428	protein chinasi A	GENEORGENEPRODUCT	5566
28428256	1510	1521	VE-caderina	GENEORGENEPRODUCT	1003
28428256	1554	1567	p120-catenina	GENEORGENEPRODUCT	1500
28428256	1601	1605	ZO-1	GENEORGENEPRODUCT	7082
28428256	1638	1648	cortattina	GENEORGENEPRODUCT	2017
28428256	1682	1686	VASP	GENEORGENEPRODUCT	7408
28428256	1719	1723	PGA2	CHEMICALENTITY	C100008
28428256	1771	1774	LPS	CHEMICALENTITY	D008070
28428256	1827	1853	segnalazione infiammatoria	DISEASEORPHENOTYPICFEATURE	 D007249
28428256	1903	1907	NFkB	GENEORGENEPRODUCT	19697
28428256	1963	1987	 Molecole di adesione EC	GENEORGENEPRODUCT	3383,7412
28428256	2019	2024	ICAM1	GENEORGENEPRODUCT	3383
28428256	2058	2063	VCAM1	GENEORGENEPRODUCT	7412
28428256	2177	2180	EP4	GENEORGENEPRODUCT	5734
28428256	2222	2226	PGA2	CHEMICALENTITY	C100008
28428256	2320	2341	danno polmonare acuto	DISEASEORPHENOTYPICFEATURE	D055371
28428256	2386	2389	ALI	DISEASEORPHENOTYPICFEATURE	D055371
28428256	2423	2426	LPS	CHEMICALENTITY	D008070
28428256	2479	2498	danno infiammatorio	DISEASEORPHENOTYPICFEATURE	D007249
28428256	2554	2557	ALI	DISEASEORPHENOTYPICFEATURE	D055371
28428256	2653	2677	recettore della trombina	GENEORGENEPRODUCT	14062
28428256	2774	2778	topi	ORGANISMTAXON	10090
28428256	2815	2818	EP4	GENEORGENEPRODUCT	19219
28428256	2928	2932	PGA2	CHEMICALENTITY	C100008
28428256	2964	2967	EP4	GENEORGENEPRODUCT	5734
28428256	3160	3173	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
28468941	40	50	caveolin-1	GENEORGENEPRODUCT	857
28468941	101	118	Segnalazione Smad	GENEORGENEPRODUCT	4086,4090, 4093
28468941	202	213	adenina 474	SEQUENCEVARIANT	RS587777017
28468941	252	261	c.474delA	SEQUENCEVARIANT	RS587777017
28468941	293	301	paziente	ORGANISMTAXON	9606
28468941	399	421	ipertensione polmonare	DISEASEORPHENOTYPICFEATURE	 D006976
28468941	479	489	caveolin-1	GENEORGENEPRODUCT	857
28468941	526	535	c.474delA	SEQUENCEVARIANT	RS587777017
28468941	633	665	ipertensione arteriosa polmonare	DISEASEORPHENOTYPICFEATURE	D000081029
28468941	713	716	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
28468941	798	808	caveolin-1	GENEORGENEPRODUCT	857
28468941	1017	1027	caveolin-1	GENEORGENEPRODUCT	857
28468941	1063	1071	paziente	ORGANISMTAXON	9606
28468941	1229	1238	c.474delA	SEQUENCEVARIANT	RS587777017
28468941	1309	1319	caveolin-1	GENEORGENEPRODUCT	857
28468941	1362	1372	caveolin-1	GENEORGENEPRODUCT	12389
28468941	1407	1428	i fibroblasti di topo	ORGANISMTAXON	10090
28468941	1631	1641	caveolin-1	GENEORGENEPRODUCT	857
28468941	1683	1693	caveolin-1	GENEORGENEPRODUCT	857
28468941	1951	1960	Smad1/5/8	GENEORGENEPRODUCT	4086,4090,4093
28468941	2054	2064	caveolin-1	GENEORGENEPRODUCT	857
28468941	2120	2148	recettori del TGFb di tipo I	GENEORGENEPRODUCT	657,658,90,94
28468941	2189	2199	ALK1/2/3/6	GENEORGENEPRODUCT	657,658,90,94
28468941	2278	2287	Smad1/5/8	GENEORGENEPRODUCT	4086,4090,4093
28468941	2370	2379	c.474delA	SEQUENCEVARIANT	RS587777017
28468941	2499	2509	caveolin-1	GENEORGENEPRODUCT	857
28468941	2628	2645	Segnalazione Smad	GENEORGENEPRODUCT	4086, 4090,4093
28468941	2735	2739	Smad	GENEORGENEPRODUCT	4086,4090,4093
28468941	2876	2879	PAH	DISEASEORPHENOTYPICFEATURE	D000081029
28468941	2910	2918	pazienti	ORGANISMTAXON	9606
28468941	2954	2964	caveolin-1	GENEORGENEPRODUCT	 857
28468941	3001	3010	c.474delA	SEQUENCEVARIANT	RS587777017
28472177	31	73	Ubiquitina carbossil-terminale esterasi L1	GENEORGENEPRODUCT	7345
28472177	106	112	UCHL1 	GENEORGENEPRODUCT	7345
28472177	209	215	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28472177	311	317	glioma	DISEASEORPHENOTYPICFEATURE	D005910
28472177	364	370	gliomi	DISEASEORPHENOTYPICFEATURE	D005910
28472177	472	478	tumori	DISEASEORPHENOTYPICFEATURE	D009369
28472177	554	560	tumori	DISEASEORPHENOTYPICFEATURE	D009369
28472177	780	786	gliomi	DISEASEORPHENOTYPICFEATURE	D005910
28472177	971	1013	ubiquitina carbossil-terminale esterasi L1	GENEORGENEPRODUCT	7345
28472177	1046	1051	UCHL1	GENEORGENEPRODUCT	7345
28472177	1138	1144	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28472177	1192	1198	gliomi	DISEASEORPHENOTYPICFEATURE	D005910
28472177	1256	1261	UCHL1	GENEORGENEPRODUCT	7345
28472177	1391	1397	glioma	DISEASEORPHENOTYPICFEATURE	D005910
28472177	1568	1572	agar	CHEMICALENTITY	D000362
28472177	1700	1703	Wnt	GENEORGENEPRODUCT	7474
28472177	1833	1838	UCHL1	GENEORGENEPRODUCT	7345
28472177	1896	1936	Test reporter TOPflash dipendente da TCF	GENEORGENEPRODUCT	6934
28472177	2001	2006	UCHL1	GENEORGENEPRODUCT	7345
28472177	2239	2245	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28472177	2280	2285	ACTA2	GENEORGENEPRODUCT	59
28472177	2320	2325	POSTN	GENEORGENEPRODUCT	10631
28472177	2358	2361	LIF	GENEORGENEPRODUCT	3976
28472177	2395	2400	FBXL7	GENEORGENEPRODUCT	23194
28472177	2434	2440	FBXW11	GENEORGENEPRODUCT	23291
28472177	2473	2478	GDF15	GENEORGENEPRODUCT	9518
28472177	2513	2517	HEY2	GENEORGENEPRODUCT	23493
28472177	2595	2600	IGLL5	GENEORGENEPRODUCT	100423062
28472177	2632	2637	ABCA4	GENEORGENEPRODUCT	24
28472177	2669	2673	AQP3	GENEORGENEPRODUCT	360
28472177	2705	2709	AQP4	GENEORGENEPRODUCT	361
28472177	2742	2747	CALB1	GENEORGENEPRODUCT	793
28472177	2780	2783	ALK	GENEORGENEPRODUCT	238
28472177	3322	3368	Segnalazione di endocitosi mediata da clatrina	GENEORGENEPRODUCT	1213
28472177	3483	3508	High Mobility Group-Box 1	GENEORGENEPRODUCT	3146
28472177	3541	3546	HMGB1	GENEORGENEPRODUCT	3146
28472177	3617	3621	FGF2	GENEORGENEPRODUCT	2247
28472177	3654	3658	IL1B	GENEORGENEPRODUCT	3553
28472177	3692	3695	TNF	GENEORGENEPRODUCT	7124
28472177	3729	3734	PDGFB	GENEORGENEPRODUCT	5155
28472177	3840	3845	UCHL1	GENEORGENEPRODUCT	7345
28472177	3930	3935	UCHL1	GENEORGENEPRODUCT	7345
28472177	4006	4012	gliomi	DISEASEORPHENOTYPICFEATURE	D005910
28472177	4168	4171	Wnt	GENEORGENEPRODUCT	7474
28472177	4203	4216	Beta catenina	GENEORGENEPRODUCT	1499
28472177	4258	4263	UCHL1	GENEORGENEPRODUCT	7345
28472177	4342	4348	glioma	DISEASEORPHENOTYPICFEATURE	D005910
28472177	4481	4487	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28487437	60	67	Ghrelin	GENEORGENEPRODUCT	58991
28487437	102	126	Recettore del glucagone 	GENEORGENEPRODUCT	14527
28487437	166	203	Il blocco del recettore del glucagone	GENEORGENEPRODUCT	2642
28487437	236	240	GcgR	GENEORGENEPRODUCT	2642
28487437	310	318	insulina	GENEORGENEPRODUCT	3630
28487437	395	412	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
28487437	477	482	GcgRs	GENEORGENEPRODUCT	2642
28487437	535	547	iperglicemia	DISEASEORPHENOTYPICFEATURE	D006943
28487437	606	614	diabete 	DISEASEORPHENOTYPICFEATURE	D003920
28487437	670	678	glicemia	CHEMICALENTITY	D001786
28487437	734	742	insulina	GENEORGENEPRODUCT	3630
28487437	876	883	grelina	GENEORGENEPRODUCT	51738
28487437	941	948	grelina	GENEORGENEPRODUCT	51738
28487437	997	1005	glucosio	CHEMICALENTITY	D005947
28487437	1048	1055	grelina	GENEORGENEPRODUCT	51738
28487437	1160	1168	glicemia	CHEMICALENTITY	D001786
28487437	1237	1244	grelina	GENEORGENEPRODUCT	58991
28487437	1310	1321	ipoglicemia	DISEASEORPHENOTYPICFEATURE	D007003
28487437	1381	1390	glucagone	GENEORGENEPRODUCT	14526
28487437	1433	1437	GcgR	GENEORGENEPRODUCT	14527
28487437	1480	1484	Gcgr	GENEORGENEPRODUCT	14527
28487437	1520	1524	topi	ORGANISMTAXON	10090
28487437	1561	1565	topi	ORGANISMTAXON	10090
28487437	1628	1632	GcgR	GENEORGENEPRODUCT	 14527
28487437	1721	1729	glicemia	CHEMICALENTITY	D001786
28487437	1805	1813	 grelina	GENEORGENEPRODUCT	58991
28487437	1921	1936	streptozotocina	CHEMICALENTITY	D013311
28487437	1994	2006	iperglicemia	DISEASEORPHENOTYPICFEATURE	D006943
28487437	2058	2065	grelina	GENEORGENEPRODUCT	58991
28487437	2106	2120	topi selvatici	ORGANISMTAXON	10090
28487437	2166	2180	l'iperglicemia	DISEASEORPHENOTYPICFEATURE	D006943
28487437	2236	2240	Gcgr	GENEORGENEPRODUCT	14527
28487437	2275	2279	topi	ORGANISMTAXON	10090
28487437	2332	2339	grelina	GENEORGENEPRODUCT	58991
28487437	2464	2487	recettore della grelina	GENEORGENEPRODUCT	208188
28487437	2557	2565	glicemia	CHEMICALENTITY	D001786
28487437	2654	2669	streptozotocina	CHEMICALENTITY	D013311
28487437	2711	2715	Gcgr	GENEORGENEPRODUCT	14527
28487437	2750	2754	topi	ORGANISMTAXON	10090
28487437	2842	2850	glicemia	CHEMICALENTITY	D001786
28487437	2886	2901	streptozotocina	CHEMICALENTITY	D013311
28487437	2964	2987	recettore della grelina	GENEORGENEPRODUCT	208188
28487437	3021	3025	topi	ORGANISMTAXON	10090
28487437	3088	3092	GcgR	GENEORGENEPRODUCT	14527
28487437	3195	3204	glucagone	GENEORGENEPRODUCT	14526
28487437	3280	3297	diabete di tipo 1	DISEASEORPHENOTYPICFEATURE	D003922
28487437	3353	3360	grelina	GENEORGENEPRODUCT	58991
28487437	3424	3435	ipoglicemia	DISEASEORPHENOTYPICFEATURE	D007003
28512644	107	111	SOD1	GENEORGENEPRODUCT	6647
28512644	145	149	SOD2	GENEORGENEPRODUCT	6648
28512644	182	185	CAT	GENEORGENEPRODUCT	847
28512644	232	241	Erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	269	277	Pazienti	ORGANISMTAXON	9606
28512644	417	439	streptococco infezione	DISEASEORPHENOTYPICFEATURE	D013290
28512644	504	513	erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	541	549	pazienti	ORGANISMTAXON	9606
28512644	634	637	CAT	GENEORGENEPRODUCT	847
28512644	670	674	SOD1	GENEORGENEPRODUCT	6647
28512644	709	713	SOD2	GENEORGENEPRODUCT	6648
28512644	813	822	erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	950	972	infezione da erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	1011	1019	pazienti	ORGANISMTAXON	9606
28512644	1102	1111	erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	1150	1158	pazienti	ORGANISMTAXON	9606
28512644	1258	1267	infezione	DISEASEORPHENOTYPICFEATURE	D007239
28512644	1315	1319	SOD1	GENEORGENEPRODUCT	6647
28512644	1359	1364	G7958	SEQUENCEVARIANT	C|AELLE|G|7958
28512644	1398	1402	SOD2	GENEORGENEPRODUCT	6648
28512644	1442	1447	T2734	SEQUENCEVARIANT	C|AELLE|T|2734
28512644	1481	1484	CAT	GENEORGENEPRODUCT	847
28512644	1523	1527	C262	SEQUENCEVARIANT	C|AELLE|C|262
28512644	1601	1610	erisipela	DISEASEORPHENOTYPICFEATURE	 D004886
28512644	1676	1680	SOD2	GENEORGENEPRODUCT	6648
28512644	1719	1725	T2734C	SEQUENCEVARIANT	C|SYB|T2734|C
28512644	1785	1793	pazienti	ORGANISMTAXON	9606
28512644	1861	1882	erisipela eritematosa	DISEASEORPHENOTYPICFEATURE	D004886
28512644	1952	1956	SOD1	GENEORGENEPRODUCT	6647
28512644	1991	1997	G7958A	SEQUENCEVARIANT	RS4998557
28512644	2224	2232	IL-1beta	GENEORGENEPRODUCT	3553
28512644	2265	2270	CCL11	GENEORGENEPRODUCT	6356
28512644	2304	2314	IL-2Ralpha	GENEORGENEPRODUCT	3559
28512644	2347	2352	CXCL9	GENEORGENEPRODUCT	4283
28512644	2385	2390	TRAIL	GENEORGENEPRODUCT	8743
28512644	2423	2430	PDGF-BB	GENEORGENEPRODUCT	5155
28512644	2464	2468	CCL4	GENEORGENEPRODUCT	6351
28512644	2558	2567	infezione	DISEASEORPHENOTYPICFEATURE	D007239
28512644	2607	2611	IL-6	GENEORGENEPRODUCT	3569
28512644	2645	2649	IL-9	GENEORGENEPRODUCT	3578
28512644	2682	2687	IL-10	GENEORGENEPRODUCT	3586
28512644	2721	2726	IL-13	GENEORGENEPRODUCT	 3596
28512644	2759	2764	IL-15	GENEORGENEPRODUCT	3600
28512644	2797	2802	IL-17	GENEORGENEPRODUCT	3605
28512644	2835	2840	G-CSF	GENEORGENEPRODUCT	1440
28512644	2874	2878	VEGF	GENEORGENEPRODUCT	7422
28512644	2970	2979	erisipela	DISEASEORPHENOTYPICFEATURE	D004886
28512644	3036	3044	IL-1beta	GENEORGENEPRODUCT	3553
28512644	3077	3081	IL-7	GENEORGENEPRODUCT	3574
28512644	3115	3119	IL-8	GENEORGENEPRODUCT	3576
28512644	3152	3157	IL-17	GENEORGENEPRODUCT	3605
28512644	3191	3195	CCL5	GENEORGENEPRODUCT	6352
28512644	3229	3232	HGF	GENEORGENEPRODUCT	3082
28512644	3287	3291	SOD2	GENEORGENEPRODUCT	6648
28512644	3330	3336	T2734C	SEQUENCEVARIANT	C|SYB|T2734|C
28512644	3387	3394	PDFG-BB	GENEORGENEPRODUCT	5155
28512644	3428	3432	CCL2	GENEORGENEPRODUCT	6347
28512644	3486	3489	CAT	GENEORGENEPRODUCT	847
28512644	3529	3534	C262T	SEQUENCEVARIANT	C|SUB|C|262|T
28584052	44	86	N-acetilglucosamina (O-GlcNAc) transferasi	GENEORGENEPRODUCT	8473
28584052	118	126	pazienti	ORGANISMTAXON	9606
28584052	174	210	Disabilità intellettiva legata all'X	DISEASEORPHENOTYPICFEATURE	D038901
28584052	243	285	N-acetilglucosamina (O-GlcNAc) transferasi	GENEORGENEPRODUCT	8473
28584052	318	321	OGT	GENEORGENEPRODUCT	8473
28584052	373	388	O-GlcNAcylation	GENEORGENEPRODUCT	8473
28584052	490	498	O-GlcNAc	GENEORGENEPRODUCT	8473
28584052	729	744	O-GlcNAcylation	GENEORGENEPRODUCT	8473
28584052	811	833	difetti dello sviluppo	DISEASEORPHENOTYPICFEATURE	D003147
28584052	879	897	neurodegenerazione	DISEASEORPHENOTYPICFEATURE	D019636
28584052	962	965	OGT	GENEORGENEPRODUCT	8473
28584052	1047	1052	umani	ORGANISMTAXON	9606
28584052	1131	1134	OGT	GENEORGENEPRODUCT	8473
28584052	1195	1231	Disabilità intellettiva legata all'X	DISEASEORPHENOTYPICFEATURE	D038901
28584052	1276	1280	XLID	DISEASEORPHENOTYPICFEATURE	D038901
28584052	1374	1385	p.Arg284Pro	SEQUENCEVARIANT	RS1114167891
28584052	1596	1599	OGT	GENEORGENEPRODUCT	8473
28584052	1740	1743	OGT	GENEORGENEPRODUCT	8473
28584052	1817	1828	O-GlcNAcase	GENEORGENEPRODUCT	10724
28584052	1870	1878	paziente	ORGANISMTAXON	9606
28584052	1943	1951	O-GlcNAc	GENEORGENEPRODUCT	8473
28584052	2094	2110	O-GlcNAcilazione	GENEORGENEPRODUCT	8473
28584052	2158	2169	O-GlcNAcase	GENEORGENEPRODUCT	10724
28584052	2411	2419	paziente	ORGANISMTAXON	9606
28584052	2489	2492	OGT	GENEORGENEPRODUCT	8473
28584052	2551	2562	p.Arg284Pro	SEQUENCEVARIANT	RS1114167891
28584052	2792	2822	fattore 1 della cellula ospite	GENEORGENEPRODUCT	3054
28584052	2895	2899	XLID	DISEASEORPHENOTYPICFEATURE	D038901
28584052	2989	2997	O-GlcNAc	GENEORGENEPRODUCT	8473
28584052	3031	3061	fattore 1 della cellula ospite	GENEORGENEPRODUCT	3054
28584052	3161	3165	XLID	DISEASEORPHENOTYPICFEATURE	D038901
28584052	3224	3227	OGT	GENEORGENEPRODUCT	8473
28604678	93	102	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	155	159	Vps4	GENEORGENEPRODUCT	27183,9525
28604678	277	352	complesso di smistamento endosomiale richiesto per il trasporto (ESCRT)-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	492	501	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	694	703	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	751	756	umano	ORGANISMTAXON	9606
28604678	920	929	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	991	997	ATPase	GENEORGENEPRODUCT	27183,9525
28604678	1035	1039	VPS4	GENEORGENEPRODUCT	27183,9525
28604678	1144	1153	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	1268	1277	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	1333	1337	Vps2	GENEORGENEPRODUCT	27243
28604678	1370	1375	Vps24	GENEORGENEPRODUCT	51652
28604678	1425	1434	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	1509	1513	Snf7	GENEORGENEPRODUCT	128866,29082
28604678	1660	1664	Vps4	GENEORGENEPRODUCT	27183,9525
28604678	1698	1701	ATP	CHEMICALENTITY	D000255
28604678	1881	1890	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28604678	1944	1948	Vps4	GENEORGENEPRODUCT	27183,9525
28604678	2025	2034	ESCRT-III	GENEORGENEPRODUCT	128866,27243,51652
28650467	110	131	recettore oppioide u1	GENEORGENEPRODUCT	4988
28650467	189	203	L-asparaginasi	CHEMICALENTITY	D001215
28650467	264	292	leucemia linfoblastica acuta	DISEASEORPHENOTYPICFEATURE	D054198
28650467	336	350	L-asparaginase	CHEMICALENTITY	D001215
28650467	433	461	leucemia linfoblastica acuta	DISEASEORPHENOTYPICFEATURE	D054198
28650467	506	511	TUTTI	DISEASEORPHENOTYPICFEATURE	D054198
28650467	565	575	asparagina	CHEMICALENTITY	D001216
28650467	610	619	aspartato	CHEMICALENTITY	D001224
28650467	654	657	NH3	CHEMICALENTITY	D000641
28650467	715	736	deficit di asparagina	DISEASEORPHENOTYPICFEATURE	OMIM:615574
28650467	828	836	leucemia	DISEASEORPHENOTYPICFEATURE	D007938
28650467	891	899	paziente	ORGANISMTAXON	9606
28650467	1054	1059	TUTTE	DISEASEORPHENOTYPICFEATURE	D054198
28650467	1125	1139	L-asparaginasi	CHEMICALENTITY	D001215
28650467	1263	1277	L-asparaginasi	CHEMICALENTITY	D001215
28650467	1347	1356	leucemica	DISEASEORPHENOTYPICFEATURE	D007938
28650467	1509	1514	TUTTI	DISEASEORPHENOTYPICFEATURE	D054198
28650467	1571	1594	oppioide recettore mu 1	GENEORGENEPRODUCT	4988
28650467	1627	1632	oprm1	GENEORGENEPRODUCT	4988
28650467	1694	1715	anidrasi carbonica 1 	GENEORGENEPRODUCT	759
28650467	1747	1750	ca1	GENEORGENEPRODUCT	759
28650467	1816	1859	enzima di coniugazione dell'ubiquitina E2C 	GENEORGENEPRODUCT	11065
28650467	1893	1898	ube2c	GENEORGENEPRODUCT	11065
28650467	1962	1967	OPRM1	GENEORGENEPRODUCT	4988
28650467	2042	2052	leucemiche	DISEASEORPHENOTYPICFEATURE	D007938
28650467	2119	2124	OPRM1	GENEORGENEPRODUCT	4988
28650467	2167	2181	L-asparaginasi	CHEMICALENTITY	D001215
28650467	2313	2321	Metadone	CHEMICALENTITY	D008691
28650467	2369	2374	OPRM1	GENEORGENEPRODUCT	4988
28650467	2457	2475	cellule leucemiche	DISEASEORPHENOTYPICFEATURE	D007938
28650467	2515	2520	OPRM1	GENEORGENEPRODUCT	4988
28650467	2573	2603	Trattamento con L-asparaginasi	CHEMICALENTITY	D001215
28650467	2650	2655	OPRM1	GENEORGENEPRODUCT	4988
28650467	2727	2741	L-asparaginasi	CHEMICALENTITY	D001215
28650467	2775	2783	metadone	CHEMICALENTITY	D008691
28650467	2824	2844	 La perdita di OPRM1	GENEORGENEPRODUCT	4988
28650467	2900	2936	la sopravvivenza cellulare leucemica	DISEASEORPHENOTYPICFEATURE	D007938
28650467	3015	3020	OPRM1	GENEORGENEPRODUCT	4988
28650467	3107	3115	paziente	ORGANISMTAXON	9606
28650467	3159	3177	cellule leucemiche	DISEASEORPHENOTYPICFEATURE	D007938
28650467	3247	3252	OPRM1	GENEORGENEPRODUCT	4988
28650467	3322	3336	L-asparaginasi	CHEMICALENTITY	D001215
28650467	3380	3385	OPRM1	GENEORGENEPRODUCT	4988
28650467	3438	3456	cellule leucemiche	DISEASEORPHENOTYPICFEATURE	D007938
28650467	3518	3523	OPRM1	GENEORGENEPRODUCT	4988
28650467	3607	3621	L-asparaginasi	CHEMICALENTITY	D001215
28650467	3668	3677	leucemia 	DISEASEORPHENOTYPICFEATURE	D007938
28650467	3705	3713	pazienti	ORGANISMTAXON	9606
28650467	3832	3837	OPRM1	GENEORGENEPRODUCT	4988
28650467	3873	3887	L-asparaginasi	CHEMICALENTITY	D001215
28650467	3945	3948	ALL	DISEASEORPHENOTYPICFEATURE	D054198
28650467	3993	3998	OPRM1	GENEORGENEPRODUCT	4988
28650467	4173	4178	Oprm1	GENEORGENEPRODUCT	4988
28650467	4269	4283	L-asparaginasi	CHEMICALENTITY	D001215
28650467	4338	4341	ALL	DISEASEORPHENOTYPICFEATURE	D054198
28660748	32	75	Recettore dell'angiotensina II sottotipo 1a	GENEORGENEPRODUCT	11607
28660748	175	193	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	249	267	Metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	314	336	cancro del colon-retto	DISEASEORPHENOTYPICFEATURE	D015179
28660748	382	385	CRC	DISEASEORPHENOTYPICFEATURE	 D015179
28660748	475	481	renina	GENEORGENEPRODUCT	19701
28660748	514	526	angiotensina	GENEORGENEPRODUCT	11606
28660748	587	593	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28660748	648	657	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
28660748	750	797	recettore 1a del sottotipo dell'angiotensina II	GENEORGENEPRODUCT	11607
28660748	831	835	AT1a	GENEORGENEPRODUCT	11607
28660748	900	918	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	965	968	CRC	DISEASEORPHENOTYPICFEATURE	D015179
28660748	1027	1045	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	1129	1134	mouse	ORGANISMTAXON	10090
28660748	1179	1194	cancro al colon	DISEASEORPHENOTYPICFEATURE	D015179
28660748	1267	1271	AT1a	GENEORGENEPRODUCT	 11607
28660748	1309	1313	topi	ORGANISMTAXON	10090
28660748	1347	1351	AT1a	GENEORGENEPRODUCT	11607
28660748	1432	1436	topi	ORGANISMTAXON	10090
28660748	1486	1490	topi	ORGANISMTAXON	10090
28660748	1568	1586	fegato metastatico	DISEASEORPHENOTYPICFEATURE	D008113
28660748	1657	1661	AT1a	GENEORGENEPRODUCT	11607
28660748	1718	1722	CD31	GENEORGENEPRODUCT	18613
28660748	1756	1792	fattore di crescita trasformante- b1	GENEORGENEPRODUCT	21803
28660748	1827	1833	TGF-b1	GENEORGENEPRODUCT	21803
28660748	1869	1874	F4/80	GENEORGENEPRODUCT	13733
28660748	1932	1936	AT1a	GENEORGENEPRODUCT	11607
28660748	2074	2079	F4/80	GENEORGENEPRODUCT	13733
28660748	2129	2135	TGF-b1	GENEORGENEPRODUCT	21803
28660748	2222	2226	AT1a	GENEORGENEPRODUCT	11607
28660748	2265	2269	AT1a	GENEORGENEPRODUCT	11607
28660748	2324	2328	AT1a	GENEORGENEPRODUCT	11607
28660748	2422	2440	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	2532	2541	metastasi	DISEASEORPHENOTYPICFEATURE	D009362
28660748	2615	2619	AT1a	GENEORGENEPRODUCT	11607
28660748	2665	2669	AT1a	GENEORGENEPRODUCT	11607
28660748	2731	2736	F4/80	GENEORGENEPRODUCT	13733
28660748	2797	2815	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	2881	2886	F4/80	GENEORGENEPRODUCT	13733
28660748	2976	2981	F4/80	GENEORGENEPRODUCT	13733
28660748	3061	3066	F4/80	GENEORGENEPRODUCT	13733
28660748	3122	3128	TGF-b1	GENEORGENEPRODUCT	21803
28660748	3162	3177	Angiotensina II	GENEORGENEPRODUCT	11606
28660748	3221	3227	TGF-b1	GENEORGENEPRODUCT	21803
28660748	3320	3330	clodronato	CHEMICALENTITY	D004002
28660748	3393	3411	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	3456	3462	TGF-b1	GENEORGENEPRODUCT	21803
28660748	3498	3503	F4/80	GENEORGENEPRODUCT	13733
28660748	3588	3606	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	3668	3677	collagene	GENEORGENEPRODUCT	12842
28660748	3766	3770	AT1a	GENEORGENEPRODUCT	11607
28660748	3913	3931	metastasi epatiche	DISEASEORPHENOTYPICFEATURE	D008113
28660748	3986	3992	TGF-b1	GENEORGENEPRODUCT	21803
28660748	4033	4037	AT1a	GENEORGENEPRODUCT	11607
28687665	46	56	a-tubulina	GENEORGENEPRODUCT	22142
28687665	89	95	Tuba1a	GENEORGENEPRODUCT	22142
28687665	376	388	a/b-tubulina	GENEORGENEPRODUCT	22142,22152,53857
28687665	460	470	a-tubulina	GENEORGENEPRODUCT	22142
28687665	502	508	TUBA1A	GENEORGENEPRODUCT	7846
28687665	567	590	malformazioni corticali	DISEASEORPHENOTYPICFEATURE	D054220
28687665	621	626	umani	ORGANISMTAXON	9606
28687665	729	735	Tuba1a	GENEORGENEPRODUCT	22142
28687665	776	780	topi	ORGANISMTAXON	10090
28687665	850	856	Tuba1a	GENEORGENEPRODUCT	22142
28687665	897	902	S140G	SEQUENCEVARIANT	P|SUB|S|140|G
28687665	1090	1096	Tuba1a	GENEORGENEPRODUCT	22142
28687665	1332	1351	La mutazione Tuba1a	GENEORGENEPRODUCT	22142
28687665	1554	1566	a/b-tubulina	GENEORGENEPRODUCT	22142,22152 ,53857
28687665	1626	1631	Tuba8	GENEORGENEPRODUCT	53857
28687665	1674	1684	a-tubulina	GENEORGENEPRODUCT	22142
28687665	1765	1788	malformazioni corticali	DISEASEORPHENOTYPICFEATURE	D054220
28687665	1858	1864	Tuba1a	GENEORGENEPRODUCT	22142
28687665	1926	1932	Tuba1a	GENEORGENEPRODUCT	22142
28747658	143	148	HIV-1	ORGANISMTAXON	11676
28747658	182	185	p17	GENEORGENEPRODUCT	155348
28747658	271	290	HIV-1-sieropositivo	DISEASEORPHENOTYPICFEATURE	D006679
28747658	318	326	pazienti	ORGANISMTAXON	9606
28747658	374	381	linfoma	DISEASEORPHENOTYPICFEATURE	D008223
28747658	419	422	p17	GENEORGENEPRODUCT	155348
28747658	562	575	linfomagenesi	DISEASEORPHENOTYPICFEATURE	D008223
28747658	713	716	p17	GENEORGENEPRODUCT	155348
28747658	785	789	S75X	SEQUENCEVARIANT	P|SUB|S|75|X
28747658	869	911	Arginina (R) a glicina (G) in posizione 76	SEQUENCEVARIANT	P|SUB|R|76|G
28747658	935	938	p17	GENEORGENEPRODUCT	155348
28747658	1013	1017	R76G	SEQUENCEVARIANT	P|SUB|R|76|G
28747658	1077	1081	S75X	SEQUENCEVARIANT	P|SUB|S|75|X
28747658	1249	1253	PTEN	GENEORGENEPRODUCT	5728
28747658	1285	1289	PI3K	GENEORGENEPRODUCT	5291
28747658	1321	1324	Akt	GENEORGENEPRODUCT	207
28747658	1434	1440	CASP-9	GENEORGENEPRODUCT	842
28747658	1473	1479	CASP-7	GENEORGENEPRODUCT	840
28747658	1512	1518	DFF-45	GENEORGENEPRODUCT	1676
28747658	1551	1555	NPM 	GENEORGENEPRODUCT	4869
28747658	1588	1593	YWHAZ	GENEORGENEPRODUCT	7534
28747658	1626	1629	Src	GENEORGENEPRODUCT	6714
28747658	1663	1667	PAX2	GENEORGENEPRODUCT	5076
28747658	1700	1705	MAPK8	GENEORGENEPRODUCT	5599
28747658	1800	1806	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28747658	1838	1842	CDK1	GENEORGENEPRODUCT	983
28747658	1876	1880	CDK2	GENEORGENEPRODUCT	1017
28747658	1913	1917	CDK8	GENEORGENEPRODUCT	1024
28747658	1950	1955	CHEK1	GENEORGENEPRODUCT	1111
28747658	1989	1994	CHEK2	GENEORGENEPRODUCT	11200
28747658	2027	2037	GSK-3 beta	GENEORGENEPRODUCT	2932
28747658	2071	2074	NPM	GENEORGENEPRODUCT	4869
28747658	2107	2111	PAK1	GENEORGENEPRODUCT	5058
28747658	2145	2154	PP2C-alfa	GENEORGENEPRODUCT	5494
28747658	2245	2269	R a G nella posizione 76	SEQUENCEVARIANT	P|SUB|R|76|G
28747658	2464	2467	p17	GENEORGENEPRODUCT	155348
28747658	2505	2509	R76G	SEQUENCEVARIANT	P|SUB|R|76|G
28777492	32	40	Gankyrin	GENEORGENEPRODUCT	53380
28777492	80	85	STAT3	GENEORGENEPRODUCT	20848
28777492	144	150	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28777492	201	210	sorafenib	CHEMICALENTITY	D000077157
28777492	268	292	carcinoma epatocellulare	DISEASEORPHENOTYPICFEATURE	D006528
28777492	358	382	carcinomi epatocellulari	DISEASEORPHENOTYPICFEATURE	D006528
28777492	427	430	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28777492	501	533	infiammazione cronica del fegato	DISEASEORPHENOTYPICFEATURE	D007249
28777492	593	605	oncoproteina	GENEORGENEPRODUCT	53380
28777492	638	646	gankyrin	GENEORGENEPRODUCT	53380
28777492	710	723	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
28777492	778	790	tumorigenesi	DISEASEORPHENOTYPICFEATURE	D009369
28777492	865	873	gankyrin	GENEORGENEPRODUCT	5716
28777492	990	998	gankyrin	GENEORGENEPRODUCT	53380
28777492	1060	1066	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28777492	1099	1103	topi	ORGANISMTAXON	10090
28777492	1185	1193	gankyrin	GENEORGENEPRODUCT	53380
28777492	1238	1241	Alb	GENEORGENEPRODUCT	11657
28777492	1278	1286	gankyrin	GENEORGENEPRODUCT	53380
28777492	1329	1353	delezione della gankyrin	GENEORGENEPRODUCT	53380
28777492	1448	1451	Mx1	GENEORGENEPRODUCT	17857
28777492	1489	1497	gankyrin	GENEORGENEPRODUCT	53380
28777492	1537	1545	Gankyrin	GENEORGENEPRODUCT	5716
28777492	1590	1631	fattore di crescita endoteliale vascolare	GENEORGENEPRODUCT	22339
28777492	1691	1697	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28777492	1739	1747	Gankyrin	GENEORGENEPRODUCT	53380
28777492	1790	1857	Src homology 2 proteina tirosina fosfatasi-1 contenente il dominio 	GENEORGENEPRODUCT	15170
28777492	1891	1896	SHP-1	GENEORGENEPRODUCT	15170
28777492	2055	2098	 trasduttore e attivatore di trascrizione 3	GENEORGENEPRODUCT	20848
28777492	2132	2137	STAT3	GENEORGENEPRODUCT	20848
28777492	2172	2191	Deficit di Gankyrin	GENEORGENEPRODUCT	53380
28777492	2299	2304	STAT3	GENEORGENEPRODUCT	20848
28777492	2347	2367	interleuchina (IL)-6	GENEORGENEPRODUCT	16193
28777492	2424	2430	cancro	DISEASEORPHENOTYPICFEATURE	D009369
28777492	2495	2499	Bmi1	GENEORGENEPRODUCT	12151
28777492	2534	2579	molecola di adesione delle cellule epiteliali	GENEORGENEPRODUCT	17075
28777492	2614	2619	EpCAM	GENEORGENEPRODUCT	17075
28777492	2701	2711	tumorigeno	DISEASEORPHENOTYPICFEATURE	D009369
28777492	2756	2779	L'infiammazione cronica	DISEASEORPHENOTYPICFEATURE	D007249
28777492	2837	2845	gankyrin	GENEORGENEPRODUCT	5716
28777492	2892	2897	umano	ORGANISMTAXON	9606
28777492	2937	2945	Gankyrin	GENEORGENEPRODUCT	5716
28777492	3005	3011	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28777492	3129	3137	pazienti	ORGANISMTAXON	9606
28777492	3197	3206	sorafenib	CHEMICALENTITY	D000077157
28777492	3255	3257	CC	DISEASEORPHENOTYPICFEATURE	 D006528
28777492	3301	3309	gankyrin	GENEORGENEPRODUCT	53380
28777492	3419	3425	tumore	DISEASEORPHENOTYPICFEATURE	D009369
28777492	3568	3571	HCC	DISEASEORPHENOTYPICFEATURE	D006528
28851297	34	43	Ag-globin	GENEORGENEPRODUCT	3047
28851297	80	85	G->A 	SEQUENCEVARIANT	RS368698783
28851297	155	179	b(0)39 talassemia globin	GENEORGENEPRODUCT	3043
28851297	224	255	produzione di emoglobina fetale	GENEORGENEPRODUCT	3040, 3048
28851297	338	347	g-globina	GENEORGENEPRODUCT	3047,3048
28851297	415	432	emoglobina fetale	GENEORGENEPRODUCT	3040,3048
28851297	470	473	HbF	GENEORGENEPRODUCT	3040,3048
28851297	522	534	b-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	562	570	pazienti	ORGANISMTAXON	9606
28851297	729	732	HbF	GENEORGENEPRODUCT	3040,3048
28851297	777	783	BCL11A	GENEORGENEPRODUCT	53335
28851297	817	820	MYB	GENEORGENEPRODUCT	4602
28851297	947	959	b-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	987	995	pazienti	ORGANISMTAXON	9606
28851297	1134	1137	HbF	GENEORGENEPRODUCT	3040,3048
28851297	1222	1231	Ag-globin	GENEORGENEPRODUCT	3047
28851297	1360	1372	b-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	1400	1408	pazienti	ORGANISMTAXON	9606
28851297	1629	1640	rs368698783	SEQUENCEVARIANT	RS368698783
28851297	1698	1710	b-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	1738	1746	pazienti	ORGANISMTAXON	9606
28851297	1809	1818	Ag-globin	GENEORGENEPRODUCT	3047
28851297	1881	1885	LYAR	GENEORGENEPRODUCT	55646
28851297	1914	1919	umano	ORGANISMTAXON	9606
28851297	1959	1963	topo	ORGANISMTAXON	10090
28851297	1996	2030	Clone reattivo dell'anticorpo Ly-1	GENEORGENEPRODUCT	17089
28851297	2100	2102	Ag	GENEORGENEPRODUCT	3047
28851297	2139	2147	+25 G->A	SEQUENCEVARIANT	RS368698783
28851297	2210	2219	Gg-globin	GENEORGENEPRODUCT	3048
28851297	2283	2296	b(0)39-globin	GENEORGENEPRODUCT	3043
28851297	2353	2372	b(+)IVSI-110-globin	GENEORGENEPRODUCT	3043
28851297	2489	2493	LYAR	GENEORGENEPRODUCT	55646
28851297	2550	2552	Ag	GENEORGENEPRODUCT	3047
28851297	2589	2598	+25 G->LA	SEQUENCEVARIANT	RS368698783
28851297	2648	2657	Gg-globin	GENEORGENEPRODUCT	3048
28851297	2716	2719	HbF	GENEORGENEPRODUCT	3040,3048
28851297	2809	2834	b(0 )39/b(0)39 talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	2862	2870	pazienti	ORGANISMTAXON	9606
28851297	2997	3010	b-thalassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	3045	3054	Gg-globin	GENEORGENEPRODUCT	3048
28851297	3091	3100	Ag-globin	GENEORGENEPRODUCT	3047
28851297	3138	3142	G->A	SEQUENCEVARIANT	RS368698783
28851297	3247	3262	b(0)-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	3332	3357	mutazione b(+)-talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	3523	3538	b(0)-talassemia	DISEASEORPHENOTYPICFEATURE	 D017086
28851297	3566	3574	pazienti	ORGANISMTAXON	9606
28851297	3653	3656	HbF	GENEORGENEPRODUCT	 elevato 3040,3048
28851297	3737	3748	rs368698783	SEQUENCEVARIANT	RS368698783
28851297	3786	3794	+25 G->A	SEQUENCEVARIANT	RS368698783
28851297	3849	3858	Ag-globin	GENEORGENEPRODUCT	3047
28851297	3920	3937	b(0)39 talassemia	DISEASEORPHENOTYPICFEATURE	D017086
28851297	3965	3973	pazienti	ORGANISMTAXON	9606
28851297	4014	4017	HbF	GENEORGENEPRODUCT	3040,3048
28883039	64	69	umano	ORGANISMTAXON	9606
28883039	102	107	BICD2	GENEORGENEPRODUCT	23299
28883039	165	171	dynein	GENEORGENEPRODUCT	1778
28883039	203	211	dynactin	GENEORGENEPRODUCT	1639
28883039	245	256	Bicaudal D2	GENEORGENEPRODUCT	23299
28883039	290	295	BICD2	GENEORGENEPRODUCT	23299
28883039	341	347	dynein	GENEORGENEPRODUCT	 1778
28883039	383	391	dynactin	GENEORGENEPRODUCT	1639
28883039	472	475	DDB	GENEORGENEPRODUCT	1639,1778,23299
28883039	571	576	BICD2	GENEORGENEPRODUCT	23299
28883039	633	641	pazienti	ORGANISMTAXON	9606
28883039	712	737	atrofia muscolare spinale	DISEASEORPHENOTYPICFEATURE	D009134
28883039	928	931	DDB	GENEORGENEPRODUCT	16 39,1778,76895
28883039	966	1013	partner della vescicola della membrana di BICD2	GENEORGENEPRODUCT	76895
28883039	1050	1062	GTPase Rab6a	GENEORGENEPRODUCT	 5870
28883039	1095	1104	Rab6a-GTP	GENEORGENEPRODUCT	5870
28883039	1195	1200	BICD2	GENEORGENEPRODUCT	76895
28883039	1268	1274	dynein	GENEORGENEPRODUCT	1778
28883039	1306	1314	dynactin	GENEORGENEPRODUCT	1639
28883039	1384	1389	BICD2	GENEORGENEPRODUCT	76895
28883039	1487	1490	DDB	GENEORGENEPRODUCT	1639,1778,23299
28883039	1615	1620	BICD2	GENEORGENEPRODUCT	76895
28883039	1770	1773	rat	ORGANISMTAXON	10116
28883039	1828	1833	BICD2	GENEORGENEPRODUCT	76895
28883039	1964	1969	BICD2	GENEORGENEPRODUCT	76895
28883039	2025	2028	DDB	GENEORGENEPRODUCT	1639,1778,23299
28883039	2224	2249	atrofia muscolare spinale	DISEASEORPHENOTYPICFEATURE	D009134
29045486	43	61	Deficit di tiamina	DISEASEORPHENOTYPICFEATURE	D013832
29045486	101	136	fattore inducibile dall'ipossia-1a 	GENEORGENEPRODUCT	15251
29045486	211	216	mouse	ORGANISMTAXON	10090
29045486	267	277	La tiamina	CHEMICALENTITY	D013831
29045486	505	523	carenza di tiamina	DISEASEORPHENOTYPICFEATURE	D013832
29045486	568	570	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	640	656	consumo di alcol	CHEMICALENTITY	D000438
29045486	712	746	funzione mitocondriale compromessa	DISEASEORPHENOTYPICFEATURE	D028361
29045486	810	823	infiammazione	DISEASEORPHENOTYPICFEATURE	D007249
29045486	869	884	eccitotossicità	DISEASEORPHENOTYPICFEATURE	D064420
29045486	1052	1060	pazienti	ORGANISMTAXON	9606
29045486	1108	1115	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
29045486	1160	1168	ischemia	DISEASEORPHENOTYPICFEATURE	D007511
29045486	1214	1216	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	1406	1413	ipossia	DISEASEORPHENOTYPICFEATURE	D000860
29045486	1457	1465	ischemia	DISEASEORPHENOTYPICFEATURE	D007511
29045486	1511	1513	TD	DISEASEORPHENOTYPICFEATURE	 D013832
29045486	1566	1600	Fattore inducibile dall'ipossia-1a	GENEORGENEPRODUCT	15251
29045486	1634	1641	HIF- 1a	GENEORGENEPRODUCT	15251
29045486	1699	1707	ossigeno	CHEMICALENTITY	D010100
29045486	1774	1776	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	1817	1823	HIF-1a	GENEORGENEPRODUCT	15251
29045486	1871	1888	danno neurologico	DISEASEORPHENOTYPICFEATURE	D009422
29045486	2027	2029	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	2069	2075	HIF-1a	GENEORGENEPRODUCT	15251
29045486	2144	2148	topo	ORGANISMTAXON	10090
29045486	2314	2326	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
29045486	2359	2366	HIF -1a	GENEORGENEPRODUCT	15251
29045486	2411	2415	MCP1	GENEORGENEPRODUCT	20296
29045486	2449	2454	BNIP3	GENEORGENEPRODUCT	12176
29045486	2488	2491	Nix	GENEORGENEPRODUCT	12177
29045486	2526	2530	Noxa	GENEORGENEPRODUCT	58801
29045486	2583	2585	TD	DISEASEORPHENOTYPICFEATURE	 D013832
29045486	2687	2689	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	2744	2755	Annessina V	GENEORGENEPRODUCT	11747
29045486	2871	2877	HIF-1a	GENEORGENEPRODUCT	15251
29045486	2922	2925	YC1	GENEORGENEPRODUCT	56878
29045486	2960	2967	tiamina	CHEMICALENTITY	D013831
29045486	3051	3057	HIF-1a	GENEORGENEPRODUCT	15251
29045486	3148	3150	TD	DISEASEORPHENOTYPICFEATURE	D013832
29045486	3231	3237	HIF-1a	GENEORGENEPRODUCT	15251
29045486	3337	3349	infiammatori	DISEASEORPHENOTYPICFEATURE	D007249
29045486	3471	3489	deficit di tiamina	DISEASEORPHENOTYPICFEATURE	D013832
29222418	32	35	HEB	GENEORGENEPRODUCT	21406
29222418	106	141	 Linfociti T gd produttori di IL-17	GENEORGENEPRODUCT	16171
29222418	409	412	HEB	GENEORGENEPRODUCT	21406
29222418	446	472	HeLa E-box binding protein	GENEORGENEPRODUCT	21406
29222418	520	525	Tcf12	GENEORGENEPRODUCT	21406
29222418	634	638	CD73	GENEORGENEPRODUCT	23959
29222418	687	690	HEB	GENEORGENEPRODUCT	21406
29222418	747	751	CD24	GENEORGENEPRODUCT	12484
29222418	785	789	CD73	GENEORGENEPRODUCT	23959
29222418	857	861	Sox4	GENEORGENEPRODUCT	20677
29222418	895	901	 Sox13	GENEORGENEPRODUCT	20668
29222418	936	940	Rorc	GENEORGENEPRODUCT	19885
29222418	1030	1033	HEB	GENEORGENEPRODUCT	21406
29222418	1078	1081	Id3	GENEORGENEPRODUCT	15903
29222418	1115	1118	HEB	GENEORGENEPRODUCT	21406
29222418	1199	1203	CD73	GENEORGENEPRODUCT	23959
29222418	1277	1282	RORgt	GENEORGENEPRODUCT	19885
29222418	1334	1339	IL-17	GENEORGENEPRODUCT	16171
29222418	1417	1421	TCRg	GENEORGENEPRODUCT	110067
29222418	1481	1484	Vg4	GENEORGENEPRODUCT	21638
29222418	1582	1586	IFNg	GENEORGENEPRODUCT	15978
29222418	1622	1625	HEB	GENEORGENEPRODUCT	21406
29222418	1655	1659	topi	ORGANISMTAXON	10090
29222418	1739	1742	HEB	GENEORGENEPRODUCT	21406
29222418	1814	1818	CD73	GENEORGENEPRODUCT	23959
29222418	1855	1859	CD73	GENEORGENEPRODUCT	23959
29222418	1993	1996	HEB	GENEORGENEPRODUCT	21406
